Citrus Sinensis ID: 043526
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 858 | 2.2.26 [Sep-21-2011] | |||||||
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.975 | 0.950 | 0.543 | 0.0 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.972 | 0.978 | 0.522 | 0.0 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.974 | 0.953 | 0.531 | 0.0 | |
| O64483 | 876 | Senescence-induced recept | no | no | 0.970 | 0.950 | 0.522 | 0.0 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.968 | 0.952 | 0.478 | 0.0 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.967 | 0.923 | 0.478 | 0.0 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.974 | 0.939 | 0.466 | 0.0 | |
| C0LGD9 | 871 | Probable LRR receptor-lik | no | no | 0.955 | 0.941 | 0.474 | 0.0 | |
| O81069 | 884 | Probable leucine-rich rep | no | no | 0.948 | 0.920 | 0.470 | 0.0 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.956 | 0.937 | 0.459 | 0.0 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 911 bits (2355), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/846 (54%), Positives = 586/846 (69%), Gaps = 9/846 (1%)
Query: 8 FFYAILLAGFALAFS--VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGIN 65
F I+ A F F V+AQDQSGF+SIDCGIP SSYNDETTD+KY+SD FVE+G
Sbjct: 6 FLSLIIFACFFAVFVLLVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTI 65
Query: 66 KNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPP 125
+I EFQ S+L KQF NVR+FP+G RNCY + P +GKG KY IR FMYGNYD K P
Sbjct: 66 HSIDPEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 126 QFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRN 185
FDLYLG N+WDS+ +DNAT + KEIIH +HV +CLV+ GTPF+SALE+RLL++
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 186 SSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADD 245
++YET S+ L+KR+D G + +RYKDD +DR+W P FPK + SL I S ++
Sbjct: 186 NTYETPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNE 245
Query: 246 SYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNI-SK 304
+ P VM+TA +P + S + F WEPKDPT KY+VYM+FAEV L N+ REF +
Sbjct: 246 GFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLN 305
Query: 305 DGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQS 364
+ +I M P YL++ + + P SG +EF L +T RSTLPPIINA E Y +F QS
Sbjct: 306 EKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQS 365
Query: 365 ETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGL 424
T DVDA+M +K YGVK++W GDPCAP Y W +NCSY N+ PRIIS+NLSSSGL
Sbjct: 366 PTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGL 425
Query: 425 TGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS 484
TGEI SNLTL+ LDLSNNSL+G +P+FL L L LNL+GNK +G IPV+L+E+S
Sbjct: 426 TGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERS 485
Query: 485 KNGSLQLSVGDNEELCSSSSD--SCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKR 542
+ L + N +LC S+S S +K KKN+++IPLVAS V +L + A+A+ KR
Sbjct: 486 NKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYKKR 545
Query: 543 RKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKM 602
+ + G L+ R++ YSEV+K+T+NF +VLG+GGFG VYHG L+D QVAVK+
Sbjct: 546 HRRGGSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND-DQVAVKI 604
Query: 603 LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK 662
LS SS QG+KEF AEV+LL+RVHH+NLT L+GY E M LIYE+MANG L LS EK
Sbjct: 605 LSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEK 664
Query: 663 ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722
+ LSWE RLQI++DAAQGLEYLH GCKPPIV RD+KP NIL+ E L+AK+ADFGLS+
Sbjct: 665 SYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSV 724
Query: 723 PIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN--E 779
+ G + +T VAGT GYLDPEY +T L+EKSD+YSFGVVLLE+++ Q VI R+ E
Sbjct: 725 ALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAE 784
Query: 780 NIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839
NIHI V M++ GDI IVD L F+ SAW+ E+A+ CAS +S RP M+ VV
Sbjct: 785 NIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVA 844
Query: 840 ELKECL 845
ELKE +
Sbjct: 845 ELKESV 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 878 bits (2268), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/856 (52%), Positives = 598/856 (69%), Gaps = 22/856 (2%)
Query: 8 FFYAILLAGFALAF--SVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGIN 65
F Y I A FAL SV AQDQSGFISIDCGIP+ SSY D+TT + Y+SD++FVETG++
Sbjct: 6 FLYLIYSAAFALCLVVSVLAQDQSGFISIDCGIPSGSSYKDDTTGINYVSDSSFVETGVS 65
Query: 66 KNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPP 125
K+I Q +Q N+R+FP+G RNCYTL P +GKG KY IRASFMYGNYD N P
Sbjct: 66 KSIPFTAQ-----RQLQNLRSFPEGSRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSP 120
Query: 126 QFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLL-- 183
+FDL+LG N+WD++ L N +++ KE++++ ++ +CL N G GTPFIS LELR L
Sbjct: 121 EFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGN 180
Query: 184 RNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGA 243
N++Y++ + ++ +R+D S+ +RY DD YDR+W PR F ++++TSLP+ S
Sbjct: 181 DNTTYDSPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIWIPRNFGYCREINTSLPVTSD- 239
Query: 244 DDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVE--VLQDNQLREFN 301
++SY S VMSTA+TPIN + + E DP +Y+VYM+FAEVE L+ NQ REF+
Sbjct: 240 NNSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDLSLKPNQTREFD 299
Query: 302 ISKDGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDF 361
IS +G + P+YL + +T+ + P S + I FSL RT +STLPPI+NA E+Y+ F
Sbjct: 300 ISINGVTVAAGFSPKYLQT-NTFFLNPESQSKIAFSLVRTPKSTLPPIVNALEIYVANSF 358
Query: 362 SQSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSS 421
SQS T D DAV ++K Y VK+NW GDPC P Y W+GLNCSY PPRI SLNLSS
Sbjct: 359 SQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRITSLNLSS 418
Query: 422 SGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELM 481
SGLTG I+ SNLT+IQ LDLSNN L+G++PEFLS+L+FLRVLNL+ N TG +P EL+
Sbjct: 419 SGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTGSVPSELL 478
Query: 482 EKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLK 541
E+S GS L +G+N LC+ SC+K VIPLVAS +L L L+ ++W ++
Sbjct: 479 ERSNTGSFSLRLGENPGLCTEI--SCRKSNSKKLVIPLVASFAALF-ILLLLSGVFWRIR 535
Query: 542 RRKDRAAILNAHGS--LEFENR-HFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQV 598
R++++ S + EN+ FT+++V+K+T+NF +VLGKGGFGTVYHG+ D+ QV
Sbjct: 536 NRRNKSVNSAPQTSPMAKSENKLLFTFADVIKMTNNFGQVLGKGGFGTVYHGFYDN-LQV 594
Query: 599 AVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL 658
AVK+LS +S QGFKEF +EV++L+RVHH NLT L+GYF E + MGLIYE+MANGN+ L
Sbjct: 595 AVKLLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHL 654
Query: 659 SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718
+ + TLSW +RLQIA+DAAQGLEYLH GCKPPIVHRD+K NILL E AKLADFGL
Sbjct: 655 AGKYQHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGL 714
Query: 719 SKVFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777
S+ F +HVST+VAGTPGYLDP F T+ LNEKSD+YSFGVVLLE+IT + VI ++
Sbjct: 715 SRSFHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIKESQ 774
Query: 778 NENIHIIQTVTNMI-AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNE 836
+ +H+ V +++ + D+ N++DS + F++ S W+ VELA+ S+ S+RPNM
Sbjct: 775 TKRVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQNVSDRPNMPH 834
Query: 837 VVTELKECLMMELARK 852
+V L ECL E + K
Sbjct: 835 IVRGLNECLQREESNK 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 869 bits (2246), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/849 (53%), Positives = 577/849 (67%), Gaps = 13/849 (1%)
Query: 3 MSNCIFFYAILLAGFALAFS-VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVE 61
M N F + A F + V AQDQSGF+SIDCGIP SSY DE TD+KYISD FVE
Sbjct: 1 MGNFNFLPLVSFASFVVVLVLVCAQDQSGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVE 60
Query: 62 TGINKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAA 121
+G +I S+FQ L KQF VR+FP+G +NCY + P +GKG KY IR FMYGNYD
Sbjct: 61 SGTIHSIDSKFQKKNLEKQFQKVRSFPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNL 120
Query: 122 NKPPQFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELR 181
K P FDLYLGVNLWDS+ L+N+T + KEII+ + V +CLV+ GTPF+S LELR
Sbjct: 121 GKAPDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELR 180
Query: 182 LLRNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRS 241
LL+N+ YET S S+ LY+R+D G+ + RYKDD +DR W P FP L+TSL I
Sbjct: 181 LLKNNIYETASDSLMLYRRWDLGATGDLPARYKDDIFDRFWMPLMFPNFLILNTSLMIDP 240
Query: 242 GADDSYLPPSAVMSTAITPINGS-HALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREF 300
+ + +LPPS VMSTA+ P+N S + YWEP+DP K+Y+Y++FAEVE L N+ REF
Sbjct: 241 TSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEVEKLPSNETREF 300
Query: 301 NI--SKDGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYME 358
++ +K+ P YL++ + Y P SG +EF L + +ST PPI+NA E Y
Sbjct: 301 SVFLNKEQIDTTSVFRPSYLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETYRT 360
Query: 359 KDFSQSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLN 418
+F T DVDA+M +K Y VK+NW GDPCAP Y W G+NCSY N+PPRIIS+N
Sbjct: 361 NEFLDLPTDQNDVDAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPPRIISVN 420
Query: 419 LSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPV 478
LS SGLTG+I P LT +Q LDLSNN L+G VP+FL+ L L LNL+ NK TG +P
Sbjct: 421 LSFSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPE 480
Query: 479 ELMEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWW 538
+L+E+SK+GSL L VG N +LC S S KK ++ ++IP VAS L F L AL + +W
Sbjct: 481 KLLERSKDGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLAL-ISFW 539
Query: 539 SLKRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQV 598
K+R+ G L+ R++ YSE+++IT+NF +VLG+GGFG VY+G L G QV
Sbjct: 540 QFKKRQQSVKT----GPLD-TKRYYKYSEIVEITNNFERVLGQGGFGKVYYGVL-RGEQV 593
Query: 599 AVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL 658
A+KMLS SS QG+KEF AEV+LL+RVHH+NL L+GY E + M LIYEY+ NG L L
Sbjct: 594 AIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYL 653
Query: 659 SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718
S + +S LSWE RLQI++DAAQGLEYLH GCKPPIVHRD+KP NIL+ E L+AK+ADFGL
Sbjct: 654 SGKNSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGL 713
Query: 719 SKVFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777
S+ F + G + VST VAGT GYLDPE++ +EKSDVYSFGVVLLE+IT Q VI R+
Sbjct: 714 SRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSR 773
Query: 778 N-ENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNE 836
EN HI V+ M++KGDI++IVD L F AW+ E+A+ CAS ++ R M++
Sbjct: 774 TEENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQ 833
Query: 837 VVTELKECL 845
VV ELKE L
Sbjct: 834 VVAELKESL 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 843 bits (2178), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/840 (52%), Positives = 566/840 (67%), Gaps = 7/840 (0%)
Query: 11 AILLAGFALAFS-VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNIS 69
+IL FAL F V AQDQSGFISIDCGIP SSYNDETT +KY+SD+ FV++G K I+
Sbjct: 9 SILFTSFALLFFLVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVDSGTTKRIA 68
Query: 70 SEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDL 129
++FQ S + NVR+FPQ R+CY + GKG KY IR FMYGNYD + P+FDL
Sbjct: 69 AQFQSSGFDRHLLNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDL 128
Query: 130 YLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYE 189
YLGVN WDS+KLD+AT + KEII IP ++V +C+V+ GTPF+S LE+RLL N++YE
Sbjct: 129 YLGVNFWDSVKLDDATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIRLLLNTTYE 188
Query: 190 TVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKK-LSTSLPIRSGADDSYL 248
T ++ L +R DY RYKDD YDR+WTPR K L+TSL + ++ Y
Sbjct: 189 TPYDALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQ 248
Query: 249 PPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQI 308
P S VMSTA T N S L + P DP AK+YVYM+FAE+EVL+ NQ REF+I + +
Sbjct: 249 PASTVMSTAETARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLKSNQTREFSIWLNEDV 308
Query: 309 LMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERS-TLPPIINAFEVYMEKDFSQSETL 367
+ YL + + P SG I FSL + LPPIINA EVY +F Q T
Sbjct: 309 ISPSFKLRYLLTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINALEVYQVNEFLQIPTH 368
Query: 368 HTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDP-PRIISLNLSSSGLTG 426
DVDA+ +K Y VK+NWQGDPC P YSW+G++C N PR++SLN+S S L G
Sbjct: 369 PQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLNISFSELRG 428
Query: 427 EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486
+I P SNLT I+ LDLS N+L+G +P FL+ L L LN++GNK TG +P L E+SKN
Sbjct: 429 QIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQRLHERSKN 488
Query: 487 GSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDR 546
GSL L G N +LC S S S K+K I + ++ LTALA+ + K+++ R
Sbjct: 489 GSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLTALAL-FRRFKKKQQR 547
Query: 547 AAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSS 606
+ +G L+ R+F YSEV+ IT+NF +V+GKGGFG VYHG + +G QVAVK+LS
Sbjct: 548 GTLGERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEE 606
Query: 607 SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTL 666
S QG+KEF AEV LLMRVHH NLT+LVGY E N+M LIYEYMAN NL L+ +++ L
Sbjct: 607 SAQGYKEFRAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAGKRSFIL 666
Query: 667 SWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726
SWE RL+I++DAAQGLEYLH GCKPPIVHRD+KP NILL E L+AK+ADFGLS+ F + G
Sbjct: 667 SWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEG 726
Query: 727 T-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785
+ +STVVAG+ GYLDPEY+ T +NEKSDVYS GVVLLE+IT Q I ++ E +HI
Sbjct: 727 SGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIASSKTEKVHISD 786
Query: 786 TVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
V +++A GDI IVD LR +++ SAW+ E+A+ C TS++RP M++VV ELK+ +
Sbjct: 787 HVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQIV 846
|
Involved in innate immune response of plants. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/854 (47%), Positives = 571/854 (66%), Gaps = 23/854 (2%)
Query: 9 FYAILLAGFALAFSVQAQDQSGFISIDCG-IPAASSYNDETTDLKYISDTTFVETGINKN 67
F L+ + + SVQAQDQ GFIS+DCG +P ++Y ++TT++ Y SD ++++G+
Sbjct: 7 FLLFLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGR 66
Query: 68 ISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQF 127
IS+E++ + L +Q + VR+FP+G RNCY N T S+Y IRA+F YGNYD + P+F
Sbjct: 67 ISAEYK-AQLQQQTWTVRSFPEGERNCYNFNLT--AKSRYLIRATFTYGNYDGLRQVPKF 123
Query: 128 DLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSS 187
D+++G + W S+KLD + E+IH+ T++ + ICLV TG G PFIS+LELR L N++
Sbjct: 124 DIHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNT 183
Query: 188 YETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSY 247
Y T S S+ + R + S T IRY +D +DR+W + K +ST L + + + Y
Sbjct: 184 YLTQSGSLIGFARV-FFSATPTFIRYDEDIHDRVWVRQFGNGLKSISTDLLVDTS--NPY 240
Query: 248 LPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDG- 306
P AV TA P N S L F W + T++ YVYM+FAE++ L+DN +REFNI+ +G
Sbjct: 241 DVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNGG 300
Query: 307 QILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLD--RTERSTLPPIINAFEVYMEKDFSQS 364
Q + ++ PE + + KP S FSL +T STLPP+IN E+Y D +
Sbjct: 301 QNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLEL 360
Query: 365 ETLHTDVDAVMNMKKMYGV--KRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSS 422
ET +V A++N+K Y + K +WQGDPCAPK+Y W+GLNCSY +D PRIISLNL+ +
Sbjct: 361 ETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAEN 420
Query: 423 GLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN-KFTGPIPVELM 481
LTG I P +S LT + LDLS N LSG +PEF + ++ L+++NL GN IP +
Sbjct: 421 KLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNSTIPDSIQ 480
Query: 482 EKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLK 541
++ + SL L + + + + K + K + +IP+VAS + L LA+ + +
Sbjct: 481 QRLDSKSLILILSK----TVTKTVTLKGKSKKVPMIPIVASVAGVFALLVILAIFF--VV 534
Query: 542 RRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVK 601
RRK+ + + S+ + R TY EVLK+T+NF +VLGKGGFGTVYHG L+D TQVAVK
Sbjct: 535 RRKNGESNKGTNPSIITKERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVK 593
Query: 602 MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDE 661
MLS SS QG+KEF+AEV+LL+RVHHRNL LVGY + +N+ LIYEYMANG+LK+ +S +
Sbjct: 594 MLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK 653
Query: 662 K-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720
+ + L+WE R+QIA++AAQGLEYLH GC PP+VHRD+K NILL E AKLADFGLS+
Sbjct: 654 RGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSR 713
Query: 721 VFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE 779
FP+ G +HVSTVVAGTPGYLDPEY+ T+WL+EKSDVYSFGVVLLEI+T+Q V + E
Sbjct: 714 SFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR-E 772
Query: 780 NIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839
HI + V +M+ KGDI++I+D L G ++ AW+ VELA+ C + +S+ RP M VVT
Sbjct: 773 RTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVT 832
Query: 840 ELKECLMMELARKK 853
EL EC+ +E AR++
Sbjct: 833 ELNECVALENARRQ 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/868 (47%), Positives = 562/868 (64%), Gaps = 38/868 (4%)
Query: 12 ILLAGFALAFSVQAQDQSGFISIDCG-IPAASSYNDETTDLKYISDTTFVETGINKNISS 70
I ++ +AL V+AQDQ GFIS+DCG +P YND +T L Y +D FV++G I
Sbjct: 14 IFISFYALLHLVEAQDQKGFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQK 73
Query: 71 EFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLY 130
F+ S K +R FP G RNCYTLN T+ + Y I+A F+YGNYD N PP FDLY
Sbjct: 74 AFE-SIFSKPSLKLRYFPDGFRNCYTLNVTQD--TNYLIKAVFVYGNYDGLNNPPSFDLY 130
Query: 131 LGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYET 190
LG NLW ++ ++ T ++EIIH + +CLV TG +P I+ LELR L+N++Y T
Sbjct: 131 LGPNLWVTVDMNGRTNGTIQEIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNT 190
Query: 191 VSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPR-EFPKTKKLSTSLPIRSGADDSYLP 249
S S+ + RY Y S + Q IRY DD DR W P + + +L+T+L I S + Y P
Sbjct: 191 QSGSLKYFFRY-YFSGSGQNIRYPDDVNDRKWYPFFDAKEWTELTTNLNINS--SNGYAP 247
Query: 250 PSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQIL 309
P VM++A TPI+ F W T ++YVYM+FAE++ L+ REF ++ +G++
Sbjct: 248 PEVVMASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTLNGKLA 307
Query: 310 MEFIVPEYLFSFSTYRVKPYS--GAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETL 367
E P+ L + + + P L +T +STLPP++NA EV+ DF Q ET
Sbjct: 308 YERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFTVIDFPQMETN 367
Query: 368 HTDVDAVMNMKKMYGVKR-NWQGDPCAPKAYSWDGLNCSYKGND-PPRIISLNLSSSGLT 425
DV A+ +++ YG+ + +WQGDPC PK + W+GLNC+ N PP + SLNLSSS LT
Sbjct: 368 PDDVAAIKSIQSTYGLSKISWQGDPCVPKQFLWEGLNCNNLDNSTPPIVTSLNLSSSHLT 427
Query: 426 GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSK 485
G IA + NLT +Q LDLSNN+L+G +PEFL+ ++ L V+NL GN F G IP L++K
Sbjct: 428 GIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNNFNGSIPQILLQKKG 487
Query: 486 -----NGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWW-- 538
G+ L D LC + + + +K N+ VIP+VAS ++ +ALA +
Sbjct: 488 LKLILEGNANLICPDG--LCVNKAGNGGAKKMNV-VIPIVASVAFVVVLGSALAFFFIFK 544
Query: 539 -------------SLKRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFG 585
S + + I ++ ++ +NR FTYSEV+ +T+NF +VLGKGGFG
Sbjct: 545 KKKTSNSQDLGPSSYTQVSEVRTIRSSESAIMTKNRRFTYSEVVTMTNNFERVLGKGGFG 604
Query: 586 TVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645
VYHG +++ QVAVKMLS SS QG+KEF+AEV+LL+RVHH+NL LVGY E N+ LI
Sbjct: 605 MVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLALI 664
Query: 646 YEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704
YEYMANG+L++ +S ++ S L+WE RL+I +++AQGLEYLH GCKPP+VHRD+K NIL
Sbjct: 665 YEYMANGDLREHMSGKRGGSILNWETRLKIVVESAQGLEYLHNGCKPPMVHRDVKTTNIL 724
Query: 705 LTENLEAKLADFGLSKVFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
L E+L AKLADFGLS+ FPI G THVSTVVAGTPGYLDPEY+ T+WLNEKSDVYSFG+VL
Sbjct: 725 LNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVL 784
Query: 764 LEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKC 823
LEIIT+Q VI ++ E HI + V M+ KGDI+NI+D L G ++ S WRAVELA+ C
Sbjct: 785 LEIITNQLVINQSR-EKPHIAEWVGLMLTKGDIQNIMDPKLYGDYDSGSVWRAVELAMSC 843
Query: 824 ASRTSSERPNMNEVVTELKECLMMELAR 851
+ +S+ RP M++VV EL ECL E AR
Sbjct: 844 LNPSSARRPTMSQVVIELNECLSYENAR 871
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 756 bits (1951), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/879 (46%), Positives = 573/879 (65%), Gaps = 43/879 (4%)
Query: 3 MSNCIFFYAILLAGFALAFSVQAQDQSGFISIDCG-IPAASSYNDETTDLKYISDTTFVE 61
M + +F +L+ F + SV+AQ+Q+GFIS+DCG +P ++Y +++T++ Y SD +++
Sbjct: 1 MKSLHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYID 60
Query: 62 TGINKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAA 121
+G+ I+ ++ + +Q + VR+FP G RNCY +N T +KY IR +F+YGNYD
Sbjct: 61 SGLVGKINDAYK-TQFQQQVWAVRSFPVGQRNCYNVNLT--ANNKYLIRGTFVYGNYDGL 117
Query: 122 NKPPQFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELR 181
N+ P FDL++G N W S+K+ T M EIIH+ ++ + +CLV TG TPFIS+LE+R
Sbjct: 118 NQFPSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVR 177
Query: 182 LLRNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRS 241
L N SY T S S+ L+ R + S ++ IRY +D +DR+W +T +ST LPI +
Sbjct: 178 PLNNESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDT 237
Query: 242 GADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFN 301
+SY P +VM TA P N S +W + TA+ YVYM+FAEV+ L N+ REFN
Sbjct: 238 S--NSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFN 295
Query: 302 ISKDGQI-LMEFIVPEYLFSFSTY---RVKPYSGAIIEFSLDRTERSTLPPIINAFEVYM 357
I+ +G + ++ P L S ST R S I F+ T STLPP++NA E+Y
Sbjct: 296 ITYNGGLRWFSYLRPPNL-SISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYT 354
Query: 358 EKDFSQSETLHTDVDAVMNMKKMYGVKR--NWQGDPCAPKAYSWDGLNCSYKGNDPPRII 415
D Q ET +V A+MN+K+ YG+ + +WQGDPCAP+ Y W+GLNCSY ++ RII
Sbjct: 355 VVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRII 414
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG- 474
SLNL+ S LTG I +S LTL+ LDLSNN LSG++P F + ++ L+++NL GN
Sbjct: 415 SLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNL 474
Query: 475 -PIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTAL 533
IP L ++ + SL L +G+N L + KKE K + ++ + AS + L L
Sbjct: 475 TAIPDSLQQRVNSKSLTLILGENLTL------TPKKESKKVPMVAIAASVAGVFALLVIL 528
Query: 534 AMIWWSLKRRKDRA-----------------AILNAHGSLEFENRHFTYSEVLKITDNFN 576
A I++ +KR+ +A +++ S+ R TY EVLK+T+NF
Sbjct: 529 A-IFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFE 587
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF 636
+VLGKGGFGTVYHG L DG +VAVKMLS SS QG+KEF+AEV+LL+RVHHR+L LVGY
Sbjct: 588 RVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYC 646
Query: 637 IEDNNMGLIYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
+ +N+ LIYEYMANG+L++ +S ++ + L+WE R+QIA++AAQGLEYLH GC+PP+VH
Sbjct: 647 DDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVH 706
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKS 754
RD+K NILL E AKLADFGLS+ FPI G HVSTVVAGTPGYLDPEY+ T+WL+EKS
Sbjct: 707 RDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKS 766
Query: 755 DVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814
DVYSFGVVLLEI+T+Q VI + E HI V M+ KGDI++IVD L G ++ AW
Sbjct: 767 DVYSFGVVLLEIVTNQPVIDKTR-ERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAW 825
Query: 815 RAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKK 853
+ VELA+ C + +S+ RP M VV EL +C+ +E AR++
Sbjct: 826 KIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQ 864
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/838 (47%), Positives = 546/838 (65%), Gaps = 18/838 (2%)
Query: 23 VQAQDQSGFISIDCGIPA-ASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQF 81
++AQDQ GFIS+DCG+ A S Y + T L + SD F+++G + I + + + K +
Sbjct: 22 LRAQDQQGFISLDCGLQADESPYTEPLTKLTFTSDADFIKSGKSGKIQNVPGMEYI-KPY 80
Query: 82 YNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKL 141
+R FP G+RNCYTL +G + Y I A F YGNYD N P+FDLYLG N+W ++ L
Sbjct: 81 TVLRYFPDGVRNCYTLIVIQG--TNYLIVAMFTYGNYDNLNTHPKFDLYLGPNIWTTVDL 138
Query: 142 DNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRY 201
EIIHIP + ICLV TG TP ISALELR LRN++Y S S+ R
Sbjct: 139 QRNVNGTRAEIIHIPRSTSLQICLVKTGTTTPLISALELRPLRNNTYIPQSGSLKTLFRV 198
Query: 202 DYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPI 261
+ + + +T+RY +D +DR+W+P P+ + L TSL + + D+ Y P V+ TA TP
Sbjct: 199 -HLTDSKETVRYPEDVHDRLWSPFFMPEWRLLRTSLTVNTSDDNGYDIPEDVVVTAATPA 257
Query: 262 NGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSF 321
N S L W + P Y Y++ AE++ L++N REFNIS + + P+
Sbjct: 258 NVSSPLTISWNLETPDDLVYAYLHVAEIQSLRENDTREFNISAGQDVNYGPVSPDEFLVG 317
Query: 322 STYRVKPYS--GAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKK 379
+ + P G L +T +STLPP++NA E ++ +F QSET DV A+ +++
Sbjct: 318 TLFNTSPVKCEGGTCHLQLIKTPKSTLPPLLNAIEAFITVEFPQSETNANDVLAIKSIET 377
Query: 380 MYGVKR-NWQGDPCAPKAYSWDGLNCSYKG-NDPPRIISLNLSSSGLTGEIAPYLSNLTL 437
YG+ R +WQGDPC P+ WDGL C Y + PPRI SL+LSSS LTG I P + NLT
Sbjct: 378 SYGLSRISWQGDPCVPQQLLWDGLTCEYTNMSTPPRIHSLDLSSSELTGIIVPEIQNLTE 437
Query: 438 IQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNE 497
++ LD SNN+L+G VPEFL++++ L V+NL GN +G +P L+ K KNG L+L++ N
Sbjct: 438 LKKLDFSNNNLTGGVPEFLAKMKSLLVINLSGNNLSGSVPQALLNKVKNG-LKLNIQGNP 496
Query: 498 ELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKD-RAAILNAHGSL 556
LC SSS C K KKN ++P+VAS SL + +A+++ +KRR R + S+
Sbjct: 497 NLCFSSS--CNK-KKNSIMLPVVASLASLAAIIAMIALLFVCIKRRSSSRKGPSPSQQSI 553
Query: 557 EFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA 616
E + +TY+EVL +T F +VLGKGGFG VYHGY++ +VAVK+LS SS QG+KEF+
Sbjct: 554 ETIKKRYTYAEVLAMTKKFERVLGKGGFGMVYHGYINGTEEVAVKLLSPSSAQGYKEFKT 613
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
EV+LL+RV+H NL +LVGY E +++ LIY+YM NG+LK+ S +S +SW RL IA+
Sbjct: 614 EVELLLRVYHTNLVSLVGYCDEKDHLALIYQYMVNGDLKKHFSG--SSIISWVDRLNIAV 671
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVSTVVAG 735
DAA GLEYLHIGCKP IVHRD+K NILL + L+AKLADFGLS+ FPIG +HVST+VAG
Sbjct: 672 DAASGLEYLHIGCKPLIVHRDVKSSNILLDDQLQAKLADFGLSRSFPIGDESHVSTLVAG 731
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795
T GYLD EY+ T+ L+EKSDVYSFGVVLLEIIT++ VI N + HI + V M+ +GD
Sbjct: 732 TFGYLDHEYYQTNRLSEKSDVYSFGVVLLEIITNKPVIDHNRDMP-HIAEWVKLMLTRGD 790
Query: 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKK 853
I NI+D L+G ++ SAW+A+ELA+ C + +S +RPNM+ VV ELKECL+ E R +
Sbjct: 791 ISNIMDPKLQGVYDSGSAWKALELAMTCVNPSSLKRPNMSHVVHELKECLVSENNRTR 848
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81069|Y2899_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g28990 OS=Arabidopsis thaliana GN=At2g28990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/855 (47%), Positives = 550/855 (64%), Gaps = 41/855 (4%)
Query: 23 VQAQDQSGFISIDCGIPA-ASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQF 81
+ AQDQ GFIS+DCG+P+ S Y+D L + SD+TF++TG ++ + I+ L KQ+
Sbjct: 17 IGAQDQEGFISLDCGLPSDESPYDDSFNGLTFTSDSTFIQTGKIDSVDKDLNIN-LSKQY 75
Query: 82 YNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKL 141
+R FP+G RNCY+L+ +G+ Y I SF+YGNYD N+ P FD++LG N W I L
Sbjct: 76 LTLRYFPEGKRNCYSLDVK--RGTTYLIVVSFVYGNYDGLNRDPNFDIHLGPNKWKRIDL 133
Query: 142 DNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRY 201
D +EIIH N + ICLV TG P ISA+E+R LRN++Y T S S+ + R
Sbjct: 134 DGEKEGTREEIIHKARSNSLDICLVKTGETLPIISAIEIRPLRNNTYVTQSGSLMMSFRV 193
Query: 202 DYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPI 261
Y S ++ +IRY DD +DR+W+P ++T L I + ++Y P ++ TA P
Sbjct: 194 -YLSNSDASIRYADDVHDRIWSPFNGSSHTHITTDLNINNS--NAYEIPKNILQTAAIPR 250
Query: 262 NGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSF 321
N S L W+P A+ Y+YM+FAE++ L+ N+ R+F++ G P L F
Sbjct: 251 NASAPLIITWDPLPINAEVYLYMHFAEIQTLEANETRQFDVILRGNFNHSGFSPTKLKVF 310
Query: 322 STYRVKPYS----GAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNM 377
+ Y +P G ++ L +T STLPP+INA E Y +FSQ ET +DVDA+ N+
Sbjct: 311 TLYTEEPMKCGSEGCYLQ--LVKTPNSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNI 368
Query: 378 KKMYGVKR-NWQGDPCAPKAYSWDGLNCSY-KGNDPPRIISLNLSSSGLTGEIAPYLSNL 435
K Y + + WQGDPC P+ SW+ + C+Y G+ P IISL+LS SGL G I L N
Sbjct: 369 KNTYKLNKITWQGDPCLPQDLSWESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNF 428
Query: 436 TLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGD 495
T +Q LDLSNNSL+G VP FL+ ++ L ++NL GN +G +P L++K K G L L +
Sbjct: 429 TQLQELDLSNNSLTGPVPIFLANMKTLSLINLSGNNLSGSVPQALLDKEKEG-LVLKLEG 487
Query: 496 NEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNAHG- 554
N +LC SS C EKKN F++P++ASA SL+ + +A+ RK +A+ N H
Sbjct: 488 NPDLCKSSF--CNTEKKNKFLLPVIASAASLVIVVVVVAL---FFVFRKKKASPSNLHAP 542
Query: 555 ----------------SLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQV 598
S + FTYSEV ++T+NF+K LG+GGFG VYHG+++ QV
Sbjct: 543 PSMPVSNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQV 602
Query: 599 AVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL 658
AVK+LS SS QG+K F+AEV+LLMRVHH NL +LVGY E ++ LIYEYM NG+LKQ L
Sbjct: 603 AVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHL 662
Query: 659 SDEKAS-TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717
S + LSWE RL+I +DAA GLEYLH GC PP+VHRDIK NILL ++L+AKLADFG
Sbjct: 663 SGKHGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFG 722
Query: 718 LSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRN 776
LS+ FPIG +VSTVVAGTPGYLDPEY+ T+WL EKSD+YSFG+VLLEII+++ I++
Sbjct: 723 LSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRP-IIQQ 781
Query: 777 ENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNE 836
E HI++ V+ MI KGD+ +I+D L ++I S W+A+ELA+ C S +S+ RPNM+
Sbjct: 782 SREKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSARRPNMSR 841
Query: 837 VVTELKECLMMELAR 851
VV ELKECL+ E +R
Sbjct: 842 VVNELKECLISETSR 856
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 734 bits (1894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/872 (45%), Positives = 551/872 (63%), Gaps = 51/872 (5%)
Query: 9 FYAILLAGFALAFSVQAQDQSGFISIDCG-IPAASSYNDETTDLKYISDTTFVETGINKN 67
F + L+ FA+ VQAQDQSGFIS+DCG +P +Y +++T++ Y SD T++++G+
Sbjct: 3 FLSFLIFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPGK 62
Query: 68 ISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQF 127
I+ ++ + +Q + +R+FP+G RNCY + T + KY IR +F+YGNYD N+ P F
Sbjct: 63 INEVYR-TQFQQQIWALRSFPEGQRNCYNFSLTAKR--KYLIRGTFIYGNYDGLNQLPSF 119
Query: 128 DLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSS 187
DLY+G N W S+ + + E+IH+ ++H+ ICLV TG TPFIS+LELR L N++
Sbjct: 120 DLYIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNT 179
Query: 188 YETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSY 247
Y T S S+ + R Y S T +RY +D +DR+W P K LST L + + + Y
Sbjct: 180 YVTKSGSLIVVARL-YFSPTPPFLRYDEDVHDRIWIPFLDNKNSLLSTELSVDTS--NFY 236
Query: 248 LPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDG- 306
P V TA P+N + L+ W D T++ Y+YM+FAE+E L+ N+ REFNI+ +G
Sbjct: 237 NVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGG 296
Query: 307 QILMEFIVPEYLFSFSTYRVKPYSG--AIIEFSLDRTERSTLPPIINAFEVYMEKDFSQS 364
+ + P + Y S F+ T ST PP+IN E+Y + Q
Sbjct: 297 ENWFSYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQL 356
Query: 365 ETLHTDVDAVMNMKKMYGVKR--NWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSS 422
+T +V A+MN+K +YG+ + +WQGDPCAP+ Y W+GLNCSY PP+IISLNLS S
Sbjct: 357 DTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLSGS 416
Query: 423 GLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK-FTGPIPVELM 481
L+G I +S LT ++ LDLSNN LSG++P S ++ L ++NL GNK +P L
Sbjct: 417 NLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPETLQ 476
Query: 482 EKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLK 541
++ N SL L D K N V+ + AS S+ L LA+++ +
Sbjct: 477 KRIDNKSLTL-----------IRDETGKNSTN--VVAIAASVASVFAVLVILAIVFVVI- 522
Query: 542 RRKDRAAILNAHGSLEF------------------ENRHFTYSEVLKITDNFNKVLGKGG 583
R+K R A G F + R FTYSEVLK+T NF +VLGKGG
Sbjct: 523 RKKQRTN--EASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERVLGKGG 580
Query: 584 FGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMG 643
FGTVYHG LDD TQVAVKMLS SS QG+KEF+AEV+LL+RVHHR+L LVGY + +N+
Sbjct: 581 FGTVYHGNLDD-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLA 639
Query: 644 LIYEYMANGNLKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPEN 702
LIYEYM G+L++ +S + + + LSWE R+QIA++AAQGLEYLH GC+PP+VHRD+KP N
Sbjct: 640 LIYEYMEKGDLRENMSGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTN 699
Query: 703 ILLTENLEAKLADFGLSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGV 761
ILL E +AKLADFGLS+ FP+ G +HV TVVAGTPGYLDPEY+ T+WL+EKSDVYSFGV
Sbjct: 700 ILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGV 759
Query: 762 VLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAV 821
VLLEI+T+Q V+ +N E HI + V M+ GDI++IVD L ++ W+ VELA+
Sbjct: 760 VLLEIVTNQPVMNKNR-ERPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELAL 818
Query: 822 KCASRTSSERPNMNEVVTELKECLMMELARKK 853
C + +SS RP M VV EL ECL +E+ RK+
Sbjct: 819 ACVNPSSSRRPTMPHVVMELNECLALEIERKQ 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 858 | ||||||
| 255549712 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.986 | 0.957 | 0.553 | 0.0 | |
| 1321686 | 876 | light repressible receptor protein kinas | 0.958 | 0.938 | 0.559 | 0.0 | |
| 255549714 | 915 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.975 | 0.914 | 0.557 | 0.0 | |
| 15233796 | 876 | Leucine-rich repeat transmembrane protei | 0.958 | 0.938 | 0.558 | 0.0 | |
| 449516792 | 877 | PREDICTED: putative leucine-rich repeat | 0.986 | 0.964 | 0.541 | 0.0 | |
| 449463629 | 877 | PREDICTED: putative leucine-rich repeat | 0.986 | 0.964 | 0.536 | 0.0 | |
| 15224738 | 881 | putative receptor-like protein kinase [A | 0.975 | 0.950 | 0.543 | 0.0 | |
| 356522218 | 890 | PREDICTED: putative leucine-rich repeat | 0.973 | 0.938 | 0.540 | 0.0 | |
| 297743150 | 918 | unnamed protein product [Vitis vinifera] | 0.956 | 0.894 | 0.543 | 0.0 | |
| 255549700 | 884 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.961 | 0.933 | 0.550 | 0.0 |
| >gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 939 bits (2426), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/860 (55%), Positives = 613/860 (71%), Gaps = 14/860 (1%)
Query: 2 KMSNCIFFYAILLAGFALAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVE 61
++SN +F + +LA LA V QDQSGFISIDCG+PA SSY D TT L Y+SD F++
Sbjct: 6 RLSNFLFRFLPILA---LAILVHCQDQSGFISIDCGLPANSSYTDATTGLNYVSDAAFID 62
Query: 62 TGINKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAA 121
TGI N++ S++ +Q +VR+FP+G RNCY + T +G+KY IRA F+Y NYD
Sbjct: 63 TGIINNLAPGLNTSSIDRQQLSVRSFPEGDRNCYQVELT--RGTKYLIRAIFLYRNYDGL 120
Query: 122 NKPPQFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELR 181
+K P FDL+LG N W ++K+ NAT + EII+ P N++ +CLVNTGLGTPFISALELR
Sbjct: 121 SKLPHFDLHLGPNKWITVKILNATIPVITEIIYTPILNYIHVCLVNTGLGTPFISALELR 180
Query: 182 LLRNSSYETVSR-SIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIR 240
L+N++YE S ++A + R D+GS+TN+T+RY DD YDR+WTP + K LST I
Sbjct: 181 PLKNTTYEIRSEGALAKFARLDFGSVTNKTVRYPDDVYDRIWTPDHYYKWTDLSTPETID 240
Query: 241 SGADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREF 300
+ + + PPS VMSTA P N S +QF+ + +D + ++Y YM+FAE+ L+ NQ R+F
Sbjct: 241 AQFHNDFQPPSIVMSTANVPTNASEDMQFFIDNEDTSLQFYFYMHFAEIVKLEANQSRQF 300
Query: 301 NISKDGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKD 360
NIS +G I ++P+YL++ S Y P + FSL + STLPP++NA E+Y D
Sbjct: 301 NISLNGTIFFGPVIPDYLYTSSVYNGLPINAGSNVFSLFKIGGSTLPPLLNAIEIYFFVD 360
Query: 361 FSQSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLS 420
SQS+T DVDA+ +K YG+ RNWQGD CAP+AY W GLNCSY NDPP+I SLNLS
Sbjct: 361 LSQSQTDQDDVDAITKIKSTYGITRNWQGDACAPQAYVWQGLNCSYSDNDPPKITSLNLS 420
Query: 421 SSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVEL 480
SSGLTGEI ++NL ++ LDLSNNSLSG VP+FLS++ L+VLNL GNK TG IPV+L
Sbjct: 421 SSGLTGEIVSDIANLKSLEFLDLSNNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRIPVDL 480
Query: 481 MEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSL 540
E+++ GSL LSV N ELC S SCKK++K++ V + + A + ++ + +
Sbjct: 481 FERTQKGSLLLSVSGNPELCPSV--SCKKKEKSIAVPVVASVASVFILAAAVAVILRYRI 538
Query: 541 KRRKDRAAILN-AHGS---LEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGT 596
R +H S +E +N+ FTYSEVLKIT+NF KVLGKGGFGTVY+G L DGT
Sbjct: 539 LRSVSETGETKLSHESNEPMELKNKQFTYSEVLKITNNFEKVLGKGGFGTVYYGTLADGT 598
Query: 597 QVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656
QVAVK+LS SS QG+KEF AEVKLLMRVHHRNLT LVG IE NMGLIYEYMANGNL+
Sbjct: 599 QVAVKILSQSSVQGYKEFLAEVKLLMRVHHRNLTTLVGCCIEGTNMGLIYEYMANGNLED 658
Query: 657 LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716
LS +TLSWE RL+IA++A QGLEYLH GCK PIVHRD+K NILL + +AK++DF
Sbjct: 659 YLSGSNLNTLSWEARLRIALEAGQGLEYLHGGCKLPIVHRDVKTTNILLNDKFQAKISDF 718
Query: 717 GLSKVFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVR 775
GLS++FP GGTHVST+VAGTPGYLDPEY+VT+WL +KSDVYSFGVVLLEIIT + VI +
Sbjct: 719 GLSRIFPADGGTHVSTIVAGTPGYLDPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVIAQ 778
Query: 776 NEN-ENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNM 834
N N EN HI Q V++MI GD+ +I D L G +E+ S W+ VELA++C S TS+ RP M
Sbjct: 779 NRNHENSHISQWVSSMIENGDVNSIADPRLNGEYEVNSVWKIVELAMECLSTTSARRPTM 838
Query: 835 NEVVTELKECLMMELARKKK 854
N+VV EL ECL E+AR ++
Sbjct: 839 NQVVIELNECLKTEMARTRE 858
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1321686|emb|CAA66376.1| light repressible receptor protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2405), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/831 (55%), Positives = 588/831 (70%), Gaps = 9/831 (1%)
Query: 23 VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFY 82
V AQDQSGFISIDCGIP SSY DE T++KY+SD FVE+G + +I S+ Q ++L +QF
Sbjct: 19 VFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSHSIVSDLQTTSLERQFQ 78
Query: 83 NVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKLD 142
NVR+FP+G RNCY + P +GKG KY IR FMYGNYD +K P+FDLY+G NLW+S+ L
Sbjct: 79 NVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVLI 138
Query: 143 NATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRYD 202
N TA+ KEII+ P +H+ +CLV+ GTPF+S LE+R L+N +Y+T ++ L +R+D
Sbjct: 139 NETAIMTKEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLKNDTYDTPYEALMLGRRWD 198
Query: 203 YGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPIN 262
+G+ TN IRYKDD YDR+W P + P K L+TSL I + + P S VM +AI P N
Sbjct: 199 FGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNHNGFRPASIVMRSAIAPGN 258
Query: 263 GSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSFS 322
S+ L+F W P DP +K+Y+YM+FAEV LQ N+ REF+I + IL E P YLF+ +
Sbjct: 259 ESNPLKFNWAPDDPRSKFYIYMHFAEVRELQRNETREFDIYINDVILAENFRPFYLFTDT 318
Query: 323 TYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYG 382
V P + E L RT STLPPIINA E+Y +F Q T DVDA+ +K Y
Sbjct: 319 RSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIKFKYR 378
Query: 383 VKRNWQGDPCAPKAYSWDGLNCSYKGND-PPRIISLNLSSSGLTGEIAPYLSNLTLIQSL 441
VK+NWQGDPC P SW+GL C + N+ PR I+LNLSSSGLTG+I P +NLT I L
Sbjct: 379 VKKNWQGDPCVPVDNSWEGLECLHSDNNTSPRSIALNLSSSGLTGQIDPAFANLTSINKL 438
Query: 442 DLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501
DLSNNSL+G VP+FL+ L L LNL+GNK TG IP +L+EKSK+GSL L G N +LC
Sbjct: 439 DLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQ 498
Query: 502 SSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNA-----HGSL 556
S S +KK +++P+VAS LL LTALA+I W K+R R I N G L
Sbjct: 499 SPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALI-WHFKKRSRRGTISNKPLGVNTGPL 557
Query: 557 EFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA 616
+ R+F YSEV+ IT+NF +VLGKGGFG VYHG+L +G QVAVK+LS S QG+KEF A
Sbjct: 558 DTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRA 616
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
EV+LLMRVHH NLT+L+GY EDN+M LIYEYMANGNL LS + + LSWE RLQI++
Sbjct: 617 EVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGKSSLILSWEERLQISL 676
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVSTVVAG 735
DAAQGLEYLH GCKPPIVHRD+KP NILL ENL+AK+ADFGLS+ FP+ G + VSTVVAG
Sbjct: 677 DAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAG 736
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795
T GYLDPEY+ T +NEKSDVYSFGVVLLE+IT + I + E++H+ V +M+A GD
Sbjct: 737 TIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWHSRTESVHLSDQVGSMLANGD 796
Query: 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846
I+ IVD L FE+ SAW+ ELA+ CAS +S +RP M++VV ELK+ +
Sbjct: 797 IKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSIF 847
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/846 (55%), Positives = 607/846 (71%), Gaps = 9/846 (1%)
Query: 13 LLAGFALAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEF 72
LL+ AL VQAQ QSGFISIDCGI ++Y D TT + Y+SD F++TG +K+I++E+
Sbjct: 40 LLSIIALLAVVQAQAQSGFISIDCGISENATYTDSTTSIDYVSDAAFIDTGKSKSIAAEY 99
Query: 73 QISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLG 132
+ +Q NVR+F +G+RNCY + KG+KY IRA F+YGNYD NK P FDLYLG
Sbjct: 100 TRYNINQQLQNVRSFAEGVRNCYKIGLK--KGAKYLIRAEFLYGNYDGQNKAPIFDLYLG 157
Query: 133 VNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVS 192
+ W+++ N+T + KEIIH+ +++ +CLVNTG GTPF+S LELR +R S+Y T
Sbjct: 158 SSKWETVDTINSTMIITKEIIHLINTSYIDVCLVNTGSGTPFMSKLELRPIRISAYSTSL 217
Query: 193 RSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSA 252
S+A + R D GS TN+T+RY DD YDR+WTP F K ++STS I + A + Y PPS
Sbjct: 218 GSLARFSRSDVGSTTNRTLRYADDVYDRIWTPNHFFKWAEISTSETIDALAQNDYRPPSI 277
Query: 253 VMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEF 312
VM TA P N + + + +D T ++ VYM+FAE+ L+ N+ R+FNIS +G+
Sbjct: 278 VMRTAGIPANDNEPMTVSIDFEDTTFRFLVYMHFAEILKLEANESRQFNISLNGEHWFGP 337
Query: 313 IVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVD 372
+ P+YL++ + + SG EFS+ +TE STLPP++NA E+Y D SQ ++ DVD
Sbjct: 338 LRPDYLYTTTVFSPTVLSGGQYEFSIYKTENSTLPPLLNAIEIYYILDLSQPQSNQEDVD 397
Query: 373 AVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYL 432
A+ N+K YG+KRNWQGDPCAP+AY W+GLNCSY GN PRIISLNLSSSGLTGEI +
Sbjct: 398 AITNIKSSYGIKRNWQGDPCAPQAYLWEGLNCSYSGNVMPRIISLNLSSSGLTGEIPSSI 457
Query: 433 SNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLS 492
S+LT ++SLDLSNN L+G+VP+FLS+L L VL L GN+ +G +P L+EKS+ L LS
Sbjct: 458 SSLTSLESLDLSNNYLTGSVPDFLSQLPSLNVLILTGNRLSGSVPPSLVEKSEQNLLVLS 517
Query: 493 VGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDR---AAI 549
VG N LC S SCK EKKN V+P+VAS +L ++ALA I ++ KRRK +
Sbjct: 518 VGGNANLCLKS--SCKNEKKNNVVVPVVASIAGVLIIISALAAILYTRKRRKQQEEDTKT 575
Query: 550 LNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ 609
N +G LE + R FTYSE+L IT+NF +VLGKGGFGTVYHGYLDD TQVAVK+LS S Q
Sbjct: 576 SNIYGPLESKERQFTYSEILNITNNFERVLGKGGFGTVYHGYLDD-TQVAVKILSPLSAQ 634
Query: 610 GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWE 669
G+KEF AEVKLL+RVHHRNLT+LVG+ E MGLIYEYMANG+L+ LLS L WE
Sbjct: 635 GYKEFHAEVKLLLRVHHRNLTSLVGFCNEGTKMGLIYEYMANGDLEHLLSGRNRHVLKWE 694
Query: 670 RRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTH 728
RRL IA++AA+GLEYLH GCKPPIVHRDIK NILL + +A+LADFGLSK FP+ GGTH
Sbjct: 695 RRLDIAVEAAKGLEYLHNGCKPPIVHRDIKTANILLNDQFQARLADFGLSKSFPVEGGTH 754
Query: 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788
VSTVVAGTPGYLDPEY +T+WL EKSDVYSFGVVLL+IIT + VI + +IHI V+
Sbjct: 755 VSTVVAGTPGYLDPEYSMTNWLTEKSDVYSFGVVLLKIITGRPVIAVIDERSIHISHWVS 814
Query: 789 NMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848
+++A GDI+ ++D CL G F+I S W+AVE+A+ C S TS+ RP MN+VV EL E L E
Sbjct: 815 SLVANGDIKTVIDPCLGGDFDINSVWKAVEVAMACTSPTSAGRPTMNQVVRELIESLAEE 874
Query: 849 LARKKK 854
AR ++
Sbjct: 875 TARAEE 880
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233796|ref|NP_194728.1| Leucine-rich repeat transmembrane protein kinase protein [Arabidopsis thaliana] gi|4938475|emb|CAB43834.1| serine/threonine-specific receptor protein kinase LRRPK [Arabidopsis thaliana] gi|7269899|emb|CAB80992.1| serine/threonine-specific receptor protein kinase LRRPK [Arabidopsis thaliana] gi|332660305|gb|AEE85705.1| Leucine-rich repeat transmembrane protein kinase protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2401), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/831 (55%), Positives = 588/831 (70%), Gaps = 9/831 (1%)
Query: 23 VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFY 82
V AQDQSGFISIDCGIP SSY DE T++KY+SD FVE+G + +I S+ Q ++L +QF
Sbjct: 19 VFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSHSIVSDLQTTSLERQFQ 78
Query: 83 NVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKLD 142
NVR+FP+G RNCY + P +GKG KY IR FMYGNYD +K P+FDLY+G NLW+S+ L
Sbjct: 79 NVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVLI 138
Query: 143 NATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRYD 202
N TA+ KEII+ P +H+ +CLV+ GTPF+S LE+R L+N +Y+T ++ L +R+D
Sbjct: 139 NETAIMTKEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLKNDTYDTPYEALMLGRRWD 198
Query: 203 YGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPIN 262
+G+ TN IRYKDD YDR+W P + P K L+TSL I + + P S VM +AI P N
Sbjct: 199 FGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNHNGFRPASIVMRSAIAPGN 258
Query: 263 GSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSFS 322
S+ L+F W P DP +K+Y+YM+FAEV LQ N+ REF+I + IL E P YLF+ +
Sbjct: 259 ESNPLKFNWAPDDPRSKFYIYMHFAEVRELQRNETREFDIYINDVILAENFRPFYLFTDT 318
Query: 323 TYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYG 382
V P + E L RT STLPPIINA E+Y +F Q T DVDA+ +K Y
Sbjct: 319 RSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIKFKYR 378
Query: 383 VKRNWQGDPCAPKAYSWDGLNCSYKGND-PPRIISLNLSSSGLTGEIAPYLSNLTLIQSL 441
VK+NWQGDPC P SW+GL C + N+ P+ I+LNLSSSGLTG+I P +NLT I L
Sbjct: 379 VKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKL 438
Query: 442 DLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501
DLSNNSL+G VP+FL+ L L LNL+GNK TG IP +L+EKSK+GSL L G N +LC
Sbjct: 439 DLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQ 498
Query: 502 SSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNA-----HGSL 556
S S +KK +++P+VAS LL LTALA+I W K+R R I N G L
Sbjct: 499 SPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALI-WHFKKRSRRGTISNKPLGVNTGPL 557
Query: 557 EFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA 616
+ R+F YSEV+ IT+NF +VLGKGGFG VYHG+L +G QVAVK+LS S QG+KEF A
Sbjct: 558 DTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRA 616
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
EV+LLMRVHH NLT+L+GY EDN+M LIYEYMANGNL LS + + LSWE RLQI++
Sbjct: 617 EVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGKSSLILSWEERLQISL 676
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVSTVVAG 735
DAAQGLEYLH GCKPPIVHRD+KP NILL ENL+AK+ADFGLS+ FP+ G + VSTVVAG
Sbjct: 677 DAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAG 736
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795
T GYLDPEY+ T +NEKSDVYSFGVVLLE+IT + I + E++H+ V +M+A GD
Sbjct: 737 TIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWHSRTESVHLSDQVGSMLANGD 796
Query: 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846
I+ IVD L FE+ SAW+ ELA+ CAS +S +RP M++VV ELK+ +
Sbjct: 797 IKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSIF 847
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449516792|ref|XP_004165430.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2392), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/857 (54%), Positives = 611/857 (71%), Gaps = 11/857 (1%)
Query: 3 MSNCIFFYAILLAGFALAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVET 62
M +F + A++F V AQDQSGFISIDCGI SSY D T++KYISD F ET
Sbjct: 1 MEQIKYFLLQIFVVLAISFLVSAQDQSGFISIDCGISGNSSYKDSVTNIKYISDVNFTET 60
Query: 63 GINKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAAN 122
GI+K+ISS+F +TLP+QF+ VR+FP+G RNCYT+ +GKG KY IRASFMYG+YD
Sbjct: 61 GISKSISSDFNTTTLPQQFWYVRSFPEGERNCYTIKLAQGKGFKYLIRASFMYGSYDGQG 120
Query: 123 KPPQFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRL 182
P FDLY+GVN W ++ + N + + +KE++H+ + + ICLVNTG G+PFISALELRL
Sbjct: 121 TAPVFDLYMGVNKWGTVVMGNESNIIIKEVVHVLPTSSICICLVNTGFGSPFISALELRL 180
Query: 183 LRNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSG 242
L+N+SY T +AL++R D GS N+T+RY DD DR+W P F K ++TS + SG
Sbjct: 181 LKNASYVTDFDLLALHRRLDVGSTINRTVRYNDDISDRIWVPYNFLNYKIMNTSSTVDSG 240
Query: 243 ADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNI 302
+SY P VMSTAIT N S L+F+W P+DP+A+Y+++++FA++E LQ NQLREFNI
Sbjct: 241 GSNSYNLPGIVMSTAITTYNASDPLEFHWVPEDPSARYHIFLHFADLEKLQANQLREFNI 300
Query: 303 SKDGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFS 362
++G P+YL S + P SG I FSL +T S LPPI+NA EVY+ D
Sbjct: 301 YQNGNYFHGPFSPDYLQSTTLSSTSPMSGENIAFSLLKTNASNLPPILNALEVYLVLDTL 360
Query: 363 QSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSS 422
QS T D+ A+MN+K YGV++NWQGDPC PK++ WDGL CSY P RI +LNLSSS
Sbjct: 361 QSRTDEQDITALMNIKSFYGVRKNWQGDPCQPKSFLWDGLICSYDDQIPNRITTLNLSSS 420
Query: 423 GLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELME 482
GL GEI Y+S LT +Q LDLSNN+LSG VP+ LS+LQ L+VL+L+ N G IP ELME
Sbjct: 421 GLVGEITTYVSELTTLQYLDLSNNNLSGPVPDSLSKLQSLKVLDLRDNPLLGSIPSELME 480
Query: 483 KSKNGSLQLSV--GDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSL 540
+SKNGSL + V G N +LC+SSS KK+ + ++ +V+S + LL + L ++W
Sbjct: 481 RSKNGSLSIRVGAGGNTDLCASSSCPKKKKSYVIMIVAIVSSFLVLLAATSVLIILW--- 537
Query: 541 KRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAV 600
R++ R + G+LE + + +YSE+ +IT+NF + +G+GGF V+ G LDDG QVAV
Sbjct: 538 -RKRARKQPVIRLGTLEEKKQQLSYSEIRRITNNFERQIGEGGFAKVFLGNLDDG-QVAV 595
Query: 601 KMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD 660
K+L SS QG+KEFEAEVKLL+R+HHRNLT+LVGY + N+ LIYEY+ NGNLK+ LS
Sbjct: 596 KVLKSSV-QGYKEFEAEVKLLLRIHHRNLTSLVGYCCQKTNLVLIYEYINNGNLKEHLSG 654
Query: 661 EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720
KAS LSWE R+Q+A+++AQGLEYLH GC+PPIVHRD+K NILL E +AK+ADFGLSK
Sbjct: 655 SKASVLSWEERMQVAVNSAQGLEYLHHGCRPPIVHRDVKSANILLNERFQAKIADFGLSK 714
Query: 721 VFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV--RNE 777
FP TH++TVVAGT GYLDPEY+ T WL EKSDVYSFGV++LEI+TS+ V++ R
Sbjct: 715 SFPTESRTHMTTVVAGTDGYLDPEYYATGWLTEKSDVYSFGVLVLEIVTSRPVLMIDRAS 774
Query: 778 NENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
++ HI Q V ++ GDI +IVD +R F++ SAW+AVE+A+KC S S +RPNM EV
Sbjct: 775 SQKYHISQWVMQLMKIGDIRSIVDQKVRENFDLSSAWKAVEIAMKCLSLNSIDRPNMKEV 834
Query: 838 VTELKECLMMELARKKK 854
V+EL ECL +E ARK+K
Sbjct: 835 VSELSECLALEKARKRK 851
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463629|ref|XP_004149534.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2378), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/857 (53%), Positives = 610/857 (71%), Gaps = 11/857 (1%)
Query: 3 MSNCIFFYAILLAGFALAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVET 62
M +F + A++F V AQDQSGFISIDCGI SSY D T++KYISD F ET
Sbjct: 1 MEQIKYFLLQIFVVLAISFLVSAQDQSGFISIDCGISGNSSYKDSVTNIKYISDVNFTET 60
Query: 63 GINKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAAN 122
GI+K+ISS+F +TLP+QF+ VR+FP+G RNCYT+ +GKG KY IRASFMYG+YD
Sbjct: 61 GISKSISSDFNTTTLPQQFWYVRSFPEGERNCYTIKLAQGKGFKYLIRASFMYGSYDGQG 120
Query: 123 KPPQFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRL 182
P FDLY+GVN W ++ + N + + +KE++H+ + + ICLVNTG G+PFISALELRL
Sbjct: 121 TAPVFDLYMGVNKWGTVVMGNESNIIIKEVVHVLPTSSICICLVNTGFGSPFISALELRL 180
Query: 183 LRNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSG 242
L+N+SY T +AL++R D GS N+T+RY DD DR+W P F K ++TS + SG
Sbjct: 181 LKNASYVTDFDLLALHRRLDVGSTINRTVRYNDDISDRIWVPYNFLNYKIMNTSSTVDSG 240
Query: 243 ADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNI 302
+SY P VMSTAIT N S L+F+W P+DP+A+Y+++++FA++E LQ NQLREFNI
Sbjct: 241 GSNSYNLPGIVMSTAITTYNASDPLEFHWVPEDPSARYHIFLHFADLEKLQANQLREFNI 300
Query: 303 SKDGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFS 362
++G P+YL S + P SG I FSL +T S LPPI+NA E+Y+ D
Sbjct: 301 YQNGNYFHGPFSPDYLQSTTLSSTSPMSGENIAFSLLKTNASNLPPILNALEIYLVLDTL 360
Query: 363 QSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSS 422
QS T D+ A+MN+K YGV++NWQGDPC PK++ WDGL CSY P RI +LNLSSS
Sbjct: 361 QSRTDEQDITALMNIKSFYGVRKNWQGDPCQPKSFLWDGLICSYDDQIPNRITTLNLSSS 420
Query: 423 GLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELME 482
GL GEI Y+S LT +Q LDLSNN+LSG VP+ LS+LQ L+VL+L+ N G IP EL+E
Sbjct: 421 GLVGEITTYVSELTTLQYLDLSNNNLSGPVPDSLSKLQSLKVLDLRDNPLLGSIPSELVE 480
Query: 483 KSKNGSLQLSV--GDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSL 540
+SKNGSL + V G N +LC+SSS KK+ + ++ +V+S + LL + L ++W
Sbjct: 481 RSKNGSLSIRVGAGGNTDLCASSSCPKKKKSYVIMIVAIVSSFLVLLAATSVLIILW--- 537
Query: 541 KRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAV 600
R++ R + G+LE + + +YSE+ +IT+NF + +G+GGF V+ G LDD +QVAV
Sbjct: 538 -RKRARKQPVIRLGTLEEKKQQLSYSEIRRITNNFERQIGEGGFAKVFLGNLDD-SQVAV 595
Query: 601 KMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD 660
K+L SS QG+KEFEAEVKLL+R+HHRNLT+LVGY + N+ LIYEY+ NGNLK+ LS
Sbjct: 596 KVLKSSV-QGYKEFEAEVKLLLRIHHRNLTSLVGYCCQKTNLVLIYEYINNGNLKEHLSG 654
Query: 661 EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720
K S LSWE R+Q+A+++AQGLEYLH GC+PPIVHRD+K NILL E +AK+ADFGLSK
Sbjct: 655 SKGSVLSWEERMQVAVNSAQGLEYLHHGCRPPIVHRDVKSANILLNERFQAKIADFGLSK 714
Query: 721 VFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV--RNE 777
FP TH++TVVAGT GYLDPEY+ T WL EKSDVYSFGV++LEI+TS+ V++ R
Sbjct: 715 SFPTESRTHMTTVVAGTDGYLDPEYYATGWLTEKSDVYSFGVLVLEIVTSRPVLMIDRAS 774
Query: 778 NENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
++ HI Q V ++ GDI +IVD +R F++ SAW+AVE+A+KC S S +RPNM EV
Sbjct: 775 SQKYHISQWVMQLMKIGDIRSIVDQKVRENFDLSSAWKAVEIAMKCLSLNSIDRPNMKEV 834
Query: 838 VTELKECLMMELARKKK 854
V+EL ECL +E ARK+K
Sbjct: 835 VSELSECLALEKARKRK 851
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15224738|ref|NP_179511.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|75318617|sp|O65924.1|Y2921_ARATH RecName: Full=Putative leucine-rich repeat receptor-like protein kinase At2g19210; Flags: Precursor gi|3135251|gb|AAC16451.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|20196929|gb|AAM14837.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|330251763|gb|AEC06857.1| putative receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2355), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/846 (54%), Positives = 586/846 (69%), Gaps = 9/846 (1%)
Query: 8 FFYAILLAGFALAFS--VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGIN 65
F I+ A F F V+AQDQSGF+SIDCGIP SSYNDETTD+KY+SD FVE+G
Sbjct: 6 FLSLIIFACFFAVFVLLVRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTI 65
Query: 66 KNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPP 125
+I EFQ S+L KQF NVR+FP+G RNCY + P +GKG KY IR FMYGNYD K P
Sbjct: 66 HSIDPEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 126 QFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRN 185
FDLYLG N+WDS+ +DNAT + KEIIH +HV +CLV+ GTPF+SALE+RLL++
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 186 SSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADD 245
++YET S+ L+KR+D G + +RYKDD +DR+W P FPK + SL I S ++
Sbjct: 186 NTYETPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNE 245
Query: 246 SYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNI-SK 304
+ P VM+TA +P + S + F WEPKDPT KY+VYM+FAEV L N+ REF +
Sbjct: 246 GFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLN 305
Query: 305 DGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQS 364
+ +I M P YL++ + + P SG +EF L +T RSTLPPIINA E Y +F QS
Sbjct: 306 EKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQS 365
Query: 365 ETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGL 424
T DVDA+M +K YGVK++W GDPCAP Y W +NCSY N+ PRIIS+NLSSSGL
Sbjct: 366 PTDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGL 425
Query: 425 TGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS 484
TGEI SNLTL+ LDLSNNSL+G +P+FL L L LNL+GNK +G IPV+L+E+S
Sbjct: 426 TGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERS 485
Query: 485 KNGSLQLSVGDNEELCSSSSD--SCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKR 542
+ L + N +LC S+S S +K KKN+++IPLVAS V +L + A+A+ KR
Sbjct: 486 NKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYKKR 545
Query: 543 RKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKM 602
+ + G L+ R++ YSEV+K+T+NF +VLG+GGFG VYHG L+D QVAVK+
Sbjct: 546 HRRGGSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND-DQVAVKI 604
Query: 603 LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK 662
LS SS QG+KEF AEV+LL+RVHH+NLT L+GY E M LIYE+MANG L LS EK
Sbjct: 605 LSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEK 664
Query: 663 ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722
+ LSWE RLQI++DAAQGLEYLH GCKPPIV RD+KP NIL+ E L+AK+ADFGLS+
Sbjct: 665 SYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSV 724
Query: 723 PIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN--E 779
+ G + +T VAGT GYLDPEY +T L+EKSD+YSFGVVLLE+++ Q VI R+ E
Sbjct: 725 ALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAE 784
Query: 780 NIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839
NIHI V M++ GDI IVD L F+ SAW+ E+A+ CAS +S RP M+ VV
Sbjct: 785 NIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVA 844
Query: 840 ELKECL 845
ELKE +
Sbjct: 845 ELKESV 850
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522218|ref|XP_003529744.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/866 (54%), Positives = 600/866 (69%), Gaps = 31/866 (3%)
Query: 8 FFYAILLAGFALAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKN 67
F YA+ A+ VQAQDQSGF SIDCG+P ASSYN++TT + YISD F++ G++K+
Sbjct: 7 FLYALFGVLTAVVL-VQAQDQSGFTSIDCGLPEASSYNEKTTGIFYISDAKFIDAGVSKS 65
Query: 68 ISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQF 127
IS Q ST +Q VR+FP G RNCY +N T G+KY IRA+F YGNYD N+PPQF
Sbjct: 66 ISPA-QKSTHLQQLAYVRSFPSGERNCYRINVT--SGTKYLIRATFFYGNYDGLNQPPQF 122
Query: 128 DLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSS 187
DL+LG N+WD++ NA+ E+ EIIH P+ +++ CLVNTG GTPFISA+ELR L N+
Sbjct: 123 DLHLGANIWDTVNFPNASLSEISEIIHTPSLDYIQPCLVNTGKGTPFISAIELRTLNNAF 182
Query: 188 YETVS-RSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDS 246
Y T S S+A Y+RYD GSITN RY D YDR+W P + +LS++L + +
Sbjct: 183 YVTASAESLAYYQRYDLGSITNLGYRYNYDVYDRIWVPHGLNQWTQLSSTLHLLDIFQND 242
Query: 247 YLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDG 306
Y P VMSTA TPIN S QFYW P + K+Y+YM+F+EVE+L +N+ R FNI +G
Sbjct: 243 YKLPEVVMSTAATPINASAPFQFYWGPDNVDDKFYIYMHFSEVEILAENETRTFNIFMNG 302
Query: 307 QILMEFIVPEYLFSFSTYRVKPYSGAI-IEFSLDRTERSTLPPIINAFEVYMEKDFSQSE 365
++ + P YL + + Y +GA FSL +T STLPPIINA E+Y DF QSE
Sbjct: 303 KLFYGPLTPGYLTTNTIYAKSALTGATRYLFSLAKTGTSTLPPIINAMEIYKVIDFPQSE 362
Query: 366 TLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLT 425
T DVDA+ N+K YGV RNWQGDPC P AY W+GLNCSY ++ PRI SLNLSSSGLT
Sbjct: 363 TEQDDVDAITNIKNAYGVDRNWQGDPCGPVAYIWEGLNCSY--DNTPRITSLNLSSSGLT 420
Query: 426 GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSK 485
G+I+ ++S LT++Q LDLSNNSLSG++P+FL++LQ L+VLNL N TGP+P L+E+SK
Sbjct: 421 GQISSFISELTMLQYLDLSNNSLSGSLPDFLTQLQSLKVLNLVNNNLTGPVPGGLVERSK 480
Query: 486 NGSLQLSVGDNEELCSSSSDSCKKEKKN-------------MFVIPLVASAVSLL-FFLT 531
GSL LS+G N LC SD C ++ N VIP S +L +
Sbjct: 481 EGSLSLSLGQNPNLC--ESDPCIQQSNNKQPDAANQNKNKNNIVIPAATSVAGILVLVII 538
Query: 532 ALAMIWWSLKRRKDRAAILNAHGSLEF--ENRHFTYSEVLKITDNFNKVLGKGGFGTVYH 589
+ I LK+RK + N +F + R ++++E++KITD+F ++LG+G FG VYH
Sbjct: 539 VVTAIICGLKKRKPQGKATNTPSGSQFASKQRQYSFNELVKITDDFTRILGRGAFGKVYH 598
Query: 590 GYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649
G +DD TQVAVKMLS S+ +G+++F AEVKLLMRVHHRNLT+LVGY E+NNMGLIYEYM
Sbjct: 599 GIIDD-TQVAVKMLSPSAVRGYEQFLAEVKLLMRVHHRNLTSLVGYCNEENNMGLIYEYM 657
Query: 650 ANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE 707
ANGNL ++LS + +A L+WE RLQIA+DAAQGLEYLH GCKPPI+HRD+K NILL E
Sbjct: 658 ANGNLDEILSGKSSRAKFLTWEDRLQIALDAAQGLEYLHNGCKPPIIHRDVKCANILLNE 717
Query: 708 NLEAKLADFGLSKVFPI-GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEI 766
N +AKLADFGLSK FP GG+++STVVAGTPGYLDPEY ++ L EKSDVYSFGVVLLE+
Sbjct: 718 NFQAKLADFGLSKSFPTDGGSYMSTVVAGTPGYLDPEYSISSRLTEKSDVYSFGVVLLEM 777
Query: 767 ITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASR 826
+T + I + E HI Q V M+ GDI+NI DS L+ F+ S WR VE+ + S
Sbjct: 778 VTGKPAIAKTP-EKTHISQWVKFMLPNGDIKNIADSRLQEDFDTSSVWRVVEIGMASVSI 836
Query: 827 TSSERPNMNEVVTELKECLMMELARK 852
+ +RP+M+ +V ELKECL ELARK
Sbjct: 837 SPVKRPSMSNIVNELKECLTTELARK 862
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743150|emb|CBI36017.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/835 (54%), Positives = 588/835 (70%), Gaps = 14/835 (1%)
Query: 27 DQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFYNVRT 86
D +G I+IDCG+P Y D T L+Y SD +F+ +GINKNISS+F +TL K NVR+
Sbjct: 59 DIAGSINIDCGLPEDCKYIDAETGLQYTSDASFIRSGINKNISSKFSSTTLHKSLTNVRS 118
Query: 87 FPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKLDNATA 146
FPQG RNCYTL P EG G+ Y IRASFMYGNYD N+ PQFDLY+GVN+WDS+KLDNA+
Sbjct: 119 FPQGKRNCYTLRPPEGHGTMYLIRASFMYGNYDELNQVPQFDLYIGVNMWDSVKLDNASH 178
Query: 147 MEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRYDYGSI 206
+ MKEI+H P+++ + +CLVN G G PFIS+LE+R +SSY+T S S+ALY+R D GS
Sbjct: 179 LVMKEILHAPSDDDIYVCLVNIGYGEPFISSLEVRHFHDSSYKTESGSLALYRRLDAGST 238
Query: 207 TNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPINGSHA 266
TN+ +R+KDDAYDR+W P P + L+T++PI S A+ Y PS VM+TAI P+N S +
Sbjct: 239 TNEIVRFKDDAYDRIWFPYNLPDCESLNTTVPIDSHAETEYKLPSKVMTTAIRPMNSSAS 298
Query: 267 LQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEF-IVPEYLFSFSTYR 325
L F ++ D T ++YVYM+FAE+E LQ+NQ R F+I+ +G E IVP+YL S +
Sbjct: 299 LDFDFDIGDSTLEFYVYMHFAELEGLQENQTRNFSITLNGNPWGEANIVPKYLHSRTVNN 358
Query: 326 VKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYGVKR 385
+P G+ ++FS+ +T S+LPPI+NA E+YM K Q+ T DV+ + +K Y V++
Sbjct: 359 KQPVRGSKLKFSIYKTLNSSLPPILNAMEIYMVKGLLQAPTCQEDVNGISRIKSFYLVEK 418
Query: 386 NWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSN 445
NWQGDPCAP WDGL CS G + PRIISL LSSSGL G I+P L NLT +Q LDLSN
Sbjct: 419 NWQGDPCAP-VQPWDGLTCSNNGYESPRIISLKLSSSGLRGTISPSLLNLTALQFLDLSN 477
Query: 446 NSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSD 505
NSL+G +PEFLSRL FL LN+ GNK +G +P +L+ +S+ GSL LSV +N +LC S+
Sbjct: 478 NSLTGELPEFLSRLSFLTALNVTGNKLSGSVPPDLIARSEKGSLSLSVANNPDLCPSA-- 535
Query: 506 SCKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAIL----NAHGSLEFENR 561
CK+ K + V P+VA+ VS L + +I WSLKRRK L SL+ EN+
Sbjct: 536 QCKENKNS--VGPIVAAVVSSLVIIFLALVIIWSLKRRKKATKSLVRSPEETWSLKMENQ 593
Query: 562 HFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLL 621
F Y E++ IT++F VLG GGFGTVYHG + +GTQVA+KMLS SS QG KEF E +LL
Sbjct: 594 RFRYLEIVSITNDFQTVLGTGGFGTVYHGCMLNGTQVAIKMLSQSSKQGMKEFRNEARLL 653
Query: 622 MRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS--DEKASTLSWERRLQIAMDAA 679
MRVHHRNL +LVGY E NMGLIYEYMA GNL+ LS D S LSW RLQIA+DAA
Sbjct: 654 MRVHHRNLASLVGYCHEGTNMGLIYEYMAGGNLQNYLSGADISTSPLSWIERLQIAVDAA 713
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVSTVVAGTPG 738
QGLEY+H GCKPPI+HRD+K NILL+E L+AK+ADFG S+ F I TH +T V GT G
Sbjct: 714 QGLEYMHCGCKPPIIHRDVKTANILLSEKLQAKIADFGFSRFFSIESETHATTAVVGTIG 773
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798
Y+DPEY++++ L EKSDVYSFG+VLLE+IT + I+++E +NIHI+Q V + + +GDI +
Sbjct: 774 YIDPEYYISNRLTEKSDVYSFGIVLLELITGKPAIIKDE-DNIHIVQWVRSFVERGDIGS 832
Query: 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKK 853
IVD L+G S WR +E A+ C S +R M+ VV +LKECL E A +
Sbjct: 833 IVDPRLQGNLNTNSVWRVLETAMACLPPISIQRVTMSHVVMQLKECLEEEKAHDQ 887
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/843 (55%), Positives = 594/843 (70%), Gaps = 18/843 (2%)
Query: 22 SVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQF 81
+V AQDQSGFISIDCG+PA SSY DETT L YISD +F++ GI I+ + ++ +Q
Sbjct: 22 AVYAQDQSGFISIDCGLPANSSYTDETTSLNYISDASFIDVGIITTITPKVTTNSTDRQQ 81
Query: 82 YNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKL 141
+VR+FP+G RNC+ N K +KY IRA F +G+YD +N+ P+FDL+LG N W ++K+
Sbjct: 82 LSVRSFPEGDRNCF--NVELAKNTKYLIRAIFAHGDYDGSNELPEFDLHLGPNKWVTVKI 139
Query: 142 DNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRY 201
NA+ +KEIIH PT N++ ICLVNT G PFISALELR L+N++Y S ++ R
Sbjct: 140 LNASIPVIKEIIHTPTLNYIHICLVNTDSGMPFISALELRPLKNTTYVAQSGALVKSTRL 199
Query: 202 DYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPI 261
D GS+TN+T+RY DD +DR+WTP F K LST + + + PPS VM TA P
Sbjct: 200 DLGSLTNKTVRYPDDVFDRIWTPDHFHKWTDLSTPDTVDAQNHIDFQPPSVVMRTANMPT 259
Query: 262 NGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSF 321
N S ++FY + D T+ +YVYM+FAE+ LQ NQ R FNIS +G I ++P +L S
Sbjct: 260 NASENMEFYIDIDDTTSLFYVYMHFAEIVELQANQSRLFNISLNGTIWYGPVIPNHLSSG 319
Query: 322 STYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMY 381
+ Y P G FSL + E STLPP++NA E+Y D SQSET DVDA+M +K Y
Sbjct: 320 TVYSQFPIIGGNNMFSLFKIEGSTLPPLLNAIEIYFVVDLSQSETDQDDVDAIMKIKSTY 379
Query: 382 GVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSL 441
G+ +NWQGDPCAP+AY W GLNCSY +DPP + SLNLSSSGL GEI ++NL ++ L
Sbjct: 380 GITKNWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSGLRGEIVSEIANLRSLELL 439
Query: 442 DLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501
DLSNNSLSG++P+FLSR+ L+VLNL GNK TG IP +L E+S+ GSL LSV N ELC
Sbjct: 440 DLSNNSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFERSQQGSLLLSVSGNPELCP 499
Query: 502 SSSDSCKKEKKNMFVIPLVASAVSLLFFLTALAMI------WWSLKRRKDRAAI---LNA 552
S SC K+KK++ V A + FF+ A A++ + + + + A I N
Sbjct: 500 SV--SCTKKKKSVVV---PVVASVVAFFILAAALVVILRYFFVRSQAKTNEAKISYETND 554
Query: 553 HGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFK 612
+E + R F+YSE+LKIT+NF+K+LGKGGFGTVYHG L+DGTQVAVK+LS SS QG+K
Sbjct: 555 EPLVESKKRQFSYSEILKITNNFDKILGKGGFGTVYHGTLNDGTQVAVKVLSLSSAQGYK 614
Query: 613 EFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL 672
EF+AEVKLL+RVHHRNLT LVGY E N+GLIYEYMANGNL+ LSD +TLSWE RL
Sbjct: 615 EFQAEVKLLLRVHHRNLTTLVGYCNEGTNLGLIYEYMANGNLEDYLSDSCLNTLSWEIRL 674
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVST 731
+IA +AAQGLEYLH GCKP IVHRD+K NILL + +AKLADFGLS++FP+ G TH+ST
Sbjct: 675 RIATEAAQGLEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGLSRIFPVDGSTHIST 734
Query: 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI 791
VVAGTPGYLDPEY+V +WL +KSDV+SFGVVLLEIIT + I + E HI Q V++M+
Sbjct: 735 VVAGTPGYLDPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQTR-ERTHISQWVSSML 793
Query: 792 AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851
KGDI IVD L G FEI S W+A ELA+ C S +S+ RP MN+ V EL +CL +E+ R
Sbjct: 794 EKGDIHGIVDPRLNGDFEINSVWKAAELAMGCVSASSARRPTMNQAVVELNDCLNIEMGR 853
Query: 852 KKK 854
++
Sbjct: 854 TRE 856
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 858 | ||||||
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.956 | 0.937 | 0.539 | 3.5e-233 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.970 | 0.945 | 0.523 | 1.1e-227 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.967 | 0.947 | 0.508 | 1.7e-215 | |
| TAIR|locus:2017572 | 882 | AT1G51790 [Arabidopsis thalian | 0.960 | 0.934 | 0.456 | 2.5e-193 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.972 | 0.937 | 0.451 | 1.4e-190 | |
| TAIR|locus:2059804 | 892 | AT2G04300 [Arabidopsis thalian | 0.968 | 0.931 | 0.470 | 4.7e-190 | |
| TAIR|locus:2118344 | 863 | AT4G29450 [Arabidopsis thalian | 0.951 | 0.945 | 0.454 | 1.8e-188 | |
| TAIR|locus:2066133 | 880 | AT2G28960 [Arabidopsis thalian | 0.960 | 0.936 | 0.459 | 1.7e-185 | |
| TAIR|locus:2195855 | 876 | AT1G51910 [Arabidopsis thalian | 0.966 | 0.946 | 0.451 | 2.2e-185 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.953 | 0.925 | 0.448 | 9.4e-185 |
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2249 (796.7 bits), Expect = 3.5e-233, P = 3.5e-233
Identities = 448/830 (53%), Positives = 569/830 (68%)
Query: 23 VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFY 82
V AQDQSGFISIDCGIP SSY DE T++KY+SD FVE+G + +I S+ Q ++L +QF
Sbjct: 19 VFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGTSHSIVSDLQTTSLERQFQ 78
Query: 83 NVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKLD 142
NVR+FP+G RNCY + P +GKG KY IR FMYGNYD +K P+FDLY+G NLW+S+ L
Sbjct: 79 NVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVLI 138
Query: 143 NATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRYD 202
N TA+ KEII+ P +H+ +CLV+ GTPF+S LE+R L+N +Y+T ++ L +R+D
Sbjct: 139 NETAIMTKEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLKNDTYDTPYEALMLGRRWD 198
Query: 203 YGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPIN 262
+G+ TN IRYKDD YDR+W P + P K L+TSL I + + P S VM +AI P N
Sbjct: 199 FGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNHNGFRPASIVMRSAIAPGN 258
Query: 263 GSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSFS 322
S+ L+F W P DP +K+Y+YM+FAEV LQ N+ REF+I + IL E P YLF+ +
Sbjct: 259 ESNPLKFNWAPDDPRSKFYIYMHFAEVRELQRNETREFDIYINDVILAENFRPFYLFTDT 318
Query: 323 TYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYG 382
V P + E L RT STLPPIINA E+Y +F Q T DVDA+ +K Y
Sbjct: 319 RSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIKFKYR 378
Query: 383 VKRNWQGDPCAPKAYSWDGLNCSYKGNDP-PRIISLNLSSSGLTGEIAPYLSNLTLIQXX 441
VK+NWQGDPC P SW+GL C + N+ P+ I+LNLSSSGLTG+I P +NLT I
Sbjct: 379 VKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKL 438
Query: 442 XXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGXXXXXXX 501
VP+FL+ L L LNL+GNK TG IP +L+EKSK+GSL L G
Sbjct: 439 DLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQ 498
Query: 502 XXXXXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNAH-----GSL 556
+++P+VAS LL LTALA+IW K+R R I N G L
Sbjct: 499 SPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALIW-HFKKRSRRGTISNKPLGVNTGPL 557
Query: 557 EFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA 616
+ R+F YSEV+ IT+NF +VLGKGGFG VYHG+L+ G QVAVK+LS S QG+KEF A
Sbjct: 558 DTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHGFLN-GDQVAVKILSEESTQGYKEFRA 616
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
EV+LLMRVHH NLT+L+GY EDN+M LIYEYMANGNL LS + + LSWE RLQI++
Sbjct: 617 EVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGKSSLILSWEERLQISL 676
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVSTVVAG 735
DAAQGLEYLH GCKPPIVHRD+KP NILL ENL+AK+ADFGLS+ FP+ G + VSTVVAG
Sbjct: 677 DAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAG 736
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795
T GYLDPEY+ T +NEKSDVYSFGVVLLE+IT + I + E++H+ V +M+A GD
Sbjct: 737 TIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWHSRTESVHLSDQVGSMLANGD 796
Query: 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
I+ IVD L FE+ SAW+ ELA+ CAS +S +RP M++VV ELK+ +
Sbjct: 797 IKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSI 846
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2197 (778.4 bits), Expect = 1.1e-227, P = 1.1e-227
Identities = 442/844 (52%), Positives = 565/844 (66%)
Query: 7 IFFYAILLAGFALAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINK 66
+ +A A F L V+AQDQSGF+SIDCGIP SSYNDETTD+KY+SD FVE+G
Sbjct: 9 LIIFACFFAVFVLL--VRAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 67 NISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQ 126
+I EFQ S+L KQF NVR+FP+G RNCY + P +GKG KY IR FMYGNYD K P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPD 126
Query: 127 FDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNS 186
FDLYLG N+WDS+ +DNAT + KEIIH +HV +CLV+ GTPF+SALE+RLL+++
Sbjct: 127 FDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSN 186
Query: 187 SYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDS 246
+YET S+ L+KR+D G + +RYKDD +DR+W P FPK + SL I S ++
Sbjct: 187 TYETPYDSLILFKRWDLGGLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLTIDSNNNEG 246
Query: 247 YLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNIS-KD 305
+ P VM+TA +P + S + F WEPKDPT KY+VYM+FAEV L N+ REF + +
Sbjct: 247 FQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNE 306
Query: 306 GQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSE 365
+I M P YL++ + + P SG +EF L +T RSTLPPIINA E Y +F QS
Sbjct: 307 KEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSP 366
Query: 366 TLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLT 425
T DVDA+M +K YGVK++W GDPCAP Y W +NCSY N+ PRIIS+NLSSSGLT
Sbjct: 367 TDQQDVDAIMRIKSKYGVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLT 426
Query: 426 GEIAPYLSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSK 485
GEI SNLTL+ +P+FL L L LNL+GNK +G IPV+L+E+S
Sbjct: 427 GEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSN 486
Query: 486 NGSLQLSVGXXXXXXXXXX--XXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLKR- 542
+ L + +++IPLVAS V +L + A+A+ KR
Sbjct: 487 KKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYKKRH 546
Query: 543 RKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKM 602
R+ + + A G L+ R++ YSEV+K+T+NF +VLG+GGFG VYHG L+D QVAVK+
Sbjct: 547 RRGGSGGVRA-GPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLNDD-QVAVKI 604
Query: 603 LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK 662
LS SS QG+KEF AEV+LL+RVHH+NLT L+GY E M LIYE+MANG L LS EK
Sbjct: 605 LSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEK 664
Query: 663 ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722
+ LSWE RLQI++DAAQGLEYLH GCKPPIV RD+KP NIL+ E L+AK+ADFGLS+
Sbjct: 665 SYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSV 724
Query: 723 PIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN--E 779
+ G + +T VAGT GYLDPEY +T L+EKSD+YSFGVVLLE+++ Q VI R+ E
Sbjct: 725 ALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAE 784
Query: 780 NIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839
NIHI V M++ GDI IVD L F+ SAW+ E+A+ CAS +S RP M+ VV
Sbjct: 785 NIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVA 844
Query: 840 ELKE 843
ELKE
Sbjct: 845 ELKE 848
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2082 (738.0 bits), Expect = 1.7e-215, P = 1.7e-215
Identities = 427/839 (50%), Positives = 551/839 (65%)
Query: 11 AILLAGFALAFS-VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNIS 69
+IL FAL F V AQDQSGFISIDCGIP SSYNDETT +KY+SD+ FV++G K I+
Sbjct: 9 SILFTSFALLFFLVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVDSGTTKRIA 68
Query: 70 SEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDL 129
++FQ S + NVR+FPQ R+CY + GKG KY IR FMYGNYD + P+FDL
Sbjct: 69 AQFQSSGFDRHLLNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDL 128
Query: 130 YLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYE 189
YLGVN WDS+KLD+AT + KEII IP ++V +C+V+ GTPF+S LE+RLL N++YE
Sbjct: 129 YLGVNFWDSVKLDDATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIRLLLNTTYE 188
Query: 190 TVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKK-LSTSLPIRSGADDSYL 248
T ++ L +R DY RYKDD YDR+WTPR K L+TSL + ++ Y
Sbjct: 189 TPYDALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQ 248
Query: 249 PPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQI 308
P S VMSTA T N S L + P DP AK+YVYM+FAE+EVL+ NQ REF+I + +
Sbjct: 249 PASTVMSTAETARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLKSNQTREFSIWLNEDV 308
Query: 309 LMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERS-TLPPIINAFEVYMEKDFSQSETL 367
+ YL + + P SG I FSL + LPPIINA EVY +F Q T
Sbjct: 309 ISPSFKLRYLLTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINALEVYQVNEFLQIPTH 368
Query: 368 HTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDP-PRIISLNLSSSGLTG 426
DVDA+ +K Y VK+NWQGDPC P YSW+G++C N PR++SLN+S S L G
Sbjct: 369 PQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLNISFSELRG 428
Query: 427 EIAPYLSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486
+I P SNLT I+ +P FL+ L L LN++GNK TG +P L E+SKN
Sbjct: 429 QIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQRLHERSKN 488
Query: 487 GSLQLSVGXXXXXXXXXXXXXXXXXXXM-FVIPLVASAVSLLFFLTALAMIWWSLKRRKD 545
GSL L G ++IPLV + ++ LTALA+ + K+++
Sbjct: 489 GSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGI-IVVLLTALAL-FRRFKKKQQ 546
Query: 546 RAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSS 605
R + +G L+ R+F YSEV+ IT+NF +V+GKGGFG VYHG ++ G QVAVK+LS
Sbjct: 547 RGTLGERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHGVIN-GEQVAVKVLSE 605
Query: 606 SSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAST 665
S QG+KEF AEV LLMRVHH NLT+LVGY E N+M LIYEYMAN NL L+ +++
Sbjct: 606 ESAQGYKEFRAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAGKRSFI 665
Query: 666 LSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725
LSWE RL+I++DAAQGLEYLH GCKPPIVHRD+KP NILL E L+AK+ADFGLS+ F +
Sbjct: 666 LSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVE 725
Query: 726 GT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII 784
G+ +STVVAG+ GYLDPEY+ T +NEKSDVYS GVVLLE+IT Q I ++ E +HI
Sbjct: 726 GSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIASSKTEKVHIS 785
Query: 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
V +++A GDI IVD LR +++ SAW+ E+A+ C TS++RP M++VV ELK+
Sbjct: 786 DHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQ 844
|
|
| TAIR|locus:2017572 AT1G51790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1873 (664.4 bits), Expect = 2.5e-193, P = 2.5e-193
Identities = 383/839 (45%), Positives = 534/839 (63%)
Query: 25 AQDQSGFISIDCGI-PAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFYN 83
AQDQSGFISIDCG+ P SSY + +TD+KY+SD+++ +TG + ++ E + + + ++
Sbjct: 23 AQDQSGFISIDCGLQPENSSYTETSTDIKYVSDSSYTDTGTSYFVAPENR-QNMKQSMWS 81
Query: 84 VRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKLDN 143
VR+FP+G+RNCYT+ +KY IRA FMYGNYD+ N+ P FDL+LG N WD+++L +
Sbjct: 82 VRSFPEGIRNCYTI--AVNSSTKYLIRADFMYGNYDSRNEIPGFDLHLGPNKWDTVELVS 139
Query: 144 ATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRYDY 203
KEII+ + + +CLVNTG GTPFIS LELR L NSSY S S+ L++R D+
Sbjct: 140 PLQTVSKEIIYYVLTDTIQVCLVNTGNGTPFISVLELRQLPNSSYAAQSESLQLFQRLDF 199
Query: 204 GSITNQTIRYKDDAYDRMWTPREFPKTKKLST-SLPIRSGADDSYLPPSAVMSTAITPIN 262
GS TN T+RY +D +DR+W P TK LS S + S + ++ P VM T I P N
Sbjct: 200 GSTTNLTVRYPNDVFDRIWFPATPNGTKPLSDPSTSLTSNSTGNFRLPQVVMRTGIVPDN 259
Query: 263 GSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDN--QLREFNISKDGQILMEFIVPEYLFS 320
+ F W P DP+ +++ Y+YF E++ + REF I +G+ E + Y +
Sbjct: 260 PRGFVDFGWIPDDPSLEFFFYLYFTELQQPNSGTVETREFVILLNGKSFGEPLSLNYFRT 319
Query: 321 FSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKM 380
+ + P +FSL +T+ S+LPP+INA E Y QS T D+ A+ N+K
Sbjct: 320 LALFTSNPLKAESFQFSLRQTQSSSLPPLINAMETYFVNKLPQSSTDPNDLSAMRNIKSA 379
Query: 381 YGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQX 440
Y VKRNW+GD C P+AY+W+GLNCS+ G + PR+I+LNLSS+GLTGEI +S L+ +Q
Sbjct: 380 YKVKRNWEGDVCVPQAYTWEGLNCSFNGTNMPRVIALNLSSAGLTGEITSDISRLSQLQI 439
Query: 441 XXXXXXXXXX-XVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGXXXXX 499
VP FL++LQFLRVL+L N+ +GPIP L+E+ + S S+
Sbjct: 440 LDLSNNNLSGPAVPAFLAQLQFLRVLHLANNQLSGPIPSSLIERLDSFSGNPSICSANAC 499
Query: 500 XXXXXXXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLKRRK--DRAAILNAHGSLE 557
FVIPLVAS LL A I+ L R+K D A + +
Sbjct: 500 EEVSQNRSKKNKLPSFVIPLVASLAGLLLLFIISAAIFLILMRKKKQDYGGNETAVDAFD 559
Query: 558 FE--NRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFE 615
E NR FTY+E++ IT+ F++ GK GFG Y G LD G +V VK++SS S QG+K+
Sbjct: 560 LEPSNRKFTYAEIVNITNGFDRDQGKVGFGRNYLGKLD-GKEVTVKLVSSLSSQGYKQLR 618
Query: 616 AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIA 675
AEVK L R+HH+NL ++GY E + M +IYEYMANGNLKQ +S+ + SWE RL IA
Sbjct: 619 AEVKHLFRIHHKNLITMLGYCNEGDKMAVIYEYMANGNLKQHISENSTTVFSWEDRLGIA 678
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG-GTHVSTVVA 734
+D AQGLEYLH GCKPPI+HR++K N+ L E+ AKL FGLS+ F G+H++T +A
Sbjct: 679 VDVAQGLEYLHTGCKPPIIHRNVKCTNVFLDESFNAKLGGFGLSRAFDAAEGSHLNTAIA 738
Query: 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG 794
GTPGY+DPEY+ ++ L EKSDVYSFGVVLLEI+T++ I++NE E +HI Q V +++++
Sbjct: 739 GTPGYVDPEYYTSNMLTEKSDVYSFGVVLLEIVTAKPAIIKNE-ERMHISQWVESLLSRE 797
Query: 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKK 853
+I I+D L G ++ SA++ VE+AV C R S +RP M++VVT LKE L +E+ RKK
Sbjct: 798 NIVEILDPSLCGDYDPNSAFKTVEIAVACVCRNSGDRPGMSQVVTALKESLAVEVERKK 856
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1847 (655.2 bits), Expect = 1.4e-190, P = 1.4e-190
Identities = 398/881 (45%), Positives = 559/881 (63%)
Query: 3 MSNCIFFYAILLAGFALAFSVQAQDQSGFISIDCG-IPAASSYNDETTDLKYISDTTFVE 61
M + +F +L+ F + SV+AQ+Q+GFIS+DCG +P ++Y +++T++ Y SD +++
Sbjct: 1 MKSLHWFLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYID 60
Query: 62 TGINKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAA 121
+G+ I+ ++ + +Q + VR+FP G RNCY +N T +KY IR +F+YGNYD
Sbjct: 61 SGLVGKINDAYK-TQFQQQVWAVRSFPVGQRNCYNVNLTAN--NKYLIRGTFVYGNYDGL 117
Query: 122 NKPPQFDLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELR 181
N+ P FDL++G N W S+K+ T M EIIH+ ++ + +CLV TG TPFIS+LE+R
Sbjct: 118 NQFPSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVR 177
Query: 182 LLRNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRS 241
L N SY T S S+ L+ R + S ++ IRY +D +DR+W +T +ST LPI +
Sbjct: 178 PLNNESYLTQSGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDETVWISTDLPIDT 237
Query: 242 GADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFN 301
+SY P +VM TA P N S +W + TA+ YVYM+FAEV+ L N+ REFN
Sbjct: 238 S--NSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFN 295
Query: 302 ISKDGQIL-MEFIVPEYLFSFSTY---RVKPYSGAIIEFSLDRTERSTLPPIINAFEVYM 357
I+ +G + ++ P L S ST R S I F+ T STLPP++NA E+Y
Sbjct: 296 ITYNGGLRWFSYLRPPNL-SISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYT 354
Query: 358 EKDFSQSETLHTDVDAVMNMKKMYGVKR--NWQGDPCAPKAYSWDGLNCSYKGNDPPRII 415
D Q ET +V A+MN+K+ YG+ + +WQGDPCAP+ Y W+GLNCSY ++ RII
Sbjct: 355 VVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRII 414
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTG- 474
SLNL+ S LTG I +S LTL+ +P F + ++ L+++NL GN
Sbjct: 415 SLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNL 474
Query: 475 -PIPVELMEKSKNGSLQLSVGXXXXXXXXXXXXXXXXXXXMFVIPLVASAVSL--LFFLT 531
IP L ++ + SL L +G +P+VA A S+ +F L
Sbjct: 475 TAIPDSLQQRVNSKSLTLILGENLTLTPKKESKK---------VPMVAIAASVAGVFALL 525
Query: 532 ALAMIWWSLKRRKDRA------------AIL-----NAHGSLEFENRHFTYSEVLKITDN 574
+ I++ +KR+ +A I+ +++ S+ R TY EVLK+T+N
Sbjct: 526 VILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNN 585
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
F +VLGKGGFGTVYHG LD G +VAVKMLS SS QG+KEF+AEV+LL+RVHHR+L LVG
Sbjct: 586 FERVLGKGGFGTVYHGNLD-GAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVG 644
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
Y + +N+ LIYEYMANG+L++ +S ++ + L+WE R+QIA++AAQGLEYLH GC+PP+
Sbjct: 645 YCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPM 704
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNE 752
VHRD+K NILL E AKLADFGLS+ FPI G HVSTVVAGTPGYLDPEY+ T+WL+E
Sbjct: 705 VHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSE 764
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812
KSDVYSFGVVLLEI+T+Q VI + E HI V M+ KGDI++IVD L G ++
Sbjct: 765 KSDVYSFGVVLLEIVTNQPVIDKTR-ERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNG 823
Query: 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKK 853
AW+ VELA+ C + +S+ RP M VV EL +C+ +E AR++
Sbjct: 824 AWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQ 864
|
|
| TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1842 (653.5 bits), Expect = 4.7e-190, P = 4.7e-190
Identities = 408/868 (47%), Positives = 542/868 (62%)
Query: 6 CIFFYAILLAGFALAFSVQAQDQSGFISIDCGI-PAASSYNDETTDLKYISDTTFVETGI 64
C+ F+ F L V+A +Q GFIS+DCG+ P Y D TDL Y +D FV++G
Sbjct: 11 CVLFFIT----FGLLHVVEAGNQEGFISLDCGLSPNEPPYVDAATDLTYTTDNDFVQSGK 66
Query: 65 NKNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKP 124
I E + ST K +R FP+G+RNCYTLN T G+ Y IRASF+YGNYD NK
Sbjct: 67 TGTIDKELE-STYNKPILQLRYFPEGVRNCYTLNVT--LGTNYLIRASFVYGNYDGLNKE 123
Query: 125 PQFDLYLGVNLWDSIK----LDNATAMEMKEIIHIPTENHVL-ICLVNTGLGTPFISALE 179
+FDLYLG NLW ++ L N E EIIH T++ VL +CL+ TG P I++LE
Sbjct: 124 LEFDLYLGPNLWANVNTAVYLMNGVTTE--EIIH-STKSKVLQVCLIKTGESIPIINSLE 180
Query: 180 LRLLRNSSYETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPR-EFPKTKKLSTSLP 238
LR L N +Y T S S+ R +Y S + + IRY +D DR W P + +L+T+L
Sbjct: 181 LRPLINDTYNTQSGSLKYLFR-NYFSTSRRIIRYPNDVNDRHWYPFFDEDAWTELTTNLN 239
Query: 239 IRSGADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLR 298
+ S + Y PP VM++A TPI+ + F W TAK+Y YM+FA+++ LQ N+ R
Sbjct: 240 VNSS--NGYDPPKFVMASASTPISKNAPFNFTWSLIPSTAKFYSYMHFADIQTLQANETR 297
Query: 299 EFNISKDGQILMEFIVPEYLFSFSTYRVKPY--SGAIIEFSLDRTERSTLPPIINAFEVY 356
EF++ +G + +E P+ + + Y +KP G L +T +STLPP+ +A EV+
Sbjct: 298 EFDMMLNGNLALERYRPKTFATGTIYFIKPQICEGGQCIIELLKTSKSTLPPLCSALEVF 357
Query: 357 MEKDFSQSETLHTDVDAVMNMKKMYGV-KRNWQGDPCAPKAYSWDGLNC--SYKGNDPPR 413
DF + ET DV A+ N++ YGV K +WQGDPC PK + WDGLNC SY PP
Sbjct: 358 TVIDFPELETNQDDVIAIKNIQNTYGVSKTSWQGDPCVPKRFMWDGLNCNNSYIST-PPT 416
Query: 414 IISLNLSSSGLTGEIAPYLSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFT 473
I LNLSSS LTG IA + NLT +Q VPEFL+ L+ L V+NL GN +
Sbjct: 417 ITFLNLSSSHLTGIIASAIQNLTHLQNLDLSNNNLTGGVPEFLAGLKSLLVINLSGNNLS 476
Query: 474 GPIPVELMEKSKNGSLQL--SVGXXXXXXXXXXXXXXXXXXXMFVIPLVASAVSLLFFL- 530
G +P L++K K L L ++ V+ LV +++L+ L
Sbjct: 477 GSVPQTLLQK-KGLKLNLEGNIYLNCPDGSCVSKDGNGGAKKKNVVVLVVVSIALVVVLG 535
Query: 531 TALAMIWWSLKRRKDRAAILNAHGSLE----FENRHFTYSEVLKITDNFNKVLGKGGFGT 586
+ALA+ KR+ R + SL+ +NR FTYSEV+K+T+NF K+LGKGGFG
Sbjct: 536 SALALFLVFRKRKTPRNEVSRTSRSLDPTITTKNRRFTYSEVVKMTNNFEKILGKGGFGM 595
Query: 587 VYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646
VYHG ++D QVAVKMLS SS QG+KEF+AEV+LL+RVHH+NL LVGY E N+ LIY
Sbjct: 596 VYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLSLIY 655
Query: 647 EYMANGNLKQ-LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL 705
EYMA G+LK+ +L ++ S L W+ RL+I ++AQGLEYLH GCKPP+VHRD+K NILL
Sbjct: 656 EYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRDVKTTNILL 715
Query: 706 TENLEAKLADFGLSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLL 764
E+ +AKLADFGLS+ FP+ G T V TVVAGTPGYLDPEY+ T+WLNEKSDVYSFG+VLL
Sbjct: 716 DEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIVLL 775
Query: 765 EIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCA 824
EIIT+Q VI E HI + V M+ KGDI++I+D G ++ S WRAVELA+ C
Sbjct: 776 EIITNQHVI-NQSREKPHIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVWRAVELAMSCV 834
Query: 825 SRTSSERPNMNEVVTELKECLMMELARK 852
+ +S+ RP M++VV EL ECL E +R+
Sbjct: 835 NPSSTGRPTMSQVVIELNECLASENSRR 862
|
|
| TAIR|locus:2118344 AT4G29450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1827 (648.2 bits), Expect = 1.8e-188, P = 1.8e-188
Identities = 389/855 (45%), Positives = 519/855 (60%)
Query: 23 VQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLP---K 79
V QDQSG+ISIDCGIP + D T++ Y+SD F+ TG+N +S E+ P
Sbjct: 19 VHGQDQSGYISIDCGIPPYDTPEDTMTNINYVSDEAFITTGVNFKVSEEYGYPKNPVLLS 78
Query: 80 QFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSI 139
VR FPQG RNCYTL ++GK Y IRASFMYGNYD P+FDLY+ VN W ++
Sbjct: 79 TLAEVRAFPQGNRNCYTLKLSQGKDHLYLIRASFMYGNYDGKKALPEFDLYVNVNFWSTV 138
Query: 140 KLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYET-VSR--SIA 196
K NA+ KEI+ + + +CLVN G GTPFIS LELR + +S Y T R S+
Sbjct: 139 KFKNASDQVTKEILSFAESDTIYVCLVNKGKGTPFISGLELRPVNSSIYGTEFGRNVSLV 198
Query: 197 LYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADD----SYLPPSA 252
LY+R+D G + N T RY+DD +DR+W+P + +S + I SG D Y PP
Sbjct: 199 LYRRWDIGYL-NGTGRYQDDRFDRIWSPY----SSNISWNSIITSGYIDVFQNGYCPPDE 253
Query: 253 VMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEF 312
V+ TA P N L+ +W DP ++Y Y+YFAE+E L+ N+ R+ I +G + E
Sbjct: 254 VIKTAAAPENVDDPLELFWTSDDPNVRFYAYLYFAELETLEKNETRKIKILWNGSPVSET 313
Query: 313 -IVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDV 371
P +S + + ++G S+ +T STLPPI+NA E++ + + T D+
Sbjct: 314 SFEPSSKYSTTFSNPRAFTGKDHWISIQKTVDSTLPPILNAIEIFTAQSLDEFSTTIEDI 373
Query: 372 DAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPY 431
A+ ++K Y V + W GDPC+P+ + W+G+ CS N+ +I SLNLSSSGL G I
Sbjct: 374 HAIESIKATYKVNKVWSGDPCSPRLFPWEGVGCSDNNNNH-QIKSLNLSSSGLLGPIVLA 432
Query: 432 LSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491
NL+L++ VPEFL+ L+ L+VLNLKGN FTG IP LM+K K G L L
Sbjct: 433 FRNLSLLESLDLSNNDLQQNVPEFLADLKHLKVLNLKGNNFTGFIPKSLMKKLKAGLLTL 492
Query: 492 SVGXXXXXXXXXXXXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILN 551
S V+P +A A S++ + L +IW L++RK A
Sbjct: 493 SADEQNLCNSCQEKKKKKS----MVVP-IAVAASVIVLVVVLVIIWIILRQRKKGAY--- 544
Query: 552 AHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKML-------- 603
+ L R FTY+EV IT+NFNKV+GKGGFG VY G L+DGT++AVKM+
Sbjct: 545 SGPLLPSGKRRFTYNEVSSITNNFNKVIGKGGFGIVYLGSLEDGTKIAVKMINDSSLAKP 604
Query: 604 ----SSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS 659
SSS + +F+ E +LL+ VHHRNL + VGY +D +M LIYEYMANGNL+ LS
Sbjct: 605 KGTSSSSLSRASNQFQVEAELLLTVHHRNLASFVGYCDDDRSMALIYEYMANGNLQAYLS 664
Query: 660 DEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719
E A LSWE+RL IA+D+AQGLEYLH GC+P IVHRD+K NIL+ +NLEAK+ADFGLS
Sbjct: 665 SENAEDLSWEKRLHIAIDSAQGLEYLHDGCRPAIVHRDVKTANILINDNLEAKIADFGLS 724
Query: 720 KVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN 778
KVFP +HV T V GTPGY+DPEY+ T LNEKSDVYSFGVVLLE+IT Q I++ E
Sbjct: 725 KVFPEDDLSHVVTTVMGTPGYVDPEYYRTFVLNEKSDVYSFGVVLLELITGQRAIIKTEE 784
Query: 779 -ENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
+NI +I V +++ +VD LRG F +SAW+ V++A+ C S RP MN++
Sbjct: 785 GDNISVIHYVWPFFEARELDGVVDPLLRGDFSQDSAWKFVDVAMSCVRDKGSNRPTMNQI 844
Query: 838 VTELKECLMMELARK 852
V ELK+CL EL R+
Sbjct: 845 VAELKQCLAAELDRE 859
|
|
| TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1799 (638.3 bits), Expect = 1.7e-185, P = 1.7e-185
Identities = 394/858 (45%), Positives = 533/858 (62%)
Query: 13 LLAGFALAFSVQAQ--DQSGFISIDCGIPAASS-YNDETTDLKYISDTTFVETGINKNIS 69
+ A+ VQAQ DQ GFIS+DCG+P S Y D T L + SD F+ +G+
Sbjct: 12 IFGALAITHLVQAQPPDQRGFISLDCGLPVNESPYTDPRTGLTFSSDADFILSGLRGEAG 71
Query: 70 SEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDL 129
+ + + +Q+ ++R FP G+RNCY L +G Y IRA F YGNYD N P+FDL
Sbjct: 72 DDN--TYIYRQYKDLRYFPDGIRNCYNLKVEQG--INYLIRAGFGYGNYDGLNVYPKFDL 127
Query: 130 YLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYE 189
++G N+W ++ L+ + +EII++ T N + ICLV TG P IS LELR LRN SY
Sbjct: 128 HVGPNMWIAVDLEFG---KDREIIYMTTSNLLQICLVKTGSTIPMISTLELRPLRNDSYL 184
Query: 190 TVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTP-REFPKTKKLSTSLPIRSGADDSYL 248
T + L R Y S + IRY DD +DR W EF +T ++T+L +RS + +
Sbjct: 185 TQFGPLDLIYRRAYSSNSTGFIRYPDDIFDRKWDRYNEF-ETD-VNTTLNVRSSSP--FQ 240
Query: 249 PPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQI 308
P AV ITP N S L+FY D + K VY +FAE++ L+ N+ REF+I + I
Sbjct: 241 VPEAVSRMGITPENASLPLRFYVSLDDDSDKVNVYFHFAEIQALRGNETREFDIELEEDI 300
Query: 309 LMEFIVPEYLFSFSTYRVKPY--SGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSET 366
+ P L S + Y + P+ S + L RT RSTLPP+I+A E + DF +ET
Sbjct: 301 IQSAYSPTMLQSDTKYNLSPHKCSSGLCYLKLVRTPRSTLPPLISAIEAFKVVDFPYAET 360
Query: 367 LHTDVDAVMNMKKMYGVKR-NWQGDPCAPKAYSWDGLNCSYKGND-PPRIISLNLSSSGL 424
DV A+ +++ YG+K +WQGDPC P+ W+ L CSY PPRIISL+LSS GL
Sbjct: 361 NPNDVAAMKDIEAFYGLKMISWQGDPCVPELLKWEDLKCSYTNKSTPPRIISLDLSSRGL 420
Query: 425 TGEIAPYLSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS 484
G IAP NLT ++ VPEFL+ ++ L ++NL N TGP+P L+++
Sbjct: 421 KGVIAPAFQNLTELRKLDLSNNSFTGGVPEFLASMKSLSIINLNWNDLTGPLPKLLLDRE 480
Query: 485 KNGSLQLSVGXXXXXXXXXXXXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLKRRK 544
KNG L+L++ +++P+VAS S+L + L +I KRR
Sbjct: 481 KNG-LKLTIQGNPKLCNDASCKNNNNQT--YIVPVVASVASVLIIIAVLILILVFKKRRP 537
Query: 545 DRAAILNA--HG-----SLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQ 597
+ L HG S+ + + FTYSEV +TDNF +VLG+GGFG VYHG L+ GTQ
Sbjct: 538 TQVDSLPTVQHGLPNRPSIFTQTKRFTYSEVEALTDNFERVLGEGGFGVVYHGILN-GTQ 596
Query: 598 -VAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656
+AVK+LS SS QG+KEF+AEV+LL+RVHH NL +LVGY E++N+ L+YEY NG+LKQ
Sbjct: 597 PIAVKLLSQSSVQGYKEFKAEVELLLRVHHVNLVSLVGYCDEESNLALLYEYAPNGDLKQ 656
Query: 657 LLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715
LS E+ S L W RL+I ++ AQGLEYLH GCKPP+VHRD+K NILL E+ +AKLAD
Sbjct: 657 HLSGERGGSPLKWSSRLKIVVETAQGLEYLHTGCKPPMVHRDVKTTNILLDEHFQAKLAD 716
Query: 716 FGLSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV 774
FGLS+ FP+GG THVST VAGTPGYLDPEY+ T+ LNEKSDVYSFG+VLLEIITS+ VI
Sbjct: 717 FGLSRSFPVGGETHVSTAVAGTPGYLDPEYYRTNRLNEKSDVYSFGIVLLEIITSRPVI- 775
Query: 775 RNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNM 834
+ E HI V M+ KGDIEN+VD L +E S W+A+E+A+ C + +S +RP M
Sbjct: 776 QQTREKPHIAAWVGYMLTKGDIENVVDPRLNRDYEPTSVWKALEIAMSCVNPSSEKRPTM 835
Query: 835 NEVVTELKECLMMELARK 852
++V ELK+CL +E +++
Sbjct: 836 SQVTNELKQCLTLENSKR 853
|
|
| TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1798 (638.0 bits), Expect = 2.2e-185, P = 2.2e-185
Identities = 389/861 (45%), Positives = 542/861 (62%)
Query: 9 FYAILLAGFALAFSVQAQDQSGFISIDCG-IPAASSYNDETTDLKYISDTTFVETGINKN 67
F + FA+ VQAQ QSGFIS+DCG IP ++Y ++ T++ YISD ++++G+ +
Sbjct: 7 FLLLSTIAFAVFHLVQAQSQSGFISLDCGLIPKDTTYTEQITNITYISDADYIDSGLTER 66
Query: 68 ISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQF 127
IS ++ S L +Q + +R+FP+G RNCY N KY IR +F+YGNYD N+ P+F
Sbjct: 67 ISDSYK-SQLQQQTWTLRSFPEGQRNCYNFNLKANL--KYLIRGTFVYGNYDGLNQMPKF 123
Query: 128 DLYLGVNLWDSIKLDNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSS 187
DL++G N W S+ L+ + EIIH+ T++ + +CLV TG TPFIS+LELR L N +
Sbjct: 124 DLHIGPNKWTSVILEGVANATIFEIIHVLTQDRLQVCLVKTGQTTPFISSLELRPLNNDT 183
Query: 188 YETVSRSIALYKRYDYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSY 247
Y T S+ + R Y T +RY DD YDR+W P +T LST+LP+ + ++ SY
Sbjct: 184 YVTQGGSLMSFARI-YFPKTAYFLRYSDDLYDRVWVPFSQNETVSLSTNLPVDTSSN-SY 241
Query: 248 LPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDG- 306
P V ++AI P +H L +W+ ++ A YVYM+FAE++ L+ N +REFNI+ +G
Sbjct: 242 NVPQNVANSAIIPAEATHPLNIWWDLQNINAPSYVYMHFAEIQNLKANDIREFNITYNGG 301
Query: 307 QILMEFIVPEYLF--SFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQS 364
Q+ I P L + S+ S F+ T STLPP+INA EVY +
Sbjct: 302 QVWESSIRPHNLSITTISSPTALNSSDGFFNFTFTMTTTSTLPPLINALEVYTLVENLLL 361
Query: 365 ETLHTDVDAVMNMKKMYGVKR--NWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSS 422
ET +V A+MN+KK YG+ + +WQGDPC+P+ Y W+GLNC Y +D P I SLNL +S
Sbjct: 362 ETYQDEVSAMMNIKKTYGLSKKISWQGDPCSPQIYRWEGLNCLYLDSDQPLITSLNLRTS 421
Query: 423 GLTGEIAPYLSNLTLIQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGN-KFTGPIPVELM 481
GLTG I +SNL ++ +P+FL+ ++ L ++NLKGN K +P +
Sbjct: 422 GLTGIITHDISNLIQLRELDLSDNDLSGEIPDFLADMKMLTLVNLKGNPKLNLTVPDSIK 481
Query: 482 EKSKNGSLQLSVGXXXXXXXXXXXXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLK 541
+ N SL+L + ++ VA ++LL T + +I+ K
Sbjct: 482 HRINNKSLKLIIDENQSSEKHGIKFPLVA-----ILASVAGVIALLAIFT-ICVIFKREK 535
Query: 542 RRKDRAA------ILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDG 595
+ A I +++ S+E ++R FTYSE+LK+T+NF +VLGKGG+G VY+G LDD
Sbjct: 536 QGSGEAPTRVNTEIRSSYQSIETKDRKFTYSEILKMTNNFERVLGKGGYGRVYYGKLDD- 594
Query: 596 TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654
T+VAVKML SS+ Q +K F+AEV+LL+RVHHR+L LVGY + +N LIYEYMANG+L
Sbjct: 595 TEVAVKMLFHSSAEQDYKHFKAEVELLLRVHHRHLVGLVGYCDDGDNFALIYEYMANGDL 654
Query: 655 KQLLSDEKAS-TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKL 713
K+ +S ++ LSWE R+QIAM+AAQGLEYLH G +PP+VHRD+K NILL E +AKL
Sbjct: 655 KENMSGNRSGHVLSWENRMQIAMEAAQGLEYLHNGSRPPMVHRDVKTTNILLNELYQAKL 714
Query: 714 ADFGLSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAV 772
ADFGLS+ P+ G ++VST+VAGTPGYLDPE T+ L+EK+DVYSFGVVLLEIIT+Q V
Sbjct: 715 ADFGLSRSSPVDGESYVSTIVAGTPGYLDPE---TNLLSEKTDVYSFGVVLLEIITNQPV 771
Query: 773 IVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERP 832
I E HI V + +GDI NI+D L F+ W+AVELA+ C + TS+ RP
Sbjct: 772 I-DTTREKAHITDWVGFKLMEGDIRNIIDPKLIKEFDTNGVWKAVELALSCVNPTSNHRP 830
Query: 833 NMNEVVTELKECLMMELARKK 853
M VV ELKECL E+ARK+
Sbjct: 831 TMPHVVMELKECLDSEIARKQ 851
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1792 (635.9 bits), Expect = 9.4e-185, P = 9.4e-185
Identities = 382/851 (44%), Positives = 532/851 (62%)
Query: 23 VQAQDQSGFISIDCGIPAASS-YNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQF 81
+ AQDQ GFIS+DCG+P+ S Y+D L + SD+TF++TG ++ + I+ L KQ+
Sbjct: 17 IGAQDQEGFISLDCGLPSDESPYDDSFNGLTFTSDSTFIQTGKIDSVDKDLNIN-LSKQY 75
Query: 82 YNVRTFPQGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKL 141
+R FP+G RNCY+L+ +G+ Y I SF+YGNYD N+ P FD++LG N W I L
Sbjct: 76 LTLRYFPEGKRNCYSLDVK--RGTTYLIVVSFVYGNYDGLNRDPNFDIHLGPNKWKRIDL 133
Query: 142 DNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRY 201
D +EIIH N + ICLV TG P ISA+E+R LRN++Y T S S+ + R
Sbjct: 134 DGEKEGTREEIIHKARSNSLDICLVKTGETLPIISAIEIRPLRNNTYVTQSGSLMMSFRV 193
Query: 202 DYGSITNQTIRYKDDAYDRMWTPREFPKTKKLSTSLPIRSGADDSYLPPSAVMSTAITPI 261
Y S ++ +IRY DD +DR+W+P ++T L I + ++Y P ++ TA P
Sbjct: 194 -YLSNSDASIRYADDVHDRIWSPFNGSSHTHITTDLNINNS--NAYEIPKNILQTAAIPR 250
Query: 262 NGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSF 321
N S L W+P A+ Y+YM+FAE++ L+ N+ R+F++ G P L F
Sbjct: 251 NASAPLIITWDPLPINAEVYLYMHFAEIQTLEANETRQFDVILRGNFNHSGFSPTKLKVF 310
Query: 322 STYRVKPYS-GAI-IEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKK 379
+ Y +P G+ L +T STLPP+INA E Y +FSQ ET +DVDA+ N+K
Sbjct: 311 TLYTEEPMKCGSEGCYLQLVKTPNSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNIKN 370
Query: 380 MYGVKR-NWQGDPCAPKAYSWDGLNCSY-KGNDPPRIISLNLSSSGLTGEIAPYLSNLTL 437
Y + + WQGDPC P+ SW+ + C+Y G+ P IISL+LS SGL G I L N T
Sbjct: 371 TYKLNKITWQGDPCLPQDLSWESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNFTQ 430
Query: 438 IQXXXXXXXXXXXXVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGXXX 497
+Q VP FL+ ++ L ++NL GN +G +P L++K K G L +
Sbjct: 431 LQELDLSNNSLTGPVPIFLANMKTLSLINLSGNNLSGSVPQALLDKEKEG---LVLKLEG 487
Query: 498 XXXXXXXXXXXXXXXXMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNAHGSLE 557
F++P++ASA SL+ + +A+ ++ +++K + L+A S+
Sbjct: 488 NPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVAL-FFVFRKKKASPSNLHAPPSMP 546
Query: 558 FENR-H--------------FTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKM 602
N H FTYSEV ++T+NF+K LG+GGFG VYHG+++ QVAVK+
Sbjct: 547 VSNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKL 606
Query: 603 LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK 662
LS SS QG+K F+AEV+LLMRVHH NL +LVGY E ++ LIYEYM NG+LKQ LS +
Sbjct: 607 LSQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGKH 666
Query: 663 AS-TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721
LSWE RL+I +DAA GLEYLH GC PP+VHRDIK NILL ++L+AKLADFGLS+
Sbjct: 667 GGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSRS 726
Query: 722 FPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN 780
FPIG +VSTVVAGTPGYLDPEY+ T+WL EKSD+YSFG+VLLEII+++ +I + E
Sbjct: 727 FPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRPII-QQSREK 785
Query: 781 IHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840
HI++ V+ MI KGD+ +I+D L ++I S W+A+ELA+ C S +S+ RPNM+ VV E
Sbjct: 786 PHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSARRPNMSRVVNE 845
Query: 841 LKECLMMELAR 851
LKECL+ E +R
Sbjct: 846 LKECLISETSR 856
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT4G29990 | light repressible receptor protein kinase; light repressible receptor protein kinase; FUNCTIONS IN- protein binding, protein serine/threonine kinase activity, protein kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- endomembrane system; EXPRESSED IN- leaf whorl, embryo, root; EXPRESSED DURING- D bilateral stage; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Leucine-rich repeat (InterPro-IPR001611), Serine/threonine protein kinase-related (InterPro-IPR017442), Protei [...] (876 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AT5G38900 | DSBA oxidoreductase family protein; DSBA oxidoreductase family protein; FUNCTIONS IN- protein d [...] (217 aa) | • | 0.561 | |||||||
 | CYP705A24 | CYP705A24; electron carrier/ heme binding / iron ion binding / monooxygenase/ oxygen binding; m [...] (521 aa) | • | 0.439 | |||||||
 | AT5G46660 | CHP-rich zinc finger protein, putative; CHP-rich zinc finger protein, putative; FUNCTIONS IN- p [...] (305 aa) | • | 0.438 | |||||||
 | AT1G09820 | pentatricopeptide (PPR) repeat-containing protein; pentatricopeptide (PPR) repeat-containing pr [...] (606 aa) | • | 0.436 | |||||||
 | CYP91A2 | CYP91A2 (CYTOCHROME P450 MONOOXYGENASE 91A2); electron carrier/ heme binding / iron ion binding [...] (500 aa) | • | 0.435 | |||||||
 | CYP77A4 | CYP77A4; electron carrier/ heme binding / iron ion binding / monooxygenase/ oxygen binding; enc [...] (512 aa) | • | 0.428 | |||||||
 | AT4G22140 | DNA binding / protein binding / zinc ion binding; DNA binding / protein binding / zinc ion bind [...] (234 aa) | • | 0.409 | |||||||
 | AT2G15580 | zinc finger (C3HC4-type RING finger) family protein; zinc finger (C3HC4-type RING finger) famil [...] (196 aa) | • | 0.408 | |||||||
 | AT1G16900 | sugar binding / transferase, transferring glycosyl groups; curculin-like (mannose-binding) lect [...] (570 aa) | • | 0.401 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 858 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-125 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-38 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-24 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-17 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 380 bits (978), Expect = e-125
Identities = 153/337 (45%), Positives = 210/337 (62%), Gaps = 18/337 (5%)
Query: 34 IDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFYNVRTFPQGMRN 93
IDCG+P+ SY D +T + ++SD F++TG + NIS E S L K + +R+FP G RN
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRN 60
Query: 94 CYTLNPTEGKGSKYSIRASFMYGNYDAANK---PPQFDLYLGVNLWDSIKLDNATAME-M 149
CYTL T GKG+KY IRA+F+YGNYD N PP FDLYLGVNLW ++ L N + +
Sbjct: 61 CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVV 120
Query: 150 KE-IIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIAL--YKRYDYGSI 206
KE IIH+ + + +CLVNTG GTPFISALELR L +S Y + S AL R ++G
Sbjct: 121 KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGSQALKLVARLNFGG- 179
Query: 207 TNQTIRYKDDAYDRMWTP-REFPKTKKLSTSLPIR-SGADDSYLPPSAVMSTAITPINGS 264
+ TIRY DD YDR+W P P ++STSL + S + Y+PPSAV+ TA+TP N S
Sbjct: 180 SEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNAS 239
Query: 265 HALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSFSTY 324
L F W+ DP +YYVY++FAE +Q + REF+I +G+ + + P+YL + +
Sbjct: 240 APLNFTWDLVDPNFEYYVYLHFAE---IQSLETREFDIYINGKTVYGDVSPKYLGTDTGA 296
Query: 325 RVKPY-----SGAIIEFSLDRTERSTLPPIINAFEVY 356
+ G ++ SL T STLPP++NA E++
Sbjct: 297 LYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIF 333
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 80/201 (39%), Positives = 119/201 (59%), Gaps = 9/201 (4%)
Query: 579 LGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTNLVGYF 636
LG+GGFGTVY G +VA+K++ E E+++L +++H N+ L G F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 637 IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHR 696
++N++ L+ EY G+LK LL E LS + L+I + +GLEYLH I+HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 697 DIKPENILLTE-NLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW-LNEKS 754
D+KPENILL N + KLADFGLSK+ + + T+V GTP Y+ PE + +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 755 DVYSFGVVLLEIITSQAVIVR 775
D++S GV+L E+ + +I +
Sbjct: 176 DIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 6e-49
Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG-----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
K LG+G FG VY G L +VAVK L +S Q +EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ L+G E+ + ++ EYM G+L L + LS L A+ A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG---YLDPEYF 745
+HRD+ N L+ ENL K++DFGLS+ V G ++ PE
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRD---LYDDDYYKVKGGKLPIRWMAPESL 176
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805
KSDV+SFGV+L EI T N +++ + KG +C
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT-LGEEPYPGMSNAEVLE----YLKKGYRLPKPPNCPP 231
Query: 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841
E+ +L ++C + +RP +E+V L
Sbjct: 232 ---EL------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 6e-49
Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 38/280 (13%)
Query: 575 FNKVLGKGGFGTVYHGYLDD-----GTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
K LG+G FG VY G L +VAVK L +S Q +EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ L+G E+ + ++ EYM G+L L + LS L A+ A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLESK 121
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG---YLDPEYF 745
+HRD+ N L+ ENL K++DFGLS+ G ++ PE
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRD---LYDDDYYRKRGGKLPIRWMAPESL 175
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT----SQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801
KSDV+SFGV+L EI T + N +++ + G
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM-----SNEEVLE----YLKNGYRLPQPP 226
Query: 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841
+C E+ +L ++C + +RP +E+V L
Sbjct: 227 NCPP---EL------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 7e-48
Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTNLVG 634
+ LG+G FG VY G VA+K++ + +E E+K+L ++ H N+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIGCKPP 692
F +++ + L+ EY G+L LL + R QI LEYLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLH---SKG 117
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
IVHRD+KPENILL E+ KLADFGL++ T GTP Y+ PE + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 753 KSDVYSFGVVLLEIIT 768
D++S GV+L E++T
Sbjct: 176 AVDIWSLGVILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 72/205 (35%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 577 KVLGKGGFGTVYHGYLDDG----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
K LG+G FG VY G L T+VAVK L +S + K+F E +++ ++ H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLL-------SDEKASTLSWERRLQIAMDAAQGLEY 684
L+G E+ + L+ EYM G+L L + STLS + L A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPE 743
L VHRD+ N L+ E+L K++DFGLS+ + P ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIIT 768
KSDV+SFGV+L EI T
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 70/201 (34%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 575 FNKVLGKGGFGTVYHGYLDD-----GTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
K LG+G FG VY G L T+VAVK L +S + +EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ L+G + + ++ EYM G+L L L+ + LQ+A+ A+G+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE-- 119
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVT 747
VHRD+ N L+TENL K++DFGLS+ + P ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 748 DWLNEKSDVYSFGVVLLEIIT 768
KSDV+SFGV+L EI T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 77/203 (37%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+ LG G FGTVY G VAVK+L S + + E+++L R+ H N+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L+ F + +++ L+ EY G+L LS LS + +IA+ +GLEYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH---SN 117
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I+HRD+KPENILL EN K+ADFGL+K + ++T V GTP Y+ PE L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPE-----VLL 171
Query: 752 E------KSDVYSFGVVLLEIIT 768
K DV+S GV+L E++T
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLT 194
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVK--MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
++LG+G FG+VY D G +AVK LS S + + E E+++L + H N+ V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI---V 62
Query: 634 GYF-----IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLH 686
Y+ E N + + EY++ G+L LL R+ QI +GL YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL----EGLAYLH 118
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSK-VFPIGGTHVSTVVAGTPGYLDPEYF 745
IVHRDIK NIL+ + KLADFG +K + I + V GTP ++ PE
Sbjct: 119 -SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAV 772
+ +D++S G ++E+ T +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 6e-37
Identities = 133/527 (25%), Positives = 226/527 (42%), Gaps = 77/527 (14%)
Query: 84 VRTFP--QGMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKL 141
+R FP G NCY +N KG YS+R F + P FD+ + S+K
Sbjct: 72 LRYFPLSDGPENCYNINRVP-KG-HYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKS 129
Query: 142 ------DNATAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYE------ 189
+ A + ++ + T+ IC +TG G P I ++E+ + + +Y
Sbjct: 130 GWSSHDEQVFA---EALVFL-TDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWG 185
Query: 190 --TVSRSIALYKRYDYGSITNQ-TIRYKDDAY--DRMWTP-REFPKT--KKLSTSLPIRS 241
+ R+ KR G+ ++ Y D + DR W + F + +ST I+
Sbjct: 186 QGVILRTA---KRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKK 242
Query: 242 GADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVE--VLQDNQLRE 299
++ P ++ +A+ + L + + DP Y V+++FAE++ + + + R
Sbjct: 243 ASNAPNFYPESLYQSALVSTDTQPDLSYTMD-VDPNRNYSVWLHFAEIDNSITAEGK-RV 300
Query: 300 FNISKDGQILMEFI-----VPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFE 354
F++ +G + + E + + SG + L + + IINA E
Sbjct: 301 FDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTH--AIINAIE 358
Query: 355 VYMEKDFSQSETLHTDVDAVMNMKKMYGV--KRNWQGDPCAPKAYSWDGLNCSYK----- 407
V+ E ++S+TL +V A+ +K G+ + W GDPC P+ + W G +C +
Sbjct: 359 VF-EIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGK 417
Query: 408 -----------------GNDPPR---IISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNS 447
ND + + S+NLS + + G I P L ++T ++ LDLS NS
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 448 LSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSS-DS 506
+G++PE L +L LR+LNL GN +G +P L + + + + DN LC +
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA-SFNFTDNAGLCGIPGLRA 536
Query: 507 CKKEKKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNAH 553
C I + FL AM WW KRR+ IL A
Sbjct: 537 CGPHLSVGAKIGIAFGVSVAFLFLVICAMCWW--KRRQ---NILRAQ 578
|
Length = 623 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 19/196 (9%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ +GKGGFG VY + G +VA+K++ S + ++ E+++L + H N+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQ------IAMDAAQGLEYLHIGC 689
+++ + + ++ E+ + G+LK LL S + L + + +GLEYLH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLK-------STNQTLTESQIAYVCKELLKGLEYLH--- 115
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
I+HRDIK NILLT + E KL DFGLS + V GTP ++ PE
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKP 173
Query: 750 LNEKSDVYSFGVVLLE 765
+ K+D++S G+ +E
Sbjct: 174 YDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 80/255 (31%), Positives = 116/255 (45%), Gaps = 46/255 (18%)
Query: 577 KVLGKGGFGTVY---HGYLDDGTQVAVK--MLSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
K +GKG FG VY DG +K LS+ S + ++ EVK+L +++H N+
Sbjct: 6 KQIGKGSFGKVYLVRR--KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 632 LVGYFIEDNNMGLIYEYMANGNL----------KQLLSDEKASTLSWERRLQIAMDAAQG 681
F E + ++ EY G+L + +E+ L W +Q+ +
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI--LDW--FVQLCL----A 115
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
L+YLH I+HRDIKP+NI LT N KL DFG+SKV TVV GTP YL
Sbjct: 116 LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIIT--------SQAVIVRNENENIHIIQTVTNMIAK 793
PE N KSD++S G VL E+ T + + I++ I
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------ILKGQYPPIPS 225
Query: 794 G---DIENIVDSCLR 805
++ N+V S L+
Sbjct: 226 QYSSELRNLVSSLLQ 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-32
Identities = 118/472 (25%), Positives = 210/472 (44%), Gaps = 56/472 (11%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ L LS + L+GEI LS+ + SLDLS+N LSG +P S + L L+L N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 472 FTGPIPVEL--------MEKSKN---GSL----------QLSVGDNEELCSSSSDS---- 506
+G IP L + S N GSL +V N +LC + S
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 507 CKKEKKN----MFVIPLVASAVSLLFFLTALAMIWWSLKRRKDRAAILNAHGSLEFE--- 559
CK+ +K ++ + + + L L A ++ + + + N G+ E +
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLA--LVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 560 ---NRHFTYSEVLKITDNFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE 615
++ T +++L N V+ +G G Y G + +G Q VK ++ +
Sbjct: 677 SKVSKSITINDILSSLKEEN-VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----S 731
Query: 616 AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIA 675
+E+ + ++ H N+ L+G + LI+EY+ NL ++L + LSWERR +IA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ A+ L +LH C P +V ++ PE I++ E L L +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI----- 840
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795
+ Y+ PE T + EKSD+Y FG++L+E++T ++ + I++ +
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900
Query: 796 IENIVDSCLRGGFEIES--AWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
++ +D +RG + + LA+ C + + RP N+V+ L+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 71/204 (34%), Positives = 94/204 (46%), Gaps = 30/204 (14%)
Query: 579 LGKGGFGTVY---HGYLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNL 632
LGKG FG V D G A+K+L KE E E +L R++H + L
Sbjct: 1 LGKGSFGKVLLVRK--KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH-IGCKP 691
F + + L+ EY G L LS E + R A + LEYLH +G
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLHSLG--- 113
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY------- 744
I++RD+KPENILL + KL DFGL+K G+ +T GTP YL PE
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
DW +S GV+L E++T
Sbjct: 172 KAVDW-------WSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 27/197 (13%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638
+GKG FG V G G +VAVK L S + F AE ++ + H NL L+G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 639 DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI 698
N + ++ EYMA G+L L + ++ ++L A+D +G+EYL + VHRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128
Query: 699 KPENILLTENLEAKLADFGLSKV---------FPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
N+L++E+L AK++DFGL+K P+ T P L + F T
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------APEALREKKFST-- 178
Query: 750 LNEKSDVYSFGVVLLEI 766
KSDV+SFG++L EI
Sbjct: 179 ---KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 1e-29
Identities = 73/208 (35%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLS---SSSGQGFKEFEAEVKLLMRV-HHRNLTNL 632
+ LG+G FG VY D VA+K+L+ S + + F E+++L + H N+ L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLL-SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
+F ++ ++ L+ EY+ G+L+ LL + LS L I LEYLH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 692 PIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTHVS-----TVVAGTPGYLDPEYF 745
I+HRDIKPENILL + KL DFGL+K+ P G+ S + GTPGY+ PE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 746 VTDWLNE---KSDVYSFGVVLLEIITSQ 770
+ L SD++S G+ L E++T
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
++G+G FG VY G L+ G VA+K +S + K E+ LL + H N+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM-DAAQGLEYLHIGCKPPI 693
+++ +I EY NG+L+Q++ K E + + + QGL YLH + +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLH---EQGV 120
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRDIK NIL T++ KLADFG++ V GTP ++ PE +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 754 SDVYSFGVVLLEIITSQ 770
SD++S G ++E++T
Sbjct: 180 SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVK---MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
KVLG+G G VY + G A+K + + K+ E+K L +
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKC 64
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-QIAMDAAQGLEYLHIGCKP 691
G F ++ + ++ EYM G+L LL +K + E L IA +GL+YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIP-EPVLAYIARQILKGLDYLHTKRH- 120
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I+HRDIKP N+L+ E K+ADFG+SKV +T V GT Y+ PE + +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 752 EKSDVYSFGVVLLEIIT 768
+D++S G+ LLE
Sbjct: 179 YAADIWSLGLTLLECAL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 10/193 (5%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638
LG G FG V+ G + +VA+K+L S ++F+ EV+ L R+ H++L +L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 639 DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI 698
+ +I E M G+L L + L + +A A+G+ YL + +HRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 699 KPENILLTENLEAKLADFGLSKVF--PIGGTHVSTV-VAGTPGYLDPEYFVTDWLNEKSD 755
NIL+ E+L K+ADFGL+++ + + + T PE + KSD
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAASHGTFSTKSD 186
Query: 756 VYSFGVVLLEIIT 768
V+SFG++L E+ T
Sbjct: 187 VWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 558 FENRHFTYSEVLKITDNFNKVLGKGGFGTVY---HGYLDDGT--QVAVKMLSSSSG-QGF 611
FE RH + K LG+G FG V + L D T QVAVK L+ S Q
Sbjct: 1 FEKRHLKFI----------KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR 50
Query: 612 KEFEAEVKLLMRVHHRNLTNLVG--YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWE 669
+FE E+++L + H N+ G ++ LI EY+ +G+L+ L + ++ +
Sbjct: 51 SDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLK 109
Query: 670 RRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
R L + +G++YL +HRD+ NIL+ K++DFGL+KV P +
Sbjct: 110 RLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY- 165
Query: 730 STVVAGTPG-----YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PG + PE T + SDV+SFGV L E+ T
Sbjct: 166 --YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 73/240 (30%), Positives = 109/240 (45%), Gaps = 41/240 (17%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHR 627
+ LG+G FG V+ G +D VAVK L ++S K+FE E +LL H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL------------SDEKASTLSWERRLQIA 675
N+ G E + +++EYM +G+L + L D L+ + LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 676 MDAAQGLEYL---HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPIGG 726
+ A G+ YL H VHRD+ N L+ +L K+ DFG+S+ + +GG
Sbjct: 129 VQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVIVRNENENIHII 784
+ + ++ PE + +SDV+SFGVVL EI T Q + E I I
Sbjct: 183 HTMLPI-----RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 68/194 (35%), Positives = 109/194 (56%), Gaps = 15/194 (7%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+++G+G FG V G Y G +VAVK + + Q F E E ++ ++HH+NL L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLG 66
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
I N + ++ E M+ GNL L + +S + LQ ++D A+G+EYL +V
Sbjct: 67 -VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLV 122
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
HRD+ NIL++E+ AK++DFGL++V +G + V T PE + KS
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSSKS 178
Query: 755 DVYSFGVVLLEIIT 768
DV+S+GV+L E+ +
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 67/204 (32%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS-----SSSGQGFKEFEAEVKLLMRVHHRNLT 630
++LG G FG+VY G LDDG AVK +S + + K+ E E+ LL ++ H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ---GLEYLHI 687
+G E++N+ + E + G+L +LL + I + Q GLEYLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-----VIRLYTRQILLGLEYLH- 119
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV- 746
VHRDIK NIL+ N KLADFG++K S G+P ++ PE
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ 175
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQ 770
+D++S G +LE+ T +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/223 (32%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 558 FENRHFTYSEVLKITDNFNKVLGKGGFGTV----YHGYLDD-GTQVAVKMLSSSSGQGFK 612
FE RH + + LGKG FG+V Y D+ G VAVK L S+ + +
Sbjct: 1 FEERHLKFI----------QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR 50
Query: 613 EFEAEVKLLMRVHHRNLTNL--VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER 670
+FE E+++L + H N+ V Y N+ L+ EY+ G+L+ L + L +
Sbjct: 51 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHRK 109
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
L A +G+EYL VHRD+ NIL+ K+ DFGL+KV P +
Sbjct: 110 LLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY-- 164
Query: 731 TVVAGTPG-----YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PG + PE + SDV+SFGVVL E+ T
Sbjct: 165 -YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 577 KVLGKGGFG-TVYHGYLDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+VLGKG FG + +D + V K L+ S + ++ E+ +L + H N+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+F++DN + + EY G L + +K E L + Y+H K I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRDIK NI LT+ KL DFG+SK+ + TVV GTP Y+ PE N K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFK 181
Query: 754 SDVYSFGVVLLEIIT 768
SD+++ G VL E++T
Sbjct: 182 SDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 567 EVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
E+ + + + LG G FG V+ G ++ T VAVK L + K+F AE +++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRH 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
L L + + ++ E M G+L + L L + + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV-------------FPIGGTHVSTVV 733
+HRD+ N+L+ EN K+ADFGL++V FPI T
Sbjct: 121 ---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA----- 172
Query: 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE + + + KSDV+SFG++L EI+T
Sbjct: 173 --------PEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 575 FNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+ LG+G +G+VY + + G VA+K++ +E E+ +L + +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYY 64
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKA--STLSWERRLQIAM---DAAQGLEYLHIG 688
G + ++ ++ ++ EY G++ ++ K TL+ E +IA +GLEYLH
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEE---EIAAILYQTLKGLEYLH-- 116
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
+HRDIK NILL E +AKLADFG+S V GTP ++ PE
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 749 WLNEKSDVYSFGVVLLEI 766
N K+D++S G+ +E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGF---KEFEAEVKLLMRVHHRNLTNLVGY 635
+G G FG V+ GY + +VA+K + +G ++F E +++M++ H L L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
E + + L++E+M +G L L ++ S E L + +D +G+ YL ++H
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKS 754
RD+ N L+ EN K++DFG+++ F + + S+ P + PE F + KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 755 DVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788
DV+SFGV++ E+ S+ N +++T+
Sbjct: 183 DVWSFGVLMWEVF-SEGKTPYENRSNSEVVETIN 215
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 24/240 (10%)
Query: 579 LGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVGY 635
+GKG FG V+ D A+K + S + EA E ++L ++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
F++ + ++ EY NG+L +LL ++ L ++ + + GL +LH I+H
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILH 124
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSD 755
RDIK N+ L K+ D G++K+ +T+V GTP YL PE NEKSD
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKSD 183
Query: 756 VYSFGVVLLEIIT--------SQAVIVRNENENIHIIQTVTNMIAKG---DIENIVDSCL 804
V++ GVVL E T +Q ++ II+ V +++ + ++D CL
Sbjct: 184 VWALGVVLYECCTGKHPFDANNQGALILK------IIRGVFPPVSQMYSQQLAQLIDQCL 237
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ LG G FG V+ G + T+VAVK L + + F E +++ ++ H L L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
E+ + ++ EYM+ G+L L + L + + +A A+G+ YL +H
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 696 RDIKPENILLTENLEAKLADFGLSKV-------------FPIGGTHVSTVVAGTPGYLDP 742
RD+ NIL+ ENL K+ADFGL+++ FPI T P
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-------------AP 173
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIIT 768
E KSDV+SFG++L EI+T
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 67/202 (33%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQG--FKEFEAEVKLLMRVHHRNLTNLVGY 635
+G G FG VY LD G +AVK + KE E+K+L + H NLV Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH---PNLVKY 64
Query: 636 F---IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+ + + + EY + G L++LL + R + + +GL YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHG 119
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV---AGTPGYLDPEYFVTDW 749
IVHRDIKP NI L N KL DFG + T + V AGTP Y+ PE
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 750 LNEK---SDVYSFGVVLLEIIT 768
+D++S G V+LE+ T
Sbjct: 180 GKGHGRAADIWSLGCVVLEMAT 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 570 KITDNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN 628
++ N K +G+G G VY G +VA+K + Q + E+ ++ H N
Sbjct: 19 ELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ + ++ + + ++ EYM G+L ++ + ++ + + + QGLEYLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLH-- 133
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE----- 743
++HRDIK +NILL+++ KLADFG + + ++VV GTP ++ PE
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRK 191
Query: 744 -YFVTDWLNEKSDVYSFGVVLLEII 767
Y K D++S G++ +E+
Sbjct: 192 DY------GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 45/226 (19%)
Query: 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEF---EAEVKLLMR------- 623
F K++G+G F TV + + A+K+L K E +VK +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTR 57
Query: 624 -VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGL 682
H + L F ++ N+ + EY NG L Q + K +L + A + L
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLAL 115
Query: 683 EYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF-----PIGGTHVSTVVA-- 734
EYLH G I+HRD+KPENILL +++ K+ DFG +KV P +T +
Sbjct: 116 EYLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 735 ------------GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
GT Y+ PE + SD+++ G ++ +++T
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKM-----LSSSSGQGFKEFEAEVKLLMRVHHRNLT 630
K+LG+G FG VY Y +D G ++AVK S + + E E++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIG 688
G +D + + EYM G++K L A T + R+ QI +G+EYLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH-- 121
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSK---VFPIGGTHVSTVVAGTPGYLDPEYF 745
IVHRDIK NIL KL DFG SK GT + +V GTP ++ PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVI 179
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQ 770
+ K+DV+S G ++E++T +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE---FEA--EVKLLMRVHHRNLT 630
K LG+G + VY + G VA+K + + K+ F A E+KLL + H N+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L+ F +N+ L++E+M +L++++ D K+ L+ + +GLEYLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEYLH---S 120
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
I+HRD+KP N+L+ + KLADFGL++ F ++ V T Y PE
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL----F 175
Query: 751 NEKS-----DVYSFGVVLLEII 767
+ D++S G + E++
Sbjct: 176 GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 63/192 (32%), Positives = 101/192 (52%), Gaps = 6/192 (3%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTNLVGYFI 637
+GKG FG VY G L T+VAVK S+ K F E ++L + H N+ L+G +
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRD 697
+ + ++ E + G+L L +K L+ ++ LQ+++DAA G+EYL +HRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 698 IKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDV 756
+ N L+ EN K++DFG+S+ G VS + P + PE +SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 757 YSFGVVLLEIIT 768
+S+G++L E +
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/195 (32%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
F K LG G FG V+ G VA+KM+ + +F E K++M++ H NL L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ + ++ EYMANG L L + K L E L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FI 122
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD+ N L+ E+ K++DFGL++ + + + S+ P + PE F + K
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 754 SDVYSFGVVLLEIIT 768
SDV+SFGV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQ--VAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ +GKG FG VY D T VA+K+ L + + ++ + E++ L + +T
Sbjct: 7 ECIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKY 64
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
G F++ + + +I EY G+ LL K L I + GLEYLH K
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGK-- 119
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+HRDIK NILL+E + KLADFG+S + +T V GTP ++ PE +E
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDE 177
Query: 753 KSDVYSFGVVLLEIIT 768
K+D++S G+ +E+
Sbjct: 178 KADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 4e-24
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEA-----EVKLLMRV-HHRNL 629
K LG G FG+VY + G VA+K + + F +E EVK L ++ H N+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
L F E++ + ++EYM GNL QL+ D K S I QGL ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-----TVVAGTPGYLDPEY 744
K HRD+KPEN+L++ K+ADFGL++ + T T Y PE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEI 169
Query: 745 FVTD-WLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTV 787
+ + D+++ G ++ E+ T + + +E + ++ I +V
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLV 633
+V+G+G FG V+ D V +K + + A E ++L + H N+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
F+ED + ++ EY G L + + S L + L + L ++H I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLI 122
Query: 694 VHRDIKPENILLTEN-LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+HRD+K +NILL ++ + K+ DFG+SK+ + + V GTP Y+ PE N+
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 753 KSDVYSFGVVLLEIIT 768
KSD+++ G VL E+ +
Sbjct: 181 KSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 65/192 (33%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF 636
+ +GKG FG V G G +VAVK + + + + F AE ++ ++ H NL L+G
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 637 IEDN-NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
+E+ + ++ EYMA G+L L S L + L+ ++D + +EYL VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 696 RDIKPENILLTENLEAKLADFGLSK-VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
RD+ N+L++E+ AK++DFGL+K T V P L + F T KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST-----KS 180
Query: 755 DVYSFGVVLLEI 766
DV+SFG++L EI
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 64/192 (33%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 579 LGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
LG G +G VY G VAVK L + +EF E ++ + H NL L+G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRD 697
+ +I E+M GNL L + ++ L +A + +EYL K +HRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129
Query: 698 IKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDV 756
+ N L+ EN K+ADFGLS+ G T+ + A P + PE + + KSDV
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 757 YSFGVVLLEIIT 768
++FGV+L EI T
Sbjct: 189 WAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 572 TDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--------EVKL 620
NF K +GKG F VY L DG VA+K + Q F+ +A E+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-----QIFEMMDAKARQDCLKEIDL 55
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD-EKASTLSWERRL-QIAMDA 678
L ++ H N+ + FIE+N + ++ E G+L +++ +K L ER + + +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
LE++H I+HRDIKP N+ +T KL D GL + F T ++V GTP
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEI 766
Y+ PE + N KSD++S G +L E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLS------SSSGQGFKEFEAEVKLLMRVHHRNLT 630
+VLGKG +GTVY G + G +AVK + ++ + +++ + EV LL + H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIG 688
+G ++DN + + E++ G++ +L+ + QI G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL----DGVAYLHNN 121
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-----TVVAGTPGYLDPE 743
C +VHRDIK N++L N KL DFG ++ G H + + GTP ++ PE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIITSQ 770
KSD++S G + E+ T +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVG 634
+++G G +G VY G ++ G A+K++ + G +E + E+ +L + HHRN+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 635 YFIE------DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
FI+ D+ + L+ E+ G++ L+ + K +TL E I + +GL +LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
+ ++HRDIK +N+LLTEN E KL DFG+S +T + GTP ++ PE D
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 749 -----WLNEKSDVYSFGVVLLEI 766
+ KSD++S G+ +E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 567 EVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
EV + T K LG G FG V+ GY + T+VA+K L S + F AE L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQH 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
L L + + +I EYM NG+L L + L+ + + +A A+G+ ++
Sbjct: 61 PRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV-------------FPIGGTHVSTVV 733
+ +HRD++ NIL++E L K+ADFGL+++ FPI T +
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
GT KSDV+SFG++L EI+T
Sbjct: 177 YGT-------------FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 64/195 (32%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLS--SSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
K LG G FG V+ GY ++ T+VAVK L + S Q F E E L+ + H L L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYA 68
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
++ + +I EYMA G+L L ++ + + + + A+G+ Y+ + +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD++ N+L++E+L K+ADFGL++V + + A P + PE K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 754 SDVYSFGVVLLEIIT 768
SDV+SFG++L EI+T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 78/221 (35%), Positives = 115/221 (52%), Gaps = 40/221 (18%)
Query: 575 FNKVLGKGGFGTVYHGYLD-DGTQV--AVKMLSS-SSGQGFKEFEAEVKLLMRV-HHRNL 629
F V+G+G FG V + DG ++ A+KML +S ++F E+++L ++ HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 630 TNLVGYFIEDNNMGLIY---EYMANGNLKQLLSDEK--------------ASTLSWERRL 672
NL+G N G +Y EY GNL L + ASTL+ ++ L
Sbjct: 66 INLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732
Q A D A G++YL + +HRD+ N+L+ ENL +K+ADFGLS+ G V
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEV--Y 172
Query: 733 VAGTPGYLDPEYFVTDWLN-----EKSDVYSFGVVLLEIIT 768
V T G L + + LN KSDV+SFGV+L EI++
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 577 KVLGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFE-----AEVKLLMRVHHRNLT 630
+ +GKG FGTV DG + K + + E E +EV +L + H N+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNI- 61
Query: 631 NLVGYFIEDNNMG-----LIYEYMANGNLKQLLSDEKASTLSWERR--LQIAMDAAQGLE 683
V Y+ + ++ EY G+L QL+ K E +I L
Sbjct: 62 --VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 684 YLHIGCKPP--IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
H P ++HRD+KP NI L N KL DFGL+K+ + T V GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEI 766
PE +EKSD++S G ++ E+
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVGY 635
+G+G +G VY G VA+K + A E+KLL ++H N+ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
F ++ L++E+M + +L +L+ ++ L QGL + H I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 696 RDIKPENILLTENLEAKLADFGLSKVF-PIGGTHVSTVVAGTPGYLDPEYFVTD-WLNEK 753
RD+KPEN+L+ KLADFGL++ F + VV T Y PE + D +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAPELLLGDKGYSTP 179
Query: 754 SDVYSFGVVLLEIITSQA 771
D++S G + E+++ +
Sbjct: 180 VDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 57/230 (24%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
F + LG+G FG VY G L T VA+K L ++ + +EF E +L+ + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERRLQ 673
N+ L+G ++ +++EY+A+G+L + L + S+L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 674 IAMDAAQGLEYL---HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK---------- 720
IA+ A G+EYL H VHRD+ N L+ E L K++DFGLS+
Sbjct: 129 IAIQIAAGMEYLSSHH------FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 721 ----VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEI 766
+ P+ ++ PE + +SD++SFGVVL EI
Sbjct: 183 QSKSLLPV-------------RWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 71/211 (33%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 577 KVLGKGGFGTVYHG---YLDDGT---QVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
+ LG G FG VY G D QVAVK L S S Q +F E ++ + +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSD-----EKASTLSWERRLQIAMDAAQGLEY 684
L+G E ++ E MA G+LK L + E+ S+L+ + L A D A+G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 685 LHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSK------VFPIGGTHVSTVVAG 735
L + +HRDI N LLT AK+ADFG+++ + GG + +
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI--- 185
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEI 766
++ PE F+ K+DV+SFGV+L EI
Sbjct: 186 --KWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 575 FNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSS-SSGQGFKEFEAEVKLLMRVHHRN 628
F + LG+ FG +Y G+L D VA+K L ++ Q + EF+ E L+ +HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLL------------SDEKA---STLSWERRLQ 673
+ L+G ++ + +++EY+ G+L + L SDE S+L L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 674 IAMDAAQGLEYL--HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK-VFPIGGTHVS 730
IA+ A G+EYL H VH+D+ NIL+ E L K++D GLS+ ++ V
Sbjct: 129 IAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
++ PE + + SD++SFGVVL EI +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVG 634
+V+G G +G VY G ++ G A+K++ + + +E + E+ +L + HHRN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYG 80
Query: 635 YFIE------DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
FI+ D+ + L+ E+ G++ L+ + K + L + I + +GL +LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
++HRDIK +N+LLTEN E KL DFG+S +T + GTP ++ PE D
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 749 -----WLNEKSDVYSFGVVLLEI 766
+ +SD++S G+ +E+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 577 KVLGKGGFGTVYH-GYLDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
K LGKG +G+VY L D A+K L S S + ++ E+++L V+H N++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH---PNII 62
Query: 634 GY---FIEDNNMGLIYEYMANGNLKQLLSDEKAST------LSWERRLQIAMDAAQGLEY 684
Y F++ N + ++ EY G+L + +S K W +Q+ GL+
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR----GLQA 118
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
LH + I+HRD+K NILL N K+ D G+SKV + T + GTP Y+ PE
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPHYMAPEV 172
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
+ + KSD++S G +L E+ T
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 15/235 (6%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQV-AVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLT 630
+V+GKG FG V D ++ A+K ++ + E ++L ++H L
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLV 63
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
NL F ++ NM L+ + + G+L+ LS + S E+ + LEYLH
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLS--QKVKFSEEQVKFWICEIVLALEYLH---S 118
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
I+HRDIKP+NILL E + DF ++ ++T +GTPGY+ PE
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQGY 176
Query: 751 NEKSDVYSFGVVLLEIITSQ----AVIVRNENENIHIIQTVTNMIAKGDIENIVD 801
+ D +S GV E + + ++ +T + +D
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 576 NKVLGKGGFGTVYHGYLDDGTQ----VAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
KV+G G FG V G L + VA+K L + SS + +F E ++ + H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLL--SDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
L G + + +I EYM NG+L + L +D K + + + + A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEM 125
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVT 747
VHRD+ NIL+ NL K++DFGLS+ +T P + PE
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 748 DWLNEKSDVYSFGVVLLEIIT 768
SDV+SFG+V+ E+++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 73/218 (33%), Positives = 112/218 (51%), Gaps = 40/218 (18%)
Query: 578 VLGKGGFGTVYHGYLD-DGTQV--AVKMLSS-SSGQGFKEFEAEVKLLMRV-HHRNLTNL 632
V+G+G FG V + DG ++ A+K + +S ++F E+++L ++ HH N+ NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 633 VGYFIEDNNMGLIY---EYMANGNLKQLLSDEK--------------ASTLSWERRLQIA 675
+G + G +Y EY +GNL L + ASTLS ++ L A
Sbjct: 62 LGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
D A+G++YL + +HRD+ NIL+ EN AK+ADFGLS+ G V V
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEV--YVKK 168
Query: 736 TPGYLDPEYFVTDWLN-----EKSDVYSFGVVLLEIIT 768
T G L + + LN SDV+S+GV+L EI++
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVK-MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LG G G V G +AVK + + K+ E+ +L + + + G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-QIAMDAAQGLEYLHIGCKPPI 693
F + ++ + EYM G+L ++L + ER L +IA+ +GL YLH K I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122
Query: 694 VHRDIKPENILLTENLEAKLADFGLSK--VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
+HRD+KP NIL+ + KL DFG+S V + T V GT Y+ PE + +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYS 177
Query: 752 EKSDVYSFGVVLLEIITSQ 770
KSD++S G+ L+E+ T +
Sbjct: 178 VKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+V+G G VY L + +VA+K + E EV+ + + +H N+
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLS--------DEK-ASTLSWERRLQIAMDAAQGL 682
F+ + + L+ Y++ G+L ++ DE +T + + +GL
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT--------VLKEVLKGL 115
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV---VAGTPGY 739
EYLH +HRDIK NILL E+ K+ADFG+S GG V GTP +
Sbjct: 116 EYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 740 LDPEYFVTDW-LNEKSDVYSFGVVLLEIITSQA 771
+ PE + K+D++SFG+ +E+ T A
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
F K LG G FG V +G VA+KM+ S EF E K++M++ H L L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ + ++ EYM+NG L L E + L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD+ N L+ + K++DFGLS+ + + + S+V + P + PE + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 754 SDVYSFGVVLLEIIT 768
SDV++FGV++ E+ +
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRVHHRNLTNL 632
K +G+G FG +Y D +K + + KE EA EV LL ++ H N+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F E+ + ++ EY G+L + ++ ++ S ++ L + + GL+++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121
Query: 693 IVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I+HRDIK +NI L++N + AKL DFG+++ ++ GTP YL PE N
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRPYN 180
Query: 752 EKSDVYSFGVVLLEIIT 768
K+D++S G VL E+ T
Sbjct: 181 NKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 57/199 (28%), Positives = 109/199 (54%), Gaps = 17/199 (8%)
Query: 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
++G+G +G VY G + G VA+K+++ + + + EV LL ++ N+ Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 636 F---IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM-DAAQGLEYLHIGCKP 691
+ ++ + +I EY G+++ L+ KA ++ E+ + + + + L+Y+H K
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIA-EKYISVIIREVLVALKYIH---KV 120
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD--W 749
++HRDIK NIL+T KL DFG++ + + ST V GTP ++ PE +T+ +
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE-VITEGKY 178
Query: 750 LNEKSDVYSFGVVLLEIIT 768
+ K+D++S G+ + E+ T
Sbjct: 179 YDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 578 VLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEA----------EVKLLMRVHH 626
V+G+G +G V G VA+K FKE E EVK+L ++ H
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK--------KFKESEDDEDVKKTALREVKVLRQLRH 59
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
N+ NL F + L++EY+ L +LL + L + Q + Y H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
I+HRDIKPENIL++E+ KL DFG ++ T T Y PE V
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 747 TDWLNEKS-DVYSFGVVLLEIITSQA 771
D K DV++ G ++ E++ +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKML-SSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVG 634
LG+G +G VY G VA+K + + +G A E+ LL + H N+ L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS-TALREISLLKELKHPNIVKLLD 65
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSD-EKASTLSWERRL--QIAMDAAQGLEYLHIGCKP 691
+ + L++EY +LK+ L + + + + Q+ +GL Y H
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL----RGLAYCHSHR-- 118
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVSTVVAGTPGYLDPEYFVTDWL 750
I+HRD+KP+NIL+ + KLADFGL++ F I T+ VV T Y PE L
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEIL----L 171
Query: 751 NEKS-----DVYSFGVVLLEIITSQA 771
K D++S G + E+IT +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 577 KVLGKGGFGTVYHG----YLDDGT---QVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
LG G FG VY G L G+ +VAVK L ++ Q KEF E L+ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAST-----LSWERRLQIAMDAAQGLE 683
+ L+G + + +I E M G+L L D + L+ + L I +D A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEA-----KLADFGLSK------VFPIGGTHVSTV 732
YL + +HRD+ N L++E K+ DFGL++ + G + V
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVIVRNENENIHIIQT 786
++ PE + +SDV+SFGV++ EI+T Q N E + +
Sbjct: 178 -----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 27/202 (13%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ +G G +G VY + G VA+K++ G F+ + E+ +L H N+ G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGCKPP 692
++ + + ++ EY G+L Q + LS LQIA + +GL YLH K
Sbjct: 69 YLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLS---ELQIAYVCRETLKGLAYLHETGK-- 122
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA------GTPGYLDPEYF- 745
+HRDIK NILLTE+ + KLADFG+S ++ +A GTP ++ PE
Sbjct: 123 -IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 746 --VTDWLNEKSDVYSFGVVLLE 765
+ K D+++ G+ +E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 579 LGKGGFGTVYH----GYL--DDGTQVAVKMLSS-SSGQGFKEFEAEVKLLMRVHHRNLTN 631
+G+G FG V+ G L + T VAVKML +S +F+ E L+ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLL--------------------SDEKASTLSWERR 671
L+G M L++EYMA G+L + L LS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS-KVFPIGGTHVS 730
L IA A G+ YL + VHRD+ N L+ EN+ K+ADFGLS ++ S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
A ++ PE + +SDV+++GVVL EI +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 74/218 (33%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 575 FNKVLGKGGFGTVYHGYL-DDGTQV--AVK-MLSSSSGQGFKEFEAEVKLLMRV-HHRNL 629
F V+G+G FG V + DG ++ A+K M +S ++F E+++L ++ HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERRLQIA 675
NL+G + L EY +GNL L ++ ASTLS ++ L A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
D A+G++YL + +HRD+ NIL+ EN AK+ADFGLS+ G V V
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEV--YVKK 180
Query: 736 TPGYLDPEYFVTDWLN-----EKSDVYSFGVVLLEIIT 768
T G L + + LN SDV+S+GV+L EI++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 573 DNFN--KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFE---AEVKLLMRVHH 626
D+F K LG G FG V + A+K+LS + K+ E E ++L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR-----LQIAM-DAAQ 680
L NL G F +D+N+ L+ EY+ G L L R+ +A AAQ
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQ 109
Query: 681 ---GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
LEYLH IV+RD+KPEN+LL + K+ DFG +K G T+ T+ GTP
Sbjct: 110 VVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTY--TLC-GTP 162
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
YL PE ++ + D ++ G+++ E++
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 77/304 (25%), Positives = 132/304 (43%), Gaps = 51/304 (16%)
Query: 562 HFTYSEVLKITDNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGFK-EF 614
F S + +IT LG+G FG V+ T V VK L + + + EF
Sbjct: 1 AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55
Query: 615 EAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL-------SDEKASTLS 667
E+ + ++ H+N+ L+G E +I EY G+LKQ L K LS
Sbjct: 56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 668 WERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------V 721
++++ + A G+++L VHRD+ N L++ E K++ LSK
Sbjct: 116 TKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 722 FPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN 780
+ + ++ P +L PE D + KSDV+SFGV++ E+ T + ++
Sbjct: 173 YK----LRNALI---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD- 224
Query: 781 IHIIQTVTNMIAKGDIE-NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839
+ V N + G +E + + C R +L +C + +RP+ +E+V+
Sbjct: 225 ----EEVLNRLQAGKLELPVPEGCPS---------RLYKLMTRCWAVNPKDRPSFSELVS 271
Query: 840 ELKE 843
L E
Sbjct: 272 ALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVK---MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G+G F VY L DG VA+K + + + E+ LL +++H N+
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSD-EKASTLSWERRL-QIAMDAAQGLEYLHIGCK 690
FIEDN + ++ E G+L +++ +K L E+ + + + LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---S 124
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
++HRDIKP N+ +T KL D GL + F T ++V GTP Y+ PE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183
Query: 751 NEKSDVYSFGVVLLEIITSQA 771
N KSD++S G +L E+ Q+
Sbjct: 184 NFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQG---FKEFEAEVKLLMRVHHRNLTNLVG 634
+ KG +G V+ G A+K++ + + E +L + + L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F N+ L+ EY+ G+L LL + + R + LEYLH I+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNGII 115
Query: 695 HRDIKPENILLTENLEAKLADFGLSKV--------FPIGGTHVSTVVAGTPGYLDPEYFV 746
HRD+KP+NIL+ N KL DFGLSKV +V GTP Y+ PE +
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVIL 174
Query: 747 TDWLNEKSDVYSFGVVLLEIIT 768
++ D +S G +L E +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 577 KVLGKGGFGTVYHGY---LDDGTQ--VAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLT 630
KVLG G FGTVY G + + VA+K+L + + KE E ++ V H ++
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKA-----STLSWERRLQIAMDAAQGLEYL 685
L+G + LI + M G L + + K L+W QIA +G+ YL
Sbjct: 73 RLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYL 125
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEY 744
+ +VHRD+ N+L+ K+ DFGL+K+ + P ++ E
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
+ KSDV+S+GV + E++T
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 60/215 (27%), Positives = 111/215 (51%), Gaps = 8/215 (3%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
F K LG G FG V+ G +VA+K ++ + ++F E K++M++ H L L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ + ++ E+M NG L L ++ LS + L + D +G+EYL + +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFI 122
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD+ N L++ K++DFG+++ + + + S+ A P + PE F + K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 754 SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788
SDV+SFGV++ E+ T + ++ N +++ ++
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKS-NYEVVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 579 LGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG+G FG V+ D VAVK L +S K+F E +LL + H ++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLL-----------SDEKASTLSWERRLQIAMDAAQG 681
G +E + + +++EYM +G+L + L + + L+ + L IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPIGGTHVSTVVAG 735
+ YL VHRD+ N L+ ENL K+ DFG+S+ + +GG H +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG-HTMLPIRW 188
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
P PE + +SDV+S GVVL EI T
Sbjct: 189 MP----PESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 36/287 (12%)
Query: 577 KVLGKGGFGTVYHGYL--DDGTQ--VAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLT 630
K+LG+G FG+V G L DDG+Q VAVK L + +EF +E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 631 NLVGYFIEDNNMG------LIYEYMANGNLKQLLSDEKASTLSWERRLQ----IAMDAAQ 680
L+G E +++ +I +M +G+L L + L + LQ +D A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GY 739
G+EYL +HRD+ N +L E++ +ADFGLSK G + +A P +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 740 LDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIEN 798
+ E KSDV++FGV + EI T Q EN I+ + + G+
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYLRHGNRLK 235
Query: 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
+ CL +++ C +RP ++ L+ L
Sbjct: 236 QPEDCLDELYDL---------MYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 68/205 (33%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKML-----SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
K+LG+G FG VY Y D G ++AVK + S + + E E++LL + H +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 631 NLVGYF--IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
G E+ + + EYM G++K L A T + RR QG+ YLH
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY--TRQILQGVSYLHSN 125
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSK---VFPIGGTHVSTVVAGTPGYLDPEYF 745
IVHRDIK NIL KL DFG SK + GT + + V GTP ++ PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQ 770
+ K+DV+S ++E++T +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRNLTNLVGY 635
++LGKG FG V+ G L D T VAVK Q K +F +E ++L + H N+ L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI-GCKPPIV 694
+ + ++ E + G+ L +K L ++ ++ A+DAA G+ YL C +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD+ N L+ EN K++DFG+S+ G + S+ + P + PE + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 754 SDVYSFGVVLLEIIT 768
SDV+S+G++L E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 68/268 (25%), Positives = 127/268 (47%), Gaps = 28/268 (10%)
Query: 577 KVLGKGGFG-TVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLV 633
K +G+G FG + +DG Q +K ++ S + E+ EV +L + H N+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
F E+ N+ ++ +Y G+L + ++ ++ ++ L + L+++H I
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKI 122
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRDIK +NI LT++ KL DFG+++V ++ GTP YL PE N K
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPYNNK 181
Query: 754 SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813
SD+++ G VL E+ T+ + G+++N+V +RG + S+
Sbjct: 182 SDIWALGCVLYEMC------------------TLKHAFEAGNMKNLVLKIIRGSYPPVSS 223
Query: 814 WRAVELAVKCAS---RTSSERPNMNEVV 838
+ +L + R +RP++N ++
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVK---MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G+G F VY L D VA+K + + ++ E+ LL +++H N+
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSD-EKASTLSWERRL-QIAMDAAQGLEYLHIGCK 690
+ FIEDN + ++ E G+L Q++ +K L ER + + + +E++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
++HRDIKP N+ +T KL D GL + F T ++V GTP Y+ PE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183
Query: 751 NEKSDVYSFGVVLLEIITSQA 771
N KSD++S G +L E+ Q+
Sbjct: 184 NFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 75/252 (29%), Positives = 114/252 (45%), Gaps = 47/252 (18%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+G G FG VY + VA+K +S S Q ++++ EV+ L ++ H N G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 635 YFIEDNNMGLIYEY-------MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
++ ++ L+ EY + + K L E A+ I A QGL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---------ICHGALQGLAYLHS 133
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
+ +HRDIK NILLTE KLADFG + + + V GTP ++ PE +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 748 DWLNE-----KSDVYSFGVVLLEIITSQAVIVRNENENI-----HIIQTVTNMIAKGD-- 795
++E K DV+S G+ +E+ + + N N HI Q + ++ D
Sbjct: 186 --MDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNDSPTLSSNDWS 240
Query: 796 --IENIVDSCLR 805
N VDSCL+
Sbjct: 241 DYFRNFVDSCLQ 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKML-----SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
K+LG+G FG VY Y +D G ++A K + S + + E E++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 631 NLVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
G + + + + EYM G++K L A T S R+ +G+ YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMSYLHSN 125
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSK---VFPIGGTHVSTVVAGTPGYLDPEYF 745
IVHRDIK NIL KL DFG SK + GT + + V GTP ++ PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQ 770
+ K+DV+S G ++E++T +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 577 KVLGKGGFGTVYHGYL--DDGT--QVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLT 630
++LGKG FG+V L +DG+ +VAVKML + S +EF E + H N+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 631 NLVGYFIEDNNMG------LIYEYMANGNLKQLL----SDEKASTLSWERRLQIAMDAAQ 680
L+G + G +I +M +G+L L E+ TL + ++ +D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GY 739
G+EYL +HRD+ N +L EN+ +ADFGLSK G + + P +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 740 LDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
L E + SDV++FGV + EI+T
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 579 LGKGGFGTVY----HGYL--DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG+G FG V+ H L D VAVK L +S ++F+ E +LL + H+++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLL-------------SDEKASTLSWERRLQIAMDAA 679
G E + +++EYM +G+L + L D L+ + L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPIGGTHVSTVV 733
G+ YL VHRD+ N L+ + L K+ DFG+S+ + +GG + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI- 188
Query: 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
++ PE + +SD++SFGVVL EI T
Sbjct: 189 ----RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKML-----SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
K+LG+G FG VY Y D G ++AVK + S + + E E++LL + H +
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 631 NLVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
G + + + + E+M G++K L A T + R+ +G+ YLH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY--TRQILEGVSYLHSN 125
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSK---VFPIGGTHVSTVVAGTPGYLDPEYF 745
IVHRDIK NIL KL DFG SK + GT + + V GTP ++ PE
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVI 181
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQ 770
+ K+D++S G ++E++T +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 577 KVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HHRN 628
K LG+G FG V ++ + VAVKML ++ + + +E++++ + H+N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD-----EKAS---------TLSWERRLQI 674
+ NL+G ++ + ++ EY A+GNL+ L E AS TL+ + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
A A+G+E+L +HRD+ N+L+TE+ K+ADFGL++ H+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRK 190
Query: 735 GTPGYLD-----PEYFVTDWLNEKSDVYSFGVVLLEIIT 768
T G L PE +SDV+SFGV+L EI T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 577 KVLGKGGFGT---VYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+V+G+G FG V H D ++ S ++ E LL ++ H N+
Sbjct: 6 RVVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
F D ++ ++ EY G+L Q + ++ + LQ + G++++H + +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRV 121
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRDIK +NI LT+N + KL DFG +++ G + T V GTP Y+ PE + N K
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNK 180
Query: 754 SDVYSFGVVLLEIIT 768
SD++S G +L E+ T
Sbjct: 181 SDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 23/200 (11%)
Query: 579 LGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
LG G FG VY + + G A K++ S + ++F E+ +L H N+ L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL---QIAMDAAQ---GLEYLHIGCKP 691
+N + ++ E+ G L ++ L ER L QI Q L +LH
Sbjct: 73 YENKLWILIEFCDGGALDSIM-------LELERGLTEPQIRYVCRQMLEALNFLH---SH 122
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL- 750
++HRD+K NILLT + + KLADFG+S T + GTP ++ PE +
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFK 181
Query: 751 ----NEKSDVYSFGVVLLEI 766
+ K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 58/199 (29%), Positives = 81/199 (40%), Gaps = 11/199 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGT----QVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTN 631
K LG G FG V G VAVK L S +F E ++ + H NL
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L G + + + ++ E G+L L + A+ A G+ YL
Sbjct: 61 LYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-VSTVVAGTP-GYLDPEYFVTDW 749
+HRD+ NILL + + K+ DFGL + P H V P + PE T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 750 LNEKSDVYSFGVVLLEIIT 768
+ SDV+ FGV L E+ T
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 575 FNKVLGKGGFGTVYH------GYLDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRV-HH 626
F K LG G FG V D +VAVKML ++ +E +E+K++ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
N+ NL+G + +I EY G+L L ++ S L+ E L + A+G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 687 I-GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEY 744
C +HRD+ N+LLT K+ DFGL++ +V A P ++ PE
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
+SDV+S+G++L EI +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638
LG+G FG V+ G + T+VA+K L + + F E +++ ++ H L L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 639 DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI 698
+ + ++ EYM+ G+L L E L + + +A A G+ Y+ + VHRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 699 KPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVY 757
+ NIL+ ENL K+ADFGL+++ + + A P + PE + KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 758 SFGVVLLEIITSQAV 772
SFG++L E+ T V
Sbjct: 188 SFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 43/231 (18%)
Query: 573 DNFN--KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSS----SGQGFKEFEAEVKLLMRVH 625
D+F KV+G+G FG V+ D QV A+K+L S Q AE +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ L F ++ ++ L+ EYM G+L LL + R + A L+ +
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA--LDSV 117
Query: 686 H-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT----------------- 727
H +G +HRDIKP+NIL+ + KLADFGL K
Sbjct: 118 HKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 728 -----------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
+ GTP Y+ PE + D +S GV+L E++
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 579 LGKGGFGTVYHGYL-DDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LGKGGFG V + G A K L +G + E K+L +V R + +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F +++ L+ M G+LK + + R + A GLE+LH + IV
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
+RD+KPEN+LL ++ +++D GL+ G AGTPGY+ PE + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 755 DVYSFGVVLLEIITSQA 771
D ++ G L E+I ++
Sbjct: 176 DWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 577 KVLGKGGFGTVYHGYLDDG----TQVAVKMLSS-SSGQGFKEFEAEVKLLMRVHHRNLTN 631
+V+GKG FG VYHG L D AVK L+ + + ++F E ++ H N+ +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 632 LVGYFIEDNNMGLI-YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L+G + L+ YM +G+L+ + E + + + + + A+G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSK-VF------PIGGTHVSTVVAGTPGYLDPE 743
VHRD+ N +L E+ K+ADFGL++ ++ T V ++ E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALE 172
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIITSQA 771
T KSDV+SFGV+L E++T A
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGA 200
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 577 KVLGKGGFGTVYHGYLD----DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTN 631
KV+G G FG V+ G L VA+K L + + ++F +E ++ + H N+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L G + +I EYM NG L + L D S++ + + A G++YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDM 126
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKV---FPIGGTHVSTVVAGTPGYLDPEYFVTD 748
VHRD+ NIL+ NLE K++DFGLS+V P GT+ ++ + PE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-EGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 749 WLNEKSDVYSFGVVLLEIIT 768
SDV+SFG+V+ E+++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRVHHRNLTNLVG 634
LGKGGFG V + G A K L+ + K +E E ++L +VH R + +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLS--DEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F ++ L+ M G+L+ + DE+ R GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
I++RD+KPEN+LL + +++D GL+ V G + AGTPG++ PE + +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 753 KSDVYSFGVVLLEIITSQ 770
D ++ GV L E+I ++
Sbjct: 177 SVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 9e-19
Identities = 59/192 (30%), Positives = 103/192 (53%), Gaps = 13/192 (6%)
Query: 579 LGKGGFGTVYHGYLDDGTQ--VAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVGY 635
+GKG FG V+ G +D+ TQ VA+K++ + ++ + E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
+++D + +I EY+ G+ LL + L + I + +GL+YLH K +H
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK---IH 124
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-TVVAGTPGYLDPEYFVTDWLNEKS 754
RDIK N+LL+E+ E KLADFG++ + T + GTP ++ PE + K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 755 DVYSFGVVLLEI 766
D++S G+ +E+
Sbjct: 183 DIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 76/289 (26%), Positives = 122/289 (42%), Gaps = 49/289 (16%)
Query: 579 LGKGGFGTVYHGYLDD------GTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTN 631
LG+G FG VY G T+VA+K ++ ++S + EF E ++ + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLL----SDE----KASTLSWERRLQIAMDAAQGLE 683
L+G ++ E MA G+LK L + + ++ +Q+A + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPIGGTHVSTVVAGTP 737
YL VHRD+ N ++ E+L K+ DFG+++ + GG + V P
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVI-VRNENENIHIIQTVTNMIAKG 794
L F T KSDV+SFGVVL E+ T Q + NE V + G
Sbjct: 191 ESLKDGVFTT-----KSDVWSFGVVLWEMATLAEQPYQGLSNEE--------VLKFVIDG 237
Query: 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
++ ++C EL C RP E+V+ LK+
Sbjct: 238 GHLDLPENC-------PDKLL--ELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLS--SSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
K LG G FG V+ G + T+VAVK L + S + F E E +++ ++ H L L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQLYA 68
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ + + ++ EYM+ G+L L D + L + +A A G+ Y+ + +
Sbjct: 69 -VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD++ NIL+ + L K+ADFGL+++ + + A P + PE + K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 754 SDVYSFGVVLLEIITSQAV 772
SDV+SFG++L E++T V
Sbjct: 184 SDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 579 LGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGF-KEFEAEVKLLMRVHHRNLTNLVGYF 636
LG+G G+V L + + A+K +++ K+ E+++ + G F
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 637 IE--DNNMGLIYEYMANGNLKQLLSDEKAST-LSWERRL-QIAMDAAQGLEYLHIGCKPP 692
++ +++G+ EY G+L + K E+ L +IA +GL YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRK 125
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA---GTPGYLDPEYFVTDW 749
I+HRDIKP NILLT + KL DFG+S G V+++ GT Y+ PE
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 750 LNEKSDVYSFGVVLLEI 766
+ SDV+S G+ LLE+
Sbjct: 180 YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLM-RVHHRNLTN 631
K + KG FG+VY G A+K+L S + +AE ++M + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F + + L+ EY+ G+ L+ W + Q + G+E LH +
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QR 116
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I+HRDIKPEN+L+ + KL DFGLS+ + GTP YL PE + +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDD 171
Query: 752 EKSDVYSFGVVLLEIIT 768
+ SD +S G V+ E +
Sbjct: 172 KMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 575 FNKVLGKGGFGTV-YHGYLDDGTQVAVKMLS--SSSGQGFKEFEAEVKLLMRVHHRNLTN 631
F +V+GKG +G V + DG Q +K L+ ++S + K E E +LL ++ H N
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH---PN 60
Query: 632 LVGYFI----EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
+V Y ED + ++ + G+L L ++K L + ++ + A L+YLH
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH- 119
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
+ I+HRD+K +N+ LT K+ D G+++V ST++ GTP Y+ PE F
Sbjct: 120 --EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 748 DWLNEKSDVYSFGVVLLEIIT 768
N KSDV++ G + E+ T
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 32/210 (15%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVG 634
+V+G+G +G VY + G VA+K++ + +E + E +L + +H N+ G
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYG 70
Query: 635 YFIEDNNMG------LIYEYMANGNLKQLLSDEKASTLSWERRL---QIAM---DAAQGL 682
FI+ N G L+ E G++ L+ +RL IA + +GL
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVK----GLRKKGKRLKEEWIAYILRETLRGL 126
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTHVSTVVAGTPGYL 740
YLH + ++HRDIK +NILLT+N E KL DFG+S +G + GTP ++
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 741 DPEYFVTDWLNE-----KSDVYSFGVVLLE 765
PE D + +SDV+S G+ +E
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 577 KVLGKGGFGTV----YHGYLDD-GTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLT 630
+VLG+G FG V Y D G VAVK L GQ ++ E+ +L ++H N+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 631 NLVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
G E + LI EY+ G+L+ L K L+ + L A +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH-- 124
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG-TPGYLDPEYFVT 747
+HRD+ N+LL + K+ DFGL+K P G + G +P + ++
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAV 179
Query: 748 DWLNE-----KSDVYSFGVVLLEIIT 768
+ L E SDV+SFGV L E++T
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 36/221 (16%)
Query: 577 KVLGKGGFGTVYHGY---LDDG-----TQVAVKMLSS-SSGQGFKEFEAEVKLLMRV-HH 626
K LG+G FG V LD T+VAVKML S ++ + + +E++++ + H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKA--------------STLSWERRL 672
+N+ NL+G +D + +I EY + GNL++ L + LS++ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732
A A+G+EYL +HRD+ N+L+TE+ K+ADFGL++ H+
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYY 196
Query: 733 VAGTPG-----YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
T G ++ PE +SDV+SFGV+L EI T
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 575 FNKVLGKGGFGTVY-------HGYLDDGTQ----------VAVKMLSSSSGQGFK-EFEA 616
F + LG+G FG V+ ++D VAVKML + + + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS---------DEKASTLS 667
E+K++ R+ N+ L+ I + + +I EYM NG+L Q LS T+S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 668 WERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727
+ + +A A G++YL VHRD+ N L+ +N K+ADFG+S+ G
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 728 HVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ A P ++ E + SDV++FGV L EI+T
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 579 LGKGGFGTVYHGY------LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG+G FG V+ D VAVK L + K+F+ E +LL + H ++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSD--------------EKASTLSWERRLQIAMDA 678
G + + + +++EYM +G+L + L + L + L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPIGGTHVSTV 732
A G+ YL VHRD+ N L+ NL K+ DFG+S+ + +GG H
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-HTMLP 188
Query: 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ P PE + +SDV+SFGV+L EI T
Sbjct: 189 IRWMP----PESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 64/200 (32%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 579 LGKGGFGTVYHGY--LDDGTQ--VAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
LG G FG+V G + G + VAVK L G KEF E ++ ++ H + L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDE---KASTLSWERRLQIAMDAAQGLEYLHIGCK 690
G + M L+ E G L + L S L E Q+AM G+ YL
Sbjct: 63 GVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAM----GMAYLE-SKH 115
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT-P-GYLDPEYFVTD 748
VHRD+ N+LL +AK++DFG+S+ G + AG P + PE
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 749 WLNEKSDVYSFGVVLLEIIT 768
+ KSDV+S+GV L E +
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 75/302 (24%), Positives = 121/302 (40%), Gaps = 40/302 (13%)
Query: 562 HFTYSEV-LKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKML-SSSSGQGFKEFEAEVK 619
+ EV L D K D VAVK+L +S ++F EVK
Sbjct: 15 EGQFGEVHLCEADGLQDFSEKAFAENDNA---DAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 620 LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD---------EKASTLSWER 670
+L R+ N+ L+G D + +I EYM NG+L Q L + +LS+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPI 724
L +A A G+ YL VHRD+ N L+ +N K+ADFG+S+ + +
Sbjct: 132 LLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII 784
G + ++ E + KSDV++FGV L EI+T + +I
Sbjct: 189 QGRAPLPI-----RWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243
Query: 785 QTVTNMIAKGDIENIVD---SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841
+ + + + +C + + EL ++C R +RP E+ L
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPNCPKDIY---------ELMLECWRRDEEDRPTFREIHLFL 294
Query: 842 KE 843
+
Sbjct: 295 QR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 33/272 (12%)
Query: 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRNLTNLVGYF 636
+G+G FG V+ G L D T VAVK + K +F E ++L + H N+ L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 637 IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHR 696
+ + ++ E + G+ L E L + +Q+ +AA G+EYL +HR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 697 DIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG-------YLDPEYFVTDW 749
D+ N L+TE K++DFG+S+ G V A T G + PE
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG------VYASTGGMKQIPVKWTAPEALNYGR 172
Query: 750 LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809
+ +SDV+SFG++L E + AV N + Q I +G + C
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIEQGVRLPCPELC------ 221
Query: 810 IESAWRAVELAVKCASRTSSERPNMNEVVTEL 841
++ +R L +C +RP+ + V EL
Sbjct: 222 PDAVYR---LMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 1e-17
Identities = 76/241 (31%), Positives = 111/241 (46%), Gaps = 25/241 (10%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+G G FG VY + VA+K +S S Q ++++ EVK L R+ H N G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
++ ++ L+ EY G+ LL K E I A QGL YLH ++
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH---SHNMI 147
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT---DWLN 751
HRDIK NILLTE + KLADFG + + + V GTP ++ PE + +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYD 202
Query: 752 EKSDVYSFGVVLLEIITSQAVIVRNENEN---IHIIQTVTNMIAKGD----IENIVDSCL 804
K DV+S G+ +E+ + + N N HI Q + + + N VDSCL
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 805 R 805
+
Sbjct: 262 Q 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 578 VLGKGGFGTVYHGYLDDGT-----QVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTN 631
+L +G FG +++G L D +V VK + + + E LL + H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 632 LVGYFIEDNNMGLI-YEYMANGNLKQLLSD------EKASTLSWERRLQIAMDAAQGLEY 684
++ IED + Y YM GNLK L LS ++ + +A+ A G+ Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK-VFP-----IGGTHVSTVVAGTPG 738
LH K ++H+DI N ++ E L+ K+ D LS+ +FP +G V
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV-----K 184
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
++ E V + SDV+SFGV+L E++T
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 57/191 (29%), Positives = 101/191 (52%), Gaps = 11/191 (5%)
Query: 579 LGKGGFGTVYHGYLDDGTQ--VAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVGY 635
+GKG FG V+ G +D+ TQ VA+K++ + ++ + E+ +L + +T G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
+++ + +I EY+ G+ LL +A + + + +GL+YLH K +H
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKK---IH 124
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSD 755
RDIK N+LL+E + KLADFG++ +T V GTP ++ PE + K+D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 756 VYSFGVVLLEI 766
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638
LG+G FG V+ G + T+VA+K L + + F E +++ ++ H L L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 639 DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI 698
+ + ++ E+M G+L L + L + + +A A G+ Y+ + +HRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 699 KPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVY 757
+ NIL+ +NL K+ADFGL+++ + + A P + PE + KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 758 SFGVVLLEIITSQAV 772
SFG++L E++T V
Sbjct: 188 SFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 59/191 (30%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 579 LGKGGFGTVYHGYLDDGTQ--VAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVGY 635
+GKG FG VY G +D+ T+ VA+K++ + ++ + E+ +L + +T G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
+++ + +I EY+ G+ LL K L I + +GL+YLH K +H
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK---IH 124
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSD 755
RDIK N+LL+E + KLADFG++ +T V GTP ++ PE + K+D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKAD 183
Query: 756 VYSFGVVLLEI 766
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSG-QGFKEFEA-EVKLLMRVHHRNLTNLVGY 635
+G+G +G VY G VA+K + + +GF E+KLL ++ H N+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 636 FIED--NNMGLIYEYMANGNLKQLLSDEKAS-TLSWERRL--QIAMDAAQGLEYLHIGCK 690
++ +++EYM + +L LL + T S + Q+ +GL+YLH
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLL----EGLQYLH-SNG 120
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTHVSTVVAGTPGYLDPE----- 743
I+HRDIK NIL+ + KLADFGL++ + + + V+ T Y PE
Sbjct: 121 --ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLLGA 176
Query: 744 --YFVTDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHII 784
Y + D++S G +L E+ + + E E + I
Sbjct: 177 TRY------GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS---SSSGQGFKEFEA---EVKLLMRVHHRNL 629
+ LG G F + Y + GT +AVK ++ ++S + + EA E++L+ R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSD----EKASTLSWERRLQIAMDAAQGLEYL 685
++G ED++ L E+MA G++ LLS ++A +++ +L +GL YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 686 HIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTV---VAGTPGYLD 741
H + I+HRD+K N+L+ + ++ADFG + GT + GT ++
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIITSQ 770
PE + DV+S G V++E+ T++
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 39/229 (17%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQ-----------------VAVKMLSSSSGQGFK-EFEA 616
F + LG+G FG V+ + + VAVK+L + + + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS----DEKAS-------- 664
EVK+L R+ N+ L+G ++++ + +I EYM NG+L Q LS D+K
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 665 -----TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719
+S+ L +A+ A G++YL VHRD+ N L+ ENL K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 720 KVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
+ G + A P ++ E + SDV++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 11/195 (5%)
Query: 579 LGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
LG GGFG V A+K + + E +E ++L +H + L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F + + ++ EY G L +L D + + R IA EYLH I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIAC-VVLAFEYLH---NRGII 115
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
+RD+KPEN+LL N KL DFG +K G T GTP Y+ PE + +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC-GTPEYVAPEIILNKGYDFSV 173
Query: 755 DVYSFGVVLLEIITS 769
D +S G++L E++T
Sbjct: 174 DYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 575 FNKVLGKGGFGTVYHGY------LDDGTQVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHR 627
K LG+G FG V T VAVKML ++ ++ +E LL +V+H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL------------------------SDEKA 663
++ L G +D + LI EY G+L+ L DE+A
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 664 STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723
T+ + A ++G++YL + +VHRD+ N+L+ E + K++DFGLS+
Sbjct: 124 LTMG--DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 724 IGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
++V P ++ E +SDV+SFGV+L EI+T
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 65/195 (33%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 579 LGKGGFGTVYHGYLDDGTQ-VAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+G G FG VY + VAVK +S S Q ++++ EVK L ++ H N G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+++++ L+ EY G+ LL K E I A QGL YLH +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHNM---I 143
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT---DWLN 751
HRDIK NILLTE + KLADFG + + V GTP ++ PE + +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYD 198
Query: 752 EKSDVYSFGVVLLEI 766
K DV+S G+ +E+
Sbjct: 199 GKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 579 LGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFE----------AEVKLLMRVHHR 627
+G+G +G V+ + G VA+K F E E E+++L ++ H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK--------FVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
NL NL+ F + L++EY + L +L ++ + +I Q + + H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
K +HRD+KPENIL+T+ + KL DFG +++ G + VA T Y PE V
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVG 174
Query: 748 D-WLNEKSDVYSFGVVLLEIITSQAV 772
D DV++ G V E++T Q +
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF 636
VLGKG +G VY L ++A+K + + + E+ L + HRN+ +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 637 IEDNNMGLIYEYMANGNLKQLLS------DEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
E+ + E + G+L LL + T+ + + QI +GL+YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---D 126
Query: 691 PPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
IVHRDIK +N+L+ T + K++DFG SK G + GT Y+ PE V D
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPE--VIDK 183
Query: 750 ----LNEKSDVYSFGVVLLEIITSQ 770
+D++S G ++E+ T +
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 38/222 (17%)
Query: 577 KVLGKGGFGTVYHG--------YLDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRV--H 625
K LG+G FG V D VAVKML +++ + + +E++L M++
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIGK 76
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAST--------------LSWERR 671
H+N+ NL+G ++ + +I EY A GNL++ L + LS++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
+ A A+G+EYL +HRD+ N+L+TE+ K+ADFGL++ G +
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDY 189
Query: 732 VVAGTPG-----YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ G ++ PE +SDV+SFG+++ EI T
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
LG G FG VY + G A K++ + S + +++ E+++L +H + L+G F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL---QIAMDAAQGLEYLHIGCKPPIV 694
D + ++ E+ G + A L +R L QI + Q LE L I+
Sbjct: 80 WDGKLWIMIEFCPGGAVD-------AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV-----VAGTPGYLDPEYFVTDW 749
HRD+K N+LLT + + KLADFG+S +V T+ GTP ++ PE + +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 750 LNE-----KSDVYSFGVVLLEI 766
+ + K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 33/258 (12%)
Query: 594 DGTQVAVKML---SSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN----MGLIY 646
+ +V ++ E E+K L R+ N+ + G+ I+ + + LI
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT 706
EY G L+++L EK LS++ +L +A+D +GL L+ P ++++ + L+T
Sbjct: 102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT 157
Query: 707 ENLEAKLADFGLSKVFPIGG-THVSTVVAGTPGYLDPEYF--VTDWLNEKSDVYSFGVVL 763
EN + K+ GL K+ +V+ +V Y + + K D+YS GVVL
Sbjct: 158 ENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212
Query: 764 LEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKC 823
EI T + + EN + + ++I + + L EI+ + C
Sbjct: 213 WEIFTGK---IPFENLT---TKEIYDLIINKNNSLKLP--LDCPLEIKC------IVEAC 258
Query: 824 ASRTSSERPNMNEVVTEL 841
S S +RPN+ E++ L
Sbjct: 259 TSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 66/228 (28%), Positives = 116/228 (50%), Gaps = 15/228 (6%)
Query: 573 DNFNKVLGKGGFGTVYH-GYLDDGTQVAVK-MLSSSSGQGFKEFEA-EVKLLMRVHHRNL 629
+N V G+G +G V + + G VA+K L S + K+ E+++L ++ H NL
Sbjct: 4 ENLGLV-GEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAST-LSWERRLQIAMDAAQGLEYLHIG 688
NL+ F + L++E++ + L L EK L R + +G+E+ H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
I+HRDIKPENIL++++ KL DFG ++ G + VA T Y PE V D
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGD 175
Query: 749 WLNEKS-DVYSFGVVLLEIITSQAVIVRNENENI--HIIQTVTNMIAK 793
++ D+++ G ++ E++T + + + + + HII+ + N+I +
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 27/202 (13%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
LG G FG VY + G A K++ + S + +++ E+ +L H N+ L+ F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL---QIAMDAAQGLEYLHIGCKPPIV 694
+NN+ ++ E+ A G + ++ L ER L QI + Q LE L+ + I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVM-------LELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV-----VAGTPGYLDPEYFVTDW 749
HRD+K NIL T + + KLADFG+S + T+ GTP ++ PE + +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS------AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 750 LNE-----KSDVYSFGVVLLEI 766
+ K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 575 FNKVLGKGGFGTVY-------HGYLDDGTQ--------VAVKMLSSSSGQGFK-EFEAEV 618
+ LG+G FG V+ +L +G VAVKML + + + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 619 KLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD-EKASTL---------SW 668
K++ R+ + N+ L+G + D+ + +I EYM NG+L Q LS E ST S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 669 ERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728
L +A+ A G++YL VHRD+ N L+ + K+ADFG+S+ G +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 729 VSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
A P ++ E + SDV++FGV L E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 567 EVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
E+ + + K LG G FG V+ + T+VAVK + S + F AE ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
L L + + +I E+MA G+L L ++ S + + + A+G+ ++
Sbjct: 61 DKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYF 745
+ +HRD++ NIL++ +L K+ADFGL++V + + A P + PE
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI 175
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
KSDV+SFG++L+EI+T
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 73/270 (27%), Positives = 128/270 (47%), Gaps = 29/270 (10%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYF 636
+G+G GTVY + G +VA+K ++ Q KE L+MR + H N+ N + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 637 IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHR 696
+ + + ++ EY+A G+L ++++ + + + + + Q LE+LH ++HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 697 DIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDV 756
DIK +NILL + KL DFG + ST+V GTP ++ PE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 757 YSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN----------IVDSCLRG 806
+S G++ +E++ + + NEN + TN +++N ++ CL
Sbjct: 199 WSLGIMAIEMVEGEPPYL-NENPLRALYLIATN--GTPELQNPEKLSAIFRDFLNRCLE- 254
Query: 807 GFEIESAWRAVELA----VKCASRTSSERP 832
++E A EL +K A SS P
Sbjct: 255 -MDVEKRGSAKELLQHPFLKIAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-16
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 22/196 (11%)
Query: 593 DDGTQVAVKMLSSSSGQG---FKEFEAEVKLLMRVHHRNLTNLVGYFI-EDNNMGLIYEY 648
G +VA+K+L + + + F E L R++H N+ L+ + ++EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708
+ L+++L+ + A RL Q L+ L IVHRD+KP+NI++++
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLM-----LQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 709 ---LEAKLADFGLSKVFPIGGTH--------VSTVVAGTPGYLDPEYFVTDWLNEKSDVY 757
AK+ DFG+ + P G +T V GTP Y PE + + SD+Y
Sbjct: 116 GVRPHAKVLDFGIGTLLP--GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 758 SFGVVLLEIITSQAVI 773
++G++ LE +T Q V+
Sbjct: 174 AWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 72/284 (25%), Positives = 115/284 (40%), Gaps = 36/284 (12%)
Query: 576 NKVLGKGGFGTVYHG-YL---DDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLT 630
+ +G+G FG VY G Y+ ++ VAVK + + +E F E ++ + H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH-IGC 689
L+G I +N + ++ E G L+ L K S L + + + L YL
Sbjct: 71 KLIG-VITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESKRF 128
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
VHRDI N+L++ KL DFGLS+ + ++ ++ PE
Sbjct: 129 ----VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 750 LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN-----IVDSCL 804
SDV+ FGV + EI+ + Q V N G IEN + +C
Sbjct: 185 FTSASDVWMFGVCMWEIL----------MLGVKPFQGVKNNDVIGRIENGERLPMPPNC- 233
Query: 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848
L KC + S+RP E+ +L + L E
Sbjct: 234 --------PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 573 DNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
DNF K+ G+G G V G QVAVK + Q + EV ++ H N+
Sbjct: 22 DNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
+ ++ + + ++ E++ G L +++ + ++ E+ + + + L +LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLAVLKALSFLH---AQ 134
Query: 692 PIVHRDIKPENILLTENLEAKLADFG----LSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
++HRDIK ++ILLT + KL+DFG +SK P + V GTP ++ PE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISR 189
Query: 748 DWLNEKSDVYSFGVVLLEII 767
+ D++S G++++E++
Sbjct: 190 LPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 577 KVLGKGGFGTVYHGYL--------DDGTQVAVKMLSS-SSGQGFKEFEAEVKLLMRV-HH 626
K LG+G FG V + VAVKML ++ + + +E++++ + H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKA--------------STLSWERRL 672
+N+ NL+G +D + ++ EY + GNL++ L + L+++ +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732
A A+G+EYL +HRD+ N+L+TE+ K+ADFGL++ + T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 733 VAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
P ++ PE +SDV+SFGV+L EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 579 LGKGGFGTVYHGYLDDGTQVA---VKMLSSSSGQGFKEFEA-----EVKLLMRVHHRNLT 630
LGKG FGTVY + D VA +K+L E E +LL ++ H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAS--TLSWERRLQIAMDAAQGLEYLHIG 688
F+E + +I EY +L L + K + TLS + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
+ I+HRD+K +NI L NL K+ DFG+S+ +G ++T GTP Y+ PE
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 749 WLNEKSDVYSFGVVLLEI 766
+ KSD++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 577 KVLGKGGFGTVYHGYL--------DDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRV-HH 626
K LG+G FG V + VAVKML ++ + + +E++++ + H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKA--------------STLSWERRL 672
+N+ NL+G +D + +I EY + GNL++ L + ++++ +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732
A+G+EYL +HRD+ N+L+TEN K+ADFGL++ + T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 733 VAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
P ++ PE +SDV+SFGV++ EI T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 71/241 (29%), Positives = 109/241 (45%), Gaps = 25/241 (10%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+G G FG VY + + VA+K +S S Q ++++ EV+ L ++ H N G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
++ ++ L+ EY G+ LL K E + A QGL YLH ++
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLH---SHNMI 137
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT---DWLN 751
HRD+K NILL+E KL DFG + + V GTP ++ PE + +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYD 192
Query: 752 EKSDVYSFGVVLLEIITSQAVIVRNENEN---IHIIQTVTNMIAKGD----IENIVDSCL 804
K DV+S G+ +E+ + + N N HI Q + + G N VDSCL
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 805 R 805
+
Sbjct: 252 Q 252
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 17/196 (8%)
Query: 579 LGKGGFGTVYH-GYLDDGTQVAVKML---SSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LG G G+V ++ GT +A K++ + SS + K+ E++++ + + G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYG 70
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F+ +NN+ + E+M G+L ++ +K + E +IA+ +GL YL+ I+
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIM 126
Query: 695 HRDIKPENILLTENLEAKLADFGLSK--VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
HRDIKP NIL+ + KL DFG+S + I T V GT Y+ PE
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTV 181
Query: 753 KSDVYSFGVVLLEIIT 768
KSDV+S G+ ++E+
Sbjct: 182 KSDVWSLGISIIELAL 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 22/198 (11%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
+G G +G VY ++ G A+K++ G+ F + E+ ++ H N+ G ++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRD 697
+ + + E+ G+L+ + LS + ++ + QGL YLH K +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 698 IKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA------GTPGYLDPEYFVTD--- 748
IK NILLT+N KLADFG+S ++ +A GTP ++ PE +
Sbjct: 132 IKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 749 WLNEKSDVYSFGVVLLEI 766
N+ D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 6e-16
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 55/225 (24%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMR 623
K +G G +G V G +VA+K + F+ E+KLL
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRH 55
Query: 624 VHHRNLTNLVGYFIED--NNMGLIY---EYMANGNLKQLLSDEKASTLSWERRLQIAMDA 678
+ H N+ L+ + +Y E M +L +++ + L+ + +Q +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLT-DDHIQYFL-- 109
Query: 679 AQ---GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
Q GL+YLH ++HRD+KP NIL+ N + K+ DFGL++
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFL 163
Query: 736 TPGYLDPEYFVTDW-------LNEKS-----DVYSFGVVLLEIIT 768
T EY VT W L+ D++S G + E++T
Sbjct: 164 T------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFE---AEVKLL-MRVHHRNLTN 631
K+LGKG FG V+ L Q A+K L + E E ++L + H LT+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F N+ + EY+ G+L + + R A + GL++LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SK 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
IV+RD+K +NILL + K+ADFG+ K +G T GTP Y+ PE + N
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYN 174
Query: 752 EKSDVYSFGVVLLEIITSQA 771
D +SFGV+L E++ Q+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVGY 635
+G G +GTVY G VA+K + + + EV LL R+ + N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 636 FI--------EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
+ + L++E++ + +L+ L L E + +GL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
C IVHRD+KPENIL+T + KLADFGL++++ VV T Y PE +
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLLQ 181
Query: 748 DWLNEKSDVYSFGVVLLEI 766
D++S G + E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 578 VLGKGGFGTVYHG-YLDDGTQVAVKM--LSSSSGQGFKE-------FEAEVKLLMRVHHR 627
++G G FG+VY G G +AVK L S S E+ LL + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYL 685
N+ +G ++ +++ + EY+ G++ LL++ A + R QI +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA-----GTPGYL 740
H I+HRDIK NIL+ K++DFG+SK T A G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITS 769
PE K+D++S G +++E++T
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKE---FEAEVKLLMRVHHRNLTNL 632
KV+G+G FG V L + +V A+K+L+ E F E +L+ ++ +T L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLS---DEKASTLS--WERRLQIAMDAAQGLEYLHI 687
F ++NN+ L+ +Y G+L LLS D ++ + + IA+D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
VHRDIKP+NIL+ N +LADFG GT S+V GTP Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 748 -----DWLNEKSDVYSFGVVLLEII 767
+ D +S GV + E++
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
+G G +G VY L G AVK++ G F + E+ ++ H N+ G ++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGCKPPIV 694
+ + EY G+L+ + LS LQIA + QGL YLH K +
Sbjct: 77 SREKLWICMEYCGGGSLQDIY--HVTGPLS---ELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 695 HRDIKPENILLTENLEAKLADFGL-SKVFPIGGTHVSTVVAGTPGYLDPEYFVTD---WL 750
HRDIK NILLT+N + KLADFG+ +K+ S + GTP ++ PE +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGY 186
Query: 751 NEKSDVYSFGVVLLEIITSQ 770
N+ D+++ G+ +E+ Q
Sbjct: 187 NQLCDIWAVGITAIELAELQ 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 66/192 (34%), Positives = 92/192 (47%), Gaps = 40/192 (20%)
Query: 573 DNFN--KVLGKGGFGTVYHGYLDDGTQV-AVK------MLSSSSGQGFKEFEAEVKLLMR 623
D+F KV+G+G FG V + + QV A+K ML + F+E E +L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFRE---ERDVLVN 57
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQ---------- 673
R +TNL F ++NN+ L+ +Y G+L LLS +E RL
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLS-------KFEDRLPEDMARFYLAE 110
Query: 674 --IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
+A+D+ L Y VHRDIKP+N+LL +N +LADFG GT S
Sbjct: 111 MVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161
Query: 732 VVAGTPGYLDPE 743
V GTP Y+ PE
Sbjct: 162 VAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 579 LGKGGFGTV----YHGYLDD-GTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG+G FG V Y D+ G QVAVK L S G + + E+++L ++H N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 633 VGYFIED--NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
G ED N + LI E++ +G+LK+ L K ++ +++L+ A+ +G++YL G +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL--GSR 128
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH--VSTVVAGTPGYLDPEYFVTD 748
VHRD+ N+L+ + K+ DFGL+K + V + + PE +
Sbjct: 129 Q-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 749 WLNEKSDVYSFGVVLLEIIT 768
SDV+SFGV L E++T
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 12/206 (5%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR-NLTNL 632
F K+ G+G GTVY + G +VA+K ++ Q KE L+MR + N+ N
Sbjct: 24 FEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNY 81
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+ ++ + + ++ EY+A G+L ++++ + + + + + Q L++LH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQ 135
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
++HRDIK +NILL + KL DFG + ST+V GTP ++ PE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNEN 778
K D++S G++ +E++ + + NEN
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYL-NEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEA-EVKLLMRV---HHRNLTNL 632
+G+G +GTVY L+ G VA+K + S +G E+ LL ++ H N+ L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 633 --VGYFIEDNN---MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
V + + + L++E++ + +L LS L E + +G+++LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
IVHRD+KP+NIL+T + + K+ADFGL++++ S VV T Y PE +
Sbjct: 126 HR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPEVLLQ 180
Query: 748 DWLNEKSDVYSFGVVLLEI 766
D++S G + E+
Sbjct: 181 SSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVGY 635
+G+G G V+ + G VA+K ++ +G +A E+K L H + L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKAS-TLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F + L+ EYM + L ++L DE+ + + + +G+ Y+H I+
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANGIM 121
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
HRD+KP N+L++ + K+ADFGL+++F + + T Y PE
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 45/299 (15%)
Query: 567 EVLKITDNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGFK-EFEAEVK 619
EV + ++ LG+G FG VY G + T+VA+K ++ ++ + EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 620 LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL----SDEKASTL----SWERR 671
++ + ++ L+G + +I E M G+LK L + + + + S ++
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFPIG 725
+Q+A + A G+ YL+ VHRD+ N ++ E+ K+ DFG+++ + G
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHII 784
G + V +P L F T SDV+SFGVVL EI T ++ NE
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTY-----SDVWSFGVVLWEIATLAEQPYQGMSNEQ---- 229
Query: 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
V + +G + + D+C F EL C RP+ E+++ +KE
Sbjct: 230 --VLRFVMEGGLLDKPDNCPDMLF---------ELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 577 KVLGKGGFGTVYHGYL-------DDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHR 627
KVLG+G FG V+ L D G A+K+L ++ + E +L V+H
Sbjct: 2 KVLGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM-DAAQGLEYLH 686
+ L F + + LI +++ G+L LS E T E ++ + + A L++LH
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALDHLH 115
Query: 687 -IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
+G I++RD+KPENILL E KL DFGLSK I + GT Y+ PE
Sbjct: 116 SLG----IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVV 170
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
+ +D +SFGV++ E++T
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 35/286 (12%)
Query: 577 KVLGKGGFGTVYHGYL---DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTN 631
K LG+G FG+V G L D +VAVK + + + ++F +E + H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 632 LVGYFIED-NNMG-----LIYEYMANGNLKQLLSDEKAST----LSWERRLQIAMDAAQG 681
L+G ++ + G +I +M +G+L L + L + ++ D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYL 740
+EYL +HRD+ N +L EN+ +ADFGLSK G + +A P ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENI 799
E KSDV+SFGV + EI T Q EN I+ + + +G+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY------DYLRQGNRLKQ 235
Query: 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
CL G + + S C +RP+ + EL++ L
Sbjct: 236 PPDCLDGLYSLMS---------SCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 49/298 (16%)
Query: 572 TDNFNKVLGKGGFGTVYHGYL-----DDGTQ-VAVKMLSSSSGQGFKE-FEAEVKLLMRV 624
T F + LG+ FG VY G+L + TQ VA+K L + +E F+ E + R+
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL------------SDEKA--STLSWER 670
H N+ L+G ++ + +I+ Y ++ +L + L D+K STL
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL------SKVFPI 724
+ I A G+E+L +VH+D+ N+L+ + L K++D GL + + +
Sbjct: 126 FVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII 784
G + + ++ PE + + SD++S+GVVL E+ S + N
Sbjct: 183 MGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVF-SYGLQPYCGYSN---- 232
Query: 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842
Q V MI + D C AW L ++C + S RP ++ + L+
Sbjct: 233 QDVIEMIRNRQVLPCPDDC--------PAW-VYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 576 NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--------------EVKL 620
LG+G +G V Y G VA+K + + E+K+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER--RLQIAMDA 678
+ + H N+ LV ++E + + L+ + MA +LK+++ + T S + LQI
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQIL--- 129
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF---PIGGTH------- 728
GL LH K +HRD+ P NI + K+ADFGL++ + P T
Sbjct: 130 -NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 729 -----VSTVVAGTPGYLDPE-YFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE 779
S VV T Y PE + + D++S G + E++T + + ENE
Sbjct: 186 RREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP-GENE 239
|
Length = 335 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFEA---EVKLL-MRVHHRNLTN 631
KVLGKG FG V L + A+K L + E E ++L + H LT+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F ++ + EY+ G+L + R A + GL++LH K
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KK 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I++RD+K +N+LL ++ K+ADFG+ K G ST GTP Y+ PE N
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYN 174
Query: 752 EKSDVYSFGVVLLEIITSQA 771
E D +SFGV+L E++ Q+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 577 KVLGKGGFGTVY-----HGYLDDGTQVAVKMLSSS----SGQGFKEFEAEVKLLMRVHHR 627
KVLGKGG+G V+ G D G A+K+L + + + +AE +L V H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNL-KQL------LSDEKASTLSWERRLQIAMDAAQ 680
+ +L+ F + LI EY++ G L L + D LS +I++
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISL---- 111
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
LE+LH + I++RD+KPENILL KL DFGL K GT V+ GT Y+
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYM 167
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITSQ 770
PE + + D +S G ++ +++T
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 12/206 (5%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR-NLTNL 632
F K+ G+G GTVY + G +VA++ ++ Q KE L+MR + N+ N
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNY 82
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+ ++ + + ++ EY+A G+L ++++ + + + + + Q LE+LH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
++HRDIK +NILL + KL DFG + ST+V GTP ++ PE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNEN 778
K D++S G++ +E+I + + NEN
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYL-NEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 577 KVLGKGGFGTVY----HGYLDDGTQVAVKMLSSSS-GQGFKEFE---AEVKLLMRVHHRN 628
+VLG G +G V+ G D G A+K+L ++ Q K E E ++L V
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 629 -LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
L L F D + LI +Y+ G L L + T S E R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLH- 122
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
+ I++RDIK ENILL L DFGLSK F + GT Y+ PE
Sbjct: 123 --QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 748 --DWLNEKSDVYSFGVVLLEIIT 768
++ D +S GV+ E++T
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 579 LGKGGFGTVYHGYLDDGTQ--VAVKMLS----------SSSGQGFKEFEAEVKLLM-RVH 625
LG G FG VY + Q +A+K ++ + + +EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLE 683
H N+ F+E++ + ++ + + L + + EK + ER I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
YLH + IVHRD+ P NI+L E+ + + DFGL+K T V GT Y PE
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPE 183
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIITSQAV 772
+ EK+DV++FG +L ++ T Q
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637
+G+G GTV+ + G +VA+K ++ + E+ ++ + + N+ N + F+
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRD 697
+ + ++ EY+A G+L ++++ + + + + + Q LE+LH ++HRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 698 IKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVY 757
IK +N+LL + KL DFG + ST+V GTP ++ PE K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 758 SFGVVLLEIITSQAVIVRNEN 778
S G++ +E++ + + NEN
Sbjct: 200 SLGIMAIEMVEGEPPYL-NEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 568 VLKITDNFNKV--LGKGGFGTVYHGY-LDDGTQVAVK--MLSSSSGQGFKEFEAEVKLLM 622
V +IT+ + + +G G FG V G VA+K M S+ K E+KLL
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 623 RVHHRNLTNLVGYFI---EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
+ H N+ +L FI ED + + E + +L +LL + L +
Sbjct: 65 HLRHENIISLSDIFISPLED--IYFVTELLGT-DLHRLL---TSRPLEKQFIQYFLYQIL 118
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+GL+Y+H +VHRD+KP NIL+ EN + K+ DFGL+++ T T Y
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYY 171
Query: 740 LDPEYFVTDW--LNEKSDVYSFGVVLLEII 767
PE +T W + + D++S G + E++
Sbjct: 172 RAPEIMLT-WQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 13/194 (6%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+G+GG+G V+ D G VA+K + S E E +L L L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F +D + L EY+ G+ + LL++ + R M A ++ LH + +
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALH---ELGYI 123
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
HRD+KPEN L+ + KL DFGLSK G + V G+P Y+ PE +
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179
Query: 755 DVYSFGVVLLEIIT 768
D +S G +L E +
Sbjct: 180 DYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 573 DNFNKVLGKGGFGTV-YHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
D+F K+ G+G G V G QVAVK + Q + EV ++ HH N+ +
Sbjct: 25 DSFIKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
+ ++ + + ++ E++ G L +++ + ++ E+ + + + L YLH
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLH---NQ 137
Query: 692 PIVHRDIKPENILLTENLEAKLADFG----LSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
++HRDIK ++ILLT + KL+DFG +SK P + GTP ++ PE
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-----KRKSLVGTPYWMAPEVISR 192
Query: 748 DWLNEKSDVYSFGVVLLEIITSQ 770
+ D++S G++++E+I +
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 574 NFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA-------EVKLLMR 623
NF KV +G+G +G VY G VA+K + + E E E+ LL
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-----ETEGVPSTAIREISLLKE 55
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
++H N+ L+ +N + L++E++ + +LK+ + S + QGL
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTHVSTVVAGTPGYLD 741
+ H ++HRD+KP+N+L+ KLADFGL++ F P+ T+ VV T Y
Sbjct: 115 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVV--TLWYRA 168
Query: 742 PEYFV-TDWLNEKSDVYSFGVVLLEIITSQAV 772
PE + + + D++S G + E++T +A+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 577 KVLGKGGFGTV------YHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT 630
+VLGKGGFG V G + ++ K + G+ E ++ L +V+ R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVV 63
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
+L + + + L+ M G+LK + + R + A + GLE LH +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---Q 120
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
IV+RD+KPENILL ++ +++D GL+ P G T V GT GY+ PE +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERY 178
Query: 751 NEKSDVYSFGVVLLEIITSQA 771
D ++ G +L E+I Q+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 577 KVLGKGGFGTV------YHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT 630
+VLGKGGFG V G + ++ K + G+ E ++ L +V+ + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVV 63
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
NL + + + L+ M G+LK + + ER L A + GLE LH +
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---R 120
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
V+RD+KPENILL + +++D GL+ P G + V GT GY+ PE
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRY 178
Query: 751 NEKSDVYSFGVVLLEIITSQA 771
D + G ++ E+I Q+
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQ----VAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTN 631
KV+G G FG V G L + VA+K L + + + ++F +E ++ + H N+ +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L G + + ++ EYM NG+L L + + + + A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT-P-GYLDPEYFVTDW 749
VHRD+ NIL+ NL K++DFGLS+V T G P + PE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 750 LNEKSDVYSFGVVLLEIIT 768
SDV+S+G+V+ E+++
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+N+ K+ G+G G V G QVAVKM+ Q + EV ++ H+N+
Sbjct: 24 ENYIKI-GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
+ ++ + ++ E++ G L ++S + L+ E+ + Q L YLH
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQ 136
Query: 692 PIVHRDIKPENILLTENLEAKLADFG----LSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
++HRDIK ++ILLT + KL+DFG +SK P + V GTP ++ PE
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISR 191
Query: 748 DWLNEKSDVYSFGVVLLEIITSQ 770
+ D++S G++++E++ +
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEF---EAEVKLLM---RV----- 624
KVLGKG FG V L ++ AVK+L K+ + +V+ M RV
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK-------KDVILQDDDVECTMTEKRVLALAG 53
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLK-QLLSDEKASTLSWERRLQIAMDAAQGLE 683
H LT L F + + + EY+ G+L + + R A + GL+
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQ 110
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
+LH + I++RD+K +N+LL K+ADFG+ K +GG ST GTP Y+ PE
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPE 166
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIITSQA 771
D ++ GV+L E++ Q+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 65/196 (33%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMR-VHHRNLTN 631
KV+GKG FG V + DG AVK+L + KE + AE +L++ V H L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F + + + +Y+ G L L E+ + R A + A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SL 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I++RD+KPENILL L DFGL K I + ++ GTP YL PE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 752 EKSDVYSFGVVLLEII 767
D + G VL E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLV 633
+ LG+G + TVY G +G VA+K++S + +G F A E LL + H N+ L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLH 69
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+ ++EYM + +L Q + + RL +GL Y+H I
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHI 124
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVSTVVAGTPGYLDPEYFV--TDWL 750
+HRD+KP+N+L++ E KLADFGL++ I T+ S VV T Y P+ + TD+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 751 NEKSDVYSFGVVLLEIITSQAVI--VRNENENIHIIQTV 787
+ D++ G + +E++ Q V + E + I TV
Sbjct: 183 SA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 577 KVLGKGGFGTVYHGYLD----DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTN 631
+V+G G FG V G L VA+K L S + + ++F +E ++ + H N+ +
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLL--SDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
L G + + +I E+M NG L L +D + + + L+ A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---S 123
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVF---PIGGTHVSTVVAGTP-GYLDPEYF 745
+ VHRD+ NIL+ NL K++DFGLS+ T+ S++ P + PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
SDV+S+G+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 572 TDNFN--KVLGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHR 627
TD + + +GKG +G VY DG+ AVK+L S +E EAE +L + +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 628 NLTNLVGYFIEDNN-----MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM------ 676
N+ G F + + + L+ E G++ +L+ L +RL AM
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK----GLLICGQRLDEAMISYILY 135
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT 736
A GL++LH I+HRD+K NILLT KL DFG+S +T V GT
Sbjct: 136 GALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GT 191
Query: 737 PGYLDPEYFVTDW-----LNEKSDVYSFGVVLLEI 766
P ++ PE + + + DV+S G+ +E+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 31/162 (19%)
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL-------KQLLSDEKASTLSWE 669
E+++L V+H N+ F + + ++ E+M G+L +Q L+D LS
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-- 179
Query: 670 RRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
G+ YLH + IVHRDIKP N+L+ K+ADFG+S++
Sbjct: 180 -----------GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 730 STVVAGTPGYLDPEYFVTDWLNE------KSDVYSFGVVLLE 765
++ V GT Y+ PE TD LN D++S GV +LE
Sbjct: 226 NSSV-GTIAYMSPERINTD-LNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ ++LG G GTVY Y L +AVK++ + + K+ +E+++L + +
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-QIAMDAAQGLEYLHIGCKP 691
G F +N + + E+M G+L E L +IA+ +GL YL K
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKGLTYLW-SLK- 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSK--VFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
I+HRD+KP N+L+ + KL DFG+S V I T+V GT Y+ PE +
Sbjct: 116 -ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQ 169
Query: 750 LNEKSDVYSFGVVLLEI 766
SDV+S G+ +E+
Sbjct: 170 YGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 574 NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLM---------- 622
VLG+G FG V Y G A+K L +G EV+ LM
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALK----KGDIIARDEVESLMCEKRIFETAN 57
Query: 623 RVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDAAQG 681
H L NL F ++++ + EY A G+L + + S E R A G
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVVLG 113
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
L+YLH + IV+RD+K +N+LL K+ADFGL K G ST GTP +L
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLA 169
Query: 742 PEYFVTDWLNEKS-----DVYSFGVVLLEIITSQ 770
PE L E S D + GV++ E++ +
Sbjct: 170 PEV-----LTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 569 LKITD-NFNKVLGKGGFGTVYHGYLDDGTQV-AVKMLSS-----SSGQGFKEFEAEVKLL 621
+K D + KV+G+G FG V QV A+K+LS S F F E ++
Sbjct: 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIM 97
Query: 622 MRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER----RLQIAMD 677
+ + L F +D + ++ EYM G+L L+S+ W R + +A+D
Sbjct: 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLALD 156
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS-KVFPIGGTHVSTVVAGT 736
A + + +HRD+KP+N+LL ++ KLADFG K+ G T V GT
Sbjct: 157 AIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 737 PGYLDPEYFVTD----WLNEKSDVYSFGVVLLEII 767
P Y+ PE + + + D +S GV L E++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 579 LGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+GKG FG VY D ++ A+K+LS KE E +L+R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 635 Y---FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER-RLQIAMDAAQGLEYLHIGCK 690
F D+++ L+ +YM+ G L L +K S +R + IA + LE+LH K
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIA-ELVLALEHLH---K 114
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD-W 749
IV+RD+KPENILL L DFGLSK + + GT YL PE + +
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 750 LNEKSDVYSFGVVLLEI 766
+ D +S GV++ E+
Sbjct: 174 YTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 37/224 (16%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEF---EAEVKLLMRVHHRNLTNL 632
K+LGKG G V+ L ++ A+K+L + E ++L + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH-IGCKP 691
F + + L+ +Y G L +LL + LS E A + LEYLH +G
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--- 123
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS------------------TVV 733
IV+RD+KPENILL E+ L+DF LSK + VS T
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 734 A----------GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
GT Y+ PE D D ++ G++L E++
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 577 KVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNL 629
K +G G FG V+ L A+K+++ K+ + E ++L V H +
Sbjct: 7 KTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
L + + ++ EY+ G L L + S L A + LEYLH
Sbjct: 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH--- 118
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST-VVAGTPGYLDPEYFVTD 748
IV+RD+KPENILL + KL DFG +K T + GTP YL PE +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVIQSK 173
Query: 749 WLNEKSDVYSFGVVLLEII 767
N+ D ++ G+++ E++
Sbjct: 174 GHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 567 EVLKITDNFNKVLGKGGFGTVYHGYLDD------GTQVAVKMLS-SSSGQGFKEF--EAE 617
EV + + LG+G FG VY G D T+VAVK ++ S+S + EF EA
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 618 VKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR------ 671
V HH + L+G + ++ E MA+G+LK L + + R
Sbjct: 62 VMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 672 --LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK------VFP 723
+Q+A + A G+ YL+ VHRD+ N ++ + K+ DFG+++ +
Sbjct: 120 EMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
GG + V P L F T SD++SFGVVL EI +
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTT-----SSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 579 LGKGGFGTV------YHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
LGKGGFG V G + ++ K L SG+ E E+ L +V+ + NL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F ++ L+ M G+LK + + L ER + + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
IV+RD+KPEN+LL + +L+D GL+ G T T AGT GY+ PE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173
Query: 753 KSDVYSFGVVLLEII 767
D ++ G + E++
Sbjct: 174 PVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 33/210 (15%)
Query: 577 KVLGKGGFGTVYHGYLD--DGTQVAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G G +GTV LD G +VA+K L S K E++LL + H N+ L
Sbjct: 21 KQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 633 VGYFIEDNNMG------LIYEYMANGNLKQLLSDEKASTLSWERRLQ-IAMDAAQGLEYL 685
+ F D ++ L+ +M +L +L+ EK S E R+Q + +GL+Y+
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLS----EDRIQFLVYQMLKGLKYI 134
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG---TPGYLDP 742
H I+HRD+KP N+ + E+ E K+ DFGL++ + + G T Y P
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAP 184
Query: 743 EYFVTDWLN--EKSDVYSFGVVLLEIITSQ 770
E + +W++ + D++S G ++ E++T +
Sbjct: 185 E-VILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA-EVKLLMRVHHRNLTNLVGYF 636
LG+G + TVY G G VA+K + + +G E+ L+ + H N+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 637 IEDNNMGLIYEYMANGNLKQLL---SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+N + L++EYM + +LK+ + A + + + +G+ + H + +
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCH---ENRV 121
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIG-GTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+HRD+KP+N+L+ + E KLADFGL++ F I T + VV T Y P+ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179
Query: 753 KS-DVYSFGVVLLEIITSQAVIVRNENEN 780
S D++S G ++ E+IT + + NE+
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFK-EFEA--EVKLLMRVHHRNLTNL 632
+VLGKGGFG V + G A K L + K E A E ++L +V+ R + +L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+ + + L+ M G+LK + + +R + A + GLE L +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
IV+RD+KPENILL + +++D GL+ P G T V GT GY+ PE +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTF 180
Query: 753 KSDVYSFGVVLLEIITSQA 771
D + G ++ E+I Q+
Sbjct: 181 SPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 573 DNFN--KVLGKGGFGTVYHGYLDDGTQV-AVK------MLSSSSGQGFKEFEAEVKLLMR 623
D+F KV+G+G FG V + ++ A+K ML + F+E E +L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE---ERNVLVN 57
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS---DEKASTLS--WERRLQIAMDA 678
+ +T L F ++N + L+ +Y G+L LLS D ++ + + +A+ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
L Y VHRDIKP+N+LL N +LADFG GT S+V GTP
Sbjct: 118 IHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 739 YLDPEYF--VTDWLNE---KSDVYSFGVVLLEII 767
Y+ PE + D + + + D +S GV + E++
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 10/192 (5%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEA-EVKLLMRVHHRNLTNLVGY 635
+G+G +GTV+ + VA+K + +G E+ LL + H+N+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
D + L++EY + +LK+ D + E +GL + H ++H
Sbjct: 68 LHSDKKLTLVFEY-CDQDLKKYF-DSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLH 122
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS- 754
RD+KP+N+L+ +N E KLADFGL++ F I S V T Y P+ L S
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 181
Query: 755 DVYSFGVVLLEI 766
D++S G + E+
Sbjct: 182 DMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 68/221 (30%), Positives = 97/221 (43%), Gaps = 45/221 (20%)
Query: 579 LGKGGFGTVYHG-YLDDGTQVAVK-MLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVG 634
LG+G FG VY + G VA+K +L + GF A E+K+L ++ H N+ L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP-ITALREIKILKKLKHPNVVPLID 74
Query: 635 YFIE-----DNNMGLIY---EYMANGNLKQLLSDEKAS-TLSWERRLQIAMDAAQ---GL 682
+E G +Y YM + +L LL + T S QI Q G+
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES-----QIKCYMLQLLEGI 128
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF----------PIGGTHVSTV 732
YLH + I+HRDIK NIL+ K+ADFGL++ + GGT T
Sbjct: 129 NYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 733 VAGTPGYLDPEYFVTDWLNEKS-----DVYSFGVVLLEIIT 768
+ T Y PE L E+ D++ G V E+ T
Sbjct: 186 LVVTRWYRPPELL----LGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 561 RHFTYSEVLKITDNFNKVLGKGGFGTVYHG-YLDDGTQ----VAVKMLSSSSG-QGFKEF 614
R +E+ K+ K+LG G FGTV+ G ++ +G VA+K + SG Q F+E
Sbjct: 2 RILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 615 EAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI 674
+ + + H + L+G ++ L+ + G+L + + S L +R L
Sbjct: 57 TDHMLAMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNW 114
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
+ A+G+ YL +VHR++ NILL + ++ADFG++ +
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 735 GTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771
TP ++ E + +SDV+S+GV + E+++ A
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 68/241 (28%), Positives = 100/241 (41%), Gaps = 64/241 (26%)
Query: 577 KVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRVHHRN 628
KV+G+G FG V L D G A+K L S Q AE +L +
Sbjct: 7 KVIGRGAFGEVR---LVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPW 62
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER-RLQIAMDAAQGLEYLHI 687
+ L F ++N + LI EY+ G++ LL K T + E R IA + ++ +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIA-ETILAIDSIH- 118
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV------------------ 729
K +HRDIKP+N+LL KL+DFGL + +H
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDF 174
Query: 730 -----------------------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEI 766
STV GTP Y+ PE F+ N++ D +S GV++ E+
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 767 I 767
+
Sbjct: 233 L 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 65/198 (32%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKE---FEAEVKLLMR-VHHRNLTN 631
KV+GKG FG V DG+ AVK+L + KE AE +L++ + H L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F + + +Y+ G L L E+ R A + A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLH---SL 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSK--VFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
I++RD+KPENILL L DFGL K V P T + GTP YL PE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKEP 172
Query: 750 LNEKSDVYSFGVVLLEII 767
+ D + G VL E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 574 NFNKV--LGKGGFGTVYHGY-LDDGTQVA---VKMLSSSSGQGFKEFEAEVKLLMRVHHR 627
F K+ +G+G +G VY G VA V+M + G E+ LL+ + H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 628 NLTNL----VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
N+ L VG ++ ++ L+ EY +L LL D + S + + + +GL+
Sbjct: 67 NIVELKEVVVGKHLD--SIFLVMEYCEQ-DLASLL-DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
YLH I+HRD+K N+LLT+ K+ADFGL++ + + ++ V T Y PE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 744 -YFVTDWLNEKSDVYSFGVVLLEIIT 768
D+++ G +L E++
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
DNF K+ G+G G V + G VAVK + Q + EV ++ H N+
Sbjct: 23 DNFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
+ ++ + + ++ E++ G L +++ + ++ E+ + + + L LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLH---AQ 135
Query: 692 PIVHRDIKPENILLTENLEAKLADFG----LSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
++HRDIK ++ILLT + KL+DFG +SK P + GTP ++ PE
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-----RRKSLVGTPYWMAPELISR 190
Query: 748 DWLNEKSDVYSFGVVLLEIITSQ 770
+ D++S G++++E++ +
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 573 DNFNKV--LGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRN 628
D+F K+ LG G G V+ + G +A K++ + + E+++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ G F D + + E+M G+L Q+L +KA + + ++++ +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE- 121
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
K I+HRD+KP NIL+ E KL DFG+S ++ GT Y+ PE
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGT 177
Query: 749 WLNEKSDVYSFGVVLLEI 766
+ +SD++S G+ L+E+
Sbjct: 178 HYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-12
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 576 NKVLGKGGFGTV-YHGYLDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
++VLG G GTV + DG AVK+ + S +AEV L+ ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 633 VGYFI--EDNN------MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
F + N + L+ +Y G+L+Q + +A T R + + Q L
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS-RAKTNRTFREHEAGLLFIQVLLA 155
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA----GTPGYL 740
+H ++HRDIK NILL N KL DFG SK++ VS V GTP Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRTFCGTPYYV 212
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE + ++K+D++S GV+L E++T
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 564 TYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFE-----AEV 618
T+SEVLK G A+K + + FK E E+
Sbjct: 11 TFSEVLKAQS------------------RKTGKYYAIKCMK----KHFKSLEQVNNLREI 48
Query: 619 KLLMRV-HHRNLTNL--VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIA 675
+ L R+ H N+ L V + + + L++E M + NL +L+ K L +R
Sbjct: 49 QALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRK-RPLPEKRVKSYM 106
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ L+++H + I HRDIKPENIL+ +++ KLADFG + I T
Sbjct: 107 YQLLKSLDHMH---RNGIFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYIS 160
Query: 736 TPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTV 787
T Y PE +TD + K D+++ G V EI++ + NE + I I V
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 14/202 (6%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K + + T VAVK L S S + K + E+ ++ H N+
Sbjct: 6 IGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
V FI D+ + ++ MA G+ + LL L I D L+Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKG 121
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG------YLDPEYFV 746
+HR +K +ILL+ + + L+ S G V +L PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 747 TDWL--NEKSDVYSFGVVLLEI 766
+ NEKSD+YS G+ E+
Sbjct: 182 QNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 65/196 (33%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMR-VHHRNLTN 631
KV+GKG FG V DG AVK+L + + K AE +L++ V H L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F + + +++ G L L E+ + R A + A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH---SI 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
IV+RD+KPENILL L DFGL K I + +T GTP YL PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 752 EKSDVYSFGVVLLEII 767
D + G VL E++
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNL 632
K+LGKG FG V G A+K+L E E ++L H LT+L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F + + + EY+ G L LS E+ S +R + L+YLH G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---K 115
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV--VAGTPGYLDPEYFVTDWL 750
IV+RD+K EN++L ++ K+ DFGL K G T +T+ GTP YL PE +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE---GITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 751 NEKSDVYSFGVVLLEIITSQAVIVRNENENI 781
D + GVV+ E++ + ++E +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEA-EVKLLMRVHHRNLTNLVG 634
+G+G +G VY D G VA+K + + +GF E+K+L +++HRN+ NL
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 635 YFIEDN----------NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
+ L++EYM + +L LL + S + +GL Y
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLL-ESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
H K +HRDIK NILL + KLADFGL++++ + T T Y PE
Sbjct: 132 CH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 745 FVTDWLNEKS-DVYSFGVVLLEIITSQAVIVRNE 777
+ + + DV+S G +L E+ T + + N+
Sbjct: 189 LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 577 KVLGKGGFGTVY-----HGYLDDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRVHHR 627
KVLG G +G V+ G+ D G A+K+L ++ + + E ++L +
Sbjct: 6 KVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 64
Query: 628 NLTNLVGY-FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM-DAAQGLEYL 685
+ Y F D + LI +Y+ G L LS + E+ +QI + LE+L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHL 121
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H K I++RDIK ENILL N L DFGLSK F + GT Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 746 V-TDWLNEKS-DVYSFGVVLLEIITSQAVIVRNENENIH 782
D ++K+ D +S GV++ E++T + + +N
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 56/193 (29%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
LG G FG V G A+K L K+ + E +LM + H + N++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F ++N + + E++ G L L KA + + EYLH I+
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLAFEYLH---SKDII 140
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
+RD+KPEN+LL K+ DFG +K P + + GTP YL PE + +
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRTFTLCGTPEYLAPEVIQSKGHGKAV 196
Query: 755 DVYSFGVVLLEII 767
D ++ GV+L E I
Sbjct: 197 DWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 573 DNFN--KVLGKGGFGTVYHGYLDDGTQ--VAVKMLSSS---SGQGFKEFEAEVKLLMRVH 625
+F+ ++G+G FG V + T A+K++ S + + FE E +L +
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS------DEKASTLSWERRLQIAMDAA 679
+ L F + +N+ L+ EY G+L LL+ DE + + L +A+ +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF-YLAELVLAIHSV 118
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+ Y VHRDIKPEN+L+ KLADFG + S + GTP Y
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 740 LDPEYFVTDWLNEKS------DVYSFGVVLLEIITSQA 771
+ PE T + K D +S GV+ E+I ++
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQV----AVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLT 630
KVLG G FGTVY G ++ +G V A+K+L+ ++G + EF E ++ + H +L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L+G + + L+ + M +G L + + K + S + L + A+G+ YL +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGS-QLLLNWCVQIAKGMMYLE---E 127
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDW 749
+VHRD+ N+L+ K+ DFGL+++ + P ++ E
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 750 LNEKSDVYSFGVVLLEIIT 768
+SDV+S+GV + E++T
Sbjct: 188 FTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 577 KVLGKGGFGTVYHGYLDDG---TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+G G FG V G G +V VK L +S++ F EV+ ++H N+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKA--STLSWERRLQ-IAMDAAQGLEYLHIGC 689
+G IE L+ E+ G+LK L + + ++ + LQ +A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLS--------------KVFPIGGTHVSTVVAG 735
+ +H D+ N LT +L K+ D+GL+ P+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL----------- 166
Query: 736 TPGYLDPEY-------FVTDWLNEKSDVYSFGVVLLEIITSQA 771
+L PE + +KS+++S GV + E+ T+
Sbjct: 167 --RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEV--KLLMRVHHRN--LTN 631
KVLGKG FG V L G AVK L + E + K ++ + N LT+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F ++ + E++ G+L + D+ L R A + GL++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLY--RATFYAAEIVCGLQFLH---SK 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I++RD+K +N++L + K+ADFG+ K G ST GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 752 EKSDVYSFGVVLLEIITSQA 771
D +SFGV+L E++ Q+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 618 VKLLMRVHHRNLTNLVGY---FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI 674
++ L +H N +VG+ F D + + E+M G+L Q+L ++A + E ++
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKV 108
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
++ +GL YL K I+HRD+KP NIL+ E KL DFG+S ++
Sbjct: 109 SIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFV 163
Query: 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEI 766
GT Y+ PE + +SD++S G+ L+E+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 52/157 (33%), Positives = 78/157 (49%), Gaps = 17/157 (10%)
Query: 617 EVKLLMRVHHRNLTNLVGY---FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQ 673
E+K+L H N +VG+ F D + + E+M G+L Q+L +KA + +
Sbjct: 49 ELKVL---HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGK 103
Query: 674 IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV- 732
I++ +GL YL K I+HRD+KP NIL+ E KL DFG+S G S
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMAN 156
Query: 733 -VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
GT Y+ PE +SD++S G+ L+E+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 579 LGKGGFGTVYHG-YLDDGTQVAVK-MLSSSSGQGFKEFEAEVKLLMRVHH-RNLTNLVGY 635
+G G G VY + G +AVK M + + + K ++ ++++ H + GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQ----------IAMDAAQGLEYL 685
FI D+++ + E M+ L +LL +R+Q + + + L YL
Sbjct: 83 FITDSDVFICMELMSTC-LDKLL-----------KRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS----TVVAGTPGYLD 741
K ++HRD+KP NILL + KL DFG+S G V T AG Y+
Sbjct: 131 KE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS------GRLVDSKAKTRSAGCAAYMA 182
Query: 742 PEYFVTDWLNEK----SDVYSFGVVLLEIITSQ 770
PE N K +DV+S G+ L+E+ T Q
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEA----EVKLLMRVHHRNLTN 631
+VLGKGGFG V + G A K L + K EA E ++L +V+ R + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG-EAMALNEKQILEKVNSRFVVS 64
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L + + + L+ M G+LK + + ER + A + GLE LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RE 121
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
IV+RD+KPENILL + +++D GL+ P G T V GT GY+ PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 752 EKSDVYSFGVVLLEIITSQA 771
D + G ++ E+I ++
Sbjct: 180 FSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRVH-HRNLTN 631
+VLGKG FG V L + G AVK+L + E E ++L H LT
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F + + + E++ G+L + +K+ R A + L +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLH---DK 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I++RD+K +N+LL KLADFG+ K G ST GTP Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYG 174
Query: 752 EKSDVYSFGVVLLEIITSQAVIVRNENEN 780
D ++ GV+L E++ A ENE+
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF-EAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/195 (30%), Positives = 86/195 (44%), Gaps = 10/195 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNL 632
K+LGKG FG V + A+K+L E E ++L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F + + + EY G L LS E+ S +R + L YLH C
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLH-SCD-- 115
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+V+RD+K EN++L ++ K+ DFGL K G + T GTP YL PE +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 753 KSDVYSFGVVLLEII 767
D + GVV+ E++
Sbjct: 175 AVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 51/219 (23%)
Query: 577 KVLGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
+G G +G V + G +VA+K LS + F++ E++LL + H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDH 73
Query: 627 RNLTNLVGYF-----IED-NNMGLIYEYMA---NGNLK-QLLSDEKASTLSWERRLQIAM 676
N+ L+ F +ED ++ L+ M N +K Q LSD+ L + QI
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY----QIL- 128
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG- 735
+GL+Y+H I+HRD+KP NI + E+ E K+ DFGL++ H + G
Sbjct: 129 ---RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMTGY 175
Query: 736 --TPGYLDPEYFVTDWL--NEKSDVYSFGVVLLEIITSQ 770
T Y PE + +W+ N+ D++S G ++ E++T +
Sbjct: 176 VATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSS-----SSGQGFKEFEAEVKLLMRVHHRNLT 630
KV+G+G FG V +V A+K+LS S F F E ++ + +
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 106
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSD----EKASTLSWERRLQIAMDAAQGLEYLH 686
L F +D + ++ EYM G+L L+S+ EK + + + +A+DA +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-YTAEVVLALDAIHSMG--- 162
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLS-KVFPIGGTHVSTVVAGTPGYLDPEYF 745
++HRD+KP+N+LL ++ KLADFG K+ G T V GTP Y+ PE
Sbjct: 163 ------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVL 215
Query: 746 VTD----WLNEKSDVYSFGVVLLEII 767
+ + + D +S GV L E++
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 25/161 (15%)
Query: 580 GKGGFGTVYHGYLDDGTQ---VAVKML--SSSSGQGFKEFEA-EVKLLMRVHHRNLTNLV 633
G+G +G VY +G A+K G + E+ LL + H N+ +LV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 634 GYFIEDNNMG--LIYEYMANGNLKQLLSDEKASTLSWERRLQIAM------DAAQGLEYL 685
F+E + L+++Y A +L Q++ + + + +M G+ YL
Sbjct: 69 EVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKR---VSIPPSMVKSLLWQILNGVHYL 124
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA----KLADFGLSKVF 722
H ++HRD+KP NIL+ K+ D GL+++F
Sbjct: 125 H---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 578 VLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVG 634
LG+G + TVY G G VA+K + +G F A E LL + H N+ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ L++EY+ + +LKQ + D+ LS +GL Y H + ++
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVL 125
Query: 695 HRDIKPENILLTENLEAKLADFGL--SKVFPIGGTHVSTVVAGTPGYLDPEYFV--TDWL 750
HRD+KP+N+L++E E KLADFGL +K P T+ + VV T Y P+ + T++
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 751 NEKSDVYSFGVVLLEIITSQAVI--VRNENENIHII 784
D++ G + E+ T + + + + +H I
Sbjct: 183 TS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 50/150 (33%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 577 KVLGKGGFGTVYHGYLDDG---TQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNL 632
K +G G FG V G ++ G QV VK L S+ Q +F E + + H NL
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLL-SDEKASTLSWERRL--QIAMDAAQGLEYLHIGC 689
+G E L+ E+ G+LK L S KA ++ + ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLS 719
K +H D+ N LLT +L K+ D+GLS
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFE---AEVKLL-MRVHHRNLTN 631
KVLGKG FG V L +V A+K+L + + E ++L + H LT
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691
L F + + + EY+ G+L + +++ R A + L +LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
+++RD+K +NILL KLADFG+ K + G +T GTP Y+ PE
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELEYG 174
Query: 752 EKSDVYSFGVVLLEIITSQ 770
D ++ GV++ E++ Q
Sbjct: 175 PSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 579 LGKGGFGTVYHGY--LDDGTQVAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRNLTNLVGY 635
LG+G + TVY G L D VA+K + +G EV LL + H N+ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
+ ++ L++EY+ + +LKQ L D+ ++++ +GL Y H + ++H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV--TDWLNEK 753
RD+KP+N+L+ E E KLADFGL++ I S V T Y P+ + TD+ + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-STQ 185
Query: 754 SDVYSFGVVLLEIITSQAVIVRNE-NENIHII 784
D++ G + E+ T + + + E +H I
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGF-KEFEAEVKLLMRVHHRNLTNL--- 632
+G+G +G V G +VA+K +S Q F + E+K+L R H N+ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDI 71
Query: 633 --VGYFIEDNNMGLIYEYMANGNLK----QLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
F N++ ++ E M K Q LS++ + QI +GL+Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY----QIL----RGLKYIH 123
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
++HRD+KP N+LL N + K+ DFGL+++ H T G+L EY
Sbjct: 124 ---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHT------GFL-TEYVA 171
Query: 747 TDW-------LNEKS-----DVYSFGVVLLEIIT 768
T W LN K D++S G +L E+++
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRNLTNLVGYF 636
LG+G + TV+ G VA+K + +G EV LL + H N+ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 637 IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHR 696
+ + L++EY+ + +LKQ L D + +S +GL Y H K I+HR
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127
Query: 697 DIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV--TDWLNEKS 754
D+KP+N+L+ E E KLADFGL++ + S V T Y P+ + T++ +
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY-STPI 185
Query: 755 DVYSFGVVLLEIITSQAVIVRNE-NENIHII 784
D++ G +L E+ T + + + E +H+I
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 40/216 (18%)
Query: 574 NFNKV--LGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEA-------EVKLLMR 623
++ K+ +G+G +G VY G G VA+K + S E E E+ LL
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-----EEEGVPSTAIREISLLKE 55
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
+ H N+ L ++++ + LI+E+++ K L S K + E QG+
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG---GTH-VST-------V 732
+ H ++HRD+KP+N+L+ KLADFGL++ F I TH V T V
Sbjct: 116 FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ G+P Y P D++S G + E+ T
Sbjct: 173 LLGSPRYSTP-----------VDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGT--QVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRN 628
NF + LG G FG V + VA+K S K+ + +E K+L ++H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLH 686
NL G F +++ + L+ E++ G L K + + QI + EYL
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI----FEYLQ 148
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
IV+RD+KPEN+LL ++ K+ DFG +KV T T + GTP Y+ PE +
Sbjct: 149 ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYT-LCGTPEYIAPEILL 201
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777
+ +D ++ G+ + EI+ NE
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 32/80 (40%), Positives = 49/80 (61%), Gaps = 5/80 (6%)
Query: 399 WDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSR 458
W G+ C N+ R++S++LS ++G+I+ + L IQ+++LSNN LSG +P+ +
Sbjct: 60 WQGITC----NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFT 115
Query: 459 LQF-LRVLNLKGNKFTGPIP 477
LR LNL N FTG IP
Sbjct: 116 TSSSLRYLNLSNNNFTGSIP 135
|
Length = 968 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 9/214 (4%)
Query: 578 VLGKGGFGTVYHGYLDDGTQ-VAVKMLSSSSG-QGFKEFE-AEVKLLMRVHHRNLTNLVG 634
V+G+G +G V + + VA+K S + KE E+K+L + N+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F + L++EY+ N+ +LL + + R I Q ++ +H K IV
Sbjct: 68 AFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIV 122
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
HRDIKPEN+L++ N KL DFG ++ G T T Y PE + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 755 DVYSFGVVLLEIITSQAVIV-RNENENIHIIQTV 787
D++S G +L E+ Q + +E + + IQ V
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 26/272 (9%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQ----VAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
KVLG G FGTVY G ++ DG VA+K+L ++S + KE E ++ V +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L+G + + + L+ + M G L + + K + + L + A+G+ YL +
Sbjct: 73 RLLGICLT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---E 127
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDW 749
+VHRD+ N+L+ K+ DFGL+++ I T P ++ E +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 750 LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809
+SDV+S+GV + E++T A + I + + +++ KG+ C +
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGA----KPYDGIP-AREIPDLLEKGERLPQPPICTIDVYM 242
Query: 810 IESAWRAVELAVKCASRTSSERPNMNEVVTEL 841
I VKC S RP E+V E
Sbjct: 243 I---------MVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKML---SSSSGQG-------FKEFEAEVKLLMRVH 625
+++GKG +G VY + G +AVK + ++ +G+ K +E++ L +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLS-----DEKASTLSWERRLQIAMDAAQ 680
H N+ +G+ + + + EY+ G++ L +E+ E+ L+
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------- 119
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP-IGGTHVSTVVAGTPGY 739
GL YLH I+HRD+K +N+L+ + K++DFG+SK I + + G+ +
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 740 LDPEYFVTDW--LNEKSDVYSFGVVLLEI 766
+ PE + + K D++S G V+LE+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 40/212 (18%)
Query: 579 LGKGGFGTVY---HGYLDDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+G+G FGTV H GT +AVK + S+ + K ++ ++MR + +V
Sbjct: 12 IGRGAFGTVNKMLHK--PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVK 67
Query: 635 YFIEDNNMGLIY---------EYMANG--NLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
++ G ++ E M + + + S + E +IA+ + L
Sbjct: 68 FY------GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS----TVVAGTPGY 739
YL K I+HRD+KP NILL N KL DFG+S G V T AG Y
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIAKTRDAGCRPY 173
Query: 740 LDPEYFVTDWLNE---KSDVYSFGVVLLEIIT 768
+ PE + +SDV+S G+ L E+ T
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 65/199 (32%), Positives = 86/199 (43%), Gaps = 17/199 (8%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKE----FEAEVKLLMRVHHRNLTN 631
KV+GKG FG V + + AVK+L + KE LL V H L
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDAAQGLEYLHIGCK 690
L F + + + +Y+ G L L E+ E R + A + A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIASALGYLH---S 114
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSK--VFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
IV+RD+KPENILL L DFGL K + G T + GTP YL PE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHKQ 171
Query: 749 WLNEKSDVYSFGVVLLEII 767
+ D + G VL E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQ----VAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
KVLG G FGTVY G ++ +G + VA+K L ++S + KE E ++ V + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L+G + + + LI + M G L + + K + S + L + A+G+ YL +
Sbjct: 73 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQIAKGMNYLE---E 127
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDW 749
+VHRD+ N+L+ K+ DFGL+K+ P ++ E +
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 750 LNEKSDVYSFGVVLLEIIT 768
+SDV+S+GV + E++T
Sbjct: 188 YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 10/209 (4%)
Query: 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNL 632
K+LGKG FG V G A+K+L E E ++L H LT L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F + + + EY G L LS E+ + ER + LEYLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRD 115
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+V+RDIK EN++L ++ K+ DFGL K G + T GTP YL PE +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNENENI 781
D + GVV+ E++ + ++E +
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+G G +G+V + G +VAVK LS S K E++LL + H N+ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 636 FI------EDNNMGLIYEYMA---NGNLK-QLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
F E N++ L+ M N +K Q L+D+ L ++ +GL+Y+
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKYI 136
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG---TPGYLDP 742
H I+HRD+KP N+ + E+ E K+ DFGL++ H + G T Y P
Sbjct: 137 H---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAP 186
Query: 743 EYFVTDWL--NEKSDVYSFGVVLLEIITSQAV 772
E + +W+ N+ D++S G ++ E++T + +
Sbjct: 187 EIML-NWMHYNQTVDIWSVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 9/209 (4%)
Query: 577 KVLGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNL 632
K+LGKG FG V G A+K+L E E ++L H LT L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F + + + EY G L LS E+ S +R + L+YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH--SEKN 116
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+V+RD+K EN++L ++ K+ DFGL K G + T GTP YL PE +
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGR 175
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNENENI 781
D + GVV+ E++ + ++E +
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSS-----SSGQGFKEFEAEVKLLMRVHHRNLT 630
KV+G+G FG V +V A+K+LS S F F E ++ + +
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 106
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER----RLQIAMDAAQGLEYLH 686
L F +D + ++ EYM G+L L+S+ W R + +A+DA + +
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF-- 163
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
+HRD+KP+N+LL ++ KLADFG G GTP Y+ PE
Sbjct: 164 -------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 747 TD----WLNEKSDVYSFGVVLLEII 767
+ + + D +S GV L E++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 12/211 (5%)
Query: 579 LGKGGFGTVYHGY--LDDGTQVAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRNLTNLVGY 635
LG+G + TV+ G L + VA+K + +G EV LL + H N+ L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
D ++ L++EY+ + +LKQ + D+ + +S +GL Y H + ++H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV-TDWLNEKS 754
RD+KP+N+L+ E E KLADFGL++ + S V T Y P+ + + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 755 DVYSFGVVLLEIITSQAVIVRNENEN-IHII 784
D++ G + E+ + + + + E+ +H+I
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 16/104 (15%)
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-- 730
+IA+ + LEYLH ++HRD+KP N+L+ N + KL DFG+S G V
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS------GYLVDSV 158
Query: 731 --TVVAGTPGYLDPEYFVTDW----LNEKSDVYSFGVVLLEIIT 768
T+ AG Y+ PE + + KSDV+S G+ ++E+ T
Sbjct: 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQ----VAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
++LG G FG + G L ++ VA+ L + S + + F AE L + H N+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCK 690
L G N M ++ EYM+NG L L + L + + + A G++YL +G
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMG-- 127
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG-----YLDPEYF 745
VH+ + +L+ +L K++ F + + G + PE
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
+ SDV+SFG+V+ E+++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVG 634
+ +GKG +G V+ +G++ AVK+L +E EAE +L + H N+ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYG 82
Query: 635 -YFIEDNNMG----LIYEYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHI 687
Y+ +D G L+ E G++ L+ ++ + I +A GL++LH+
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
+HRD+K NILLT KL DFG+S +T V GTP ++ PE
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 198
Query: 748 DW-----LNEKSDVYSFGVVLLEI 766
+ + + DV+S G+ +E+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 578 VLGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY- 635
++G+GGFG VY D G A+K L K + + + ++ R + +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54
Query: 636 -----------FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDAAQGLE 683
F + + I + M G+L LS + E+ ++ A + GLE
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS---EKEMRFYATEIILGLE 111
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
++H +V+RD+KP NILL E+ +++D GL+ F H S GT GY+ PE
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 744 YFVTDWLNEKS-DVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788
+ S D +S G +L +++ + +++ ++ H I +T
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-10
Identities = 35/75 (46%), Positives = 47/75 (62%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L L + L+G I P + +L + SLDLS+NSLSG +PE + +LQ L +L+L N FTG I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 477 PVELMEKSKNGSLQL 491
PV L + LQL
Sbjct: 325 PVALTSLPRLQVLQL 339
|
Length = 968 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 579 LGKGGFGTVYHG-YLDDGTQ--VAVKMLSSSSGQGFK-EFEAEVKLLMRVHHRNLTNLVG 634
LG G FG V G Y Q VA+K+L + + + + E E +++ ++ + + ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
E + L+ E + G L + LS +K ++ +++ + G++YL V
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT-P-GYLDPEYFVTDWLNE 752
HRD+ N+LL AK++DFGLSK ++ AG P + PE +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 753 KSDVYSFGVVLLE 765
+SDV+S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 23/199 (11%)
Query: 579 LGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQGF--KEFEAEVKLLMRVHHRNLTNLV 633
LG G FGTV G VAVK+L + + E E ++ ++ + + ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIGCKP 691
G E + L+ E G L + L K T L Q++M G++YL +
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM----GMKYLE---ET 114
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
VHRD+ N+LL AK++DFGLSK G + A T G +++ + +N
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKAL---GADENYYKAKTHGKWPVKWYAPECMN 171
Query: 752 -----EKSDVYSFGVVLLE 765
KSDV+SFGV++ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 573 DNFNKV--LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHR 627
D++ K+ LG+G + TVY G +G VA+K++ +G F A E LL + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHA 63
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
N+ L + L++EY+ + +L Q + D+ L E +GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIH- 120
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
+ I+HRD+KP+N+L+++ E KLADFGL++ + S V T Y P+ +
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLG 177
Query: 748 DWLNEKS---DVYSFGVVLLEIITSQAVI-----VRNENENIHIIQTVTN 789
E S D++ G + +E+I A ++++ E I ++ N
Sbjct: 178 S--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 27/228 (11%)
Query: 551 NAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTV---YHGYLDDGTQVAVKMLSS-- 605
N S+E + FT VLK N K +G G G V Y LD VA+K LS
Sbjct: 1 NQFYSVEVGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPF 54
Query: 606 SSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI------EDNNMGLIYEYMANGNLKQLLS 659
+ K E+ L+ V+H+N+ +L+ F E ++ L+ E M + NL Q++
Sbjct: 55 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ 113
Query: 660 DEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719
E L ER + G+++LH I+HRD+KP NI++ + K+ DFGL+
Sbjct: 114 ME----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
Query: 720 KVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
+ G + + T T Y PE + E D++S G ++ E++
Sbjct: 167 RT--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 52/222 (23%)
Query: 579 LGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN--------- 628
LG G G V+ D +VAVK + + Q K E+K++ R+ H N
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 629 -----LTNLVGYFIEDNNMGLIYEYM----ANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
LT VG E N++ ++ EYM AN + LS+E A ++
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LL 124
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
+GL+Y+H ++HRD+KP N+ + TE+L K+ DFGL+++ +H G
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH--------KG 173
Query: 739 YLDPEYFVTDW------------LNEKSDVYSFGVVLLEIIT 768
YL E VT W + D+++ G + E++T
Sbjct: 174 YLS-EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-10
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 577 KVLGKGGFGTVYHGYLDD---GTQVAVKMLS---SSSGQGFKEFEAEVKLLMRVHHRNLT 630
+++GKGG G VY Y D +VA+K + S + K F E K+ + H +
Sbjct: 8 RLIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 631 NLVGYFIEDNNMGLIYE--YMANGNLKQLL---------SDEKASTLSWERRLQIAMDAA 679
+ Y I + + Y Y+ LK LL S E A S L I
Sbjct: 66 PV--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV------------FPIGGT 727
+EY+H ++HRD+KP+NILL E + D+G +
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 728 HVSTV-----VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
S++ + GTP Y+ PE + +E +D+Y+ GV+L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 38/214 (17%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
K +G G +G+V G +VA+K LS S K E+ LL + H N+ L+
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 634 GYFI------EDNNMGLIYEYMANGNLKQL----LSDEKASTLSWERRLQIAMDAAQGLE 683
F E + L+ YM +L+++ LS++K L ++ GL+
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQ--------MLCGLK 131
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG---TPGYL 740
Y+H I+HRD+KP N+ + E+ E K+ DFGL++ H + G T Y
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYR 181
Query: 741 DPEYFVTDWL--NEKSDVYSFGVVLLEIITSQAV 772
PE + +W+ N+ D++S G ++ E++T + +
Sbjct: 182 APE-VILNWMHYNQTVDIWSVGCIMAEMLTGKTL 214
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 45/142 (31%), Positives = 67/142 (47%), Gaps = 27/142 (19%)
Query: 644 LIYEYMANGNLKQLLSDEKASTLSWE-RRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPEN 702
++ EY+ G+ LL + L + R+ A + LEYLH IVHRD+KP+N
Sbjct: 78 MVMEYVEGGDCATLLKN--IGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLKPDN 131
Query: 703 ILLTENLEAKLADFGLSKVFPIGGTHVSTV-----------------VAGTPGYLDPEYF 745
+L+T KL DFGLSK IG ++T V GTP Y+ PE
Sbjct: 132 LLITSMGHIKLTDFGLSK---IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
Query: 746 VTDWLNEKSDVYSFGVVLLEII 767
+ + D ++ G++L E +
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 579 LGKGGFGTVYHGYLDDGTQ-VAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+G G +G+V Y Q VAVK LS S + E++LL + H N+ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 636 F-----IED-NNMGLIYEYMA---NGNLK-QLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
F IE+ N + L+ M N +K Q LSDE L ++ +GL+Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKYI 134
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H I+HRD+KP N+ + E+ E ++ DFGL++ ++ VA T Y PE
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ---ADDEMTGYVA-TRWYRAPEIM 187
Query: 746 VTDWL--NEKSDVYSFGVVLLEIITSQAVIVRNE 777
+ +W+ N+ D++S G ++ E++ +A+ N+
Sbjct: 188 L-NWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 579 LGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVGYF 636
LGKG +G+VY + G +A+K + + F + E+ +L + + + G F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 637 IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-QIAMDAAQGLEYLHIGCKPPIVH 695
+ + + EYM G+L +L + A+ E L +I +GL++L + I+H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIH 126
Query: 696 RDIKPENILLTENLEAKLADFGLSK--VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE- 752
RD+KP N+L+ N + KL DFG+S V + T++ G Y+ PE + N+
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQN 181
Query: 753 -----KSDVYSFGVVLLEI 766
+SDV+S G+ +LE+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 573 DNFN--KVLGKGGFGTV-YHGYLDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHH 626
D+F KV+G+G FG V D G A+K+L + + AE +L+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ + F + N+ LI E++ G++ LL K TLS E + ++ +H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGL---------------------------- 718
+ +HRDIKP+N+LL KL+DFGL
Sbjct: 119 ---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 719 ------SKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
++ + ++ GTP Y+ PE F+ N+ D +S GV++ E++
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-10
Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 15/87 (17%)
Query: 640 NNMGLIYEYMANGNLKQLLS-----DEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
NN+ L+ EY+ G++K LL DE+ + I+ + A L+YLH + I+
Sbjct: 77 NNVYLVMEYLIGGDVKSLLHIYGYFDEEMA------VKYIS-EVALALDYLH---RHGII 126
Query: 695 HRDIKPENILLTENLEAKLADFGLSKV 721
HRD+KP+N+L++ KL DFGLSKV
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 28/225 (12%)
Query: 578 VLGKGGFGTVYH-GYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY- 635
++G+GGFG VY D G A+K L K + + + ++ R + +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54
Query: 636 -----------FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
F + + I + M G+L LS + + E R A + GLE+
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRF-YAAEIILGLEH 112
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
+H +V+RD+KP NILL E+ +++D GL+ F H S GT GY+ PE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 745 FVTDWLNEKS-DVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788
+ S D +S G +L +++ + +++ ++ H I +T
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 47/218 (21%)
Query: 575 FNKV--LGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEA-------EVKLLMRV 624
+ KV +G+G +G VY G VA+K + + E E E+ LL +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-----EDEGVPSTAIREISLLKEL 55
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL------QIAMDA 678
+H N+ L+ +N + L++E++ + +LK+ + + + + L Q+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLL--- 109
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI---GGTHVSTVVAG 735
QG+ Y H ++HRD+KP+N+L+ KLADFGL++ F + TH VV
Sbjct: 110 -QGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV-- 161
Query: 736 TPGYLDPEYFVTDWLNEKS-----DVYSFGVVLLEIIT 768
T Y PE L + D++S G + E++
Sbjct: 162 TLWYRAPEIL----LGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 572 TDNFNKVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFEAEVK----LLMRVHH 626
NF VLGKG FG V ++ A+K+L + E + L ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
LT L F + + + EY+ G+L + ++ + + A + + GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
+ I++RD+K +N++L K+ADFG+ K + G T GTP Y+ PE
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIAPEIIA 174
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQ 770
+ D +++GV+L E++ Q
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 35/231 (15%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEA-EVKLLMRVHHR 627
D + K+ + +G +G VY G VA+K L +GF E+ +L+++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 628 NLTNL----VGYFIEDNNMGLIY---EYMANGNLKQLLSDEKASTLSWERR---LQIAMD 677
N+ + VG +N+ IY EY+ + +LK L+ K L E + LQ+
Sbjct: 65 NIVTVKEVVVG-----SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL-- 116
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTHVSTVVAG 735
G+ +LH I+HRD+K N+LL K+ DFGL++ + P+ + VV
Sbjct: 117 --SGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVV-- 168
Query: 736 TPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHII 784
T Y PE + + D++S G + E++T + + ++E + ++ I
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 579 LGKGGFGTVYHGY-LDDGTQVA----VKMLSSSSGQGFKEFE--AEVKLLMRVHHRNLTN 631
+G+G +G V+ L +G + V++ + G A ++ L H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 632 L-----VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
L V + + L++E++ + +L L + E + +GL++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
+VHRD+KP+NIL+T + + KLADFGL++++ T V T Y PE +
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLL 182
Query: 747 TDWLNEKSDVYSFGVVLLEI 766
D++S G + E+
Sbjct: 183 QSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 43/229 (18%)
Query: 577 KVLGKGGFGTV-YHGYLDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNL 632
KV+G+G FG V D G A+K+L + + AE +L+ + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F + N+ LI E++ G++ LL K TL+ E + ++ +H +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIH---QLG 121
Query: 693 IVHRDIKPENILLTENLEAKLADFGL---------------------------------- 718
+HRDIKP+N+LL KL+DFGL
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 719 SKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
++ + ++ GTP Y+ PE F+ N+ D +S GV++ E++
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 58/194 (29%), Positives = 87/194 (44%), Gaps = 10/194 (5%)
Query: 579 LGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNLVG 634
+GKG FG V D ++ A+K + + E AE +L +V+ + L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
F + L+ ++ G L L E LS R + A LE LH K ++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLH---KFNVI 115
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
+RD+KPENILL L DFGL K+ + + GTP YL PE + +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 755 DVYSFGVVLLEIIT 768
D ++ GV+L E++T
Sbjct: 175 DWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSSGQGFKEFEAEV--KLLMRVHHRN-- 628
NF VLGKG FG V ++ A+K+L + E + K ++ + +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
LT L F + + + EY+ G+L + ++ + A + A GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH-- 118
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
I++RD+K +N++L K+ADFG+ K G T GTP Y+ PE
Sbjct: 119 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEIIAYQ 176
Query: 749 WLNEKSDVYSFGVVLLEIITSQA 771
+ D ++FGV+L E++ QA
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 616 AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR---- 671
+E+ L H + F D+ + LI EY + G+L + + L ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 672 --LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG-GTH 728
QI + L+ +H ++HRD+K NI L KL DFG SK +
Sbjct: 174 LFYQIVL----ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
V++ GTP YL PE + ++K+D++S GV+L E++T
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQ--VAVKMLSSSSGQGFKEFEAEV--KLLMRVHHRN- 628
NF VLGKG FG V GT A+K+L + E + K ++ + +
Sbjct: 3 NFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 629 -LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
LT L F + + + EY+ G+L + ++ + A + A GL +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH- 118
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
I++RD+K +N++L K+ADFG+ K GG T GTP Y+ PE
Sbjct: 119 --SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAY 175
Query: 748 DWLNEKSDVYSFGVVLLEIITSQA 771
+ D ++FGV+L E++ Q
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 578 VLGKGGFGTVYHGYLDDGT--QVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLV 633
+G G +G V +D + +VA+K + + K E+K+L H N+ +
Sbjct: 12 NIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 634 GYFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHI 687
++ + M + +L ++ ++ T R Q+ +GL+Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLL----RGLKYIHS 125
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKV---FPIGGTHVSTVVAGTPGYLDPE- 743
++HRD+KP N+L+ E+ E ++ DFG+++ P + T T Y PE
Sbjct: 126 AN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 744 YFVTDWLNEKSDVYSFGVVLLEII 767
D++S G + E++
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 555 SLEFENRHFTYSEVLKITDNFNKVLGKGGFGTV---YHGYLDDGTQVAVKMLSS--SSGQ 609
S+E + FT VLK N K +G G G V Y L+ VA+K LS +
Sbjct: 12 SVEIGDSTFT---VLKRYQNL-KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQT 65
Query: 610 GFKEFEAEVKLLMRVHHRNLTNLVGYFI------EDNNMGLIYEYMANGNLKQLLSDEKA 663
K E+ L+ V+H+N+ L+ F E ++ ++ E M + NL Q++ E
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME-- 122
Query: 664 STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723
L ER + G+++LH I+HRD+KP NI++ + K+ DFGL++
Sbjct: 123 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
G + + T T Y PE + E D++S G ++ E+I
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 577 KVLGKGGFGTVYHGYLDD--GTQVAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G G G V D G VAVK LS + K E+ LL V+H+N+ +L
Sbjct: 27 KPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 633 VGYFI------EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ F E ++ L+ E M + NL Q++ E L ER + G+++LH
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME----LDHERMSYLLYQMLCGIKHLH 140
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
I+HRD+KP NI++ + K+ DFGL++ VV T Y PE +
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAV 772
E D++S G ++ E++ +
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVI 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 20/200 (10%)
Query: 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL 705
Y+ + +K LLSD+ + L+ L A+G+E+L VHRD+ N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 706 TENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLL 764
+ K+ DFGL++ +VS P ++ PE + SDV+S+G++L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 765 EIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCA 824
EI + MI N + S R + ++ VKC
Sbjct: 331 EIFSLGGTP-------------YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCW 377
Query: 825 SRTSSERPN---MNEVVTEL 841
+ +RP+ ++++V L
Sbjct: 378 NSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 562 HFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDD--GTQVAVKMLS------SSSGQGFKE 613
FT VLK N K +G G G V Y D G VA+K LS + + + ++E
Sbjct: 11 TFT---VLKRYQNL-KPIGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAKRAYRE 65
Query: 614 FEAEVKLLMRVHHRNLTNLVGYFIEDNNMG------LIYEYMANGNLKQLLSDEKASTLS 667
L+ V+H+N+ L+ F ++ L+ E M + NL Q++ + L
Sbjct: 66 L----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LD 116
Query: 668 WERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727
ER + G+++LH I+HRD+KP NI++ + K+ DFGL++
Sbjct: 117 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173
Query: 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767
VV T Y PE + E D++S G ++ E+I
Sbjct: 174 MTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 7e-09
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 26/181 (14%)
Query: 611 FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER 670
F E V LM+ + N L LI +Y+ +G+L LL E + + E
Sbjct: 54 FNAIEPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA-EV 111
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE-AKLADFGLSKVFPIGGTHV 729
+ I + L LH K I+H DIK EN+L + L D+GL K+
Sbjct: 112 KK-IIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGT 162
Query: 730 STVVAGTPGYLDPE------YFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782
+ GT Y PE Y V+ DW ++ GV+ E++T + +E+E +
Sbjct: 163 PSCYDGTLDYFSPEKIKGHNYDVSFDW-------WAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 783 I 783
+
Sbjct: 216 L 216
|
Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 34/177 (19%)
Query: 564 TYSEVLKITDNFNKVLGKGGFGTVY---HGYLDDGTQVAVKM-LSSSSGQGFKEFEA--E 617
Y ++ KI G+G FG V+ H VA+K L + +GF A E
Sbjct: 13 KYEKLAKI--------GQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFP-ITALRE 61
Query: 618 VKLLMRVHHRNLTNLVGYFIEDNNMG--------LIYEYMANGNLKQLLSDEKAS-TLSW 668
+K+L + H N+ NL+ L++E+ + +L LLS++ TLS
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSE 120
Query: 669 ERR-LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
++ +++ ++ GL Y+H + I+HRD+K NIL+T++ KLADFGL++ F +
Sbjct: 121 IKKVMKMLLN---GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 577 KVLGKGGFGTV---YHGYLDDGTQVAVKMLSSSSGQGF--KEFEAEVKLLMRVH-HRNLT 630
K LG+G +G V + + VA+K +++ + K E+KLL H+N+T
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 631 NLVGYFI--EDNNMGL-IYEYMANGNLKQLL-SDEKASTLSWERRL-QIAMDAAQGLEYL 685
L I N L +YE + +L Q++ S + + ++ + QI GL+Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC----GLKYI 121
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H ++HRD+KP N+L+ + E K+ DFGL++ F G++ EY
Sbjct: 122 H---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN-------AGFMT-EYV 170
Query: 746 VTDW-------LNEKS-----DVYSFGVVLLEII 767
T W L+ +S DV+S G +L E++
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA-EVKLLMRVHHRNLTNLVGYFI 637
+G+G +G VY DG L G G E+ LL + H N+ L F+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 638 E--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ--------GLEYLHI 687
D + L+++Y A +L ++ +AS + ++ +Q+ + G+ YLH
Sbjct: 69 SHSDRKVWLLFDY-AEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 688 GCKPPIVHRDIKPENILLT----ENLEAKLADFGLSKVF--PIGGTHVSTVVAGTPGYLD 741
++HRD+KP NIL+ E K+AD G +++F P+ V T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 742 PEYFVTDWLNEKS-DVYSFGVVLLEIITSQAV 772
PE + K+ D+++ G + E++TS+ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA-EVKLLMRVHHRNLTNLVGYFI 637
+G+G +G VY DG L G G E+ LL + H N+ +L F+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 638 E--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ--------GLEYLHI 687
D + L+++Y A +L ++ +AS + ++ +Q+ + G+ YLH
Sbjct: 69 SHADRKVWLLFDY-AEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 688 GCKPPIVHRDIKPENILLT----ENLEAKLADFGLSKVF--PIGGTHVSTVVAGTPGYLD 741
++HRD+KP NIL+ E K+AD G +++F P+ V T Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 742 PEYFVTDWLNEKS-DVYSFGVVLLEIITSQAV 772
PE + K+ D+++ G + E++TS+ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
++ISL+LS + L+GEI + L ++ L L +N+ +G +P L+ L L+VL L NKF
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 473 TGPIPVELMEKSKNGSLQLSVGD-----NEELCSS 502
+G IP L + + L LS + E LCSS
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
|
Length = 968 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 577 KVLGKGGFGTVY----HGYLDDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRVHHRN 628
KVLG G +G V+ D G A+K+L ++ + + E +L V
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 629 LTNLVGY-FIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQG 681
+ Y F + + LI +Y++ G + + S+++ S E L
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL--------A 117
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
LE+LH K IV+RDIK ENILL L DFGLSK F + GT Y+
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 742 PEYFVTDWLNEKS-DVYSFGVVLLEIIT 768
PE + K+ D +S G+++ E++T
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+GL YLH I+HRD+K ENI + + + + D G ++ FP+ +AGT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG-LAGTVET 222
Query: 740 LDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777
PE D N K+D++S G+VL E++ + I +
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 68/250 (27%), Positives = 102/250 (40%), Gaps = 67/250 (26%)
Query: 573 DNFN--KVLGKGGFGTV-YHGYLDDGTQVAVKMLSSSSGQGFKE-----FEAEVKLLMRV 624
++F+ KV+GKG FG V D G A+K L S + FK+ +AE +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLAES 58
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWE-RRLQIAMDAAQGLE 683
+ +L F + + LI E++ G+L +L K T S + R +A + +E
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMA-ECVLAIE 115
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF-----------PIGGTHV--- 729
+H K +HRDIKP+NIL+ KL+DFGLS F + G
Sbjct: 116 AVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 730 ----------------------------------STVVAGTPGYLDPEYFVTDWLNEKSD 755
STV GTP Y+ PE F+ ++ D
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV--GTPDYIAPEIFLQQGYGQECD 230
Query: 756 VYSFGVVLLE 765
+S G ++ E
Sbjct: 231 WWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 595 GTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652
GT V V++ L + + + K + EV L H N+ F + + +I +MA G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI-GCKPPIVHRDIKPENILLTENLEA 711
+ LL +S I A +GL YLH G +HR+IK +IL++ +
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGLV 140
Query: 712 KLADFGLSKVFP-IGGTHVSTVVAGTPGY-------LDPEYFVTDW--LNEKSDVYSFGV 761
L+ GLS ++ + + VV P + L PE D N KSD+YS G+
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 762 VLLEIITSQ 770
E+ T +
Sbjct: 199 TACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 5e-08
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 38/198 (19%)
Query: 607 SGQGFKEFEA-----EVKLLMRVHHRNLTNLVGYFIEDNNMGL--IYEYMANGNLKQLLS 659
S +G KE E EV ++ + H+N+ + F+ N L + E+ G+L + +
Sbjct: 47 SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ 106
Query: 660 D--------EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE- 710
E+ + + R+L A+ L+ G + ++HRD+KP+NI L+ +
Sbjct: 107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER--VLHRDLKPQNIFLSTGIRH 164
Query: 711 ----------------AKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV--TDWLNE 752
AK+ DFGLSK IG ++ GTP Y PE + T ++
Sbjct: 165 IGKITAQANNLNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 753 KSDVYSFGVVLLEIITSQ 770
KSD+++ G ++ E+ + +
Sbjct: 223 KSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 4/111 (3%)
Query: 659 SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718
+ L+ E + + A+G+E+L +HRD+ NILL+EN K+ DFGL
Sbjct: 163 DELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGL 219
Query: 719 SKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
++ +V A P ++ PE +SDV+SFGV+L EI +
Sbjct: 220 ARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 4/114 (3%)
Query: 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715
Q D S L+ E + + A+G+E+L +HRD+ NILL+EN K+ D
Sbjct: 161 QETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICD 217
Query: 716 FGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
FGL++ +V A P ++ PE +SDV+SFGV+L EI +
Sbjct: 218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
E+ LL + H N+ L + + L++EY+ + +LK+ + + + + RL I
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRL-IKT 106
Query: 677 DAAQ---GLEYLHIGCKPPIVHRDIKPENILLTENLEA-KLADFGLSKVFPIG-GTHVST 731
Q G+ Y H ++HRD+KP+N+L+ A KLADFGL++ F I T
Sbjct: 107 YLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 732 VVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQ 770
VV T Y PE + + + D++S G + E++ +
Sbjct: 164 VV--TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
L L F + + L+ EY+ G+L + ++ L E A + L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLH-- 113
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
+ I++RD+K +N+LL + KL D+G+ K +G ++ GTP Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 749 WLNEKSDVYSFGVVLLEIITSQA---VIVRNENEN 780
D ++ GV++ E++ ++ +I N + N
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 44/183 (24%), Positives = 74/183 (40%), Gaps = 27/183 (14%)
Query: 613 EFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI--------YEYMANGNLKQLLSDEKAS 664
+ E E+ L R++H N+ + + N +I Y +M + D K
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDR 263
Query: 665 TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF-- 722
L + R I +EY+H ++HRDIK ENI L + + L DFG + F
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 723 ---PIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE 779
V TV + PE D E +D++S G++LL++++ + +
Sbjct: 320 EREAFDYGWVGTVATNS-----PEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374
Query: 780 NIH 782
Sbjct: 375 KPG 377
|
Length = 501 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 60/255 (23%), Positives = 111/255 (43%), Gaps = 64/255 (25%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE---------AEVKLLMRVHH 626
K +G+G +G V + +VA+K ++++ F+ E+KLL + H
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDH 63
Query: 627 RNLTNLVGYFIED----------NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
N+ I+D N++ ++YE M + +L Q++ + TLS +
Sbjct: 64 ENVIA-----IKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYFLY 115
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT 736
+GL+Y+H ++HRD+KP N+LL N + K+ DFGL++
Sbjct: 116 QLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR------------TTSE 160
Query: 737 PGYLDPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQAVIVRNENENIHII 784
G EY VT W LN DV+S G + E++ + + + +H +
Sbjct: 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF--PGKDYVHQL 218
Query: 785 QTVTNMIAKGDIENI 799
+ +T ++ E++
Sbjct: 219 KLITELLGSPSEEDL 233
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 579 LGKGGFGTVYHGYL-----DDG------TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR 627
LG+G F +Y G L D V +K+L S + F L+ ++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAS-TLSWERRLQIAMDAAQGLEYLH 686
+L L G + D N+ ++ EY+ G L L EK + +L W +L +A A L YL
Sbjct: 62 HLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 687 IGCKPPIVHRDIKPENILLTEN-------LEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+VH ++ +NIL+ KL+D G+ PI V P +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVERIP-W 170
Query: 740 LDPEYFVTDW--LNEKSDVYSFGVVLLEI 766
+ PE L +D +SFG LLEI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVK-MLSSSSGQGFKEFE-AEVKLLMRVHHR 627
D + K+ +G+G +G VY + G VA+K +G E+ LL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 628 N-LTNL--VGYFIEDN---NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA-- 679
+ L V + E N ++ L++EY+ SD K S R + A
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLD--------SDLKKFMDSNGRGPGRPLPAKTI 112
Query: 680 --------QGLEYLHIGCKPPIVHRDIKPENILLTENLEA-KLADFGLSKVF--PIGG-T 727
+G+ + H K ++HRD+KP+N+L+ + K+AD GL + F P+ T
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 728 HVSTVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAV 772
H +V T Y PE + + + D++S G + E+ Q +
Sbjct: 170 H--EIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 579 LGKGGFGTVYHGYLDDGTQVA---VKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVG 634
+G G FG V + T VA VK L +++ + EF + + H N+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR------LQ-IAMDAAQGLEYLHI 687
+E L++EY G+LK LS E+ W RR LQ +A + A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGL--------------SKVFPIGGTHVSTVV 733
K +H D+ N LT +L K+ D+G+ K P+ V
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771
G + E + S+V++ GV L E+ + A
Sbjct: 175 EFHGGLITAEQ------TKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 40/164 (24%)
Query: 579 LGKGGFGTVYHGYLD--DGTQVAVKMLSS------SSGQGFKEFEAEVKLLMRVHHRNL- 629
+G G FG V+ D DG +VA+K + + S + F+E +K+L H N+
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVL 62
Query: 630 -------TNLVGYFIEDNNMGLIYEYMANGNLK-----QLLSDEKASTLSWERRLQIAMD 677
+ F E + ++ E M + K Q LS + + QI
Sbjct: 63 SALDILQPPHIDPFEE---IYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY----QIL-- 113
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721
+GL+YLH I+HRDIKP N+L+ N K+ DFGL++V
Sbjct: 114 --RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 6e-07
Identities = 70/268 (26%), Positives = 106/268 (39%), Gaps = 89/268 (33%)
Query: 579 LGKGGFGTVYHGYLDDGTQ--VAVKMLSSSSGQGFKEFEA------------EVKLLMRV 624
LGKG +G V+ +D T+ VA+K K F+A E+ L +
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 625 -HHRNLTNLVGYFIEDNN--MGLIYEYMAN--------GNLK---------QLLSDEKAS 664
H N+ L+ +N+ + L++EYM L+ QLL KA
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL---KA- 119
Query: 665 TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF-P 723
L+Y+H G ++HRD+KP NILL + KLADFGL++
Sbjct: 120 -----------------LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159
Query: 724 IGGTHVSTV----VAGTPGYLDPEYFVTDWLNEKSDVYSFGV-------VLLEIITSQAV 772
+ + V VA T Y PE + S Y+ GV +L E++ + +
Sbjct: 160 LEENPENPVLTDYVA-TRWYRAPEILL------GSTRYTKGVDMWSVGCILGEMLLGKPL 212
Query: 773 IVRNENEN-IHIIQTVTNMIAKGDIENI 799
N + I V + DIE+I
Sbjct: 213 FPGTSTLNQLEKIIEVIGPPSAEDIESI 240
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 666 LSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725
L+ E + + A+G+E+L +HRD+ NILL+EN K+ DFGL++
Sbjct: 176 LTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 726 GTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+V A P ++ PE +SDV+SFGV+L EI +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 63/246 (25%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQV-AVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G G FG V D + A+K L + +AE +L + + L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLL------SDEKASTLSWERRLQIAMDAAQGLEYLH 686
F + +N+ + +Y+ G++ LL ++ A R IA + +E +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYIA-ELTCAIESVH 118
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGL---------SKVFPIGGTH--------- 728
K +HRDIKP+NIL+ + KL DFGL SK + G H
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 729 ------------------------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLL 764
++ + GTP Y+ PE + + D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 765 EIITSQ 770
E++ Q
Sbjct: 236 EMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-07
Identities = 26/69 (37%), Positives = 40/69 (57%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + +L+LS++ L+GEI + + + ++ LDL N L G +P L+ L L L L N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 472 FTGPIPVEL 480
G IP EL
Sbjct: 200 LVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 37/136 (27%), Positives = 62/136 (45%), Gaps = 7/136 (5%)
Query: 637 IEDNNMGLIYE---YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
IE +N Y+ A ++ ++ LS+ + + A G+E+L
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNC 260
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNE 752
VHRD+ N+L+ E K+ DFGL++ ++S P ++ PE +
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 753 KSDVYSFGVVLLEIIT 768
SDV+SFG++L EI T
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 27/64 (42%), Positives = 38/64 (59%), Gaps = 2/64 (3%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
LNLS++ TG I ++ +++LDLSNN LSG +P + L+VL+L GN G I
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 477 PVEL 480
P L
Sbjct: 181 PNSL 184
|
Length = 968 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
+H L L F ++ + + EY+ G+L + ++ L E + + + L Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
LH + I++RD+K +N+LL KL D+G+ K G ++ GTP Y+ PE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEI 167
Query: 745 FVTDWLNEKSDVYSFGVVLLEIITSQA 771
+ D ++ GV++ E++ ++
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 61/246 (24%), Positives = 95/246 (38%), Gaps = 59/246 (23%)
Query: 577 KVLGKGGFGTV-YHGYLDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNL 632
K LG G FG V +D A+K L + +AE +L + + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER--RLQIAMDAAQGLEYLHIGCK 690
F + +N+ + +Y+ G++ LL + E R IA + +E +H K
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP---EVLARFYIA-ELTLAIESVH---K 119
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGL---------SKVFPIG---------------- 725
+HRDIKP+NIL+ + KL DFGL SK + G
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 726 ------GTHVSTV---------------VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLL 764
G + T+ + GTP Y+ PE + + D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 765 EIITSQ 770
E++ Q
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 1/98 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + L++S++ L G I ++ +Q L L+ N G +P+ + L L+L N+
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQ 486
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKK 509
F+G +P +L S+ L+LS SCKK
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 36/186 (19%)
Query: 594 DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI-------- 645
+V VK + G K E+ +L + HR + NL+ + + + ++
Sbjct: 118 QRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172
Query: 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL 705
+ Y+ +++ L E+ + I + L YLH I+HRD+K ENI L
Sbjct: 173 FTYV-----------DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFL 218
Query: 706 TENLEAKLADFGLS-KVFPIGGTHVSTVV----AGTPGYLDPEYFVTDWLNEKSDVYSFG 760
E A L DFG + K+ H T +GT PE D K+D++S G
Sbjct: 219 DEPENAVLGDFGAACKL----DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAG 274
Query: 761 VVLLEI 766
+VL E+
Sbjct: 275 LVLFEM 280
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 33/110 (30%), Positives = 52/110 (47%), Gaps = 4/110 (3%)
Query: 660 DEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719
+E L E L + A+G+ +L +HRD+ NILLT K+ DFGL+
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 720 KVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ +V A P ++ PE +SDV+S+G++L EI +
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 5/100 (5%)
Query: 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
L I + ++YLH + I+HRDIK ENI + + L DFG + FP+
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240
Query: 732 V-VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQ 770
AGT PE D D++S G+VL E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 25/75 (33%), Positives = 42/75 (56%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L+L + L G+I L+NLT ++ L L++N L G +P L +++ L+ + L N +G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 477 PVELMEKSKNGSLQL 491
P E+ + L L
Sbjct: 229 PYEIGGLTSLNHLDL 243
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 4/116 (3%)
Query: 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKL 713
K E + L + L+ + AQG+++L +HRD+ N+LLT+ AK+
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKI 253
Query: 714 ADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
DFGL++ +V A P ++ PE +SDV+S+G++L EI +
Sbjct: 254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 32/78 (41%), Positives = 43/78 (55%), Gaps = 2/78 (2%)
Query: 419 LSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPV 478
L + L+GEI + LT + LDL N+L+G +P L L+ L+ L L NK +GPIP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 479 ELMEKSKNGSLQLSVGDN 496
+ K SL LS DN
Sbjct: 279 SIFSLQKLISLDLS--DN 294
|
Length = 968 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 59/245 (24%), Positives = 90/245 (36%), Gaps = 57/245 (23%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNL 632
K LG G FG V +D A+K L +AE +L + + L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
F + +N+ + +Y+ G++ LL R + A +E +H K
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA--VESVH---KMG 121
Query: 693 IVHRDIKPENILLTENLEAKLADFGL---------SKVFPIGGTHV-------------- 729
+HRDIKP+NIL+ + KL DFGL SK + G HV
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ-SGDHVRQDSMDFSNEWGDP 180
Query: 730 ------------------------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLE 765
+ + GTP Y+ PE + + D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 766 IITSQ 770
++ Q
Sbjct: 241 MLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 9/100 (9%)
Query: 575 FNKVLGKGGFGTVYH------GYLDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRV-HH 626
F K LG G FG V G D+ +VAVKML +S+ +E +E+K+L + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTL 666
+N+ NL+G + +I EY G+L L +KA T
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-KKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 61/245 (24%), Positives = 113/245 (46%), Gaps = 40/245 (16%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE---------AEVKLLMRVHH 626
+V+GKG +G V G +VA+K ++ FE E+KLL + H
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-------FEHVSDATRILREIKLLRLLRH 58
Query: 627 RNLTNLVGYFI-----EDNNMGLIYEYMANGNLKQLLSDEKAST-LSWERRLQIAMDAAQ 680
++ + + E ++ +++E M + +L Q++ KA+ L+ E +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHHQFFLYQLLR 114
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV-FPIGGTHVS-TVVAGTPG 738
L+Y+H + HRD+KP+NIL + + K+ DFGL++V F T + T T
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 739 YLDPEY---FVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI-HIIQTVTNMIAKG 794
Y PE F + + D++S G + E++T + + +N+ H + +T+++
Sbjct: 172 YRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLF---PGKNVVHQLDLITDLLGTP 227
Query: 795 DIENI 799
E I
Sbjct: 228 SPETI 232
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-05
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 11/101 (10%)
Query: 671 RLQIAMDAAQ---GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727
Q+ A Q ++Y+H I+HRDIK EN+L+ + L DFG + F G+
Sbjct: 259 LAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFG-AACF-ARGS 313
Query: 728 HVSTVVAGTPGYLD---PEYFVTDWLNEKSDVYSFGVVLLE 765
+ G G +D PE D D++S G+V+ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 18/134 (13%)
Query: 644 LIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRD 697
+ E+++ G+L ++ L +E A S E L L +LH + I++RD
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL--------ALNFLH---ERGIIYRD 121
Query: 698 IKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVY 757
+K +N+LL KL D+G+ K G ST GTP Y+ PE + D +
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 758 SFGVVLLEIITSQA 771
+ GV++ E++ ++
Sbjct: 181 ALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 19/189 (10%)
Query: 591 YLDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648
Y G V V+ L + + + + E+ + +H N+ FI DN + ++ +
Sbjct: 21 YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80
Query: 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTE 707
MA G+ K L+ +S I + L+Y+ H+G VHR +K +IL++
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG----YVHRSVKASHILIS- 135
Query: 708 NLEAKLADFGLSKVFP-IGGTHVSTVVAGTPGY-------LDPEYFVTDW--LNEKSDVY 757
++ K+ GL I VV P Y L PE + + KSD+Y
Sbjct: 136 -VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194
Query: 758 SFGVVLLEI 766
S G+ E+
Sbjct: 195 SVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 22/56 (39%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 674 IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
I D LEY+H + I H DIKPENI++ N + D+G++ F I G H+
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-04
Identities = 25/66 (37%), Positives = 39/66 (59%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L+LS++ LTGEI L + + L L +NSL G +P+ L + LR + L+ N F+G +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 477 PVELME 482
P E +
Sbjct: 421 PSEFTK 426
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 20/59 (33%), Positives = 33/59 (55%)
Query: 419 LSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIP 477
L + +GE+ + L L+ LD+SNN+L G + + L++L+L NKF G +P
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 30/72 (41%), Positives = 38/72 (52%), Gaps = 6/72 (8%)
Query: 412 PRIISLNLSSSGLTGEIAPYL---SNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
PR+ L L S+ +GEI L +NLT+ LDLS N+L+G +PE L L L L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTV---LDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 469 GNKFTGPIPVEL 480
N G IP L
Sbjct: 389 SNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 579 LGKGGFGTVYHG----YLDDG----TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT 630
LG+G F ++ G D G T+V +K+L S + F ++ ++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGC 689
G + + ++ EY+ G+L L K +SW +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 690 KPPIVHRDIKPENILLTENLEA--------KLADFGLS-KVFPIGGTHVSTVVAGTPGYL 740
+ H ++ +N+LL + KL+D G+S V P ++ P ++
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIP-WV 171
Query: 741 DPEYFV-TDWLNEKSDVYSFGVVLLEI 766
PE L+ +D +SFG L EI
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 29/67 (43%), Positives = 36/67 (53%), Gaps = 14/67 (20%)
Query: 681 GLEYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-- 737
GL LH IG IVHRDIKPEN+L+T + + K+ DFG + T + P
Sbjct: 321 GLRKLHRIG----IVHRDIKPENLLVTVDGQVKIIDFG-------AAVDMCTGINFNPLY 369
Query: 738 GYLDPEY 744
G LDP Y
Sbjct: 370 GMLDPRY 376
|
Length = 507 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 13/148 (8%)
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
N+ L Y + ++++ L+ ++ G L +S K + E + A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS--KFLNIPEECVKRWAAEMVVALDALH- 102
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFG-LSKVFP-IGGTHVSTVVAGTPGYLDPEYF 745
+ IV RD+ P NILL + +L F S+V G V + Y PE
Sbjct: 103 --REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVG 154
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAVI 773
E D +S G +L E++T + ++
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 19/64 (29%), Positives = 31/64 (48%)
Query: 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
+ L L S+ L GEI L ++ + L +NS SG +P ++L + L++ N
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
Query: 473 TGPI 476
G I
Sbjct: 441 QGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 24/64 (37%), Positives = 35/64 (54%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L L+S+ L G+I L + ++ + L N+LSG +P + L L L+L N TGPI
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 477 PVEL 480
P L
Sbjct: 253 PSSL 256
|
Length = 968 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 575 FNKVLGKGGFGTVYH------GYLDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRV-HH 626
K LG+G FG V VAVKML ++ +K E+K+L+ + HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 627 RNLTNLVGYFIEDNN-MGLIYEYMANGNLKQLL 658
N+ NL+G + + +I EY GNL L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF 636
++G G FG VY +D +VA+K + Q + E+ ++ ++H N+ L Y+
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 637 ----IEDNN----MGLIYEYM---ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ N + ++ E++ + +K + A L + + + L Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA-KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
H I HRD+KP+N+L+ N KL DFG +K G VS + + Y PE
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YRAPEL 241
Query: 745 FV--TDWLNEKSDVYSFGVVLLEII 767
+ T++ D++S G ++ E+I
Sbjct: 242 MLGATNYTTH-IDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 24/58 (41%), Positives = 32/58 (55%), Gaps = 2/58 (3%)
Query: 416 SLNLSSSGLTGEIAP-YLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
SL+LS++ LT I L ++ LDLS N+L+ PE S L LR L+L GN
Sbjct: 4 SLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 575 FNKVLGKGGFGTVY----HGYL--DDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRV-HH 626
F K LG G FG V +G D VAVKML S+ +E +E+K+L + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAS 664
N+ NL+G +I EY G+L L ++ S
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDS 136
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 25/98 (25%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
+ P + +L+LS + L+ ++ LSNL+ + +LDLS N +S ++P + L L L+L
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217
Query: 469 GNKFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDS 506
N I + + L + +N+ S
Sbjct: 218 NNS---IIELLSSLSNLKNLSGLELSNNKLEDLPESIG 252
|
Length = 394 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 858 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.62 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.34 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.33 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.28 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.09 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.07 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.04 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.91 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.82 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.8 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.8 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.79 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.75 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.75 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.74 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.73 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.67 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.66 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.64 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.62 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.48 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.43 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.38 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 97.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.29 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.29 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-86 Score=784.69 Aligned_cols=472 Identities=26% Similarity=0.432 Sum_probs=361.7
Q ss_pred HHHhhhccCCCCeEEeccCCCCCCCCcCCCCceeeecCccccccCcccccccccccCCcccccccccccC--CCCCceee
Q 043526 19 LAFSVQAQDQSGFISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSEFQISTLPKQFYNVRTFP--QGMRNCYT 96 (858)
Q Consensus 19 ~~~~~~~~~~~~~~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~~~~~~~~~~~~~tlR~Fp--~~~~ncy~ 96 (858)
+..++.++++.++++||||++.+. ++|.+|++|++|..|+. |.....+.. ....++|+|+|+|| +|+||||+
T Consensus 13 ~~~~~~~~~~~~~~~I~CGs~~~~--~~d~~~~~w~~D~~~~~-~~~~~~~~~---~~~~~~~~t~R~F~~~~g~~~cY~ 86 (623)
T PLN03150 13 AVLASLASPEPFTMRISCGARVNV--RTAPTNTLWYKDFAYTG-GIPANATRP---SFIAPPLKTLRYFPLSDGPENCYN 86 (623)
T ss_pred HhhcccccCCCccEEEeCCCCCCc--ccCCCCCEEcCCccccc-CccccccCc---ccccchhhccccCCcccccccceE
Confidence 444555566789999999986443 23458999999988863 444433321 24567899999999 58899999
Q ss_pred eCCCCCCCceEEEEEEeeeccCCCCCCCCeeeEEecceeEEEEecCC--ccccceeEEEEecCCCeeEEEEeecCCCCce
Q 043526 97 LNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNLWDSIKLDN--ATAMEMKEIIHIPTENHVLICLVNTGLGTPF 174 (858)
Q Consensus 97 l~~~~~~~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~~~--~~~~~~~e~i~~~~~~~~~vcl~~~~~~~pf 174 (858)
+|++ ++|||+||++|+|||||+++++|.|||++|||+|.+|+.+. .....++|+|+.+++++++|||+++++|+||
T Consensus 87 ~~~~--~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pF 164 (623)
T PLN03150 87 INRV--PKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPA 164 (623)
T ss_pred eeec--CCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCc
Confidence 9877 89999999999999999999999999999999999998753 2345778999999999999999999999999
Q ss_pred eeeEEeeeccCcccccc-----cceeeeEEeeccCCcCC-cccccCCCCC--CcccccCCC---CCCcccccccccccCC
Q 043526 175 ISALELRLLRNSSYETV-----SRSIALYKRYDYGSITN-QTIRYKDDAY--DRMWTPREF---PKTKKLSTSLPIRSGA 243 (858)
Q Consensus 175 is~lEl~~l~~~~y~~~-----~~~~~~~~r~~~g~~~~-~~~ryp~D~~--dR~W~~~~~---~~~~~~~t~~~i~~~~ 243 (858)
||+||||||++++|... +.+|.+++|.|+|+.+. ..+|||||+| ||+|.|+.. ..|..++|...|....
T Consensus 165 Is~iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~ 244 (623)
T PLN03150 165 ILSIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKAS 244 (623)
T ss_pred eeEEEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCccccccccccccccc
Confidence 99999999999999643 24588999999997542 3589999999 999998765 4588898888887666
Q ss_pred CCCCCChHHhhhcceecCCCCcceEEecCCCCCCCceEEEEEeeeccc-cccCcceEEEEEECCceeeeeccc-----cc
Q 043526 244 DDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEV-LQDNQLREFNISKDGQILMEFIVP-----EY 317 (858)
Q Consensus 244 ~~~~~~P~~v~~tA~t~~~~~~~l~~~~~~~~~~~~y~v~lhFae~~~-~~~~~~R~F~i~~ng~~~~~~~~p-----~~ 317 (858)
+.++.+|+.|||||+++.++..++++.|+ ++++..|+|+|||||++. ....++|+|||++||+.+.+.+.+ ..
T Consensus 245 ~~~~~~P~~VyqTA~~~~~~~~~lty~~~-v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~ 323 (623)
T PLN03150 245 NAPNFYPESLYQSALVSTDTQPDLSYTMD-VDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGER 323 (623)
T ss_pred CCCccChHHHhhhhccccCCCCceEEEee-cCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCc
Confidence 77889999999999998876667776665 678899999999999984 566789999999999987764332 22
Q ss_pred ceeeeEEeeeecCCceEEEEEEecCCCCCChhhhhhhhhhccCCCCCCCchhHHHHHHHHHHHcCCC--CCCCCCCCCCC
Q 043526 318 LFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYGVK--RNWQGDPCAPK 395 (858)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~i~L~~t~~S~LpPi~~a~e~~~~~~~~~~~~~~~~~~al~~~k~~~~~~--~~w~~dpc~~~ 395 (858)
..+.........++..++|+|.++..+ |||+||+|+|.+.+. +.+|.+.|+.||+++|+.++.. .+|+||||+|.
T Consensus 324 ~~~~~~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~-~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~ 400 (623)
T PLN03150 324 YTALVLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITA-ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQ 400 (623)
T ss_pred ccceEEEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeecccc-ccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCc
Confidence 222222222222335569999998766 799999999999984 5789999999999999988643 38999999998
Q ss_pred CCCccceeccCCCC-CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC
Q 043526 396 AYSWDGLNCSYKGN-DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474 (858)
Q Consensus 396 ~~~w~gv~C~~~~~-~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g 474 (858)
.+.|.||.|+.... ....++.|+|++|+|+|.+|++|++|++|+.|+|++|+|+|.+|..+++|++|+.|||++|+|+|
T Consensus 401 ~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg 480 (623)
T PLN03150 401 QHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480 (623)
T ss_pred ccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCC
Confidence 89999999964221 11245566666666666666666666666666666666666666556666666666666666666
Q ss_pred CCChhhhccCcCCCcc-----------------------ccccCcccccCC
Q 043526 475 PIPVELMEKSKNGSLQ-----------------------LSVGDNEELCSS 502 (858)
Q Consensus 475 ~iP~~~~~~~~l~~l~-----------------------l~~~~n~~lc~~ 502 (858)
.+|..++++++|+.|+ +.+.+|+.+|+.
T Consensus 481 ~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCC
Confidence 6666555555555443 345678888875
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-71 Score=611.71 Aligned_cols=324 Identities=42% Similarity=0.714 Sum_probs=278.7
Q ss_pred eccCCCCCCC-CcCCCCceeeecCccccccCcccccccc--cccCCcccccccccccCCCCCceeeeCCCCCCCceEEEE
Q 043526 34 IDCGIPAASS-YNDETTDLKYISDTTFVETGINKNISSE--FQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSKYSIR 110 (858)
Q Consensus 34 idCG~~~~~~-~~~~~~~~~~~~D~~~~~~g~~~~~~~~--~~~~~~~~~~~tlR~Fp~~~~ncy~l~~~~~~~~~ylvR 110 (858)
||||++.+++ |+|+.|||+|++|.+|+++|++++|++. .......++|+|+|+||+|.||||++++..++|+|||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR 80 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR 80 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence 8999988877 9999999999999999999999999432 223567889999999999999999998864467799999
Q ss_pred EEeeeccCCCCC-----CCCeeeEEecceeEEEEecCCcc-ccceeE-EEEecCCCeeEEEEeecCCCC-ceeeeEEeee
Q 043526 111 ASFMYGNYDAAN-----KPPQFDLYLGVNLWDSIKLDNAT-AMEMKE-IIHIPTENHVLICLVNTGLGT-PFISALELRL 182 (858)
Q Consensus 111 ~~f~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~~-~~~~~e-~i~~~~~~~~~vcl~~~~~~~-pfis~lEl~~ 182 (858)
++|+|||||+++ ++|.|||++|+|.|++|+..++. ...++| +|++.++++++|||+++++|+ ||||+|||||
T Consensus 81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~ 160 (347)
T PF12819_consen 81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP 160 (347)
T ss_pred EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence 999999999884 37889999999999999988722 357899 555555899999999999999 9999999999
Q ss_pred ccCcccccc--c--ceeeeEEeeccCCcCCcccccCCCCCCcccccCC-CCCCcccccccccc-cCCCCCCCChHHhhhc
Q 043526 183 LRNSSYETV--S--RSIALYKRYDYGSITNQTIRYKDDAYDRMWTPRE-FPKTKKLSTSLPIR-SGADDSYLPPSAVMST 256 (858)
Q Consensus 183 l~~~~y~~~--~--~~~~~~~r~~~g~~~~~~~ryp~D~~dR~W~~~~-~~~~~~~~t~~~i~-~~~~~~~~~P~~v~~t 256 (858)
|++++|+.. . .+|.+++|.|+|+..+. ||||+|+|||+|+|+. .+.|..++|+.+++ ...+++|.||+.||||
T Consensus 161 lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~~-iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~T 239 (347)
T PF12819_consen 161 LPDSLYPDTDANSSQALETVYRLNVGGSSSF-IRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQT 239 (347)
T ss_pred CCccceeccccCCCceeEEEEeecCCCcccc-cCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHh
Confidence 999999633 2 66999999999975433 9999999999999874 56799999988876 6678899999999999
Q ss_pred ceecCCCCcceEEecCCCCCCCceEEEEEeeeccccc-cCcceEEEEEECCceeeeecccccceeeeE--Eee---eecC
Q 043526 257 AITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQ-DNQLREFNISKDGQILMEFIVPEYLFSFST--YRV---KPYS 330 (858)
Q Consensus 257 A~t~~~~~~~l~~~~~~~~~~~~y~v~lhFae~~~~~-~~~~R~F~i~~ng~~~~~~~~p~~~~~~~~--~~~---~~~~ 330 (858)
|+++.+.+.+++++|..++++.+|||+||||||+.+. ..++|+|||++||+.+.+++.|.++....+ |.. ....
T Consensus 240 A~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 319 (347)
T PF12819_consen 240 ARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPD 319 (347)
T ss_pred hhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecC
Confidence 9999998888999999999999999999999999864 444899999999999988899988765443 443 2223
Q ss_pred CceEEEEEEecCCCCCChhhhhhhhhhc
Q 043526 331 GAIIEFSLDRTERSTLPPIINAFEVYME 358 (858)
Q Consensus 331 ~~~~~i~L~~t~~S~LpPi~~a~e~~~~ 358 (858)
+..++|+|.++.+|+|||||||+|||.+
T Consensus 320 ~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 320 SGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred CCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 3466999999999999999999999964
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-54 Score=476.08 Aligned_cols=287 Identities=50% Similarity=0.836 Sum_probs=255.3
Q ss_pred cccccCHHHHHHHHhhcc--ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeee
Q 043526 559 ENRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF 636 (858)
Q Consensus 559 ~~~~~~~~el~~~t~~f~--~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 636 (858)
..+.|+++|+.++|++|. +.||+|+||.||+|.+++|+.||||++.....+..++|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 457799999999999998 699999999999999999999999988766543256699999999999999999999999
Q ss_pred eeCC-eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEee
Q 043526 637 IEDN-NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715 (858)
Q Consensus 637 ~~~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~D 715 (858)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 499999999999999999876543889999999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCC-CccccHHHHHHHHHhcC
Q 043526 716 FGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE-NENIHIIQTVTNMIAKG 794 (858)
Q Consensus 716 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~-~~~~~l~~~v~~~~~~~ 794 (858)
||+|+..+....+......||.+|+|||++..+.+++|+|||||||+|+||+||+++.+... ..+..+..|++..+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997765412222211179999999999999999999999999999999999999887654 34556899999999999
Q ss_pred Cchhhhchhhc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 795 DIENIVDSCLR-GGFEI-ESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 795 ~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
.+.+++|+.+. +.++. +++.++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999987 56664 68899999999999999999999999999996644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=510.80 Aligned_cols=420 Identities=27% Similarity=0.465 Sum_probs=311.0
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|+++|.+|..+++|++|+.|+|++|+++|.+|..+..|++|+.|+|++|+++|.+|..+..+..|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 46788889999999899999999999999999999999999999999999999999999999999998888887776665
Q ss_pred c---------------------ccCcccccCCCC----Cccccc-CCceEEehhhhHHHHHHHHHHHHHHHHHHhhccch
Q 043526 492 S---------------------VGDNEELCSSSS----DSCKKE-KKNMFVIPLVASAVSLLFFLTALAMIWWSLKRRKD 545 (858)
Q Consensus 492 ~---------------------~~~n~~lc~~s~----~~~~~~-~~~~~vi~iv~~~v~ll~~l~~~~~i~~~~krrk~ 545 (858)
+ +.||+.+|+... ..|... +.....+.++++ +++++++++++++++++||++.
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 657 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCT-LGAFLVLALVAFGFVFIRGRNN 657 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHH-HHHHHHHHHHHHHHHHHHhhhc
Confidence 3 456788887531 122211 111111111111 2222222222222222232221
Q ss_pred h--hhhhccCCCccc------cccccCHHHHHHHHhhccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHH
Q 043526 546 R--AAILNAHGSLEF------ENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEA 616 (858)
Q Consensus 546 ~--~~~~~~~~~~~~------~~~~~~~~el~~~t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~ 616 (858)
. .......+..+. ....++++++.... ...+.||+|+||.||+|+. .+|+.||||++...... ..+
T Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~ 732 (968)
T PLN00113 658 LELKRVENEDGTWELQFFDSKVSKSITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSS 732 (968)
T ss_pred ccccccccccccccccccccccchhhhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHH
Confidence 1 111111111110 01224444443322 2346899999999999996 58999999998654322 235
Q ss_pred HHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 043526 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHR 696 (858)
Q Consensus 617 E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~ 696 (858)
|++.+++++|||||+++++|.+++..++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+.++++|+||
T Consensus 733 ~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred HHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 6889999999999999999999999999999999999999995 37899999999999999999998878899999
Q ss_pred CCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccC
Q 043526 697 DIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRN 776 (858)
Q Consensus 697 DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~ 776 (858)
||||+||+++.++.+++. ||........ ....|+..|+|||++.+..++.|+|||||||++|||+||+.|+...
T Consensus 808 dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred CCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 999999999999988886 6655443211 1235789999999999999999999999999999999999999765
Q ss_pred CCccccHHHHHHHHHhcCCchhhhchhhcCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 777 ENENIHIIQTVTNMIAKGDIENIVDSCLRGG--FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 777 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
......+..|++...........+|+.+... .+.++..++.+++.+|++.+|++||+|+||++.|+++....
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 5555667788877666555666677766443 34567778999999999999999999999999999876533
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=390.31 Aligned_cols=255 Identities=36% Similarity=0.529 Sum_probs=212.2
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcc--hHhHHHHHHHHHhcccceeeeeeeeeeeCC-eeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG--FKEFEAEVKLLMRVHHRNLTNLVGYFIEDN-NMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~~~gs 653 (858)
+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 4599999999999999655559999998654322 569999999999999999999999999988 7999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC-eEecCCCCcceEEcCCC-CEEEeeecCcccccCCCcceee
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP-IVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|.++++..+...+++..+++|+.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++...... ...+
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~ 202 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMT 202 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cccc
Confidence 999998855568999999999999999999999 677 99999999999999997 99999999998765432 2223
Q ss_pred cccCCCCccCccccc--cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 732 VVAGTPGYLDPEYFV--TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 732 ~~~gt~~y~APE~~~--~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
...||+.|||||.+. ...++.|+|||||||++|||+||+.||..... .+.+......+. +...+
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~---------Rp~~p 268 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGL---------RPPIP 268 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCC---------CCCCC
Confidence 367999999999999 66999999999999999999999999976542 222222222221 22223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
......+..++.+||..+|++||++.+++..|+.+...-.
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 3355678899999999999999999999999998655333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=369.90 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=215.0
Q ss_pred cccCHHHHHHHHhhccccccccCceEEEEEEEC-CCCEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeee
Q 043526 561 RHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638 (858)
Q Consensus 561 ~~~~~~el~~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 638 (858)
..++.+|+... +.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||+++|.|..
T Consensus 74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34566677654 67999999999999976 7899999999544 33456889999999999999999999999999
Q ss_pred CC-eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 639 DN-NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 639 ~~-~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
+. ...++||||++|||++.+... +.+++...-+|+.++++||.|||+ +++|+||||||+|||++..|++||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence 99 599999999999999999754 468999999999999999999994 4899999999999999999999999999
Q ss_pred CcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 718 LSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 718 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
.++.+-.. ....++||..|||||.+.+..++.++||||||+.++|+.+|+.|+...........+.+...+.+. .
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-p- 299 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-P- 299 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-C-
Confidence 99887543 445678999999999999999999999999999999999999999765322223333322222111 1
Q ss_pred hhhchhhcCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSCLRGGFEI-ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+. ....++.+++..|+++||.+||+++|++++
T Consensus 300 --------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 --------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222 356789999999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=384.99 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=216.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|.||.||.|.++....||+|.++... ...+.|.+|+++|++++|+|||+++|+|..++.++||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 4457799999999999999888899999998653 345789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.++|+...+..++..+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+....+........
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 999999866778999999999999999999999 99999999999999999999999999999996544443333333
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.-...|.|||.+..+.++.|||||||||+||||+| |+.|+....+. + +...+.+| -+-.-+..+
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----e-v~~~le~G---------yRlp~P~~C 429 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----E-VLELLERG---------YRLPRPEGC 429 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----H-HHHHHhcc---------CcCCCCCCC
Confidence 34568999999999999999999999999999999 77777655432 1 12222222 122234556
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
..++.+|+..||+.+|++|||++.+...|+++...+
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 778999999999999999999999999998876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=373.41 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=209.6
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+...+.||+|+|+.||+++. ++|+.||+|++.+. .....+...+|+++.+.++|||||+++++|++.+..|+|.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 44568999999999999996 89999999999764 344567789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
|++++|..+++ +.+.++++++..++.||+.||.||| +.+|+|||||-.|+||++++++||+|||||..+..++.
T Consensus 100 C~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E- 173 (592)
T KOG0575|consen 100 CHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE- 173 (592)
T ss_pred cCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence 99999999997 3458999999999999999999999 89999999999999999999999999999998864432
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||++.....+..+||||+||+||-||.|++||+...- .+. ...+...+ -..
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----ket-y~~Ik~~~----------Y~~ 237 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----KET-YNKIKLNE----------YSM 237 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----HHH-HHHHHhcC----------ccc
Confidence 23456899999999999988899999999999999999999999975431 111 11111110 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.....+..+|+.++|+++|.+|||.++|+.+
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 33456678899999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=355.75 Aligned_cols=195 Identities=28% Similarity=0.550 Sum_probs=176.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|+||+||+|+++ ++.+||||.+... .....+.+..|+++|+.++|||||.+++++..++.++||||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 356999999999999975 7899999999876 4445677899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC------CCEEEeeecCcccccCCC
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN------LEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~------~~~kL~DFGla~~~~~~~ 726 (858)
+|.++++..+ .+++.....++.|+|.||++|| +.+||||||||+||||+.. -.+||+|||+|+.+...
T Consensus 95 DLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~- 168 (429)
T KOG0595|consen 95 DLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG- 168 (429)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-
Confidence 9999998765 7999999999999999999999 9999999999999999865 45899999999998743
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~ 777 (858)
.......|++-|||||+++.++|+.|+|+||+|+++|||++|+.||....
T Consensus 169 -~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 169 -SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred -hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 23345689999999999999999999999999999999999999997544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=381.38 Aligned_cols=255 Identities=30% Similarity=0.471 Sum_probs=215.7
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|.||+||+|+.. +.+.||||.++..... ..++|++|++++..++|||||+|+|.|.+++.+++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 45578999999999999853 3457999999987665 7889999999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc--------cCc----hhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 647 EYMANGNLKQLLSDEK--------AST----LSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~--------~~~----l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
|||..|+|.++|+.+. ... ++..+.+.||.|||.||+||- ++.+|||||.++|+||.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEec
Confidence 9999999999996543 223 889999999999999999999 8999999999999999999999999
Q ss_pred eecCcccccCCCcceee-cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHh
Q 043526 715 DFGLSKVFPIGGTHVST-VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
|||+++..-..+.+... ...-.++|||||.+..+++|+++|||||||+|||+++ |+.|+....+++ |...++
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------VIe~i~ 719 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------VIECIR 719 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------HHHHHH
Confidence 99999975433222211 1223569999999999999999999999999999998 899987766443 445566
Q ss_pred cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 793 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+|.+.+. +..+..++.+|+..||+.+|++||+++||-..|+..-+
T Consensus 720 ~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 720 AGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred cCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 6654332 34455689999999999999999999999999998544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=353.29 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=202.8
Q ss_pred hhccccccccCceEEEEEE-ECCCCEEEEEEeccCCCc-------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQ-------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 644 (858)
+-..+.||+|+||.|-+|. .++|+.||||++++.... ......+|+++|++++|||||++++++...+..|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 3446889999999999998 458999999999864221 22345799999999999999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCccc
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLSKV 721 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla~~ 721 (858)
|||||+||+|.+.+-.++ .+.+.....++.|++.|+.||| ++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 254 VlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999997665 5777888999999999999999 9999999999999999765 7799999999998
Q ss_pred ccCCCcceeecccCCCCccCccccccCCC---CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWL---NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~---s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
.. ........+||+.|.|||++.+... ..|.|+||+||+||-+++|.+||....... .+. ..+..|....
T Consensus 329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~----eQI~~G~y~f 401 (475)
T KOG0615|consen 329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLK----EQILKGRYAF 401 (475)
T ss_pred cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHH----HHHhcCcccc
Confidence 75 3345667899999999999986543 357899999999999999999997654221 111 1222221100
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....-.+...+.++++.+||..||++|||+.|++++
T Consensus 402 ------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 ------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 001123457789999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=336.83 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=207.6
Q ss_pred hccccccccCceEEEEEE-ECCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeee-eeeeCCe-eEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVG-YFIEDNN-MGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV~Ey 648 (858)
...+.||+|+||+|||+. +.+|..+|.|.+.-. +....++...|+.+|+.++|||||++++ -+.++.+ +.+||||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 334789999999999998 669999999998732 4455678899999999999999999998 5556555 8899999
Q ss_pred ccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 649 MANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
+..|+|...++.-+ .+.+++..+++++.|++.||.++|... +. |+||||||.||+|+.+|.+||+|||+++++..
T Consensus 102 c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 99999999996533 557999999999999999999999422 44 89999999999999999999999999999875
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
..+ .....+||+.||+||.+.+..++.|+||||+||+++||+.-.+||.+.. + ......+.+++...+.+
T Consensus 181 ~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~-~~L~~KI~qgd~~~~p~--- 250 (375)
T KOG0591|consen 181 KTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----L-LSLCKKIEQGDYPPLPD--- 250 (375)
T ss_pred hhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----H-HHHHHHHHcCCCCCCcH---
Confidence 443 3345689999999999999999999999999999999999999997642 2 22333444443322221
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+..+.+|+..|+..||+.||+.-.+++.++.
T Consensus 251 -----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 251 -----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3345678899999999999999997666665554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=367.29 Aligned_cols=270 Identities=27% Similarity=0.455 Sum_probs=226.7
Q ss_pred cccCHHHHHHHHhhc-----------cccccccCceEEEEEEEC----CCCEEEEEEeccC-CCcchHhHHHHHHHHHhc
Q 043526 561 RHFTYSEVLKITDNF-----------NKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRV 624 (858)
Q Consensus 561 ~~~~~~el~~~t~~f-----------~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l 624 (858)
..++|+|--++..+| .++||.|.||.|++|+++ ....||||.++.. .+....+|+.|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 345666555554444 468999999999999976 2356999999865 345678899999999999
Q ss_pred ccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 625 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
.||||++|-|.........+|+|||+||+|+.+|+.+.+ .+.+.+...++++||.||.||- +.++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 999999999999999999999999999999999998775 5999999999999999999999 999999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCcceeecccC--CCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGTHVSTVVAG--TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENI 781 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~ 781 (858)
++.+..+|++|||+++.+.++.....+...| ..+|.|||.+...+++.++|||||||+|||.++ |++|+.++.+.+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd- 842 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD- 842 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-
Confidence 9999999999999999876554333333333 458999999999999999999999999999887 999998776422
Q ss_pred cHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 782 HIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 782 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+...+.+| .+-..++++...+.+|++.||++|-.+||.+.||+..|.+++....
T Consensus 843 -----VIkaIe~g---------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 843 -----VIKAIEQG---------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -----HHHHHHhc---------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 22222222 2334567888899999999999999999999999999999887654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=336.35 Aligned_cols=237 Identities=29% Similarity=0.429 Sum_probs=198.5
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.++||+|+||+|+.++. ++++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|++++.++||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 358999999999999985 579999999998653 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
||.|..+|++.. .+++..+.-++.+|+.||.||| +.+||||||||+|||||++|.++|+|||+++..-..+ ..+
T Consensus 109 GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t 182 (357)
T KOG0598|consen 109 GGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DAT 182 (357)
T ss_pred CccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Ccc
Confidence 999999997654 7999999999999999999999 9999999999999999999999999999999643332 233
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
..++||+.|||||++....++..+|.||+|+++|||++|.+||.... ...+....... . + ...+.
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~-k--------~-~~~p~ 247 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKG-K--------L-PLPPG 247 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcC-c--------C-CCCCc
Confidence 45789999999999999999999999999999999999999997643 12222222221 1 0 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCC
Q 043526 811 ESAWRAVELAVKCASRTSSERP 832 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RP 832 (858)
-...+..+++...+.++|++|.
T Consensus 248 ~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhc
Confidence 2445678999999999999996
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.08 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=205.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC--eeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--NMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~Ey~~~ 651 (858)
..+.||+|+||.||++... +|...|||..........+.+.+|+++|++++|||||+++|...... .+.+.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3478999999999999965 59999999987664444677999999999999999999999855554 68999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccccC--CCcc
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVFPI--GGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~~~--~~~~ 728 (858)
|||.+++..... .+++..+..+.+||++||+||| +++|+||||||+|||++. ++.+||+|||+++.... ....
T Consensus 101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999987766 7999999999999999999999 999999999999999999 79999999999987753 1122
Q ss_pred eeecccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDW-LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......||+.|||||++..+. ...++|||||||++.||+||++||... .....++-....+... ..
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~---------P~ 243 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL---------PE 243 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC---------CC
Confidence 234578999999999998643 335999999999999999999999753 1111222221111111 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
.+.....+..+++.+|+..+|++|||+++++++-....
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 23345567889999999999999999999999876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=352.75 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=206.1
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|+||+||+|+|.. .||||+++.... ...+.|..|+..+++-+|.||+-+.|+|..+.. .+|+.+|+|.
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 35789999999999999853 599999986643 356789999999999999999999999998877 9999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC-CCcceee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-GGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~-~~~~~~~ 731 (858)
+|+.+||..+ ..|+..+.+.||+|||+||.||| .++|||||||+.||++.+++.|||+|||++..-.. .+.....
T Consensus 473 SLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~ 548 (678)
T KOG0193|consen 473 SLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE 548 (678)
T ss_pred hhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence 9999998765 57999999999999999999999 99999999999999999999999999999975422 1222233
Q ss_pred cccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 732 VVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
..-|...|||||++.. ..++..+||||||+++|||+||..||.....+ .+..++..|-+. .|.. ..
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------qIifmVGrG~l~--pd~s---~~ 617 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------QIIFMVGRGYLM--PDLS---KI 617 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh------heEEEecccccC--ccch---hh
Confidence 3457789999999874 47899999999999999999999999732211 111222222110 0000 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
......++.+|+..||..++++||.+.+|+..|++++.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 23445688999999999999999999999999999776
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=346.92 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=202.3
Q ss_pred hhccccccccCceEEEEEEE------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCC-eeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDN-NMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~-~~~ 643 (858)
..+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||++++++|...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 34568899999999999974 2457899999975432 3346789999999999 8999999999987654 588
Q ss_pred EEEeeccCCChHHHhhhcc------------------------------------------------------------c
Q 043526 644 LIYEYMANGNLKQLLSDEK------------------------------------------------------------A 663 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~------------------------------------------------------------~ 663 (858)
+||||+++|+|.+++.... .
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 9999999999999986532 1
Q ss_pred CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce-eecccCCCCccCc
Q 043526 664 STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDP 742 (858)
Q Consensus 664 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~AP 742 (858)
..+++.+++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++......... .....++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 24788899999999999999999 8999999999999999999999999999998654322211 1223456789999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHH
Q 043526 743 EYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAV 821 (858)
Q Consensus 743 E~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 821 (858)
|.+.+..++.++|||||||++|||++ |..||....... . ....+..+... ..+......+.+++.
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~----~~~~~~~~~~~---------~~~~~~~~~l~~li~ 311 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E----FCQRLKDGTRM---------RAPENATPEIYRIML 311 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H----HHHHHhcCCCC---------CCCCCCCHHHHHHHH
Confidence 99998889999999999999999997 999986543221 1 11112222110 011223456889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHHHH
Q 043526 822 KCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 822 ~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+|++.+|++||++.|+++.|+++++
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=341.17 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=205.8
Q ss_pred hccccccccCceEEEEEE-ECCCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.|.+.||+|+|.+|++|+ .++++++|||++.+. .....+-...|-++|.+| .||.|++|+-.|+++..+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 456899999999999999 458999999998754 223345567788899999 899999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.++|+.. ..|++.....++.+|+.||+||| +.|||||||||+|||||+||.+||+|||.|+.++.....
T Consensus 156 A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 156 APNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred cCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999765 47999999999999999999999 999999999999999999999999999999988543211
Q ss_pred ----------ee--ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 729 ----------VS--TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 729 ----------~~--~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
.. ..++||..|.+||++.....+..+|+|||||+||+|+.|.+||.... +..+.+.+...
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqkI~~l------ 302 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQKIQAL------ 302 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHHHHHh------
Confidence 11 34789999999999999999999999999999999999999997643 22222222221
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
+-.+ +..-...+.+|+.+.|..||.+|++.+||.++-
T Consensus 303 ----~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 ----DYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----cccC----CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1112 222235678999999999999999999988764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.62 Aligned_cols=244 Identities=23% Similarity=0.421 Sum_probs=208.2
Q ss_pred ccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
+.||+|+.|.||.+. ..+++.||||++........+-...|+.+|+..+|+|||.++..|..++++++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 569999999999998 5689999999998887777777899999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
|.+... .+++.++..|++++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+..... .....+|
T Consensus 359 DvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVG 431 (550)
T KOG0578|consen 359 DVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVG 431 (550)
T ss_pred hhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccC
Confidence 998654 4899999999999999999999 99999999999999999999999999999988765443 4456789
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 815 (858)
|+.|||||......|.+|.||||||++++||+-|++||.... - .+ +...+......++- .+......
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---P--lr-AlyLIa~ng~P~lk-------~~~klS~~ 498 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---P--LR-ALYLIATNGTPKLK-------NPEKLSPE 498 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---h--HH-HHHHHhhcCCCCcC-------CccccCHH
Confidence 999999999999999999999999999999999999997422 1 11 11112221111111 12344567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 043526 816 AVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 816 l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.+++.+||+.|+++||+++|++++
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhcC
Confidence 8999999999999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.67 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=209.3
Q ss_pred cccCHHHHHHHHhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC
Q 043526 561 RHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN 640 (858)
Q Consensus 561 ~~~~~~el~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 640 (858)
-.+.|+++.+. +-||.|+.|.||+|+++ ++.||||+++.- -..+++.|++++||||+.+.|+|....
T Consensus 119 WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 119 WEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred ccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 45667777655 56999999999999995 578999998532 246789999999999999999999999
Q ss_pred eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 641 NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
.+|+|||||..|-|...|+..+ .+.-.....|..+||.||.||| ...|||||||+-||||+.+..+||+|||-++
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchH
Confidence 9999999999999999997654 6777888899999999999999 8999999999999999999999999999998
Q ss_pred cccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 721 VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 721 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
..... .....++||..|||||++.+..+++|.|||||||||||||||.-||.+....- .++ | +-
T Consensus 261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIw-----G----VG 324 (904)
T KOG4721|consen 261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIW-----G----VG 324 (904)
T ss_pred hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEE-----e----cc
Confidence 76543 23345789999999999999999999999999999999999999986543110 000 0 00
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...|.-..+..+..-+.-|+++||.-.|..||++.+++.+|.-+-.+
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11122223455666788899999999999999999999999764433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.23 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=198.9
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..+|+|++|+|||++.+ +|+.||||++..+.. ...+-.++|+++|+.++|+|+|.+++.|..+..++||+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 36899999999999965 799999999975533 3345679999999999999999999999999999999999998 4
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
+.+-|... ...++.....+++.|+++|+.|+| +.+++||||||+||||+.++.+||||||+|+.+...+. ..+..
T Consensus 87 vL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-~YTDY 161 (396)
T KOG0593|consen 87 VLHELERY-PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-NYTDY 161 (396)
T ss_pred HHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-hhhhh
Confidence 44445433 346888899999999999999999 89999999999999999999999999999999875333 23445
Q ss_pred cCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC--chhhhchh-------
Q 043526 734 AGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD--IENIVDSC------- 803 (858)
Q Consensus 734 ~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~--~~~~~d~~------- 803 (858)
+.|..|+|||.+.+ ..|....||||+||++.||++|.+.|.+.. +.+..-.++..+.+-- ..+++...
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 67999999999987 678999999999999999999998886543 2222222322221100 01111111
Q ss_pred ---------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 ---------LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 ---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+...+ .....-+++++..|++.||.+|++-+|++.+
T Consensus 240 lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 240 LPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00111 1223467899999999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=334.05 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=199.8
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcc---hHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEEeec
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG---FKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIYEYM 649 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~ 649 (858)
..||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4799999999999998 68999999997654333 4678899999999999999999999877 34688999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
++|+|.+++... ..++|.++++++.|++.||+||| + .+++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999999764 36899999999999999999999 5 478899999999999999999999999998654321
Q ss_pred eeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 729 VSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +........+. ..
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~i~~~~~---------~~ 241 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDLIINKNN---------SL 241 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcCC---------CC
Confidence 22457889999999975 67899999999999999999999999754321 11111111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
..+......+.+++.+||+.+|++|||++|+++.|+..
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11223455788999999999999999999999999884
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.83 Aligned_cols=259 Identities=22% Similarity=0.386 Sum_probs=208.4
Q ss_pred hhccccccccCceEEEEEE-ECCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+++.+.||.|..++||+|+ .+.++.||||++.-.. ....+.+.+|+..++.++||||++++..|..+..+++||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 4566899999999999999 5678999999997543 3346889999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+||+.++++..-...+++..+..|++++++||.||| .+|.||||||+.||||+++|.+||+|||.+..+...+....
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 999999998877778999999999999999999999 99999999999999999999999999998776654442221
Q ss_pred ---ecccCCCCccCccccc--cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 731 ---TVVAGTPGYLDPEYFV--TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 731 ---~~~~gt~~y~APE~~~--~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
...+||+.|||||.++ -..|+.|+||||||+...||.+|..||..... .+.....+... .....-..+.
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn~-pp~~~t~~~~ 258 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQND-PPTLLTSGLD 258 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcCC-CCCcccccCC
Confidence 4468999999999965 35789999999999999999999999976542 11222222221 1111100010
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..........+.+++..|+++||.+|||+++++++
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00011223378899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.09 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=202.5
Q ss_pred ccccccCceEEEEEE-ECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~~~ 651 (858)
+.||+|.||.||+|+ ..+|+.||+|+++... .....-..+|+.+|+++.||||++|.+...+. ..+|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 579999999999999 6799999999987654 44456678999999999999999999999887 689999999998
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.-++... .-.|+..++..++.|++.||+|+| +++|+|||||.+|||||.+|.+||+|||||+++........+
T Consensus 203 -DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T 277 (560)
T KOG0600|consen 203 -DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT 277 (560)
T ss_pred -hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence 888888643 357999999999999999999999 999999999999999999999999999999988766655556
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCC-ccccHHHHHHHHHhcCCch--hhhchh-h--
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNEN-ENIHIIQTVTNMIAKGDIE--NIVDSC-L-- 804 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~-~~~~l~~~v~~~~~~~~~~--~~~d~~-l-- 804 (858)
..+-|..|.|||.+.+ ..|+.+.|+||.||||.||++|++.+.+... +..+.+-.+.....+..+. .+..-. +
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 6667999999999986 5799999999999999999999998876542 1111111111111111111 010000 0
Q ss_pred cCCCCH--H-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 805 RGGFEI--E-----SAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 805 ~~~~~~--~-----~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
...+.. . .....++|+..+|+.||.+|.|+.++++
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011111 1 1335688999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.78 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=204.3
Q ss_pred hccccccccCceEEEEEE-ECCCCEEEEEEeccCCCc-chHhHHHHHHHHHhcc-cceeeeeeeeeeeCC-eeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDN-NMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~lV~Ey~ 649 (858)
...+.||.|.||.||+|+ .++|+.||||+++.+-.. ...--++|++.|+++. |||||++.+.+.+.+ .+++|||||
T Consensus 13 ~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M 92 (538)
T KOG0661|consen 13 TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM 92 (538)
T ss_pred HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh
Confidence 334679999999999999 568999999999765332 2233478999999998 999999999999988 899999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+. +|+++++.+ ...|++.++..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+..... ..
T Consensus 93 d~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--pP 165 (538)
T KOG0661|consen 93 DC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--PP 165 (538)
T ss_pred hh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC--CC
Confidence 87 999999877 678999999999999999999999 999999999999999999999999999999976433 33
Q ss_pred eecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---chh--hhchh
Q 043526 730 STVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IEN--IVDSC 803 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~~--~~d~~ 803 (858)
.+..+.|..|+|||++. ++.|+.+.||||+||+++|+.+-++.|.+.. +.+..-.+...+..-. +.+ .+...
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 34556899999999876 6789999999999999999999998886543 2222222222222111 111 11111
Q ss_pred hcC------CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRG------GFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~------~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.- ..+ .....+.++++.+|+..||.+|||++|.+++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 110 011 1256688999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=327.72 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=202.7
Q ss_pred hhccccccccCceEEEEEEEC----CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
..+.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+..+++++||||+++++++..++..++|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 355688999999999999853 467899999876533 334578999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+|||++.++.++++|||.+........
T Consensus 87 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 87 YMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred eCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999999997543 46899999999999999999999 89999999999999999999999999998765432221
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......++..|+|||.+.+..++.++|||||||+++|+++ |+.||...... .+.. .+.++.. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~----~~~~~~~---------~ 227 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIK----AVEDGFR---------L 227 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH----HHHCCCC---------C
Confidence 11122335678999999998999999999999999999875 99998654321 1111 1122110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
..+......+.+++.+|++.+|++||+++||.+.|+++
T Consensus 228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=327.25 Aligned_cols=249 Identities=33% Similarity=0.534 Sum_probs=195.0
Q ss_pred ccccccccCceEEEEEEEC-----CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999976 357899999965433 3468899999999999999999999999988889999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+++|+|.++|+......+++.++++|+.||++||+||| +.+++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998875567999999999999999999999 78999999999999999999999999999987632211
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......+...|+|||.+....++.++||||||+++|||++ |+.|+..... . +... .+.++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~---~~~~-~~~~~~~~~-------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--E---EIIE-KLKQGQRLP-------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--H---HHHH-HHHTTEETT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--c---cccc-cccccccce--------
Confidence 12223346678999999998889999999999999999999 6788754421 1 1111 122221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.+......+.+++.+||..+|++||+++++++.|
T Consensus 226 -~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122344688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.46 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=205.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|++|.||+|... +++.||+|.+... .....++.+|++++++++||||+++++++..++..++||||++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 44578999999999999965 6889999998754 334577899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++..++.++.|+++||+||| +.+++||||||+||++++++.+||+|||++.............
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 9999997765567899999999999999999999 8899999999999999999999999999998765432222222
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||.+.+..++.++|||||||+++||++ |..|+.....+ .. ...+..+ .....+..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~---------~~~~~~~~ 229 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV----YELLEKG---------YRMERPEG 229 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCC---------CCCCCCCC
Confidence 234568999999988889999999999999999998 88888643211 11 1111111 11111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
...++.+++.+|++.+|++||++.++++.|+++
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.49 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=200.5
Q ss_pred hccccccccCceEEEEEEECC-----------------CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD-----------------GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGY 635 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~ 635 (858)
.+.+.||+|+||.||+|.+++ +..||+|.+..... ....+|.+|++++.+++||||++++++
T Consensus 8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 87 (304)
T cd05096 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV 87 (304)
T ss_pred eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 456789999999999998542 34799999876433 234679999999999999999999999
Q ss_pred eeeCCeeEEEEeeccCCChHHHhhhcc-----------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 043526 636 FIEDNNMGLIYEYMANGNLKQLLSDEK-----------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI 698 (858)
Q Consensus 636 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DL 698 (858)
+...+..++||||+++|+|.+++.... ...++|.++++++.||+.||+||| +.+|+||||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~dl 164 (304)
T cd05096 88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDL 164 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCc
Confidence 999999999999999999999986432 124788999999999999999999 889999999
Q ss_pred CCcceEEcCCCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhC--CCcccc
Q 043526 699 KPENILLTENLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITS--QAVIVR 775 (858)
Q Consensus 699 k~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG--~~p~~~ 775 (858)
||+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||++++||+++ ..|+..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 999999999999999999999865433221 12223457789999999888899999999999999999974 556654
Q ss_pred CCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 776 NENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 776 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.. .......+........... ....+......+.+++.+|++.+|++||+++||.+.|++
T Consensus 245 ~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 245 LT--DEQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CC--HHHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 32 2222333322222111000 000112334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.75 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=206.1
Q ss_pred HhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 345568999999999999998888899999987543 3457789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.......+++.++.+++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++...........
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 99999997665567899999999999999999999 889999999999999999999999999999876532221111
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....+..|+|||++.+..++.++||||||++++||+| |+.||...... .+.. .+..+. ....+.
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~ 227 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQ----QVDQGY---------RMPCPP 227 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHHcCC---------CCCCCC
Confidence 1223457999999998889999999999999999999 88888643311 1111 111110 001122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.....+.+++.+|++.+|++||+++++++.|++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 334578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.39 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=202.1
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccC----CC-cchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS----SG-QGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.+.||+|+||.|+.|.. .+|+.||+|++... .. ...+...+|+.++++++ ||||++++.++......++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 34567899999999999985 47899999977653 12 23455668999999999 99999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPI 724 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~ 724 (858)
|||+.+|+|.+++.. ...+.+.++.++++|++.|++|+| +++|+||||||+|||++.+ +++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999987 347888999999999999999999 9999999999999999999 999999999999874
Q ss_pred CCcceeecccCCCCccCccccccCC-CC-CchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDW-LN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
..........|++.|+|||.+.+.. ++ .++||||+||+||-|++|+.||++... .. +...+..+..
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~-l~~ki~~~~~------ 240 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PN-LYRKIRKGEF------ 240 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HH-HHHHHhcCCc------
Confidence 2233445678999999999999866 65 789999999999999999999986321 11 1111222210
Q ss_pred hhcCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 803 CLRGGFEIES-AWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 803 ~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.++... ..++..++.+|+..+|.+|+++.+|++
T Consensus 241 ----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 ----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 112222 667899999999999999999999983
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=364.94 Aligned_cols=257 Identities=30% Similarity=0.459 Sum_probs=210.5
Q ss_pred hhccccccccCceEEEEEEEC--CCC----EEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD--DGT----QVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~--~g~----~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
-.+.+.||+|.||.||+|.+. +|. .||||.++.. +.+...+|.+|..+|++++|||||+++|.|.+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 345678999999999999965 343 4899998765 455678999999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcc-----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 646 YEYMANGNLKQLLSDEK-----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
+|||++|+|..+|++.+ ...+...+.+.++.|||+|+.||+ +.++|||||..+|+||++...+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 99999999999998764 346888999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCcceeecc-cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 721 VFPIGGTHVSTVV-AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 721 ~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
............. .-...|||||.+..+.++.|+|||||||++||++| |..||....+.+ + .......|
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v---~~~~~~gg---- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--V---LLDVLEGG---- 921 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--H---HHHHHhCC----
Confidence 5543332222222 22358999999999999999999999999999999 777876554322 1 11122222
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
+| ..+..+...+.+++..||+.+|++||++..+++++..+++.
T Consensus 922 ----RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 ----RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ----cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11 12445566788999999999999999999999998886654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.13 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=201.1
Q ss_pred cccccccCceEEEEEE-ECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|.||.||+|+ .++|+.||||+++... ........+|++.|+.++|+||+.++++|...+.+.||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 3679999999999999 5689999999997543 22346678999999999999999999999999999999999987
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|+..++++. ..++-.++..++.++++|++||| +..|+||||||.|+|++++|.+||+|||+|+.+.........
T Consensus 86 dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~- 160 (318)
T KOG0659|consen 86 DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH- 160 (318)
T ss_pred cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc-
Confidence 9999997654 57888999999999999999999 899999999999999999999999999999998654433332
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHH--HHHhcCCch---hhhchh-hc
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT--NMIAKGDIE---NIVDSC-LR 805 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~--~~~~~~~~~---~~~d~~-l~ 805 (858)
.+-|..|+|||.+.+ ..|+...||||.||++.||+-|.+-|.+.. +-.++....+ ....++.+. ++.|-. ++
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 256899999998875 678999999999999999999876654432 2222221111 111111111 111110 00
Q ss_pred --CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 --GG-----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 --~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. .-......+++++..++..||.+|.+++|++++
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 112234566999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=342.73 Aligned_cols=254 Identities=30% Similarity=0.431 Sum_probs=206.7
Q ss_pred cccccccCceEEEEEEECC--C--CE-EEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLDD--G--TQ-VAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~--g--~~-vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.||+|+||.||+|.+.. + .. ||||..+.. ......+|++|+++++.++|||||+++|++..+..+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4789999999999999653 3 23 899998853 34567889999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
+|.||+|.++|+.... .++..+++.++.++|.||+||| +.+++||||.++|+|++.++.+||+|||+++......
T Consensus 242 l~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~- 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV- 316 (474)
T ss_pred ecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCccee-
Confidence 9999999999987653 6999999999999999999999 9999999999999999999999999999987643110
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHH-hcCCchhhhchhhc
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMI-AKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~-~~~~~~~~~d~~l~ 805 (858)
.......-...|+|||.+....++.++|||||||++||+.+ |..|+...... .++..+ .++. +
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~---------r 381 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGY---------R 381 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCc---------c
Confidence 00001123468999999999999999999999999999999 78888765421 222222 2221 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
...+......+..+..+|+..+|++||+|.++.+.|+.+.....
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 12223445567788889999999999999999999999776544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.75 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=200.9
Q ss_pred hccccccccCceEEEEEEE------CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||.||+|.. +++..||||+++... ....+.+.+|++++..+ +||||++++++|..++..++|
T Consensus 38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv 117 (375)
T cd05104 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI 117 (375)
T ss_pred ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceee
Confidence 4568899999999999973 246689999997543 23446788999999999 899999999999999999999
Q ss_pred EeeccCCChHHHhhhcc---------------------------------------------------------------
Q 043526 646 YEYMANGNLKQLLSDEK--------------------------------------------------------------- 662 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~--------------------------------------------------------------- 662 (858)
|||+++|+|.++++...
T Consensus 118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (375)
T cd05104 118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ 197 (375)
T ss_pred ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence 99999999999986432
Q ss_pred ----------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce-ee
Q 043526 663 ----------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-ST 731 (858)
Q Consensus 663 ----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~ 731 (858)
...++|.++++++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++......... ..
T Consensus 198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 124788999999999999999999 8899999999999999999999999999998664332211 11
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...++..|+|||.+.+..++.++|||||||+++||++ |..||...... ..+.+. +.++... ..+.
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~----~~~~~~~---------~~~~ 340 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKM----IKEGYRM---------LSPE 340 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHH----HHhCccC---------CCCC
Confidence 2234567999999999999999999999999999998 78887654321 111111 1221100 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
....++.+++.+|++.+|++||++.||++.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.59 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=201.4
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++.+++|+|++++.+++.+++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 347899999999999985 589999999986432 2233467889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.......+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++........ .
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--V 158 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--e
Confidence 999998886555456899999999999999999999 89999999999999999999999999999987543221 2
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+...+... ...++.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~----------~~~~~~ 226 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVKED----------QEEYSE 226 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhhcc----------cccCCc
Confidence 23468999999999999999999999999999999999999997543211 111111111110 011222
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
.....+.+++.+|++.+|++||+ +++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 33457889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.27 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=205.6
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|+
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 3457899999999999998888999999986543 235788999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.++++......+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..............
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 999997766667899999999999999999999 88999999999999999999999999999987654322222233
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||++....++.++|||||||+++||+| |+.||...... ..... +.++... ......
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~~~~---------~~~~~~ 229 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRGYRM---------PRMENC 229 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCCCC---------CCCCCC
Confidence 45678999999988889999999999999999998 88888643311 11111 1111100 011122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..++.+++.+|+..+|++||+++++.+.|++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.52 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=214.4
Q ss_pred HhhccccccccCceEEEEEEECCCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.-.+.+.||+|-||.|..+..+.+..||||+++..... ...+|.+|+++|.+++||||++++|.|..++.+++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 33456889999999999999988999999999876544 45899999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++..+....+.-....+|+.|||.||+||. +.++|||||.++|+|+|+++++||+|||+++-+-.+..+..
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999998876545566677889999999999999 89999999999999999999999999999996644433322
Q ss_pred -ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh--CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 -TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 -~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt--G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
...+-.++|||+|.+..++++.++|||+||+.+||+++ ...||....++ +.++........+....++ .
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~~l------~ 767 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQVVL------S 767 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcceec------c
Confidence 22334679999999999999999999999999999875 67888665432 2233333333322211111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.+.-+..++.+++++||..+.++||+++++...|++.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1344566788999999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=332.29 Aligned_cols=241 Identities=28% Similarity=0.457 Sum_probs=208.2
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.||+|+||.||||+- .+.+.||+|.+.+. .....+.+.+|+++++.++|||||.+++.|+...++++|.||+.| +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 6799999999999995 47899999999754 334567799999999999999999999999999999999999987 9
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|..+|.+.. .++++++..|+.|++.||.||| +.+|+|||+||+|||++..+.+|+||||+|+.+.. ++...+.+
T Consensus 87 L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vltsi 160 (808)
T KOG0597|consen 87 LFTILEQDG--KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTSI 160 (808)
T ss_pred HHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc-Cceeeeec
Confidence 999997654 6999999999999999999999 99999999999999999999999999999998865 34555667
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.||+-|||||...++.++..+|+||+||++|||.+|++||.... +.+.++....+. -..+....
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d~-----------v~~p~~~S 224 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKDP-----------VKPPSTAS 224 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcCC-----------CCCccccc
Confidence 89999999999999999999999999999999999999996432 333333332221 11234566
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+..++...+.+||.+|.+-.+++.+
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 788899999999999999999998875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.69 Aligned_cols=248 Identities=26% Similarity=0.434 Sum_probs=201.1
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||++.++++..+|+|.+.... ....++..|++++++++||||+++++++..++..++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 3457899999999999999888899999986432 334678999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.++++... ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.............
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 86 LLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 999997543 35899999999999999999999 88999999999999999999999999999886543322222223
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+.+..++.++||||||++++||++ |+.||..... ...... +.++... . .+...
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~----i~~~~~~--~-------~~~~~ 226 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEM----ISRGFRL--Y-------RPKLA 226 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCCC--C-------CCCCC
Confidence 35668999999988889999999999999999999 8888864331 111121 1111100 0 01112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
...+.+++.+|++.+|++||+++|+++.|
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 34688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=339.87 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=201.8
Q ss_pred hhccccccccCceEEEEEEE------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 644 (858)
..+.+.||+|+||.||+|.. ++++.||||+++.... .....+.+|+++++.+ +|+||++++++|...+..++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 34568899999999999874 2345799999975433 2345688999999999 89999999999999999999
Q ss_pred EEeeccCCChHHHhhhcc--------------------------------------------------------------
Q 043526 645 IYEYMANGNLKQLLSDEK-------------------------------------------------------------- 662 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~-------------------------------------------------------------- 662 (858)
||||+++|+|.++++...
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999986432
Q ss_pred ------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce-eecccC
Q 043526 663 ------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-STVVAG 735 (858)
Q Consensus 663 ------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~g 735 (858)
...+++.++++++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++......... .....+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 124788999999999999999999 8999999999999999999999999999998654332211 112234
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
+..|+|||++.+..++.++|||||||+++||++ |+.||....... .+ ......+. ....+.....
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~----~~~~~~~~---------~~~~~~~~~~ 342 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF----YKMVKRGY---------QMSRPDFAPP 342 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH----HHHHHccc---------CccCCCCCCH
Confidence 568999999998889999999999999999997 999986543211 11 11111110 0011111235
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
++.+++.+|++.+|++||++.+|++.|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 7889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=319.30 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=209.2
Q ss_pred hhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.+.||+|+||.||+|...+++.+|+|.+.........++..|+.+++.++||||+++++++...+..++||||++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 34457899999999999998889999999998776656678999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++.++++++.|++.||+||| +.+++|+||||+||++++++.+||+|||.+......... ...
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~ 163 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSD 163 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccC
Confidence 9999998766667899999999999999999999 889999999999999999999999999999876433221 223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||.+....++.++||||||++++||++ |+.||..... ......+. .+ .....+..
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~----~~---------~~~~~~~~ 228 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT----AG---------YRMPCPAK 228 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH----hC---------CcCCCCCC
Confidence 345678999999988889999999999999999998 7888864331 11111111 11 01111233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
....+.+++.+|++.+|.+||+++++++.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 44578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=331.24 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=197.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||++... +|+.||||+++... ......+..|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999997542 233456788999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 999998654 36899999999999999999999 8999999999999999999999999999987542221 12233
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..||+.|+|||.+.+..++.++|||||||+++||++|+.||.....+ .+.. .+..+.. .++...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~----~~~~~~~----------~~p~~~ 218 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE----LILMEEI----------RFPRTL 218 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHH----HHHcCCC----------CCCCCC
Confidence 56899999999999889999999999999999999999999653311 1111 1111110 112233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
..++.+++.+|++.||++|| ++.+++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 45688999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.72 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=199.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 34578999999999999975 68899999987542 2335678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++.+..+... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...........
T Consensus 84 ~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 84 KNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9777655432 246889999999999999999999 89999999999999999999999999999987654333233
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH------------hcCCchh
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI------------AKGDIEN 798 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~------------~~~~~~~ 798 (858)
....|+..|+|||.+.+..++.++|||||||+++||++|+.||....... .+ ..+.... .......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QL-FTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHhhCCCCHHHHHhhhccchhcc
Confidence 34568999999999998889999999999999999999999997543211 11 1111100 0000000
Q ss_pred hhchhhcC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRG------GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.... .........+.+++.+|++.+|++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 0011134568999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.65 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=202.1
Q ss_pred hccccccccCceEEEEEEE-----CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 645 (858)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3457899999999988653 3678999999876533 3456788999999999999999999988764 357899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++++|.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++.++|+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999653 4899999999999999999999 889999999999999999999999999999876533
Q ss_pred Ccce--eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GTHV--STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.... .....++..|+|||.+....++.++||||||++++||+||+.|+......-...............+.+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 11223556799999998888999999999999999999999997543211111111100000001111222222
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.....+.....++.+++.+|++.+|++||+++++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 22122233456889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=328.42 Aligned_cols=239 Identities=26% Similarity=0.350 Sum_probs=194.5
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||+|+||.||+|... +++.||+|++... .......+.+|++++.+++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 6889999998643 233456788899999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9999654 36899999999999999999999 8999999999999999999999999999987643222 2223456
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .+...... .+.. ..+.....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~-~~~~----------~~~~~~~~ 218 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKIL-QEPL----------RFPDGFDR 218 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHH-cCCC----------CCCCcCCH
Confidence 89999999999998999999999999999999999999965331 11111111 1110 11222345
Q ss_pred HHHHHHHHccccCCCCCCC---HHHHHH
Q 043526 815 RAVELAVKCASRTSSERPN---MNEVVT 839 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPs---m~eVl~ 839 (858)
.+.+++.+|+..+|++||+ +.|++.
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 6789999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=333.01 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=206.2
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||.|+.|.|-.|++ .+|+.+|||++.+... .......+|+.+|+.+.|||++++++.+..+.++|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 3457899999999999995 5999999999976632 23456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|.|++++..++ .+.+.++.+++.||+.|+.|+| ..+|+||||||+|+|||..+++||+|||+|.+...+ ..
T Consensus 95 ~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--kl 167 (786)
T KOG0588|consen 95 PGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KL 167 (786)
T ss_pred CCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC--cc
Confidence 9999999997654 7999999999999999999999 899999999999999999999999999999875433 22
Q ss_pred eecccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
-...+|.++|.|||.+.+..|. .++||||+||||+.||||+.||++.. +..++.+.-+|.|
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------------------ir~LLlKV~~G~f 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------------------IRVLLLKVQRGVF 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------------------HHHHHHHHHcCcc
Confidence 3446799999999999988774 78999999999999999999998533 1122222222333
Q ss_pred --CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 809 --EIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 809 --~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
+.....++.+|+.+|+..||+.|.|++||.++-
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 344566889999999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.68 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=203.9
Q ss_pred hccccccccCceEEEEEEEC----CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|.+. +...||||.++.... ....+|.+|+.++++++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 34578999999999999974 245799999875433 3456789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+++++|.+++.... ..+++.++++++.|++.||+||| +.+|+||||||+||++++++.++|+|||+++.......
T Consensus 87 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 87 MENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred CCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999997654 36899999999999999999999 89999999999999999999999999999987752221
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......++..|+|||.+.+..++.++||||||++++||++ |..||...... .+. ..+.++...
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~~--------- 227 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVI----KAVEDGYRL--------- 227 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHH----HHHHcCCCC---------
Confidence 12222334678999999998889999999999999999998 99998654321 111 111111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
..+......+.+++.+|++.+|++||+++||+++|++++
T Consensus 228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111223456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.46 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=201.4
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|...++..+|||.+.... ....++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 3457899999999999998777789999987543 334679999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++..... .+++.++++++.||+.||+||| +.+++|+||||+||++++++.+||+|||.++.............
T Consensus 86 l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 86 LLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 9999976433 6899999999999999999999 89999999999999999999999999999886543322222223
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||...+..++.++||||||+++|||++ |+.||...... ..... +..+... ..+...
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~----~~~~~~~---------~~~~~~ 226 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEK----VSQGLRL---------YRPHLA 226 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH----HhcCCCC---------CCCCCC
Confidence 35678999999988889999999999999999999 89888643321 11111 1111100 011122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
...+.+++.+|++.+|++||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.91 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=202.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|++|.||+|..+++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 9 QLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 44578999999999999988888999999976433 3467999999999999999999999885 456789999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.++++......+++.+++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++..+...........
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 999997655556899999999999999999999 88999999999999999999999999999987654332222223
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||...+..++.++|+||||++++||++ |+.||..... ...... +..+. ....+...
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~~---------~~~~~~~~ 228 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ----VERGY---------RMPCPQDC 228 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCC---------CCCCCCcC
Confidence 35668999999988889999999999999999999 8888864321 111111 11110 01112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+.+++.+|+..+|++|||+.++.+.|++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.89 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=200.2
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|..+++..+|+|.+..... ...++.+|++++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 34578999999999999988788999999864432 34678899999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.............
T Consensus 86 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 86 LLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999997544 36899999999999999999999 88999999999999999999999999999876543222222222
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+. ....+...
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~~~ 226 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVE----SVSAGY---------RLYRPKLA 226 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHH----HHHcCC---------cCCCCCCC
Confidence 23457999999998889999999999999999999 78888643321 1111 111110 00111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
..++.+++.+|+..+|++||+++|+++.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 45788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.68 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=203.9
Q ss_pred hhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.+.||+|+||.||+|..++...||+|+++.... ..+++.+|++++++++||||+++++.+. .+..++||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 456688999999999999987777899999975432 3467899999999999999999999875 45678999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++.+++.++.|+++||+||| +.+++||||||+||++++++.++|+|||.++............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 9999997655556899999999999999999999 8999999999999999999999999999998765433222223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||+.....++.++||||||++++||+| |+.||....... .......+. ....+..
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~~~ 227 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY---------RMPCPPE 227 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhcCC---------CCCCccc
Confidence 345678999999988889999999999999999999 777775433111 111111110 0011223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
....+.+++.+|++.+|++||+++++++.|++..
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4557889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.57 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=206.0
Q ss_pred HHHhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 570 KITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 570 ~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
..+..+.+.||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+|++++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 344566789999999999999988999999999875443 356889999999999999999999986 456789999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.......+++.+++.++.|++.||+||| +.+++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 9999999997766667899999999999999999999 8899999999999999999999999999998765332222
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....++..|+|||.+....++.++||||||++++||++ |+.||...... ..... +..+.. ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~---------~~~ 224 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQN----LERGYR---------MPR 224 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHH----HHcCCC---------CCC
Confidence 223345678999999988889999999999999999999 99998654321 11111 111100 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
+.....++.+++.+|+..+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.39 Aligned_cols=243 Identities=24% Similarity=0.423 Sum_probs=206.1
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+.||+|+||.||||.. ++++.||+|++.-.. .....+.++|+.++..++++||.++++.+..+..+.++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6799999999999995 479999999997553 34567889999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+.|+... .+++....-|++++..|+.||| ..+.+|||||+.|||+.++|.+|++|||.+..+....... ..++
T Consensus 99 ~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 99 LDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred hhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 99996544 4588888899999999999999 8999999999999999999999999999998876543333 6688
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
||+.|||||++....|+.|+||||||++.+||.+|.+|+...... ...-++.+.-...++.....
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk~~PP~L~~~~S~ 237 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPKSAPPRLDGDFSP 237 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccCCCCCccccccCH
Confidence 999999999999889999999999999999999999998754321 11112222222222334566
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.+++..|+.++|+.||++.+++++
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 78999999999999999999999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.06 Aligned_cols=252 Identities=31% Similarity=0.521 Sum_probs=202.7
Q ss_pred hccccccccCceEEEEEEECC------CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD------GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|.... ...||+|.+..... ....++.+|++.+++++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 345789999999999998642 25799999875433 23467899999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhccc--------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEE
Q 043526 647 EYMANGNLKQLLSDEKA--------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK 712 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~k 712 (858)
||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+++||||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence 99999999999965421 45889999999999999999999 88999999999999999999999
Q ss_pred EeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHH
Q 043526 713 LADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNM 790 (858)
Q Consensus 713 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~ 790 (858)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |..||...... .+. ..
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~----~~ 238 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI----EM 238 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HH
Confidence 999999986533221 12223346788999999988889999999999999999998 99998654321 111 22
Q ss_pred HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 791 IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 791 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
+..+... ..+.....++.+++.+|++.+|.+||+++||+++|+.
T Consensus 239 i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2222111 1122344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.83 Aligned_cols=242 Identities=28% Similarity=0.394 Sum_probs=196.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||++... +|+.||+|++... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 7999999999754 2234456788999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9999886543 6899999999999999999999 8899999999999999999999999999987532221 11223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||.....+. . .... ..+.. ..+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~---~~~~-~~~~~----------~~p~~~ 218 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--L---FELI-LMEEI----------RFPRTL 218 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--H---HHHH-hcCCC----------CCCCCC
Confidence 568999999999998899999999999999999999999986543211 1 1111 11110 112233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
..++.+++.+|++.+|++|| ++.+++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 45678999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.13 Aligned_cols=241 Identities=26% Similarity=0.344 Sum_probs=198.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 4578999999999999965 78999999986432 2334568889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++..... .
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 85 GGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 999999997543 6889999999999999999999 899999999999999999999999999999876432 1
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|++.|+|||.+.+..++.++|||||||+++||++|+.||...... .+ . ..+..+.. ..+.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~---~-~~i~~~~~----------~~~~ 219 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GI---Y-EKILAGKL----------EFPR 219 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---H-HHHHhCCc----------CCCc
Confidence 2346899999999999888999999999999999999999998654311 11 1 11111110 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
.....+.+++.+|++.||.+||+ ++|++++
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 22446789999999999999995 8888776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=327.82 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=214.2
Q ss_pred cccccccCceEEEEEEECC-CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
...||-|.||.||.|.|+. .-.||||.++... ...++|++|+.+|+.++|||+|+|+|+|..+..+|||+|||.+|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 4689999999999999874 5679999997653 4568999999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.++|+......++--..+.++.||+.||+||. .+.+|||||.++|+|+.++..+|++|||+++++..+.........
T Consensus 351 LdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAK 427 (1157)
T KOG4278|consen 351 LDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAK 427 (1157)
T ss_pred HHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCcc
Confidence 99999988777888888999999999999999 899999999999999999999999999999998654333222222
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
=.+.|.|||-+....++.|+|||+|||+|||+.| |..|+.+- ++.+ +...+.. ..+...+..+.
T Consensus 428 FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSq-VY~LLEk---------gyRM~~PeGCP 492 (1157)
T KOG4278|consen 428 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ-VYGLLEK---------GYRMDGPEGCP 492 (1157)
T ss_pred CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHH-HHHHHhc---------cccccCCCCCC
Confidence 2468999999999999999999999999999998 77887543 2222 3333322 23334456677
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.++.+|++.||+.+|.+||++.|+-+.++.+++.
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 8999999999999999999999999999887654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.23 Aligned_cols=231 Identities=29% Similarity=0.425 Sum_probs=194.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||.|+||+|..++.+ +|..+|+|++++... ...+....|..+|+.+.||.++++.+.|.+.+..+|||||++|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 378999999999999965 788999999976532 2345567899999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|.|..+|+..+ +++++.+..+|.||+.||+||| +.+|++|||||+|||+|.+|.+||+|||+|+..... +-
T Consensus 129 GElFS~Lrk~~--rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 129 GELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred ccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 99999997654 7999999999999999999999 999999999999999999999999999999987532 34
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..+||+.|+|||.+.+..+..++|-|||||++|||+.|.+||..... . .+...+.++.+ .++.-
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~----~iY~KI~~~~v----------~fP~~ 263 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--I----QIYEKILEGKV----------KFPSY 263 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--H----HHHHHHHhCcc----------cCCcc
Confidence 56899999999999999999999999999999999999999976542 1 11122222211 12333
Q ss_pred HHHHHHHHHHHccccCCCCC
Q 043526 812 SAWRAVELAVKCASRTSSER 831 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~R 831 (858)
-...+.+|+...++.|-.+|
T Consensus 264 fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHHhhhhHhh
Confidence 34467788888888887777
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.29 Aligned_cols=252 Identities=30% Similarity=0.469 Sum_probs=203.6
Q ss_pred hhccccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
..+.+.||+|+||.||+|... +++.||||.++..... ..+.+.+|++++++++||||+++++++......++|
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence 445678999999999999863 3478999999765444 457899999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcc------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEE
Q 043526 646 YEYMANGNLKQLLSDEK------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKL 713 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL 713 (858)
|||+++++|.+++.... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEEE
Confidence 99999999999997542 245789999999999999999999 889999999999999999999999
Q ss_pred eeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHH
Q 043526 714 ADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMI 791 (858)
Q Consensus 714 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~ 791 (858)
+|||+++........ ......++..|+|||++.+..++.++|||||||+++||++ |+.||.....+ ..... +
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~----~ 237 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC----I 237 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH----H
Confidence 999998765322211 1122345678999999999999999999999999999999 99998654322 11111 1
Q ss_pred hcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 792 AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 792 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
..+.... .+......+.+++.+|++.+|++||+++||++.|+
T Consensus 238 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1221111 11223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.95 Aligned_cols=242 Identities=27% Similarity=0.369 Sum_probs=197.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||++... +|+.||||++.... ......+.+|+++++.++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 78999999997542 234567888999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 999998654 36899999999999999999999 8999999999999999999999999999987542221 12233
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+.+..++.++|||||||+++||++|+.||...... ..... +..+. ...+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~-~~~~~----------~~~p~~~ 218 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFEL-ILMED----------IKFPRTL 218 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHH-hccCC----------ccCCCCC
Confidence 56899999999999888999999999999999999999999653311 11111 11110 0112233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
..++.+++.+|++.+|++|| +++|++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 45678999999999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.03 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=200.9
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHh--cccceeeeeeeeeeeCC----eeEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMR--VHHRNLTNLVGYFIEDN----NMGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~lV~Ey~ 649 (858)
.++||+|+||.||||.+. ++.||||++... ..+.|+.|-++.+. ++|+||++++++-.... +..||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 467999999999999995 599999999743 44667777777665 58999999999887766 899999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC------CCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG------CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+.|||.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|||+|..+.
T Consensus 291 ~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 291 PKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred cCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 999999999765 699999999999999999999964 36789999999999999999999999999999886
Q ss_pred CCCc-ceeecccCCCCccCccccccCC-CC-----CchhHHHHHHHHHHHHhCCCccccCCCccccH-----------HH
Q 043526 724 IGGT-HVSTVVAGTPGYLDPEYFVTDW-LN-----EKSDVYSFGVVLLEIITSQAVIVRNENENIHI-----------IQ 785 (858)
Q Consensus 724 ~~~~-~~~~~~~gt~~y~APE~~~~~~-~s-----~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l-----------~~ 785 (858)
.+.. ......+||.+|||||++.+.. +. .+.||||+|.+||||++.....+....++.++ .+
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 4422 2223468999999999986532 22 46899999999999999765553222111111 11
Q ss_pred HHHHH-HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 786 TVTNM-IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 786 ~v~~~-~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.++.. +++..-..+.+.... ...+.-+.+.+..||..||+-|.|+.-|-+.+.++.+...
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 12211 122111222222211 1345678899999999999999999999999988765554
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=333.61 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=201.9
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 646 (858)
+.+.||+|+||.||+|... .+..||||++..... ...+.+..|+++++++. ||||++++++|.+.+..++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 4578999999999999852 235799999975433 33467899999999996 999999999999999999999
Q ss_pred eeccCCChHHHhhhcc----------------------------------------------------------------
Q 043526 647 EYMANGNLKQLLSDEK---------------------------------------------------------------- 662 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~---------------------------------------------------------------- 662 (858)
||+++|+|.++++...
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 9999999999986532
Q ss_pred ------------------------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEE
Q 043526 663 ------------------------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK 712 (858)
Q Consensus 663 ------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~k 712 (858)
...+++.++++++.|+++||+||| +.+|+||||||+|||+++++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEE
Confidence 124788889999999999999999 88999999999999999999999
Q ss_pred EeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHH
Q 043526 713 LADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNM 790 (858)
Q Consensus 713 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~ 790 (858)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .....
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-----~~~~~ 352 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----TFYNK 352 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----HHHHH
Confidence 9999999865432221 1122346778999999988889999999999999999997 888886532211 11111
Q ss_pred HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 791 IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 791 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+..+. ....+......+.+++.+|+..+|++||++.+|+++|+++++
T Consensus 353 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 12211 001122334578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.35 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=202.4
Q ss_pred hhccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeC-CeeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED-NNMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~~ 643 (858)
..+.+.||+|+||.||+|... +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|... ...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 445688999999999999632 357899999875432 2345678899999999 899999999988754 5688
Q ss_pred EEEeeccCCChHHHhhhcc-----------------------------------------------------------cC
Q 043526 644 LIYEYMANGNLKQLLSDEK-----------------------------------------------------------AS 664 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~-----------------------------------------------------------~~ 664 (858)
++|||+++|+|.+++.... ..
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 9999999999999986432 12
Q ss_pred chhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce-eecccCCCCccCcc
Q 043526 665 TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPE 743 (858)
Q Consensus 665 ~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE 743 (858)
.++|..+.+++.||+.||+||| +.+|+||||||+|||+++++.++|+|||+++.+....... .....++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 6899999999999999999999 8899999999999999999999999999998764332221 22234567899999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHH
Q 043526 744 YFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVK 822 (858)
Q Consensus 744 ~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 822 (858)
++.+..++.++|||||||+++||++ |..||......+ . ....+..+... ..+.....++.+++.+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~~~---------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E----FCRRLKEGTRM---------RAPEYATPEIYSIMLD 311 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H----HHHHHhccCCC---------CCCccCCHHHHHHHHH
Confidence 9999999999999999999999998 999986432211 1 11111221110 1112234578899999
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHH
Q 043526 823 CASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 823 Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
|++.+|++||++.|++++|+++++
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.71 Aligned_cols=242 Identities=25% Similarity=0.397 Sum_probs=198.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 44678999999999999975 6899999998753 2234467889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 101 VGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred CCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 9999999997543 6788899999999999999999 8999999999999999999999999999998764322
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... . + ....+.++.. ..+
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~---~-~~~~i~~~~~----------~~p 235 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--F---R-IYEKILAGRL----------KFP 235 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--H---H-HHHHHhcCCc----------CCC
Confidence 234689999999999988899999999999999999999999964321 1 1 1111222211 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
.....++.+++.+|++.||.+||+ +++++++
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112346789999999999999997 6887765
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.17 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=200.1
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
++||+|+||.||+|..++++.+|+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998765433 2346889999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
+++.... ..+++.+++.++.|++.||.||| +.+++||||||+||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9986543 35889999999999999999999 8999999999999999999999999999987543322222222234
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
+..|+|||++.+..++.++||||||++++||++ |..||...... .....+..+. ....+.....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~ 221 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQVEKGY---------RMSCPQKCPD 221 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHHcCC---------CCCCCCCCCH
Confidence 567999999998889999999999999999998 88898644211 1111111111 0111223345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
.+.+++.+|+..+|++||++.|+++.|+
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.91 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=205.7
Q ss_pred hccccccccCceEEEEEEE------CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||.||++.. .++..+|+|.+..........+..|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 3457899999999999984 2356799999977665566789999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcc-----------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeee
Q 043526 648 YMANGNLKQLLSDEK-----------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716 (858)
Q Consensus 648 y~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DF 716 (858)
|+++++|.+++.... ...+++.++++++.|++.||+||| +.+++||||||+|||+++++.+||+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEeccC
Confidence 999999999996432 235899999999999999999999 899999999999999999999999999
Q ss_pred cCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcC
Q 043526 717 GLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 717 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
|+++........ ......++..|+|||.+.+..++.++|||||||+++||++ |+.||....... . ...+..+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~----~~~i~~~ 238 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--V----IECITQG 238 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHcC
Confidence 999865432211 1122335678999999998889999999999999999999 888886443211 1 1112222
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.... .+......+.+++.+|++.+|.+||+++|+.+.|+++...
T Consensus 239 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111 0112234689999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.34 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=200.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+|+.. +|+.||||+++... ......+..|++++..++||||+++++++..++..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999975 68999999997542 2344678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..... ..
T Consensus 85 g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 85 GGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 999999996543 6889999999999999999999 89999999999999999999999999999986543 22
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|++.|+|||.+.+..++.++|||||||+++||++|+.||......+ ....+... . .............
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~---~---~~~~~~~~~~~~~ 227 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKYW---K---ETLQRPVYDDPRF 227 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHhc---c---ccccCCCCCcccc
Confidence 34568999999999998899999999999999999999999997543211 11111110 0 0000000000011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....++.+++.+|+..+|.+||++++++++
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 234578899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=311.63 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=201.5
Q ss_pred hhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.+.||+|++|.||+|..+.+..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 34457899999999999998877789999886543 23467889999999999999999999875 45688999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.++++......+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.............
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 9999997655556899999999999999999999 8899999999999999999999999999998764332222222
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||...+...+.++||||||++++||+| |+.||...... ....+ ...+.. ...+..
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~~~---------~~~~~~ 227 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQ----VERGYR---------MPCPQG 227 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCCC---------CCCCcc
Confidence 345678999999988889999999999999999999 88888653311 11111 111110 011123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
....+.+++.+|+..+|++||++++|++.|++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.64 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=206.0
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++.+++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 4578999999999999742 3567999998776666667899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 649 MANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
+++++|.+++.... ...++|.++++++.||+.||+||| +.+|+||||||+|||++.++.++|+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEEC
Confidence 99999999996542 234899999999999999999999 8999999999999999999999999
Q ss_pred eecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHh
Q 043526 715 DFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 715 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
|||++......... ......++..|+|||.+.+..++.++||||||++++||+| |+.||....... .. ....
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~----~~~~ 239 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VI----ECIT 239 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHh
Confidence 99999765432211 1223346778999999998899999999999999999999 999986543211 11 1122
Q ss_pred cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 793 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.+.... .+......+.+++.+|++.+|++||++++|++.|+++..
T Consensus 240 ~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 221111 111234568899999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=324.87 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=200.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||.||++... +|..+|+|.+..... ....++.+|++++++++||||+++++++..++..++||||+++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 3468999999999999965 789999999875432 33467899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 89 ~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 160 (331)
T cd06649 89 SLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (331)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccc
Confidence 9999996543 5889999999999999999999 54 6999999999999999999999999998765332 122
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC----------------
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---------------- 795 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---------------- 795 (858)
...|+..|+|||.+.+..++.++|||||||+++||++|+.||......+ +..........+.
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccccccc
Confidence 3468999999999998889999999999999999999999996433211 1111111000000
Q ss_pred --------------chhhhchhhcCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 796 --------------IENIVDSCLRGG----FEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 796 --------------~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
..+..+...... .......++.+++.+|++.+|++||+++|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000011000000 0112345789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=323.31 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=201.1
Q ss_pred hccccccccCceEEEEEEEC-CCC----EEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGT----QVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
...+.||+|+||.||+|++. +|+ .||+|.++... ....+++..|+.+++.++||||++++++|... ...+|+|
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence 33478999999999999854 444 38999987543 33456789999999999999999999999765 5679999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++..+++++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 89 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred cCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999997653 35889999999999999999999 89999999999999999999999999999987654332
Q ss_pred cee-ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 HVS-TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
... ....++..|+|||++....++.++|||||||++|||++ |+.|+...... .+ ......+. .
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~---------~ 229 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI----SSILEKGE---------R 229 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHhCCC---------C
Confidence 221 12234668999999999999999999999999999998 99998643211 11 11111111 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+......+.+++.+|+..+|.+||++.++++.|.++...
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 011122344678999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=340.02 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=201.6
Q ss_pred hhccccccccCceEEEEEEEC-C-CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-D-GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++..++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 445688999999999999854 4 67889998765554555677889999999999999999999999999999999999
Q ss_pred CCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 651 NGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 651 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+|+|.+++... ....+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988653 2346889999999999999999999 89999999999999999999999999999987643321
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.......||++|+|||++.+..++.++|||||||+++||++|+.||..... .+..... ..+... .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~-~~~~~~---------~ 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQV-LYGKYD---------P 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-HhCCCC---------C
Confidence 122345689999999999988999999999999999999999999864321 1111111 111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+......+.+++.+|+..+|++||++++++++
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 112234568899999999999999999998753
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=316.51 Aligned_cols=252 Identities=30% Similarity=0.499 Sum_probs=200.6
Q ss_pred hccccccccCceEEEEEEE-----CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||.||+|.. .+++.||+|.+.... .....++.+|++++++++||||+++++++..++..++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 4567899999999999984 356789999997543 2334678899999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcc---------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEE
Q 043526 648 YMANGNLKQLLSDEK---------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK 712 (858)
Q Consensus 648 y~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~k 712 (858)
|+++++|.+++.... ...+++.+.+.++.|++.||+||| +.+|+||||||+|||+++++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEE
Confidence 999999999985322 235789999999999999999999 88999999999999999999999
Q ss_pred EeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHH
Q 043526 713 LADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNM 790 (858)
Q Consensus 713 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~ 790 (858)
|+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |..||..... ..+ ...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~----~~~ 238 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEV----IEM 238 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHH
Confidence 999999986543221 11223345678999999988889999999999999999999 8888864321 111 122
Q ss_pred HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 791 IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 791 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
+..+... ..+.....++.+++.+|++.+|.+||++.+|.++|+.
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2221111 0112233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.98 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=197.2
Q ss_pred cccccCceEEEEEEE---CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 578 VLGKGGFGTVYHGYL---DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~---~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.||+|+||.||+|.+ ++++.+|+|+++.... ...+++..|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3678999999865432 23567899999999999999999999885 45678999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee--
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-- 730 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-- 730 (858)
+|.+++... ..+++..+.+++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999654 36899999999999999999999 89999999999999999999999999999987654332211
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....++..|+|||.+....++.++|||||||+++||++ |+.||..... ..+.+ .+.++... ..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~----~i~~~~~~---------~~~ 220 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQ----MIESGERM---------ECP 220 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHCCCCC---------CCC
Confidence 12234578999999988888999999999999999998 9999865432 11111 22222111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.....++.+++.+|++.+|++||++.+|++.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 22345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.70 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 79999999886543 23346789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee-ecc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-TVV 733 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~ 733 (858)
.+++.... ..+++.+++.++.|+++||+||| +.+++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99996543 36889999999999999999999 88999999999999999999999999999876532211110 111
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..+..|+|||.+.++.++.++||||||++++||++ |..|+...... .....+... .....+...
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~~~~~~~~~---------~~~~~~~~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------QTREAIEQG---------VRLPCPELC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------HHHHHHHcC---------CCCCCcccC
Confidence 22456999999998889999999999999999998 88887543211 111111111 111112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
...+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=323.86 Aligned_cols=248 Identities=20% Similarity=0.337 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +++.+|+|+++.. .......+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 7889999999754 223345677888888776 799999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 9999988654 36899999999999999999999 88999999999999999999999999999875422221 223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCC---ccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN---ENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~---~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
...||..|+|||++.+..++.++|||||||+++||++|+.||..... .......++...+.++.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CC
Confidence 35689999999999998999999999999999999999999963221 111122233332222211 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPN------MNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPs------m~eVl~~ 840 (858)
+.....++.+++.+|+..+|++||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 2333456889999999999999998 5676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=310.10 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=204.8
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|++|.||+|..++++.+|||.+.... ...+++.+|++++++++|+|++++++++......++||||+++++
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 4467899999999999998888899999987543 345789999999999999999999999999899999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......+++.++..++.|++.|++||| +.+++|+||||+||++++++.+||+|||++..............
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 999998766567999999999999999999999 88999999999999999999999999999887643222222222
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+.+...+.++||||||++++||++ |+.||...... ...+.+ ..+. ....+...
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~----~~~~---------~~~~~~~~ 229 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQV----ERGY---------RMPRPPNC 229 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----HcCC---------CCCCCCCC
Confidence 34568999999998889999999999999999999 89988543311 111111 1110 00111222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..++.+++.+|+..+|++||+++++.+.|+.
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 4578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=338.30 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=209.7
Q ss_pred ccccccccCceEEEEEEECCC-CEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeee-eee------CCeeEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLDDG-TQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGY-FIE------DNNMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~-~~~------~~~~~lV 645 (858)
..++|.+|||+.||.|....+ ..+|+|++-..+....+...+|+++|+.|+ |+|||.+++. ... .-+.+|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 357899999999999997665 999999998888888899999999999997 9999999993 321 1357899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
||||++|+|-|+|..+....|++.++++|+.|+++|+++|| .+.++|||||||-+||||+.+++.||||||.|.-....
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~ 199 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS 199 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence 99999999999998766667999999999999999999999 55788999999999999999999999999988643221
Q ss_pred C-ccee-------ecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC
Q 043526 726 G-THVS-------TVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 726 ~-~~~~-------~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
. .... ....-|+.|+|||++. +..+++|+||||+||+||-|+....||+....
T Consensus 200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------------- 263 (738)
T KOG1989|consen 200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------------- 263 (738)
T ss_pred CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------------
Confidence 1 1100 1124689999999885 67899999999999999999999999976531
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
..+++....-.........+.+||..||+.+|++||++-+|+..+.++....
T Consensus 264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1222222222222466778999999999999999999999999998876443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.46 Aligned_cols=242 Identities=31% Similarity=0.438 Sum_probs=195.8
Q ss_pred ccccccCceEEEEEEE----CCCCEEEEEEeccC----CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYL----DDGTQVAVKMLSSS----SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.||+|+||.||+++. .+++.||||+++.. .......+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 36889999998743 223345678899999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+.+..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999996543 5788889999999999999999 89999999999999999999999999999875432221
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......|++.|+|||.+.+..++.++|||||||+++||++|+.||...... ..... +..+.. ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~-~~~~~~----------~~ 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDK-ILKGKL----------NL 219 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHH-HHcCCC----------CC
Confidence 223356899999999999888899999999999999999999999654311 11111 111110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
+......+.+++.+|++.+|++|| ++++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 222345678999999999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.49 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=204.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++|||++++++++...+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 34578999999999999964 78999999876432 233456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 650 ANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
++|+|.+++.... ...+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999885432 345788999999999999999999 89999999999999999999999999999887643221
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......|+..|+|||.+.+...+.++|+||||++++||++|+.|+.........+.+. +...... ..
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~--------~~ 228 (267)
T cd08228 162 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK----IEQCDYP--------PL 228 (267)
T ss_pred -HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH----HhcCCCC--------CC
Confidence 1123457889999999988888999999999999999999999986543221111111 1111100 00
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
........+.+++.+|+..+|++||++++|++.|+++
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1122345688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=319.44 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=204.4
Q ss_pred hccccccccCceEEEEEEEC-CCC--EEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGT--QVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|..+ +|. .+|+|.++... .....++.+|++++.++ +||||+++++++..++..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 44578999999999999964 554 45777776432 23456788999999999 899999999999999999999999
Q ss_pred ccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 649 MANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
+++|+|.++++... ...+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeC
Confidence 99999999997542 235789999999999999999999 8999999999999999999999999
Q ss_pred eecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhc
Q 043526 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAK 793 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~ 793 (858)
|||++...... .......++..|+|||.+....++.++|||||||+++||+| |..||...... +... ....
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~-~~~~ 238 (303)
T cd05088 167 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE-KLPQ 238 (303)
T ss_pred ccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHH-HHhc
Confidence 99998643211 11112234567999999988888999999999999999998 99998643321 1111 1111
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhcccc
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKKE 855 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~~~~ 855 (858)
+. ....+......+.+++.+|++.+|++||+++++++.|++++..+.....+.
T Consensus 239 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~ 291 (303)
T cd05088 239 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 291 (303)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhh
Confidence 10 001112233467899999999999999999999999999887776444433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.79 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=203.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|++|.||+|... +|+.|++|.+... ......++.+|++++++++|||++++++++..++..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 4578999999999999965 7899999998643 234567789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.++++......+++.++++++.|++.||.||| +.+++|+||||+||++++++.++|+|||+++........ ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~ 159 (256)
T cd08529 84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-AN 159 (256)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-hh
Confidence 99999998765567999999999999999999999 889999999999999999999999999998876543222 22
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||+..+..++.++|+||||++++||++|+.||..... ... .....++... ..+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~~~~---------~~~~~ 224 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GAL----ILKIIRGVFP---------PVSQM 224 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHH----HHHHHcCCCC---------CCccc
Confidence 34578899999999988899999999999999999999999865431 111 1111111111 11113
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 34578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=316.92 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=196.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||+++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 34578999999999999965 78999999987543 23345678999999999999999999999999999999999985
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 88 -~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~ 161 (288)
T cd07871 88 -DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYS 161 (288)
T ss_pred -CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-ccc
Confidence 8999886543 35789999999999999999999 89999999999999999999999999999976533221 122
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhh--------
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENI-------- 799 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~-------- 799 (858)
...+++.|+|||.+.+ ..++.++||||+||+++||+||+.||......+ ....+....... ....+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3457899999998865 568899999999999999999999996543211 111111111100 00000
Q ss_pred -hchhhcCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 -VDSCLRGGF----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 -~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+...... ......+..+++.+|++.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 01123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.46 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=196.2
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||+|+||.||++..+ +|+.+|+|.+.... ......+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 79999999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 99987665567899999999999999999999 8999999999999999999999999999988764322 223346
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
|+..|+|||++.+..++.++||||+||++|||++|+.||...... ........... ..... . .......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~----~-----~~~~~~~ 224 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTL-EDEVK----F-----EHQNFTE 224 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhh-ccccc----c-----ccccCCH
Confidence 899999999999888999999999999999999999998643321 11111111111 11100 0 0012234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
++.+++.+|++.+|++||+++|+++.+
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhh
Confidence 678999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.20 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=197.9
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCC--------------cchHhHHHHHHHHHhcccceeeeeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--------------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 638 (858)
.+.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|++++|||||+|+.+..+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 3346799999999999995 4899999999964311 123578899999999999999999999876
Q ss_pred C--CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeee
Q 043526 639 D--NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716 (858)
Q Consensus 639 ~--~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DF 716 (858)
. +.+|||+|||..|.+...-... ..++..++++++++++.||+||| .++|+||||||+|+||+++|.+||+||
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeecc
Confidence 5 5799999999998876553222 13899999999999999999999 999999999999999999999999999
Q ss_pred cCcccccCCCcc----eeecccCCCCccCccccccCC----CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHH
Q 043526 717 GLSKVFPIGGTH----VSTVVAGTPGYLDPEYFVTDW----LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788 (858)
Q Consensus 717 Gla~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~----~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~ 788 (858)
|.+...+.+... .-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+... ..+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~~l~---- 328 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--LELF---- 328 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--HHHH----
Confidence 999876433111 112367999999999987632 45788999999999999999999976431 1111
Q ss_pred HHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 789 NMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 789 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..++...|.-....++...+.+|++++|++||++|.+..+|..+.--
T Consensus 329 --------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 329 --------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11222233322333556788899999999999999999999877643
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.64 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=204.7
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|++|.||+|.. .+|+.+|||.+.... .....++.+|+++++.++||||+++++++.+++..+++|||++
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 457899999999999995 589999999886532 2234678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 651 NGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 651 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|.+++... ....+++.+++.++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 99999998642 2346899999999999999999999 899999999999999999999999999998876433221
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....|+..|+|||.+.+...+.++||||||++++||++|..||.....+.. ..... +... ..+.+ .
T Consensus 163 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~-~~~~-----~~~~~---~ 229 (267)
T cd08229 163 -AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKK-IEQC-----DYPPL---P 229 (267)
T ss_pred -cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH---HHhhh-hhcC-----CCCCC---C
Confidence 2234578899999999888899999999999999999999999864332211 11111 1110 00000 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.......+.+++.+|+..+|++||||.+|.+.++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 122345788999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.63 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=197.0
Q ss_pred cccccCceEEEEEEEC---CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 578 VLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.||+|+||.||+|.+. ++..||+|++...... ..+++.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 4567999998765432 3467899999999999999999999885 457889999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee--
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST-- 731 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~-- 731 (858)
|.+++.... ..+++.++++++.|++.||+||| +.+++||||||+|||++.++.+||+|||++............
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986543 46899999999999999999999 889999999999999999999999999999865433222111
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...++..|+|||.+....++.++|||||||+++||++ |..||...... . +...+..+. ....+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~----~~~~~~~~~---------~~~~~~ 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--E----VMSFIEQGK---------RLDCPA 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--H----HHHHHHCCC---------CCCCCC
Confidence 1223568999999988889999999999999999996 99998654321 1 111222221 111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
....++.+++.+|+..+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=292.83 Aligned_cols=245 Identities=29% Similarity=0.412 Sum_probs=208.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+..+.||+|.||.||.|+.+ ++-.||+|++.+. ..+...++.+|+++-+.++||||++++++|.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 44689999999999999965 7889999998654 3345678999999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
.+|+|...|+..+...+++.....++.|+|.||.|+| .+.|+||||||+|+|++.++..||+|||-+..-+ ...
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k 178 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK 178 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence 9999999999878888999999999999999999999 9999999999999999999999999999887644 233
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||..|.+||...+...+.+.|+|++|++.+|++.|.+||.....+ ..-+. +.+ . .-.++
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--etYkr----I~k--------~--~~~~p 242 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ETYKR----IRK--------V--DLKFP 242 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HHHHH----HHH--------c--cccCC
Confidence 45578999999999999999999999999999999999999999754411 11111 111 1 11123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|+..+|.+|.+..|++++
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 4455678899999999999999999999876
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.12 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=193.9
Q ss_pred hccccccccCceEEEEEEEC--CCCEEEEEEeccCCC--cchHhHHHHHHHHHhc---ccceeeeeeeeeee-----CCe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRV---HHRNLTNLVGYFIE-----DNN 641 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~~~ 641 (858)
.+.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+++++.+ +||||++++++|.. ...
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 34578999999999999863 578899999875432 2234566777777665 69999999999852 356
Q ss_pred eEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 642 MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
.++||||++ ++|.+++.......+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 899999997 59999997665556899999999999999999999 89999999999999999999999999999987
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh----cCCch
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA----KGDIE 797 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~----~~~~~ 797 (858)
.... .......|+..|+|||.+.+..++.++|||||||+++||++|++||...... .....+..... +.+..
T Consensus 160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 160 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhchh
Confidence 5433 2223456899999999998888999999999999999999999999764321 11122211110 00000
Q ss_pred hh--hchhhcC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NI--VDSCLRG--GFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~--~d~~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+. ....+.. ..+ ......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0000000 000 1123467799999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=315.26 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=199.7
Q ss_pred ccccccccCceEEEEEEEC-----CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 647 (858)
+.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++... ...++|||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 4578999999999999752 5889999999876666667899999999999999999999987543 46889999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++...+ ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 88 YLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred ecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999996543 35899999999999999999999 88999999999999999999999999999987654332
Q ss_pred cee--ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh-cCC---chhhhc
Q 043526 728 HVS--TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA-KGD---IENIVD 801 (858)
Q Consensus 728 ~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~-~~~---~~~~~d 801 (858)
... ....++..|+|||.+.+..++.++|||||||+++||++|..++...... ....+..... ... +.+.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHHHHh
Confidence 211 1122345699999998888999999999999999999987765322110 0000000000 000 001111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.......+.....++.+++.+|+..+|++|||++||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1100011223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.96 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=199.1
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
++..+.||+|+||.||++... +|+.+|+|.+..... .....+.+|+++++.++||||++++++|..++..++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 344578999999999999976 788999999875432 334678999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.... .+++.....++.|++.||+|||+ ..+|+||||||+|||+++++.+||+|||++...... ..
T Consensus 87 ~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~ 159 (333)
T cd06650 87 GGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159 (333)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---cc
Confidence 999999996543 58889999999999999999993 247999999999999999999999999998765322 12
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---------------
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD--------------- 795 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~--------------- 795 (858)
....|+..|+|||.+.+..++.++|||||||+++||++|+.||....... +...... ...+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGC-PVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcC-cccCCccccccCcccCCccc
Confidence 23468899999999998889999999999999999999999986433211 1110000 00000
Q ss_pred --------------chhhhchhhcCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 --------------IENIVDSCLRGGF----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 --------------~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+....... ......++.+++.+|++.+|++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000111110000 00123568899999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=323.29 Aligned_cols=249 Identities=28% Similarity=0.348 Sum_probs=197.3
Q ss_pred ccccccccCceEEEEEEE----CCCCEEEEEEeccC----CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSS----SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~----~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.||+|+||.||+++. .+|+.||+|++... .....+.+..|++++.++ +||||+++++++..++..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 457899999999999875 36899999998643 222345678899999999 599999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 84 LDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999654 36889999999999999999999 889999999999999999999999999999865443
Q ss_pred CcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
.........||..|+|||.+.+. .++.++|||||||+++||+||+.||........ . ..+...+... +
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~-~~~~~~~~~~------~--- 227 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-Q-SEVSRRILKC------D--- 227 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-H-HHHHHHHhcC------C---
Confidence 33333345689999999998764 478899999999999999999999964332111 1 1111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
...+......+.+++.+|++.+|++|| ++++++++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 -PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111222345678999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.57 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=191.2
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++|+||+++++++..++..++||||+++|+
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 467999999999999965 789999999865433 234678999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+.. ..++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 159 L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 159 LEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred ccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 87543 3456778899999999999999 88999999999999999999999999999987643221 12334
Q ss_pred cCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 734 AGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 734 ~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.|+..|+|||.+.. ...+.++|||||||++|||++|+.||....... ....+...... . ....
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~-~---------~~~~ 296 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMS-Q---------PPEA 296 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhcc-C---------CCCC
Confidence 68999999998743 234568999999999999999999997432211 11111111000 0 0011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.....++.+++.+||+.+|++||+++|++++
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12334578899999999999999999999986
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.60 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=201.9
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||.||+|++. .++.||||+++..... ..+.+..|++++.++. ||||++++++|..++..++|
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv 119 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII 119 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence 34578999999999999863 3468999999755332 3457889999999997 99999999999999999999
Q ss_pred EeeccCCChHHHhhhccc--------------------------------------------------------------
Q 043526 646 YEYMANGNLKQLLSDEKA-------------------------------------------------------------- 663 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~-------------------------------------------------------------- 663 (858)
|||+++|+|.++++..+.
T Consensus 120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (401)
T cd05107 120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199 (401)
T ss_pred EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence 999999999999965321
Q ss_pred ----------------------------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 664 ----------------------------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 664 ----------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
..+++.+.++++.|++.||+||| +.+|+||||||+|||+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCC
Confidence 23678888999999999999999 88999999999999999999
Q ss_pred CEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||+++........ ......++..|+|||.+....++.++|||||||+++||++ |+.||......+ ..
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-----~~ 351 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-----QF 351 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-----HH
Confidence 9999999999865332211 1122346788999999988889999999999999999998 888875432111 11
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
...+..+. ....+.....++.+++.+|+..+|.+||+++||++.|++++
T Consensus 352 ~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111 11112223457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.96 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=196.2
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||+|+||+||++... +|+.+|+|.+..... ...+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 789999999864322 2345678899999999999999999999999999999999999999
Q ss_pred HHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 655 KQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 655 ~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
.+++... ....+++.+++.++.||+.||+||| +.+|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 2346899999999999999999999 89999999999999999999999999999976643322 2233
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+.+..++.++|||||||+++||++|+.||....... .... +......+. ...+...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~~----------~~~~~~~ 224 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKE-LKQRILNDS----------VTYPDKF 224 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHH-HHHhhcccC----------CCCcccC
Confidence 468999999999999999999999999999999999999997543211 1011 111111100 0112233
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
...+.+++.+|++.+|++|| ++++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 45688999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=322.12 Aligned_cols=248 Identities=19% Similarity=0.324 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||++... +++.||||+++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999965 78999999997542 23345678899999888 799999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999988654 36899999999999999999999 8999999999999999999999999999987532211 1223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc---cccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE---NIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~---~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...... ......+....+.++.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------RI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------CC
Confidence 356899999999999989999999999999999999999999643211 11122233332222211 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPN------MNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPs------m~eVl~~ 840 (858)
+.....++.+++.+|++.+|.+||+ +++++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2223456889999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.38 Aligned_cols=242 Identities=25% Similarity=0.402 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|+.. +|+.||||++... .......+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 6889999998753 223445677888888866 799999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+.+.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 99999986543 6889999999999999999999 88999999999999999999999999999875432221 223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .+. .. +..+.. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~---~~-i~~~~~----------~~p~~ 218 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLF---ES-ILHDDV----------LYPVW 218 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHH---HH-HHcCCC----------CCCCC
Confidence 356899999999999888999999999999999999999999754321 111 11 111110 01112
Q ss_pred HHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERP-------NMNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RP-------sm~eVl~~ 840 (858)
...++.+++.+|++.+|++|| ++++++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 234678999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.77 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=201.2
Q ss_pred ccccccccCceEEEEEEEC-CCC---EEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGT---QVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~---~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
..+.||+|+||.||+|... +++ .+|+|.+.... ....+++..|++++++++|||++++.+++...+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4578999999999999964 333 79999987543 334567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+|||++..........
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 89 ENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999997543 46899999999999999999999 8899999999999999999999999999998664332221
Q ss_pred ee--cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 730 ST--VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 730 ~~--~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.. ....+..|+|||++....++.++|||||||++|||++ |+.||.....+ ..... +.++. ..
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~-i~~~~---------~~ 229 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKA-INDGF---------RL 229 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHH-HhcCC---------CC
Confidence 11 1223457999999988889999999999999999998 99998643321 11111 11110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.........+.+++.+|++.+|++||+|.+|++.|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.39 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=206.5
Q ss_pred hhccccccccCceEEEEEEEC--------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 642 (858)
..+.+.||+|+||.||+|... ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++......
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 96 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCce
Confidence 345688999999999999741 34579999987543 33457789999999999 899999999999999999
Q ss_pred EEEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 643 GLIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
++||||+++|+|.+++.... ...+++.+++.++.||++||+||| +.+++||||||+||+++++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 97 YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcCC
Confidence 99999999999999997642 235789999999999999999999 8899999999999999999
Q ss_pred CCEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHH
Q 043526 709 LEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQT 786 (858)
Q Consensus 709 ~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~ 786 (858)
+.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..|+..... .+.
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~ 248 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----EEL 248 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHH
Confidence 999999999998765432221 122345678999999988889999999999999999998 7777754321 111
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
. ..+.++... ..+......+.+++.+|+..+|.+||++.|+++.|++++.....
T Consensus 249 ~-~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 249 F-KLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred H-HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1 112221110 11223345788999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=321.95 Aligned_cols=236 Identities=25% Similarity=0.409 Sum_probs=191.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|+.+ +++.||||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 6899999998743 233456677888888876 699999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 99999986543 6889999999999999999999 89999999999999999999999999999875432221 223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .+ . ..+..+.. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~---~-~~i~~~~~----------~~~~~ 218 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DL---F-EAILNDEV----------VYPTW 218 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HH---H-HHHhcCCC----------CCCCC
Confidence 356899999999999888999999999999999999999999754311 11 1 11111111 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCH
Q 043526 812 SAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
...++.+++.+|++.+|++||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 34467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=324.17 Aligned_cols=243 Identities=27% Similarity=0.370 Sum_probs=198.2
Q ss_pred hhccccccccCceEEEEEEECC--CCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDD--GTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+.+.+.||+|+||.||+|..++ +..||+|++... .......+.+|+++++.++||||+++++++..++..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 3456889999999999998543 368999998643 22345678899999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999997543 6889999999999999999999 899999999999999999999999999999865422
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+.. .
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~----------~ 246 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGII----------Y 246 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCC----------C
Confidence 12346899999999999888899999999999999999999999753311 11111112110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
++......+.+++.+|++.+|++|+ ++++++++
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1122234578999999999999995 89988775
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=326.46 Aligned_cols=242 Identities=27% Similarity=0.386 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++..++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999997532 233466788999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++...+ .+++.++..++.||+.||+||| + .+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9999886543 6899999999999999999999 6 7999999999999999999999999999875432221 222
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|++.|+|||.+.+..++.++|||||||+++||++|+.||.....+. +.. .+..+. ..++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~----~i~~~~----------~~~p~~ 218 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----LILMEE----------IRFPRT 218 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHH----HHhcCC----------CCCCCC
Confidence 3468999999999998889999999999999999999999996543211 111 111111 011222
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
...++.+++.+|++.+|++|+ ++++++++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 345678999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.77 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=202.3
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+.+.||+|+||.||+|... ....+|+|.+..... ....++..|+.+++.++||||+++++.+..++..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 3478999999999999853 235799998875433 334678899999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcc----------------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE
Q 043526 648 YMANGNLKQLLSDEK----------------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL 705 (858)
Q Consensus 648 y~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl 705 (858)
|+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEE
Confidence 999999999986421 235889999999999999999999 8999999999999999
Q ss_pred cCCCCEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccH
Q 043526 706 TENLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHI 783 (858)
Q Consensus 706 ~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l 783 (858)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~ 238 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--ERL 238 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--HHH
Confidence 999999999999998654332211 122345678999999988889999999999999999999 9888854321 111
Q ss_pred HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 784 IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 784 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.+ ...++. ....+......+.+++.+|++.+|++||+++|+++.|++++.
T Consensus 239 ~~----~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 FN----LLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH----HHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12 111111 111122234578899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.61 Aligned_cols=241 Identities=28% Similarity=0.416 Sum_probs=191.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +++.||||+++... ....+.+..|.+++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999987532 23344556677776654 899999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999986543 6889999999999999999999 8999999999999999999999999999997643322 2223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .+ ... +... ...++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~---~~~-i~~~----------~~~~~~~ 218 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--EL---FDS-ILND----------RPHFPRW 218 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HH---HHH-HHcC----------CCCCCCC
Confidence 456899999999999888999999999999999999999999754321 11 111 1111 0111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMN-EVVT 839 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~ 839 (858)
...++.+++.+|++.+|++||++. ++.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 344678999999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.86 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=211.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe-eEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN-MGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~Ey~ 649 (858)
...+.+|+|+||.++..+.+ +++.+++|.+... +....+...+|+.++++++|||||.+.+.|.+++. .++||+|+
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence 34578999999999998865 6789999998754 33445578899999999999999999999999998 99999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+||+|.+.+...++..+++.+..+++.|++.|+.||| +..|+|||||+.||+++.+..+||+|||+|+.+......
T Consensus 87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~- 162 (426)
T KOG0589|consen 87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL- 162 (426)
T ss_pred CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh-
Confidence 9999999998888788999999999999999999999 899999999999999999999999999999998765423
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.||.||.+.+..+..|+||||+||+++||++-+++|...+..+ .+.... +......+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li~ki~----------~~~~~Plp 227 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LILKIN----------RGLYSPLP 227 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HHHHHh----------hccCCCCC
Confidence 334679999999999999999999999999999999999999997654221 111111 11112334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++..++..|++.+|+.||++.+++.+
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 5566789999999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=316.06 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=202.7
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
...+.||+|+||.||++... ....+|+|.+.... .....++.+|++++.++ +|+||+++++++..++..+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34578999999999999863 23679999987542 33446788999999999 799999999999999999999
Q ss_pred EeeccCCChHHHhhhc--------------ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCE
Q 043526 646 YEYMANGNLKQLLSDE--------------KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEA 711 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~ 711 (858)
|||+++|+|.++++.. ....+++..+++++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeE
Confidence 9999999999999652 2346899999999999999999999 8999999999999999999999
Q ss_pred EEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHH
Q 043526 712 KLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTN 789 (858)
Q Consensus 712 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~ 789 (858)
||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+. +..
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~ 245 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFK 245 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH------HHH
Confidence 999999998765432211 112234578999999988889999999999999999998 888875432111 111
Q ss_pred HHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 790 MIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 790 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
....+. ....+......+.+++.+|+..+|++|||++|+++.|++++
T Consensus 246 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111 01112233457889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.14 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=199.9
Q ss_pred ccccccccCceEEEEEEEC-C---CCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe------e
Q 043526 575 FNKVLGKGGFGTVYHGYLD-D---GTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN------M 642 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~---g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~ 642 (858)
+.+.||+|+||.||+|... + +..||+|+++... ......+.+|++.++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999864 2 3679999987542 2334678999999999999999999999876554 7
Q ss_pred EEEEeeccCCChHHHhhhcc----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 643 GLIYEYMANGNLKQLLSDEK----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
++|+||+++|+|..++.... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999985432 346899999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++......... .....++..|+|||.+....++.++|||||||+++||++ |..||..... ..+.+.+ ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~~ 233 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL----RHGNR 233 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCC
Confidence 98764332221 112234678999999988889999999999999999999 8888854332 1111111 11111
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
...+.....++.+++.+|++.+|.+||++.|+++.|+++
T Consensus 234 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=313.13 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=198.7
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... .++.||||++..... ....++.+|+.+++.++||||+++++++.++...++||
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 88 (277)
T cd05062 9 TMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 88 (277)
T ss_pred eeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEE
Confidence 44578999999999999753 356799999864322 33457889999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc--------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 647 EYMANGNLKQLLSDEK--------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
||+++|+|.++++... ...+++.+++.++.|+++||+||| +.+++||||||+||++++++.++|+|||+
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 89 ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 9999999999996532 124678899999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++......... .....++..|+|||.+.+..++.++|||||||+++||++ |..||.....+ ... ..+.++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~----~~~~~~~~ 239 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVL----RFVMEGGL 239 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHcCCc
Confidence 87654322211 112345678999999998889999999999999999999 67887643311 111 11111111
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.. .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 LD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 112234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.98 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=203.7
Q ss_pred hhccccccccCceEEEEEEE------CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 644 (858)
..+.+.||+|+||.||+|.. ..+..||||+++... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 34568899999999999974 135679999987553 23346789999999999 79999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++|+|.++++......+++.+++.++.|++.||+||| +.+|+|+||||+|||++.++.++++|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997655445899999999999999999999 88999999999999999999999999999986643
Q ss_pred CCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 725 GGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 725 ~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
.... ......++..|+|||.+.+..++.++|||||||+++||++ |+.||....... ........+.
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-----~~~~~~~~~~------- 261 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-----KFYKLIKEGY------- 261 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-----HHHHHHHcCC-------
Confidence 3221 1112335678999999998889999999999999999998 898886433211 1111111111
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
....+.....++.+++.+|+..+|++||++.|+++.|+++
T Consensus 262 --~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.33 Aligned_cols=259 Identities=22% Similarity=0.378 Sum_probs=194.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 645 (858)
.+.+.||+|+||.||+|... +|+.||||++... ......++.+|++++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 34578999999999999954 7899999998743 223345788999999999999999999988643 247999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+. ++|.+++.... .+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 83 FELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 99996 68999886543 6899999999999999999999 899999999999999999999999999999865322
Q ss_pred Cc--ceeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH----------
Q 043526 726 GT--HVSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI---------- 791 (858)
Q Consensus 726 ~~--~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~---------- 791 (858)
.. .......|+..|+|||.+.+ ..++.++|||||||+++||+||+.||..... ......+....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHH
Confidence 11 11123468999999999865 6788999999999999999999999865331 11111111111
Q ss_pred -hcCCchhhhchhhcC-CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 792 -AKGDIENIVDSCLRG-GFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 792 -~~~~~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+...... ..+ ......+.+++.+|++.+|++||+++|++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000001111100000 000 0123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.91 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=197.4
Q ss_pred ccccccccCceEEEEEEECC-CC--EEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeE
Q 043526 575 FNKVLGKGGFGTVYHGYLDD-GT--QVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMG 643 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~ 643 (858)
+.+.||+|+||.||+|...+ +. .+|+|.++... ....+.+..|++++++++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999999754 33 68999887542 33456788999999999999999999987542 2468
Q ss_pred EEEeeccCCChHHHhhhc----ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 644 LIYEYMANGNLKQLLSDE----KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
++|||+++|+|.+++... ....+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999987432 2345899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 720 KVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 720 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
+......... .....++..|+|||...+..++.++||||||+++|||++ |+.||..... ..+ ...+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~----~~~~~~~~~~ 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEI----YDYLRQGNRL 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHHHHcCCCC
Confidence 8764332211 122345678999999998889999999999999999999 7888854321 111 1222222111
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
. .+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 234 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 K---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1122344688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.88 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=204.6
Q ss_pred HhhccccccccCceEEEEEEEC--------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCe
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNN 641 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 641 (858)
.+.+.+.||+|+||.||++... ++..+|+|.+.... .....++..|++++.++ +||||+++++++...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3455689999999999999752 23579999997542 33456788899999999 79999999999999999
Q ss_pred eEEEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC
Q 043526 642 MGLIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE 707 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~ 707 (858)
.++||||+++|+|.+++...+ ...++|.++++++.|++.||+||| +.+++||||||+||++++
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 175 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcC
Confidence 999999999999999997643 135899999999999999999999 889999999999999999
Q ss_pred CCCEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHH
Q 043526 708 NLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQ 785 (858)
Q Consensus 708 ~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~ 785 (858)
++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||+++||++ |+.||..... .+
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~~ 250 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----EE 250 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HH
Confidence 9999999999987654321111 111223568999999988889999999999999999998 7888754321 11
Q ss_pred HHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 786 TVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
+...+..+.. ...+.....++.+++.+|+..+|++||+|.+|++.|++++...
T Consensus 251 -~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 -LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred -HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111222111 0112233457889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.15 Aligned_cols=246 Identities=30% Similarity=0.472 Sum_probs=203.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|++|.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++...+..++||||+++++
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 44678999999999999874 78999999976644 56789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.++....... ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~ 159 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SG 159 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc----cC
Confidence 999997665557899999999999999999999 89999999999999999999999999999987633221 22
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||++....++.++||||||++++||++ |+.||.....+ . +...+..+.. ...+...
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~----~~~~~~~~~~---------~~~~~~~ 224 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D----VVPHVEKGYR---------MEAPEGC 224 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHhcCCC---------CCCccCC
Confidence 34567999999988889999999999999999997 88888643211 1 1111111110 1111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+.+++.+|+..+|++||+++|++++|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 4578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.45 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=198.1
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||.|+. ++|..+|+|++++.. ....+...+|-.+|....+|.||+|+..|++.+.+||||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 6899999999999995 489999999998763 334566888999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC--------
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-------- 724 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~-------- 724 (858)
++..+|.... .|++..+..++.+++-|++-|| +.|++||||||+|+|||..|.+||+||||+.-+..
T Consensus 227 D~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 227 DMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred cHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 9999997654 7999999999999999999999 99999999999999999999999999999863310
Q ss_pred ---------------CCc----cee-------------------ecccCCCCccCccccccCCCCCchhHHHHHHHHHHH
Q 043526 725 ---------------GGT----HVS-------------------TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEI 766 (858)
Q Consensus 725 ---------------~~~----~~~-------------------~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~El 766 (858)
+.. ... ...+|||.|||||++.+..++..+|.||+|||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 000 000 124699999999999999999999999999999999
Q ss_pred HhCCCccccCCCccc--cHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 043526 767 ITSQAVIVRNENENI--HIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN---MNEVVT 839 (858)
Q Consensus 767 ltG~~p~~~~~~~~~--~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~ 839 (858)
|.|-+||......+. .+..|.. .|..........+..+||.+|++ ||++|.- ++||.+
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999976553211 1222211 12222233445788899999999 9999986 445443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.24 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=195.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 34578999999999999975 789999999875432 233567889999999999999999999999999999999996
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 87 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 161 (303)
T cd07869 87 TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYS 161 (303)
T ss_pred cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCC
Confidence 58888876543 45888999999999999999999 8999999999999999999999999999987543221 1122
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---ch------hhhc
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IE------NIVD 801 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~------~~~d 801 (858)
...|++.|+|||.+.+ ..++.++||||+||+++||++|+.||.........+ ..+........ .. ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-ERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhCCCChhhccchhhcccccc
Confidence 3457899999998865 457889999999999999999999997543211111 11111110000 00 0000
Q ss_pred hhhc--CCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLR--GGFEI-------ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... ..... .....+.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 00000 112457799999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.02 Aligned_cols=257 Identities=31% Similarity=0.474 Sum_probs=201.4
Q ss_pred hccccccccCceEEEEEEEC-CCC--EEEEEEeccC-CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGT--QVAVKMLSSS-SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|..+ +|. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 34578999999999999875 443 4788888743 233456789999999999 799999999999999999999999
Q ss_pred ccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 649 MANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
+++|+|.++++... ...+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999996532 135889999999999999999999 8999999999999999999999999
Q ss_pred eecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhc
Q 043526 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAK 793 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~ 793 (858)
|||++...... ........+..|+|||...+..++.++|||||||+++||++ |..||...... +... .+..
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~-~~~~ 233 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYE-KLPQ 233 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH-HHhc
Confidence 99998643211 11111123457999999988889999999999999999998 99998654321 1111 1111
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
+ .....+......+.+++.+|++.+|.+||+++++++.|++++....+
T Consensus 234 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 234 G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1 00111122345688999999999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.81 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=204.2
Q ss_pred HhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.+.||+|+||.||++...++..+|+|.+.... .....+.+|++++++++|+|++++.+++.+ ...+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 345668899999999999998888889999887542 235678999999999999999999999887 778999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.......+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 99999997765567899999999999999999999 889999999999999999999999999999765433222222
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...++..|+|||++....++.++|+|||||+++||+| |+.||...... .+.. .+..+... ....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~~---------~~~~ 226 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM---------PRPE 226 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhCCCCC---------CCcc
Confidence 2345678999999988889999999999999999999 88888643311 1111 11121111 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
....++.+++.+|++.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=328.55 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=200.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 4578999999999999965 79999999997532 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC----
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---- 726 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~---- 726 (858)
+|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 85 GGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999765 46899999999999999999999 8999999999999999999999999999998764432
Q ss_pred ------------------------cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc
Q 043526 727 ------------------------THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782 (858)
Q Consensus 727 ------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~ 782 (858)
........||+.|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--- 236 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ--- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH---
Confidence 11123356899999999999999999999999999999999999999754311
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN-MNEVVTE 840 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~~ 840 (858)
.......... ..+.-.........+.+++.+|+. +|.+||+ ++|++++
T Consensus 237 --~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 --ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111111100 001000111134578899999997 9999999 9999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.86 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=200.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||+||++... +++.||||.+..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 3478999999999999964 789999999865322 223557889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.......+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--I 158 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--c
Confidence 999999887654456899999999999999999999 88999999999999999999999999999987543222 1
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ....+...+..+. ..++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~----------~~~~~ 226 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKEDQ----------EEYSE 226 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhcc----------cccCc
Confidence 23468999999999998889999999999999999999999997543211 1111111111110 11222
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....+.+++.+|+..||++|| ++++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 3345678999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.50 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=199.8
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++..++||||+++++++...+..++++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 44578999999999999853 3578999999755433 2456889999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEE
Q 043526 647 EYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK 712 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~k 712 (858)
||+++++|.+++.... ...+++..+++++.|++.||+||| +.+|+||||||+||++++++.+|
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCceE
Confidence 9999999999985321 235888999999999999999999 88999999999999999999999
Q ss_pred EeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHH
Q 043526 713 LADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNM 790 (858)
Q Consensus 713 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~ 790 (858)
|+|||+++........ ......+++.|+|||.+.+..++.++|||||||+++||++ |..|+..... ..+. ..
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~----~~ 238 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVI----EM 238 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH----HH
Confidence 9999998865432211 1122345778999999988889999999999999999998 7777754321 1111 11
Q ss_pred HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 791 IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 791 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
+.++... ..+......+.+++..|++.+|++||++++|++.|+.
T Consensus 239 i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222111 1122334568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.28 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEEC-CCC--EEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGT--QVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~--~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +|. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 444 46888887533 33456788999999999 799999999999999999999999999
Q ss_pred CChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 652 GNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 652 gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
|+|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999997543 135789999999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 718 LSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 718 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++...... ........+..|+|||++....++.++||||||++++||++ |..||...... ..... +..+..
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~-~~~~~~ 229 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK-LPQGYR 229 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHH-HhCCCC
Confidence 98632211 11111223567999999988889999999999999999997 99998643311 11111 111110
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
...+......+.+++.+|+..+|.+||++.++++.|++++
T Consensus 230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0011123346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.95 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=201.0
Q ss_pred ccccccCceEEEEEEECC--CC--EEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLDD--GT--QVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|++|.||+|.+.+ ++ .||||.++.... ...+++..|++.+++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 33 699999987655 556789999999999999999999999988 889999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce--
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-- 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-- 729 (858)
|+|.+++.+.....++|...+.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654356899999999999999999999 8999999999999999999999999999998765432221
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....++..|+|||++.+..++.++|||||||+++||++ |+.|+...... ++...+. ..... + ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~---~~~~~-------~--~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKID---KEGER-------L--ER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---hcCCc-------C--CC
Confidence 122446788999999988889999999999999999999 99998643321 1111111 11100 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
+......+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.67 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=204.4
Q ss_pred hhccccccccCceEEEEEEECC-----CCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeee-CCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDD-----GTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-DNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV 645 (858)
..+.+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++|||++++++++.. +...+++
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 87 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence 3456889999999999999765 7889999987543 2345668899999999999999999998876 4678899
Q ss_pred EeeccCCChHHHhhhccc------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 646 YEYMANGNLKQLLSDEKA------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
+||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+++||||||+||++++++.+||+|||++
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 999999999999976432 46899999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 720 KVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 720 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
+.+....... .....++..|+|||.+.+..++.++||||||++++|+++ |+.||.... ...+..++ ..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~----~~~~~- 237 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYL----KDGYR- 237 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHH----HcCCC-
Confidence 8664332221 122345678999999988889999999999999999999 999986532 11222221 11110
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+ .........+.+++.+|+..+|++||++.++++.|+++..
T Consensus 238 ------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 ------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0111223468899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.92 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=205.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 45678999999999999976 8999999988643 2233567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 650 ANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
++|+|.+++.... ...+++.+++.++.|+++||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999986532 346899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
. .....++..|+|||.+.+..++.++|||||||+++||++|+.|+..... ........ +..+.... .
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~-~~~~~~~~--------~ 228 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKK-IEKCDYPP--------L 228 (267)
T ss_pred c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhh-hhcCCCCC--------C
Confidence 1 2234578899999999888899999999999999999999999864331 22221111 11111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
........+.+++.+|+..+|++||++.+|++.|+++
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1113345788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.67 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEEC-CCC----EEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGT----QVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.||+|+||.||+|.+. +|+ .+++|.+..... ....++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 478999999999999964 454 477888754432 23467788888999999999999999875 45577899999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH- 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~- 728 (858)
++|+|.+++.... ..++|..++.++.||+.||+||| +.+++||||||+|||+++++.+||+|||+++........
T Consensus 91 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 91 PLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 9999999997543 46899999999999999999999 889999999999999999999999999999876433221
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+ ...+..+....
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~~--------- 231 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EV----PDLLEKGERLA--------- 231 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCCCcCC---------
Confidence 2223456778999999998889999999999999999998 99998654311 11 11122221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.+......+.+++.+|+..+|++||++.|+++.|+.+..
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 011123356789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.56 Aligned_cols=241 Identities=29% Similarity=0.436 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +++.||||+++... ......+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999997542 23345567778887764 899999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 9999999654 36889999999999999999999 8999999999999999999999999999987532221 1223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...||..|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+. +..+. + .++..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~----i~~~~------~----~~~~~ 218 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS----IRMDN------P----CYPRW 218 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCC------C----CCCcc
Confidence 356899999999999888999999999999999999999999654311 11111 11110 0 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMN-EVVT 839 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~ 839 (858)
...++.+++.+|++.+|++||++. ++.+
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 334678999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=325.16 Aligned_cols=236 Identities=25% Similarity=0.417 Sum_probs=201.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.|.++||+|+||+|+.+.++ +++.+|||++++.. ..+.+..+.|.+++... +||.|+.++.+|+.++++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 34589999999999999976 78899999998764 34556778888888777 499999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+.||++..+.+ ...+++..+.-++..|+.||+||| +.+||+||||-+|||||.+|.+||+|||+++..-..+ .
T Consensus 451 ~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~ 523 (694)
T KOG0694|consen 451 VAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-D 523 (694)
T ss_pred cCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCC-C
Confidence 99999554443 347999999999999999999999 9999999999999999999999999999998754333 3
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC--
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG-- 806 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~-- 806 (858)
.+..+.||+.|||||.+.+..|+.+.|-|||||+|||||.|..||.+.+. .+++|..+..
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------ee~FdsI~~d~~ 585 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------EEVFDSIVNDEV 585 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------------------HHHHHHHhcCCC
Confidence 45678999999999999999999999999999999999999999976542 2334444332
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
.|+.-...+.+.++.+++.++|++|.-+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 3566777889999999999999999976
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.13 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEEC--C--CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD--D--GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~--~--g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|.+. + +..+|+|.+..... ...+++.+|+++++++.|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 36899999876544 24567899999999999999999999876 4567999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.... .+++..++.++.|++.||+||| ..+++||||||+|||++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 6899999999999999999999 889999999999999999999999999999876543322211
Q ss_pred --cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 732 --VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 732 --~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
...++..|+|||...+..++.++||||||++++||++ |..||..... ..+...+ ..+... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~~---------~~ 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGERL---------PR 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCcC---------CC
Confidence 1223467999999998889999999999999999998 8999865432 1222222 221110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
+......+.+++.+|+..+|++||++.++++.|++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=318.77 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=215.7
Q ss_pred hhccccccccCceEEEEEEEC---CC--CEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD---DG--TQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~---~g--~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
-.+.++||.|-||.||+|.+. .| -.||||.-+.. .....+.|++|..+|++++||||++++|.|.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 344578999999999999964 23 35889988764 445577899999999999999999999999764 578999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
|.++-|.|..+|+.++ ..++......++.||..||+||| +...|||||..+|||+....-+||+|||+++.+..+.
T Consensus 470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999998765 47888999999999999999999 9999999999999999999999999999999987766
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
........-.+.|||||.+.-..++.++|||.|||++||++. |..||....+... ...+.+|. +
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------I~~iEnGe---------R 610 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------IGHIENGE---------R 610 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------EEEecCCC---------C
Confidence 555554444678999999999999999999999999999987 9999987654321 11122221 2
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
-..+..+...+..|..+||..+|.+||++.|+...|.+++++|.
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 23455667788999999999999999999999999999888655
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.55 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=200.8
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++..++..+++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence 3578999999999999632 4668999998876666667899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhccc-------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEee
Q 043526 649 MANGNLKQLLSDEKA-------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~D 715 (858)
+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+++||||||+|||+++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECC
Confidence 999999999975432 35889999999999999999999 89999999999999999999999999
Q ss_pred ecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhc
Q 043526 716 FGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAK 793 (858)
Q Consensus 716 FGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~ 793 (858)
||++......... ......+++.|+|||.+.+..++.++|||||||+++||++ |+.||...... .. ... ...
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~---~~~-~~~ 239 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EA---IEC-ITQ 239 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HH---HHH-HHc
Confidence 9998765432211 1122334678999999998889999999999999999998 88888543311 11 111 111
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
+... ..+......+.+++.+|++.+|.+||+++||.+.|+
T Consensus 240 ~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1100 011123346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.32 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=198.3
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+.+.||+|++|.||+|... .+..||+|.+..... .....|..|+.++++++|+||+++++++.+.+..++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 3578999999999999975 356799998865432 334578999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhccc-----CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---CEEEeeecCc
Q 043526 648 YMANGNLKQLLSDEKA-----STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL---EAKLADFGLS 719 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DFGla 719 (858)
|+++++|.+++...+. ..++|.++++++.||+.||+||| +.+++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999976532 35899999999999999999999 88999999999999998764 5999999999
Q ss_pred ccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 720 KVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 720 ~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
+......... ......+..|+|||++.+..++.++|||||||+++||++ |..||.....+. +.. .+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~-- 238 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VME----FVTGGG-- 238 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HHHcCC--
Confidence 8763222111 111223467999999998889999999999999999997 888886543221 111 111110
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
....+......+.+++.+|++.+|++||++.+|+++|++
T Consensus 239 -------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 -------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111122334578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.05 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +|+.||+|.++... ......+..|.+++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 78999999997532 23345567777777754 899999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999998654 36889999999999999999999 8999999999999999999999999999987532222 2223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||.+.+..++.++|||||||+++||++|+.||..... ..+... +..+. ...+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~----~~~~~----------~~~~~~ 218 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFES----IRVDT----------PHYPRW 218 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCC----------CCCCCC
Confidence 45689999999999988999999999999999999999999965431 111111 11110 011122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMN-EVV 838 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~-eVl 838 (858)
...++.+++.+|++.||++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 344678999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=304.59 Aligned_cols=248 Identities=33% Similarity=0.487 Sum_probs=203.5
Q ss_pred ccccccCceEEEEEEECC----CCEEEEEEeccCCCcc-hHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|.... +..+|+|.++...... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 8899999998654433 67899999999999999999999999999999999999999
Q ss_pred CChHHHhhhcc-------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 652 GNLKQLLSDEK-------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 652 gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
++|.+++.... ...+++.+++.++.|+++||+||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 357899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 725 GGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 725 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
... .......++..|+|||.+....++.++||||+|++++||++ |+.||..... ..+.+ .+..+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~----~~~~~~~------ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLE----YLRKGYR------ 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHH----HHHcCCC------
Confidence 321 11223456889999999988889999999999999999999 5888865421 11111 1111110
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
...+.....++.+++.+|++.+|++||+++|++++|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=325.09 Aligned_cols=255 Identities=21% Similarity=0.231 Sum_probs=194.0
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
...+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++..+...++|+|++. +
T Consensus 95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred EEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 4457899999999999995 478999999753 2456889999999999999999999999999999999986 6
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|..++.... .+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++............
T Consensus 168 ~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 168 DLYCYLAAKR--NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 8988886543 6889999999999999999999 8899999999999999999999999999997543322222334
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc------cccHHHHHHHHH---hcC------Cch
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE------NIHIIQTVTNMI---AKG------DIE 797 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~------~~~l~~~v~~~~---~~~------~~~ 797 (858)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ...+...+...- .+. .+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 57999999999999888999999999999999999999887543211 111111111000 000 000
Q ss_pred hhhchh----hcCC--C-C----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSC----LRGG--F-E----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~----l~~~--~-~----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+..... .... . . .....++.+++.+|++.||++|||++|++++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 0000 0 0 1224478899999999999999999999863
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.24 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=192.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHH---HhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLL---MRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+.+.||+|+||.||+|... +|+.||||+++... ....+.+..|++++ ++++||||+++++++..++..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999865 78999999997432 22334566666554 56789999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|..+++. ..+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 83 YAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred CCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 9999999988854 35899999999999999999999 8999999999999999999999999999987532222
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... +.... +..+.. .
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~-i~~~~~----------~ 219 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDS-IVNDEV----------R 219 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHhCCC----------C
Confidence 1223456899999999999888999999999999999999999999654311 11111 111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
++......+.+++.+|++.+|.+|| ++++++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1222345678999999999999999 46666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.28 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=200.6
Q ss_pred hccccccccCceEEEEEEE-----CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 645 (858)
...+.||+|+||.||++.+ .++..||+|.++... ......+.+|++++++++|||++++.+++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence 3346799999999999984 357889999987553 33456789999999999999999999999875 568899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++++|.+++.... ..++|.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 87 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 87 MEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999999996543 36899999999999999999999 899999999999999999999999999999876433
Q ss_pred Ccc--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCC----------ccccHHHHHHHHHhc
Q 043526 726 GTH--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN----------ENIHIIQTVTNMIAK 793 (858)
Q Consensus 726 ~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~----------~~~~l~~~v~~~~~~ 793 (858)
... ......++..|+|||.+.+..++.++||||||++++||+|++.|...... .+......+ ..+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHHc
Confidence 221 11234466789999999888899999999999999999998766432110 000111111 11111
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
+. ....+......+.+++.+|++.+|++||+++++++.|+++
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 GK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred Cc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 0011222456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=326.69 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=197.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 44578999999999999965 7899999998643 2233455788999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++... .++...+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++..........
T Consensus 126 ~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 126 PGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 999999998653 4778888899999999999999 8999999999999999999999999999998764433223
Q ss_pred eecccCCCCccCccccccC----CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 730 STVVAGTPGYLDPEYFVTD----WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.....||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ........... .+.
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~-------~~~ 267 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKN-------SLT 267 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCC-------cCC
Confidence 3345699999999998643 4788999999999999999999999754321 11111111100 010
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSE--RPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 840 (858)
-........++.+++.+|+..+|.+ ||+++|++++
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0011123457889999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=335.17 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC--------e
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--------N 641 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--------~ 641 (858)
+.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+..+..++|+|++++.+.+...+ .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 34567899999999999985 579999999986542 334567889999999999999999988775432 3
Q ss_pred eEEEEeeccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 642 MGLIYEYMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
.++||||+++|+|.++++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 679999999999999996533 346889999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCC-cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 720 KVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 720 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
+.+.... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+... ..+...
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~-~~~~~~- 263 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKT-LAGRYD- 263 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH-hcCCCC-
Confidence 8764321 1222345689999999999998999999999999999999999999964321 1112211 111111
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.....++.+++.+|++.+|.+||++.+++++
T Consensus 264 --------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 --------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1122334578899999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=291.36 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=207.0
Q ss_pred hccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC-----eeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN-----NMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E 647 (858)
.+.+.||+|||.-||.++ +.++..+|+|++.....++.+..++|++..++++|||++++++++..+. +.+++++
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 456789999999999998 6789999999998877778889999999999999999999999986544 4899999
Q ss_pred eccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 648 YMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 648 y~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|...|+|.+.+...+ +..+++.+.+.|+.+|++||++||.. .++++||||||.|||+.+++.++|.|||.+...+..
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 999999999997654 45799999999999999999999932 445999999999999999999999999998865422
Q ss_pred C--ccee------ecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC
Q 043526 726 G--THVS------TVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 726 ~--~~~~------~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
- .... .....|..|+|||.+. +...++++|||||||+||+|+.|..||+.....+..+.
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla---------- 252 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA---------- 252 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE----------
Confidence 1 1100 1123588999999986 56788999999999999999999999975332111110
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
..+....+.-.-....+..+.+++..|++.||.+||+..+++.+++.++
T Consensus 253 --LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111111111112224567889999999999999999999999998864
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=316.58 Aligned_cols=242 Identities=25% Similarity=0.405 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 68899999997542 23445677888888887 699999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 99999986543 6899999999999999999999 89999999999999999999999999999875322221 122
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||.+.+..++.++|||||||+++||++|+.||...... .+ .. .+..... ..+..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~---~~-~i~~~~~----------~~~~~ 218 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--EL---FQ-SILEDEV----------RYPRW 218 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HH---HH-HHHcCCC----------CCCCc
Confidence 346899999999999999999999999999999999999999643311 11 11 1111110 11222
Q ss_pred HHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNM-----NEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~~ 840 (858)
....+.+++.+|++.+|.+||++ .+++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 34567899999999999999999 777664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.08 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe-----eEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN-----MGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~~lV~Ey~ 649 (858)
.+++|+|+||.||+|.+. +++.||||+.-..... -.+|+++|+++.|||||+++-+|....+ ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 378999999999999964 6799999998655332 2568899999999999999999876433 45899999
Q ss_pred cCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccCCC
Q 043526 650 ANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 650 ~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~~~ 726 (858)
+. +|.+.++.. ....++.-.+.-+..||.+||+||| +.+|+||||||+|+|+|.+ |.+||||||.|+.+..++
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 98 999999742 2346777788889999999999999 8999999999999999976 999999999999987665
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc--------CCch
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK--------GDIE 797 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~--------~~~~ 797 (858)
...+.. -+..|+|||.+.+ ..++.+.||||.||++.||+-|++.|.+.. ...++...++ .+.- ....
T Consensus 181 pniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik-~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 PNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIK-VLGTPTREDIKSMNPN 256 (364)
T ss_pred CceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHH-HhCCCCHHHHhhcCcc
Confidence 554432 4789999999885 579999999999999999999998886633 2223333222 1111 1111
Q ss_pred --hhhchhhcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 --NIVDSCLRGG-----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 --~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.-.+.+... .......+.++++.++++.+|.+|.++.|++++
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111111 123445688999999999999999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.82 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=203.1
Q ss_pred hhccccccccCceEEEEEEECC----CCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
..+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 3456789999999999998643 2468999887654 3445679999999999999999999998875 45789999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 87 LAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred cCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999997543 35899999999999999999999 88999999999999999999999999999987654322
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......++..|+|||.+....++.++||||||++++||++ |..||......+ .... +..+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~--------- 227 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGR----IENGERL--------- 227 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH----HHcCCcC---------
Confidence 22222334568999999988889999999999999999996 999986544221 1111 1111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
..+......+.+++.+|+..+|.+||++.++++.|+++.+++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011223457889999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=320.05 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=199.9
Q ss_pred hhccccccccCceEEEEEEE------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeC-CeeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED-NNMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~~ 643 (858)
..+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|++++.++ +||||++++++|... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 45568999999999999973 3578999999975432 2345788999999999 689999999988654 4578
Q ss_pred EEEeeccCCChHHHhhhcc-------------------------------------------------------------
Q 043526 644 LIYEYMANGNLKQLLSDEK------------------------------------------------------------- 662 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~------------------------------------------------------------- 662 (858)
+||||+++|+|.++++...
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 9999999999999986532
Q ss_pred ----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-eeecccCCC
Q 043526 663 ----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-VSTVVAGTP 737 (858)
Q Consensus 663 ----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~ 737 (858)
...+++.++.+++.|+++||+||| +.+|+||||||+|||+++++.+||+|||++......... ......++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 124688899999999999999999 899999999999999999999999999999865332211 111223567
Q ss_pred CccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHH
Q 043526 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRA 816 (858)
Q Consensus 738 ~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 816 (858)
.|+|||.+.+..++.++||||||++++||++ |..|+....... . ....+.++.... .+.....++
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~----~~~~~~~~~~~~---------~~~~~~~~~ 311 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E----FCRRLKEGTRMR---------APDYTTPEM 311 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H----HHHHHhccCCCC---------CCCCCCHHH
Confidence 8999999988889999999999999999997 888886433211 1 111122221110 011122467
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 817 VELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 817 ~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.+++..|++.+|++||++.||+++|+.+++
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=326.14 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=193.6
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||+||+|+. ++++.||||++.... ......+..|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 347899999999999985 478999999997542 2334678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc---
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT--- 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~--- 727 (858)
+|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 85 gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 85 GGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999996543 6888999999999999999999 89999999999999999999999999999764311000
Q ss_pred -------------------------------------------ceeecccCCCCccCccccccCCCCCchhHHHHHHHHH
Q 043526 728 -------------------------------------------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLL 764 (858)
Q Consensus 728 -------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ 764 (858)
.......||..|+|||.+.+..++.++|||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0011246899999999999888999999999999999
Q ss_pred HHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 043526 765 EIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVK--CASRTSSERPNMNEVVTE 840 (858)
Q Consensus 765 ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPsm~eVl~~ 840 (858)
||+||+.||........ ......... .+..........++.+++.+ |+..+|.+||+++|++++
T Consensus 240 elltG~~Pf~~~~~~~~-----~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTPTET-----QLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCHHHH-----HHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999975432111 111110000 00000111223456677776 556677779999999885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.91 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=208.7
Q ss_pred HHHhhccccccccCceEEEEEE-ECCCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 570 KITDNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 570 ~~t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+-.+++.+.||+|.||.|-+|. ...|+.||||.+++... ++.-.+.+|+++|+.++||||+.++..|...+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4456777899999999999998 46899999999986643 4455678899999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||..+|.|+|++...+ .+++.+...+++||+.|+.|+| ..+++|||||.+|||+|.++++||+|||++..+...
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999997765 7999999999999999999999 899999999999999999999999999999887644
Q ss_pred CcceeecccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
. .-..++|.+-|.+||.+.+..|. +..|.||+||+||-|+.|..||++.+. ...+++ +..|
T Consensus 207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQ-Is~G---------- 268 (668)
T KOG0611|consen 207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQ-ISRG---------- 268 (668)
T ss_pred c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHH-hhcc----------
Confidence 3 23457899999999999988764 789999999999999999999976541 112222 2222
Q ss_pred cCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 805 RGGF-EIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 805 ~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.| ..+......-|+.+|+..+|++|.|..+|..+.
T Consensus 269 --aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 --AYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22 223334566789999999999999999999876
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=303.97 Aligned_cols=252 Identities=26% Similarity=0.315 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||+|... ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999864 346799999876543 33457889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcc---cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 653 NLKQLLSDEK---ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 653 sL~~~L~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+|.++++... ....++..+..++.|++.||+||| +.+++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997543 224678888899999999999999 8899999999999999999999999999987543322211
Q ss_pred -eecccCCCCccCccccccC-------CCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 730 -STVVAGTPGYLDPEYFVTD-------WLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 730 -~~~~~gt~~y~APE~~~~~-------~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
.....++..|+|||.+... .++.++|+||||++++||++ |+.||......+ .... .+.. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~~-~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---TVRE-QQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---Hhhc-ccCCCC
Confidence 1234567889999988632 35789999999999999996 999986543221 1111 1111 111112
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
++.+. ......+.+++..|+ .+|++||+++||++.|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22221 122335778889998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=302.15 Aligned_cols=245 Identities=28% Similarity=0.445 Sum_probs=198.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeee-eCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI-EDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||++..+ |+.+|+|.++... ..+.+..|+.++++++|+|++++++++. .++..++||||++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 44578999999999999874 7889999986442 3467899999999999999999999765 456789999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.++++......+++..+++++.|++.||+||| +.+++||||||+||++++++.+||+|||+++...... ..
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~ 158 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 158 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC----CC
Confidence 9999998766556899999999999999999999 8899999999999999999999999999987653221 12
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||++....++.++|||||||+++||++ |+.|+.... ..+... .+..+... .....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~-~~~~~~~~---------~~~~~ 223 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVP-RVEKGYKM---------DAPDG 223 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHH-HHhcCCCC---------CCCCC
Confidence 234568999999988889999999999999999998 888875432 111111 11111111 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
....+.+++.+|++.+|++||+++++++.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 34578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=315.83 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=195.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccc-eeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHR-NLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|... +++.||||++... .....+.+..|.+++..++|+ +|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 34578999999999999965 6789999998753 233456788899999999765 588899999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 83 VNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 99999999986543 6889999999999999999999 89999999999999999999999999999875322221
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......|+..|+|||++.+..++.++|||||||+++||+||+.||...... .+... +.+.. ..+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~----i~~~~----------~~~ 220 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQS----IMEHN----------VSY 220 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH----HHcCC----------CCC
Confidence 223456899999999999988999999999999999999999999754311 11111 11111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNM-----NEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~~ 840 (858)
+.....++.+++.+|+..+|.+|++. +++.++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 22334567899999999999999976 566543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=304.11 Aligned_cols=246 Identities=28% Similarity=0.444 Sum_probs=198.3
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCCC-----cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG-----QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.||+|++|.||+|.. ++++.+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 47899999999999985 4789999999864321 12356888999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.... .+++..+.+++.|++.||+||| +.+|+||||+|+||++++++.++|+|||+++.........
T Consensus 87 ~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 87 PGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred CCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999986543 5888999999999999999999 8899999999999999999999999999997654322111
Q ss_pred e--ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 730 S--TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 730 ~--~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
. ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........... ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~---------~~~ 227 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQPT---------NPQ 227 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHHhccCC---------CCC
Confidence 1 2345778999999999888999999999999999999999998643211 11111111110 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+......+.+++.+|+..+|.+||++.|++++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 222334568899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.99 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=197.8
Q ss_pred hccccccccCceEEEEEEECC---------------CCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD---------------GTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 637 (858)
.+.+.||+|+||.||++...+ ...||+|.++... ......+.+|++++++++|||++++++++.
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 445789999999999987532 2358999987543 233457899999999999999999999999
Q ss_pred eCCeeEEEEeeccCCChHHHhhhcc----------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC
Q 043526 638 EDNNMGLIYEYMANGNLKQLLSDEK----------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE 707 (858)
Q Consensus 638 ~~~~~~lV~Ey~~~gsL~~~L~~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~ 707 (858)
..+..++||||+++++|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+||++++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGN 164 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcC
Confidence 9999999999999999999986532 124689999999999999999999 889999999999999999
Q ss_pred CCCEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh--CCCccccCCCccccHH
Q 043526 708 NLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVIVRNENENIHII 784 (858)
Q Consensus 708 ~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt--G~~p~~~~~~~~~~l~ 784 (858)
++.+||+|||++.......... .....++..|+|||....+.++.++|||||||+++||++ |..||..... ....
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~~~~ 242 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--EQVI 242 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--HHHH
Confidence 9999999999997654332211 122334678999999988889999999999999999998 5556654321 1122
Q ss_pred HHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 785 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..+............ ...+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 221111111100000 00111233578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.65 Aligned_cols=249 Identities=26% Similarity=0.472 Sum_probs=200.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|...+++.+|+|.+..... ...++.+|++++++++|||++++++++......++||||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 44578999999999999987788999999864432 34678999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++..+..++.|++.|++||| +.+++|+||||+||+++.++.+||+|||++..............
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 86 LSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 999987543 35789999999999999999999 88999999999999999999999999999876543222112222
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++.+|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+ .+.++. .... +...
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~--~~~~-------~~~~ 226 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVE----TINAGF--RLYK-------PRLA 226 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH----HHhCCC--CCCC-------CCCC
Confidence 34678999999988889999999999999999998 88888643311 1111 111110 0001 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
...+.+++.+|++.+|++||+++|++++|+
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.79 Aligned_cols=237 Identities=29% Similarity=0.390 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHH-HHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVK-LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||+||+|... +|+.||||++.... .....++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 79999999986432 222344555554 56789999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 9999998654 36889999999999999999999 8999999999999999999999999999987542221 2223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|++.|+|||.+.+..++.++|||||||+++||++|+.||..... .+..... ..+. + ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i-~~~~--------~--~~~~~ 218 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNI-LNKP--------L--RLKPN 218 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHH-HcCC--------C--CCCCC
Confidence 45689999999999988899999999999999999999999965431 1111111 1111 0 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMN 835 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~ 835 (858)
....+.+++.+|++.+|.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 245688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=321.97 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=199.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||++... +|+.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 34578999999999999964 78999999997542 234466888999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 84 PGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999997652 36899999999999999999999 8999999999999999999999999999998765444333
Q ss_pred eecccCCCCccCccccc------cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 730 STVVAGTPGYLDPEYFV------TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~------~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.....||+.|+|||.+. ...++.++|||||||+++||++|+.||...... ............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~------- 227 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRF------- 227 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCc-------
Confidence 34456899999999986 456788999999999999999999999654321 111111111100
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.-.........+.+++..|++ +|.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000111234567889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=306.69 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=201.6
Q ss_pred hccccccccCceEEEEEEEC-C---CCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-D---GTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~---g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|... + +..+|+|.++... ....+.+..|+.++.+++||||+++++++..++..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 34578999999999999853 2 3479999986543 23356789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++++|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+|||+++++.++|+|||++.........
T Consensus 87 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 87 MENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999997543 46899999999999999999999 899999999999999999999999999999876543322
Q ss_pred eeec--ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 729 VSTV--VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 729 ~~~~--~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.... ..++..|+|||++.+..++.++|+||||++++|+++ |+.||...... .....+ .++. .
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~----~~~~---------~ 227 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAI----EEGY---------R 227 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHH----hCCC---------c
Confidence 2211 223567999999998889999999999999999887 99998654321 111111 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
..........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.02 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=199.1
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|+. .+|+.||+|++..........+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 3457899999999999996 578999999997665555667889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.++++.. ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 92 ~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~ 165 (267)
T cd06646 92 SLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKS 165 (267)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCc
Confidence 999998654 36889999999999999999999 88999999999999999999999999999986642211 1223
Q ss_pred ccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 733 VAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 733 ~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
..|+..|+|||.+. ...++.++|||||||+++||++|+.|+........ ... .... ....+.+.. .
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~-----~~~~---~~~~~~~~~--~ 234 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL-----MSKS---NFQPPKLKD--K 234 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-hee-----eecC---CCCCCCCcc--c
Confidence 45788999999874 34578899999999999999999999854321110 000 0000 000011100 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
......+.+++.+|+..+|++||++++++++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 12345788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=316.51 Aligned_cols=248 Identities=20% Similarity=0.327 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 68899999997542 23345678899998888 699999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 9999988654 36899999999999999999999 8999999999999999999999999999987532221 1223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc-cccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE-NIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~-~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .......+...+..... ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCCC
Confidence 456899999999999989999999999999999999999999643221 11222222222222110 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNM------NEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm------~eVl~~ 840 (858)
.....+.+++.+|+..+|++|+++ +++.++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 233467899999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=320.74 Aligned_cols=238 Identities=30% Similarity=0.376 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEE----CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.||+|+||.||+++. .+|+.+|+|++.... ......+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999874 368999999997542 2234567789999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++... ..+++.++..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 99999999654 36899999999999999999999 89999999999999999999999999999886543222 22
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|++.|+|||.+....++.++|||||||+++||++|+.||..... . ..... +..... ..+.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~---~~~~~-i~~~~~----------~~p~ 219 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--K---ETMTM-ILKAKL----------GMPQ 219 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--H---HHHHH-HHcCCC----------CCCC
Confidence 335689999999999888889999999999999999999999965331 1 11111 111110 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNE 836 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~e 836 (858)
.....+.+++.+|++.+|++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.41 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=200.9
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
..+.||+|+||.||+|... .+..||+|.+..... .....+.+|++++..++||||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 4578999999999999864 246899999865432 334578899999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcc--------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 648 YMANGNLKQLLSDEK--------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 648 y~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
|+++|+|.+++.... ...++|..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcccc
Confidence 999999999996533 224789999999999999999999 899999999999999999999999999998
Q ss_pred ccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 720 KVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 720 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
+....... .......++..|+|||.+.+...+.++|||||||+++||+| |+.||...... ..... +..+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~----~~~~~~~ 240 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKF----VIDGGHL 240 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHH----HhcCCCC
Confidence 86543322 12223446788999999988889999999999999999998 88888643321 11111 1121111
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
. .+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 241 ~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 241 D---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 122234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=322.80 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=191.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||+||++... +|+.||||+++... ......+..|++++.+++||||+++++.+.++...++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 3578999999999999864 78999999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc---
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT--- 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~--- 727 (858)
+|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 85 GGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999754 36899999999999999999999 89999999999999999999999999999875432110
Q ss_pred -------------------------------ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccC
Q 043526 728 -------------------------------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRN 776 (858)
Q Consensus 728 -------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~ 776 (858)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346999999999999889999999999999999999999999654
Q ss_pred CCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 043526 777 ENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCAS--RTSSERPNMNEVVTE 840 (858)
Q Consensus 777 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPsm~eVl~~ 840 (858)
... ... ... .... ..+. ... ......++.+++.+++. .++..||+++|++++
T Consensus 240 ~~~--~~~---~~i-~~~~-~~~~---~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 TPQ--ETY---KKV-MNWK-ETLI---FPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CHH--HHH---HHH-HcCc-Cccc---CCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 311 111 111 1100 0000 000 01122345566665433 344467999999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.16 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=202.7
Q ss_pred ccccccccCceEEEEEEEC-----CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIY 646 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 646 (858)
+.+.||+|+||.||+|.++ +++.+|||.++..... ..+++.+|++.++.++||||+++++++.. +...++||
T Consensus 8 ~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred hheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 3478999999999999864 3789999999765443 46789999999999999999999999887 55789999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++++|.+++.... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 88 e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 88 EYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred ecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 9999999999997654 35899999999999999999999 8899999999999999999999999999998765332
Q ss_pred cce--eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc---------HHHHHHHHHhcCC
Q 043526 727 THV--STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH---------IIQTVTNMIAKGD 795 (858)
Q Consensus 727 ~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~---------l~~~v~~~~~~~~ 795 (858)
... .....++..|+|||...+..++.++||||||++++||+||+.|+......... ........+..
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 241 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE-- 241 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc--
Confidence 211 11223456799999998888999999999999999999999987543221110 01111111111
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
......+.....++.+++.+|+..+|++||+|.||+++|+++
T Consensus 242 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 -------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111222345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.46 Aligned_cols=240 Identities=29% Similarity=0.375 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHH-HHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVK-LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +|+.+|+|++.... .....++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 79999999986542 223345555554 46778999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|..++... ..+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 9999988654 36899999999999999999999 8999999999999999999999999999987532221 1223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||.+.+..++.++|||||||+++||++|+.||...... +..... ..+.. . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~-~~~~~------~----~~~~ 218 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNI-LHKPL------V----LRPG 218 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHH-HcCCc------c----CCCC
Confidence 456899999999999988999999999999999999999999754311 111111 11110 0 1112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVV 838 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl 838 (858)
....+.+++.+|++.+|.+||++++.+
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 344677999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.37 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=195.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||++... +++.+|+|++... .......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 44578999999999999975 6889999998642 2223456788999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||++..........
T Consensus 126 ~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 126 PGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 999999999643 4788899999999999999999 8999999999999999999999999999998764333323
Q ss_pred eecccCCCCccCccccccC----CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 730 STVVAGTPGYLDPEYFVTD----WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.....||+.|+|||.+... .++.++||||+||+++||++|+.||...... ........... .+.
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~~~~i~~~~~-------~~~ 267 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GTYSKIMDHKN-------SLN 267 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCc-------ccC
Confidence 3345699999999998653 3788999999999999999999999754311 11111111100 010
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSE--RPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 840 (858)
-.........+.+++..|+..++.+ ||+++|++++
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111223456778888898755543 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=295.59 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~ 651 (858)
+.|++|+||.||+|+. ++++.||+|+++..... -.-.-++|+.+|.+++|||||.+..+..- -+..++|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 5699999999999995 47899999999865322 23456899999999999999999887753 4679999999998
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|..+++..+ +++...++..++.|+++|++||| ...|+|||||++|+|++..|.+||+|||+|+.+...-.. .+
T Consensus 162 -DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~-~T 235 (419)
T KOG0663|consen 162 -DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP-YT 235 (419)
T ss_pred -hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCccc-Cc
Confidence 9999997655 68999999999999999999999 889999999999999999999999999999998654332 23
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH---hcCCchhhh-------
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI---AKGDIENIV------- 800 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~---~~~~~~~~~------- 800 (858)
..+-|..|+|||.+.+ ..++++.|+||+|||+.||+++++.|.+.. +.+..+.+-..+ .+..+..+.
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 3445899999999885 578999999999999999999998886543 222222222211 111111110
Q ss_pred -------chhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 -------DSCLRGGFEIE-SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 -------d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...++..+... ....-.+|+..++..||.+|-|++|.+++
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 01111112111 23456788999999999999999998764
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=316.36 Aligned_cols=257 Identities=20% Similarity=0.315 Sum_probs=195.5
Q ss_pred cccccccc--CceEEEEEEE-CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 575 FNKVLGKG--GFGTVYHGYL-DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G--~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+.++||+| +||+||++.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34679999 7889999986 4899999999975422 23356778999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH- 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~- 728 (858)
++|+|.+++.......+++..+++++.|++.||+||| +.+|+||||||+|||++.++.++++||+........+..
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997655556899999999999999999999 889999999999999999999999999865443211111
Q ss_pred -----eeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 729 -----VSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 729 -----~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||........ ...... +......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~-----~~~~~~~~ 232 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLN-----GTVPCLLD 232 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhc-----CCcccccc
Confidence 0112346678999999875 4588999999999999999999999975432111 111100 00000000
Q ss_pred -------------------hhh-----------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 -------------------SCL-----------------RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 -------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... ...........+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 000112234578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.30 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=200.9
Q ss_pred hccccccccCceEEEEEEEC-CC---CEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DG---TQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|... +| ..||||++... ......+|..|+.+++.++||||+++.+++..++..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 86 (269)
T cd05065 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEF 86 (269)
T ss_pred EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEec
Confidence 45688999999999999964 33 36999998754 233456899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 87 MENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999997543 46899999999999999999999 899999999999999999999999999998765432211
Q ss_pred ee--eccc--CCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 729 VS--TVVA--GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 729 ~~--~~~~--gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.. .... .+..|+|||++....++.++|||||||+++||++ |..||..... .....++ ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i----~~~~-------- 228 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI----EQDY-------- 228 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH----HcCC--------
Confidence 11 1111 2357999999998889999999999999999987 9999865432 1222222 1110
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.-..+.+....+.+++.+|++.+|.+||++++|++.|+++
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=315.78 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=194.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+.+.||+|+||.||+|... +++.||||+++... ......+..|.+++..+ +|++|+++.+++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 4578999999999999865 67899999987542 22334567778888777 5899999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 84 ~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~ 157 (323)
T cd05616 84 NGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-T 157 (323)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-c
Confidence 9999999986543 6889999999999999999999 89999999999999999999999999999875432221 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..+.+. +.+.. ..++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~----i~~~~----------~~~p 221 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQS----IMEHN----------VAYP 221 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCC----------CCCC
Confidence 2345689999999999999999999999999999999999999975432 111111 11111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNM-----NEVVT 839 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~ 839 (858)
.....++.+++.+|++.+|++|++. +++.+
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 2334578899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.03 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=200.0
Q ss_pred hhccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+..+++++||||+++++++...+..++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 344578999999999999753 245899999864432 2335678899999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcc--------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 646 YEYMANGNLKQLLSDEK--------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
|||+++|+|.+++.... ...+++..+.+++.|++.||+||| +.+|+||||||+||++++++.++|+|||
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999999999996532 124567788999999999999999 8999999999999999999999999999
Q ss_pred CcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCC
Q 043526 718 LSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGD 795 (858)
Q Consensus 718 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~ 795 (858)
+++........ ......++..|+|||.+.+..++.++|||||||+++||++ |..||.....+ +.. ..+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~-~~~~~~~ 238 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVL-KFVMDGG 238 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-HHHHcCC
Confidence 98865332211 1122234678999999998889999999999999999999 67787543321 111 1111111
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.. ..+......+.+++.+|++.+|++||++.++++.|++.+.
T Consensus 239 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 239 YL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 10 0112224578999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.26 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=195.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++..++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 3578999999999999965 78999999997532 2334567889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc--
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-- 728 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-- 728 (858)
+|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 85 GGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 999999997543 6899999999999999999999 899999999999999999999999999998764321100
Q ss_pred -----------------------------------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCcc
Q 043526 729 -----------------------------------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVI 773 (858)
Q Consensus 729 -----------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~ 773 (858)
......||+.|+|||++....++.++|||||||+++||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 001235899999999999888999999999999999999999999
Q ss_pred ccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043526 774 VRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN---MNEVVTE 840 (858)
Q Consensus 774 ~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~~ 840 (858)
...... +.......... .+...........+.+++.+|+. +|.+|++ ++|++++
T Consensus 240 ~~~~~~-----~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 240 CSDNPQ-----ETYRKIINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCHH-----HHHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 754311 11111111000 00000111223467788888886 8999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=322.05 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=196.2
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC-----eeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN-----NMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E 647 (858)
.+.||+|+||.||++.. .+|+.||||++.... ....+++.+|+++++.++||||+++++++...+ ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 47899999999999996 479999999986532 234567889999999999999999999998776 7899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+. ++|.+.+... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 85 LMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred ccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 997 5788887543 36899999999999999999999 89999999999999999999999999999987543332
Q ss_pred ceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh-------
Q 043526 728 HVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI------- 799 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~------- 799 (858)
.......++..|+|||.+.+. .++.++|||||||+++||++|+.||...... .....+..........++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 223334578899999998764 5789999999999999999999999654321 111111111111110000
Q ss_pred ---hchhhcC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 ---VDSCLRG--------GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ---~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+...... ........++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 0111224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=300.25 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=199.1
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
+.||+|++|.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee-eccc
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-TVVA 734 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 734 (858)
+++.... ..+++..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9996543 36789999999999999999999 88999999999999999999999999999876542221111 1122
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
++..|+|||.+.+..++.++|+||||++++||+| |..||...... .... .+..+. ....+....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRE----RIESGY---------RMPAPQLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHH----HHhcCC---------CCCCCccCC
Confidence 3567999999988889999999999999999999 78887543311 1111 111110 011122234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
.++.+++.+|+..+|.+||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 57889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.21 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=199.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||++... +++.||||.+..... .....+..|+.++++++|+|++++.+.+..++..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3478999999999999965 789999999865422 223457789999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++.......+++.+++.++.|++.||+||| +.+|+||||||+||++++++.++|+|||++.........
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 158 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-- 158 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc--
Confidence 999999997655557899999999999999999999 899999999999999999999999999998765433221
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|+..|+|||.+.+..++.++||||||++++||++|+.||........ .......... . ...+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~-----~-----~~~~~~ 226 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE-----V-----QEEYSE 226 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhh-----h-----hhhcCc
Confidence 234689999999999988899999999999999999999999975432110 0011111100 0 001112
Q ss_pred HHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
.....+.+++.+|++.+|++||+ ++|++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 23346789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.40 Aligned_cols=246 Identities=21% Similarity=0.380 Sum_probs=200.2
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..+.||+|++|.||+|.. .+++.||+|.+..........+.+|+++++.++|||++++++.+..+...++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 346799999999999985 4789999999987666666788999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........ .....
T Consensus 104 L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (296)
T cd06654 104 LTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (296)
T ss_pred HHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence 99998643 4789999999999999999999 88999999999999999999999999999876543221 12234
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.|++.|+|||.+.+...+.++|||||||+++||++|+.||....... .+. .....+. . .+ ..+....
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~----~~~~~~~-~-----~~--~~~~~~~ 243 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALY----LIATNGT-P-----EL--QNPEKLS 243 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHH----HHhcCCC-C-----CC--CCccccC
Confidence 68889999999988888999999999999999999999996543211 111 1111110 0 00 0112233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.+++.+|+..+|++||+++|++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 567899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=306.86 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=198.4
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEecc--CCCcchHhHHHHHHHHHhcccceeeeeeeeeee-----CCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-----DNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~~~~lV~Ey 648 (858)
+.||+|++|.|..+.. .+|+.||||++.. ......++-.+|+++|++++|+||+.+.+.+.. -+..++|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 6799999999999985 4899999999973 344456788999999999999999999998865 3568999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC-Cc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG-GT 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~-~~ 727 (858)
|+. +|...++..+ .++..+...++.|+++||.|+| +.+|+||||||+|+|++.+..+||+|||+|+..... ..
T Consensus 108 Met-DL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 108 MET-DLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred Hhh-HHHHHHHcCc--cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 954 9999997654 5899999999999999999999 999999999999999999999999999999987543 11
Q ss_pred ceeecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC-----------C
Q 043526 728 HVSTVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG-----------D 795 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~-----------~ 795 (858)
...+..+.|..|.|||.+. ...++.+.||||.||++.||++|++.|.+.+ ..+..+.+...+... .
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--YVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--hHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 2224456799999999886 5689999999999999999999999886543 122222222221111 1
Q ss_pred chhhhchhhc-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 IENIVDSCLR-GGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 ~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+..... ...+ .......++|+.+|+..||.+|+|++|.+++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111000 0001 1234467899999999999999999999875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=304.40 Aligned_cols=246 Identities=27% Similarity=0.460 Sum_probs=194.8
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeC------CeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED------NNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~~~~lV~E 647 (858)
.+.||+|+||.||+|... +++.||+|++.... ....++..|+.++.++ +|||++++++++... ...++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 467999999999999964 68899999986543 3446788999999998 699999999998753 45889999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++++|.+++.......+++..+..++.|++.||+||| +.+|+|+||||+||++++++.++|+|||++........
T Consensus 90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~ 166 (272)
T cd06637 90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 166 (272)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc
Confidence 999999999998765567899999999999999999999 88999999999999999999999999999886543221
Q ss_pred ceeecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 728 HVSTVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+....... .. .. ..... .+
T Consensus 167 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~-~~-~~~~~-----~~ 234 (272)
T cd06637 167 -RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL-FL-IPRNP-----AP 234 (272)
T ss_pred -cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HH-HH-HhcCC-----CC
Confidence 223356889999999986 3457889999999999999999999986432110 00 00 01100 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+ ........+.+++.+|+..+|.+||+++|++++
T Consensus 235 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 235 RL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 111223468899999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=303.87 Aligned_cols=240 Identities=21% Similarity=0.342 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEECC-------------CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeE
Q 043526 577 KVLGKGGFGTVYHGYLDD-------------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 643 (858)
+.||+|+||.||+|.+.+ ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358999887655555567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC-------EEEeee
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE-------AKLADF 716 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~-------~kL~DF 716 (858)
+||||+++|+|..++.... ..+++..+++++.||++||+||| +.+|+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999886543 35899999999999999999999 899999999999999987664 899999
Q ss_pred cCcccccCCCcceeecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHH-hCCCccccCCCccccHHHHHHHHHhcC
Q 043526 717 GLSKVFPIGGTHVSTVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEII-TSQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 717 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~Ell-tG~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+ . ... ..+
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-~~~-~~~ 224 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-ERF-YEG 224 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-HHH-Hhc
Confidence 998754321 2245788899999886 567889999999999999998 5777765432111 0 000 011
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
. .. ........+.+++.+|++.+|++||++++|++.|+
T Consensus 225 ~--------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 Q--------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred C--------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 01112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=305.98 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=200.1
Q ss_pred hccccccccCceEEEEEEE-CCCC----EEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGT----QVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~----~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||+||+|.+ .+|+ .||+|+++.... ....++.+|+.++..++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence 3457899999999999985 3555 489999875433 3456788999999999999999999999754 5679999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.++++... ..+++.+++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 89 LMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999997643 36899999999999999999999 89999999999999999999999999999987653322
Q ss_pred cee-ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 HVS-TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
... ....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..+ +..+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~-------- 230 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDL----LEKGERL-------- 230 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCcC--------
Confidence 211 12234678999999988889999999999999999998 8888864331 112121 1121100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
..+......+.+++.+|+..+|++||++.++++.|+++...
T Consensus 231 -~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 -PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11122345688999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=307.35 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=198.9
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||+|+||+||+|... +|+.+|+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 467999999999999864 789999999865422 2234578899999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++........ ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 159 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IR 159 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--cc
Confidence 99999987655557999999999999999999999 89999999999999999999999999999876543221 12
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||.+.+..++.++|+||||++++||++|+.||....... ....+...+.+.. ..+...
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~~~----------~~~~~~ 227 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLETE----------EVYSAK 227 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhccc----------cccCcc
Confidence 3468999999999998889999999999999999999999997543211 1111111111110 011222
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
....+.+++..|++.+|++||+ +.+++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 3346789999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.75 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=201.2
Q ss_pred hccccccccCceEEEEEEECC-----------------CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD-----------------GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGY 635 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~ 635 (858)
.+.+.||+|+||.||+|...+ +..||+|++..... ...+++.+|++++++++|||+++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 445789999999999988542 24689999875533 345678999999999999999999999
Q ss_pred eeeCCeeEEEEeeccCCChHHHhhhcc---------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc
Q 043526 636 FIEDNNMGLIYEYMANGNLKQLLSDEK---------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT 706 (858)
Q Consensus 636 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~ 706 (858)
+..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeec
Confidence 999999999999999999999996543 126899999999999999999999 88999999999999999
Q ss_pred CCCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh--CCCccccCCCccccH
Q 043526 707 ENLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVIVRNENENIHI 783 (858)
Q Consensus 707 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt--G~~p~~~~~~~~~~l 783 (858)
.++.++|+|||+++........ ......++..|+|||.+....++.++|||||||+++||++ |..|+.... ....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--~~~~ 242 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--DQQV 242 (296)
T ss_pred CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--hHHH
Confidence 9999999999998765432211 1223345778999999988889999999999999999998 566765432 1122
Q ss_pred HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 784 IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 784 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+............. ..+.....++.+++.+|++.+|++||++.||++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22222211111111100 0112233578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=302.69 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEEC----CCCEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeee-CCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLD----DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-DNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~~ 650 (858)
+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+.+++.++|||++++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998643 23345678899999999999999999998764 556889999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce-
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV- 729 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~- 729 (858)
+|+|.+++.... ..+++..++.++.|+++||+||| +.+++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997543 34678888999999999999999 8899999999999999999999999999997653321111
Q ss_pred --eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCC-ccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 730 --STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA-VIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 730 --~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~-p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.....++..|+|||.+....++.++|||||||+++||++|+. |+.... ...+ .... ..+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~---~~~~-~~~~~~--------- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDI---TVYL-LQGRRL--------- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHH---HHHH-hcCCCC---------
Confidence 112345678999999988889999999999999999999654 454321 1111 1111 111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
..+......+.+++.+|+..+|++||++.|+++.|+++.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.32 Aligned_cols=249 Identities=30% Similarity=0.450 Sum_probs=197.6
Q ss_pred ccccccCceEEEEEEECC-------CCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYLDD-------GTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.||+|+||.||+|...+ ++.+|+|.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 23467889999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcc-----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-----CEEEeeecC
Q 043526 649 MANGNLKQLLSDEK-----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-----EAKLADFGL 718 (858)
Q Consensus 649 ~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-----~~kL~DFGl 718 (858)
+++++|.+++.... ...+++.+++.++.|++.||+||| +.+++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997542 234789999999999999999999 88999999999999999887 899999999
Q ss_pred cccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++........ ......++..|+|||.+.+..++.++|||||||+++||+| |+.||..... ......+ ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV----TAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH----hcCCc
Confidence 8765432211 1112345678999999998899999999999999999998 9998864321 1111111 11110
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+......+.+++.+|+..+|.+||++++|++.|++
T Consensus 232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 ---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01112234577899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.08 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=201.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|+||.||++... +++.+|+|.++.. .....+.+..|+.+++.++|+|++++++.+..++..++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 4578999999999999965 7899999998643 2334567888999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++...+.++.|++.||+||| +.+|+|+||||+||++++++.++++|||++........ ....
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 159 (255)
T cd08219 84 DLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACT 159 (255)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cccc
Confidence 9999987655567899999999999999999999 89999999999999999999999999999976643322 2223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|+..|+|||.+.+...+.++|+||||+++++|++|+.||..... ..... .+..+.... .+...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~-~~~~~~~~~---------~~~~~ 224 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLIL-KVCQGSYKP---------LPSHY 224 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHH-HHhcCCCCC---------CCccc
Confidence 4688899999999888899999999999999999999999864321 11111 111221111 11223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+++.+|+..+|++||++.|++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 3467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=320.76 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=206.0
Q ss_pred cccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHH
Q 043526 578 VLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 656 (858)
+||+|.+|+||.|+. ++...+|||-+..+..+..+-+.+|+.+.++++|.|||+++|.|.+++.+-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999995 4677899999998888888889999999999999999999999999999999999999999999
Q ss_pred HhhhcccCch--hHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeecCcccccCCCcceeecc
Q 043526 657 LLSDEKASTL--SWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 657 ~L~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
+|+..-+ ++ ++.+.-.+.+||++||.||| +..|||||||.+|||++ -.|.+||+|||-++.+..- +..+..+
T Consensus 662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHhccC-CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 9976542 44 67788888999999999999 89999999999999997 4689999999999987532 3455667
Q ss_pred cCCCCccCccccccC--CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 734 AGTPGYLDPEYFVTD--WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 734 ~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
.||..|||||.+..+ .|..++|||||||.+.||.||++||...+.... ++..+ |. .. .....+.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----AMFkV--Gm----yK--vHP~iPee 803 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----AMFKV--GM----YK--VHPPIPEE 803 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----hhhhh--cc----ee--cCCCCcHH
Confidence 899999999999854 688999999999999999999999976654321 11111 10 00 12334667
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
...+...++++|+.++|..||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7888999999999999999999999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=302.92 Aligned_cols=252 Identities=34% Similarity=0.526 Sum_probs=199.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchH--hHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFK--EFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||+||+++.. +++.+|+|++......... ....|+..+++++||||+++++++......++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 35678999999999999976 5678999999876543322 34569999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++.. ...+++.+++.++.|+++||++|| +.+|+|+||||+||++++++.++|+|||.+..... .....
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999973 346899999999999999999999 88999999999999999999999999999876421 22233
Q ss_pred ecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....++..|+|||.+. +...+.++||||+|+++++|++|+.|+..... .+........... ....... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~----~~~~~~~---~~ 226 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKR----PLPSSSQ---QS 226 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHT----HHHHHTT---SH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccc----ccccccc---cc
Confidence 4456889999999998 88899999999999999999999999876521 1111111111100 0000000 00
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++||++.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112678999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=306.20 Aligned_cols=246 Identities=24% Similarity=0.403 Sum_probs=195.9
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|+||.||+|.. .+++.||+|.+.... .....++..|++++.+++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 457899999999999985 478999999986542 333467889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|..+. .+++..+..++.|++.||+||| +.+|+|+||||+|||++.++.++|+|||++...... ....
T Consensus 85 ~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (279)
T cd06619 85 SLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152 (279)
T ss_pred ChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccC
Confidence 997653 4678888999999999999999 899999999999999999999999999999765322 1223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc--HHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH--IIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~--l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
..|+..|+|||.+.+..++.++||||||++++||++|+.||......... ........ .... .+.+ ...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~---~~~ 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDED-----PPVL---PVG 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hccC-----CCCC---CCC
Confidence 46889999999999888999999999999999999999998653321111 11111111 1110 0001 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
....++.+++.+|++.+|++||+++|++++-
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 2334678999999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.78 Aligned_cols=237 Identities=29% Similarity=0.381 Sum_probs=188.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHH-HHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVK-LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|+.. +|+.||+|++.... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 78999999986432 222344555554 57889999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|..++... ..+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9999888653 36788889999999999999999 8899999999999999999999999999987532211 1223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.... +..+. + ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~-i~~~~--------~--~~~~~ 218 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDN-ILHKP--------L--QLPGG 218 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHH-HhcCC--------C--CCCCC
Confidence 45689999999999988899999999999999999999999965431 111111 11111 0 11223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMN 835 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~ 835 (858)
....+.+++.+|++.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.25 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=200.9
Q ss_pred hccccccccCceEEEEEEEC--------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 643 (858)
.+.+.||+|+||.||++... ....+|+|.++... .....++..|+++++++ +||||+++++++..++..+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 45688999999999999742 34579999987543 23456788999999999 6999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 644 LIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
+||||+++|+|.+++.... ...++|.++++++.|++.||+||| +.+++||||||+|||+++++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCC
Confidence 9999999999999996532 235899999999999999999999 89999999999999999999
Q ss_pred CEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||...... .+
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~---- 245 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL---- 245 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH----
Confidence 99999999998664322111 111223467999999988889999999999999999999 88887543211 11
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
...+..+... ..+.....++.+++.+|+..+|++||++.|+++.|+++..
T Consensus 246 ~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111221111 1122234468899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.99 Aligned_cols=239 Identities=23% Similarity=0.323 Sum_probs=188.1
Q ss_pred cccccCceEEEEEEECC-------------------------CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeee
Q 043526 578 VLGKGGFGTVYHGYLDD-------------------------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 632 (858)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13589999876544445678889999999999999999
Q ss_pred eeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---
Q 043526 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL--- 709 (858)
Q Consensus 633 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~--- 709 (858)
+++|.++...++||||+++|+|..++.... ..+++..+++++.|+++||+||| +.+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986533 36889999999999999999999 88999999999999998654
Q ss_pred ----CEEEeeecCcccccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHH-hCCCccccCCCccccH
Q 043526 710 ----EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEII-TSQAVIVRNENENIHI 783 (858)
Q Consensus 710 ----~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~Ell-tG~~p~~~~~~~~~~l 783 (858)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+ .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 3799999987643221 12346788999998865 56889999999999999995 6888886543211 1
Q ss_pred HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 784 IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 784 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
... .... . ..+......+.+++.+|++.+|++||++++|++.|.
T Consensus 231 ~~~----~~~~---------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERF----YEKK---------H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH----HHhc---------c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 1110 0 011111236889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=301.57 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=190.2
Q ss_pred ccccccCceEEEEEEECCCC-----------EEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 577 KVLGKGGFGTVYHGYLDDGT-----------QVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999975432 5788887655433 6788999999999999999999999988 778999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-------CEEEeeecC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-------EAKLADFGL 718 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-------~~kL~DFGl 718 (858)
|||+++|+|.+++..... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976542 6889999999999999999999 89999999999999999888 799999999
Q ss_pred cccccCCCcceeecccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHhC-CCccccCCCccccHHHHHHHHHhcCC
Q 043526 719 SKVFPIGGTHVSTVVAGTPGYLDPEYFVTD--WLNEKSDVYSFGVVLLEIITS-QAVIVRNENENIHIIQTVTNMIAKGD 795 (858)
Q Consensus 719 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ElltG-~~p~~~~~~~~~~l~~~v~~~~~~~~ 795 (858)
+..... .....++..|+|||++... .++.++||||||++++||++| ..|+....... +.... ....
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----~~~~~-~~~~ 223 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----KERFY-QDQH 223 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----HHHHH-hcCC
Confidence 886543 2223467789999998866 789999999999999999994 66665432111 11110 0000
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
..+......+.+++.+|+..+|.+||++.||++.|+
T Consensus 224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001111257889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=314.22 Aligned_cols=239 Identities=24% Similarity=0.398 Sum_probs=191.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
++.+.||+|+||.||+|... +|+.||+|++... .....+.+..|.+++..+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45688999999999999864 7899999998753 2233456778888888885 57788899999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++... ..+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 83 VNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 9999999998654 36899999999999999999999 89999999999999999999999999999875432221
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......|++.|+|||.+.+..++.++|||||||+++||++|+.||..... ..+.+.+ .++.. .+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i----~~~~~----------~~ 220 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSI----MEHNV----------SY 220 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCC----------CC
Confidence 22334689999999999988899999999999999999999999975431 1111111 11110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
+.....++.+++.+|++.+|.+|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 22234567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.49 Aligned_cols=240 Identities=21% Similarity=0.353 Sum_probs=190.6
Q ss_pred ccccccCceEEEEEEEC-C-------CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYLD-D-------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~-------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.||+|+||.||+|... . ...+|+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999863 2 235888888665555557789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC--------EEEeeecCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE--------AKLADFGLSK 720 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~--------~kL~DFGla~ 720 (858)
+++|+|.++++... ..+++..+++++.||+.||+||| +.+|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997654 36899999999999999999999 899999999999999987765 6999999886
Q ss_pred cccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCC-CccccCCCccccHHHHHHHHHhcCCchh
Q 043526 721 VFPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQ-AVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 721 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~-~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+....... ... ....
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~~~-~~~~----- 220 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----KLQ-FYED----- 220 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----HHH-HHHc-----
Confidence 5432 122457889999999976 45789999999999999999995 4443222110 000 0000
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
....+.....++.+++.+|++.+|++||+++++++.|+
T Consensus 221 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112223356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.81 Aligned_cols=243 Identities=25% Similarity=0.430 Sum_probs=198.2
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.||+|+||.||+|... +|+.||+|.+.... ....+.+..|++++++++||||+++++++..++..++||||+++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 467999999999999864 68899999987443 3345678899999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.. ..+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++|+|||++........ .....
T Consensus 89 L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06642 89 ALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhcc
Confidence 9999854 35889999999999999999999 89999999999999999999999999999976543221 12234
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.|+..|+|||++.+..++.++|||||||+++||++|+.|+....... ... .+..+. .........
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~ 226 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLF----LIPKNS---------PPTLEGQYS 226 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHh----hhhcCC---------CCCCCcccC
Confidence 57889999999998889999999999999999999999986432111 111 111111 011122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.+++.+|++.+|++||+|.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 578899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=316.70 Aligned_cols=241 Identities=28% Similarity=0.367 Sum_probs=189.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHH-HHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEV-KLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 67889999987432 12233444444 356788999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.... .+.+.+...++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 99999996543 5778888899999999999999 8999999999999999999999999999987543221 1223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|++.|+|||.+.+..++.++|||||||+++||++|+.||...... .... ... ... + .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~---~i~-~~~--------~--~~~~~ 218 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYD---NIL-NKP--------L--QLKPN 218 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHH---HHH-hCC--------c--CCCCC
Confidence 456899999999999989999999999999999999999999753311 1111 111 110 0 11122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
....+.+++.+|++.+|.+||++.+.+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 3456789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.93 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=203.5
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||.||.++. ++++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 3457899999999999884 47899999998654 23445778999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++.......+++.++..++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~ 158 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MA 158 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cc
Confidence 999999998765567899999999999999999999 88999999999999999999999999999987644332 22
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|+..|+|||...+...+.++||||||++++||++|+.||..... .+..... ..+.... .+.
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~-~~~~~~~---------~~~ 223 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKI-VQGNYTP---------VVS 223 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH-HcCCCCC---------Ccc
Confidence 334688999999999888889999999999999999999999864321 1111111 1111111 112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
....++.+++.+|+..+|.+||+++|+++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2345688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.90 Aligned_cols=246 Identities=23% Similarity=0.380 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
..||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999954 68899999988766666778999999999999999999999999999999999999999999
Q ss_pred HHhhhcccCch--hHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccccCCCcceeec
Q 043526 656 QLLSDEKASTL--SWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 656 ~~L~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
++++... ..+ ++..+..++.|++.||+||| +.+|+||||||+||+++. ++.++|+|||++........ ....
T Consensus 94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9997543 234 78889999999999999999 899999999999999986 67899999999876543221 1223
Q ss_pred ccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 733 VAGTPGYLDPEYFVTD--WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
..|+..|+|||++... .++.++||||||++++||++|+.|+......... .+...... .....+.
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~~~-----------~~~~~~~ 235 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGMFK-----------IHPEIPE 235 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhhhc-----------cCCCCCc
Confidence 4578899999998654 3788999999999999999999998643321111 11000000 0011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....++.+++.+|++.+|.+||+++|++++
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 334568899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.92 Aligned_cols=248 Identities=26% Similarity=0.417 Sum_probs=200.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC-CeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-NNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~ 649 (858)
.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+... ...++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 45678999999999999965 67899999986543 23456788999999999999999999987644 4578999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.......+++.++..++.|++.|+++|| +.+++||||||+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 158 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M 158 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence 9999999998765567899999999999999999999 88999999999999999999999999999987643322 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....+++.|+|||...+..++.++||||||++++||++|+.||..... ...... +..+... ..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~-~~~~~~~---------~~~ 223 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYR-IIEGKLP---------PMP 223 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH-HHhcCCC---------CCc
Confidence 2334578899999999988899999999999999999999999864321 111111 1122111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.79 Aligned_cols=249 Identities=31% Similarity=0.492 Sum_probs=201.4
Q ss_pred ccccccccCceEEEEEEECC-----CCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLDD-----GTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.||+|+||.||++...+ +..||+|++...... ..+.+..|++.+..++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 34689999999999999753 488999999765443 567899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++++|.+++.......+++.++..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 99999999997655433899999999999999999999 889999999999999999999999999999876544222
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......++..|+|||.+.+..++.++||||+|++++||++ |..|+.... ...+.+. +..+... .
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~----~~~~~~~---------~ 224 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEY----LKKGYRL---------P 224 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH----HhcCCCC---------C
Confidence 2222336789999999988889999999999999999999 777775422 1111111 1111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.+.....++.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112345788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.31 Aligned_cols=250 Identities=23% Similarity=0.409 Sum_probs=198.2
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 3447899999999999985 478999999997665555667889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... .+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++...... ......
T Consensus 92 ~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~ 165 (267)
T cd06645 92 SLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKS 165 (267)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccccc
Confidence 9999986543 6899999999999999999999 889999999999999999999999999998765322 112233
Q ss_pred ccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 733 VAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 733 ~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
..|+..|+|||.+. ...++.++|||||||+++||++|+.|+....... .+.. .. .... ..+.+.. .
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~----~~-~~~~---~~~~~~~--~ 234 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFL----MT-KSNF---QPPKLKD--K 234 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHh----hh-ccCC---CCCcccc--c
Confidence 46899999999874 4567899999999999999999999986433211 1100 00 0000 0000100 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1123457899999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=299.45 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=189.4
Q ss_pred cccccCceEEEEEEECC---CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 578 VLGKGGFGTVYHGYLDD---GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|++.++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 35688888764432 334578899999999999999999999999999999999999999
Q ss_pred hHHHhhhccc---CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-e
Q 043526 654 LKQLLSDEKA---STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-V 729 (858)
Q Consensus 654 L~~~L~~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 729 (858)
|.+++..... ...++...+.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976542 33568888999999999999999 889999999999999999999999999998754332211 1
Q ss_pred eecccCCCCccCccccc-------cCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 730 STVVAGTPGYLDPEYFV-------TDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~-------~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
.....++..|+|||+.. ....+.++|||||||+++||++ |..||....... .....+.++. ..+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~~-~~~~~ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-----VLKQVVREQD-IKLPK 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhhccC-ccCCC
Confidence 12234567899999874 2356789999999999999999 677775433211 1112122211 11112
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
+.+ +......+.+++..|+ .+|++||+++||++.|.
T Consensus 233 ~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 PQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Ccc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 221 2223345667888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.21 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=198.1
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHh--cccceeeeeeeeeeeCC----eeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMR--VHHRNLTNLVGYFIEDN----NMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~----~~~lV~E 647 (858)
.+.+.||+|.||.||+|.| .|+.||||++...++ +.+.+|.++.+. ++|+||+.+++.=..++ .++||++
T Consensus 214 ~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 3457899999999999999 588999999986654 445666766655 59999999998765443 5889999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhc-----CCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI-----GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
|.+.|||+|+|.. .+++-...++++..+|.||++||. ..++.|.|||||++|||+..++.+.|+|+|||...
T Consensus 290 YHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred cccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999999975 368999999999999999999994 35788999999999999999999999999999987
Q ss_pred cCCCcc---eeecccCCCCccCccccccCC----C--CCchhHHHHHHHHHHHHhCC----------CccccCCCccccH
Q 043526 723 PIGGTH---VSTVVAGTPGYLDPEYFVTDW----L--NEKSDVYSFGVVLLEIITSQ----------AVIVRNENENIHI 783 (858)
Q Consensus 723 ~~~~~~---~~~~~~gt~~y~APE~~~~~~----~--s~ksDVwSfGvll~ElltG~----------~p~~~~~~~~~~l 783 (858)
+..... .....+||.+|||||++.... + -..+||||||.++||+.-.. .||.+.-....++
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 655332 234568999999999986432 1 14589999999999997421 3443322111111
Q ss_pred HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 784 IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 784 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+.++..+--..+...++..+ .+.+.+..+.++++.||..+|.-|.|+--+.+.|.++.+
T Consensus 447 -eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 447 -EEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred -HHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11111111111111122222 134678889999999999999999999999999998764
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.92 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=204.2
Q ss_pred HHhhccccccccCceEEEEEEEC--------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCC
Q 043526 571 ITDNFNKVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDN 640 (858)
Q Consensus 571 ~t~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 640 (858)
....+.+.||+|+||.||++... .+..||+|.+.... ....+++.+|+++++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 34566789999999999999742 12368999887543 23457889999999999 7999999999999999
Q ss_pred eeEEEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc
Q 043526 641 NMGLIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT 706 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~ 706 (858)
..++++||+++|+|.+++.... ...++|.+++.++.|++.||+||| +.+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999997532 235889999999999999999999 89999999999999999
Q ss_pred CCCCEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHH
Q 043526 707 ENLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHII 784 (858)
Q Consensus 707 ~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~ 784 (858)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||..... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence 99999999999998654322111 112233567999999998889999999999999999998 7888754321 1
Q ss_pred HHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 785 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
.... .+..+... ..+.....++.+++.+|++.+|++||++.|+++.|+++....
T Consensus 244 ~~~~-~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELFK-LLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHH-HHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111 11111111 111223457889999999999999999999999999977443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=336.05 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=201.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||+|... +|+.||||++..... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 4578999999999999965 689999999975422 234678999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcc---------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 651 NGNLKQLLSDEK---------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 651 ~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
+|+|.+++.... ...+++..+++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 999999986421 234667888999999999999999 88999999999999999999999999999987
Q ss_pred ccCCCc-----------------ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHH
Q 043526 722 FPIGGT-----------------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII 784 (858)
Q Consensus 722 ~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~ 784 (858)
...... .......||+.|+|||.+.+..++.++|||||||+++||+||+.||...........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~ 242 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh
Confidence 621110 011124689999999999999999999999999999999999999965322111000
Q ss_pred HHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHH
Q 043526 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERP-NMNEVVTELKECLMM 847 (858)
Q Consensus 785 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~ 847 (858)
.. ..++.-. ....+....+.+++.+|++.+|++|| +++++.+.|+..++.
T Consensus 243 ----~~--------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 243 ----DV--------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ----hh--------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0000000 00112334678999999999999995 678888888887653
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.72 Aligned_cols=259 Identities=28% Similarity=0.424 Sum_probs=198.9
Q ss_pred hccccccccCceEEEEEEEC-----------------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-----------------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGY 635 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 635 (858)
.+.+.||+|+||.||++... ++..+|+|+++... .....++.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 44578999999999998532 24569999997543 3345678999999999999999999999
Q ss_pred eeeCCeeEEEEeeccCCChHHHhhhcc---------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc
Q 043526 636 FIEDNNMGLIYEYMANGNLKQLLSDEK---------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT 706 (858)
Q Consensus 636 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~ 706 (858)
+..++..++||||+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVG 164 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEEc
Confidence 999999999999999999999997543 124778899999999999999999 88999999999999999
Q ss_pred CCCCEEEeeecCcccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh--CCCccccCCCccccH
Q 043526 707 ENLEAKLADFGLSKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT--SQAVIVRNENENIHI 783 (858)
Q Consensus 707 ~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt--G~~p~~~~~~~~~~l 783 (858)
+++.++|+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++ |..|+..... ...
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--~~~ 242 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--EQV 242 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--HHH
Confidence 99999999999998654332211 112234578999999888889999999999999999998 6677754321 111
Q ss_pred HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 784 IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 784 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
................. ..+......+.+++.+|++.+|++||++.||++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111000000 0112234578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.77 Aligned_cols=196 Identities=24% Similarity=0.418 Sum_probs=161.1
Q ss_pred cccccccCceEEEEEEEC---CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ 650 (858)
.+.||+|+||+||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 56789999986542 23567889999999999999999998864 456889999986
Q ss_pred CCChHHHhhhcc-------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE----cCCCCEEEeeecCc
Q 043526 651 NGNLKQLLSDEK-------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL----TENLEAKLADFGLS 719 (858)
Q Consensus 651 ~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl----~~~~~~kL~DFGla 719 (858)
+ +|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 8888875322 235889999999999999999999 8999999999999999 45678999999999
Q ss_pred ccccCCCcc--eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCC
Q 043526 720 KVFPIGGTH--VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777 (858)
Q Consensus 720 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~ 777 (858)
+........ ......||+.|+|||.+.+ ..++.++||||+||+++||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876432211 1234568999999999876 458899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.19 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=199.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.+.||+|++|.||+|... +++.+|+|.+..... .+++.+|++.+++++|||++++++++..+...++++||+++++
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4577999999999999976 489999999875533 6789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........ .....
T Consensus 85 L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 159 (256)
T cd06612 85 VSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNTV 159 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccccc
Confidence 999986533 46899999999999999999999 88999999999999999999999999999987654321 22334
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.|+..|+|||.+.+..++.++||||||++++||++|+.|+........ +.. ..... ...+. .+....
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~-~~~~~-----~~~~~--~~~~~~ 226 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFM-IPNKP-----PPTLS--DPEKWS 226 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhh-hccCC-----CCCCC--chhhcC
Confidence 578899999999888899999999999999999999999865332110 000 00000 00000 111223
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.+++.+|++.+|++||+++|++++
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 468899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=322.81 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=191.3
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++.+..++..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 357899999999999996 478999999987532 2234578889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC----
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---- 726 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~---- 726 (858)
+|+|.+++... ..+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 85 GGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999654 36788899999999999999999 8899999999999999999999999999975321000
Q ss_pred ------------------------------------------cceeecccCCCCccCccccccCCCCCchhHHHHHHHHH
Q 043526 727 ------------------------------------------THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLL 764 (858)
Q Consensus 727 ------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ 764 (858)
........||+.|+|||.+.+..++.++|||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00011246899999999999888999999999999999
Q ss_pred HHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043526 765 EIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN---MNEVVTE 840 (858)
Q Consensus 765 ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~~ 840 (858)
||++|+.||....... ......... ..+..........++.+++.+|+ .+|++|++ ++|++++
T Consensus 240 elltG~~Pf~~~~~~~-----~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 240 EMLVGQPPFLAQTPLE-----TQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHhCCCCCCCCCHHH-----HHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999997543211 111111100 00000011122345667776654 59999997 7877764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.23 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=199.0
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
..+.||+|+||.||+|... ++..||+|++..... ....++.+|++++++++||||+++++++..++..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 3478999999999999863 467899999875432 334678999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcc--------------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC
Q 043526 648 YMANGNLKQLLSDEK--------------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE 707 (858)
Q Consensus 648 y~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~ 707 (858)
|+++|+|.+++.... ...+++.+++.++.|++.||+||| +.+++||||||+||++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEecC
Confidence 999999999996432 124788999999999999999999 889999999999999999
Q ss_pred CCCEEEeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHH
Q 043526 708 NLEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQ 785 (858)
Q Consensus 708 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~ 785 (858)
++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||+++||++ |..||.....+ +
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-----~ 240 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-----E 240 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence 99999999999876532211 11112234567999999988889999999999999999998 77787543211 1
Q ss_pred HHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 786 TVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
... .+..+.... .+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 241 ~~~-~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIY-YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 122222110 112234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=322.69 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=193.0
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 3578999999999999854 7899999998643 22334678889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc--
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-- 728 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-- 728 (858)
+|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 85 GGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999654 36888999999999999999999 899999999999999999999999999998643210000
Q ss_pred --------------------------------------------eeecccCCCCccCccccccCCCCCchhHHHHHHHHH
Q 043526 729 --------------------------------------------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLL 764 (858)
Q Consensus 729 --------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ 764 (858)
......||+.|+|||.+.+..++.++|||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 001245899999999999888999999999999999
Q ss_pred HHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 043526 765 EIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSER---PNMNEVVTE 840 (858)
Q Consensus 765 ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~eVl~~ 840 (858)
||++|+.||...... .. ......... .+.-........++.+++.+|+. +|.+| +++.|++++
T Consensus 240 elltG~~Pf~~~~~~--~~---~~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 240 ECLIGWPPFCSENSH--ET---YRKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhcCCCCCCCCCHH--HH---HHHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999653321 11 111111000 00000011234567899999997 66665 599998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.43 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=194.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|..++..++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 34578999999999999965 6899999998642 2223456888999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 84 ~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999653 246889999999999999999999 8999999999999999999999999999987665443333
Q ss_pred eecccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 730 STVVAGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
.....||+.|+|||.+.. ..++.++|||||||++|||++|+.||..... .+.............+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~--- 231 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQFPP--- 231 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCcccCCC---
Confidence 334568999999999863 4578899999999999999999999964321 111111111111000000
Q ss_pred cCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASR--TSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|++. ++..||++++++++
T Consensus 232 ---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0111334567777776654 33448899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.88 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=198.1
Q ss_pred ccccccccCceEEEEEEECC--CCEEEEEEeccCC----------CcchHhHHHHHHHHHh-cccceeeeeeeeeeeCCe
Q 043526 575 FNKVLGKGGFGTVYHGYLDD--GTQVAVKMLSSSS----------GQGFKEFEAEVKLLMR-VHHRNLTNLVGYFIEDNN 641 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~----------~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~ 641 (858)
+.+.||+|+||.||+|..+. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+++.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 34679999999999999764 7889999885321 2234557778887765 799999999999999999
Q ss_pred eEEEEeeccCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 642 MGLIYEYMANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
.++||||+++++|.+++... ....+++..+++++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999988542 24468899999999999999999992 268999999999999999999999999999
Q ss_pred ccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh
Q 043526 720 KVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 720 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~ 799 (858)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... +.++.....
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~~~ 233 (269)
T cd08528 162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATK-IVEAVYEPL 233 (269)
T ss_pred eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHH-HhhccCCcC
Confidence 8754432 22345688899999999988899999999999999999999999864321 111111 111111100
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
........+.+++.+|++.+|++||++.|+.+++++
T Consensus 234 --------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 234 --------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred --------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 011223568899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=321.81 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=209.9
Q ss_pred cccccccCceEEEEEEE-CCCC----EEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGT----QVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~----~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.++||+|+||+||||.| ..|+ +||+|++.... .+...++++|+-.|.+++|||+++++|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 57899999999999985 4454 68999987654 446789999999999999999999999998876 77999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+.|+|.++++.++ ..+.-...+.|..|||+||.||| .+.++||||.++|||+.+...+||.|||+++.+..++...
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998866 46788889999999999999999 8999999999999999999999999999999987665544
Q ss_pred eec-ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 730 STV-VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 730 ~~~-~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
... ..-.+.|||-|.+....++.++|||||||.+||++| |..|++....++ +...++.| .+-.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle~g---------eRLs 920 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLEKG---------ERLS 920 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHhcc---------ccCC
Confidence 332 233567999999999999999999999999999998 889987654222 22222222 1112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
-++-....+..++.+||..|+..||+++++...+.++...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2455677889999999999999999999999999886543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.80 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=201.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||+||++... +|+.+|+|++.... ....+++.+|+++++.++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCC
Confidence 34478999999999999964 78999999886543 33457889999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++... ..+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++....... ..
T Consensus 88 ~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~ 160 (284)
T cd06620 88 GSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---AD 160 (284)
T ss_pred CCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cC
Confidence 9999998654 368999999999999999999993 2589999999999999999999999999987543221 12
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc------ccHHHHHHHHHhcCCchhhhchhhc
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN------IHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~------~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
...|+..|+|||.+.+...+.++|+|||||+++||+||+.||....... ..+..+......+.. +.+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~- 233 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRL- 233 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------CCC-
Confidence 3468899999999988889999999999999999999999997543211 111222222211110 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
........+.+++.+|++.+|++||+++|++++.
T Consensus 234 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 --PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0112345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.65 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=199.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||.|++|.||+|... +|+.||+|.+.... ......+.+|+++++.++|+|++++++++..+...++|+||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 3467999999999999965 78999999987543 344567889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... .+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||+++...... .....
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (274)
T cd06609 85 SCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNT 157 (274)
T ss_pred cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccccc
Confidence 999999754 6899999999999999999999 8899999999999999999999999999998775432 12233
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..++..|+|||++.+..++.++||||||+++|||+||+.||..... . ... ..+..+....+. .. ..
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~---~~~-~~~~~~~~~~~~-----~~---~~ 223 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--M---RVL-FLIPKNNPPSLE-----GN---KF 223 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--H---HHH-HHhhhcCCCCCc-----cc---cc
Confidence 4678899999999988899999999999999999999999864331 1 111 111111111111 00 02
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+++.+|+..+|++||++++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 3467899999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.46 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=201.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|+||.+|++... +|+.||+|.+... .....+++.+|++++++++||||+++.+++...+..++|+||+++
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 4578999999999999854 7899999998643 233456789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.......+++.++++++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~ 159 (256)
T cd08218 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-AR 159 (256)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-hh
Confidence 99999997655556889999999999999999999 889999999999999999999999999999765432211 22
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||...+...+.++|+|||||+++||++|+.|+..... ...+.... .+... ..+..
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~-~~~~~---------~~~~~ 224 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKII-RGSYP---------PVSSH 224 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHh-cCCCC---------CCccc
Confidence 34578899999999988899999999999999999999999864321 11121111 11110 11223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.+++.+|++.+|.+||+|.||+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 34568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.80 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=202.4
Q ss_pred hccccccccCceEEEEEEEC-CCC----EEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGT----QVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||.||+|... +|+ .+|+|.+..... ....++.+|++.+++++||||++++++|.. ...++|||
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 44578999999999999864 343 589998875543 344678899999999999999999999987 78899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 89 LMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999997654 35899999999999999999999 89999999999999999999999999999987654332
Q ss_pred cee-ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 HVS-TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
... ....++..|+|||.+....++.++|+||||++++|+++ |+.||.....+ ++. ..+..+..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~--------- 229 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIP----DLLEKGER--------- 229 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHH----HHHhCCCC---------
Confidence 221 11223568999999988889999999999999999999 99998654311 111 12222110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+......+.+++.+|+..+|.+||++.++++.|+++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 011122334678999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=323.27 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=193.0
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+++.. +|+.||||++.... ......+.+|++++++++||||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999954 78999999986432 2234668889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC----
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---- 726 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~---- 726 (858)
+|+|.+++.... .+++.....++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 85 GGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 999999996543 6788889999999999999999 8999999999999999999999999999975331000
Q ss_pred --------------------------------------cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh
Q 043526 727 --------------------------------------THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768 (858)
Q Consensus 727 --------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt 768 (858)
........||+.|+|||.+.+..++.++|||||||+++||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000112468999999999998889999999999999999999
Q ss_pred CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 043526 769 SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERP---NMNEVVTE 840 (858)
Q Consensus 769 G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---sm~eVl~~ 840 (858)
|+.||......+ ..... .... .. +...........+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 240 G~~Pf~~~~~~~-----~~~~i-~~~~-~~-----~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAE-----TQLKV-INWE-TT-----LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHH-----HHHHH-hccC-cc-----ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999997543211 11111 1100 00 000011122345667777765 5999999 88998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.81 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=195.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 34578999999999999965 788999999875432 3345678899999999999999999999999999999999985
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 89 -~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 162 (309)
T cd07872 89 -DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYS 162 (309)
T ss_pred -CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccc
Confidence 8888876543 35789999999999999999999 89999999999999999999999999999876533221 122
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---chhh------hc
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IENI------VD 801 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~~~------~d 801 (858)
...++..|+|||.+.+ ..++.++|||||||+++||+||+.||....... ....+........ ...+ .+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 3457889999998864 567899999999999999999999996543211 1111111111000 0000 00
Q ss_pred hhhcCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGG-------FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...... .......++.+++.+|++.||.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 001224467899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.86 Aligned_cols=244 Identities=29% Similarity=0.495 Sum_probs=196.9
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|.. +++.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||+++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 4567899999999999975 67889999986542 346789999999999999999999998654 4789999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......+++.++++++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 157 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DNS 157 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CCC
Confidence 999997765556899999999999999999999 8999999999999999999999999999987643221 112
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..+..|+|||.+.+..++.++|+||||++++||++ |+.||......+ . ......+. ........
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~---------~~~~~~~~ 222 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V----KECVEKGY---------RMEPPEGC 222 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H----HHHHhCCC---------CCCCCCcC
Confidence 23567999999988889999999999999999998 888886543211 1 11111111 01111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+.+++.+|++.+|++||+++++++.|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 4567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.01 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=199.5
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccce-eeeeeeeeeeCC------eeEEEE
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRN-LTNLVGYFIEDN------NMGLIY 646 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~------~~~lV~ 646 (858)
+.||+|+||+||+|+. .+|+.||+|+++.... .......+|+.++++++|+| |+.+.+++...+ .+++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 4599999999999994 5899999999986543 34566789999999999999 999999999877 788999
Q ss_pred eeccCCChHHHhhhccc--CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 647 EYMANGNLKQLLSDEKA--STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||++. +|..++..... ..++...+..++.||++||+||| +++|+||||||+||||+++|.+||+|||+|+....
T Consensus 97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 99987 99999977653 35666889999999999999999 99999999999999999999999999999997753
Q ss_pred CCcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH---hcCCchhh-
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI---AKGDIENI- 799 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~---~~~~~~~~- 799 (858)
.... .+...+|..|.|||.+.+. .++...||||+||++.||+++++.|.+... .+....+-..+ .+..+..+
T Consensus 173 p~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 173 PMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred Cccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCccCCCCcc
Confidence 3322 2334578999999999865 799999999999999999999888866543 11111121111 11111111
Q ss_pred --hchh--hcCCC---CH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 --VDSC--LRGGF---EI-----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 --~d~~--l~~~~---~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+-. ..... +. .......+++.+|++.+|.+|.|++.++++
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 00000 00 112367899999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=298.07 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=188.8
Q ss_pred cccccCceEEEEEEECCC---CEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 578 VLGKGGFGTVYHGYLDDG---TQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985443 346677766443 2345789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC-ccee
Q 043526 654 LKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVS 730 (858)
Q Consensus 654 L~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~-~~~~ 730 (858)
|.++++... ...+++.....++.||++||+||| +.+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997643 234667788899999999999999 8899999999999999999999999999986432111 1112
Q ss_pred ecccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHhC-CCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 731 TVVAGTPGYLDPEYFVT-------DWLNEKSDVYSFGVVLLEIITS-QAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~ElltG-~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
....++..|+|||++.. ...+.++|||||||+++||+++ ..|+..... .......+.+ ....+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~~-~~~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIKD-QQVKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhh-cccccCCC
Confidence 23457889999998743 2457899999999999999975 556643221 1122222222 12223333
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
.+... ....+.+++..|+ .+|++||++++|++.|.
T Consensus 233 ~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33222 2345677888999 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=323.90 Aligned_cols=255 Identities=20% Similarity=0.344 Sum_probs=189.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC--------CeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--------NNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~~~l 644 (858)
.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...++
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 34578999999999999964 78999999885432 2345799999999999999999887432 23678
Q ss_pred EEeeccCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCccc
Q 043526 645 IYEYMANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKV 721 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~ 721 (858)
||||+++ +|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999985 777776532 2456899999999999999999999 89999999999999999664 799999999987
Q ss_pred ccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh--
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN-- 798 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~-- 798 (858)
+..... .....|++.|+|||.+.+ ..++.++|||||||+++||++|.+||...... ..+... ...........
T Consensus 221 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i-~~~~~~p~~~~~~ 296 (440)
T PTZ00036 221 LLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRI-IQVLGTPTEDQLK 296 (440)
T ss_pred ccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH-HHHhCCCCHHHHH
Confidence 643322 223467999999998865 46899999999999999999999999654321 111111 11111000000
Q ss_pred -------------hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 -------------IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 -------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+....+...++.....++.+++.+|++.+|.+|||+.|++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000011111122234578899999999999999999999865
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.25 Aligned_cols=247 Identities=30% Similarity=0.388 Sum_probs=207.3
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|.-|+||.+.++ ++..+|+|++.+.. .....+.+.|-++|+.+.||.+..|++.++.++..|+|||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 67999999999999986 46899999997653 334567788999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC--------
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-------- 724 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~-------- 724 (858)
+|..+++.+..+.+++..+..++.+++-||+||| ..|||.|||||+||||-++|.+-|+||.|+.....
T Consensus 163 dL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 163 DLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred cHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 9999999888899999999999999999999999 99999999999999999999999999998764311
Q ss_pred -------------------------CCc----------------------ceeecccCCCCccCccccccCCCCCchhHH
Q 043526 725 -------------------------GGT----------------------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVY 757 (858)
Q Consensus 725 -------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVw 757 (858)
... ..+..++||-.|+|||++.+...+.+.|.|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW 319 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW 319 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence 000 011235789999999999999999999999
Q ss_pred HHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC----
Q 043526 758 SFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN---- 833 (858)
Q Consensus 758 SfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---- 833 (858)
+|||++|||+.|+.||.+..+++ .+..++-..+.-....+.+..+.+||.+.|.+||.+|.-
T Consensus 320 tfGIflYEmLyG~TPFKG~~~~~--------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 320 TFGIFLYEMLYGTTPFKGSNNKE--------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred HHHHHHHHHHhCCCCcCCCCchh--------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 99999999999999998766432 123333333333333456778899999999999999998
Q ss_pred HHHHHHH
Q 043526 834 MNEVVTE 840 (858)
Q Consensus 834 m~eVl~~ 840 (858)
++||-++
T Consensus 386 A~eIK~H 392 (459)
T KOG0610|consen 386 AAEIKRH 392 (459)
T ss_pred hHHhhcC
Confidence 6776553
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.24 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=195.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 44578999999999999965 7889999998642 2223456788999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++... .++...+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 126 ~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 126 PGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 999999998653 4788888999999999999999 8999999999999999999999999999998765433333
Q ss_pred eecccCCCCccCccccccC----CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 730 STVVAGTPGYLDPEYFVTD----WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~----~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.....||+.|+|||.+... .++.++|||||||++|||++|+.||..... ...............+
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~------ 268 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKNSLTF------ 268 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCcccC------
Confidence 3455799999999998653 378999999999999999999999975431 1111111111110000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSE--RPNMNEVVTEL 841 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~L 841 (858)
.........+.+++..|+..++.+ ||+++|++++.
T Consensus 269 -~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 -PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 011123456788999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.29 Aligned_cols=246 Identities=21% Similarity=0.369 Sum_probs=199.7
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
...+.||+|++|.||+|.. .+|+.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 3457899999999999995 589999999997665555677889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... .+++.++..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++........ ....
T Consensus 102 ~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 174 (297)
T cd06656 102 SLTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (297)
T ss_pred CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence 999998643 4789999999999999999999 88999999999999999999999999999876543322 1223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..+++.|+|||.+.+..++.++|+|||||++++|++|+.||.......... .....+ .. .+ ..+...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~-~~-----~~--~~~~~~ 241 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG-TP-----EL--QNPERL 241 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCC-CC-----CC--CCcccc
Confidence 457889999999998889999999999999999999999996533211100 000000 00 00 011223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
...+.+++.+|+..+|++||+++++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 345779999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.69 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=197.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+.||+|+||.||+|... ++..+|+|.+........+.+..|+++++.++|||++++++++..++..++|+||+++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l 89 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 89 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence 467999999999999965 6788999998766555667889999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
..++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++....... .......
T Consensus 90 ~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 164 (282)
T cd06643 90 DAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI 164 (282)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccccc
Confidence 99886532 46899999999999999999999 8899999999999999999999999999987653221 1223346
Q ss_pred CCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 735 GTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 735 gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
++..|+|||++. ...++.++|||||||++|||++|++||...... ..+........ .... .+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~-------~~ 231 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEP-PTLA-------QP 231 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhhcCC-CCCC-------Cc
Confidence 889999999874 345778999999999999999999998643211 11111111100 0000 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|+..+|.+||++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223468899999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=306.21 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=198.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|+||.||++... +|..+|+|.+..... ....++.+|++++++++||||+++++++..++..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 3478999999999999965 788999999875432 23456889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.++++.. ..+++..+..++.|+++||+|||+ ..+++||||||+|||+++++.+||+|||++....... ...
T Consensus 85 ~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 85 SLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 999999754 468899999999999999999993 2589999999999999999999999999987653221 223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC-----------------
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD----------------- 795 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~----------------- 795 (858)
..|+..|+|||.+.+..++.++||||||++++||++|+.||...... ....+.........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCCccc
Confidence 46789999999998888899999999999999999999998543211 11111110000000
Q ss_pred ---chhhhchhhcCC---C-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 796 ---IENIVDSCLRGG---F-EIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 796 ---~~~~~d~~l~~~---~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
..+..+...... . ......++.+++.+|+..+|++||+++|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000111100000 0 011234688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=298.18 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=202.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++.+++++||||+++++.+..++..++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 3467999999999999976 68999999987653 334567899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... ..+++.....++.|+++||+||| + .+++|+||||+||++++++.++|+|||.+.........
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--- 157 (265)
T cd06605 85 SLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--- 157 (265)
T ss_pred cHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---
Confidence 9999997653 57889999999999999999999 7 89999999999999999999999999998765322111
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+...........+.+........ . ..+..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~ 227 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-P---------RLPSG 227 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-C---------CCChh
Confidence 1567889999999998899999999999999999999999987543222222233222221110 0 01111
Q ss_pred -HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 812 -SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 812 -~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...++.+++.+|+..+|++||++.+++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 34568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=304.92 Aligned_cols=246 Identities=21% Similarity=0.385 Sum_probs=200.2
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..+.||.|++|.||+|.. .+|+.||+|.+........+.+.+|++.++.++|||++++++++...+..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 346899999999999985 5799999999976655566788999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++... .+++.++..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ .....
T Consensus 103 L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 175 (296)
T cd06655 103 LTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTM 175 (296)
T ss_pred HHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCc
Confidence 99998643 5899999999999999999999 89999999999999999999999999999876543322 12234
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.++..|+|||.+.+..++.++|||||||++|||++|+.||....... ..... ....... +. .+....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~-~~~~~~~-----~~--~~~~~~ 242 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLI-ATNGTPE-----LQ--NPEKLS 242 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhcCCcc-----cC--CcccCC
Confidence 57889999999998889999999999999999999999986543211 11111 1100000 00 112233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.+++.+|+..+|++||++.+++++
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 467899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=288.84 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=200.8
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|.|+.||++.. .+|+.+|+|++... +..+.+++.+|+++.+.++||||+++...+.+....++|+|+|.|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 346899999999999985 48999999988643 445778899999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla~~~~~~~~~ 728 (858)
++|..-+-.. ..+++..+-..++||+++|+|+| ..+|||||+||+|+|+... -.+||+|||+|..++ +..
T Consensus 95 ~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~ 167 (355)
T KOG0033|consen 95 GELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGE 167 (355)
T ss_pred hHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC--Ccc
Confidence 9998777544 36788888999999999999999 9999999999999999643 358999999999887 223
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
..-..+||++|||||.+....++..+|||+.||+|+-|+.|.+||.+... -.+. ..+.++... ++ +.+
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rly----e~I~~g~yd--~~----~~~ 235 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLY----EQIKAGAYD--YP----SPE 235 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHH----HHHhccccC--CC----Ccc
Confidence 34457899999999999999999999999999999999999999976331 1111 112222110 00 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
-.....+..+|+.+|+..||.+|.|+.|.+.+
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 12335578899999999999999999988764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=309.32 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=209.2
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEE
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.+.||+|.||.||+++.+ +|+.+|+|.+.+.... ......+|+++|+++. |||||.+.+.+......++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 3455688999999999999976 5999999999876543 3468999999999998 999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC----CCEEEeeecCcccc
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN----LEAKLADFGLSKVF 722 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~----~~~kL~DFGla~~~ 722 (858)
|++.||.|.+.+... .+++..+..++.|++.++.||| +.+|+||||||+|+|+... +.+|++|||++...
T Consensus 116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999765 3899999999999999999999 8999999999999999743 47999999999987
Q ss_pred cCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
.. .......+||+.|+|||.+....++.++||||+||++|.|++|.+||.......... .+..+.. ++.++
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~-~f~~~ 260 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF-DFTSE 260 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-CCCCC
Confidence 65 334456789999999999999999999999999999999999999998765332211 2223222 11111
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+ ......+.+++..|+..||.+|+++.+++++
T Consensus 261 ~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 261 PW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred Cc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 2335678899999999999999999999996
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=300.77 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=198.8
Q ss_pred cccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 576 NKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.||+|+||.||+|+.+ +.+.+|+|.+...... ...++..|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 367999999999999864 3467999998765443 457799999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhccc-------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 649 MANGNLKQLLSDEKA-------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+|+||||||+||++++++.++++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 999999999976542 25899999999999999999999 88999999999999999999999999999875
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
.............++..|+|||.+.+...+.++||||||++++||++ |..||..... ..+... ...+....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~----~~~~~~~~-- 238 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNR----LQAGKLEL-- 238 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHH----HHcCCcCC--
Confidence 43222222223345678999999988888999999999999999999 7778754321 111111 11111110
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
..+......+.+++.+|++.+|++||++.|+++.|+
T Consensus 239 ------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 ------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011123347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.49 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=192.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhc---ccceeeeeeeeeee-----CCeeE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRV---HHRNLTNLVGYFIE-----DNNMG 643 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~~~~~ 643 (858)
..+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+++++++ +||||+++++++.. ....+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 4578999999999999865 7899999998754222 234556677776665 69999999998864 24578
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+||||+++ +|.+++.......+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 84 LVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 99999985 8999887655556899999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc----CCchhh
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK----GDIENI 799 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~----~~~~~~ 799 (858)
... ......|+..|+|||.+.+..++.++|||||||+++||++|++||...... .....+...... .+....
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 160 CQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred Ccc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhhCcccc
Confidence 321 122345789999999999888999999999999999999999998643321 111111111100 000000
Q ss_pred --hchhhcCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 --VDSCLRGG-------FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 --~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........ .......++.+++.+|++.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 001224467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=318.93 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=193.2
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+||+++++++..++..++|||++. ++
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 3478999999999999975 68899999632 2346789999999999999999999999999999999995 68
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-ceeec
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVSTV 732 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~ 732 (858)
|.+++.... ..++|.+++.|+.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 246 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 246 LYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 998886533 36899999999999999999999 88999999999999999999999999999987643221 12224
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc--cccHHHHHHHHHhcCCc--hh--------hh
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE--NIHIIQTVTNMIAKGDI--EN--------IV 800 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~--~~~l~~~v~~~~~~~~~--~~--------~~ 800 (858)
..||..|+|||++.+..++.++|||||||++|||++|..++...... .......+...+..... .+ +.
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 56999999999999999999999999999999999988765433211 11111111111111110 00 00
Q ss_pred chh-------hcCCCC---H----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSC-------LRGGFE---I----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~-------l~~~~~---~----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... ...... . .....+.+|+.+|++.||.+|||+.|++++
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000 0 112367899999999999999999999875
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=317.69 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=196.7
Q ss_pred HhhccccccccCceEEEEEEEC---CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.+.||+|+||.||++... .++.||||.+... ....+|++++++++||||+++++++......++|||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 4556688999999999999753 4678999988643 3456899999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+. ++|.+++.. ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.++|+|||+++........
T Consensus 168 ~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 168 YK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred cC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 86 588888843 347899999999999999999999 889999999999999999999999999999766433221
Q ss_pred -eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc-ccHHHHHHHHHhcCCc-------hhh
Q 043526 729 -VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-IHIIQTVTNMIAKGDI-------ENI 799 (858)
Q Consensus 729 -~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~-~~l~~~v~~~~~~~~~-------~~~ 799 (858)
......||+.|+|||++....++.++|||||||++|||++|+.||....... ......+...+..... ..+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 2234568999999999998899999999999999999999999997654321 1111111111110000 000
Q ss_pred ------hchhhcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 ------VDSCLRGGFE-------IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....+..+. ......+.+++.+|+..+|++||++.|++++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000010 0113467789999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=314.79 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=205.5
Q ss_pred cccccccCceEEEEEEEC--CCC--EEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD--DGT--QVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
-|+||+|+||.|++|.|. .|+ .||||.++..... ...+|++|+.+|.+++|||+++|+|...+ ....+|+|+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 368999999999999986 454 5899999876554 67899999999999999999999999987 67789999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
.|||.+.|+......|-......++.|||.||.||. +++.|||||..+|+||-....+||+||||.+.+...+.+..
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 999999998855667888899999999999999999 99999999999999999999999999999999876655542
Q ss_pred ec--ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TV--VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~--~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.. ..-.+.|+|||.+....++.++|||+|||.+|||+| |+.||.+-. ..++++.+. ++. .| .
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~~iD----~~e-------rL--p 335 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILKNID----AGE-------RL--P 335 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHHhcc----ccc-------cC--C
Confidence 21 123467999999999999999999999999999998 678886533 223222211 111 11 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
-+..+.+.+.++++.||..+|.+||++..|.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2455677899999999999999999999998544
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=298.29 Aligned_cols=243 Identities=24% Similarity=0.425 Sum_probs=199.8
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.||+|+||.||+|... +++.||+|.+.... ......+..|++++++++||||+++++++..++..++||||+++|+
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 467999999999999965 68999999987543 3445678899999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++... .+++.+...++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 89 L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06640 89 ALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccc
Confidence 99998643 5788999999999999999999 88999999999999999999999999999976643221 22234
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.++..|+|||.+.+...+.++|+|||||+++||+||+.|+....... . .. ....+. .........
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~---~~-~~~~~~---------~~~~~~~~~ 226 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--V---LF-LIPKNN---------PPTLTGEFS 226 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--H---hh-hhhcCC---------CCCCchhhh
Confidence 57889999999988889999999999999999999999986543211 0 00 011110 111233455
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.+++.+|++.+|++||++++++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.69 Aligned_cols=195 Identities=25% Similarity=0.419 Sum_probs=160.1
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~~ 651 (858)
..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999965 45789999986542 23567889999999999999999998854 4568899999875
Q ss_pred CChHHHhhhcc-------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE----cCCCCEEEeeecCcc
Q 043526 652 GNLKQLLSDEK-------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL----TENLEAKLADFGLSK 720 (858)
Q Consensus 652 gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl----~~~~~~kL~DFGla~ 720 (858)
+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7877774321 235889999999999999999999 8999999999999999 566789999999998
Q ss_pred cccCCCcc--eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCC
Q 043526 721 VFPIGGTH--VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777 (858)
Q Consensus 721 ~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~ 777 (858)
........ ......||..|+|||.+.+ ..++.++|||||||+++||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433221 1223467899999999876 457899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=295.95 Aligned_cols=245 Identities=29% Similarity=0.440 Sum_probs=198.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-----CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-----GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..+.||+|++|.||+|... +++.|++|.+.... .+..+.+..|+++++.++|+|++++++++..+...++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3478999999999999976 89999999986543 22456789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 84 VPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999996543 5889999999999999999999 8899999999999999999999999999988754332
Q ss_pred eeecccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDW-LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......|+..|+|||.+.... ++.++|+||||++++||++|+.||..... .............. .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~---------~ 222 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKELP---------P 222 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccCC---------C
Confidence 223455788999999987766 89999999999999999999999865431 11111111111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+......+.+++.+|+..+|.+||++++++++
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 122234567899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=286.02 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=199.1
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC----Ccc----hHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS----GQG----FKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~----~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.||.|..++|.++..+ +|.+.|+|++.... +.. .+.-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 468999999999998854 78999999986332 111 23456789999998 599999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
+|.|+.|.|+|+|.+. ..+++.+..+|++|+.+|++||| ...||||||||+|||+|++.++||+|||++..++.+
T Consensus 102 Fdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 9999999999999654 47999999999999999999999 999999999999999999999999999999988765
Q ss_pred CcceeecccCCCCccCccccc------cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh
Q 043526 726 GTHVSTVVAGTPGYLDPEYFV------TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~ 799 (858)
... ...+||++|+|||.+. ...++...|+||+||++|-|+.|.+||.... . -.+.+++.+|.. ++
T Consensus 177 ekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Q----mlMLR~ImeGky-qF 247 (411)
T KOG0599|consen 177 EKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--Q----MLMLRMIMEGKY-QF 247 (411)
T ss_pred hhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--H----HHHHHHHHhccc-cc
Confidence 433 3468999999999885 2467889999999999999999999996532 0 011223333321 11
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
-.+.+ .+....+.+|+.+|++.||.+|.|.+|++++
T Consensus 248 ~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 248 RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11111 1335578899999999999999999999885
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.29 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=199.0
Q ss_pred cccccccCceEEEEEEEC-CCC----EEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGT----QVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.||+|+||.||+|... +|. .+|+|.+..... ....++.+|+.+++.++||||++++++|... ...+++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 367999999999999853 454 478898875433 2334788999999999999999999998754 467999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.........
T Consensus 91 ~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 91 PHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 9999999987543 35889999999999999999999 8999999999999999999999999999998764332221
Q ss_pred -eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 730 -STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 730 -~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+ .+..+... .
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~---------~ 231 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPD----LLEKGERL---------P 231 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHCCCCC---------C
Confidence 122335678999999988889999999999999999998 8888864321 11111 11111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.+......+.+++..|+..+|++||+++++++.|+++...+.
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 111233468899999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.58 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=197.1
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCC------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.||+|+||.||+|...+|+.+|||.+..... .....+.+|++.+++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 467999999999999988999999999864422 12356888999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc--
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-- 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-- 727 (858)
++++|.+++.... .+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 85 PGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999996543 5789999999999999999999 88999999999999999999999999999876532111
Q ss_pred ---ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 ---HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
.......|+..|+|||.+.+..++.++||||||++++||++|+.||....... .. .... ...+.. +.+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~-~~~~--~~~~~~-----~~~ 230 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AM-FYIG--AHRGLM-----PRL 230 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HH-HHhh--hccCCC-----CCC
Confidence 11123457889999999998888999999999999999999999996533111 00 0000 000110 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+.....++.+++.+|++.+|++||++.|+++
T Consensus 231 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 ----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1223456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=297.67 Aligned_cols=246 Identities=24% Similarity=0.419 Sum_probs=197.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc---------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 644 (858)
+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+..|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 3468999999999999864 6899999988654322 12567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||.++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 84 FLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999654 36889999999999999999999 88999999999999999999999999999987642
Q ss_pred CCcc-----eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh
Q 043526 725 GGTH-----VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 725 ~~~~-----~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~ 799 (858)
.... ......|+..|+|||.+.+..++.++||||||++++||++|+.||...... ..+... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~----- 227 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKI-GEN----- 227 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHH-hcc-----
Confidence 2111 111234788999999998888899999999999999999999999653211 111111 110
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....+......+.+++.+|++.+|.+||++.|++++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0111122334578899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=300.62 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=194.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|++|.||+|+.. +|+.||||.++... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 3467999999999999965 78999999986542 2234678899999999999999999999999999999999998
Q ss_pred CChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++|.+++.... ...+++.++..++.|+++||+||| +.+++||||||+||++++++.+||+|||++........ ..
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VY 158 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cc
Confidence 58988886543 357899999999999999999999 89999999999999999999999999999876533211 11
Q ss_pred ecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh--cC---Cchhh-----
Q 043526 731 TVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA--KG---DIENI----- 799 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~--~~---~~~~~----- 799 (858)
....++..|+|||.+.+ ..++.++|||||||+++||+||+.||....... ........... +. ....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 22346889999998865 457889999999999999999999986543111 11111000000 00 00000
Q ss_pred -hchhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 -VDSCLRGG---FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 -~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
++...... .......++.+++.+|++.||++|||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 001124567899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.38 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=198.2
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++.++.++|||++++++.+..++..++||||+++++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 3467999999999999975 689999999987766667789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|..++.+.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++....... ......
T Consensus 96 l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 170 (292)
T cd06644 96 VDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSF 170 (292)
T ss_pred HHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccccee
Confidence 998876543 46899999999999999999999 8899999999999999999999999999887543221 112234
Q ss_pred cCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 734 AGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 734 ~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.++..|+|||++. ...++.++|||||||++|||++|+.|+...... ...... ........ ..
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~-~~~~~~~~-------~~ 237 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKI-AKSEPPTL-------SQ 237 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHH-hcCCCccC-------CC
Confidence 5788999999985 345678999999999999999999998643211 111111 11110000 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.....++.+++.+|+..+|++||+++|++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 12234468899999999999999999999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=297.76 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=190.9
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCCC-----cchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG-----QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 647 (858)
.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++... ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 47899999999999986 4789999999864321 2345688899999999999999999988753 56789999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++++|.+++.... .+++...+.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 87 YMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999996543 5889999999999999999999 88999999999999999999999999999876532211
Q ss_pred --ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 --HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.......++..|+|||.+.+..++.++|||||||+++||++|+.||..... ...+........ .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~~~~~~~~~---------~ 227 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAIFKIATQPT---------N 227 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcCCC---------C
Confidence 111234578899999999888899999999999999999999999864321 111111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+......+.+++ +|+..+|++||+++||+++
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111222233455555 7888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=294.95 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=202.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|++|.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++..++..+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 34578999999999999964 68899999998766666788999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.++..++.|++.||+||| +.+++|+||||+||++++++.+||+|||++........ ....
T Consensus 86 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 160 (262)
T cd06613 86 SLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKS 160 (262)
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccc
Confidence 9999987642 46889999999999999999999 88999999999999999999999999999876543221 1223
Q ss_pred ccCCCCccCccccccC---CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 733 VAGTPGYLDPEYFVTD---WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
..++..|+|||.+... .++.++||||||++++||+||+.|+........ . .. ...... ....+ ...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~----~~-~~~~~~---~~~~~--~~~ 229 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-L----FL-ISKSNF---PPPKL--KDK 229 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-H----HH-HHhccC---CCccc--cch
Confidence 4578899999998776 788999999999999999999999865431110 1 00 111100 00011 012
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|+..+|.+||++++|+.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2334578899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.72 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=200.2
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|++|.||++.. .+++.+|||.+.... ......+..|++++++++|||++++++.+..++..++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 3457899999999999986 478999999986542 3345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccCCCcce
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~~~~~~ 729 (858)
+++|.+++.......+++..+++++.|+++||+||| +.+++|+||||+||+++++ +.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 999999998765567899999999999999999999 8899999999999999865 4589999999987643321
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|+..|+|||.+.....+.++||||||+++++|++|+.||...... ..+..... +.... .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~-~~~~~---------~~ 222 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMS-GTFAP---------IS 222 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHh-cCCCC---------CC
Confidence 22345788999999999888899999999999999999999998654311 11111111 11111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|+..+|++||++.|++++
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1234468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=311.05 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=194.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+++.+ +++.+|+|++... .......+..|+.++..++|+||+++.+++..++..++||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 4578999999999999975 5788999998642 12233457889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.++++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++...........
T Consensus 85 ~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 85 GGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred CCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 999999997532 36889999999999999999999 89999999999999999999999999999876544333333
Q ss_pred ecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 731 TVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+............. .
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~-----~- 229 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKERFQ-----F- 229 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCcccc-----C-
Confidence 4457999999999986 34678899999999999999999999965331 122222111110000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSS--ERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~--~RPsm~eVl~~ 840 (858)
..........+.+++.+|++.++. .|++++|++++
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000112345677888887755444 47899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=311.24 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=194.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+++.. +++.||+|++... .......+.+|..++..++|+||+++.+++..++..++||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999965 7889999998642 22234557889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 85 gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 85 GGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred CCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999997532 36889999999999999999999 89999999999999999999999999999987654433333
Q ss_pred ecccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 731 TVVAGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
....|++.|+|||.+.. +.++.++|||||||++|||++|+.||..... .+............. +...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~~-~p~~-- 232 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEERFQ-FPSH-- 232 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCccc-CCCc--
Confidence 34569999999998865 4678899999999999999999999965331 111111111110000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSE--RPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 840 (858)
......++.+++.+|++..+.+ |+++++++++
T Consensus 233 ---~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 233 ---ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0122456778888888765544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.13 Aligned_cols=260 Identities=22% Similarity=0.343 Sum_probs=200.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++..+...++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 34578999999999999964 78999999987654 333567899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++.... ..+++.+++.++.||++||+||| +.+++|+||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 999999987544 56899999999999999999999 88999999999999999999999999999987654432222
Q ss_pred ecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc------hhhhch-
Q 043526 731 TVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI------ENIVDS- 802 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~------~~~~d~- 802 (858)
....|+..|+|||.+.+. .++.++||||+|++++||++|.++|..... ......+......... .++.+.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 334688899999998654 468999999999999999999777754321 1111111111111000 000000
Q ss_pred --hhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 --CLRG-------GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 --~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... ....+....+.+++.+|+..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0001224678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.26 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=196.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|++|.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 4467999999999999976 68999999986442 22345688999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+.|..++... ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........ ...
T Consensus 85 ~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07847 85 TVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158 (286)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence 8888877543 36899999999999999999999 89999999999999999999999999999987644322 122
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc-----------C-Cchh
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK-----------G-DIEN 798 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~-----------~-~~~~ 798 (858)
...++..|+|||.+.+ ..++.++||||||++++||++|+.||......+. ...+...... . ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhccccccccc
Confidence 3457889999999875 5578999999999999999999999975432211 1111111000 0 0000
Q ss_pred hhchhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+......+ ......+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000001 1123567899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=303.23 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=195.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 3578999999999999865 68999999987543 3334567889999999999999999999999999999999997 5
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||+|||++......... ...
T Consensus 89 ~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 163 (301)
T cd07873 89 DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSN 163 (301)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-ccc
Confidence 8998886543 36889999999999999999999 899999999999999999999999999998765332211 122
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc---CCchhhhch------
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK---GDIENIVDS------ 802 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~---~~~~~~~d~------ 802 (858)
..++..|+|||.+.+ ..++.++|||||||+++||+||+.||...... .....+...... ..+..+.+.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 346889999998865 45788999999999999999999998654321 111111111100 001111100
Q ss_pred hhc---C----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLR---G----GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~---~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... . .........+.+++.+|++.+|.+|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0 0011223467899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=304.53 Aligned_cols=248 Identities=28% Similarity=0.356 Sum_probs=199.0
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|++|.||+|... +++.+|+|.+...... ..+.+..|+++++.++||||+++++.+...+..++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 3467999999999999965 5899999999765332 44678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc--
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-- 728 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-- 728 (858)
+++|.+++.......+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 999999997655567999999999999999999999 899999999999999999999999999998765322110
Q ss_pred --------------------------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc
Q 043526 729 --------------------------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782 (858)
Q Consensus 729 --------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~ 782 (858)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~ 240 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE-T 240 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-H
Confidence 0112357889999999998889999999999999999999999986543211 1
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN----MNEVVT 839 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----m~eVl~ 839 (858)
..... +....-.........+.+++.+|++.+|++||+ ++|+++
T Consensus 241 ----~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 ----FSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ----HHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 111100011113567889999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=310.12 Aligned_cols=240 Identities=28% Similarity=0.453 Sum_probs=200.1
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||.|+||.||.|+. .+.+.||||+++-.. ...+.++..|++.|++++|||++.+.|||..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 4599999999999994 578899999997543 33567899999999999999999999999999999999999975
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
|-.|++...+ +++.+.++..|..+.+.||+||| +.+.||||||+.|||+++.|.+||+|||.|....+. ..
T Consensus 111 SAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----ns 181 (948)
T KOG0577|consen 111 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NS 181 (948)
T ss_pred cHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----hc
Confidence 8888886554 57899999999999999999999 999999999999999999999999999999887543 34
Q ss_pred ccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 733 VAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 733 ~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
++||+.|||||++. .+.|+-|+||||+|++..||...++|...+.- .. +.-.+.+... |.|. .
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MS-ALYHIAQNes-----PtLq---s 247 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MS-ALYHIAQNES-----PTLQ---S 247 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HH-HHHHHHhcCC-----CCCC---C
Confidence 68999999999885 57899999999999999999999999865431 11 1111111111 1121 3
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+....+..++..|+++-|.+|||.++++++
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 4567788999999999999999999998875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=316.56 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=192.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||++... +|+.||+|++... .......+..|++++..++||||+++++.+..++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 3478999999999999965 7899999999643 22345678889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc---
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT--- 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~--- 727 (858)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 85 GGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999996543 6889999999999999999999 89999999999999999999999999999875432100
Q ss_pred -------------------------------ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccC
Q 043526 728 -------------------------------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRN 776 (858)
Q Consensus 728 -------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~ 776 (858)
.......||+.|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0011346899999999999999999999999999999999999999754
Q ss_pred CCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043526 777 ENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPN---MNEVVTE 840 (858)
Q Consensus 777 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~~ 840 (858)
.... .... +.... ..+. .. .......++.+++.+|+ .+|.+|++ ++|++++
T Consensus 240 ~~~~-----~~~~-i~~~~-~~~~---~p--~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 240 TPQE-----TYRK-VMNWK-ETLV---FP--PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CHHH-----HHHH-HHcCC-Ccee---cC--CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 3211 1111 11100 0000 00 01112346677777765 49999985 6676665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=311.36 Aligned_cols=240 Identities=28% Similarity=0.375 Sum_probs=186.7
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc---ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV---HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
||+|+||+||+|+.. +|+.||||++.... ......+..|..++.+. +||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 78999999986432 12234455666666665 699999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ..+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 9999998654 36899999999999999999999 8999999999999999999999999999987543222 1223
Q ss_pred cccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...||..|+|||.+.+. .++.++|||||||+++||++|+.||...... + ....+..+.. .+. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~-~~~~i~~~~~------~~~---~~ 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----Q-MYRNIAFGKV------RFP---KN 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----H-HHHHHHcCCC------CCC---Cc
Confidence 45689999999998754 4789999999999999999999998653311 1 1111211111 000 01
Q ss_pred HHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERP----NMNEVVT 839 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RP----sm~eVl~ 839 (858)
.....+.+++.+|++.+|.+|| +++++++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1234677999999999999999 4566555
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.29 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=202.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
++.+.||.|++|+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+..++..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 34578999999999999954 78899999987543 33567889999999999999999999999999999999999999
Q ss_pred CChHHHhhhccc-CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc--
Q 043526 652 GNLKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-- 728 (858)
Q Consensus 652 gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-- 728 (858)
++|.++++.... ..+++.....++.|++.||+||| +.+++||||||+||++++++.++|+|||++..+......
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999976543 56899999999999999999999 899999999999999999999999999999876543322
Q ss_pred -eeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 729 -VSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 729 -~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
......|+..|+|||.+... ..+.++|+|||||+++||++|+.||....... .+.. ..... .+.+..
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~----~~~~~------~~~~~~ 229 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLML----TLQND------PPSLET 229 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHH----HhcCC------CCCcCC
Confidence 12334588899999998876 78999999999999999999999986543211 1111 11110 001110
Q ss_pred CC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GF-EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. .......+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.29 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=196.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|+||.||+|..+ +++.||+|++...... ..+.+.+|++++++++||||+++++++..++..++|+||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 4578999999999999975 6899999998654322 346788999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.++.... ..++|.+++.++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++........ ...
T Consensus 85 ~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07846 85 TVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYT 158 (286)
T ss_pred cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-ccC
Confidence 9998876543 35899999999999999999999 88999999999999999999999999999887644322 222
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC--Cchhh------hch
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG--DIENI------VDS 802 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~--~~~~~------~d~ 802 (858)
...++..|+|||++.+ ..++.++||||||++++||++|++||..... ......+......- ..... .+.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3457889999999875 4578899999999999999999988864331 11111111100000 00000 000
Q ss_pred hhcCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRGGF---------EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...... .......+.+++.+|+..+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 01224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.33 Aligned_cols=189 Identities=25% Similarity=0.367 Sum_probs=161.3
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+...+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++...+..++|+|++.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 344578999999999999975 6788999975432 23568999999999999999999999999999999995
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++... ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 141 ~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 214 (357)
T PHA03209 141 SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL 214 (357)
T ss_pred CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence 5888888653 346899999999999999999999 889999999999999999999999999998753222 1122
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccc
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV 774 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~ 774 (858)
...||..|+|||.+.+..++.++|||||||++|||+++..++.
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 3468999999999998899999999999999999999766553
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=299.92 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=195.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|+||.||+|... +|+.+|+|++.... ......+.+|++++++++|||++++++++.+.+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ 83 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC
Confidence 4578999999999999965 79999999986542 22335678899999999999999999999999999999999974
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... ..+++..++.++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 84 -~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~ 157 (284)
T cd07839 84 -DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YS 157 (284)
T ss_pred -CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-cC
Confidence 8888876543 46899999999999999999999 889999999999999999999999999999865432211 12
Q ss_pred cccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC------chhhhchhh
Q 043526 732 VVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD------IENIVDSCL 804 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~------~~~~~d~~l 804 (858)
...++..|+|||.+.+. .++.++|||||||+++||+||+.|+......... ...+........ +....+...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHhhhcccccc
Confidence 33568899999988764 4689999999999999999999987544322111 111111110000 000000000
Q ss_pred cCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGF---------EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... ......++.+++.+|++.+|.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 01234577899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=296.59 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=196.2
Q ss_pred ccccccccCceEEEEEEEC----CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC------ee
Q 043526 575 FNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NM 642 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~ 642 (858)
+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 3578999999999999853 46889999987542 334567889999999999999999999886542 24
Q ss_pred EEEEeeccCCChHHHhhhcc----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 643 GLIYEYMANGNLKQLLSDEK----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
++++||+++|+|.+++.... ...+++...++++.|++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence 68899999999998875332 225788999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++........ ......++..|++||.+....++.++||||||++++||++ |+.|+..... ..+..+ +..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~----~~~~~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNY----LIKGNR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHH----HHcCCc
Confidence 9876432211 1122335578999999988888999999999999999999 7888764332 111111 111110
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
+ ..+......+.+++.+|+..+|++||++.|+++.|+++
T Consensus 234 -------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 -------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.97 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=199.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.+.||+|++|.||+|... +++.+|+|.+........+.+.+|++++++++|||++++++.+..+...++||||+++++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 3467999999999999975 789999999987665566789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++........ .....
T Consensus 89 L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 163 (280)
T cd06611 89 LDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDTF 163 (280)
T ss_pred HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-cccee
Confidence 999986543 36899999999999999999999 88999999999999999999999999998876533221 22234
Q ss_pred cCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 734 AGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 734 ~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.++..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.. +..+.... +. .
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~-----~~--~ 230 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLK-ILKSEPPT-----LD--Q 230 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHH-HhcCCCCC-----cC--C
Confidence 5889999999875 345678999999999999999999998654311 11111 11111100 00 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+......+.+++.+|++.+|.+||++++++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11223467899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.73 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=200.8
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~ 649 (858)
+.+.||.|+||.||++.. .+|+.+|+|.+.... ....+++..|++++++++|||++++++++.. +...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 446799999999999985 478999999986542 3345678889999999999999999998764 34578999999
Q ss_pred cCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 650 ANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGC--KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 650 ~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
++++|.+++.... ...+++.+++.++.|++.||+|||..+ +.+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999996542 357899999999999999999999554 678999999999999999999999999999876543
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
... .....++..|+|||.+....++.++|+||||+++++|++|+.|+..... ..+ ...+..+..
T Consensus 164 ~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~----~~~~~~~~~--------- 227 (265)
T cd08217 164 SSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQL----ASKIKEGKF--------- 227 (265)
T ss_pred ccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHH----HHHHhcCCC---------
Confidence 321 2234588999999999988899999999999999999999999875431 111 112222211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+......+.+++.+|+..+|++||++++|+++
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11223344578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.46 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=192.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 644 (858)
...+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 33578999999999999864 7899999998643 2234567889999999999999999999986543 4789
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++ +|.+.++. .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 104 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 104 VMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 9999976 56666532 4788899999999999999999 89999999999999999999999999999976432
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHH------------------
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT------------------ 786 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~------------------ 786 (858)
. .......||..|+|||.+.+..++.++|||||||++|||++|+.||....... .+...
T Consensus 176 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 176 N--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred C--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHHHHHH
Confidence 2 12233468899999999999899999999999999999999999997543211 00000
Q ss_pred HHHHHhcC------CchhhhchhhcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 787 VTNMIAKG------DIENIVDSCLRG---GFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 787 v~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
+....... ...+........ .........+.+++.+|++.||++|||++|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000 000000000000 00011234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=301.00 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=197.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
..||+|+||.||++... +++.||||.+........+.+.+|+..++.++||||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46999999999999864 78999999987665555677899999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
+++... .+++.++..++.||+.||+||| +.+|+||||||+||++++++.++|+|||++........ ......|
T Consensus 108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 180 (292)
T cd06658 108 DIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG 180 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence 988542 5889999999999999999999 88999999999999999999999999999876543222 1223457
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 815 (858)
+..|+|||...+..++.++||||||++++||++|+.||...... ..... +.. ...+.+.. .......
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~-----~~~~~~~~--~~~~~~~ 247 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRR----IRD-----NLPPRVKD--SHKVSSV 247 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHh-----cCCCcccc--ccccCHH
Confidence 89999999998888999999999999999999999998643211 11111 111 01111111 1122346
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 043526 816 AVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 816 l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.+++.+|+..+|.+||+++|++++
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 7789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.25 Aligned_cols=259 Identities=21% Similarity=0.342 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|++|.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++..++..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 467999999999999865 78999999987543 2234578899999999999999999999999999999999996 5
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++.++..++.|++.||+||| +.+++||||+|+||++++++.+||+|||++......... ...
T Consensus 84 ~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~~~ 159 (284)
T cd07860 84 DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTH 159 (284)
T ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-ccc
Confidence 8999987666667899999999999999999999 889999999999999999999999999998765432211 122
Q ss_pred ccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC-C----chhh------h
Q 043526 733 VAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG-D----IENI------V 800 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~-~----~~~~------~ 800 (858)
..++..|+|||.+.+. ..+.++||||||++++||+||+.||...... ..+.+.....-... . ...+ +
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 3467889999988754 4588999999999999999999998654321 11111111100000 0 0000 0
Q ss_pred chhhcCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGG---FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....... .......++.+++.+|++.+|.+||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000 001123457799999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.16 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=199.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++++++|+||+++++.+...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 3478999999999999965 7899999998766443 567899999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.... .+++..+..++.|+++||+||| +.+|+|+||+|+||++++++.+||+|||++............
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 84 GTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999997543 5789999999999999999999 889999999999999999999999999999876544332222
Q ss_pred ---cccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 732 ---VVAGTPGYLDPEYFVTDW---LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 732 ---~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
...++..|+|||++.... .+.++||||||++++||++|+.||...... ......+ ..+. .+.+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~----~~~~-----~~~~~ 228 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHV----GAGH-----KPPIP 228 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHH----hcCC-----CCCCC
Confidence 345788999999998765 889999999999999999999999654321 1111111 1110 00010
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
........+.+++.+|++.+|.+||++.|++.
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 --DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01112456779999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.86 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=195.3
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCCC---c-------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEE
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG---Q-------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 644 (858)
.+.||+|++|.||+|.. .+|+.+|+|.++.... . ..+.+.+|++.++.++|||++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 46899999999999985 4789999998853211 1 12457889999999999999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++++|.++++.. ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++....
T Consensus 86 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999765 36899999999999999999999 88999999999999999999999999999976543
Q ss_pred CCcc-eeecccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 725 GGTH-VSTVVAGTPGYLDPEYFVTDW--LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 725 ~~~~-~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
.... ......|+..|+|||.+.... ++.++||||||++++||++|+.|+...... ......... .....+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~~ 234 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLGNK-RSAPPIP 234 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhhcc-ccCCcCC
Confidence 2111 122345788999999987654 789999999999999999999998543211 111111001 0011111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ........+.+++.+|+..+|++||++++|+++
T Consensus 235 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 PD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 111234578899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=294.53 Aligned_cols=245 Identities=26% Similarity=0.433 Sum_probs=198.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|++.+++++||||+++++++..++..++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 34567999999999999864 78999999986443 23346788999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++... .+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++....... ....
T Consensus 87 ~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 87 GSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 9999998643 5889999999999999999999 8999999999999999999999999999987654322 1122
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...++..|+|||.+.+...+.++|+|||||+++||++|..|+..... .. .... +..+.. ...+..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~---~~~~-~~~~~~---------~~~~~~ 224 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--MK---VLFL-IPKNNP---------PTLEGN 224 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--HH---HHHH-HhcCCC---------CCCCcc
Confidence 34578899999999888889999999999999999999999864321 11 1111 111111 111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.+++.+|++.+|.+||++++++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 34568899999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.49 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
..||+|+||.||++... +++.||+|.+........+.+.+|+..++.++|||++++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 36999999999999864 78999999997655555677889999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
+++.. ..+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++........ ......|
T Consensus 107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 179 (297)
T cd06659 107 DIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG 179 (297)
T ss_pred HHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence 98754 35889999999999999999999 88999999999999999999999999999876543221 2223468
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 815 (858)
+..|+|||++.+..++.++|||||||+++||++|+.||..... ......+ ...... .+. ........
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~----~~~~~~-----~~~--~~~~~~~~ 246 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRL----RDSPPP-----KLK--NAHKISPV 246 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH----hccCCC-----Ccc--ccCCCCHH
Confidence 8999999999888899999999999999999999999864331 1111111 111100 000 01112345
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 043526 816 AVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 816 l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.+++.+|++.+|.+||++++++++
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=299.23 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=199.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
++.+.||+|++|.||+|..+ +++.||||.++... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 44578999999999999975 68899999987542 3345778999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++.+..+.... ..+++.++..++.|++.||+||| ..+++|+||+|+||++++++.+||+|||++...........
T Consensus 84 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 84 RTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 87777665432 35899999999999999999999 88999999999999999999999999999987654433233
Q ss_pred ecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc------------CCch
Q 043526 731 TVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK------------GDIE 797 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~------------~~~~ 797 (858)
....++..|+|||++.+. .++.++||||||++++||++|+.||...... ............ ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 345678899999999877 8899999999999999999999988643311 111111111000 0000
Q ss_pred -----hhhch-hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 -----NIVDS-CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 -----~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+..+. .+...++.....++.+++.+|+..+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00001112235678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.01 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=200.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 4578999999999999965 68999999986542 23446788999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~~~ 730 (858)
++|.+++.......+++..++.++.|+++||+||| +.+++|+||||+||++++++ .+||+|||.+........ ..
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (257)
T cd08225 84 GDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LA 159 (257)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-cc
Confidence 99999997665556899999999999999999999 88999999999999999885 469999999987643322 22
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|++.|+|||...+..++.++||||||++++||++|+.|+.... ..+.+..... +.... ...
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-~~~~~---------~~~ 224 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ-GYFAP---------ISP 224 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc-ccCCC---------CCC
Confidence 23458889999999988889999999999999999999999985432 2222222211 11111 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....+.+++.+|+..+|++||++.|++++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=296.22 Aligned_cols=250 Identities=24% Similarity=0.428 Sum_probs=197.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
++.+.||+|+||.||++... +|+.+|+|.++.. ......++.+|++++++++||||+++++.+..++..++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 34578999999999999976 7899999998754 223356788999999999999999999999999999999999999
Q ss_pred CChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++|..++.... ...+++..+..++.|++.||.|||+ +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 158 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LA 158 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---cc
Confidence 99999986532 2368999999999999999999993 358999999999999999999999999998765322 12
Q ss_pred ecccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 731 TVVAGTPGYLDPEYFVTD------WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
....++..|+|||.+.+. .++.++|+|||||+++||++|+.||...... ........ +..+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~-~~~~~~-------- 227 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSA-IVDGDP-------- 227 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHH-HhhcCC--------
Confidence 234578899999998543 3478999999999999999999998643211 11111111 111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+......+.+++.+|+..+|++||++++++++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11122345567899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.97 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=191.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV 645 (858)
..+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 3578999999999999854 78999999987542 23346778899999999999999999988644 347899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++ +|.+.+.. .+++.++..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 101 MELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred hhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 999976 67766642 4788999999999999999999 899999999999999999999999999999865322
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHH------------------
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV------------------ 787 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v------------------ 787 (858)
.......|+..|+|||.+.+..++.++|||||||+++||++|+.||....... .+...+
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhcHHH
Confidence 12233468999999999998889999999999999999999999996543110 000000
Q ss_pred HHHHhcCC-chhhhchh-----hc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 788 TNMIAKGD-IENIVDSC-----LR---GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 788 ~~~~~~~~-~~~~~d~~-----l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........ ...+..+. +. ...+......+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 00000000 00 00011124567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.21 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeee-----eCCeeEEEEee
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFI-----EDNNMGLIYEY 648 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-----~~~~~~lV~Ey 648 (858)
.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +||||+++++++. .++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 478999999999999864 68899999886532 2235678899999999 6999999999884 34568999999
Q ss_pred ccCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 649 MANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 649 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
+++++|.++++.. ....+++..+..++.|+++||.||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 9999999988642 2346889999999999999999999 8899999999999999999999999999988654322
Q ss_pred cceeecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
. ......|+..|+|||++. ...++.++|||||||+++||++|+.|+....... .+ .. ..........+
T Consensus 179 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~----~~-~~~~~~~~~~~ 251 (286)
T cd06638 179 L-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-AL----FK-IPRNPPPTLHQ 251 (286)
T ss_pred C-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HH----hh-ccccCCCcccC
Confidence 1 222346899999999875 3457889999999999999999999986543111 00 00 00110001111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
+......+.+++.+|++.+|++||++.|+++++
T Consensus 252 -------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 252 -------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111234688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.34 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=191.9
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC-----CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-----GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 647 (858)
.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 478999999999999864 68999999885322 12245788899999999999999999988764 45789999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++++|.+++.... .+++...++++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 87 HMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred ecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999986543 5788889999999999999999 88999999999999999999999999999886532111
Q ss_pred --ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 --HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 --~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.......|+..|+|||.+.+..++.++|||||||+++||++|+.||...... ..+....... ..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~---------~~ 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKIATQP---------TN 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHHHHHhcCC---------CC
Confidence 1122345788999999998888899999999999999999999998643211 1111111110 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+......+.+++.+|+. +|++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11233344567788889985 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=294.09 Aligned_cols=244 Identities=25% Similarity=0.466 Sum_probs=196.5
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcc---cceeeeeeeeeeeCCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVH---HRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.||+|+||.||+|.. .+|+.+|+|.+.... .....++.+|++++++++ |||++++++++..+...++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 46799999999999996 478999999987543 344567889999999997 9999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.++++.. .+++...+.++.|++.||+||| +.+|+|+||+|+||++++++.++|+|||++..+..... ..
T Consensus 86 ~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06917 86 GGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KR 158 (277)
T ss_pred CCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cc
Confidence 99999998643 6899999999999999999999 89999999999999999999999999999987654332 22
Q ss_pred ecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .... .+... ..+.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~-~~~~~-----~~~~~~~--- 224 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMM-LIPKS-----KPPRLED--- 224 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhh-ccccC-----CCCCCCc---
Confidence 33468889999998875 45688999999999999999999998643211 1111 00110 0011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|+..+|++||++.|++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1134578899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=293.18 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~~~ 651 (858)
.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 468999999999999974 689999999875433 3456789999999999999999999998654 468999999999
Q ss_pred CChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|.+++... ....+++.....++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--- 159 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--- 159 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc---
Confidence 9999987542 2346889999999999999999999 8999999999999999999999999999987653221
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....+.....+...... ......+ .... ...
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~--~~~ 235 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPEL-KDEP--GNG 235 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhh-ccCC--CCC
Confidence 12345788999999999888999999999999999999999999755321111112111111 1111111 0000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2234578899999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.43 Aligned_cols=246 Identities=26% Similarity=0.469 Sum_probs=193.2
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeee------CCeeEEEE
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIE------DNNMGLIY 646 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~------~~~~~lV~ 646 (858)
+.+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|||++++++++.. .+..+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 347899999999999996 478999999986543 2345688899999998 69999999999853 45789999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++|+|.+++.......+++..++.++.|++.||+||| +.+|+|+||||+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 99 EFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175 (282)
T ss_pred EeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence 9999999999997766567889999999999999999999 8899999999999999999999999999987653221
Q ss_pred cceeecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
. ......|+..|+|||.+. ...++.++|||||||+++||++|+.||....... .+ .. ..... .
T Consensus 176 ~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~----~~-~~~~~-----~ 243 (282)
T cd06636 176 G-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-AL----FL-IPRNP-----P 243 (282)
T ss_pred c-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-hh----hh-HhhCC-----C
Confidence 1 122345888999999875 3467889999999999999999999986433110 00 00 00000 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+.+ ........+.+++.+|+..+|.+||++.|+++
T Consensus 244 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 01123457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=296.15 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=198.0
Q ss_pred CHHHHHHHHhhc--cccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeC
Q 043526 564 TYSEVLKITDNF--NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED 639 (858)
Q Consensus 564 ~~~el~~~t~~f--~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 639 (858)
++.++.+++++| .+.||+|+||.||++.. ++|+.+|+|++.... ....++.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 334444444444 46899999999999996 478999999986542 2245678899999998 799999999998754
Q ss_pred -----CeeEEEEeeccCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEE
Q 043526 640 -----NNMGLIYEYMANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK 712 (858)
Q Consensus 640 -----~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~k 712 (858)
+..++||||+++++|.++++.. ....+++..++.++.|++.||+||| +.+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999988642 2356899999999999999999999 88999999999999999999999
Q ss_pred EeeecCcccccCCCcceeecccCCCCccCccccccC-----CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHH
Q 043526 713 LADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD-----WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 713 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v 787 (858)
|+|||++........ ......|+..|+|||.+... .++.++|||||||+++||++|+.|+...... ..+
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~---- 242 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTL---- 242 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHH----
Confidence 999999886543221 12234578899999987543 3688999999999999999999998653311 111
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. +.++....+.+ +......+.+++.+|++.+|++||++.|++++
T Consensus 243 ~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11111111111 11233468899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.69 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=192.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 644 (858)
...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 34578999999999999854 78999999987532 23446788899999999999999999987543 35799
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++ +|.+.+.. .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 v~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 107 VMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 9999975 77777642 4788999999999999999999 89999999999999999999999999999986533
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHH--------------
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM-------------- 790 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~-------------- 790 (858)
. .......|+..|+|||.+.+..++.++|||||||+++||++|+.||....... ....+...
T Consensus 179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 179 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred C--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHhhhH
Confidence 2 12233468999999999999899999999999999999999999996543211 11111000
Q ss_pred -----HhcCC------chhhhchhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 791 -----IAKGD------IENIVDSCLR---GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 791 -----~~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..... ........+. ...+......+.+++.+|++.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 0000000000 00011123467899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=309.72 Aligned_cols=196 Identities=29% Similarity=0.453 Sum_probs=170.3
Q ss_pred HhhccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-c-----ceeeeeeeeeeeCCeeEE
Q 043526 572 TDNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-H-----RNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~l 644 (858)
++...+.||+|+||.|-||. .++++.||||+++..... ..+-..|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 44557899999999999998 457999999999866433 356678999999997 3 589999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC--CCEEEeeecCcccc
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN--LEAKLADFGLSKVF 722 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~--~~~kL~DFGla~~~ 722 (858)
|+|.+.. +|+++|+.++...++......|+.||+.||.+|| +.+|||+||||+||||.+. ..+||+|||.+...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999976 9999999999889999999999999999999999 9999999999999999754 46999999999875
Q ss_pred cCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccC
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRN 776 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~ 776 (858)
...-. ...-+..|+|||++.+..++.+.||||||||+.||.+|.+.|.+.
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 43211 233577899999999999999999999999999999997766543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.49 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=196.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-----chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-----GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.||+|++|.||+|... +|+.||||.+...... ....+..|++++++++|+||+++++++..++..++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 4567999999999999965 7899999999755332 234567899999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+ +|+|.+++.... ..+++..++.++.||++||+||| +.+|+|+||||+||+++.++.++|+|||+++........
T Consensus 84 ~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 84 M-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred c-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 9 899999997543 36899999999999999999999 889999999999999999999999999999876443221
Q ss_pred eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---------Cchh
Q 043526 729 VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---------DIEN 798 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---------~~~~ 798 (858)
.....++..|+|||.+.+ ..++.++|||||||+++||++|.++|...... ............. ....
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 159 -MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred -ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHHHHHHcCCCchhhhhhcccccc
Confidence 122345778999998864 46789999999999999999997776543321 1111111111000 0000
Q ss_pred hhchhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..........+ ......+.+++.+|+..+|++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000111 1234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=291.39 Aligned_cols=249 Identities=23% Similarity=0.426 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCCC------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.||+|++|.||+|.. .+|+.+|+|.+..... ...+.+..|++.+++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999985 5789999999874331 1246788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~ 727 (858)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||||+||+++.++ .+||+|||.+........
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 85 MAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred cCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999996543 6889999999999999999999 88999999999999998776 599999999877643321
Q ss_pred c---eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 H---VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 ~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
. ......|+..|+|||.+.+..++.++||||+|++++||++|+.||...... ............. .
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~---------~ 228 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT---------T 228 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC---------C
Confidence 1 112345788999999998888899999999999999999999998643321 1111111111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.....++.+++.+|+..+|.+||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111223344578899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=320.92 Aligned_cols=254 Identities=20% Similarity=0.329 Sum_probs=186.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhccc------ceeeeeeeeeeeC-CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH------RNLTNLVGYFIED-NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~~~-~~~~lV 645 (858)
.+.+.||+|+||+||+|... +++.||||+++... ....++..|++++..++| ++++++++++..+ ...++|
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 34578999999999999864 68899999996432 223455667777777654 4588898888765 468899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCC---------------
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENL--------------- 709 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~--------------- 709 (858)
||++ +++|.+++... ..+++.++..|+.||+.||+||| + .+|+||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred Eecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9987 67899888654 36899999999999999999999 6 5999999999999998765
Q ss_pred -CEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHH
Q 043526 710 -EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT 788 (858)
Q Consensus 710 -~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~ 788 (858)
.+||+|||.+.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 285 ~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~ 358 (467)
T PTZ00284 285 CRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN--LEHLHLME 358 (467)
T ss_pred ceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH
Confidence 49999999876432 222345789999999999999999999999999999999999999975432 11111111
Q ss_pred HHHhc-----------CCchhhhchh--hcCCC---------------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 789 NMIAK-----------GDIENIVDSC--LRGGF---------------EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 789 ~~~~~-----------~~~~~~~d~~--l~~~~---------------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.. ....++++.. +.... .......+.+|+.+||+.||++|||++|++++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 11000 0000010000 00000 00113457799999999999999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=288.17 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=203.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|++|.||+|... +|+.||||++..... .....+..|++.+.+++|+|++++++++...+..++||||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999976 599999999876644 44678999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++... ..+++..++.++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+.......... .
T Consensus 85 ~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 85 SLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 999999754 46899999999999999999999 8 999999999999999999999999999998764332221 2
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...++..|+|||.+.+...+.++|+||||++++||+||+.|+..... ....+...... .+... ..+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~-~~~~~---------~~~~~ 226 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAIC-DGPPP---------SLPAE 226 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHh-cCCCC---------CCCcc
Confidence 34578899999999988899999999999999999999999865542 11112121111 11110 11112
Q ss_pred -HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 812 -SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 812 -~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.+++.+|+..+|++||++.|++++
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 34578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=296.58 Aligned_cols=247 Identities=21% Similarity=0.375 Sum_probs=199.7
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
...+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.++++++|||++++++.+...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 3457899999999999985 478999999987655555677899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... .+++.++..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......... ...
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~ 174 (293)
T cd06647 102 SLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (293)
T ss_pred cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-ccc
Confidence 999998653 4789999999999999999999 899999999999999999999999999988765433222 223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+....++.++||||||+++|||++|+.||........ +......+. .....+...
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~ 241 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGT--------PELQNPEKL 241 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-----eeehhcCCC--------CCCCCcccc
Confidence 4578899999999888889999999999999999999999965332110 000000000 000011123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+++.+|+..+|++||++.+++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3467899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.00 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=196.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|++|.||+|... +|+.||+|++.... ......+.+|++.+++++|||++++++++..++..+++|||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 467999999999999964 79999999987543 2234678899999999999999999999999999999999995 6
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++..+++++.|+++||+||| +.+++||||+|+||+++.++.++|+|||++......... ...
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~ 158 (283)
T cd07835 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTH 158 (283)
T ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cCc
Confidence 9999987655457899999999999999999999 889999999999999999999999999999765432211 122
Q ss_pred ccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC--------Cchhhhchh
Q 043526 733 VAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG--------DIENIVDSC 803 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~--------~~~~~~d~~ 803 (858)
..++..|+|||.+.+. .++.++||||||++++||++|+.||...... ..+........... .+.+.....
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 3467899999987654 5688999999999999999999998654321 11111111100000 000000000
Q ss_pred hc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LR------GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ..........+.+++.+|++.+|.+||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00011223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=308.41 Aligned_cols=245 Identities=29% Similarity=0.526 Sum_probs=197.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEec----cCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe--eEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLS----SSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN--MGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~E 647 (858)
|.++||+|+|-+||||... +|.+||--.++ ..+....++|..|+++|+.|+||||++++.+|.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4568999999999999964 78888843332 2244456889999999999999999999999987665 778999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccCCC
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~~~ 726 (858)
.+..|+|..++...+ ..+.....+|++||++||.|||+. .++|+|||||-+||+|+.+ |.+||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999997765 678889999999999999999954 7899999999999999865 89999999999987543
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
+. ..+.|||.|||||+.. ..|++..||||||++++||+|+..||.. ..+-+ .+.+.+-.|....-+.+.
T Consensus 200 -~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~A-QIYKKV~SGiKP~sl~kV--- 268 (632)
T KOG0584|consen 200 -HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPA-QIYKKVTSGIKPAALSKV--- 268 (632)
T ss_pred -cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHH-HHHHHHHcCCCHHHhhcc---
Confidence 22 2367999999999887 7899999999999999999999999852 22223 333334444322222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...++.++|.+|+.. .++|||+.|+++.
T Consensus 269 -----~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 -----KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 134688999999999 9999999999863
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=285.15 Aligned_cols=246 Identities=26% Similarity=0.471 Sum_probs=202.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+.||+|++|.||++... +++.+++|++........+++.+|++.+++++|+|++++++++..+...++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999975 7899999999876655668899999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++.... ..+++..+..++.|+++||++|| ..+++||||+|+||++++++.++|+|||.+........ .....
T Consensus 85 ~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 85 KDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 99987653 46899999999999999999999 89999999999999999999999999999987654332 23456
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
++..|+|||.+.....+.++||||||++++||++|+.|+...... ........ ........ ......
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~~~~~-------~~~~~~ 225 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIAT-NGPPGLRN-------PEKWSD 225 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHh-cCCCCcCc-------ccccCH
Confidence 788999999998888899999999999999999999998654211 11111110 11111110 111135
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.+++.+|++.+|++||++.|++++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=289.48 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=196.3
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||.|++|.||+++.. +++.+|+|.+..... ...+.+.+|++++++++||||+++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 589999999875432 3346789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99997643 5889999999999999999999 8999999999999999999999999999998765432 122346
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
|+..|+|||.+....++.++|+||||+++|||++|+.|+.....+.. ......... .....++.....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~---------~~~~~~~~~~~~ 221 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILKG---------NGKLEFPNYIDK 221 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHHhcc---------CCCCCCCcccCH
Confidence 78899999999888889999999999999999999999976542211 111111110 001112222355
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHH
Q 043526 815 RAVELAVKCASRTSSERPN-----MNEVVT 839 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 839 (858)
.+.+++.+|++.+|++||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7899999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=292.69 Aligned_cols=244 Identities=26% Similarity=0.370 Sum_probs=194.3
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||+|+||+||++... +|+.+|+|.+.... ......+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 78999999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++.......+++.++..++.|++.||.||| +.+++||||+|+||++++++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99997665557899999999999999999999 8899999999999999999999999999987654321 222345
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
++..|+|||.+.+..++.++||||||++++||++|+.||....... . ...+....... ....+.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~-~~~~~~~~~~~----------~~~~~~~~~~ 223 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-E-KEELKRRTLEM----------AVEYPDKFSP 223 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-c-HHHHHhccccc----------cccCCccCCH
Confidence 7889999999988888999999999999999999999996543211 0 01111100000 0111222345
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHH
Q 043526 815 RAVELAVKCASRTSSERP-----NMNEVVT 839 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RP-----sm~eVl~ 839 (858)
.+.+++.+|++.+|++|| +..++++
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 678999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=292.96 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=193.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 4578999999999999965 789999999875432 2235577899999999999999999999999999999999985
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 88 ~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 162 (291)
T cd07844 88 DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-YSN 162 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-ccc
Confidence 9999886543 36889999999999999999999 889999999999999999999999999998754322111 122
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc---CCchhhh--------
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK---GDIENIV-------- 800 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~---~~~~~~~-------- 800 (858)
..++..|+|||.+.+ ..++.++||||+|++++||++|+.||....... .....+...... +......
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 246788999998875 457899999999999999999999986543111 111111111000 0000000
Q ss_pred ------chhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 ------DSCLRGGF-EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 ------d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000 01112567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=293.19 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=192.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++|+||+++.+++..++..++||||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 3578999999999999864 789999999875433 233467889999999999999999999999999999999996 6
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+.+.... ..+.+.++..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||+++........ ...
T Consensus 88 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 162 (291)
T cd07870 88 DLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YSS 162 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CCC
Confidence 7877765433 35788889999999999999999 889999999999999999999999999998764322211 122
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc-------------CCchh
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK-------------GDIEN 798 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~-------------~~~~~ 798 (858)
..++..|+|||.+.+ ..++.++|||||||+++||++|+.||.........+... ...+.. ....+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI-WTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH-HHHcCCCChhhhhhhhhcccccch
Confidence 346889999999875 357889999999999999999999997543221111111 110000 00000
Q ss_pred hhchhhcCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGF-----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......... .......+.+++.+|+..+|++|||++|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000 01123567899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=293.33 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.||+|+||.||++... +|+.+|+|.+.... ......+.+|+..+.++. ||||+++++++..++..+++|||+.. +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 57999999999999964 78999999987543 234567889999999996 99999999999999999999999874 5
Q ss_pred hHHHh---hhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 654 LKQLL---SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 654 L~~~L---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
|.++. .......+++..+.+++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++....... .
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 164 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--K 164 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc--c
Confidence 55433 33334578999999999999999999993 35899999999999999999999999999976543221 1
Q ss_pred ecccCCCCccCccccccC---CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TVVAGTPGYLDPEYFVTD---WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
....|+..|+|||.+... .++.++|||||||+++||++|+.||.... .....+...... . .+.+...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~-~-----~~~~~~~ 234 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKG-D-----PPILSNS 234 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCC-C-----CCcCCCc
Confidence 223578899999998765 68899999999999999999999986432 111212211111 1 0111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......++.+++.+|+..+|++||++++|+++
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345578899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=297.66 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=196.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+++++.++||||+++++.+..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 3578999999999999965 68899999987543 2234578899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC----
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---- 726 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~---- 726 (858)
+++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 85 GGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999996543 6899999999999999999999 8899999999999999999999999999987421100
Q ss_pred ----------cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 727 ----------THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 727 ----------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
........++..|+|||.+....++.++|+||||++++||++|+.||...... +..... ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~-~~~~~ 233 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQV-ISDDI 233 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-Hhccc
Confidence 00111235678999999998888999999999999999999999998643311 111111 11110
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..+.. .......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 234 ---~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 ---EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00000 01223467899999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=292.48 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=197.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~ 649 (858)
..+.||+|++|.||+|... +|+.+|+|++.... ......+.+|++++++++|||++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3467999999999999965 68999999998663 33446788999999999999999999999988 8899999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++ +|.+++.... ..+++.+++.++.|+++||+||| +.+++|+||||+||++++++.+||+|||++..........
T Consensus 83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 85 8988886542 46899999999999999999999 8899999999999999999999999999998765443222
Q ss_pred eecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhh------
Q 043526 730 STVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENI------ 799 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~------ 799 (858)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+....... .....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhccccccchhh
Confidence 233456788999998764 45789999999999999999999998654321 1111111111000 00000
Q ss_pred --------hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 --------VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 --------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.......+...+.+++.+|+..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111125578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=293.91 Aligned_cols=244 Identities=21% Similarity=0.363 Sum_probs=198.6
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
+.||+|++|.||++.. .+++.+|+|++........+.+.+|+.+++.++|||++++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 6899999999999995 478999999987655555567889999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
+++.. ..+++.++..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+........ ......|
T Consensus 105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 177 (285)
T cd06648 105 DIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVG 177 (285)
T ss_pred HHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccC
Confidence 99876 35889999999999999999999 88999999999999999999999999998876543221 2223458
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 815 (858)
+..|+|||...+..++.++||||||++++||++|+.||..... ...... +..+.. +.+. ........
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~-~~~~~~-----~~~~--~~~~~~~~ 244 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKR-IRDNLP-----PKLK--NLHKVSPR 244 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHH-HHhcCC-----CCCc--ccccCCHH
Confidence 8999999999888899999999999999999999999864321 111111 111110 0111 01113357
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 043526 816 AVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 816 l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.+++.+|+..+|++||++++++++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHccC
Confidence 8899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=300.27 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=194.4
Q ss_pred cccccc--CceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKG--GFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+| +||+||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999964 89999999987543 22346788899999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee-
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS- 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 730 (858)
++|.+++.......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998765556899999999999999999999 88999999999999999999999999986544322111110
Q ss_pred -----ecccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHH-------------
Q 043526 731 -----TVVAGTPGYLDPEYFVTD--WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM------------- 790 (858)
Q Consensus 731 -----~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~------------- 790 (858)
....++..|+|||++.+. .++.++|||||||+++||++|+.||....... .+.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCccccccchh
Confidence 112345679999998763 47899999999999999999999986543211 111110000
Q ss_pred -------------------HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 791 -------------------IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 791 -------------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+......+..+...........+.+++.+|++.+|++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000001111111111123345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=291.18 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=195.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCC------eeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDN------NMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------~~~lV 645 (858)
.+.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+++++++ +|+||+++++++.... ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 34578999999999999975 688999999875543 346789999999999 6999999999997654 48999
Q ss_pred EeeccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 646 YEYMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
|||+++++|.+++.... ...+++..+..++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999986543 457899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCcceeecccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
... .......|+..|+|||.+.. ..++.++|||||||+++||++|+.||..... ...+ ... ..+....
T Consensus 165 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~----~~~-~~~~~~~ 237 (275)
T cd06608 165 STL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-MRAL----FKI-PRNPPPT 237 (275)
T ss_pred cch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-HHHH----HHh-hccCCCC
Confidence 322 22233458889999998753 3467899999999999999999999864321 1111 111 1111000
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+. .+......+.+++.+|+..+|++|||++|++++
T Consensus 238 -----~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 -----LK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----CC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 112234578899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=296.03 Aligned_cols=242 Identities=28% Similarity=0.437 Sum_probs=193.2
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|+++++.++|||++++.++|..++..++|+||++
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 3478999999999999965 789999999864432 234568899999999999999999999999999999999997
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
|+|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||+|+||++++++.++|+|||++......
T Consensus 99 -g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----- 168 (307)
T cd06607 99 -GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----- 168 (307)
T ss_pred -CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence 57777775433 36899999999999999999999 889999999999999999999999999998765322
Q ss_pred ecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
....++..|+|||.+. ...++.++||||||+++|||+||+.|+....... .... +....... +
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~-~~~~~~~~-----~--- 234 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYH-IAQNDSPT-----L--- 234 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHH-HhcCCCCC-----C---
Confidence 2245788999999874 4567889999999999999999999986433111 1111 11111000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|+..+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 112234578899999999999999999999884
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=280.43 Aligned_cols=265 Identities=23% Similarity=0.418 Sum_probs=208.6
Q ss_pred CHHHHHHHHhhccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCe
Q 043526 564 TYSEVLKITDNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNN 641 (858)
Q Consensus 564 ~~~el~~~t~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 641 (858)
++.|+-+.|. +.||+|++|.|--++ +.+|.++|||++.+.......+..+|++++...+ |+||+.++++|+++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 4667777776 689999999999887 7899999999999888888899999999999985 9999999999999999
Q ss_pred eEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---CEEEeeecC
Q 043526 642 MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL---EAKLADFGL 718 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DFGl 718 (858)
+|||||-|.||+|..+|++++ .+++.++.++..+||.||++|| .++|.|||+||+|||-.... .+|||||.+
T Consensus 151 FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999997765 7999999999999999999999 99999999999999997654 489999998
Q ss_pred cccccCCC------cceeecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHH
Q 043526 719 SKVFPIGG------THVSTVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 719 a~~~~~~~------~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v 787 (858)
..-..... +..-...+|+..|||||+.. ...|+.++|.||+||+||-|++|.+||.+.-.+.. .|-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWd 302 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWD 302 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---Ccc
Confidence 76542221 11223456888999999863 34688999999999999999999999987543221 010
Q ss_pred HHHHhcCCchhhhchhhcCCCC--H----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFE--I----ESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~--~----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+...-+---..++.....+.|. . ..+.+..+++...+..++.+|.++.++++
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000000001122222233332 1 23556789999999999999999999887
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=293.18 Aligned_cols=241 Identities=28% Similarity=0.426 Sum_probs=197.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 4578999999999999965 68999999986532 2334678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++... ..+++..+..++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++...... .
T Consensus 85 ~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 85 GGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 99999999665 46899999999999999999999 899999999999999999999999999999876433 2
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|++.|+|||.+.+...+.++||||||++++||++|+.||..... . .....+..+.. ..+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~----~~~~~~~~~~~----------~~~~ 219 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--I----QIYEKILEGKV----------RFPS 219 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--H----HHHHHHhcCCc----------cCCc
Confidence 234588999999999888889999999999999999999999865331 1 11111111111 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....+.+++.+|+..+|.+|| +++|++++
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 2245778999999999999999 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=292.40 Aligned_cols=246 Identities=23% Similarity=0.412 Sum_probs=200.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+.||+|++|.||+|..+ +++.+|+|++..... ....+..|++.++.++|+|++++++++...+..++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 367999999999999976 789999999976544 457789999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++.... ..+++.++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 103 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 177 (286)
T cd06614 103 TDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV 177 (286)
T ss_pred HHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence 99997654 47899999999999999999999 89999999999999999999999999998876543221 122345
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
++..|+|||.+.+..++.++||||||++++||++|+.|+...... ...... ......... .......
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~~~~~-------~~~~~~~ 244 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLI-TTKGIPPLK-------NPEKWSP 244 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-HhcCCCCCc-------chhhCCH
Confidence 788999999998888899999999999999999999998643211 111111 111111100 0111335
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.+++.+|++.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 68899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=291.44 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=187.7
Q ss_pred cccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHH---hcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 578 VLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLM---RVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~---~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.||+|+||.||++... +|+.+|+|.+...... ....+.+|..+++ ..+|||++.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 7899999998654221 1233444444333 3479999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999986543 6899999999999999999999 8899999999999999999999999999987553221 1
Q ss_pred ecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....|+..|+|||.+.. ..++.++|||||||+++||++|+.||.......... ....... .. ...+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~------~~----~~~~ 219 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT------VN----VELP 219 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhc------CC----cCCc
Confidence 23458999999998864 567899999999999999999999997543222111 1111100 01 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....++.+++.+|+..+|.+|| +++|++++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 23345788999999999999999 59999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=301.79 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=189.5
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEEE
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLIY 646 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~ 646 (858)
.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 47899999999999985 478899999987532 22345678899999999999999999987543 3578999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
|++ +++|.+++.. ..+++.++..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 100 ~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 100 NLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred ecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 987 6799888753 35899999999999999999999 899999999999999999999999999999865432
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch---
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS--- 802 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~--- 802 (858)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+...... ...+....
T Consensus 172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIMEVVGT-PSPEVLKKISS 245 (343)
T ss_pred ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCC-CCHHHHHhcch
Confidence 223468999999999876 5688999999999999999999999865321 1111111111100 00000000
Q ss_pred -----hhc--CCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 -----CLR--GGFEI--------ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 -----~l~--~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+. ...+. .....+.+++.+|+..||.+|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000 112346799999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=290.15 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=196.8
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||+|+||.||+++.. +|+.+|+|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 599999999875533 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-------
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT------- 727 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~------- 727 (858)
.+++.... .+++..+.+++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 6899999999999999999999 88999999999999999999999999999876533211
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.......++..|+|||.......+.++||||||++++||++|+.||.....+ ..... ...+... ..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~------~~-- 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQN-ILNGKIE------WP-- 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhcCCcC------CC--
Confidence 1223345788999999998888899999999999999999999998654311 11111 1111100 00
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
........+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00012457889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=292.20 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=195.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~ 649 (858)
+.+.||+|++|.||+|..+ +++.+|+|.++.... .....+.+|++++++++||||+++++++... +..++||||+
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 3478999999999999976 689999999975432 2234577899999999999999999999877 8899999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++ +|.+++.... ..+++.+++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||++.........
T Consensus 89 ~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 162 (293)
T cd07843 89 EH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP- 162 (293)
T ss_pred Cc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc-
Confidence 85 9999886543 36899999999999999999999 889999999999999999999999999999876543211
Q ss_pred eecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh----------------
Q 043526 730 STVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA---------------- 792 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~---------------- 792 (858)
.....++..|+|||.+.+. ..+.++|+||||++++||++|+.||...... .....+.....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHhhccchh
Confidence 1223468899999988754 4689999999999999999999998654321 11111111000
Q ss_pred -cCCchhhhchhhcCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 793 -KGDIENIVDSCLRGGFEIE-SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 793 -~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...........+...++.. ....+.+++.+|++.+|++||+++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000001111111112111 35567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=292.13 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=190.0
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHH-HHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKL-LMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|+||.||+|... +|+.||+|+++.... ....++..|+.. ++..+|||++++++++..++..++||||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 3578999999999999965 799999999875432 233456666665 566789999999999999999999999997
Q ss_pred CChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
|+|.+++... ....+++..++.++.|++.||+||| +. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 5888887653 2346899999999999999999999 65 89999999999999999999999999988654221
Q ss_pred eeecccCCCCccCcccccc----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 729 VSTVVAGTPGYLDPEYFVT----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
......|+..|+|||.+.+ ..++.++|+|||||+++||++|+.||........ ........ ....+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~---- 229 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ----QLKQVVEE-PSPQLP---- 229 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH----HHHHHHhc-CCCCCC----
Confidence 1223457889999998864 4568899999999999999999999864332111 11111111 101110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
......++.+++.+|+..+|.+||+++++++
T Consensus 230 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=289.45 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=200.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||.|+||.||+|... +++.+|+|.+.... ....+.+.+|++.+++++||||+++++++..++..++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 34578999999999999975 69999999997543 234678999999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++... ..+++.++..++.|+++||+||| +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus 83 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 83 LGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 999999999765 46889999999999999999999 8899999999999999999999999999988764432 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|+..|+|||.+.+...+.++|+||||+++++|++|+.|+...... ........... .....+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~----------~~~~~~ 222 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET----------ADVLYP 222 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc----------ccccCc
Confidence 23345788999999998888999999999999999999999998765432 11111111111 011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNM--NEVV 838 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm--~eVl 838 (858)
......+.+++.+|+..+|.+||++ +|++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2334678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=324.71 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=193.4
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 647 (858)
+.+.+.||+|+||.||+|... ++..+|+|.+.... ......+..|+.+++.++|||||++++++... ..+++|||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 345678999999999999965 67889999987542 23456789999999999999999999988653 56899999
Q ss_pred eccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCC----CCCeEecCCCCcceEEcCC-------------
Q 043526 648 YMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGC----KPPIVHRDIKPENILLTEN------------- 708 (858)
Q Consensus 648 y~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~----~~~IvH~DLk~~NILl~~~------------- 708 (858)
|+++|+|.++|.... ...+++..++.|+.||+.||+|||... ..+|+||||||+||||+.+
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 999999999997532 346899999999999999999999422 1469999999999999642
Q ss_pred ----CCEEEeeecCcccccCCCcceeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc
Q 043526 709 ----LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782 (858)
Q Consensus 709 ----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~ 782 (858)
..+||+|||++....... ......||+.|+|||.+.. ..++.++|||||||+||||+||+.||.....
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~---- 248 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN---- 248 (1021)
T ss_pred cCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc----
Confidence 348999999998764322 2234568999999999864 4588999999999999999999999964331
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
..+.+ ..+..+. .+. .......+.+|+..||..+|.+||++.|+++
T Consensus 249 ~~qli-~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQLI-SELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHH-HHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11111 1111111 000 0112346889999999999999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=283.04 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=202.8
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~~ 650 (858)
.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++||||+++++.+... +..++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 468999999999999976 799999999876543 4567889999999999999999999999988 88999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-e
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-V 729 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 729 (858)
+++|.+++.... .+++.+++.++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 85 GGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999997654 7899999999999999999999 899999999999999999999999999999876544321 1
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....++..|+|||.......+.++||||||++++||++|+.||..... ....+......+ .....+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~---------~~~~~~ 226 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSG---------EPPEIP 226 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccccC---------CCcCCC
Confidence 2335678899999999888899999999999999999999999875441 111111111000 011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|+..+|.+||++.|++++
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2335678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.40 Aligned_cols=261 Identities=20% Similarity=0.360 Sum_probs=194.9
Q ss_pred ccccccccCceEEEEEEEC---CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIY 646 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 646 (858)
+.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++.+++||||+++++++... +..++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 4567999999999999964 47999999998643 33446778899999999999999999999988 7899999
Q ss_pred eeccCCChHHHhhhcc---cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC----CCCEEEeeecCc
Q 043526 647 EYMANGNLKQLLSDEK---ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE----NLEAKLADFGLS 719 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~----~~~~kL~DFGla 719 (858)
||+++ +|.+.+.... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99985 6777664332 236889999999999999999999 899999999999999999 899999999999
Q ss_pred ccccCCCc--ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccc--------cHHHHHH
Q 043526 720 KVFPIGGT--HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI--------HIIQTVT 788 (858)
Q Consensus 720 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~--------~l~~~v~ 788 (858)
........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.....+.. .+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643322 11223457889999998865 4578999999999999999999999975443220 0111110
Q ss_pred HHHhcC------------CchhhhchhhcCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 789 NMIAKG------------DIENIVDSCLRGGFE---------I--ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 789 ~~~~~~------------~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+... ......+......++ . ....++.+++.+|++.+|++|||+.|++++
T Consensus 240 -~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 -VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred -HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 000000000000011 0 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=295.13 Aligned_cols=242 Identities=27% Similarity=0.421 Sum_probs=193.2
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||+|+||.||+|+.. +|..+|+|.+..... ....++..|++++++++|||++++++++..++..++||||+++
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 109 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG 109 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC
Confidence 467999999999999964 789999999874422 2345788899999999999999999999999999999999974
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+.+... ...++|.++..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++...... .
T Consensus 110 -~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~ 179 (317)
T cd06635 110 -SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----N 179 (317)
T ss_pred -CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----c
Confidence 888877543 346899999999999999999999 889999999999999999999999999998764322 2
Q ss_pred cccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 732 VVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 732 ~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
...|+..|+|||++. .+.++.++|||||||+++||++|+.||...... .........+. ....
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~---------~~~~ 245 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNES---------PTLQ 245 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHhccC---------CCCC
Confidence 345788999999974 456889999999999999999999998653211 11111111110 0001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.......+.+++.+|++.+|.+||++.++++++
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 122344688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=292.30 Aligned_cols=258 Identities=20% Similarity=0.271 Sum_probs=192.4
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
.+|.|+++.||++.. +|+.||||+++.. .....+.+.+|+++++.++||||+++++++..++..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344455555555544 7999999998754 3445678999999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc------e
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH------V 729 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~------~ 729 (858)
+++.......+++.....++.|+++||+||| +.+|+||||||+||+++.++.+||+|||.+......... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9998765567889999999999999999999 889999999999999999999999999988755322111 1
Q ss_pred eecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh----cCC-------c
Q 043526 730 STVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA----KGD-------I 796 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~----~~~-------~ 796 (858)
.....++..|+|||.+.. ..++.++|||||||+++||++|+.||....... .+.+....... ... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcCCc
Confidence 122346778999999875 357889999999999999999999997543211 11111110000 000 0
Q ss_pred hh----hhchh----hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 EN----IVDSC----LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ..++. ...........++.+++.+||..+|++||++++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 00000 0011122334578899999999999999999999885
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=286.60 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=192.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcc-cceeeeeeeeeeeC--CeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIED--NNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~Ey~ 649 (858)
+.+.||+|+||.||+|... +++.+|+|+++... .........|+..+.++. |+|++++++++.++ +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4567999999999999954 78999999987542 222334567888888885 99999999999987 8899999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+ |+|.+.+.... ..++|.+++.++.|++.||+||| +.+++||||||+||+++. +.+||+|||+++........
T Consensus 83 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 83 D-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred C-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 7 58888886543 46899999999999999999999 889999999999999999 99999999999876432221
Q ss_pred eecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC-----------Cch
Q 043526 730 STVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG-----------DIE 797 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~-----------~~~ 797 (858)
....++..|+|||.+. +...+.++|||||||+++||++|+.||..... .............. ...
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2245788999999765 45678899999999999999999999965331 12222222111110 000
Q ss_pred hhhchhhcC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSCLRG----GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+...+ .........+.+++.+|+..+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0011235688999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=283.63 Aligned_cols=247 Identities=31% Similarity=0.464 Sum_probs=202.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|++|.||++... +++.+|+|++..... ...+++.+|+++++.++|||++++.+.+..++..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3467999999999999965 689999999976533 4567789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|.+++.... ...+++.++..++.++++||+||| +.+++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 99999997653 467999999999999999999999 8899999999999999999999999999998764432 12
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|++.|+|||.......+.++||||+|+++++|++|+.|+..... ....... ..+... ..+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~---------~~~ 224 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKI-LKGQYP---------PIP 224 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHH-hcCCCC---------CCC
Confidence 2334678899999999888899999999999999999999999865431 1111111 111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|+..+|++||++.|++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=288.06 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=196.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|++|.||+|+.. +|+.||||.++..... ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 3578999999999999975 7899999998765332 346678899999999999999999999999999999999985
Q ss_pred ChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 653 NLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... ...+++.++.+++.|++.||+||| +.+++||||||+||++++++.++|+|||++......... ..
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FS 158 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-cc
Confidence 8888886543 346899999999999999999999 889999999999999999999999999999765432211 12
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh---cCCchhhhc-hhhcC
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA---KGDIENIVD-SCLRG 806 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~---~~~~~~~~d-~~l~~ 806 (858)
...++..|++||.+.+ ..++.++||||||++++||++|+.||......+ .... +..... ......+.+ +.+..
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLK-IFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHH-HHHHhCCCChhhHHHHhcCchhcc
Confidence 2346889999998865 456889999999999999999999986543221 1111 111000 000000000 00000
Q ss_pred C-----------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 G-----------FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~-----------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ........+.+++.+|++.+|.+||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 011224567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=290.88 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=206.3
Q ss_pred HhhccccccccCceEEEEEEE-CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+++.+.||+|.|+.|-.|++ =+|..||||++.+..- .....+.+|++.|+.++|||||+++++...+..+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 345678899999999999984 4899999999976533 3456789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeecCcccccCCCc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~~~~~ 727 (858)
-++|+|+++|..+. ..+++....+++.||+.|+.|+| ...+|||||||+||.+= .-|-+||.|||++..+..+..
T Consensus 99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999997664 46899999999999999999999 88999999999998764 568899999999988766543
Q ss_pred ceeecccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
-+...|...|-|||.+.+..|. ++.||||+||+||-|++|++||+.....+ .+.-++|-..
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TLTmImDCKY-- 236 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TLTMIMDCKY-- 236 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hhhhhhcccc--
Confidence 3456799999999999988775 67899999999999999999998654322 1222333211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
..+.....+..+|+..|+..||.+|.+.+||+.
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 235566778899999999999999999999875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=290.38 Aligned_cols=244 Identities=20% Similarity=0.359 Sum_probs=197.3
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
..||+|+||.||++..+ +|+.||||.+..........+..|+..++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999864 78999999987655555677899999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
+++... .+++.....++.|++.||+||| +.+++||||+|+||++++++.++|+|||++........ ......|
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 987543 4789999999999999999999 88999999999999999999999999999876543221 2233457
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 815 (858)
+..|+|||.+.+..++.++|+||||++++||++|+.||..... ......+.... .+.+.. .......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~---------~~~~~~--~~~~~~~ 245 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL---------PPKLKN--LHKVSPS 245 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhC---------CcccCC--cccCCHH
Confidence 8999999999888889999999999999999999999864321 11111111100 011100 0112345
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 043526 816 AVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 816 l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.+++.+|++.+|.+||++.+++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhcC
Confidence 7789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=284.09 Aligned_cols=245 Identities=26% Similarity=0.406 Sum_probs=200.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|++|.||++... +|+.+|+|.+.... .....++.+|++++++++|+||+++.+++......++||||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 3468999999999999854 78899999987542 23456788899999999999999999999999999999999999
Q ss_pred CChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|.+++.... ...+++..++.++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++...... .
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~ 157 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---M 157 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---C
Confidence 99999986532 346899999999999999999999 899999999999999999999999999999876543 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||.....+. + ...+..+... ..+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~----~~~~~~~~~~---------~~~ 222 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--L----RYKVQRGKYP---------PIP 222 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHHhcCCCC---------CCc
Confidence 223457889999999998889999999999999999999999986543211 1 1111111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|+..+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2344568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=285.09 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=203.7
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+.||+|++|.||++.++ .|..+|||.+... .+.++...|+.++++++.|++|+++|.+.....+++|||||..|++
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 467999999999999965 7999999998654 3568899999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+.++-+ .+++++.++..+++..++||+||| ...=+|||||+.|||++-+|.+||+|||.|..+... -.....+.
T Consensus 116 SDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTVI 190 (502)
T KOG0574|consen 116 SDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTVI 190 (502)
T ss_pred HHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCccc
Confidence 9999755 468999999999999999999999 777899999999999999999999999999866321 12334567
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
||+.|||||++..-.|..++||||+|+...||..|++|+.+-..-. +..++... +...-..+.....
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AIFMIPT~-------PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AIFMIPTK-------PPPTFKKPEEWSS 257 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------eeEeccCC-------CCCCCCChHhhhh
Confidence 9999999999999999999999999999999999999986532100 00000100 0011112455677
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
++-++++.|+.+.|++|-++.+++++
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 89999999999999999999988875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.45 Aligned_cols=259 Identities=26% Similarity=0.368 Sum_probs=194.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCC----------
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN---------- 640 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---------- 640 (858)
.+.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|||++++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 34578999999999999975 689999999975432 23356788999999999999999999987655
Q ss_pred eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 641 NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
..++|+||+++ +|.+.+... ...+++.+++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 78999999986 777777543 346899999999999999999999 8899999999999999999999999999998
Q ss_pred cccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---c
Q 043526 721 VFPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---I 796 (858)
Q Consensus 721 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~ 796 (858)
..............++..|+|||.+.+ ...+.++|||||||+++||++|+.||.... .......+........ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhc
Confidence 765433222222345778999998764 456889999999999999999999986432 1111111221111100 0
Q ss_pred hhhhch--------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 ENIVDS--------------CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ~~~~d~--------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.++... .+.... ......+.+++.+|+..+|.+||++++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000000 0124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=284.99 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=188.9
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHH-HhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLL-MRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|++|.||+|... +|+.||||.+..... .....+..|...+ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 789999999865432 1223344554443 445899999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999996543 6889999999999999999999 88999999999999999999999999999876432 22
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...|+..|+|||.+.+..++.++||||||++++||++|..||...... .. .. .+..+... ........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~---~~-~~~~~~~~------~~~~~~~~ 219 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AV---FD-NILSRRIN------WPEEVKEF 219 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HH---HH-HHHhcccC------CCCccccc
Confidence 345788999999998877899999999999999999999998654321 11 11 11111100 00001112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
....+.+++.+|+..+|++||++.++.+.|+
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 3457889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.59 Aligned_cols=244 Identities=26% Similarity=0.449 Sum_probs=200.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|++|.||++... +++.+|+|.+..... .....+.+|++++++++|||++++++++..++..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 4578999999999999865 688999999976644 3557789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......... ..
T Consensus 84 ~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 84 GSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 9999999654 46899999999999999999999 889999999999999999999999999999876543322 23
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...++..|+|||.......+.++||||+|++++||++|+.|+..... .. . ..... .... ...+..
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~--~-~~~~~-~~~~---------~~~~~~ 222 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MA--A-LFRIV-QDDH---------PPLPEG 222 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HH--H-HHHHh-ccCC---------CCCCCC
Confidence 34578899999999877788999999999999999999999864331 11 1 11111 1100 111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
....+.+++.+|+..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3457789999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=288.54 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=198.0
Q ss_pred ccccccccCceEEEEEEE----CCCCEEEEEEeccCC----CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.||+|++|.||++.. .+++.||||.++... ....+.+..|++++.++ +||||+++.+.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 457899999999999874 367899999986432 22345688999999999 599999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.+++... ..+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 84 LDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999998653 36889999999999999999999 899999999999999999999999999998876443
Q ss_pred CcceeecccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDW--LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.........|+..|+|||...+.. .+.++||||||++++||++|..||...... .......+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~--------- 228 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSK--------- 228 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccC---------
Confidence 322233345788999999987654 788999999999999999999998643211 11111111111110
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
...+......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 229 --~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 --PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11112233467899999999999999999888777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=285.10 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=187.6
Q ss_pred cccccCceEEEEEEE-CCCCEEEEEEeccCCCc---chHhHHHHHH---HHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 578 VLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ---GFKEFEAEVK---LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---~~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+||+|+||.||++.. .+|+.||+|.+...... ....+..|.. .++...||||+++.+++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46899999998754221 1222344443 3444579999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999988643 36899999999999999999999 8899999999999999999999999999987653322 1
Q ss_pred ecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....|+..|+|||.+.++ .++.++||||+|++++||++|+.||........... ...... .+.. .+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~------~~~~----~~ 219 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLT------MAVE----LP 219 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhhc------cCCC----CC
Confidence 234689999999998754 688999999999999999999999975432111100 010000 0111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....++.+++.+|+..+|.+|| ++++++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 22345788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=287.31 Aligned_cols=259 Identities=23% Similarity=0.315 Sum_probs=194.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhc---ccceeeeeeeeeeeCCe-----eE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRV---HHRNLTNLVGYFIEDNN-----MG 643 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~-----~~ 643 (858)
..+.||+|+||.||+|+.+ +++.+|+|++...... ....+.+|+.++.++ +|||++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 3468999999999999976 5899999999744322 234566777777666 59999999999998776 99
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
++|||+.+ +|.+++.......+++.+++.++.|+++||+||| +.+++|+||+|+||++++++.+||+|||++....
T Consensus 83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 99999975 8999887655456899999999999999999999 8899999999999999999999999999998764
Q ss_pred CCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---c----
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---I---- 796 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~---- 796 (858)
..... ....++..|+|||.+.+...+.++|+|||||+++||++|++||..... ...+............ .
T Consensus 159 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 159 FEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred CCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCcc
Confidence 33221 223468889999999988899999999999999999999988865332 1111111111000000 0
Q ss_pred --hhhhchhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 --ENIVDSCLRGGF---EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 --~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
............ ..+....+.+++.+|++.+|.+||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000000 11234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=283.19 Aligned_cols=234 Identities=23% Similarity=0.299 Sum_probs=185.3
Q ss_pred ccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCChHH
Q 043526 579 LGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656 (858)
Q Consensus 579 LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 656 (858)
||+|+||.||++.. .+|+.+|+|.+....... . |+.....+ +|||++++++.+..++..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 59999999999995 478899999986542221 1 22222222 69999999999999999999999999999999
Q ss_pred HhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCcceeecccC
Q 043526 657 LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 657 ~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
++.... .+++.++..++.|+++||+||| +.+++||||||+||+++.++ .++|+|||++...... ....|
T Consensus 99 ~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~ 168 (267)
T PHA03390 99 LLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDG 168 (267)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCC
Confidence 997653 7899999999999999999999 88999999999999999998 9999999998765422 12357
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHH
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 815 (858)
+..|+|||.+.+..++.++||||||++++||++|+.||.....+......+.... .... .........
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~ 236 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKL----------PFIKNVSKN 236 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccC----------CcccccCHH
Confidence 8899999999988899999999999999999999999975443333322222221 1000 011133456
Q ss_pred HHHHHHHccccCCCCCCC-HHHHHH
Q 043526 816 AVELAVKCASRTSSERPN-MNEVVT 839 (858)
Q Consensus 816 l~~l~~~Cl~~dP~~RPs-m~eVl~ 839 (858)
+.+++.+|++.+|.+||+ ++|+++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhc
Confidence 889999999999999995 688875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=286.47 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=195.3
Q ss_pred ccccccccCceEEEEEEE----CCCCEEEEEEeccCC----CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.||+|+||.||++.. .+|+.||+|++.... ....+.+..|+++++++ +|+||+++.+++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 357899999999999985 478999999987532 22346678899999999 599999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++++|.+++.... .+++.+...++.|+++||+||| +.+++||||+|+|||+++++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 84 LDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999997543 6888999999999999999999 899999999999999999999999999999876443
Q ss_pred CcceeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.........|+..|+|||.+.. ...+.++||||||++++||++|+.|+..... ...............
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~--------- 228 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE--------- 228 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC---------
Confidence 3222233458899999999875 3467899999999999999999999864321 111111111111110
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
..++......+.+++.+|+..+|++|| +.++++.+
T Consensus 229 --~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111222345678999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.36 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=192.7
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~ 649 (858)
..+.||+|+||.||+|... +|+.||+|.++..... ....+.+|++++++++|+|++++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 3468999999999999965 7999999998754322 234567899999999999999999998765 5689999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++ +|.+++.... ..+++.++..++.|+++||+||| +.+++||||||+||++++++.+||+|||++.........
T Consensus 91 ~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~- 164 (309)
T cd07845 91 EQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP- 164 (309)
T ss_pred CC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC-
Confidence 75 8888886543 46899999999999999999999 889999999999999999999999999999876533211
Q ss_pred eecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhhhchh--
Q 043526 730 STVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENIVDSC-- 803 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~~d~~-- 803 (858)
.....++..|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+....... ......+..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhhhccccc
Confidence 122335778999998865 5578999999999999999999999865432 11111111111100 000000000
Q ss_pred ----hcC-CC-C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 ----LRG-GF-E-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 ----l~~-~~-~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.. .. . ......+.+++.+|++.||++||+++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00 0 0124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=289.06 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=193.2
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|++|.||+|... +|+.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 3468999999999999965 789999999865432 234678899999999999999999999999999999999996
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++|.+++.......+++.....++.||+.||+||| +.+++|+||+|+||++++ ++.+||+|||++........ ..
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-TF 160 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-cc
Confidence 58888886555445688889999999999999999 889999999999999985 56799999999976543211 11
Q ss_pred ecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh-------c-
Q 043526 731 TVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV-------D- 801 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~-------d- 801 (858)
....++..|+|||.+.+ ..++.++|||||||+++||+||+.||......+ .+... ....... ..... +
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~-~~~~~~~-~~~~~~~~~~~~~~ 237 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKI-FRILGTP-NEETWPGVTSLPDY 237 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HHHhCCC-Chhhccccccchhh
Confidence 22356789999998865 457899999999999999999999986543211 11111 0100000 00000 0
Q ss_pred --h--hhcCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 --S--CLRGG----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 --~--~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ..... .......++.+++.+|++.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 011224467899999999999999999999874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=285.98 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=181.4
Q ss_pred hhccccccccCceEEEEEEECC----CCEEEEEEeccCCCcch-----------HhHHHHHHHHHhcccceeeeeeeeee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSSGQGF-----------KEFEAEVKLLMRVHHRNLTNLVGYFI 637 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~~~~~ 637 (858)
+.+.+.||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 3456789999999999999654 45667775433222111 11223334456678999999999876
Q ss_pred eCC----eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEE
Q 043526 638 EDN----NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKL 713 (858)
Q Consensus 638 ~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL 713 (858)
... ..++++|++.. ++.+.+... ...++..+..++.|+++||+||| +.+|+||||||+|||++.++.++|
T Consensus 94 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 94 FKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence 554 34677777644 666666433 23578888999999999999999 889999999999999999999999
Q ss_pred eeecCcccccCCCcc------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHH
Q 043526 714 ADFGLSKVFPIGGTH------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 714 ~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v 787 (858)
+|||+++.+...... ......||+.|+|||...+..++.++|||||||+++||++|+.||........ +....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHHh
Confidence 999999876432211 11234689999999999999999999999999999999999999976532221 11111
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.... +..+....+. .......+.+++..|+..+|++||+++++++.|
T Consensus 247 ~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDF----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHH----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1000 0011111000 111235688999999999999999999999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=285.71 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=191.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCe-----eEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNN-----MGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~-----~~lV 645 (858)
..+.||+|+||.||+|... +|+.||||.++.... .....+.+|+++++.++ ||||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 3468999999999999965 789999999865432 23467888999999995 6999999999987666 8999
Q ss_pred EeeccCCChHHHhhhcc---cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCccc
Q 043526 646 YEYMANGNLKQLLSDEK---ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKV 721 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~ 721 (858)
|||+++ +|.+++.... ...+++..++.++.||++||+||| +.+|+||||||+||+++. ++.+||+|||++..
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999986 8988886543 246899999999999999999999 899999999999999998 88999999999876
Q ss_pred ccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC-----
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD----- 795 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~----- 795 (858)
....... .....+++.|+|||.+.+ ..++.++||||||++++||++|..||....... .+... ...+....
T Consensus 161 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~ 237 (295)
T cd07837 161 FSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHI-FKLLGTPTEQVWP 237 (295)
T ss_pred cCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH-HHHhCCCChhhCc
Confidence 5322111 122346788999998864 457899999999999999999999986533111 11111 11110000
Q ss_pred -chhhhchhhcCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 -IENIVDSCLRGGF--------EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 -~~~~~d~~l~~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+..+..-.... ......++.+++.+|+..+|.+||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000 01234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=284.02 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|++|.||+|... +|+.+|+|.+...... ....+..|++++++++|+||+++++++..++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 467999999999999965 7899999998755332 456788999999999999999999999999999999999985
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.+++.++.|++.||+||| +.+|+|+||||+||++++++.++|+|||.+........ ....
T Consensus 83 ~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~~~ 157 (283)
T cd05118 83 DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTH 157 (283)
T ss_pred CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cccC
Confidence 8888886643 47899999999999999999999 88999999999999999999999999999987654331 1222
Q ss_pred ccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhhhc---h---
Q 043526 733 VAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENIVD---S--- 802 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~~d---~--- 802 (858)
..++..|+|||.+.+. ..+.++|+||||+++++|+||+.||...... .....+...+... ......+ .
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 4577889999998876 7889999999999999999999998654321 1111111111110 0000000 0
Q ss_pred hhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRG-------GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... ........++.+++.+|+..+|.+||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=286.10 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=195.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.||+|++|.||+|... +++.||||++..... .......+|+..+++++ |||++++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4578999999999999975 588999999875433 22334567899999999 999999999999999999999999 7
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.......+++.+++.++.|++.+|+||| +.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 156 (283)
T cd07830 82 GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YT 156 (283)
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--cC
Confidence 89999987665557899999999999999999999 88999999999999999999999999999986643222 12
Q ss_pred cccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---------Cchhhhc
Q 043526 732 VVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---------DIENIVD 801 (858)
Q Consensus 732 ~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---------~~~~~~d 801 (858)
...++..|+|||.+. ...++.++|+||||++++||++|+.||....... ............ ......+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 345788999999875 4557899999999999999999999885443211 011110000000 0000000
Q ss_pred hhhcCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGG-------FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+... ........+.+++.+|++.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 001113578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=282.48 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=193.9
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccC-----CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS-----SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 645 (858)
.+.+.||+|+||.||+|.. .+|+.||+|.+... ..+....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 3457899999999999985 47999999987532 223446788999999999999999999998764 457899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
+||+++++|.+++.... .+++....+++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999986543 5788999999999999999999 889999999999999999999999999999865321
Q ss_pred Cc--ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GT--HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.. .......|+..|+|||.+.+...+.++|+|||||+++||++|+.||...... ..+.......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------- 225 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFKIATQP--------- 225 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHHHHcCC---------
Confidence 11 1112345788999999998888899999999999999999999998643211 1111111111
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....+......+.+++.+|+. +|.+||+..+++.+
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0111233344578899999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=289.07 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=191.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|++|.||+|..+ +|+.||||.++.... ....++..|++.+.+.. ||||+++++++..+...++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 34578999999999999986 489999999975432 33456677887777775 9999999999999999999999986
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+ +|.+++.... ..+++..+..++.|++.||+||| + .+|+||||+|+||++++++.+||+|||++.........
T Consensus 98 ~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 98 T-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred c-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 4 7777765433 37899999999999999999999 5 58999999999999999999999999998765432221
Q ss_pred eecccCCCCccCccccccCC----CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 730 STVVAGTPGYLDPEYFVTDW----LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~----~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
....++..|+|||.+.+.. ++.++||||||++++||++|+.||.....+ . +......... ... +.
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~---~~~~~~~~~~-~~~-----~~ 240 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-F---EVLTKILQEE-PPS-----LP 240 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-H---HHHHHHhcCC-CCC-----CC
Confidence 2235778999999987543 788999999999999999999998643211 1 1111111111 000 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.......++.+++.+|+..+|++||++++++++-
T Consensus 241 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 241 --PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0112345688999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.55 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=192.4
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E 647 (858)
..+.||+|+||.||+|.. .+|+.||||.++... ......+.+|+.++++++||||+++++++... ...++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 357899999999999985 478999999986432 23346688899999999999999999987654 35799999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++ +|.+.+.. ..+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 89 LMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred hccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 9975 88887753 35899999999999999999999 88999999999999999999999999999886543222
Q ss_pred ce--eecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc---hhhhc
Q 043526 728 HV--STVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI---ENIVD 801 (858)
Q Consensus 728 ~~--~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~---~~~~d 801 (858)
.. .....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+...+..... ..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 123457889999998754 5688999999999999999999999864321 1111111111111110 11110
Q ss_pred hh----h---cC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SC----L---RG--GFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~----l---~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. + .. ..+ .....++.+++.+|++.+|++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0 00 000 1124568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=294.94 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=191.9
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEEE
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLIY 646 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~ 646 (858)
.+.||+|+||.||+|... +|+.||+|.+... ......++.+|++++++++||||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 478999999999999954 7999999998643 223345678899999999999999999988644 3478999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+.+ +|.+.+.. .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 101 e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 101 ELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred eccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 99965 88888753 2788999999999999999999 8899999999999999999999999999998754322
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHH----------------
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM---------------- 790 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~---------------- 790 (858)
......++..|+|||.+.+..++.++|||||||++++|++|+.||...... .....+...
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 173 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI--DQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred --CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 122345788999999999989999999999999999999999998654311 101101000
Q ss_pred ---HhcCC------chhhhchhhcCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 791 ---IAKGD------IENIVDSCLRGG----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 791 ---~~~~~------~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.. ..+.+...+... .+......+.+++.+|++.||++||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 001111100000 011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=311.04 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=185.8
Q ss_pred HhhccccccccCceEEEEEEEC--CCCEEEEEEe--------------c---cCCCcchHhHHHHHHHHHhcccceeeee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD--DGTQVAVKML--------------S---SSSGQGFKEFEAEVKLLMRVHHRNLTNL 632 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l--------------~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l 632 (858)
.+.+.+.||+|+||+||++.++ ++...++|.+ . .........+.+|++++++++||||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 3455688999999999998754 2222222211 0 0111234568899999999999999999
Q ss_pred eeeeeeCCeeEEEEeeccCCChHHHhhhcc---cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEK---ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 633 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
++++...+..++|+|++. ++|.+++.... .......+...++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCC
Confidence 999999999999999986 47777765432 112335567789999999999999 89999999999999999999
Q ss_pred CEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCcc-ccCCCc-cccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVI-VRNENE-NIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~-~~~~~~-~~~l~~~v 787 (858)
.+||+|||+++.+............|+..|+|||.+.+..++.++|||||||++|||++|+.++ ...... ...+...+
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999999876544333333457899999999999989999999999999999999998544 322211 12222221
Q ss_pred HHHH--hcCC------chhhhchhhcCC----C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 788 TNMI--AKGD------IENIVDSCLRGG----F-----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 788 ~~~~--~~~~------~~~~~d~~l~~~----~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... .++. +.+.++...... . .......+.+++.+|++.||.+||++.|++++
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1100 0000 000000000000 0 00112356778999999999999999999875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=298.04 Aligned_cols=246 Identities=22% Similarity=0.412 Sum_probs=201.1
Q ss_pred ccccccCceEEEEEEECC-CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
-.||.|+||.||+|..++ +-..|-|++...+.....+|+-|+++|..+.||+||+|++.|+.++.++++.|||.||...
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 358999999999999654 4456789998888888999999999999999999999999999999999999999999999
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
..+-.- +..+.+.++.-++.|++.||.||| +..|||||||+.|||++-+|.++|+|||.+..... .......+.|
T Consensus 118 aimlEL-~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIG 192 (1187)
T KOG0579|consen 118 AIMLEL-GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIG 192 (1187)
T ss_pred HHHHHh-ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhccccC
Confidence 887554 357999999999999999999999 99999999999999999999999999998764321 1223345789
Q ss_pred CCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 736 TPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 736 t~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
|+.|||||+.+ ...|+.++||||||+.|.||.-+.+|..... ....+.. +.......++ -+.
T Consensus 193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRVllK-iaKSePPTLl-------qPS 259 (1187)
T KOG0579|consen 193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLK-IAKSEPPTLL-------QPS 259 (1187)
T ss_pred CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHHHHH-HhhcCCCccc-------Ccc
Confidence 99999999876 4578899999999999999999999864322 1111111 1111111111 134
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....+.+++.+|+.++|..||++.+++++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 566788999999999999999999998864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=289.99 Aligned_cols=242 Identities=26% Similarity=0.433 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||+|++|.||+|+.. +++.+|+|.+... ......++.+|+++++.++|+|++++.+++..++..++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 467999999999999964 7889999998643 22334578889999999999999999999999999999999997
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+.+.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...... .
T Consensus 99 ~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~ 169 (308)
T cd06634 99 GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169 (308)
T ss_pred CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----c
Confidence 58888775433 45889999999999999999999 889999999999999999999999999998765432 2
Q ss_pred cccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 732 VVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 732 ~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
...|+..|+|||.+. ....+.++|||||||+++||++|+.|+...... ...... ..+.... . .
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~-~~~~~~~-----~---~ 235 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHI-AQNESPA-----L---Q 235 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHHH-hhcCCCC-----c---C
Confidence 345788999999874 356788999999999999999999998643211 111111 1111100 0 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.......+.+++.+|+..+|++||++++++++-
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 122345678999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=288.16 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=190.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCC--------ee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--------NM 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--------~~ 642 (858)
...+.||+|+||.||+|... +|+.||||.+..... .....+.+|++++++++||||++++++|...+ ..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 44578999999999999965 799999999864422 22345678999999999999999999987654 35
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
++||||+.+ +|.+.+.... ..+++.+++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 95 YLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 999999975 8888876432 36899999999999999999999 889999999999999999999999999999876
Q ss_pred cCCCcc---eeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh---cCC
Q 043526 723 PIGGTH---VSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA---KGD 795 (858)
Q Consensus 723 ~~~~~~---~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~---~~~ 795 (858)
...... ......++..|+|||.+.+. .++.++||||||++++||++|+.|+...... .....+..... .+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSITPEV 247 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhh
Confidence 432221 11223467889999988654 4688999999999999999999988654321 11111111110 000
Q ss_pred ch-----hhhch-hhcCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 IE-----NIVDS-CLRGGF---------EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 ~~-----~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. +..+. .+.... .......+.+++.+|+..+|.+||+++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00000 000000 00113456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=311.94 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=207.0
Q ss_pred hccccccccCceEEEEEEEC----C----CCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----D----GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~----g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 643 (858)
.+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|+|++.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 34568999999999999843 1 35799999986533 4567899999999999 5999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcc------------c--CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 644 LIYEYMANGNLKQLLSDEK------------A--STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~------------~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
+|+||++.|+|.++|+.++ . ..+...+.+.++.|||.||+||+ +.+++||||..+|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999998765 0 13888999999999999999999 89999999999999999999
Q ss_pred CEEEeeecCcccccCCCcceeecccC--CCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTHVSTVVAG--TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQT 786 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~ 786 (858)
.+||+|||+|+..............| ...|||||.+....++.|+|||||||+||||+| |..|+..... ...+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~~l--- 531 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-TEEL--- 531 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-HHHH---
Confidence 99999999999765544443332233 346999999999999999999999999999999 6777754210 1111
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
...+++|... ..+..+..++.++++.||..+|++||++.|+++.++..+.
T Consensus 532 -~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 -LEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 2234444321 1233445678899999999999999999999999999654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=291.50 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=193.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeC--CeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED--NNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~~lV~E 647 (858)
.+.+.||+|+||.||+|... +|+.+|||++... .......+.+|+.+++++ +||||+++++++... ...++|||
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE 89 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence 34578999999999999965 6889999988543 223345677899999999 999999999998654 36899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|++ ++|.+++... .++|..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 90 YME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 997 4999888643 6889999999999999999999 88999999999999999999999999999987644322
Q ss_pred c----eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH-----------
Q 043526 728 H----VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI----------- 791 (858)
Q Consensus 728 ~----~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~----------- 791 (858)
. ......|+..|+|||.+.+ ...+.++||||||++++||+||+.||....... ....+....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHH
Confidence 1 2223457889999998764 567889999999999999999999986433211 111111000
Q ss_pred hcCCchhhhchhhcCC-CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 792 AKGDIENIVDSCLRGG-FE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 792 ~~~~~~~~~d~~l~~~-~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......+++...... .+ .....++.+++.+|++.+|++||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001111000000 00 1134578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=287.60 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=200.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
++||+|+||.||-+..+ +|+.+|.|.+.+. ..+...-.+.|-++|.+++.+.||.+--.|..++.+++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 68999999999999865 8999999988643 2334455688999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.-+|.+.....+++..++.++.+|+-||++|| ...||.||+||.|||+|+.|+++|+|.|+|..++.+.....
T Consensus 271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~-- 345 (591)
T KOG0986|consen 271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG-- 345 (591)
T ss_pred ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc--
Confidence 9999998877778999999999999999999999 99999999999999999999999999999998876654433
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.+||.||||||++.++.|+...|-||+||++|||+.|+.||....... -.+-+.+.+.+. ...++..-
T Consensus 346 rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--k~eEvdrr~~~~----------~~ey~~kF 413 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--KREEVDRRTLED----------PEEYSDKF 413 (591)
T ss_pred ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--hHHHHHHHHhcc----------hhhccccc
Confidence 479999999999999999999999999999999999999997543210 000111111110 12234444
Q ss_pred HHHHHHHHHHccccCCCCCCCH
Q 043526 813 AWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
+.+..++....+++||++|.-.
T Consensus 414 S~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccC
Confidence 5677888889999999998743
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.45 Aligned_cols=240 Identities=29% Similarity=0.443 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++|||++++++++.+++..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 56999999999999964 789999999875432 234568889999999999999999999999999999999996 5
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+.+.... ..+++.+++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++..... ...
T Consensus 106 ~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 106 SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 7888775433 46899999999999999999999 88999999999999999999999999998865322 123
Q ss_pred ccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 733 VAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 733 ~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
..|+..|+|||++. ...++.++|||||||+++||++|..|+..... ...+....... .... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~--------~~ 242 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND-SPTL--------QS 242 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC-CCCC--------Cc
Confidence 45788999999984 45678899999999999999999999865431 11111111111 1100 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|.+||++.+++++
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122457899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=293.07 Aligned_cols=259 Identities=19% Similarity=0.343 Sum_probs=194.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E 647 (858)
..+.||+|++|.||+|... +|+.||+|++.... ....+.+..|+.++++++||||+++++++.. ....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 3478999999999999954 79999999987542 2345677889999999999999999998763 346899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+. |+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 89 LME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred hhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 996 5899988654 35899999999999999999999 88999999999999999999999999999976543221
Q ss_pred c---eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh-----------
Q 043526 728 H---VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA----------- 792 (858)
Q Consensus 728 ~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~----------- 792 (858)
. ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHhhhhhc
Confidence 1 1123467889999998765 46789999999999999999999999654311 11111111100
Q ss_pred cCCchhhhchhh-cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 793 KGDIENIVDSCL-RGGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 793 ~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.+.+.+..+..- ....+ .....++.+++.+|++.+|++||++++++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 011111111000 00011 12346789999999999999999999988853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=288.65 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=200.0
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEec--cCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLS--SSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+||...||++.-.+.+.+|+|++. ..+.+....|..|++.|.+++ |-+||++++|-..++.++|||||-+-
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~- 444 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI- 444 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-
Confidence 46899999999999998888889998875 345566788999999999995 99999999999999999999997654
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce-ee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-ST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~ 731 (858)
+|..+|++.......| .++.+..|++.|+.++| ..+|||.||||.|+|+-. |.+||+|||.|...+.+.+.. ..
T Consensus 445 DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 445 DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeec
Confidence 9999998877655666 77889999999999999 899999999999999865 589999999999987765543 34
Q ss_pred cccCCCCccCccccccC-----------CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 732 VVAGTPGYLDPEYFVTD-----------WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~-----------~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
..+||+.||+||.+... ++++++||||+||+||+|+.|+.||....+ .|.+ +..+.
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~aK-------l~aI~ 586 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIAK-------LHAIT 586 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHHH-------HHhhc
Confidence 56899999999988521 367899999999999999999999964321 1111 23344
Q ss_pred chhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGGF-EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
|+.-.-.| ....-.+++++++.||.+||++||+..|++++
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 44222122 22333459999999999999999999999874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=294.47 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=194.7
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E 647 (858)
.+.||+|+||.||+|.. .+|+.||||.+... .......+.+|+.+++.++|+||+++++++... ...++|+|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 46899999999999985 47899999998753 233456678899999999999999999988654 34799999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 90 LMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred CCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 996 6898888654 36899999999999999999999 8899999999999999999999999999998764332
Q ss_pred ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh-----------cCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA-----------KGD 795 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~-----------~~~ 795 (858)
.......++..|+|||.+.. ..++.++|||||||+++||++|+.||...... ........... .+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhcCchh
Confidence 12223457889999998864 56889999999999999999999998643211 11111111000 000
Q ss_pred chhhhchhhc---C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHH
Q 043526 796 IENIVDSCLR---G---GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE--LKE 843 (858)
Q Consensus 796 ~~~~~d~~l~---~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--L~~ 843 (858)
....+..... . ........++.+++.+|++.+|++||+++|++++ ++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000000000 0 0011234568899999999999999999999987 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=322.21 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=199.6
Q ss_pred ccccccCceEEEEEE-ECCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..||.|.||.||-|. .++|.-.|+|-++.. .....+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 579999999999998 678999999987643 34456778999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce---e
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV---S 730 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~---~ 730 (858)
|.+.+...+ ..++.....+..|++.|++||| +.|||||||||.||+|+.+|.+|++|||.|.......... -
T Consensus 1321 La~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999996544 4566666677899999999999 8999999999999999999999999999999876542111 1
Q ss_pred ecccCCCCccCccccccC---CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TVVAGTPGYLDPEYFVTD---WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
....||+.|||||.+.+. .-..++||||+|||++||+||++||...+++- .++-.+..|....
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-----aIMy~V~~gh~Pq--------- 1461 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-----AIMYHVAAGHKPQ--------- 1461 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-----HHHhHHhccCCCC---------
Confidence 235799999999999743 34578999999999999999999998766431 1223334443222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.....+-.+++..|+..||++|.++.|++++
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 233445566799999999999999888877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=287.73 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=192.8
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcc--------------hHhHHHHHHHHHhcccceeeeeeeeeeeCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQG--------------FKEFEAEVKLLMRVHHRNLTNLVGYFIEDN 640 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 640 (858)
.+.||+|+||.||+|... +|+.||||.++...... ...+.+|+++++.++||||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999964 79999999986542221 125778999999999999999999999999
Q ss_pred eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 641 NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
..++||||++ |+|.+++... ..+++.....++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence 9999999997 5999998643 35889999999999999999999 8999999999999999999999999999997
Q ss_pred cccCCC-------------cceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHH
Q 043526 721 VFPIGG-------------THVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT 786 (858)
Q Consensus 721 ~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~ 786 (858)
...... ........++..|+|||.+.+. .++.++|||||||+++||++|+.||...... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--~~~~~ 245 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI--DQLGR 245 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 654111 1111123467889999998754 4689999999999999999999998654321 11122
Q ss_pred HHHHHhcCC---chhhhc------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 787 VTNMIAKGD---IENIVD------------SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 787 v~~~~~~~~---~~~~~d------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+........ .....+ ..... .......++.+++.+|++.+|++||+++|++.+
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 211111100 000000 00000 001124567899999999999999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=282.00 Aligned_cols=244 Identities=27% Similarity=0.432 Sum_probs=198.3
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeec
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+.+.||+|++|.||+|... +|+.||+|++.... ....+.+..|++++++++ ||||+++++++..++..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 4578999999999999965 79999999987532 233467888999999998 999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc--
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-- 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-- 727 (858)
++++|.+++.... .+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 85 PNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999997643 6999999999999999999999 88999999999999999999999999999887643221
Q ss_pred -----------------ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHH
Q 043526 728 -----------------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM 790 (858)
Q Consensus 728 -----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~ 790 (858)
.......++..|+|||.......+.++||||||++++|+++|+.|+..... ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~---~~~~ 234 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLT---FQKI 234 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHH---HHHH
Confidence 112234578899999999888899999999999999999999999875431 111 1111
Q ss_pred HhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 043526 791 IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNM----NEVVT 839 (858)
Q Consensus 791 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm----~eVl~ 839 (858)
. . .....+......+.+++.+|+..+|++||++ +|+++
T Consensus 235 ~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 L-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 0 0111222334568899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=280.47 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=197.1
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|++++++++|+|++++++++...+..++|+||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 467999999999999965 69999999998653 3334678899999999999999999999999999999999998 5
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.++..++.|+++||+||| +.+|+||||+|+||++++++.++|+|||++......... ...
T Consensus 83 ~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~ 157 (282)
T cd07829 83 DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTH 157 (282)
T ss_pred CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-cCc
Confidence 9999997653 36899999999999999999999 889999999999999999999999999999876433221 122
Q ss_pred ccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---c---hhh--hchh
Q 043526 733 VAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---I---ENI--VDSC 803 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~---~~~--~d~~ 803 (858)
..++..|+|||.+.+. .++.++|||||||+++||++|+.||..... ......+........ . .++ .+..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 3456789999998766 788999999999999999999988865331 111111111111000 0 000 0000
Q ss_pred hcCC----C---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGG----F---EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~----~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... . -......+.+++.+|+..+|++||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0 00124578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=288.50 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=201.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC-----eeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN-----NMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV 645 (858)
.+.+.||+|++|.||+|... +|+.+|||++.... ....+.+.+|++.++.++||||+++.+++...+ ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34578999999999999965 58999999987653 344577899999999999999999999998775 78999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++ +|.+++.... .+++..++.++.|+++||+||| +.+|+||||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 83 TELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 999984 8998886543 7899999999999999999999 889999999999999999999999999999876543
Q ss_pred Cc--ceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC--------
Q 043526 726 GT--HVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG-------- 794 (858)
Q Consensus 726 ~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~-------- 794 (858)
.. .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||...... .....+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhhc
Confidence 21 112234578899999999877 8899999999999999999999998654321 1111111111000
Q ss_pred ---Cchhhhchh-hcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 043526 795 ---DIENIVDSC-LRGG-----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE--LKEC 844 (858)
Q Consensus 795 ---~~~~~~d~~-l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--L~~~ 844 (858)
...+.+... .... ........+.+++.+|++.+|++||++++++++ +++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000 0000 001134567899999999999999999999985 5553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.16 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=192.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC-----CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-----SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||.||++... .+..+++|.++.. ......++..|+.++++++||||+++++++......++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 34578999999999999864 3455666665432 12233456788999999999999999999999999999999
Q ss_pred eccCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 648 YMANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 648 y~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|+++++|.+++... ....+++.+++.++.|+++||+||| +.+++|+||||+||++++ +.++|+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999998652 2457899999999999999999999 899999999999999976 56999999998776432
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.. ......|+..|+|||...+..++.++|+||||+++++|++|..|+.... ........ ..+...
T Consensus 159 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~-~~~~~~-------- 223 (260)
T cd08222 159 CD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRI-VEGPTP-------- 223 (260)
T ss_pred cc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH-HcCCCC--------
Confidence 22 2223457889999999988888899999999999999999999985322 11111111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.....++.+++.+|+..+|++||++.|++++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1122334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=273.12 Aligned_cols=236 Identities=30% Similarity=0.405 Sum_probs=193.1
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
||+|++|.||++... +++.+|+|.+...... ....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 6899999998755332 456788999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
.+++.... .+++.....++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99997553 5899999999999999999999 8999999999999999999999999999988764332 1223446
Q ss_pred CCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 735 gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
++..|+|||...+...+.++|+||||++++||++|+.||..... . ........ +. ...+.....
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~~~-~~----------~~~~~~~~~ 218 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--K---EIYEKILK-DP----------LRFPEFLSP 218 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHhc-CC----------CCCCCCCCH
Confidence 78899999999888889999999999999999999999864432 1 11111111 10 011222245
Q ss_pred HHHHHHHHccccCCCCCCCHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNE 836 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~e 836 (858)
.+.+++.+|+..+|++||++++
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 6789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=270.91 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=197.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeee----CCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIE----DNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~~lV~Ey~~ 650 (858)
++||-|-.|.|..+..+ +|+.+|+|++... ....+|+++.-.. .|||||.+++.+.. ...+.+|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 68999999999999865 8999999998654 4456788765554 69999999998864 356789999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~ 727 (858)
||.|++.++++....+++.++-.|+.||+.|+.||| +..|.||||||+|+|.+. |-.+||+|||+|+.-....
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~- 218 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG- 218 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence 999999999988888999999999999999999999 999999999999999974 4569999999998754322
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......-|+.|.|||++...+++..+|+||+||++|-|++|-+||..... ..+..-++..+..|.. ++-++.+
T Consensus 219 -~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gqy-~FP~pEW--- 291 (400)
T KOG0604|consen 219 -DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQY-EFPEPEW--- 291 (400)
T ss_pred -cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccCc-cCCChhH---
Confidence 22234568999999999999999999999999999999999999976442 3333334444444321 1111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.+....++++.++..+|++|.|++|++.+
T Consensus 292 --s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 292 --SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1235677899999999999999999998764
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=291.65 Aligned_cols=242 Identities=27% Similarity=0.447 Sum_probs=205.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|.|+.|..|+.. +|..||||.+.+.... ....+.+|+++|..++|||||+++++...+..+++||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 3578999999999999964 7999999999766433 234588999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|.+++++..+. ......+..++.|+.+|++||| +..|+|||||++||||+.+.++||+|||++..+..+ ....
T Consensus 140 ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lq 212 (596)
T KOG0586|consen 140 GELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQ 212 (596)
T ss_pred chhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc--cccc
Confidence 99999997665 4566888999999999999999 999999999999999999999999999999987643 3334
Q ss_pred cccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...|++.|.|||.+.+..+ .+++|+||+|+++|-|+.|..||++.. +.++-++.+.+.+..
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------------lk~Lr~rvl~gk~rI 274 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------------LKELRPRVLRGKYRI 274 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------------------cccccchheeeeecc
Confidence 5679999999999987654 689999999999999999999997543 344455556555532
Q ss_pred --HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 811 --ESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 811 --~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
-...+..+++++++..+|.+|++++++.+.-
T Consensus 275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 2344667899999999999999999998753
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=282.08 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=189.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCC--------eeE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--------NMG 643 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--------~~~ 643 (858)
..+.||+|++|.||+|... +++.+|||++..... .....+.+|++++++++||||+++++++.+.. ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 3578999999999999965 789999999865432 22356788999999999999999999875543 468
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+|+||+.+ +|...+... ...+++.++..++.|+++||+||| +.+|+|+||||+||++++++.++|+|||+++...
T Consensus 92 lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 92 MVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred EEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 99999975 677776543 346899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCcc----------eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh
Q 043526 724 IGGTH----------VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 724 ~~~~~----------~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
..... ......++..|+|||.+.+ ..++.++|||||||+++||++|++||...... .....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~~~~~~~~~~~ 244 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--DQLHLIFKLCG 244 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence 32211 1122356788999998765 45789999999999999999999998643321 11111111000
Q ss_pred c---C------CchhhhchhhcCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 793 K---G------DIENIVDSCLRGGFE-------IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 793 ~---~------~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. . .+....+.......+ ......+.+++.+|+..+|++||++.|++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 0 000000000000000 1122467899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=263.66 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=193.1
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC-CCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..||.|+.|.|++++++ +|..+|||.+... ..+..++.+..+.++.+-+ +|.||+.+|||..+....+.||.|.. .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 45999999999999975 6999999998754 3445566777777766665 89999999999999999999999864 5
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
+..++..- ..++++.-.-++...++.||.||.+ .++|+|||+||+|||+|+.|++|+||||++.++-+...+ +..
T Consensus 177 ~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--trs 251 (391)
T KOG0983|consen 177 AEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--TRS 251 (391)
T ss_pred HHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc--ccc
Confidence 55555443 3468888888999999999999986 679999999999999999999999999999887544333 345
Q ss_pred cCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 734 AGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 734 ~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
+|-+.|||||.+. ...|..++||||||+.++||.||..||..-..+ ... +...+.++ .++|.+. .
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~---ltkvln~e------PP~L~~~--~ 319 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEV---LTKVLNEE------PPLLPGH--M 319 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHH---HHHHHhcC------CCCCCcc--c
Confidence 7899999999986 357888999999999999999999999764322 111 11111111 1233221 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.-+..+.+++..|+++|+.+||...+++++
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 145578899999999999999999998875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=289.56 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=190.4
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEEEE
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGLIY 646 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~ 646 (858)
.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46899999999999995 479999999986532 223456889999999999999999999987543 468999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+.. +|.+++. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 100 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~ 171 (342)
T cd07879 100 PYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171 (342)
T ss_pred ccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC
Confidence 99975 7776652 35889999999999999999999 8899999999999999999999999999987653221
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH-----------hcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI-----------AKG 794 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~-----------~~~ 794 (858)
....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+.... ...
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 172 ----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred ----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHHhccc
Confidence 22356788999999875 46889999999999999999999999753311 1111111100 000
Q ss_pred Cchhhhch---hhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 043526 795 DIENIVDS---CLRGGF---EIESAWRAVELAVKCASRTSSERPNMNEVVTE--LKECLM 846 (858)
Q Consensus 795 ~~~~~~d~---~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~--L~~~~~ 846 (858)
........ ...... .......+.+++.+|++.+|++||+++|++++ ++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 000000 00123467899999999999999999999966 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=270.03 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=200.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcc---hHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQG---FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+|-++||+|.||.|..++-+ +|+.+|+|++++...-. ...-+.|-++|+..+||.+..+.-.|+.++.+|+||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 45589999999999999854 89999999998764333 334567889999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
.||.|.-+|+..+ .+++.....+-.+|+.||.||| +++||.||||.+|.|+|.+|.+||+|||+++.--.. ...
T Consensus 251 nGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t 324 (516)
T KOG0690|consen 251 NGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT 324 (516)
T ss_pred cCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence 9999999996644 7899999999999999999999 899999999999999999999999999999864322 234
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
...++||+.|+|||++....+..+.|.|.+||++|||++|+.||...+.+. +...+.. ..+ .++
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLIl~------------ed~--kFP 388 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELILM------------EDL--KFP 388 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHHHh------------hhc--cCC
Confidence 556889999999999999999999999999999999999999997544321 1111110 011 134
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....+...|+...+.+||.+|. .++||.++
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 44455777888899999999997 45555543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=290.46 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=190.6
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC-------------
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------------- 639 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------------- 639 (858)
...+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 3457899999999999996 47899999999776666677889999999999999999999776543
Q ss_pred -CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeec
Q 043526 640 -NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFG 717 (858)
Q Consensus 640 -~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFG 717 (858)
...++||||++ ++|.+++... .+++..++.++.||++||+||| +.+|+||||||+||+++ +++.+||+|||
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 5898887532 5889999999999999999999 88999999999999998 45678999999
Q ss_pred CcccccCCCcce--eecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC
Q 043526 718 LSKVFPIGGTHV--STVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 718 la~~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
+++......... .....++..|+|||.+.. ..++.++|||||||+++||++|+.||....... ........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~ 238 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES-VPVV 238 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCC
Confidence 997653321111 122357889999998754 567889999999999999999999996543111 01111000 0000
Q ss_pred C------chhhhchhh-----cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 795 D------IENIVDSCL-----RGGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 795 ~------~~~~~d~~l-----~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ........+ ....+ .....++.+++.+|++.+|++||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000000000 00000 1123567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.32 Aligned_cols=199 Identities=32% Similarity=0.479 Sum_probs=172.7
Q ss_pred cccccccCceEEEEEE-ECCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~E 647 (858)
.+.||+|+||.||+|+ -++|+.||||.++... ....+...+|+++|++++|+|||++++.-.... ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3679999999999999 5589999999998643 345567889999999999999999998766544 5679999
Q ss_pred eccCCChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc--CCCC--EEEeeecCcccc
Q 043526 648 YMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT--ENLE--AKLADFGLSKVF 722 (858)
Q Consensus 648 y~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~--~~~~--~kL~DFGla~~~ 722 (858)
||.+|||...|.+.. ...+++.+.+.++.+++.||.||| +.+|+||||||.||++- ++|+ -||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999997643 457999999999999999999999 89999999999999983 4444 799999999988
Q ss_pred cCCCcceeecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCc
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE 779 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~ 779 (858)
+.+. .....+||..|.+||.+. .+.++..+|.|||||++||..||..||.+....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 7654 445578999999999998 588999999999999999999999999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=307.38 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=188.3
Q ss_pred Hhhcc--ccccccCceEEEEEEEC-CCCEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeee---------
Q 043526 572 TDNFN--KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--------- 638 (858)
Q Consensus 572 t~~f~--~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------- 638 (858)
..+|. ++||+||||.|||++-+ ||+.+|||++... +........+|++.+++++|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 34454 57999999999999966 9999999999755 33445678899999999999999999865421
Q ss_pred --------------------------------------------------------C-----------------------
Q 043526 639 --------------------------------------------------------D----------------------- 639 (858)
Q Consensus 639 --------------------------------------------------------~----------------------- 639 (858)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC
Q 043526 640 -------------------------------NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688 (858)
Q Consensus 640 -------------------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 688 (858)
..+|+-||||+...|.++++.+.... .-...++++++|++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH-- 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH-- 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH--
Confidence 11467899999988888887654211 46678899999999999999
Q ss_pred CCCCeEecCCCCcceEEcCCCCEEEeeecCccccc------------C-----CCcceeecccCCCCccCccccccC---
Q 043526 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP------------I-----GGTHVSTVVAGTPGYLDPEYFVTD--- 748 (858)
Q Consensus 689 ~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~------------~-----~~~~~~~~~~gt~~y~APE~~~~~--- 748 (858)
+++||||||||.||++|++..+||+|||+|.... . .+....+..+||.-|+|||.+.+.
T Consensus 715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8999999999999999999999999999998721 0 011123456799999999999754
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCC
Q 043526 749 WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTS 828 (858)
Q Consensus 749 ~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP 828 (858)
.++.|+|+||+||+++||+. ||... ++.... ...++.+.+..- ..+.......-..++.++++.||
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts-MERa~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTS-MERASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCch-HHHHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCC
Confidence 59999999999999999996 45432 222222 222333333221 11233344456789999999999
Q ss_pred CCCCCHHHHHH
Q 043526 829 SERPNMNEVVT 839 (858)
Q Consensus 829 ~~RPsm~eVl~ 839 (858)
.+|||+.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=280.78 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=189.5
Q ss_pred ccccccccCceEEEEEEEC-C--CCEEEEEEeccCC--CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeC----CeeEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-D--GTQVAVKMLSSSS--GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED----NNMGL 644 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~--g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~~~l 644 (858)
+.+.||+|+||.||++... + ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+... ...++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 4578999999999999965 4 7899999987532 22346788899999999 599999999876433 45778
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
++||+. ++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 84 ~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 84 YEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 889886 5899988643 36899999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcc---eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc-------
Q 043526 725 GGTH---VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK------- 793 (858)
Q Consensus 725 ~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~------- 793 (858)
.... ......|+..|+|||.+.+ ..++.++|+|||||+++||++|+.||...... .....+......
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 2211 1123468899999998765 56789999999999999999999998653311 111111111000
Q ss_pred ----CCchhhhchh-hcCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 794 ----GDIENIVDSC-LRGG-----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 794 ----~~~~~~~d~~-l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......... .... ........+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0000 001124578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=281.68 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=190.2
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeee-CCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-DNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~~~ 651 (858)
.+.||+|+||.||++... +|+.||||++... .....+.+..|+++++.++||||+++.+++.. .+..++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 478999999999999854 8999999988643 22334678899999999999999999999876 56788999998 4
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|.++++.. .+++.....++.|+++||+||| +.+|+||||+|+||++++++.++|+|||++...... ..
T Consensus 94 ~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----~~ 163 (328)
T cd07856 94 TDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MT 163 (328)
T ss_pred cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----cC
Confidence 6898888543 4788888999999999999999 889999999999999999999999999998754321 12
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH-----------hcCCchhh
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI-----------AKGDIENI 799 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~-----------~~~~~~~~ 799 (858)
...++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+.... ..+...++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 2346788999998765 56889999999999999999999998654311 1111111100 00111111
Q ss_pred hchh-hcCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 VDSC-LRGGFEI-----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+... .....+. .....+.+++.+|++.+|++||++++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 0111111 123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=286.80 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=191.0
Q ss_pred HHHHHhhc--cccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC---
Q 043526 568 VLKITDNF--NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--- 639 (858)
Q Consensus 568 l~~~t~~f--~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--- 639 (858)
+..++++| .+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++.+++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 33344444 36799999999999985 579999999987532 22345678899999999999999999988643
Q ss_pred ---CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeee
Q 043526 640 ---NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716 (858)
Q Consensus 640 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DF 716 (858)
...+++++++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecc
Confidence 3467888876 77998887543 5899999999999999999999 899999999999999999999999999
Q ss_pred cCcccccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHH-----
Q 043526 717 GLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM----- 790 (858)
Q Consensus 717 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~----- 790 (858)
|++...... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ..+...+...
T Consensus 165 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 239 (345)
T cd07877 165 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGA 239 (345)
T ss_pred ccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence 998764321 223457889999998865 56788999999999999999999998643321 1111111100
Q ss_pred -----HhcCCchhhh---chhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 791 -----IAKGDIENIV---DSCLRGGF---EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 791 -----~~~~~~~~~~---d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+........+ .......+ ......++.+++.+|++.+|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 00000000 00123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=268.86 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=195.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..||.|+||+|+|-.++ .|+.+|||+++.... .+.++++.|.+...+- +.||||+++|.+..++..++.||.|+- |
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 45999999999999865 799999999986644 5667888888876555 699999999999999999999999975 6
Q ss_pred hHHH---hhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 654 LKQL---LSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 654 L~~~---L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
|..+ ....+...+++.-.-.|....+.||.||-+ ...|+|||+||+|||++..|.+||||||.+..+.. ....
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiAk 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIAK 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--HHHh
Confidence 5543 334445578888888888899999999985 67899999999999999999999999999987643 2233
Q ss_pred ecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 731 TVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
+.-+|-..|||||.+.. ..+..++||||+|+.|+|+.||+.|+..-. ++.+.+...+.... ..+. ....
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----svfeql~~Vv~gdp-p~l~----~~~~ 295 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----SVFEQLCQVVIGDP-PILL----FDKE 295 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----HHHHHHHHHHcCCC-Ceec----Cccc
Confidence 44568889999999863 348899999999999999999999986533 23333443333221 1111 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+....+..++-.|+.+|-..||...++.++
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 23456688999999999999999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.32 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=203.4
Q ss_pred cccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCC-eeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN-NMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 647 (858)
..++-+|.||.||+|.|. +.+.|-||.++....+ ....+++|.-.+..+.|||+.++.+.+.++. ..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 357889999999999654 3456778888755433 4567889999999999999999999998764 5678899
Q ss_pred eccCCChHHHhhhcc------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 648 YMANGNLKQLLSDEK------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 648 y~~~gsL~~~L~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
++.-|+|..+|...+ .+.++-.+...++.|++.|++||| +.+|+|.||.++|.+||+..++||+|-.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999998433 446778888999999999999999 99999999999999999999999999999998
Q ss_pred ccCCCccee-ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhh
Q 043526 722 FPIGGTHVS-TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 722 ~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~ 799 (858)
+.+...+.- ........||+||.+.+..++.++|||||||+||||+| |+.|+..-+..+ +...+.+|.
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------m~~ylkdGy---- 515 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------MEHYLKDGY---- 515 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------HHHHHhccc----
Confidence 765544432 22234568999999999999999999999999999998 888886544222 223333331
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
++ .-+..+..++..++.-||...|++||+++|++.-|.+.-
T Consensus 516 ---Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 516 ---RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ---ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11 124556778999999999999999999999999998853
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=280.39 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=188.8
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEEEE
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGLIY 646 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~ 646 (858)
.+.||+|+||.||+|.. .+|+.||||++.... ......+..|++++++++||||+++++++..+. ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 46899999999999985 479999999986432 223456889999999999999999999987653 458999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+ +++|.+++.. ..+++..++.++.|+++||+||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 100 e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~- 171 (343)
T cd07880 100 PFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE- 171 (343)
T ss_pred ecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence 998 6799888754 35899999999999999999999 899999999999999999999999999999865322
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHH----------HHHhcCC
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT----------NMIAKGD 795 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~----------~~~~~~~ 795 (858)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||....... .+..... ..+....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhcchh
Confidence 122356889999998875 457899999999999999999999987543211 1111000 0000000
Q ss_pred chhhhchhhcC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 796 IENIVDSCLRG------GFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 796 ~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
........... .........+.+++.+|++.+|++||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.92 Aligned_cols=220 Identities=21% Similarity=0.189 Sum_probs=176.0
Q ss_pred cCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhh
Q 043526 582 GGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD 660 (858)
Q Consensus 582 G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~ 660 (858)
|.+|.||++.. .+|+.+|+|++.... .+..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 478999999997543 234455555566799999999999999999999999999999999865
Q ss_pred cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCcc
Q 043526 661 EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740 (858)
Q Consensus 661 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~ 740 (858)
.. .+++..+..++.|+++||+||| +.+|+||||||+||++++++.++++|||.+...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 5899999999999999999999 899999999999999999999999999987655322 12234567899
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHH
Q 043526 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELA 820 (858)
Q Consensus 741 APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 820 (858)
|||......++.++||||+|++++||++|+.|+....... .. .... ..+......+.+++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~-----~~~~----~~~~~~~~~~~~li 209 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT-----HTTL----NIPEWVSEEARSLL 209 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc-----cccc----CCcccCCHHHHHHH
Confidence 9999988888999999999999999999998764321100 00 0000 01112234678999
Q ss_pred HHccccCCCCCCCHH
Q 043526 821 VKCASRTSSERPNMN 835 (858)
Q Consensus 821 ~~Cl~~dP~~RPsm~ 835 (858)
.+|++.||++||++.
T Consensus 210 ~~~l~~dp~~R~~~~ 224 (237)
T cd05576 210 QQLLQFNPTERLGAG 224 (237)
T ss_pred HHHccCCHHHhcCCC
Confidence 999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=283.74 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=191.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe------eEEEE
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN------MGLIY 646 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~lV~ 646 (858)
.+.||+|++|.||+|... +++.||||++.... ......+.+|+.++++++|||++++.+++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 478999999999999975 68899999986432 2234567789999999999999999998876654 89999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+ +++|.+++.. ..+++.++..++.|+++||+||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 100 e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 100 HLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred ecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 998 5699998864 35899999999999999999999 889999999999999999999999999999865432
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc-----------C
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK-----------G 794 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~-----------~ 794 (858)
.....++..|+|||.+.+ ...+.++|||||||+++||++|+.||...... .....+...... .
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCCHHHHhhccch
Confidence 223357888999998865 46789999999999999999999998644321 111111111000 0
Q ss_pred CchhhhchhhcC---CC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 795 DIENIVDSCLRG---GF---EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 795 ~~~~~~d~~l~~---~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....+...... .+ ......++.+++.+|+..+|++|||+.||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 00 01124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=286.42 Aligned_cols=236 Identities=23% Similarity=0.346 Sum_probs=193.2
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+...+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++.+. +|||++++.+.+.++.+.++|||.+.+
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 4556799999999999885 478999999997662 2335567666555 699999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE-cCCCCEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl-~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+-|.+.+...+ .+. .++..|+.+|+.|+.||| +++|+||||||+|||+ ++.++++|+|||.++..... .
T Consensus 401 ~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 401 GELLRRIRSKP--EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred cHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 98888886544 233 777889999999999999 8999999999999999 58999999999999876543 1
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...+-|..|.|||......+++++|+||||++||||++|+.||.....+ ..++..+.. +.+..
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~------------~~~s~ 533 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQM------------PKFSE 533 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcC------------Ccccc
Confidence 1223478899999999999999999999999999999999999876543 122222222 23334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+...++|+.+||+.+|.+||+|.++..+
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 556678899999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=261.71 Aligned_cols=238 Identities=31% Similarity=0.473 Sum_probs=194.0
Q ss_pred CceEEEEEEEC-CCCEEEEEEeccCCCcc-hHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhh
Q 043526 583 GFGTVYHGYLD-DGTQVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD 660 (858)
Q Consensus 583 ~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~ 660 (858)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999998765554 68899999999999999999999999999999999999999999999876
Q ss_pred cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCcc
Q 043526 661 EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740 (858)
Q Consensus 661 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~ 740 (858)
.. .+++.+++.++.+++++++||| +.+++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 44 3889999999999999999999 8899999999999999999999999999998765432 223345788999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHH
Q 043526 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELA 820 (858)
Q Consensus 741 APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 820 (858)
+||.......+.++||||||++++||++|+.|+...... ..+.+. ...+..... ........++.+++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~i 221 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKK----IGKPKPPFP-------PPEWKISPEAKDLI 221 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH----HhccCCCCc-------cccccCCHHHHHHH
Confidence 999998888899999999999999999999998653211 111111 111110000 00000335788999
Q ss_pred HHccccCCCCCCCHHHHHH
Q 043526 821 VKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 821 ~~Cl~~dP~~RPsm~eVl~ 839 (858)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=299.57 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=203.5
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.++||+|+||.|..++++ +++.+|.|++++. ......-|..|-.+|.....+-|+.+.-.|+++.++|+|||||+|
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 488999999999999975 7899999999863 334456789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|-.+|.... .+++.-+..++..|+.||+-|| +.|+|||||||+|||||..|.+||+|||.+-.+..++.-.+.
T Consensus 160 GDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~ 234 (1317)
T KOG0612|consen 160 GDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSS 234 (1317)
T ss_pred chHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEec
Confidence 99999997654 7888889999999999999999 999999999999999999999999999999999888887888
Q ss_pred cccCCCCccCccccc----c-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 732 VVAGTPGYLDPEYFV----T-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 732 ~~~gt~~y~APE~~~----~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
..+|||.|++||++. + +.|.+.+|.||+||++|||+.|..||.... ++........... .+.-
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----lveTY~KIm~hk~-------~l~F 302 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----LVETYGKIMNHKE-------SLSF 302 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----HHHHHHHHhchhh-------hcCC
Confidence 889999999999986 2 578899999999999999999999996432 2332222221111 1211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPN---MNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs---m~eVl~~ 840 (858)
+-....+.+..+||.+.++ +|+.|.. ++++..+
T Consensus 303 P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 303 PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1113355677788887776 5677776 7776554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=299.47 Aligned_cols=141 Identities=32% Similarity=0.485 Sum_probs=126.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+|... +++.||||+++.... .....+..|+.++..++||||+++++.+...+..++||||++
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 3578999999999999976 789999999975432 224678889999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
+++|.+++.... .+++..++.|+.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999996543 5788999999999999999999 7899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=276.23 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=195.6
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+++||+|.||+||-|+++ +|+.||||++.+.. .....++.+|+.+|+.++||.||.+--.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 479999999999999965 89999999997542 233477899999999999999999999999999999999999765
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCcccccCCCcce
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla~~~~~~~~~~ 729 (858)
-|.-.|.+ ....+++..-..++.||+.||.||| -.+|+|+||||+|||+... -++||||||+|+...+. ..
T Consensus 649 MLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sF 722 (888)
T KOG4236|consen 649 MLEMILSS-EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SF 722 (888)
T ss_pred HHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh--hh
Confidence 55555544 4457888888899999999999999 8999999999999999754 46999999999987643 34
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
...++||+.|+|||++.++.+...-|+||.||++|--++|..||.... ++.+.+... .+ +....+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQNA-------aF----MyPp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQNA-------AF----MYPPNP 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhhcc-------cc----ccCCCc
Confidence 455789999999999999999999999999999999999999997543 222222110 00 111112
Q ss_pred -HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 -IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 -~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.....++++...++..=++|-|..+-+.+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2334567788888888888888888776654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=256.54 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=194.3
Q ss_pred hccccccccCceEEEEEEEC---C--CCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeee-CCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD---D--GTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIE-DNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~---~--g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV 645 (858)
+....||+|.+|.||+|.-. + .+.+|+|+++..... ......+|+.+++.++|||++.+...+.+ +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 33467999999999999632 2 237999999865332 24567889999999999999999999988 7788999
Q ss_pred EeeccCCChHHHhhhcc---cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC----CCEEEeeecC
Q 043526 646 YEYMANGNLKQLLSDEK---ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN----LEAKLADFGL 718 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~----~~~kL~DFGl 718 (858)
+||.+. +|...++.++ ...++-.....|+.||+.|+.||| +.=|+||||||.|||+..+ |.+||+|+|+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999988 8988886544 346888889999999999999999 7789999999999999877 8999999999
Q ss_pred cccccCCCcc--eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCC-----ccccHH--HHHH
Q 043526 719 SKVFPIGGTH--VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNEN-----ENIHII--QTVT 788 (858)
Q Consensus 719 a~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~-----~~~~l~--~~v~ 788 (858)
++.+...-.. ....++-|+.|.|||.+.+ ..++.+.||||.||++.||+|-++.|...+. ...+.- +.+-
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9988543222 2233456899999999986 5789999999999999999999988865432 111111 1111
Q ss_pred HHH---hcCCchhh---hch------hhcCCCCHH-----------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 789 NMI---AKGDIENI---VDS------CLRGGFEIE-----------SAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 789 ~~~---~~~~~~~~---~d~------~l~~~~~~~-----------~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
..+ .+..+..+ .+- .-...++.. ......+|+.+++..||.+|-|+++.+++.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111 11111111 000 000001000 112367899999999999999999988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=287.73 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=166.7
Q ss_pred hccccccccCceEEEEEEEC-C----CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeee------eeeCCee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-D----GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY------FIEDNNM 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~----g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~~~~~~ 642 (858)
.+.+.||+|+||.||+|++. + +..||||++...... +....| .+.+..+.++..++.. +..+...
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 34578999999999999975 5 789999987643211 111111 1222223333332222 2456679
Q ss_pred EEEEeeccCCChHHHhhhccc------------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 643 GLIYEYMANGNLKQLLSDEKA------------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
++||||+++++|.++++.... .......+..++.|++.||+||| +.+|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEE
Confidence 999999999999999865321 01123345679999999999999 889999999999999
Q ss_pred EcC-CCCEEEeeecCcccccCCCcceeecccCCCCccCccccccC----------------------CCCCchhHHHHHH
Q 043526 705 LTE-NLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD----------------------WLNEKSDVYSFGV 761 (858)
Q Consensus 705 l~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksDVwSfGv 761 (858)
+++ ++.+||+|||+++.+............+++.|+|||.+... .+..++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 996 57899999999987654444444556789999999965321 2345679999999
Q ss_pred HHHHHHhCCCccccCCCccccHHHHHHHHHhcCC-c---hhhhchh----hcCCCC--HHHHHHHHHHHHHccccCCCCC
Q 043526 762 VLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD-I---ENIVDSC----LRGGFE--IESAWRAVELAVKCASRTSSER 831 (858)
Q Consensus 762 ll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~-~---~~~~d~~----l~~~~~--~~~~~~l~~l~~~Cl~~dP~~R 831 (858)
+++||+++..+.... +.+........+. . .....+. +...++ ........+|+.+|++.||++|
T Consensus 368 iL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 368 IFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999977654321 1111111110000 0 0001110 000000 0012234589999999999999
Q ss_pred CCHHHHHHH
Q 043526 832 PNMNEVVTE 840 (858)
Q Consensus 832 Psm~eVl~~ 840 (858)
||++|++++
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=280.96 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=176.6
Q ss_pred ccccccccCceEEEEEEE-----------------CCCCEEEEEEeccCCCcchHh--------------HHHHHHHHHh
Q 043526 575 FNKVLGKGGFGTVYHGYL-----------------DDGTQVAVKMLSSSSGQGFKE--------------FEAEVKLLMR 623 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~~~~--------------~~~E~~~l~~ 623 (858)
..+.||+|+||+||+|.. .+++.||||++........++ +..|+..+.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 347899999999999964 245789999987543332233 3446677777
Q ss_pred ccccee-----eeeeeeeee--------CCeeEEEEeeccCCChHHHhhhcc----------------------cCchhH
Q 043526 624 VHHRNL-----TNLVGYFIE--------DNNMGLIYEYMANGNLKQLLSDEK----------------------ASTLSW 668 (858)
Q Consensus 624 l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~ 668 (858)
++|.++ ++++++|.. ++..+|||||+++|+|.++++... ...++|
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 776654 677888753 356899999999999999986431 123467
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccC
Q 043526 669 ERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748 (858)
Q Consensus 669 ~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~ 748 (858)
..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++...............+++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 889999999999999999 88999999999999999999999999999976543322222223457899999987532
Q ss_pred CC----------------------CCchhHHHHHHHHHHHHhCCC-ccccCCCccc-------cHHHHHHHHHhcCCchh
Q 043526 749 WL----------------------NEKSDVYSFGVVLLEIITSQA-VIVRNENENI-------HIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 749 ~~----------------------s~ksDVwSfGvll~ElltG~~-p~~~~~~~~~-------~l~~~v~~~~~~~~~~~ 798 (858)
.. ..+.||||+||+++||++|.. |+........ .+..|.. ......
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~~-- 461 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQKY-- 461 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccCC--
Confidence 21 134699999999999999875 5543211110 0111111 111000
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTS---SERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPsm~eVl~~ 840 (858)
+ -...........+++.+++..+| .+|+|++|+++|
T Consensus 462 --~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 --D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 00011234567889999998765 689999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=280.08 Aligned_cols=248 Identities=26% Similarity=0.454 Sum_probs=202.0
Q ss_pred hccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeee-----CCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIE-----DNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-----~~~~~lV~ 646 (858)
.+.+.||.|.+|.||+++ .++|+.+|||++...... .++...|.++++.. .|||++.++|++.. ++.++|||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 456889999999999999 568999999998765433 36778888888887 59999999999864 46799999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
|||.+||..|+++...+..+.|..+..|++.++.|+.+|| ...++|||||-.|||++.++.+|++|||++..+...
T Consensus 101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT- 176 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST- 176 (953)
T ss_pred eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc-
Confidence 9999999999998877889999999999999999999999 889999999999999999999999999998876432
Q ss_pred cceeecccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
........||+.|||||++.. ..++..+|+||+|++..||.-|.+|+.++.. ++.++.- . ..
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------mraLF~I---p--RN 243 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFLI---P--RN 243 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------hhhhccC---C--CC
Confidence 233456789999999999863 3567789999999999999999999876431 1111000 0 01
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+...-.-+.....++.+++..|+.+|-++||++.++++
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111123456778999999999999999999988875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=263.24 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=195.1
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+|..+||+|+||.|..|.-+ +.+.+|||++++...- +.+--+.|-++|... +-|.++++..+++.-+.+++|||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence 477899999999999999855 5677999999865322 223345566666665 57889999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+.||+|--++++-. .+.++.+..+|.+||-||-+|| +++|+.||||.+|||+|.+|.+||+|||+++.--.+ .
T Consensus 431 yvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~ 504 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-G 504 (683)
T ss_pred EecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC-C
Confidence 999999999987654 6889999999999999999999 999999999999999999999999999999864322 2
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
..+..+.||+.|+|||.+..+.+....|.|||||+||||+.|.+||+..+.++ +.+.++ +.. -.
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~aI~------------ehn--vs 568 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQAIM------------EHN--VS 568 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH------------Hcc--Cc
Confidence 33456789999999999999999999999999999999999999998755322 222222 111 23
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPN 833 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPs 833 (858)
|+...+.+...+....+.+.|.+|.-
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccC
Confidence 56666778888899999999998863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=231.34 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEE-ECCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.||+|.+|+|++|+ .++++.||+|+++-. +........+|+-+++.++|+|||++++....+..+-+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 569999999999999 567899999998743 344456789999999999999999999999999999999999986 8
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|..+..+.+ ..++......++.|+++||.++| ++.+.|||+||+|.||+.+|++|++|||+++.+...-...+ ..
T Consensus 87 lkkyfdsln-g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrcys-ae 161 (292)
T KOG0662|consen 87 LKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS-AE 161 (292)
T ss_pred HHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-ce
Confidence 888876654 46888899999999999999999 99999999999999999999999999999998764432222 23
Q ss_pred cCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHH--HHHHHHHhcCCc---hhhhchhhcCC
Q 043526 734 AGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII--QTVTNMIAKGDI---ENIVDSCLRGG 807 (858)
Q Consensus 734 ~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~--~~v~~~~~~~~~---~~~~d~~l~~~ 807 (858)
+-|..|.+|..+.+ +.++...|+||-||++.|+....+|...+..-..++. -|+.....++.+ ..+.|-.....
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 45889999999886 4678899999999999999985555443332111221 222222233322 22223222222
Q ss_pred CCHH-----HHH----HHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIE-----SAW----RAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~-----~~~----~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
++.. ... .=.++..+.+.-+|.+|.++++.+++
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 3221 111 22577778888899999999988764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=263.53 Aligned_cols=262 Identities=18% Similarity=0.321 Sum_probs=199.8
Q ss_pred HHHhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhccc--c----eeeeeeeeeeeCCee
Q 043526 570 KITDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH--R----NLTNLVGYFIEDNNM 642 (858)
Q Consensus 570 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--p----nIv~l~~~~~~~~~~ 642 (858)
...+...+.+|+|.||.|-++... .+..||||+++..... .+..+-|+++|+++.+ | -+|.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 334444578999999999999854 5789999999755332 2445778999999942 2 378888999999999
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---------------
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE--------------- 707 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~--------------- 707 (858)
|+|+|.+ |-|+.++|..++..+++..++..|+.|+++++++|| +.+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 459999999988889999999999999999999999 999999999999999832
Q ss_pred -----CCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc-c
Q 043526 708 -----NLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-I 781 (858)
Q Consensus 708 -----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~-~ 781 (858)
+..+||.|||.|..-.... ...+.|..|.|||++.+-.++.++||||+||+|.|+.||...|+..++.+ .
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2348999999998753322 34567999999999999999999999999999999999999998766322 1
Q ss_pred cHHHHHHH--------------HHhcCCc-----------hhhhchhhc----CCCCHHHHHHHHHHHHHccccCCCCCC
Q 043526 782 HIIQTVTN--------------MIAKGDI-----------ENIVDSCLR----GGFEIESAWRAVELAVKCASRTSSERP 832 (858)
Q Consensus 782 ~l~~~v~~--------------~~~~~~~-----------~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RP 832 (858)
.+.+.+.. ....+.+ ..+.+++.. ......+..++++|+..++..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 11121111 0111100 111111110 011235667899999999999999999
Q ss_pred CHHHHHHH
Q 043526 833 NMNEVVTE 840 (858)
Q Consensus 833 sm~eVl~~ 840 (858)
|+.|++++
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=259.11 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=194.3
Q ss_pred ccccccccCceEEEEEE-ECCCCEEEEEEeccCCC--cc-----hHhHHHHHHHHHhcccceeeeeeeeeeeC-CeeEEE
Q 043526 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSG--QG-----FKEFEAEVKLLMRVHHRNLTNLVGYFIED-NNMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~--~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV 645 (858)
+..+||+|+|+.||+|. +...+-||||+-..... .. .+...+|..+.+.+.||.||++++++.-+ +.+|-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 34689999999999998 56778899998643211 11 23456788999999999999999999754 668999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccc
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVF 722 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~ 722 (858)
.|||+|.+|.-+|+.++ .+++.++..|+.||+.||.||.+ .+++|+|-||||.|||+.. -|.+||+|||+++.+
T Consensus 547 LEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred eeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 99999999999998765 68999999999999999999994 4789999999999999954 478999999999998
Q ss_pred cCCCcc------eeecccCCCCccCcccccc----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh
Q 043526 723 PIGGTH------VSTVVAGTPGYLDPEYFVT----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 723 ~~~~~~------~~~~~~gt~~y~APE~~~~----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
..+... .+...+||..|++||.+.- .+++.|.||||.||++|+.+.|+.||..... ..++ +.
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdI-------Lq 695 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDI-------LQ 695 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHH-------Hh
Confidence 654332 3445789999999999863 3678899999999999999999999976432 1111 11
Q ss_pred cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 793 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+..+..... ..-...+....+...++.+|++..-++|....++..
T Consensus 696 eNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 211111111 111122334556788999999998888888777653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=249.44 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=192.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEecc--CCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC--------CeeEEE
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSS--SSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--------NNMGLI 645 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~~~~lV 645 (858)
..||+|.||.|++|+.+ +|+.||+|++-. ....--....+|+++|..++|+|++.+++.|... ..+++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 46999999999999954 688899987543 2222234568899999999999999999998643 348999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|++|+. +|..+|... ...++..++.+++.++..||.|+| +..|+|||+|+.|+||+.++.+||+|||+++.+...
T Consensus 103 f~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred HHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 999987 898888654 347889999999999999999999 899999999999999999999999999999876533
Q ss_pred Ccc---eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH---hcCCchh
Q 043526 726 GTH---VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI---AKGDIEN 798 (858)
Q Consensus 726 ~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~---~~~~~~~ 798 (858)
... ..+..+-|..|.+||.+.+ ..++++.|||+-||++.||+||.+-++...+ .+..+.+.... ..+-+.+
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccCCcccCCC
Confidence 221 2233445889999999885 5789999999999999999999988776542 22222222221 1111111
Q ss_pred hhchhh----------cCCCC--HHH------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCL----------RGGFE--IES------AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l----------~~~~~--~~~------~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+..-.| .+.+. .+. ..+.++|+..++..||.+|+.+.+++.+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111001 11110 011 2267789999999999999999988765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=282.38 Aligned_cols=241 Identities=29% Similarity=0.432 Sum_probs=185.8
Q ss_pred ccccccCceE-EEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGT-VYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+++|.|+.|+ ||+|.+ +|++||||++-... ..-..+|+..|+.- +|||||++++.-.++...|+..|.|.. +|
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 6789999984 699999 57899999985332 23457899999888 599999999988899999999999976 99
Q ss_pred HHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---C--CCEEEeeecCcccccCCCc
Q 043526 655 KQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---N--LEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 655 ~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~--~~~kL~DFGla~~~~~~~~ 727 (858)
.+++.... .....-...+.+..|++.||++|| +.+||||||||+||||+. + ..++|+|||+++.+..+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 99997741 111111345778899999999999 899999999999999986 3 4699999999999876544
Q ss_pred cee--ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhC-CCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 HVS--TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITS-QAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 ~~~--~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG-~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
..+ ....||.||+|||.+....-+.+.||||+||++|..++| ..||.+.-..+.++.. +. ..+. .+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~-~~L~--~L 735 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GN-YTLV--HL 735 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cc-ccee--ee
Confidence 333 356799999999999988888899999999999999996 8898754322211111 00 0000 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ..++ +..+|+.+|+..+|..||++.+|+.+
T Consensus 736 ~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 EP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 10 0111 77899999999999999999999763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=232.78 Aligned_cols=204 Identities=26% Similarity=0.413 Sum_probs=166.7
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccC-CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..||+|++|.|-+-++ .+|+..|||++... ..+..++.+.|+.+..+. .+|.+|.++|...+....++.||.|+- |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 4599999999988875 48999999999765 344556777888765554 799999999999999999999999976 7
Q ss_pred hHHHhhh--cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 654 LKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 654 L~~~L~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|..+-.+ .++..+++.-.-+||..+.+||.|||+ ...++|||+||+|||++.+|++|+||||.+..+.+. -..+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--iAkt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--IAKT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh--hHHH
Confidence 7766543 235678899999999999999999995 678999999999999999999999999999876432 1223
Q ss_pred cccCCCCccCccccc----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 732 VVAGTPGYLDPEYFV----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 732 ~~~gt~~y~APE~~~----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
.-.|-..|||||.+. ...|+-|+||||+|+.+.||.+++.|+.....+-.++.+
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 346778899999885 347889999999999999999999999876644333333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=233.63 Aligned_cols=211 Identities=39% Similarity=0.695 Sum_probs=184.2
Q ss_pred ccccCceEEEEEEEC-CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHH
Q 043526 579 LGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 656 (858)
||+|.+|.||++... +|+.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999976 4899999999765443 35679999999999999999999999999999999999999999999
Q ss_pred HhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccccCCCcceeecccC
Q 043526 657 LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 657 ~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
++.... ..+++..+..++.++++++++|| +.+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987542 35889999999999999999999 889999999999999999 89999999999987654321 1223456
Q ss_pred CCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHH
Q 043526 736 TPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814 (858)
Q Consensus 736 t~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~ 814 (858)
...|++||..... ..+.+.|+|++|+++++| .
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~ 188 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------P 188 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------H
Confidence 7889999999876 788999999999999999 3
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 815 RAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 815 ~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.+.+++..|++.+|++||++.++++.+
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=241.16 Aligned_cols=241 Identities=21% Similarity=0.344 Sum_probs=194.2
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+||+|+++.|..+++. +.+.+|+|++++. ..+...-.+.|-.+.... +||.+|-+..+|+.+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 368999999999999964 7789999999764 334455667777776665 69999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|--++++.+ .++++.+..+..+|.-||.||| ++||+.||||.+|||+|.+|.+||+|+|+++.--..+ ..+
T Consensus 335 ggdlmfhmqrqr--klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-d~t 408 (593)
T KOG0695|consen 335 GGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DTT 408 (593)
T ss_pred Ccceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC-ccc
Confidence 999988886554 6899999999999999999999 9999999999999999999999999999998643222 334
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCC--CccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE--NENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~--~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
..+.||+.|+|||.+.+..+....|.|++||+++||+.|+.||+... +.+.+--++.-+.+.+..+ + .
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--------r--i 478 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--------R--I 478 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--------c--c
Confidence 56789999999999999999999999999999999999999997543 3333333333333333211 1 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC
Q 043526 809 EIESAWRAVELAVKCASRTSSERP 832 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RP 832 (858)
+...+.+...+++.-+.+||.+|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 233344566788888899999886
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=259.70 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEECCCC-EEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLDDGT-QVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~-~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..||-|+||.|=.+..+... .+|+|++++. +....+....|-.+|...+.|.||+++-.|.+....|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 46999999999988876444 3888888754 2333455678899999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
.|...|+.+. .++..+...++..+.+|++||| +.+||.|||||+|.++|.+|-+||.|||+|+....+... -.
T Consensus 506 ElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT--wT 578 (732)
T KOG0614|consen 506 ELWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT--WT 578 (732)
T ss_pred hhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce--ee
Confidence 9999997654 7899999999999999999999 999999999999999999999999999999988765443 35
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
++||+.|.|||.+.++..+.++|.||+|++++||++|++||...+. ...-. .+..| +|. -.++...
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn----~ILkG-----id~---i~~Pr~I 644 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYN----LILKG-----IDK---IEFPRRI 644 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHH----HHHhh-----hhh---hhccccc
Confidence 7899999999999999999999999999999999999999976441 11111 11111 111 0123344
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
.....+++++....+|.||.- ..||.++
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 556778899999999999986 4555544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=253.23 Aligned_cols=215 Identities=26% Similarity=0.413 Sum_probs=177.8
Q ss_pred cccCHHHHHHHHhhc-----cccccccCceEEEEEE-ECCCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeee
Q 043526 561 RHFTYSEVLKITDNF-----NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTN 631 (858)
Q Consensus 561 ~~~~~~el~~~t~~f-----~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~ 631 (858)
+.-.|..|.++..+- .+.||-|+||.|..+. .++...+|.|.+++.+. .......+|-.+|.....+-||+
T Consensus 614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr 693 (1034)
T KOG0608|consen 614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR 693 (1034)
T ss_pred hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence 344455555554332 2579999999999987 55677899999987643 23455678999999999999999
Q ss_pred eeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCE
Q 043526 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEA 711 (858)
Q Consensus 632 l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~ 711 (858)
|+-.|++++.+|+||||++||++-.+|.... .|.+..+..++.++..|+++.| ..|+|||||||+|||||.+|.+
T Consensus 694 LyySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCce
Confidence 9999999999999999999999999997654 6888999999999999999999 9999999999999999999999
Q ss_pred EEeeecCcccccC--------CCcce---------------------------------eecccCCCCccCccccccCCC
Q 043526 712 KLADFGLSKVFPI--------GGTHV---------------------------------STVVAGTPGYLDPEYFVTDWL 750 (858)
Q Consensus 712 kL~DFGla~~~~~--------~~~~~---------------------------------~~~~~gt~~y~APE~~~~~~~ 750 (858)
||+||||+.-+.. .+.+. ....+||+.|+|||++....+
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 9999999875421 11110 012469999999999999999
Q ss_pred CCchhHHHHHHHHHHHHhCCCccccCCCcc
Q 043526 751 NEKSDVYSFGVVLLEIITSQAVIVRNENEN 780 (858)
Q Consensus 751 s~ksDVwSfGvll~ElltG~~p~~~~~~~~ 780 (858)
+..+|.||.||+|+||+.|+.||......+
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 999999999999999999999998765443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=243.07 Aligned_cols=259 Identities=23% Similarity=0.378 Sum_probs=194.9
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E 647 (858)
++.||-|+||.||..... +|+.||.|++...- -...+++.+|+++|+.++|.|++..++..+-. .++++++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 478999999999999854 89999999986432 23457889999999999999999998877654 35678889
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
.|.. +|...+-+. +.++-+.+.-++.||++||+||| +.+|.||||||.|.|++.|..+||||||+++.-..+..
T Consensus 138 LmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8865 888887543 46888888999999999999999 89999999999999999999999999999997655444
Q ss_pred ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch---------
Q 043526 728 HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE--------- 797 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~--------- 797 (858)
...+..+-|..|.|||.+++ ..++.+.||||.||++.|++..+-.|+... .++..+.+...+.....+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--PIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--hHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 44444455889999999986 578999999999999999998887776543 222233333322221111
Q ss_pred --hhhchhhcCC-----C----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 798 --NIVDSCLRGG-----F----EIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 798 --~~~d~~l~~~-----~----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
.++....+.. | +.....+...+..+++..+|++|.+.++.++++-
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111100 0 1122335567788889999999999998887653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=230.08 Aligned_cols=197 Identities=36% Similarity=0.531 Sum_probs=171.9
Q ss_pred ccccccccCceEEEEEEECC-CCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45679999999999999764 899999999876554 5678999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++..... .+++..+..++.+++.++.+|| +.+++|+||+++||+++.++.++|+|||.+.............
T Consensus 83 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 83 DLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 99999976442 1789999999999999999999 7899999999999999999999999999998775442112233
Q ss_pred ccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHhCCCcccc
Q 043526 733 VAGTPGYLDPEYF-VTDWLNEKSDVYSFGVVLLEIITSQAVIVR 775 (858)
Q Consensus 733 ~~gt~~y~APE~~-~~~~~s~ksDVwSfGvll~ElltG~~p~~~ 775 (858)
..++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4577889999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=223.03 Aligned_cols=252 Identities=21% Similarity=0.381 Sum_probs=194.4
Q ss_pred ccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCC--eeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDN--NMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~~lV~Ey~~ 650 (858)
..+.+|+|.++.|+.|. ..+.+.++||+++... .+...+|+++|..++ ||||+++++...+.. ...||+||+.
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 34679999999999998 5688899999997543 366789999999997 999999999987754 5789999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccccCCCcce
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+.+...+- ..++...+...+.+++.||.|+| ++||.|||+||.|++||. .-.++|.|+|+|.++..+..
T Consensus 119 n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-- 188 (338)
T KOG0668|consen 119 NTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 188 (338)
T ss_pred cccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCce--
Confidence 97776654 25777888899999999999999 999999999999999995 46799999999998865432
Q ss_pred eecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh-------hc
Q 043526 730 STVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI-------VD 801 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~-------~d 801 (858)
....+.+..|.-||.+.. ..+.-.-|+|||||++.+|+..+.||..+.....+++..++- +....+... +|
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV-LGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV-LGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH-hChHHHHHHHHHHccCCC
Confidence 233455778899998864 567788999999999999999999998877655555544331 111111000 11
Q ss_pred hhhcC---C------------CCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRG---G------------FEIE-SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~---~------------~~~~-~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+...+ . .+.. ...+.++++.+.+..|-.+|||++|..++
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11110 0 0011 13578899999999999999999998875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=227.50 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEEEe
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLIYE 647 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~E 647 (858)
+.+|.|.- .|..+... .+++||+|++... .....++..+|..++..+.|+|+++++.++.-. .+.++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777776 45445422 6889999987643 234567788999999999999999999998543 45889999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
+|.. +|...++ -.++..+...|..|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 102 LMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred hhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc--
Confidence 9975 8988886 24778889999999999999999 999999999999999999999999999999865433
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch----------
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE---------- 797 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~---------- 797 (858)
...+..+.|..|.|||.+.+..+.+.+||||.||++.||++|+-.|.+. ..+.+|-+-.-.-|...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 3444556788999999999888999999999999999999999877632 23333332211111110
Q ss_pred -----------------h-hhchhhcCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 -----------------N-IVDSCLRGGF--EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 -----------------~-~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+ +.|..+.... +......+.+++.+||..+|++|-++++++++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0111111110 11233456799999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=243.02 Aligned_cols=190 Identities=25% Similarity=0.395 Sum_probs=163.1
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCC--------cchHhHHHHHHHHHhcc---cceeeeeeeeeeeCCeeEE
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--------QGFKEFEAEVKLLMRVH---HRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 644 (858)
+.+|+|+||.|+.|.++ +..+|+||.+.+... ...-..-.|+++|..++ |+||++++++|++++.++|
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 67999999999999976 677899999875421 11223556999999997 9999999999999999999
Q ss_pred EEeec-cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 645 IYEYM-ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 645 V~Ey~-~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+||-. ++-+|++++..+. .+++.++.-|++||+.|+++|| +.+|||||||-+||.++.+|-+||.|||.+....
T Consensus 647 ~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 99965 4569999997654 6999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCcceeecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccc
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIV 774 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~ 774 (858)
.+ ....+.||.+|.|||.+.+..| ...-||||+|++||-++..+.||.
T Consensus 722 sg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 33 2345789999999999997665 567899999999999999888864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=239.41 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=205.5
Q ss_pred ccCHHHHHHHHhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc------cceeeeeee
Q 043526 562 HFTYSEVLKITDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH------HRNLTNLVG 634 (858)
Q Consensus 562 ~~~~~el~~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~ 634 (858)
++.+.|++...+......|+|-|++|.+|... .|..||||++...... .+.=+.|+++|.+|. -.++++++.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 45567777777777778999999999999854 6889999999765322 345578999999995 468999999
Q ss_pred eeeeCCeeEEEEeeccCCChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEE
Q 043526 635 YFIEDNNMGLIYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAK 712 (858)
Q Consensus 635 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~k 712 (858)
.|...+++|||+|-+.- +|.+.|.... ...|....+..++.|+.-||..|- ..+|+|.||||+|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence 99999999999998754 8999997644 446888899999999999999999 8899999999999999976 4589
Q ss_pred EeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHH----
Q 043526 713 LADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT---- 788 (858)
Q Consensus 713 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~---- 788 (858)
|||||.|.......-.. ..-+..|.|||.+.+-.++...|+||.||.||||.||+-.|.+..+... +...+
T Consensus 578 LCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M--Lrl~me~KG 652 (752)
T KOG0670|consen 578 LCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM--LRLFMELKG 652 (752)
T ss_pred eccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH--HHHHHHhcC
Confidence 99999998765433221 1224579999999999999999999999999999999998876654332 11111
Q ss_pred ----HHHhcCCc-hhhhch--------------------------------hhcCC--C---CHHHHHHHHHHHHHcccc
Q 043526 789 ----NMIAKGDI-ENIVDS--------------------------------CLRGG--F---EIESAWRAVELAVKCASR 826 (858)
Q Consensus 789 ----~~~~~~~~-~~~~d~--------------------------------~l~~~--~---~~~~~~~l~~l~~~Cl~~ 826 (858)
.+++.+.. .+-+|. .|.+. + +......+.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 12222211 011111 11111 1 233466788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 043526 827 TSSERPNMNEVVTE 840 (858)
Q Consensus 827 dP~~RPsm~eVl~~ 840 (858)
||++|.+..+.+++
T Consensus 733 dP~KRit~nqAL~H 746 (752)
T KOG0670|consen 733 DPEKRITVNQALKH 746 (752)
T ss_pred ChhhcCCHHHHhcC
Confidence 99999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-25 Score=246.47 Aligned_cols=246 Identities=24% Similarity=0.404 Sum_probs=199.0
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
...+|.|.+|.|||++. ..++..|||+++-.......-.++|+-+++..+||||+.++|.+...+..+++||||.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 36799999999999994 58999999999988888888889999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeeccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 734 (858)
++.-+... .+++.++...+++..+|++||| +.+=+|||||-.|||+++.+.+|++|||.+..+... -.....+.
T Consensus 100 Qdiy~~Tg--plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Krksfi 173 (829)
T KOG0576|consen 100 QDIYHVTG--PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFI 173 (829)
T ss_pred cceeeecc--cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh-hhhhhccc
Confidence 99876554 7899999999999999999999 889999999999999999999999999988765321 12334567
Q ss_pred CCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch-hhcCCCCH
Q 043526 735 GTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS-CLRGGFEI 810 (858)
Q Consensus 735 gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~-~l~~~~~~ 810 (858)
||+.|||||+.. .+.+.+++|||+.|+...|+-.-.+|..+.. -.+... .. ....+++ .++. ..
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-----pmr~l~-Lm----TkS~~qpp~lkD--k~ 241 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-----PMRALF-LM----TKSGFQPPTLKD--KT 241 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-----hHHHHH-Hh----hccCCCCCcccC--Cc
Confidence 999999999874 5678999999999999999988777754321 001000 00 0111111 1221 12
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.....+-++++.|+.++|++||+++.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 34556779999999999999999988765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=225.18 Aligned_cols=130 Identities=28% Similarity=0.446 Sum_probs=108.9
Q ss_pred HhhccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-----c---ceeeeeeeeeee----
Q 043526 572 TDNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-----H---RNLTNLVGYFIE---- 638 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~~~~---- 638 (858)
.+-..+.||=|.|.+||.+.. .+.+-||+|+.+.... -.+..+.|+++|+.++ | ..||+|+++|..
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 344567899999999999984 4677899999875422 2345688999999984 3 469999999975
Q ss_pred CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE
Q 043526 639 DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL 705 (858)
Q Consensus 639 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl 705 (858)
+.+.|||+|++ |-+|..+|....-+.++...+.+|++||+.||.|||. ..+|||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 45799999998 4599999988887889999999999999999999997 4599999999999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=208.02 Aligned_cols=170 Identities=21% Similarity=0.235 Sum_probs=127.9
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.++++.. ...++|.+++.|+.|+++||+||| +.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6899999754 346999999999999999999999 544 999999999999999 99988754321
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..|++.|+|||.+.+..++.++|||||||++|||+||+.||.........+....... ...... + ......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~---~----~~~~~~ 134 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-PADDPR---D----RSNLES 134 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-ccCCcc---c----cccHHH
Confidence 2578999999999999999999999999999999999999864332111111111111 110000 0 001111
Q ss_pred HH--HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 812 SA--WRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 812 ~~--~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.. .++.+++.+|+..+|++||++.|+++++......
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 12 2689999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=264.61 Aligned_cols=196 Identities=17% Similarity=0.249 Sum_probs=140.1
Q ss_pred hccc-ceeeeeeeee-------eeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 043526 623 RVHH-RNLTNLVGYF-------IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694 (858)
Q Consensus 623 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~Iv 694 (858)
.++| +||++++++| .+.+.+.+++||+ +++|.++|... ...+++.+++.++.||++||+||| +.+|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 4556 6888888887 3334577888987 55999999643 346999999999999999999999 89999
Q ss_pred ecCCCCcceEEcC-------------------CCCEEEeeecCcccccCCCc---------------ceeecccCCCCcc
Q 043526 695 HRDIKPENILLTE-------------------NLEAKLADFGLSKVFPIGGT---------------HVSTVVAGTPGYL 740 (858)
Q Consensus 695 H~DLk~~NILl~~-------------------~~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 740 (858)
||||||+||||+. ++.+|++|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566666666654211000 0011235788999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHH
Q 043526 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELA 820 (858)
Q Consensus 741 APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 820 (858)
|||++.+..++.++|||||||+||||++|..|+.... . .... +... ...+.. .....+..+++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~---~~~~-~~~~----~~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----R---TMSS-LRHR----VLPPQI-----LLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----H---HHHH-HHHh----hcChhh-----hhcCHHHHHHH
Confidence 9999999999999999999999999999888754211 0 0100 0000 011100 11223456888
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 043526 821 VKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 821 ~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+|++.+|.+||+|.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 89999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=209.63 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=186.1
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeee-eeeeCCeeEEEEeec
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVG-YFIEDNNMGLIYEYM 649 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~-~~~~~~~~~lV~Ey~ 649 (858)
++..+.||+|.||.+-.+.++ ..+.+++|.+... ....++|.+|..---.+ .|.||+.-++ .|+..+...+++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 344678999999999999986 5778999988643 23457899888754445 5899998775 466777888999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-C-CCCEEEeeecCcccccCCCc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-E-NLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~-~~~~kL~DFGla~~~~~~~~ 727 (858)
+.|+|.+-+... .+.+....+++.|++.||.|+| +..+||||||.+||||= . ...+||||||+.+.....
T Consensus 105 P~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-- 176 (378)
T KOG1345|consen 105 PRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-- 176 (378)
T ss_pred ccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce--
Confidence 999999888653 4778888999999999999999 99999999999999993 3 347999999998764321
Q ss_pred ceeecccCCCCccCccccccC-----CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 728 HVSTVVAGTPGYLDPEYFVTD-----WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~-----~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
......+..|.+||..... ...+.+|+|.||++++.++||+.||+........+..|....-+.. .
T Consensus 177 --V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~----- 247 (378)
T KOG1345|consen 177 --VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--P----- 247 (378)
T ss_pred --ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--c-----
Confidence 1112235578999977532 3467799999999999999999999866555566666655432221 1
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.+...+. .-...++++.++-+.++|++|=-..++.++-+..
T Consensus 248 ~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred cCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 1111111 1223566777888889999986666665555444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=214.14 Aligned_cols=248 Identities=20% Similarity=0.332 Sum_probs=193.4
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
...|.+...|..|+|+|+ |..+++|++... +....++|.+|...|+.+.||||++++|.|.......++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345888899999999995 455666776533 44556889999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|+..|++...-..+..++.+++.++|+|++|||+- ++-|..--|.++.|++|++.+++|+= +-+++. ......
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs-----fqe~gr 346 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS-----FQEVGR 346 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee-----eecccc
Confidence 99999988877889999999999999999999942 44566667999999999999998852 111111 111122
Q ss_pred cCCCCccCccccccCC---CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 734 AGTPGYLDPEYFVTDW---LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
.-.+.||+||.++... .-+++|+|||.+++||+.|.+.||.+...-+... . +.-..++-..++
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----k---------ialeglrv~ipp 412 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----K---------IALEGLRVHIPP 412 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----h---------hhhccccccCCC
Confidence 3467899999997543 3468999999999999999999997654322110 0 011113333455
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
.....+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 56677889999999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=215.61 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=191.9
Q ss_pred cccccccCceEEEEEEEC----CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.||+|.|++||++... ..+.||+|.+...+. ..+...|++.|..+. +.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 468999999999999843 467899999875533 356889999999995 9999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccCC----
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIG---- 725 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~~---- 725 (858)
.....++.. .++..++..++..+..||+++| ..|||||||||+|+|.+.. +.-.|.|||+|......
T Consensus 119 H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 119 HDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred ccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 988888875 3668888999999999999999 9999999999999999854 66899999999832100
Q ss_pred --------------C-------------------------cceeecccCCCCccCccccc-cCCCCCchhHHHHHHHHHH
Q 043526 726 --------------G-------------------------THVSTVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLE 765 (858)
Q Consensus 726 --------------~-------------------------~~~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~E 765 (858)
+ .......+||+||.|||++. ....+++.||||.||+++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0 00011346999999999987 4667899999999999999
Q ss_pred HHhCCCccccCCCccccHHHHHH--------H-HHhcCC--c---------hhh------h--chhhcCCC---C-----
Q 043526 766 IITSQAVIVRNENENIHIIQTVT--------N-MIAKGD--I---------ENI------V--DSCLRGGF---E----- 809 (858)
Q Consensus 766 lltG~~p~~~~~~~~~~l~~~v~--------~-~~~~~~--~---------~~~------~--d~~l~~~~---~----- 809 (858)
+++++.||....++-..+.+.+. + ....|. + .++ + ..+..... .
T Consensus 271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 99999999876654443333321 0 011111 0 000 0 00000000 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+++++.+|+..||.+|-+++|.+++
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0112267899999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=213.25 Aligned_cols=158 Identities=24% Similarity=0.262 Sum_probs=123.6
Q ss_pred hccccccccCceEEEEEEEC--CCCEEEEEEeccCC-----CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--DGTQVAVKMLSSSS-----GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||+||+|... +|+.+|||++.... ......|.+|++++++++|+|+++.+.. .+..++||
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVm 97 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVR 97 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEE
Confidence 44578999999999999864 57888999875331 1234568999999999999999853322 24579999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCcceEEcCCCCEEEeeecCcccccCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI-KPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DL-k~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
||+++++|... ... . ...++.++++||+||| +.+|+|||| ||+|||++.++.+||+|||+++.+...
T Consensus 98 E~~~G~~L~~~-~~~--~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 98 GWTEGVPLHLA-RPH--G------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EccCCCCHHHh-Ccc--c------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 99999999732 111 0 1467889999999999 899999999 999999999999999999999977543
Q ss_pred Cccee-------ecccCCCCccCccccc
Q 043526 726 GTHVS-------TVVAGTPGYLDPEYFV 746 (858)
Q Consensus 726 ~~~~~-------~~~~gt~~y~APE~~~ 746 (858)
..... ....+++.|+|||++.
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCC
Confidence 32211 2456788899999885
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=200.59 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=194.1
Q ss_pred hhccccccccCceEEEEEEECCC--CEEEEEEeccCCCcchHhHHHHHHHHHhccc----ceeeeeeeee-eeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDG--TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH----RNLTNLVGYF-IEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~lV 645 (858)
+...+.||+|+||.||.+..... +.+|+|............+..|..++..+.+ +++..+++.. ..+...++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34567899999999999996543 5789998776544333377888888888873 5788888888 477788999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-----CCEEEeeecCcc
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-----LEAKLADFGLSK 720 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-----~~~kL~DFGla~ 720 (858)
|+.+ |.+|.++........++..+.++|+.|++.+|++|| +.|++||||||.|+++... ..+.|.|||+++
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9976 669999886655678999999999999999999999 9999999999999999865 469999999999
Q ss_pred ccc--CCCc----ce---eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH
Q 043526 721 VFP--IGGT----HV---STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI 791 (858)
Q Consensus 721 ~~~--~~~~----~~---~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~ 791 (858)
... .... .. .....||..|.+++...+...+++.|+||++.++.|++.|..||........ ...+....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~~~ 253 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEKDP 253 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHHHh
Confidence 332 2211 11 1235599999999999999999999999999999999999999965442211 11111111
Q ss_pred hcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 792 AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 792 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
.. ..... .......++.++...+-..+..++|....+...|++....+
T Consensus 254 ~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11 01110 11112234555555555689999999999999998876655
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-19 Score=191.45 Aligned_cols=258 Identities=30% Similarity=0.475 Sum_probs=195.4
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccc-eeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHR-NLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
..+.||.|+||.||++... ..+++|.+...... ....+.+|+..+..+.|+ +++++.+.+......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 3467999999999999986 88999998765433 367899999999999988 79999999977777899999999
Q ss_pred CCChHHHhhhccc-CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCcc
Q 043526 651 NGNLKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 651 ~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~ 728 (858)
++++.+++..... ..+.......++.|++.+++|+| +.+++|||+||+||+++... .++++|||.++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999977654321 25888899999999999999999 88899999999999999998 7999999999866543322
Q ss_pred -----eeecccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 729 -----VSTVVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 729 -----~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
......|+..|+|||.+.. .......|+||+|++++++++|..|+...... .........+...... ..
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc-cc
Confidence 2345678999999999987 57889999999999999999999996544321 0011111111111100 00
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...............+.+++..|+..+|.+|.++.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000001223467789999999999999999988765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-18 Score=179.95 Aligned_cols=266 Identities=18% Similarity=0.239 Sum_probs=197.0
Q ss_pred hccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.||+|+||.++.|+ +-+++.||||.-...+. ..++..|.+..+.|. .++|...+-+..++.+-.||+|.+ |
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 346889999999999998 66899999998654432 356778888888874 788988888888888899999988 5
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-----CEEEeeecCcccccCCC
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-----EAKLADFGLSKVFPIGG 726 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-----~~kL~DFGla~~~~~~~ 726 (858)
-||+|+..-+ +..|+..+++.+|.|+..-++|+| ++.+|.|||||+|+||...+ .+.|.|||+|+.+.+..
T Consensus 108 PSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 108 PSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred cCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 6898887644 357999999999999999999999 89999999999999997543 48999999999886543
Q ss_pred cce------eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 727 THV------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 727 ~~~------~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
+.. .....||.+||+-....+...+.+.|+-|+|-+++..|-|..||++..-... .+ -...+.+..-..-+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~-kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KE-KYEKIGETKRSTPI 260 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HH-HHHHhccccccCCH
Confidence 322 2345699999999999999999999999999999999999999987653221 11 11112111111111
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhccc
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKK 854 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~~~ 854 (858)
+... ..++ + ++..-+...-..+-.|-|..+-+...+.+++...+...+.
T Consensus 261 ~~Lc-~g~P-~---efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg 309 (449)
T KOG1165|consen 261 EVLC-EGFP-E---EFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDG 309 (449)
T ss_pred HHHH-hcCH-H---HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccc
Confidence 1111 1222 2 3333333333567788899999888888877655544443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.5e-20 Score=213.05 Aligned_cols=246 Identities=23% Similarity=0.293 Sum_probs=180.5
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC-CcchHhHHHHHHH--HHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS-GQGFKEFEAEVKL--LMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-....+...+||-+|+.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 44578999999999999998888 9999987654 3345555554443 445589999999887777777788889987
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc--cCCCcc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTH 728 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~--~~~~~~ 728 (858)
. +|+|.|..+. -+...+.+-|+.|++.||..+| ..+|+|||||.+||||+.-.-+.|+||...+.. +.++..
T Consensus 105 h-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 105 H-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred h-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 7 9999997654 5778888999999999999999 999999999999999999999999999876643 333222
Q ss_pred eeecc----cCCCCccCccccccC-----------CCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHh
Q 043526 729 VSTVV----AGTPGYLDPEYFVTD-----------WLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 729 ~~~~~----~gt~~y~APE~~~~~-----------~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
....+ ..-.+|+|||.+... ..+++.||||.||++.||++ |+++|.-. +...- +
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------QL~aY--r 248 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------QLLAY--R 248 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------HHHhH--h
Confidence 22222 223479999987531 26789999999999999998 56666421 11111 1
Q ss_pred cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 793 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
.+. .......|+ .. +...+.++++.|++.||++|.++++.++.-
T Consensus 249 ~~~-~~~~e~~Le-~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 249 SGN-ADDPEQLLE-KI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccC-ccCHHHHHH-hC---cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 111 111111111 00 011567899999999999999999999873
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=174.13 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=190.5
Q ss_pred hhccccccccCceEEEEEE-ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccc-ceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH-RNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+...+.||+|+||.+|.|. ..+|++||||+-+..... .++..|.++.+.++| ..|..+..+..+++.-.+|||.+
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 3456789999999999998 679999999997765443 467788899999875 56777778888889999999987
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla~~~~~~~~ 727 (858)
|.||.++..-.. ..++..+.+-++-|++.-++|+| .++++||||||+|+|..-+ ..+.++|||+++.+.+..+
T Consensus 94 GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 669999886554 46899999999999999999999 8999999999999999743 4689999999998754332
Q ss_pred ce------eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 728 HV------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 728 ~~------~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
.. .....||.+|.+-....+...+.+.|+-|+|.+|....-|..||++...... ..-...+.+..+...+.
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKMSTPIE 246 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhcCCCHH
Confidence 21 1235689999888777777778899999999999999999999987542211 11122333333332222
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
... ..+| .++.-.+..|-..--++-|...-+.+...
T Consensus 247 ~LC-~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 247 VLC-KGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHh-CCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 222 2222 24555666777777777787766655443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-19 Score=178.68 Aligned_cols=138 Identities=18% Similarity=0.213 Sum_probs=108.4
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCc--c-------hHh-----------------HHHHHHHHHhcccceee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--G-------FKE-----------------FEAEVKLLMRVHHRNLT 630 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~HpnIv 630 (858)
..||+|++|.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999889999999999754211 1 112 23489999999888774
Q ss_pred eeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCCCcceEEcCCC
Q 043526 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 631 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
....+.. ...++||||++++++...+.. ...+++.+...++.|++.+|+++ | +.+|+||||||+|||++ ++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 4333222 234899999999877655322 23688999999999999999999 6 77999999999999998 47
Q ss_pred CEEEeeecCcccc
Q 043526 710 EAKLADFGLSKVF 722 (858)
Q Consensus 710 ~~kL~DFGla~~~ 722 (858)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-20 Score=215.10 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=184.0
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccC--CCcc----hHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQG----FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..++|.|++|.|+.... ...+..+.|.+... .... ...+..|+.+-..++|||++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 46799999997776663 24444555543311 1111 12255677777888999999998888887777777999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+++ +|..++... ..+.-.++..++.|+..|++|+| +.||.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 403 ~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred ccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 999 999999654 35788899999999999999999 99999999999999999999999999999987654322
Q ss_pred --ceeecccCCCCccCccccccCCCCC-chhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 --HVSTVVAGTPGYLDPEYFVTDWLNE-KSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 --~~~~~~~gt~~y~APE~~~~~~~s~-ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
.......|.-.|+|||.+....+.+ ..||||.|+++..|.+|+.||.....+.....+ ....++.. + .
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~~~~~~-~----~ 547 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNYSDQRN-I----F 547 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hccccccc-c----c
Confidence 4455677899999999999887765 589999999999999999999765543322200 00000000 0 0
Q ss_pred cCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 805 RGGF--EIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 805 ~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.+.. ......+...++.++++.+|.+|-++++|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111 1223445678899999999999999999976
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=179.73 Aligned_cols=168 Identities=15% Similarity=0.162 Sum_probs=129.0
Q ss_pred HhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHh---------HHHHHHHHHhcccceeeeeeeeeeeC---
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKE---------FEAEVKLLMRVHHRNLTNLVGYFIED--- 639 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~---------~~~E~~~l~~l~HpnIv~l~~~~~~~--- 639 (858)
.+...+++|.|+||.||.... ++..+|||.+.......... +.+|++.+.+++|++|..+..++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 334457999999999999665 57789999997654333222 68899999999999999999886643
Q ss_pred -----CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 640 -----NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 640 -----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
...++||||++|.+|.++.. ++. ....+++.+|..+| ..+++|||+||+||+++.++ ++|+
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999988742 222 24569999999999 89999999999999999988 9999
Q ss_pred eecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHH
Q 043526 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEII 767 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ell 767 (858)
|||........... ..+.....+..++|+|+||+.+.-..
T Consensus 177 Dfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988655321111 11333445667899999999876554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=195.03 Aligned_cols=215 Identities=26% Similarity=0.395 Sum_probs=163.5
Q ss_pred HHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCe-EecCCC
Q 043526 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI-VHRDIK 699 (858)
Q Consensus 621 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~I-vH~DLk 699 (858)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.|.+... ...++|.-...++++|+.||+|||+ .+| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence 35678999999999999999999999999999999999763 4578999999999999999999994 444 999999
Q ss_pred CcceEEcCCCCEEEeeecCcccccCC-CcceeecccCCCCccCccccccC-------CCCCchhHHHHHHHHHHHHhCCC
Q 043526 700 PENILLTENLEAKLADFGLSKVFPIG-GTHVSTVVAGTPGYLDPEYFVTD-------WLNEKSDVYSFGVVLLEIITSQA 771 (858)
Q Consensus 700 ~~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDVwSfGvll~ElltG~~ 771 (858)
++|.++|..+.+||+|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876421 11111112234579999998753 25778999999999999999999
Q ss_pred ccccCCCccc--cHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 772 VIVRNENENI--HIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 772 p~~~~~~~~~--~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
||........ .+...++. + ....+.+.+.... +...++..++..||..+|++||++++|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~----~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK----G-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh----c-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9986543322 23333222 1 1122222221110 223368899999999999999999999988876544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.6e-18 Score=172.42 Aligned_cols=138 Identities=21% Similarity=0.264 Sum_probs=110.5
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcc--------------------------hHhHHHHHHHHHhcccceee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG--------------------------FKEFEAEVKLLMRVHHRNLT 630 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~HpnIv 630 (858)
..||+|++|.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 5799999999999998789999999987652210 11235788999999999875
Q ss_pred eeeeeeeeCCeeEEEEeeccCCChHHH-hhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCC
Q 043526 631 NLVGYFIEDNNMGLIYEYMANGNLKQL-LSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTEN 708 (858)
Q Consensus 631 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~-L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~ 708 (858)
....+... ..++||||++++++... +.. ..++..+..+++.|++.++.++| . .+|+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 55444333 24799999998865443 322 24677889999999999999999 6 8999999999999999 8
Q ss_pred CCEEEeeecCccccc
Q 043526 709 LEAKLADFGLSKVFP 723 (858)
Q Consensus 709 ~~~kL~DFGla~~~~ 723 (858)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=164.56 Aligned_cols=184 Identities=17% Similarity=0.132 Sum_probs=138.4
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCc----chHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ----GFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
...|++|+||+||.+.- .+.+++.+.+...... ....+.+|+++|++++ |+++.+++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 36799999999996655 6788888877655331 1225789999999995 5778888886 45689999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCcceEEcCCCCEEEeeecCcccccCCCcc-
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI-KPENILLTENLEAKLADFGLSKVFPIGGTH- 728 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DL-k~~NILl~~~~~~kL~DFGla~~~~~~~~~- 728 (858)
|.+|...+.. ....++.|++++|+++| +.+|+|||| ||+|||+++++.++|+|||++.........
T Consensus 82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 82 GAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred CccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9998765421 11357789999999999 899999999 799999999999999999999865433210
Q ss_pred ---e--------eecccCCCCccCccccccC-CCC-CchhHHHHHHHHHHHHhCCCccccC
Q 043526 729 ---V--------STVVAGTPGYLDPEYFVTD-WLN-EKSDVYSFGVVLLEIITSQAVIVRN 776 (858)
Q Consensus 729 ---~--------~~~~~gt~~y~APE~~~~~-~~s-~ksDVwSfGvll~ElltG~~p~~~~ 776 (858)
. ..-...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+....
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0112357778888754321 222 5678899999999999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.7e-17 Score=171.02 Aligned_cols=228 Identities=20% Similarity=0.246 Sum_probs=147.2
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcc----------cceeeeeeeeee----
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVH----------HRNLTNLVGYFI---- 637 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~----------HpnIv~l~~~~~---- 637 (858)
.+.||.|+++.||.++.. +|+++|||++.... ....+++.+|.-....+. |-.++..++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999975 69999999986433 234566777765555532 222332222221
Q ss_pred -----eCC--------eeEEEEeeccCCChHHHhhh---cc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 043526 638 -----EDN--------NMGLIYEYMANGNLKQLLSD---EK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIK 699 (858)
Q Consensus 638 -----~~~--------~~~lV~Ey~~~gsL~~~L~~---~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk 699 (858)
... ..+++|+-+. ++|.+.+.. .. ...+....++.+..|+++.+++|| ..|++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccc
Confidence 111 2367788774 588887642 11 124556677888899999999999 8999999999
Q ss_pred CcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCcccccc--------CCCCCchhHHHHHHHHHHHHhCCC
Q 043526 700 PENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT--------DWLNEKSDVYSFGVVLLEIITSQA 771 (858)
Q Consensus 700 ~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwSfGvll~ElltG~~ 771 (858)
|+|++++++|.++|+||+....... .... ...+..|.+||.... -.++.+.|.|++|+++|.|++|+.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999987765432 1111 334578999997643 246889999999999999999999
Q ss_pred ccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCC
Q 043526 772 VIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSER 831 (858)
Q Consensus 772 p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 831 (858)
||.....+... ...+. ... +....+..|+..+++.+|++|
T Consensus 249 Pf~~~~~~~~~--------------~~~f~-----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP--------------EWDFS-----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS--------------GGGGT-----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc--------------cccch-----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99754321110 00111 222 455678899999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.2e-18 Score=188.35 Aligned_cols=225 Identities=29% Similarity=0.308 Sum_probs=177.5
Q ss_pred cccccCceEEEEEE----ECCCCEEEEEEeccCCCc--chHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeecc
Q 043526 578 VLGKGGFGTVYHGY----LDDGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~----~~~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+|+|+||.|+.+. .+.|..+|.|++++.... .......|..++..++ ||.+|++...++.+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998764 346788999988755322 1224566778888887 9999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|.|...+.... .+...........+|-+++++| +.+|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999998886543 5777777888889999999999 999999999999999999999999999999875432221
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
.||..|||||.+. ......|.||||++++||+||..||.. +.++..+. .. -..+.
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~---------~~--~~~p~ 208 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILK---------AE--LEMPR 208 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhh---------hc--cCCch
Confidence 7899999999998 456789999999999999999999864 11111111 11 12344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
+......+++..+..++|..|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 455566678888888888888755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.8e-16 Score=187.03 Aligned_cols=190 Identities=21% Similarity=0.245 Sum_probs=154.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc---cceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH---HRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
...+.||+|+||+||+|...+|+.||+|+-+.......-- -.+++.||+ -+.|..+..++.-.+..+||+||.+
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 3357899999999999998889999999988766553221 122333443 3456666666677788899999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-------CCCEEEeeecCccccc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-------NLEAKLADFGLSKVFP 723 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-------~~~~kL~DFGla~~~~ 723 (858)
.|+|.+++. ..+.++|.-.+.++.|+++.+++|| ..+||||||||+|.||.. ...++|+|||.+-.+.
T Consensus 778 ~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 778 YGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred cccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999997 4457999999999999999999999 999999999999999942 3458999999987653
Q ss_pred CC-CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 043526 724 IG-GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771 (858)
Q Consensus 724 ~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~ 771 (858)
.- ....-....+|-.+-.+|+..+..++.+.|.|.+.-+++-||.|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 21 1123345678889999999999999999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=161.71 Aligned_cols=131 Identities=20% Similarity=0.282 Sum_probs=104.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-----ccceeeeeeeeeeeCC---e-eEEEEe
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-----HHRNLTNLVGYFIEDN---N-MGLIYE 647 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~-~~lV~E 647 (858)
+.||+|+||.||. .-+++.. +||++........+++.+|++.++.+ .||||++++|++..+. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6899999999996 3234444 79988765555567899999999999 5799999999998874 3 337899
Q ss_pred e--ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHH-HHhhcCCCCCeEecCCCCcceEEcC----CCCEEEeeec
Q 043526 648 Y--MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGL-EYLHIGCKPPIVHRDIKPENILLTE----NLEAKLADFG 717 (858)
Q Consensus 648 y--~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~IvH~DLk~~NILl~~----~~~~kL~DFG 717 (858)
| +++|+|.+++.+. .+++. ..++.+++.++ +||| +.+|+||||||+|||++. +..++|+||+
T Consensus 86 ~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 86 FDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 9 5679999999653 25544 35677888777 9999 899999999999999974 3479999944
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.2e-15 Score=178.30 Aligned_cols=73 Identities=41% Similarity=0.698 Sum_probs=69.3
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEK 483 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~ 483 (858)
.++|+.|+|++|+|+|.+|+.+++|++|+.|||++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence 3578999999999999999999999999999999999999999999999999999999999999999988653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.3e-16 Score=159.78 Aligned_cols=134 Identities=22% Similarity=0.410 Sum_probs=114.8
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCc--------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.||+|++|.||+|.. +|..++||+....... ....+..|++.+..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999988 6778999987643221 124577899999999999998888888888889999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
++|++|.+.+.... + ++..++.+++.+|.++| ..+++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985432 2 88899999999999999 89999999999999999 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=155.54 Aligned_cols=130 Identities=25% Similarity=0.409 Sum_probs=108.9
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCc--------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.||+|++|.||+|.+ +|..+++|+....... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 6788999986543211 1255778999999999988776666777777789999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
++++|.+.+..... .++.+++++|++|| +.+++|||++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754321 78999999999999 89999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=159.11 Aligned_cols=138 Identities=20% Similarity=0.240 Sum_probs=106.9
Q ss_pred ccccccccCceEEEEEE--ECCCCEEEEEEeccCCCc------------------------chHhHHHHHHHHHhcccce
Q 043526 575 FNKVLGKGGFGTVYHGY--LDDGTQVAVKMLSSSSGQ------------------------GFKEFEAEVKLLMRVHHRN 628 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~------------------------~~~~~~~E~~~l~~l~Hpn 628 (858)
+.+.||+|++|.||+|. ..+|+.||||+++..... ....+..|++.+.++.+..
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 35789999999999998 568999999998754210 0123567999999997633
Q ss_pred --eeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC-eEecCCCCcceEE
Q 043526 629 --LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP-IVHRDIKPENILL 705 (858)
Q Consensus 629 --Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-IvH~DLk~~NILl 705 (858)
+.+++++ ...++||||+++++|....... ..+...+...++.|++.++++|| ..+ |+||||||+||++
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli 182 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILV 182 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEE
Confidence 2333332 2358999999998887765322 23555667899999999999999 888 9999999999999
Q ss_pred cCCCCEEEeeecCcccc
Q 043526 706 TENLEAKLADFGLSKVF 722 (858)
Q Consensus 706 ~~~~~~kL~DFGla~~~ 722 (858)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999988754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=153.98 Aligned_cols=136 Identities=18% Similarity=0.201 Sum_probs=107.3
Q ss_pred hhccccccccCceEEEEEEECCCCEEEEEEeccCCCc----------------------chHhHHHHHHHHHhcccce--
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ----------------------GFKEFEAEVKLLMRVHHRN-- 628 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~----------------------~~~~~~~E~~~l~~l~Hpn-- 628 (858)
+...+.||+|+||.||++..++|+.||||++...... ....+..|...+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 3445789999999999999889999999987643210 1123567888888888874
Q ss_pred eeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 629 Iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++| ..+|+||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 334433 2455899999999999876421 345678899999999999 8999999999999999999
Q ss_pred CCEEEeeecCccccc
Q 043526 709 LEAKLADFGLSKVFP 723 (858)
Q Consensus 709 ~~~kL~DFGla~~~~ 723 (858)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.7e-15 Score=174.87 Aligned_cols=131 Identities=23% Similarity=0.356 Sum_probs=108.7
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEe-ccCCC-------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKML-SSSSG-------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l-~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.||+|+||.||+|.+.+.. +++|+. ..... ...+++.+|++++..++|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999875544 444432 22111 123568899999999999999988888888788899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
|+++++|.+++. .+..++.+++++|++|| +.+++||||||+|||+ +++.++|+|||+++.
T Consensus 417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999998874 45679999999999999 8999999999999999 678999999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=158.37 Aligned_cols=197 Identities=21% Similarity=0.268 Sum_probs=138.2
Q ss_pred ccceeeeeeeeeee---------------------------CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHH
Q 043526 625 HHRNLTNLVGYFIE---------------------------DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMD 677 (858)
Q Consensus 625 ~HpnIv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ 677 (858)
+|||||++.++|.+ +..+++||.-.+. +|..++..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999887743 2347889987766 8999986543 455566678899
Q ss_pred HHHHHHHhhcCCCCCeEecCCCCcceEEc--CC--CCEEEeeecCcccccCCC-----cceeecccCCCCccCccccccC
Q 043526 678 AAQGLEYLHIGCKPPIVHRDIKPENILLT--EN--LEAKLADFGLSKVFPIGG-----THVSTVVAGTPGYLDPEYFVTD 748 (858)
Q Consensus 678 ia~aL~yLH~~~~~~IvH~DLk~~NILl~--~~--~~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~ 748 (858)
+++|+.||| .++|.|||+|++|||+. +| -.+.|+|||++-.-...+ ........|...-||||.....
T Consensus 350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999 99999999999999994 33 347899999875432211 1112234577789999988632
Q ss_pred C------CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHH
Q 043526 749 W------LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVK 822 (858)
Q Consensus 749 ~------~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 822 (858)
. .-.|+|.|+.|-+.||+++...||.....-..+... .++..+. ..+......+.+++..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLP---------alp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLP---------ALPSRVPPVARQLVFD 492 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCC---------CCcccCChHHHHHHHH
Confidence 1 236899999999999999999999763311111111 1111111 1233344567899999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 043526 823 CASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 823 Cl~~dP~~RPsm~eVl~~L~ 842 (858)
.+++||++|++..-....|+
T Consensus 493 lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HhcCCccccCCccHHHhHHH
Confidence 99999999999876666554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2e-15 Score=166.63 Aligned_cols=173 Identities=25% Similarity=0.347 Sum_probs=128.8
Q ss_pred eeEEEEeeccCCChHHHhhhc-ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 641 NMGLIYEYMANGNLKQLLSDE-KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
.+++.|+++...+|.++|... .....+|...+.++.|++.|++| ++.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 477999999999999999643 35667899999999999999999 57899999999999999999999999999
Q ss_pred ccccCCC-----cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC
Q 043526 720 KVFPIGG-----THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 720 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
....... ....+...||..||+||.+.+..++.|+||||+|++|+|+++ +|.... +. .....-++.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~-er----~~t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQF-ER----IATLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHH-HH----HHhhhhhhcC
Confidence 8776544 223345679999999999999999999999999999999997 121100 00 0001112222
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNE 836 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e 836 (858)
.+. +.....+ .+-..++.+++...|.+||+..+
T Consensus 476 ~ip----~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 476 IIP----PEFLQDY-----PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred CCC----hHHhhcC-----cHHHHHHHHhcCCCcccCchHHH
Confidence 221 1111111 12357888999999999994433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.2e-14 Score=134.23 Aligned_cols=133 Identities=23% Similarity=0.215 Sum_probs=113.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccc--ceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH--RNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+.||+|.++.||++..++ ..+++|....... ...+..|+..+..++| .++.+++++...++..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 568999999999999855 7899999865533 4678999999999987 4888998888888889999999998777
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 654 4566778899999999999954446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.2e-14 Score=141.10 Aligned_cols=135 Identities=22% Similarity=0.301 Sum_probs=97.0
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCc--chHhH----------------------HHHHHHHHhcccce--e
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--GFKEF----------------------EAEVKLLMRVHHRN--L 629 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~Hpn--I 629 (858)
.+.||+|+||.||+|...+|+.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999888999999998754221 11111 24555555554432 3
Q ss_pred eeeeeeeeeCCeeEEEEeeccCCChHH-HhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcC
Q 043526 630 TNLVGYFIEDNNMGLIYEYMANGNLKQ-LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTE 707 (858)
Q Consensus 630 v~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~ 707 (858)
.+.+++ ...++||||++++.+.. .+.... .. .+...++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 333332 24589999999954432 121111 11 667889999999999999 7 8999999999999999
Q ss_pred CCCEEEeeecCcccc
Q 043526 708 NLEAKLADFGLSKVF 722 (858)
Q Consensus 708 ~~~~kL~DFGla~~~ 722 (858)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.4e-13 Score=141.27 Aligned_cols=134 Identities=22% Similarity=0.289 Sum_probs=105.2
Q ss_pred cccc-ccCceEEEEEEECCCCEEEEEEeccCC-------------CcchHhHHHHHHHHHhccccee--eeeeeeeeeCC
Q 043526 577 KVLG-KGGFGTVYHGYLDDGTQVAVKMLSSSS-------------GQGFKEFEAEVKLLMRVHHRNL--TNLVGYFIEDN 640 (858)
Q Consensus 577 ~~LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~ 640 (858)
..|| .|+.|+||+.... +..++||++.... ......+.+|++++.+++|+++ ++.+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999885 7789999885311 1223567889999999998885 66777654432
Q ss_pred e----eEEEEeeccC-CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEee
Q 043526 641 N----MGLIYEYMAN-GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715 (858)
Q Consensus 641 ~----~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~D 715 (858)
. .++|||++++ .+|.+++... .++.. .+.+++++|.+|| +.||+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 3599999997 6999888542 23332 3578999999999 99999999999999999999999999
Q ss_pred ecCccc
Q 043526 716 FGLSKV 721 (858)
Q Consensus 716 FGla~~ 721 (858)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.4e-13 Score=161.82 Aligned_cols=204 Identities=25% Similarity=0.360 Sum_probs=136.5
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
+.|..|++|.||..+++ ..+.+|.|+ .+... +.+- ++.....|.+| |+=.
T Consensus 89 klisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee---------------------chhh
Confidence 78999999999999876 466777743 22210 0000 22222233332 3333
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC---------
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG--------- 726 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~--------- 726 (858)
..+.... .++. +++.+++||| +.+|+|||+||+|.+|+.-|.+|+.|||+.+......
T Consensus 140 tllk~~g--~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 140 TLLKNIG--PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhcccCC--CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 3333222 2221 2278999999 9999999999999999999999999999998642110
Q ss_pred -----cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 727 -----THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 727 -----~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
......++||+.|+|||++....|....|.|++|+++||.+-|+.||+....++ .+.+.+...+.
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i~--------- 276 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIE--------- 276 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhcc---------
Confidence 011234689999999999999999999999999999999999999998765332 12222221110
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMN 835 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 835 (858)
+.+. +.....++.+++.++++.+|.+|--..
T Consensus 277 --wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 277 --WPEE-DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred --cccc-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 0011 222344678889999999999987443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-12 Score=149.43 Aligned_cols=140 Identities=21% Similarity=0.255 Sum_probs=101.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcc----------------------------------------hHhHHH
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG----------------------------------------FKEFEA 616 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~~~~ 616 (858)
+.||.|++|.||+|++++|+.||||+.+...... .-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986432110 012455
Q ss_pred HHHHHHhcc-----cceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHH-HHHHhhcCCC
Q 043526 617 EVKLLMRVH-----HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ-GLEYLHIGCK 690 (858)
Q Consensus 617 E~~~l~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~~ 690 (858)
|++.+.+++ ++++.-..-+.......+|||||++|++|.+....... .. .+.+++.++++ .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence 665555553 33333222222234557899999999999987653221 11 34567777666 467888 8
Q ss_pred CCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 691 ~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
.+++|+|+||.||++++++.+++.|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.9e-14 Score=166.06 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=185.3
Q ss_pred hccccccccCceEEEEEEEC--CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++.||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 33466999999999777643 44567777766443 222233344666656665 99999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccC-CC
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPI-GG 726 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~-~~ 726 (858)
.+++++.+.+........+....-..+.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..+.. .+
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999999999832222245666777889999999999995 56899999999999999999 999999999998766 32
Q ss_pred -cceeecccC-CCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 727 -THVSTVVAG-TPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 727 -~~~~~~~~g-t~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...........|...... ....
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~ 253 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR-------FTQL 253 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc-------cccC
Confidence 233344567 999999999887 455678999999999999999999998665444333333322100 0000
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.-........++..+++..+|+.|.+.+++..
T Consensus 254 ----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 254 ----PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----ccccCChhhhhcccccccCCchhccccccccc
Confidence 00112234567788888899999999888754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-12 Score=133.45 Aligned_cols=204 Identities=25% Similarity=0.414 Sum_probs=141.1
Q ss_pred HHHHhcccceeeeeeeeeeeC-----CeeEEEEeeccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCC
Q 043526 619 KLLMRVHHRNLTNLVGYFIED-----NNMGLIYEYMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKP 691 (858)
Q Consensus 619 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 691 (858)
.-|-.+-|-|||++..|+.+. .+..++.|||..|+|..+|++.+ ...+....-.+|+.||..||.||| .|++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCC
Confidence 344556799999999998654 35788999999999999997654 345666777899999999999999 6799
Q ss_pred CeEecCCCCcceEEcCCCCEEEeeecCcccccC---CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh
Q 043526 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPI---GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768 (858)
Q Consensus 692 ~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt 768 (858)
+|+|+++.-+-|++..++-+|+.--.-...... ..........+.++|.+||+-.....+.++|||+||+..+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999888753211111100 00111123346789999999888888899999999999999998
Q ss_pred CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 769 SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 769 G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
|.--...... .. ..+..+...+- .+... .-..++..|++..|..||+|.+++.+.
T Consensus 278 lEiq~tnseS-~~---------~~ee~ia~~i~-~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSES-KV---------EVEENIANVII-GLENG-------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcc-ee---------ehhhhhhhhee-eccCc-------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 7643211110 00 00000100000 00000 112567889999999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.9e-11 Score=117.04 Aligned_cols=128 Identities=20% Similarity=0.187 Sum_probs=96.1
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHH
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 656 (858)
+.|+.|.++.||++... |+.+++|....... ....+..|++.+..+.+.++++-+-.+ .....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCcccc
Confidence 46889999999999875 77899999765432 234568899999998776655433222 2334579999999988764
Q ss_pred HhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC-----eEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 657 LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP-----IVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 657 ~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
.. .....++.+++++|+.|| ..+ ++|+|++|.||+++ ++.+++.|||.+..
T Consensus 81 ~~----------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 31 111345678999999999 555 59999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.8e-11 Score=150.62 Aligned_cols=137 Identities=29% Similarity=0.525 Sum_probs=94.2
Q ss_pred hhhhhhhhhhccCCCCCCCchhHHHHHHHHHHHcC----CCCCCC-CCCCCCCCCCccceeccCCCCCCCcEEEEEecCC
Q 043526 348 PIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYG----VKRNWQ-GDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSS 422 (858)
Q Consensus 348 Pi~~a~e~~~~~~~~~~~~~~~~~~al~~~k~~~~----~~~~w~-~dpc~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n 422 (858)
|.+-.+-++..... .-..+.|..||++||+.+. .+.+|+ ++.|| .|.||+|+. ..+|+.|+|++|
T Consensus 10 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~----~~~v~~L~L~~~ 79 (968)
T PLN00113 10 PYLIFMLFFLFLNF--SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC----LWQGITCNN----SSRVVSIDLSGK 79 (968)
T ss_pred ChHHHHHHHHHHHc--cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cCcceecCC----CCcEEEEEecCC
Confidence 44444444433332 2346689999999999873 356896 34554 899999974 247888888888
Q ss_pred CCcccccchhccccccccccCCCCCCccCCCcccc-cccccceeeccCCcCc----------------------CCCChh
Q 043526 423 GLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLS-RLQFLRVLNLKGNKFT----------------------GPIPVE 479 (858)
Q Consensus 423 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~-~l~~L~~L~L~~N~l~----------------------g~iP~~ 479 (858)
+++|.+|+.|..|++|+.|+|++|+++|.+|..+. .+++|+.|+|++|+++ |.+|..
T Consensus 80 ~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~ 159 (968)
T PLN00113 80 NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPND 159 (968)
T ss_pred CccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChH
Confidence 88888888888888888888888888877776654 5666666666555555 455566
Q ss_pred hhccCcCCCcccccc
Q 043526 480 LMEKSKNGSLQLSVG 494 (858)
Q Consensus 480 ~~~~~~l~~l~l~~~ 494 (858)
++.+++|+.|+++.+
T Consensus 160 ~~~l~~L~~L~L~~n 174 (968)
T PLN00113 160 IGSFSSLKVLDLGGN 174 (968)
T ss_pred HhcCCCCCEEECccC
Confidence 666666766666544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.8e-10 Score=128.68 Aligned_cols=137 Identities=16% Similarity=0.183 Sum_probs=89.8
Q ss_pred ccccccCceEEEEEEECC-CCEEEEEEeccCCCcc----------------------------------h------HhHH
Q 043526 577 KVLGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQG----------------------------------F------KEFE 615 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~----------------------------------~------~~~~ 615 (858)
+.||+|++|+||+|++++ |+.||||+++...... . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999987 9999999997441100 0 1234
Q ss_pred HHHHHHHhcc----cceeeeeeeeeee-CCeeEEEEeeccCCChHHHh--hhccc--CchhHHHHHHHHHHHHHHHHHhh
Q 043526 616 AEVKLLMRVH----HRNLTNLVGYFIE-DNNMGLIYEYMANGNLKQLL--SDEKA--STLSWERRLQIAMDAAQGLEYLH 686 (858)
Q Consensus 616 ~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~L--~~~~~--~~l~~~~~~~i~~~ia~aL~yLH 686 (858)
.|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+.- ..... ..+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 3333333333322 34567999999999998753 22110 122222233333333 3
Q ss_pred cCCCCCeEecCCCCcceEEcCCC----CEEEeeecCccccc
Q 043526 687 IGCKPPIVHRDIKPENILLTENL----EAKLADFGLSKVFP 723 (858)
Q Consensus 687 ~~~~~~IvH~DLk~~NILl~~~~----~~kL~DFGla~~~~ 723 (858)
..|++|+|+||.||+++.++ .+++.|||++..++
T Consensus 278 ---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 57899999999999999988 89999999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.5e-11 Score=134.37 Aligned_cols=249 Identities=20% Similarity=0.175 Sum_probs=177.4
Q ss_pred HHHhhccccccc--cCceEEEEEEE---CCCCEEEEEEecc--CCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCe
Q 043526 570 KITDNFNKVLGK--GGFGTVYHGYL---DDGTQVAVKMLSS--SSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNN 641 (858)
Q Consensus 570 ~~t~~f~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~l~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 641 (858)
.-+....+.+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+...+++ .|+|.++....+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 334455677999 99999999986 3788899998443 2223334445566666666 49999998899999999
Q ss_pred eEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHH----HHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeee
Q 043526 642 MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ----GLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADF 716 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DF 716 (858)
.++-+|++. .+|..+.+... ..++....+.+..+..+ |+.++| ...++|-|+||.||+...+ ...+++||
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ceeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 999999886 58888876432 23556667777777777 999999 9999999999999999999 88999999
Q ss_pred cCcccccCCCcce----eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh
Q 043526 717 GLSKVFPIGGTHV----STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 717 Gla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
|+...+....... .....|...|++||... +.++.++|+|++|.+..|..+|-.....+.+.. |. .++
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~--~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS--QLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc--ccc
Confidence 9998876544221 12225778899999765 456889999999999999999877655442221 10 011
Q ss_pred cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 793 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.+- +...+-..-..++...+.++++.+|..|++.+++..
T Consensus 340 ~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 111111111223444788899999999998887754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-09 Score=125.12 Aligned_cols=167 Identities=19% Similarity=0.203 Sum_probs=127.6
Q ss_pred ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHH
Q 043526 592 LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR 671 (858)
Q Consensus 592 ~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~ 671 (858)
..++.+|.|...+...........+.++.|+.++||||++++..+.+++..|+|+|-+. -|..++... .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 45789999999887766444556778899999999999999999999999999999875 466666432 34455
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCC
Q 043526 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751 (858)
Q Consensus 672 ~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s 751 (858)
.-.+.||+.||.+||+ +.+++|++|.-+.|++++.|..||++|-++...+.... ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 6678999999999996 56899999999999999999999999988765432221 001111122466676554322
Q ss_pred CchhHHHHHHHHHHHHhCC
Q 043526 752 EKSDVYSFGVVLLEIITSQ 770 (858)
Q Consensus 752 ~ksDVwSfGvll~ElltG~ 770 (858)
-..|.|-||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=110.99 Aligned_cols=142 Identities=18% Similarity=0.224 Sum_probs=110.6
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccc--eeeeeeeeeeeCC---eeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHR--NLTNLVGYFIEDN---NMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~---~~~lV~Ey~~ 650 (858)
+.|+.|..+.||++...+|+.+++|....... ....++..|++++..+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999999765432 2456789999999999764 4566777766542 5689999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG------------------------------------------ 688 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------ 688 (858)
+.++.+.+.. ..++..++..++.+++++|+.||..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876532 2467777888888888888888842
Q ss_pred -----------CCCCeEecCCCCcceEEcC--CCCEEEeeecCccc
Q 043526 689 -----------CKPPIVHRDIKPENILLTE--NLEAKLADFGLSKV 721 (858)
Q Consensus 689 -----------~~~~IvH~DLk~~NILl~~--~~~~kL~DFGla~~ 721 (858)
....++|+|+++.||++++ ++.+.|.||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 66689999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.5e-09 Score=105.77 Aligned_cols=135 Identities=18% Similarity=0.192 Sum_probs=96.4
Q ss_pred ccccccCceEEEEEEECC-------CCEEEEEEeccCC------------C----------cchHhHH----HHHHHHHh
Q 043526 577 KVLGKGGFGTVYHGYLDD-------GTQVAVKMLSSSS------------G----------QGFKEFE----AEVKLLMR 623 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~------------~----------~~~~~~~----~E~~~l~~ 623 (858)
..||.|.=+.||.|.-.+ +..+|||+.+... . ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 5799999875321 0 0011223 78889988
Q ss_pred ccc--ceeeeeeeeeeeCCeeEEEEeeccCCChHH-HhhhcccCchhHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCC
Q 043526 624 VHH--RNLTNLVGYFIEDNNMGLIYEYMANGNLKQ-LLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKPPIVHRDIK 699 (858)
Q Consensus 624 l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~IvH~DLk 699 (858)
+.. -++.+++++ ...++||||+.+..+.. .+.+ ..++..+...+..+++.+|..| | ..+++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 854 344455543 45689999998754432 2221 1234455677889999999999 7 7899999999
Q ss_pred CcceEEcCCCCEEEeeecCcccc
Q 043526 700 PENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 700 ~~NILl~~~~~~kL~DFGla~~~ 722 (858)
+.|||+++ +.+.|+|||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999974 67999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.6e-08 Score=110.39 Aligned_cols=169 Identities=19% Similarity=0.273 Sum_probs=131.7
Q ss_pred CceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEEeeccC-CChHH
Q 043526 583 GFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIYEYMAN-GNLKQ 656 (858)
Q Consensus 583 ~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~ 656 (858)
...+.||+... ||..+++|+++....+....-..-++.++++.|+|+|++.+.+.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34577999854 899999999966554444344566889999999999999998873 3468899999986 57877
Q ss_pred Hhhhcc-------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 657 LLSDEK-------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 657 ~L~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+-.... +...++...+.++.|+..||.++| +.|..-+-|.+++||++.+..++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 653221 234678899999999999999999 8899999999999999999999999988877665
Q ss_pred CCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCc
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAV 772 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p 772 (858)
.+.. |.+.+ ..+-|.-.||.+++-|.||..-
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4320 11111 2467999999999999999754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=98.68 Aligned_cols=141 Identities=23% Similarity=0.309 Sum_probs=107.6
Q ss_pred ccccccCceEEEEEEECCCCEEEEEE-eccCCC-------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKM-LSSSSG-------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~-l~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+|.+|+-+.|+++.+ .|+...||. +.+.-. -..++..+|++.+.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5788999999999998 567767764 333211 1345678899999999876776666677777788899999
Q ss_pred ccC-CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---EEEeeecCccc
Q 043526 649 MAN-GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE---AKLADFGLSKV 721 (858)
Q Consensus 649 ~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~---~kL~DFGla~~ 721 (858)
+++ .++.+++...............++..|-+.+.-|| ..+|+||||.++||++..++. +.+.|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 987 47888886554333333333788899999999999 899999999999999976543 58999998764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-08 Score=98.11 Aligned_cols=131 Identities=22% Similarity=0.334 Sum_probs=102.4
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCc--------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..+++|+=+.+|.+.+. |..+++|.-..+.-. ...+-..|++++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 444666653322111 124467789999998776776666677788888999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
++|-.|.+.+... +..++..+=.-+.-|| ..+|+|+||.++||++..+. +.+.|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888544 3567777888888999 89999999999999998875 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.4e-09 Score=120.01 Aligned_cols=240 Identities=20% Similarity=0.192 Sum_probs=169.5
Q ss_pred cccccccCceEEEEEEEC--CCCEEEEEEeccCCCcchHh--HHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD--DGTQVAVKMLSSSSGQGFKE--FEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~--~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
...||.|.|+.|++...+ ++..+++|.+.........+ -..|+.+...+ .|.+++.....+...+..++--||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 457999999999988754 67889999886553332222 24455555555 58889988888888888889999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccCCCcce
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++...+.- ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.+..+...
T Consensus 350 ~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---- 420 (524)
T KOG0601|consen 350 GGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---- 420 (524)
T ss_pred CcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccccee----
Confidence 9988877622 335778889999999999999999 9999999999999999986 88899999998753211
Q ss_pred eecccCCCCcc--CccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 730 STVVAGTPGYL--DPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 730 ~~~~~gt~~y~--APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.......-+++ +|+......+..+.|++|||.-+.|.++|........ +|. .+..+.+. .
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~--~i~~~~~p---------~ 482 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSL--TIRSGDTP---------N 482 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cce--eeeccccc---------C
Confidence 11222333444 4444446677889999999999999999875432211 010 01111110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.+... ..+..++..+..+++..||.+.+...+.+.
T Consensus 483 ~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 483 LPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111 456677888889999999999888776554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.3e-10 Score=104.99 Aligned_cols=83 Identities=29% Similarity=0.409 Sum_probs=79.0
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
..+++.|-||+|+|+ .+|+.|+.|.+|+.|++++|++. .+|.++++|++|+.|+++-|+|. .+|..++.++.|..|+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 357899999999999 99999999999999999999999 99999999999999999999998 9999999999999999
Q ss_pred ccccCc
Q 043526 491 LSVGDN 496 (858)
Q Consensus 491 l~~~~n 496 (858)
+.+|+-
T Consensus 109 ltynnl 114 (264)
T KOG0617|consen 109 LTYNNL 114 (264)
T ss_pred cccccc
Confidence 999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.3e-07 Score=101.03 Aligned_cols=140 Identities=16% Similarity=0.103 Sum_probs=101.4
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCC-----------cchHhHHHHHHHHHhccccee--eeeeeeeee-----C
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG-----------QGFKEFEAEVKLLMRVHHRNL--TNLVGYFIE-----D 639 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-----------~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~-----~ 639 (858)
.+-+-....|.+..+ +|+.+.||+...... .....+.+|.+.+.++...+| .+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344334445667766 678899997743321 111247889999988864444 344566543 2
Q ss_pred CeeEEEEeeccCC-ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-------CCCE
Q 043526 640 NNMGLIYEYMANG-NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-------NLEA 711 (858)
Q Consensus 640 ~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-------~~~~ 711 (858)
...++|+|++++. +|.+++........+...+..++.++++.+.-|| ..||+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3467999999986 8999985432234556677899999999999999 999999999999999975 4679
Q ss_pred EEeeecCccc
Q 043526 712 KLADFGLSKV 721 (858)
Q Consensus 712 kL~DFGla~~ 721 (858)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.2e-07 Score=93.81 Aligned_cols=125 Identities=27% Similarity=0.334 Sum_probs=82.2
Q ss_pred EEEEEEECCCCEEEEEEeccCC-------------Cc-------------chHhHHHHHHHHHhcccce--eeeeeeeee
Q 043526 586 TVYHGYLDDGTQVAVKMLSSSS-------------GQ-------------GFKEFEAEVKLLMRVHHRN--LTNLVGYFI 637 (858)
Q Consensus 586 ~Vy~~~~~~g~~vAVK~l~~~~-------------~~-------------~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~ 637 (858)
.||.|...+|..+|||+.+... .. ......+|.+.|.++..-+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999999999999875320 00 1234667999999997653 4444433
Q ss_pred eCCeeEEEEeecc--CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHH-hhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 638 EDNNMGLIYEYMA--NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY-LHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 638 ~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
....+||||++ +..+..+.. . .++......++.+++..+.. +| ..+|+||||.+.|||++++ .+.|.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~-~---~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKD-V---DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHH-C---GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred --eCCEEEEEecCCCccchhhHHh-c---cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 23479999999 545544332 1 12244556777888885555 57 8899999999999999988 99999
Q ss_pred eecCcccc
Q 043526 715 DFGLSKVF 722 (858)
Q Consensus 715 DFGla~~~ 722 (858)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.9e-08 Score=95.71 Aligned_cols=138 Identities=18% Similarity=0.337 Sum_probs=76.4
Q ss_pred EEeccCCCCCCCCcCCCCceeeecCccccccCcc-----------cccccccccCCcccccccccccCCCCCceeeeCCC
Q 043526 32 ISIDCGIPAASSYNDETTDLKYISDTTFVETGIN-----------KNISSEFQISTLPKQFYNVRTFPQGMRNCYTLNPT 100 (858)
Q Consensus 32 ~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~-----------~~~~~~~~~~~~~~~~~tlR~Fp~~~~ncy~l~~~ 100 (858)
+.||||+ ..+ ++..|+.|.+|..|..++.. ...........-.+.|+|-|+=|. .-.|.+|.+
T Consensus 3 ~~IN~Gg---~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~ip~~ 76 (174)
T PF11721_consen 3 LRINAGG---PAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDIPVV 76 (174)
T ss_dssp EEEEETS---SSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEEE--
T ss_pred EEEECCC---Ccc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEEecC
Confidence 6899997 334 45679999999999643320 011111111222356889999333 578999856
Q ss_pred CCCCceEEEEEEe---eeccCCCCCCCC---eeeEEeccee-EEEEecCCcc---c-cceeEE-EEecCCCeeEEEEee-
Q 043526 101 EGKGSKYSIRASF---MYGNYDAANKPP---QFDLYLGVNL-WDSIKLDNAT---A-MEMKEI-IHIPTENHVLICLVN- 167 (858)
Q Consensus 101 ~~~~~~ylvR~~f---~ygnyd~~~~~p---~Fd~~~~~~~-w~~v~~~~~~---~-~~~~e~-i~~~~~~~~~vcl~~- 167 (858)
++|.|-||++| +++. ++....| +|||.++|+. ...+++.... . ....+. -+.+.++.+.|+|..
T Consensus 77 --~~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~ 153 (174)
T PF11721_consen 77 --PNGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWA 153 (174)
T ss_dssp --S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE
T ss_pred --CCcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEec
Confidence 78999999999 4444 3333333 7999999965 6677654222 1 233344 234588899999996
Q ss_pred ----------cCCCCceeeeE
Q 043526 168 ----------TGLGTPFISAL 178 (858)
Q Consensus 168 ----------~~~~~pfis~l 178 (858)
...|.|.||||
T Consensus 154 ~~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 154 GKGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp --SEEEEEEESSSSSSSEEEE
T ss_pred CCCcEEeeccccCCCcEEeeC
Confidence 44566888887
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1e-08 Score=121.64 Aligned_cols=240 Identities=22% Similarity=0.321 Sum_probs=157.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.+-+|.++.+..+.-. .|.-.+.|...... ....+....+-.++-..+||-++....-+.......||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 35667788877765522 23223333322111 111222222233333345666666655555667789999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC--------
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI-------- 724 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~-------- 724 (858)
+|...|+... ..+..-.......+.++++||| ...+.|+|++|.|.|...++..+++|||.......
T Consensus 890 ~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 890 DLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred CchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 9999997654 3444455566677889999999 77799999999999999999999999984432210
Q ss_pred -------------CC---------cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc
Q 043526 725 -------------GG---------THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782 (858)
Q Consensus 725 -------------~~---------~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~ 782 (858)
.. ........||+.|.+||...+......+|.|++|++++|.++|..||........
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~- 1043 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI- 1043 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh-
Confidence 00 0012235689999999999999889999999999999999999999976542211
Q ss_pred HHHHHHHHHhcCCchhhhchhhc-CCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLR-GGFEIESAWRAVELAVKCASRTSSERPNMN 835 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 835 (858)
. ..+...... ...+.+...+..+++...+..+|.+|-.|.
T Consensus 1044 -f------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 -F------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred -h------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 0 011111000 112334455667788888888888888775
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.6e-08 Score=81.34 Aligned_cols=61 Identities=41% Similarity=0.543 Sum_probs=54.4
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l 472 (858)
|+|+.|+|++|+|+..-+..|.++++|++|+|++|+++..-|..|..|++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5789999999999954446889999999999999999966667899999999999999986
|
... |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=7.4e-09 Score=98.90 Aligned_cols=142 Identities=20% Similarity=0.316 Sum_probs=109.6
Q ss_pred EEEEEecCCCCCChhhhhhhhhhccCCC--CCCCchhHHHHHHHHHHHcCCCCCCCCCCCCCCCCCccceeccCCCCCCC
Q 043526 335 EFSLDRTERSTLPPIINAFEVYMEKDFS--QSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPP 412 (858)
Q Consensus 335 ~i~L~~t~~S~LpPi~~a~e~~~~~~~~--~~~~~~~~~~al~~~k~~~~~~~~w~~dpc~~~~~~w~gv~C~~~~~~~~ 412 (858)
.++|.-+..+.+||=|..+-.+.++++. |.+.+|..+..|.++|...-...-.+--|- | -+..|
T Consensus 37 rLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lpr--------g------fgs~p 102 (264)
T KOG0617|consen 37 RLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPR--------G------FGSFP 102 (264)
T ss_pred hhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCcc--------c------cCCCc
Confidence 6777888888899988766655555544 447899999999999875311111111111 0 14457
Q ss_pred cEEEEEecCCCCcc-cccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 413 RIISLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 413 ~l~~L~L~~n~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
.+..|||+.|+|+. .+|..|..|+.|+.|+|++|.|. .+|..+++|++|+.|.|..|.|- ++|.+++.+.+|+.|++
T Consensus 103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 88999999999874 68889999999999999999999 89999999999999999999998 89999999998887665
Q ss_pred c
Q 043526 492 S 492 (858)
Q Consensus 492 ~ 492 (858)
.
T Consensus 181 q 181 (264)
T KOG0617|consen 181 Q 181 (264)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.6e-06 Score=90.64 Aligned_cols=258 Identities=15% Similarity=0.176 Sum_probs=156.2
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeee------e-eCCeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYF------I-EDNNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~------~-~~~~~~lV~E 647 (858)
...||+|+-+.+|--- .-...+-|++.........+..+ .|... .||-+-.-+.+= - +.....+.|+
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4679999999998532 11123457776554433233222 22222 455433211111 1 1223678888
Q ss_pred eccCC-ChHHHhhh----cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 648 YMANG-NLKQLLSD----EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 648 y~~~g-sL~~~L~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
.+++. -+..+.+- ......+|+-.++.++.+|.+.+-|| ..|.+-||+.++|+|+++++.+.|.|-......
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 87764 22233211 11335789999999999999999999 889999999999999999999999986544333
Q ss_pred cCCCcceeecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhC-CCccccCCC---ccccHHHHHHHHHhc
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITS-QAVIVRNEN---ENIHIIQTVTNMIAK 793 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG-~~p~~~~~~---~~~~l~~~v~~~~~~ 793 (858)
.. .......+|...|.+||... +..-+...|.|.+||++++++.| +.||.+-.. ....+- ..+..
T Consensus 168 ~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~Ia~ 241 (637)
T COG4248 168 AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDIAH 241 (637)
T ss_pred cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhhhc
Confidence 22 22233456889999999764 33446778999999999999987 889865321 000000 00111
Q ss_pred CCchhhhchh--hc---CCCCHH-HHHHHHHHHHHcccc--CCCCCCCHHHHHHHHHHHHHH
Q 043526 794 GDIENIVDSC--LR---GGFEIE-SAWRAVELAVKCASR--TSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 794 ~~~~~~~d~~--l~---~~~~~~-~~~~l~~l~~~Cl~~--dP~~RPsm~eVl~~L~~~~~~ 847 (858)
|.....-|.. +. ...+.+ ....+..+..+|+.. ++.-||+.+.++..|.++.++
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1110001100 00 001111 123566777888865 467899999999999885544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1e-06 Score=91.51 Aligned_cols=133 Identities=23% Similarity=0.239 Sum_probs=94.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC----------------------CcchHhHHHHHHHHHhcccc--ee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS----------------------GQGFKEFEAEVKLLMRVHHR--NL 629 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------------~~~~~~~~~E~~~l~~l~Hp--nI 629 (858)
.+.+.||.|.=+.||.|..+.|.++|||.-+... .-+....++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457899999999999999999999999653110 00123467788899888644 55
Q ss_pred eeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 630 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
.+.++ .+..++||||+++-.|...- ++-...-.++..|++-+.-+- ..||||+|++.-||++++||
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 55554 35678999999986665442 122223344444444444444 57899999999999999999
Q ss_pred CEEEeeecCcc
Q 043526 710 EAKLADFGLSK 720 (858)
Q Consensus 710 ~~kL~DFGla~ 720 (858)
.+.+.||--+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999997654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-07 Score=106.15 Aligned_cols=155 Identities=23% Similarity=0.297 Sum_probs=79.7
Q ss_pred ECCceeeeecccccceeeeEEeeeecCCceEEEEEEecCCCCCChhhhhhh---hhhccCCCCCCCchhHHHHHHHHHHH
Q 043526 304 KDGQILMEFIVPEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFE---VYMEKDFSQSETLHTDVDAVMNMKKM 380 (858)
Q Consensus 304 ~ng~~~~~~~~p~~~~~~~~~~~~~~~~~~~~i~L~~t~~S~LpPi~~a~e---~~~~~~~~~~~~~~~~~~al~~~k~~ 380 (858)
+.|+++++..-|+.+... +..+ =++|..|.-..+|-.+.++. .++.. +++..++..++..|-.++..
T Consensus 14 fsgNDFsg~~FP~~v~qM--------t~~~-WLkLnrt~L~~vPeEL~~lqkLEHLs~~-HN~L~~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 14 FSGNDFSGDRFPHDVEQM--------TQMT-WLKLNRTKLEQVPEELSRLQKLEHLSMA-HNQLISVHGELSDLPRLRSV 83 (1255)
T ss_pred ccCCcCCCCcCchhHHHh--------hhee-EEEechhhhhhChHHHHHHhhhhhhhhh-hhhhHhhhhhhccchhhHHH
Confidence 445555555666666555 3333 57888888888999888765 44333 35567777777777777765
Q ss_pred c---CCCCCCCCCCCCCCCCCccc---eeccCC--------CCCCCcEEEEEecCCCCcccccch-hccccccccccCCC
Q 043526 381 Y---GVKRNWQGDPCAPKAYSWDG---LNCSYK--------GNDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSN 445 (858)
Q Consensus 381 ~---~~~~~w~~dpc~~~~~~w~g---v~C~~~--------~~~~~~l~~L~L~~n~l~g~ip~~-~~~l~~L~~L~Ls~ 445 (858)
. +.+++ +|-|- ..+...- +.-+.+ -....+...||||+|+|. +||.. +.+|+.|-.||||+
T Consensus 84 ~~R~N~LKn-sGiP~--diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 84 IVRDNNLKN-SGIPT--DIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred hhhcccccc-CCCCc--hhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 4 22332 23221 0011110 111100 001123345555555555 44432 34555555555555
Q ss_pred CCCccCCCcccccccccceeeccCCcCc
Q 043526 446 NSLSGNVPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 446 N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
|.|. .+|+.+..|.+|++|+|++|.|.
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence 5555 45555555555555555555443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-06 Score=100.47 Aligned_cols=144 Identities=18% Similarity=0.246 Sum_probs=94.0
Q ss_pred hcc-ccccccCceEEEEEEECCCCEEEEEEeccCCCc--------------------------c--------------hH
Q 043526 574 NFN-KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--------------------------G--------------FK 612 (858)
Q Consensus 574 ~f~-~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------------------------~--------------~~ 612 (858)
+|+ +.|+.++-|+||+|++++|+.||||+.+..-.. . .-
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 444 579999999999999999999999998643110 0 01
Q ss_pred hHHHHHHHHHhcc-----cceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHH-HHHhh
Q 043526 613 EFEAEVKLLMRVH-----HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQG-LEYLH 686 (858)
Q Consensus 613 ~~~~E~~~l~~l~-----HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~a-L~yLH 686 (858)
++..|...+.+++ .+++.-..=|+.-.....|+|||++|-.+.+...-.. ...+-. .++..++++ +..+=
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~ 282 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLL 282 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHH
Confidence 2334444444442 3333322223333566789999999998888742222 233422 232222221 11222
Q ss_pred cCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 687 ~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
..+++|.|.+|.||+++.++...+.|||+...++.
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 45899999999999999999999999999887653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.7e-06 Score=84.78 Aligned_cols=138 Identities=17% Similarity=0.142 Sum_probs=103.7
Q ss_pred ccccCceEEEEEEECCCCEEEEEEeccC------CCcchHhHHHHHHHHHhcccce--eeeeeeeee-eC----CeeEEE
Q 043526 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSS------SGQGFKEFEAEVKLLMRVHHRN--LTNLVGYFI-ED----NNMGLI 645 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~------~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~-~~----~~~~lV 645 (858)
-|+||-+.|++-.++ |+.+=+|+-... .+.....|.+|...|.++...+ +.+++ ++. .. ..-.||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 366888889887774 446888876522 1345678999999999996433 44444 332 21 236799
Q ss_pred EeeccC-CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC--EEEeeecCccc
Q 043526 646 YEYMAN-GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE--AKLADFGLSKV 721 (858)
Q Consensus 646 ~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~--~kL~DFGla~~ 721 (858)
+|-+++ -+|.+++.+......+...+..++.++++.++-|| ..++.|+|+.++|||++.++. +++.||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 48999986655446677888999999999999999 999999999999999986666 99999976553
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.9e-07 Score=89.79 Aligned_cols=107 Identities=16% Similarity=0.211 Sum_probs=58.8
Q ss_pred EEeeccCCcCCcccccCCCCCCcccccCCCC---CCcccccc----cccccCCCCCCCChHHhhhcceecCCCCcceEEe
Q 043526 198 YKRYDYGSITNQTIRYKDDAYDRMWTPREFP---KTKKLSTS----LPIRSGADDSYLPPSAVMSTAITPINGSHALQFY 270 (858)
Q Consensus 198 ~~r~~~g~~~~~~~ryp~D~~dR~W~~~~~~---~~~~~~t~----~~i~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~ 270 (858)
+.|+|+|+. .| +|..++.|+++... .|.-..+. ..........+..++.++||+....+ .+.+.
T Consensus 2 ~~~IN~Gg~-----~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~---~f~Y~ 72 (174)
T PF11721_consen 2 VLRINAGGP-----AY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS---SFSYD 72 (174)
T ss_dssp EEEEEETSS-----SE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS---SEEEE
T ss_pred EEEEECCCC-----cc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC---ceEEE
Confidence 579999974 34 89999999987653 23111110 00122233335678899999998432 35444
Q ss_pred cCCCCCCCceEEEEEeeeccccc-----cCcceEEEEEECCceeeeecc
Q 043526 271 WEPKDPTAKYYVYMYFAEVEVLQ-----DNQLREFNISKDGQILMEFIV 314 (858)
Q Consensus 271 ~~~~~~~~~y~v~lhFae~~~~~-----~~~~R~F~i~~ng~~~~~~~~ 314 (858)
. |..++-.|-|.|||||+..-. ..++|+|||++||+.+.+.+.
T Consensus 73 i-p~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~D 120 (174)
T PF11721_consen 73 I-PVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFD 120 (174)
T ss_dssp E-E--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-
T ss_pred E-ecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccC
Confidence 3 345667899999999997422 257999999999998876543
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.5e-07 Score=99.37 Aligned_cols=81 Identities=27% Similarity=0.374 Sum_probs=64.5
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCc----------------------cCCCcc-cccccccceeec
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS----------------------GNVPEF-LSRLQFLRVLNL 467 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~----------------------g~iP~~-l~~l~~L~~L~L 467 (858)
.++++.|+|++|-|. .+|.+++.+..|+.||||+|+|. |.+|.+ +.+|.+|++|||
T Consensus 434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred hhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence 357777888877777 78888888877888888777554 245444 888999999999
Q ss_pred cCCcCcCCCChhhhccCcCCCccccc
Q 043526 468 KGNKFTGPIPVELMEKSKNGSLQLSV 493 (858)
Q Consensus 468 ~~N~l~g~iP~~~~~~~~l~~l~l~~ 493 (858)
.+|.+. .||+.++++.++++|.++.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~g 537 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDG 537 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecC
Confidence 999998 9999999999999776653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.4e-06 Score=86.17 Aligned_cols=107 Identities=23% Similarity=0.255 Sum_probs=85.0
Q ss_pred hHhHHHHHHHHHhcccce--eeeeeeeeeeCC----eeEEEEeeccCC-ChHHHhhhcccCchhHHHHHHHHHHHHHHHH
Q 043526 611 FKEFEAEVKLLMRVHHRN--LTNLVGYFIEDN----NMGLIYEYMANG-NLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683 (858)
Q Consensus 611 ~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~ 683 (858)
.....+|...+.++.... ..+.+++..... ..++|+|++++. +|.+++..... .+...+..++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 456788888888886433 456666665532 357999999984 89999865332 556678899999999999
Q ss_pred HhhcCCCCCeEecCCCCcceEEcCCC---CEEEeeecCcccc
Q 043526 684 YLHIGCKPPIVHRDIKPENILLTENL---EAKLADFGLSKVF 722 (858)
Q Consensus 684 yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DFGla~~~ 722 (858)
-|| ..+|+|+|++++|||++.+. .+.+.||+-++..
T Consensus 133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999 99999999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.3e-07 Score=99.56 Aligned_cols=78 Identities=23% Similarity=0.338 Sum_probs=50.4
Q ss_pred EEEEEecCCCCcccccchhc-cccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccc
Q 043526 414 IISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLS 492 (858)
Q Consensus 414 l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~ 492 (858)
+..|.++.|+|. .+|.+.+ +|.+|.+|||.+|+|. ++|+++..|++|..||||+|.++ .+|.+++++ .|+.| .
T Consensus 230 L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L--~ 303 (565)
T KOG0472|consen 230 LKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFL--A 303 (565)
T ss_pred HHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeeh--h
Confidence 456666666666 6666655 6777777777777777 67777777777777777777776 566666666 44433 3
Q ss_pred ccCcc
Q 043526 493 VGDNE 497 (858)
Q Consensus 493 ~~~n~ 497 (858)
..|||
T Consensus 304 leGNP 308 (565)
T KOG0472|consen 304 LEGNP 308 (565)
T ss_pred hcCCc
Confidence 34443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.5e-07 Score=106.55 Aligned_cols=143 Identities=23% Similarity=0.300 Sum_probs=88.6
Q ss_pred CCceEEEEEEecCCCCCChhhh----h-hhhhhccCCCCCC--CchhH-HHHHHHHHHHcCCCCCCCCCCCCCCCCCccc
Q 043526 330 SGAIIEFSLDRTERSTLPPIIN----A-FEVYMEKDFSQSE--TLHTD-VDAVMNMKKMYGVKRNWQGDPCAPKAYSWDG 401 (858)
Q Consensus 330 ~~~~~~i~L~~t~~S~LpPi~~----a-~e~~~~~~~~~~~--~~~~~-~~al~~~k~~~~~~~~w~~dpc~~~~~~w~g 401 (858)
.... ++.|.++....+|+.+- + ++++....+.... +.... ..+|+.|.-. .|-=+|-|.| -
T Consensus 310 ~sL~-tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyla----nN~Ltd~c~p------~ 378 (1081)
T KOG0618|consen 310 KSLR-TLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLA----NNHLTDSCFP------V 378 (1081)
T ss_pred ceee-eeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHh----cCcccccchh------h
Confidence 4444 78889999999988322 1 2333333322221 22222 2233333222 2223566643 3
Q ss_pred eeccCCCCCCCcEEEEEecCCCCcccccc-hhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhh
Q 043526 402 LNCSYKGNDPPRIISLNLSSSGLTGEIAP-YLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVEL 480 (858)
Q Consensus 402 v~C~~~~~~~~~l~~L~L~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~ 480 (858)
+.|. .+|+.|+|++|+|. ++|+ .+.+|..|+.|+||+|.|+ .||+++.+++.|++|...+|++. .+| ++
T Consensus 379 l~~~------~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~ 448 (1081)
T KOG0618|consen 379 LVNF------KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-EL 448 (1081)
T ss_pred hccc------cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hh
Confidence 3343 57888888888888 6775 5778888888888888888 78888777777777777777776 666 66
Q ss_pred hccCcCCCccccc
Q 043526 481 MEKSKNGSLQLSV 493 (858)
Q Consensus 481 ~~~~~l~~l~l~~ 493 (858)
.++++|+.++++-
T Consensus 449 ~~l~qL~~lDlS~ 461 (1081)
T KOG0618|consen 449 AQLPQLKVLDLSC 461 (1081)
T ss_pred hhcCcceEEeccc
Confidence 6666666655443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.6e-07 Score=104.32 Aligned_cols=151 Identities=23% Similarity=0.316 Sum_probs=100.9
Q ss_pred HHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc--------eeecccCCCCccCcccccc
Q 043526 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH--------VSTVVAGTPGYLDPEYFVT 747 (858)
Q Consensus 676 ~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~--------~~~~~~gt~~y~APE~~~~ 747 (858)
.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+......... ......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 455699999995 678999999999999999999999999987654331110 1111223457999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccC
Q 043526 748 DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRT 827 (858)
Q Consensus 748 ~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d 827 (858)
...+.++|+||+||+++-+..|+.+.....+.... ...... .+..-...+..+...++.+=+.+.+..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~----------~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRN----------LLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhc----------ccccccccccccCcHHHHHHHHHHhcCC
Confidence 88999999999999999999554443322211110 000000 0000011122334456777788889999
Q ss_pred CCCCCCHHHHHH
Q 043526 828 SSERPNMNEVVT 839 (858)
Q Consensus 828 P~~RPsm~eVl~ 839 (858)
+.-||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998776643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.8e-05 Score=80.29 Aligned_cols=138 Identities=16% Similarity=0.262 Sum_probs=84.9
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccccee--eeeeeeeeeCCeeEEEEeeccCCC-
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL--TNLVGYFIEDNNMGLIYEYMANGN- 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~~~~lV~Ey~~~gs- 653 (858)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25567888876533 33557889999999864444 566777777777889999999863
Q ss_pred hHHHh---------------------hhcccCchhHHHHHH-HHH----------HHHH-HHHHhhc-CCCCCeEecCCC
Q 043526 654 LKQLL---------------------SDEKASTLSWERRLQ-IAM----------DAAQ-GLEYLHI-GCKPPIVHRDIK 699 (858)
Q Consensus 654 L~~~L---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-aL~yLH~-~~~~~IvH~DLk 699 (858)
+...+ |.............. +-. .+.+ ..++|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 111000111111000 000 0101 1122221 123457899999
Q ss_pred CcceEEcCCCCEEEeeecCcc
Q 043526 700 PENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 700 ~~NILl~~~~~~kL~DFGla~ 720 (858)
|.||++++++ +.|.||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.7e-06 Score=102.56 Aligned_cols=70 Identities=24% Similarity=0.329 Sum_probs=35.4
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
.|+.|+|++|+|+ .+|... ++|+.|+|++|+|+ .||..+ .+|+.|+|++|+|+ .+|..++++++|..|++
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 4555555555555 344322 34555555555555 355422 34455555555555 55555555555554433
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.8e-07 Score=99.90 Aligned_cols=156 Identities=19% Similarity=0.210 Sum_probs=102.1
Q ss_pred EEEEEecCCCCCChhhhhhhhhhccCCCCCCCchhHHHHHHHHHHH---c--C---CCCCCCCCCCCCCCCCccce--ec
Q 043526 335 EFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKM---Y--G---VKRNWQGDPCAPKAYSWDGL--NC 404 (858)
Q Consensus 335 ~i~L~~t~~S~LpPi~~a~e~~~~~~~~~~~~~~~~~~al~~~k~~---~--~---~~~~w~~dpc~~~~~~w~gv--~C 404 (858)
-+.|..+.--+|||-+.-+..+..+.+.+++-..-++..|-++... . + -+.+... ....-....-| +|
T Consensus 154 fLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pt--sld~l~NL~dvDlS~ 231 (1255)
T KOG0444|consen 154 FLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPT--SLDDLHNLRDVDLSE 231 (1255)
T ss_pred hhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCC--chhhhhhhhhccccc
Confidence 4556667777888888888887777766555444333333222221 1 0 0111100 00000001111 22
Q ss_pred cCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCc-CCCC
Q 043526 405 SYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT-GPIP 477 (858)
Q Consensus 405 ~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~-g~iP 477 (858)
++.. -..++++.||||+|+|+ .+...++...+|++|+||.|+|+ .+|+.+++|++|+.|++.+|+|+ --||
T Consensus 232 N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiP 309 (1255)
T KOG0444|consen 232 NNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIP 309 (1255)
T ss_pred cCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCc
Confidence 2110 13457889999999999 78888888899999999999999 89999999999999999999987 3489
Q ss_pred hhhhccCcCCCcccccc
Q 043526 478 VELMEKSKNGSLQLSVG 494 (858)
Q Consensus 478 ~~~~~~~~l~~l~l~~~ 494 (858)
..++++.+|..+..+.|
T Consensus 310 SGIGKL~~Levf~aanN 326 (1255)
T KOG0444|consen 310 SGIGKLIQLEVFHAANN 326 (1255)
T ss_pred cchhhhhhhHHHHhhcc
Confidence 99999998887766544
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.4e-06 Score=63.72 Aligned_cols=36 Identities=42% Similarity=0.607 Sum_probs=20.9
Q ss_pred ccccccCCCCCCccCCCcccccccccceeeccCCcCc
Q 043526 437 LIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 437 ~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
+|++|+|++|+++ .||..+++|++|+.|+|++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4566666666666 55555666666666666666665
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=97.93 E-value=3e-06 Score=69.10 Aligned_cols=58 Identities=34% Similarity=0.442 Sum_probs=50.5
Q ss_pred cccccccCCCCCCccCCC-cccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 436 TLIQSLDLSNNSLSGNVP-EFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 436 ~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++|+.|+|++|+|+ .|| ..|..+++|+.|+|++|+++...|..+..+++|+.|+++.|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 47899999999999 555 67899999999999999999777778999999998777544
|
... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.1e-05 Score=86.95 Aligned_cols=142 Identities=23% Similarity=0.227 Sum_probs=90.1
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcc-------------------------------------hHhHHHHHH
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG-------------------------------------FKEFEAEVK 619 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~~~~E~~ 619 (858)
+.||.-+.|.||+|++++|+.||||+-+..-... .-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999976431110 112555555
Q ss_pred HHHhc----cccee---eeeeeee-eeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC
Q 043526 620 LLMRV----HHRNL---TNLVGYF-IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP 691 (858)
Q Consensus 620 ~l~~l----~HpnI---v~l~~~~-~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 691 (858)
...++ +|-+. |.+=..+ .-.....|+||||+|..+.|.-.-. ...++-.....-+.++..-+-+ ..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf-----~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIF-----KT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHH-----hc
Confidence 44443 34441 1122222 2235678999999998776653211 1223433333333332222222 45
Q ss_pred CeEecCCCCcceEEcC----CCCEEEeeecCcccccC
Q 043526 692 PIVHRDIKPENILLTE----NLEAKLADFGLSKVFPI 724 (858)
Q Consensus 692 ~IvH~DLk~~NILl~~----~~~~kL~DFGla~~~~~ 724 (858)
|++|+|=.|.||+++. ++.+.+-|||+......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 7999999999999994 67899999999876643
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.86 E-value=6.1e-06 Score=82.12 Aligned_cols=80 Identities=33% Similarity=0.405 Sum_probs=29.0
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCccc-ccccccceeeccCCcCcCCCC--hhhhccCcCCC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFL-SRLQFLRVLNLKGNKFTGPIP--VELMEKSKNGS 488 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~L~L~~N~l~g~iP--~~~~~~~~l~~ 488 (858)
.+++.|+|++|+|+ .++ .+..|+.|+.|+|++|+++ .|+..+ ..+++|+.|+|++|++.. +- ..+..+++|..
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRV 117 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--E
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcce
Confidence 46777777777777 454 4667777777777777777 565444 357777777777777762 21 23444555544
Q ss_pred ccccccCcc
Q 043526 489 LQLSVGDNE 497 (858)
Q Consensus 489 l~l~~~~n~ 497 (858)
| +..|||
T Consensus 118 L--~L~~NP 124 (175)
T PF14580_consen 118 L--SLEGNP 124 (175)
T ss_dssp E--E-TT-G
T ss_pred e--eccCCc
Confidence 3 344554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=5.1e-05 Score=78.39 Aligned_cols=135 Identities=22% Similarity=0.250 Sum_probs=86.3
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCcc-------------------h-----HhHHHHHHHHHhcc--cceeee
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG-------------------F-----KEFEAEVKLLMRVH--HRNLTN 631 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------~-----~~~~~E~~~l~~l~--HpnIv~ 631 (858)
.|+.|.-+.||+|.-.++..+|||+++...... . .-..+|...|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 567788889999998889999999986432110 0 01233445555543 222222
Q ss_pred eeeeeeeCCeeEEEEeeccCCC-hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC
Q 043526 632 LVGYFIEDNNMGLIYEYMANGN-LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE 710 (858)
Q Consensus 632 l~~~~~~~~~~~lV~Ey~~~gs-L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~ 710 (858)
.+++. .-.|||||+.... -.=.|... .+...+...+..++++.+.-|-. ..++||+||+.-|||+. ++.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence 22222 3469999997541 11112111 12222566677777777777762 47899999999999999 889
Q ss_pred EEEeeecCcccc
Q 043526 711 AKLADFGLSKVF 722 (858)
Q Consensus 711 ~kL~DFGla~~~ 722 (858)
+.|+|+|-|...
T Consensus 205 p~iID~~QaV~~ 216 (268)
T COG1718 205 PYIIDVSQAVTI 216 (268)
T ss_pred EEEEECcccccc
Confidence 999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=75.82 Aligned_cols=142 Identities=18% Similarity=0.242 Sum_probs=84.2
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccce--eeeeeeeeee---CCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN--LTNLVGYFIE---DNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~---~~~~~lV~Ey~~~ 651 (858)
+.|+.|..+.||+...++ ..+++|..... ........|..+++.+.... +.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468899999999999877 68999997544 34567788888888885433 4455554432 3346899999999
Q ss_pred CChHH----------------Hh---hhcc--cCchhH-H--------HHHHH------------HHHHHH-HHHHhhc-
Q 043526 652 GNLKQ----------------LL---SDEK--ASTLSW-E--------RRLQI------------AMDAAQ-GLEYLHI- 687 (858)
Q Consensus 652 gsL~~----------------~L---~~~~--~~~l~~-~--------~~~~i------------~~~ia~-aL~yLH~- 687 (858)
..+.. .+ +... ...+.+ . ..... ...+.+ .++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 1110 001111 0 00000 111222 2333331
Q ss_pred ---CCCCCeEecCCCCcceEEc-CCCCEEEeeecCccc
Q 043526 688 ---GCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKV 721 (858)
Q Consensus 688 ---~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGla~~ 721 (858)
.....++|+|+.++|||++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2356799999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=73.64 Aligned_cols=128 Identities=16% Similarity=0.188 Sum_probs=79.7
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHH---------HHHHHHHhccc---ceeeeeeeeee-----eCC
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFE---------AEVKLLMRVHH---RNLTNLVGYFI-----EDN 640 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~---------~E~~~l~~l~H---pnIv~l~~~~~-----~~~ 640 (858)
++......-|.+-.. +|+.+.+|..+.......+.|. +++..+.+++. -....++.+.. ...
T Consensus 38 v~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~ 116 (229)
T PF06176_consen 38 VFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS 116 (229)
T ss_pred eecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence 344333333433333 6788999988765443333322 23333334432 22223222222 223
Q ss_pred eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 641 NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
...++|||++|..|.+... ++. .++..+++++.-|| ..|++|+|..|.|++++++ .+++.||+..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 4668999999988876642 221 34566778899999 8999999999999999965 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.80 E-value=1.3e-05 Score=79.88 Aligned_cols=80 Identities=30% Similarity=0.439 Sum_probs=27.6
Q ss_pred CCCcEEEEEecCCCCcccccchhc-cccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhh-ccCcCC
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELM-EKSKNG 487 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~-~~~~l~ 487 (858)
.+.+++.|+|++|+|+ .|. .++ .|++|+.||||+|+++ .|+. +..|++|+.|+|++|+++ .+++.+. .+++|+
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 3457899999999998 564 566 6899999999999999 6764 888999999999999999 6766554 688888
Q ss_pred Ccccccc
Q 043526 488 SLQLSVG 494 (858)
Q Consensus 488 ~l~l~~~ 494 (858)
.|.++.|
T Consensus 92 ~L~L~~N 98 (175)
T PF14580_consen 92 ELYLSNN 98 (175)
T ss_dssp EEE-TTS
T ss_pred EEECcCC
Confidence 8776543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.1e-05 Score=60.91 Aligned_cols=40 Identities=38% Similarity=0.645 Sum_probs=34.5
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVP 453 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 453 (858)
++|+.|+|++|+|+ .+|+.|++|++|+.|+|++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 36889999999999 89999999999999999999999 444
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=8.5e-06 Score=87.79 Aligned_cols=86 Identities=29% Similarity=0.396 Sum_probs=70.3
Q ss_pred eeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccC-CcCcC
Q 043526 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG-NKFTG 474 (858)
Q Consensus 402 v~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~-N~l~g 474 (858)
|+|+..| +.|+..+.|.|..|+|+-.-|.+|+.|.+|+.||||+|+++-.=|+.|..|++|..|-|-+ |+++
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~- 129 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT- 129 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence 8898755 6788999999999999944445899999999999999999977799999999997776655 9998
Q ss_pred CCCh-hhhccCcCCC
Q 043526 475 PIPV-ELMEKSKNGS 488 (858)
Q Consensus 475 ~iP~-~~~~~~~l~~ 488 (858)
.+|. .+..+..++.
T Consensus 130 ~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQR 144 (498)
T ss_pred hhhhhHhhhHHHHHH
Confidence 7775 4555655543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00041 Score=70.75 Aligned_cols=132 Identities=20% Similarity=0.404 Sum_probs=93.7
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCC----------------CcchHhHHHHHHHHHhcc------cceeeeeee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS----------------GQGFKEFEAEVKLLMRVH------HRNLTNLVG 634 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l~~ 634 (858)
..||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999988885 4556667889887654 223567777777666665 888999999
Q ss_pred eeeeCCeeEEEEeeccC--C----ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 635 YFIEDNNMGLIYEYMAN--G----NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 635 ~~~~~~~~~lV~Ey~~~--g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
+.+.+....+|+|.+.+ | +|.+++... .++. ...+.+.+.. +||- +..|+.+|++|+||++..+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEEEec
Confidence 99999999999998764 2 677887443 3444 4444444444 4444 5569999999999999643
Q ss_pred C----CEEEee-ecCcc
Q 043526 709 L----EAKLAD-FGLSK 720 (858)
Q Consensus 709 ~----~~kL~D-FGla~ 720 (858)
. .+.|.| ||...
T Consensus 155 ~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCCceEEEEEeCCCCcc
Confidence 2 477777 55433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00028 Score=74.57 Aligned_cols=138 Identities=19% Similarity=0.163 Sum_probs=83.6
Q ss_pred ccccCc-eEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCChHH
Q 043526 579 LGKGGF-GTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656 (858)
Q Consensus 579 LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 656 (858)
|..|.. ..||+...+ +..+.||+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 344444 788998764 4678888875443 345678898888884 3334566777766667889999999987764
Q ss_pred Hh-------------------hhcccC--chh--HHHHHHHHH--------------------HHHHHHHHhhc----CC
Q 043526 657 LL-------------------SDEKAS--TLS--WERRLQIAM--------------------DAAQGLEYLHI----GC 689 (858)
Q Consensus 657 ~L-------------------~~~~~~--~l~--~~~~~~i~~--------------------~ia~aL~yLH~----~~ 689 (858)
.. |..... .+. ...+..... .+.+.+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 111000 100 000000000 01111222210 11
Q ss_pred CCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 690 KPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 690 ~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
...++|+|+.|.|||++++....|.||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3568999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=7e-06 Score=76.30 Aligned_cols=77 Identities=27% Similarity=0.361 Sum_probs=67.1
Q ss_pred CCcEEEEEecCCCCcccccchhccc-cccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNL-TLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l-~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..+++.++|++|.|. .+|+.|... +.++.|+|++|+|+ .+|.++..++.|+.||++.|.|. ..|..+..+.++-.|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 357899999999999 888877665 59999999999999 99999999999999999999998 788888887776554
Q ss_pred c
Q 043526 490 Q 490 (858)
Q Consensus 490 ~ 490 (858)
+
T Consensus 129 d 129 (177)
T KOG4579|consen 129 D 129 (177)
T ss_pred c
Confidence 4
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0001 Score=74.61 Aligned_cols=104 Identities=24% Similarity=0.279 Sum_probs=82.6
Q ss_pred HHHHHHHHhccc-ceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhh-cccCchhHHHHHHHHHHHHHHHHHhhcCCCCC
Q 043526 615 EAEVKLLMRVHH-RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD-EKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692 (858)
Q Consensus 615 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 692 (858)
..|.-+++.+++ +++.+++|+| ...+|.||...+++...-.. ..-..-+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888876 6999999999 34689999997766432000 01124689999999999999999999766566
Q ss_pred eEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 693 IVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 693 IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
+.-.|++++|+-+++++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=1.9e-05 Score=88.75 Aligned_cols=83 Identities=28% Similarity=0.235 Sum_probs=67.0
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
..+..|+|..|+++..--..+.+|++|+.||||+|.++-.-++.++..++|+.|+|++|+++.--|.++..+++|+.|.|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 46788999999998666667888999999999999998777888888899999999999998555667777777777665
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+-|
T Consensus 349 s~N 351 (873)
T KOG4194|consen 349 SHN 351 (873)
T ss_pred ccc
Confidence 544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0003 Score=68.96 Aligned_cols=127 Identities=23% Similarity=0.254 Sum_probs=86.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChHH
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQ 656 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 656 (858)
+.|++|.+|.||.|.+. |..+|+|+-+..+. ...+..|+++|..+.-.++.+=+-.+-+ -.+.|||+.|-.|.+
T Consensus 28 ~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~ 101 (201)
T COG2112 28 KELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhh
Confidence 57999999999999995 45889998765543 4789999999999987766543332222 234599999988876
Q ss_pred HhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC-cceEEcCCCCEEEeeecCccc
Q 043526 657 LLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKP-ENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 657 ~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~-~NILl~~~~~~kL~DFGla~~ 721 (858)
.-... + .+-...+++.---|- ..||-|+.|.- ...+|..+..+.|+||.-|+.
T Consensus 102 ~~~~~-----~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG-----D----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc-----c----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 64321 1 122233444433344 67899999874 444444444999999998874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=3.7e-05 Score=86.55 Aligned_cols=97 Identities=28% Similarity=0.335 Sum_probs=81.9
Q ss_pred CccceeccCC-----------CCCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceee
Q 043526 398 SWDGLNCSYK-----------GNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466 (858)
Q Consensus 398 ~w~gv~C~~~-----------~~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~ 466 (858)
.-.-..|+.. |..|+..+.|+|++|.|+..=+..|-+|.+|+.++|.+|.|+ .||.......+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 3344678753 355678899999999999888888999999999999999999 9999877778899999
Q ss_pred ccCCcCcCCCChhhhccCcCCCccccccC
Q 043526 467 LKGNKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 467 L~~N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|.+|.++..-.+++..++.|++|+|+-|.
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhch
Confidence 99999996666788889999988887653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.2e-05 Score=91.65 Aligned_cols=180 Identities=19% Similarity=0.176 Sum_probs=131.8
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccce-eeeeeeeeeeCCeeEEEEeeccCC-ChH
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN-LTNLVGYFIEDNNMGLIYEYMANG-NLK 655 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~Ey~~~g-sL~ 655 (858)
-.++|+.+.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++...++++++..+ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 46789999999887433344445555433 34456789999999999 777777777788889999999887 222
Q ss_pred HHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccC
Q 043526 656 QLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735 (858)
Q Consensus 656 ~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 735 (858)
..... ....+...+...+.+.-++++++|| +..=+|+| ||+..+ ...+..||+....+.... ......+
T Consensus 324 ~~~~~-se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~ 392 (829)
T KOG0576|consen 324 LEMTV-SEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIG 392 (829)
T ss_pred ccCCh-hhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--ccccCCC
Confidence 22211 1123445556667777889999999 54458888 777766 578999999887765432 3445678
Q ss_pred CCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCcc
Q 043526 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVI 773 (858)
Q Consensus 736 t~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~ 773 (858)
++.++|||......+..+.|+|+.|+-..+|--|-+|-
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99999999999999999999999998777777776553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=6.4e-05 Score=90.94 Aligned_cols=69 Identities=28% Similarity=0.340 Sum_probs=54.7
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccC
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS 484 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~ 484 (858)
+.+++.|+|++|+|+ .||... .+|+.|+|++|+|+ .||..+++|++|+.|+|++|+|+|.+|..+..+.
T Consensus 401 ~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 401 PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 356788888888888 577543 46778888888888 7888888888888888888888888888775554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00015 Score=88.05 Aligned_cols=55 Identities=9% Similarity=0.121 Sum_probs=36.0
Q ss_pred ecCCCCCChhhhhhhh----------------hhccCCCCCCCchhHHHHHHHHHHHcC---CCCC----CCC--CCCCC
Q 043526 340 RTERSTLPPIINAFEV----------------YMEKDFSQSETLHTDVDAVMNMKKMYG---VKRN----WQG--DPCAP 394 (858)
Q Consensus 340 ~t~~S~LpPi~~a~e~----------------~~~~~~~~~~~~~~~~~al~~~k~~~~---~~~~----w~~--dpc~~ 394 (858)
....+.-||.+..-|. +..+.+...+|.+.++..+.++.+.+. .+.+ |+| |.|.-
T Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~ 97 (754)
T PRK15370 18 NEASTEVPLKEEIWNKISAFFSSEHQVEAQNCIAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCIL 97 (754)
T ss_pred hhhccCCCchhHHHHHHHHHhccchHHHHHHHHHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCccccc
Confidence 3345566777764442 224445557889999999999998773 3444 876 57754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=2.8e-05 Score=91.93 Aligned_cols=79 Identities=29% Similarity=0.454 Sum_probs=53.3
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLS 492 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~ 492 (858)
++.+|+|++|+++ ..|..|..+.+|+.|+++.|.+. .+|.+.+++++|++|+|.+|.+. .+|.++..+.+|+.|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3666677766666 66666666666666666666666 66666666666666666666666 666666666666666666
Q ss_pred cc
Q 043526 493 VG 494 (858)
Q Consensus 493 ~~ 494 (858)
+|
T Consensus 123 ~N 124 (1081)
T KOG0618|consen 123 FN 124 (1081)
T ss_pred hh
Confidence 55
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0011 Score=82.45 Aligned_cols=78 Identities=14% Similarity=0.219 Sum_probs=56.5
Q ss_pred ccccccCceEEEEEEECCC---CEEEEEEeccCC-CcchHhHHHHHHHHHhcc-ccee--eeeeeeeeeC---CeeEEEE
Q 043526 577 KVLGKGGFGTVYHGYLDDG---TQVAVKMLSSSS-GQGFKEFEAEVKLLMRVH-HRNL--TNLVGYFIED---NNMGLIY 646 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV~ 646 (858)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4578999999999887654 467777764432 123357889999999995 6665 6777777654 4578999
Q ss_pred eeccCCCh
Q 043526 647 EYMANGNL 654 (858)
Q Consensus 647 Ey~~~gsL 654 (858)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=4.4e-05 Score=82.43 Aligned_cols=91 Identities=24% Similarity=0.227 Sum_probs=78.8
Q ss_pred CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCC
Q 043526 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGS 488 (858)
Q Consensus 409 ~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~ 488 (858)
...++++.|+|++|+|++.-+.+|..+.+|++|.|..|+|.-.--..|-+|..|+.|+|.+|+++-.-|..+..+..|+.
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 45789999999999999999999999999999999999998444456788999999999999999888888888888886
Q ss_pred ccccccCcccccC
Q 043526 489 LQLSVGDNEELCS 501 (858)
Q Consensus 489 l~l~~~~n~~lc~ 501 (858)
|.+ -+||..|.
T Consensus 351 l~l--~~Np~~Cn 361 (498)
T KOG4237|consen 351 LNL--LSNPFNCN 361 (498)
T ss_pred eeh--ccCcccCc
Confidence 654 46777764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0017 Score=68.14 Aligned_cols=73 Identities=21% Similarity=0.301 Sum_probs=48.8
Q ss_pred ccccccCceEEEEEEECC--CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeee-eeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLDD--GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTN-LVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.|..|-...+|+....+ ++.+++|+....... ..+..+|+.++..+....+++ +++.+ + ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCCc
Confidence 457778888999998764 678999987644222 233457888888886444443 33322 2 248999999876
Q ss_pred h
Q 043526 654 L 654 (858)
Q Consensus 654 L 654 (858)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0015 Score=66.16 Aligned_cols=123 Identities=26% Similarity=0.398 Sum_probs=88.7
Q ss_pred hhccccccccCc-eEEEEEEECCCCEEEEEEeccC-----------CC----------cchHhHHHHHHHHHhcc---cc
Q 043526 573 DNFNKVLGKGGF-GTVYHGYLDDGTQVAVKMLSSS-----------SG----------QGFKEFEAEVKLLMRVH---HR 627 (858)
Q Consensus 573 ~~f~~~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~-----------~~----------~~~~~~~~E~~~l~~l~---Hp 627 (858)
-+|-+.||.|.. |.||+++. +|+.+|+|.++.. -. .-...|..|.+...+++ +.
T Consensus 39 I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e 117 (207)
T PF13095_consen 39 IEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE 117 (207)
T ss_pred EeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence 355688999999 99999999 5779999994321 00 11235888999888885 44
Q ss_pred ee--eeeeeeeeeC------------------CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhc
Q 043526 628 NL--TNLVGYFIED------------------NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687 (858)
Q Consensus 628 nI--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 687 (858)
++ |+.+||..-. ....+|.||++... ....+-+.+|.+-|..+|
T Consensus 118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~~- 181 (207)
T PF13095_consen 118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKILH- 181 (207)
T ss_pred CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHHH-
Confidence 56 8888887322 12468888887633 112233456777788899
Q ss_pred CCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 688 ~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
..+|+-+|+++.|.. .-||+|||.+
T Consensus 182 --k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 --KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred --HCCeeeccCcccccc-----CCEEEecccC
Confidence 899999999999986 5689999854
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.002 Score=71.90 Aligned_cols=151 Identities=19% Similarity=0.236 Sum_probs=90.5
Q ss_pred CeEEeccCCCC-CCCCcCCCCceeeecC---ccccccCcccccc---cccccCCcccccccccccCCCCCceeeeCCC-C
Q 043526 30 GFISIDCGIPA-ASSYNDETTDLKYISD---TTFVETGINKNIS---SEFQISTLPKQFYNVRTFPQGMRNCYTLNPT-E 101 (858)
Q Consensus 30 ~~~~idCG~~~-~~~~~~~~~~~~~~~D---~~~~~~g~~~~~~---~~~~~~~~~~~~~tlR~Fp~~~~ncy~l~~~-~ 101 (858)
-+..++||++. ...|.+|.-.|.|.+. .+..+-..+..|. ...........|+|.|.=.....+ ++|.-. .
T Consensus 179 ~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~-~nltw~~~ 257 (347)
T PF12819_consen 179 TVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDP-LNLTWSFV 257 (347)
T ss_pred EEEeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHhhhcccccccc-eEEEeccC
Confidence 35689999854 3778889999999963 2232222222232 111112233448899988755422 444221 2
Q ss_pred CCCceEEEEEEeeeccCCC---CCCCCeeeEEecceeEEE-EecCCcc---ccceeEEEE-ecCCCeeEEEEeecCCC--
Q 043526 102 GKGSKYSIRASFMYGNYDA---ANKPPQFDLYLGVNLWDS-IKLDNAT---AMEMKEIIH-IPTENHVLICLVNTGLG-- 171 (858)
Q Consensus 102 ~~~~~ylvR~~f~ygnyd~---~~~~p~Fd~~~~~~~w~~-v~~~~~~---~~~~~e~i~-~~~~~~~~vcl~~~~~~-- 171 (858)
+++..|+||.+|- .... ....-+||+++++..|.. +...... .+.+...++ +..+..+.|.|..+..+
T Consensus 258 ~~~~~y~v~lHFa--Ei~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~l 335 (347)
T PF12819_consen 258 DPGFSYYVRLHFA--EIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTL 335 (347)
T ss_pred CCCccEEEEEEEe--ecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCc
Confidence 3788999999993 1121 111357999999999873 3322211 112334444 44456788999987665
Q ss_pred CceeeeEEeeec
Q 043526 172 TPFISALELRLL 183 (858)
Q Consensus 172 ~pfis~lEl~~l 183 (858)
.|+|+|+|+..+
T Consensus 336 ppiLNalEIy~v 347 (347)
T PF12819_consen 336 PPILNALEIYKV 347 (347)
T ss_pred CceeEeeeeEeC
Confidence 599999999753
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0015 Score=69.74 Aligned_cols=137 Identities=15% Similarity=0.089 Sum_probs=78.6
Q ss_pred ccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceee-eeeeeeeeCCeeEEEEeeccCCChHHH
Q 043526 579 LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT-NLVGYFIEDNNMGLIYEYMANGNLKQL 657 (858)
Q Consensus 579 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 657 (858)
+..|-...+|+... +|+.+++|........-..+..+|.++++.+....++ ++++.. . -.+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677888998874 5678889876543322112467888888888654443 233332 2 3689999998665321
Q ss_pred -----------------hhhcc--cCchhHHHH-HHHHH---------HHHHHHHHhhc-----CCCCCeEecCCCCcce
Q 043526 658 -----------------LSDEK--ASTLSWERR-LQIAM---------DAAQGLEYLHI-----GCKPPIVHRDIKPENI 703 (858)
Q Consensus 658 -----------------L~~~~--~~~l~~~~~-~~i~~---------~ia~aL~yLH~-----~~~~~IvH~DLk~~NI 703 (858)
+|... ...++...+ ..... .+.+.+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12111 111111111 11111 11111222211 1134589999999999
Q ss_pred EEcCCCCEEEeeecCccc
Q 043526 704 LLTENLEAKLADFGLSKV 721 (858)
Q Consensus 704 Ll~~~~~~kL~DFGla~~ 721 (858)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0032 Score=68.71 Aligned_cols=75 Identities=12% Similarity=0.092 Sum_probs=55.7
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccc---ceeeeeeeeeee---CCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH---RNLTNLVGYFIE---DNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~---~~~~~lV~Ey~~ 650 (858)
+.||.|..+.||+....+|+ +.+|..+. ......+..|.+.++.+.- -.+.+++++|.. .+..++|||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 56999999999998776664 66677533 1123578899999988853 356778887754 366899999999
Q ss_pred CCCh
Q 043526 651 NGNL 654 (858)
Q Consensus 651 ~gsL 654 (858)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00022 Score=53.58 Aligned_cols=33 Identities=39% Similarity=0.963 Sum_probs=24.4
Q ss_pred hhHHHHHHHHHHHcC-----CCCCCCC----CCCCCCCCCccceecc
Q 043526 368 HTDVDAVMNMKKMYG-----VKRNWQG----DPCAPKAYSWDGLNCS 405 (858)
Q Consensus 368 ~~~~~al~~~k~~~~-----~~~~w~~----dpc~~~~~~w~gv~C~ 405 (858)
+.|++||++||+.+. .+.+|+. +|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-----~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-----SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-----CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-----eeccEEeC
Confidence 579999999999874 4779963 556 89999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 858 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-54 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 450 bits (1161), Expect = e-153
Identities = 129/314 (41%), Positives = 189/314 (60%), Gaps = 9/314 (2%)
Query: 541 KRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNK--VLGKGGFGTVYHGYLDDGTQV 598
K L++ + FE+ ++ + T+NF+ ++G G FG VY G L DG +V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 599 AVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL 658
A+K + S QG +EFE E++ L H +L +L+G+ E N M LIY+YM NGNLK+ L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 659 --SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716
SD ++SWE+RL+I + AA+GL YLH I+HRD+K NILL EN K+ DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 717 GLSKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVR 775
G+SK TH+STVV GT GY+DPEYF+ L EKSDVYSFGVVL E++ +++ IV+
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 776 N-ENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNM 834
+ E +++ + G +E IVD L ES + + AVKC + +S +RP+M
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303
Query: 835 NEVVTELKECLMME 848
+V+ +L+ L ++
Sbjct: 304 GDVLWKLEYALRLQ 317
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-121
Identities = 114/290 (39%), Positives = 173/290 (59%), Gaps = 8/290 (2%)
Query: 561 RHFTYSEVLKITDNFNK--VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFK-EFEAE 617
+ F+ E+ +DNF+ +LG+GGFG VY G L DGT VAVK L QG + +F+ E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 618 VKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--SDEKASTLSWERRLQIA 675
V+++ HRNL L G+ + L+Y YMANG++ L E L W +R +IA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ +A+GL YLH C P I+HRD+K NILL E EA + DFGL+K+ THV+T V G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRN---ENENIHIIQTVTNMIA 792
T G++ PEY T +EK+DV+ +GV+LLE+IT Q ++++ ++ V ++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842
+ +E +VD L+G ++ E + +++A+ C + ERP M+EVV L+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-117
Identities = 96/301 (31%), Positives = 163/301 (54%), Gaps = 22/301 (7%)
Query: 561 RHFTYSEVLKITDNFNK--------VLGKGGFGTVYHGYLDDGTQVAVKMLSS----SSG 608
F++ E+ +T+NF++ +G+GGFG VY GY++ T VAVK L++ ++
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTE 71
Query: 609 QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSD-EKASTLS 667
+ ++F+ E+K++ + H NL L+G+ + +++ L+Y YM NG+L LS + LS
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 668 WERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG- 726
W R +IA AA G+ +LH + +HRDIK NILL E AK++DFGL++
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT 786
T +++ + GT Y+ PE + + KSD+YSFGVVLLEIIT + + ++
Sbjct: 189 TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDI 246
Query: 787 VTNMIA-KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
+ + IE+ +D + + S +A +C ++RP++ +V L+E
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 846 M 846
Sbjct: 306 A 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-77
Identities = 76/312 (24%), Positives = 123/312 (39%), Gaps = 35/312 (11%)
Query: 560 NRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAE 617
+ + +V +G FG V+ L VAVK+ Q + + E E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYE 68
Query: 618 VKLLMRVHHRNLTNLVGYFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWERRLQ 673
V L + H N+ +G ++ LI + G+L L KA+ +SW
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCH 125
Query: 674 IAMDAAQGLEYLH-------IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726
IA A+GL YLH G KP I HRDIK +N+LL NL A +ADFGL+ F G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 727 THV-STVVAGTPGYLDPEYF-----VTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN 780
+ + GT Y+ PE + D+Y+ G+VL E+ + +E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 781 -IHIIQTVTNMIAKGDIENIVDSCLRGG-FEIESAWRA-------VELAVKCASRTSSER 831
+ + + + D++ +V + + W+ E +C + R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVV--VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 832 PNMNEVVTELKE 843
+ V + +
Sbjct: 304 LSAGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-66
Identities = 87/309 (28%), Positives = 141/309 (45%), Gaps = 25/309 (8%)
Query: 538 WSLKRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQ 597
L G+++ ++ + ++ N + +G G FGTV+ G+
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAEWH-GSD 62
Query: 598 VAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655
VAVK+L + EF EV ++ R+ H N+ +G + N+ ++ EY++ G+L
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 656 QLL-SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714
+LL L RRL +A D A+G+ YLH PPIVHR++K N+L+ + K+
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV 774
DFGLS++ S AGTP ++ PE + NEKSDVYSFGV+L E+ T Q
Sbjct: 182 DFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP-- 238
Query: 775 RNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNM 834
N++ Q V + K I + + C + +RP+
Sbjct: 239 ---WGNLNPAQVVAAVGFKCKRLEIPRNLN-------PQVA--AIIEGCWTNEPWKRPSF 286
Query: 835 NEVVTELKE 843
++ L+
Sbjct: 287 ATIMDLLRP 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 5e-65
Identities = 88/302 (29%), Positives = 141/302 (46%), Gaps = 38/302 (12%)
Query: 560 NRHFTYSEVLKITDN---FNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQG----- 610
F S + + DN + K +GKGGFG V+ G + D + VA+K L +G
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 611 --FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSW 668
F+EF+ EV ++ ++H N+ L G M + E++ G+L L D KA + W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD-KAHPIKW 121
Query: 669 ERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE-----AKLADFGLSKVFP 723
+L++ +D A G+EY+ PPIVHRD++ NI L E AK+ADFGLS+
Sbjct: 122 SVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS- 179
Query: 724 IGGTHVSTVVAGTPGYLDPEYFVTDWL--NEKSDVYSFGVVLLEIITSQAVIVRNENENI 781
H + + G ++ PE + EK+D YSF ++L I+T + + +
Sbjct: 180 ---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFDEYSY 233
Query: 782 HIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841
I+ + + +G I + C R + C S +RP+ + +V EL
Sbjct: 234 GKIKFINMIREEGLRPTIPEDC-------PPRLR--NVIELCWSGDPKKRPHFSYIVKEL 284
Query: 842 KE 843
E
Sbjct: 285 SE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-63
Identities = 53/277 (19%), Positives = 112/277 (40%), Gaps = 29/277 (10%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTN 631
NF L + G ++ G G + VK+L S + ++F E L H N+
Sbjct: 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 632 LVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
++G + LI +M G+L +L + + + ++ A+D A+G+ +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF---V 746
+P I + ++++ E++ A+++ + F S P ++ PE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKP 184
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806
D +D++SF V+L E++T + ++ ++ + +G I
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKVALEGLRPTIPPGI--- 236
Query: 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
+L C + ++RP + +V L++
Sbjct: 237 ----SPHVS--KLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 77/328 (23%), Positives = 124/328 (37%), Gaps = 43/328 (13%)
Query: 563 FTYSEVLKITDNFN--KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKL 620
SE DN +++G+G +G VY G LD VAVK+ S ++ Q F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFIN-EKNIYR 60
Query: 621 LMRVHHRNLTNLVGYFIEDNNMG-----LIYEYMANGNLKQLLSDEKASTLSWERRLQIA 675
+ + H N+ + G L+ EY NG+L + LS T W ++A
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLA 117
Query: 676 MDAAQGLEYLH------IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG--- 726
+GL YLH KP I HRD+ N+L+ + ++DFGLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 727 ----THVSTVVAGTPGYLDPEYF-------VTDWLNEKSDVYSFGVVLLEIITSQAVIVR 775
+ + GT Y+ PE + ++ D+Y+ G++ EI +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 776 NENENIHIIQTVTNMIAKGDIENIVDSCLRGGF--EIESAWRA--------VELAVKCAS 825
E+ + + T + E++ R + AW+ E C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 826 RTSSERPNMNEVVTELKECLMMELARKK 853
+ + R + E LMM R K
Sbjct: 298 QDAEARLTAQXAEERMAE-LMMIWERNK 324
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-62
Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 29/288 (10%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+V+G+G FG V VA+K + S S + K F E++ L RV+H N+ L G
Sbjct: 12 VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68
Query: 635 YFIEDNNMGLIYEYMANGNLKQLL-SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+ N + L+ EY G+L +L E + + + +QG+ YLH +
Sbjct: 69 ACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 694 VHRDIKPENILLTENLE-AKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+HRD+KP N+LL K+ DFG + T G+ ++ PE F +E
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNE--NENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810
K DV+S+G++L E+IT R + +E + + G ++ +
Sbjct: 183 KCDVFSWGIILWEVIT------RRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL------- 229
Query: 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKKELWH 858
L +C S+ S+RP+M E+V + LM + L +
Sbjct: 230 PKPIE--SLMTRCWSKDPSQRPSMEEIVKIMTH-LMRYFPGADEPLQY 274
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-61
Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 33/281 (11%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML----SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
+++G GGFG VY + G +VAVK Q + E KL + H N+
Sbjct: 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L G +++ N+ L+ E+ G L ++LS ++ + + + A+ A+G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 691 PPIVHRDIKPENILLTE--------NLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP 742
PI+HRD+K NIL+ + N K+ DFGL++ T + AG ++ P
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMS-AAGAYAWMAP 183
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802
E ++ SDV+S+GV+L E++T + I + + I +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGVAMNKLALPIPST 238
Query: 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
C + +L C + RP+ ++ +L
Sbjct: 239 C-------PEPFA--KLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-60
Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 33/295 (11%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
K +GKG +G V+ G G +VAVK+ ++ + E E+ + + H N+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIA 98
Query: 635 YFIEDN----NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH---- 686
I+ + LI +Y NG+L L K++TL + L++A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 687 -IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV---STVVAGTPGYLDP 742
KP I HRD+K +NIL+ +N +AD GL+ F V GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 743 E------YFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796
E +D+YSFG++L E+ E + V + + D+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 797 ENIVDSCLRGGF-EIESAWRA-------VELAVKCASRTSSERPNMNEVVTELKE 843
IV C++ + W + +L +C + + R V L +
Sbjct: 276 REIV--CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-59
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 33/295 (11%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +GKG +G V+ G G VAVK+ SS + + E E+ + + H N+ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIA 69
Query: 635 YFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH---- 686
+ + LI Y G+L L + +TL L+I + A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 687 -IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV---STVVAGTPGYLDP 742
KP I HRD+K +NIL+ +N + +AD GL+ + + + GT Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 743 E------YFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796
E ++ D+++FG+VL E+ E+ V N + D+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 797 ENIVDSCLRGG-FEIESAWRA-------VELAVKCASRTSSERPNMNEVVTELKE 843
+V C+ I + W + +L +C + S R + L +
Sbjct: 247 RKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-59
Identities = 58/299 (19%), Positives = 116/299 (38%), Gaps = 38/299 (12%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+++GKG FG VYHG +VA++++ + K F+ EV + H N+
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+G + ++ +I L ++ D K L + QIA + +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKV----FPIGGTHVSTVVAGTPGYLDPEYFVTD 748
I+H+D+K +N+ +N + + DFGL + + G +L PE
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 749 WL---------NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI 799
++ SDV++ G + E+ + + + + G N+
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEA-IIWQMGTGMKPNL 263
Query: 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKKELWH 858
+ ++ + C + ERP +++ L++ + + R+ H
Sbjct: 264 SQI------GMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEK--LPKRNRRLSHPGH 312
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-57
Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 23/275 (8%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ +G G FGTVY G VAVKML ++ + Q + F+ EV +L + H N+
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+GY + ++ ++ +L L + + ++ + IA A+G++YLH
Sbjct: 86 MGYSTAPQ-LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVF-PIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
I+HRD+K NI L E+ K+ DFGL+ G+H ++G+ ++ PE N
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 752 ---EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808
+SDVY+FG+VL E++T Q + N N II+ V D+ + +C
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ-LPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC----- 254
Query: 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
+ L +C + ERP+ ++ E++E
Sbjct: 255 --PKRMK--RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-57
Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 575 FNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+VLGKG FG + + G + +K L + + F EVK++ + H N+ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
G +D + I EY+ G L+ ++ S W +R+ A D A G+ YLH I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFP-------------IGGTHVSTVVAGTPGYL 740
+HRD+ N L+ EN +ADFGL+++ V G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE-NI 799
PE +EK DV+SFG+VL EII N + + + +G ++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRV-----NADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846
+C ++ + V+C +RP+ ++ L+ M
Sbjct: 245 PPNCP-------PSFF--PITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-56
Identities = 69/295 (23%), Positives = 128/295 (43%), Gaps = 33/295 (11%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +GKG FG V+ G G +VAVK+ SS + + EAE+ + + H N+ +
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIA 103
Query: 635 YFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH---- 686
+DN L+ +Y +G+L L+ T++ E +++A+ A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 687 -IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV---STVVAGTPGYLDP 742
KP I HRD+K +NIL+ +N +AD GL+ + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 743 E------YFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796
E +++D+Y+ G+V EI ++ +E+ + V + + ++
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 797 ENIVDSCLRGGF-EIESAWRA-------VELAVKCASRTSSERPNMNEVVTELKE 843
+V C + I + W++ ++ +C + R + L +
Sbjct: 281 RKVV--CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 38/271 (14%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVK--MLSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
F+ +G+G F TVY G + +VA + + F+ E ++L + H N+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 632 LVGYFI----EDNNMGLIYEYMANGNLKQLLSDEKASTLS----WERRLQIAMDAAQGLE 683
+ + L+ E M +G LK L K + W R QI +GL+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QIL----KGLQ 143
Query: 684 YLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP 742
+LH PPI+HRD+K +NI +T K+ D GL+ + + V+ GTP ++ P
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKAVI-GTPEFMAP 199
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH-IIQTVTNMIAKGDIENIVD 801
E + +E DVY+FG+ +LE+ TS+ +E +N I + VT+ + + +
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVAI 256
Query: 802 SCLRGGFEIESAWRAVELAVKCASRTSSERP 832
++ E+ C + ER
Sbjct: 257 PEVK------------EIIEGCIRQNKDERY 275
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+ +G+G FG +DG Q +K +S S + +E EV +L + H N+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
F E+ ++ ++ +Y G+L + ++ +K ++ L + L+++H I
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKI 146
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE------YFVT 747
+HRDIK +NI LT++ +L DFG+++V + GTP YL PE Y
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY--- 202
Query: 748 DWLNEKSDVYSFGVVLLEIIT 768
N KSD+++ G VL E+ T
Sbjct: 203 ---NNKSDIWALGCVLYELCT 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 65/243 (26%), Positives = 93/243 (38%), Gaps = 27/243 (11%)
Query: 539 SLKRRKDRAAILNAHGSLEFENRHFTYSEVLKIT-DNFN--KVLGKGGFGTVYHG-YLDD 594
S+ + + R S ++ + S +F LG G +G V+ +D
Sbjct: 22 SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKED 81
Query: 595 GTQVAVKMLSSSSGQGFKEFE---AEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMA 650
G AVK S S +G K+ AEV +V H L + E + L E
Sbjct: 82 GRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-C 139
Query: 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE 710
+L+Q AS L + D L +LH +VH D+KP NI L
Sbjct: 140 GPSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGR 195
Query: 711 AKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE-----YFVTDWLNEKSDVYSFGVVLLE 765
KL DFGL +G V G P Y+ PE Y +DV+S G+ +LE
Sbjct: 196 CKLGDFGLLVE--LGTAGAGEVQEGDPRYMAPELLQGSY------GTAADVFSLGLTILE 247
Query: 766 IIT 768
+
Sbjct: 248 VAC 250
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-40
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ LG+GGF V L DG A+K + Q +E + E + +H N+ LV Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 636 FIEDNNMG----LIYEYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHIGC 689
+ + L+ + G L + +K + L+ ++ L + + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA--------GTPGYLD 741
HRD+KP NILL + + L D G I + T Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 742 PEYFVT---DWLNEKSDVYSFGVVLLEIIT 768
PE F ++E++DV+S G VL ++
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVK---MLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G+G F VY L DG VA+K + + + E+ LL +++H N+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKAS--TLSWERRLQIAMDAAQGLEYLHIGCK 690
FIEDN + ++ E G+L +++ K + + + LE++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE------Y 744
++HRDIKP N+ +T KL D GL + F T ++V GTP Y+ PE Y
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 745 FVTDWLNEKSDVYSFGVVLLEIITSQ 770
N KSD++S G +L E+ Q
Sbjct: 214 ------NFKSDIWSLGCLLYEMAALQ 233
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 38/215 (17%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+++G GGFG V+ DG +K + ++ ++ E EVK L ++ H N+ + G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72
Query: 636 FIEDNNMG----------------LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
+ + + E+ G L+Q + + L L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+G++Y+H +++RD+KP NI L + + K+ DFGL G + GT Y
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRY 187
Query: 740 LDPE------YFVTDWLNEKSDVYSFGVVLLEIIT 768
+ PE Y ++ D+Y+ G++L E++
Sbjct: 188 MSPEQISSQDY------GKEVDLYALGLILAELLH 216
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-38
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ +G+G FG V+ G L D T VAVK + +F E ++L + H N+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+G + + ++ E + G+ L E + L + LQ+ DAA G+EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKC 233
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDPEYFV 746
+HRD+ N L+TE K++DFG+S+ G + ++ T PE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTA----PEALN 288
Query: 747 TDWLNEKSDVYSFGVVLLEIIT 768
+ +SDV+SFG++L E +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 10/201 (4%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+G G +G DG + K S + + +EV LL + H N+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 634 GYFIEDNNMGL--IYEYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHIGC 689
I+ N L + EY G+L +++ ++ L E L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 690 KPP--IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
++HRD+KP N+ L KL DFGL+++ + T V GTP Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 748 DWLNEKSDVYSFGVVLLEIIT 768
NEKSD++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCA 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ LG+GGFG V+ D A+K + + ++ EVK L ++ H +
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 635 YFIEDNNM---------GLIY---EYMANGNLKQLLSDEKASTLSWERR-LQIAMDAAQG 681
++E N +Y + NLK ++ L I + A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF-----------PIGGTHVS 730
+E+LH ++HRD+KP NI T + K+ DFGL P+
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 731 TVVAGTPGYLDPE------YFVTDWLNEKSDVYSFGVVLLEIIT 768
T GT Y+ PE Y + K D++S G++L E++
Sbjct: 188 TGQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 74/238 (31%), Positives = 102/238 (42%), Gaps = 57/238 (23%)
Query: 557 EFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSGQGF 611
+FE RH F + LGKG FG+V D G VAVK L S+ +
Sbjct: 6 QFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 55
Query: 612 KEFEAEVKLLMRVHHRNLTNLVG--YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWE 669
++FE E+++L + H N+ G Y N+ LI EY+ G+L+ L K +
Sbjct: 56 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHI 114
Query: 670 RRLQIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728
+ LQ +G+EYL +HRD+ NIL+ K+ DFGL+KV P
Sbjct: 115 KLLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLP----- 165
Query: 729 VSTVVAGTPGYLDPEYFVTD--------W-----LNE-----KSDVYSFGVVLLEIIT 768
D E+F W L E SDV+SFGVVL E+ T
Sbjct: 166 -----------QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 27/228 (11%)
Query: 559 ENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKM--LSSSSGQGFKEFEA 616
EN +F V + K +G GG V+ + A+K L + Q +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 617 EVKLLMRVHHRNLT--NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-- 672
E+ L ++ + L Y I D + ++ E N +L L +K+ +
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-T 731
+ + + +H + IVH D+KP N L+ + KL DFG++ T V
Sbjct: 135 NM----LEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 732 VVAGTPGYLDPE-----------YFVTDWLNEKSDVYSFGVVLLEIIT 768
GT Y+ PE ++ KSDV+S G +L +
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 49/234 (20%)
Query: 569 LKITDNFN--KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH 625
L+ +F VLG+G FG V D A+K + + + +EV LL ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLN 60
Query: 626 HRNLTNLVGYFIEDNNMGL----------IY---EYMANGNLKQLLSDEKASTLSWERRL 672
H+ + ++E N ++ EY NG L L+ E +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYW 119
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF---------- 722
++ + L Y+H I+HRD+KP NI + E+ K+ DFGL+K
Sbjct: 120 RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 723 ----PIGGTHVSTVVAGTPGYLDPE-------YFVTDWLNEKSDVYSFGVVLLE 765
P ++++ + GT Y+ E Y NEK D+YS G++ E
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHY------NEKIDMYSLGIIFFE 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LG+G FG V+ G + T+VA+K L + + F E +++ ++ H L L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
E+ ++ EYM+ G+L L E L + + +A A G+ Y+ + V
Sbjct: 247 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD++ NIL+ ENL K+ADFGL+++ + + A P + PE + K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 754 SDVYSFGVVLLEIIT 768
SDV+SFG++L E+ T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 72/225 (32%), Positives = 101/225 (44%), Gaps = 31/225 (13%)
Query: 557 EFENRHFTYSEVLKITDNFNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSGQGF 611
+FE RH F + LGKG FG+V D G VAVK L S+ +
Sbjct: 37 QFEERHLK----------FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 86
Query: 612 KEFEAEVKLLMRVHHRNLTNLVG--YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWE 669
++FE E+++L + H N+ G Y N+ LI EY+ G+L+ L K +
Sbjct: 87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHI 145
Query: 670 RRLQIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728
+ LQ +G+EYL +HRD+ NIL+ K+ DFGL+KV P +
Sbjct: 146 KLLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 729 VSTVVAGTPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PG PE + SDV+SFGVVL E+ T
Sbjct: 202 ---YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LG+G FG V+ G + T+VA+K L + + F E +++ ++ H L L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
E+ ++ EYM+ G+L L E L + + +A A G+ Y+ + V
Sbjct: 330 VVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNEK 753
HRD++ NIL+ ENL K+ADFGL+++ + + A P + PE + K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 754 SDVYSFGVVLLEIIT 768
SDV+SFG++L E+ T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 575 FNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL 629
+ LGKG FG+V D G VAVK L S ++F+ E+++L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 630 TNLVG--YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH- 686
G Y ++ L+ EY+ +G L+ L +A L R L + +G+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS 145
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
C VHRD+ NIL+ K+ADFGL+K+ P+ Y V
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD---------------KDYYVV 186
Query: 747 TD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
+ W L++ +SDV+SFGVVL E+ T
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 7/196 (3%)
Query: 575 FNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
LG G +G VY G + VAVK L + + +EF E ++ + H NL L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
G + +I E+M GNL L + +S L +A + +EYL K
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFVTDWLNE 752
+HR++ N L+ EN K+ADFGLS++ G T+ + A P + PE + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 753 KSDVYSFGVVLLEIIT 768
KSDV++FGV+L EI T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 575 FNKVLGKGGFGTVYHGYLDD-----GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRN 628
+ LG+G FG V D G VAVK L + +G Q ++ E+ +L ++H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 629 LTNLVG--YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ G ++ L+ EY+ G+L+ L ++ + L A +G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 687 -IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL----- 740
+HRD+ N+LL + K+ DFGL+K P G + G
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWY 204
Query: 741 DPE-----YFVTDWLNEKSDVYSFGVVLLEIIT 768
PE F SDV+SFGV L E++T
Sbjct: 205 APECLKEYKFYY-----ASDVWSFGVTLYELLT 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-36
Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 24/200 (12%)
Query: 578 VLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTNL- 632
+ GG G +Y D +G V +K L S + AE + L V H ++ +
Sbjct: 87 CIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 633 -VGYFIEDNNMGLIY---EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ + + Y EY+ +LK+ L + ++ L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
+V+ D+KPENI+LTE + KL D G + GTPG+ PE V
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEI-VRT 251
Query: 749 WLNEKSDVYSFGVVLLEIIT 768
+D+Y+ G L +
Sbjct: 252 GPTVATDIYTVGRTLAALTL 271
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 30/224 (13%)
Query: 566 SEVLKITDN---FNKVLGKGGFGTVYHGYLDDGTQVAVKM--LSSSSGQGFKEFEAEVKL 620
+E + + K +G GG V+ + A+K L + Q + E+
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60
Query: 621 LMRVHHRNLT--NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAM 676
L ++ + L Y I D + ++ E N +L L +K+ + +
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM-- 117
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-TVVAG 735
+ + +H + IVH D+KP N L+ + KL DFG++ T V G
Sbjct: 118 --LEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 736 TPGYLDPE-----------YFVTDWLNEKSDVYSFGVVLLEIIT 768
T Y+ PE ++ KSDV+S G +L +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 48/221 (21%)
Query: 575 FNKVLGKGGFGTVYHGYLD-----DGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
+ LG+G FG V D G QVAVK L S G + + E+++L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 629 LTNLVG--YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ G N + LI E++ +G+LK+ L K ++ +++L+ A+ +G++YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLG 143
Query: 687 -IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
VHRD+ N+L+ + K+ DFGL+K D EY+
Sbjct: 144 SRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKEYY 183
Query: 746 VTD--------W-----LNE-----KSDVYSFGVVLLEIIT 768
W L + SDV+SFGV L E++T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 577 KVLGKGGFGTVYHGY---LDDGTQVAVKMLSS--SSGQGFKE-FEAEVKLLMRVHHRNLT 630
+++G+GG G VY + VA+K++S SS F+ + E + R+ ++
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 631 NL--VGYFIEDNNMGLIY---EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ G E + G +Y + +L +L + L+ R + I L+
Sbjct: 98 PIHDFG---EID--GQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAA 150
Query: 686 H-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVSTVVAGTPGYLDPE 743
H G HRD+KPENIL++ + A L DFG++ T + V GT Y+ PE
Sbjct: 151 HAAG----ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPE 205
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIIT 768
F ++D+Y+ VL E +T
Sbjct: 206 RFSESHATYRADIYALTCVLYECLT 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 31/205 (15%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +GKG FG V G G +VAVK + + + + F AE ++ ++ H NL L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 635 Y-FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKPP 692
E + ++ EYMA G+L L S L + L+ ++D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKV---------FPIGGTHVSTVVAGTPGYLDPE 743
VHRD+ N+L++E+ AK++DFGL+K P+ T A PE
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------A-------PE 184
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIIT 768
+ KSDV+SFG++L EI +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-35
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
K LG G FG V+ + T+VAVK + S + F AE ++ + H L L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
++ +I E+MA G+L L ++ S + + + A+G+ ++ + +
Sbjct: 251 VVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 695 HRDIKPENILLTENLEAKLADFGLSKV-------------FPIGGTHVSTVVAGTPGYLD 741
HRD++ NIL++ +L K+ADFGL++V FPI T A
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------A------- 353
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE KSDV+SFG++L+EI+T
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
VLGKG +G VY G L + ++A+K + + + E+ L + H+N+ +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ---GLEYLHIGCKPP 692
F E+ + + E + G+L LL + E+ I Q GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ--TIGFYTKQILEGLKYLH---DNQ 142
Query: 693 IVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
IVHRDIK +N+L+ T + K++DFG SK T GT Y+ PE + D
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPE--IIDKGP 199
Query: 752 E----KSDVYSFGVVLLEIITSQ 770
+D++S G ++E+ T +
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 46/217 (21%), Positives = 83/217 (38%), Gaps = 31/217 (14%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA-----------------EVK 619
+ L +G F + D A+K S + ++F E++
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 620 LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL------Q 673
++ + + G + + +IYEYM N ++ + ++ +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 674 IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733
I Y+H + I HRD+KP NIL+ +N KL+DFG S+ S
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 734 AGTPGYLDPEYFVTDWL--NEKSDVYSFGVVLLEIIT 768
GT ++ PE+F + K D++S G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 577 KVLGKGGFGTVYHGY---LDDGTQVAVKMLSS--SSGQGFKE-FEAEVKLLMRVHHRNLT 630
++LG GG V+ VAVK+L + + F F E + ++H +
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 631 NLVGYFIEDNNMGLIY----EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ + G + EY+ L+ ++ E ++ +R +++ DA Q L + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH 133
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV--STVVAGTPGYLDPEY 744
+ I+HRD+KP NI+++ K+ DFG+++ G V + V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
D ++ +SDVYS G VL E++T
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLT 214
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 570 KITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRN 628
KI+ VLG G GT+ + + D VAVK + F + EV+LL H N
Sbjct: 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPN 79
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ + + E A L++ + ++K + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLH-- 135
Query: 689 CKPPIVHRDIKPENILLTE-----NLEAKLADFGLSKVFPIGGTHVSTV--VAGTPGYLD 741
IVHRD+KP NIL++ ++A ++DFGL K +G S V GT G++
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 742 PEYFVTDW---LNEKSDVYSFGVVLLEIIT 768
PE D D++S G V +I+
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG-----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
KVLG G FGTVY G VA+K L ++S + KE E ++ V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HI 687
+ L+G + LI + M G L + + K + + L + A+G+ YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFV 746
VHRD+ N+L+ K+ DFGL+K+ P ++ E +
Sbjct: 137 RL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 747 TDWLNEKSDVYSFGVVLLEIIT 768
+SDV+S+GV + E++T
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 27/210 (12%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLT--NL 632
K +G GG V+ + A+K L + Q + E+ L ++ + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIGCK 690
Y I D + ++ E N +L L +K+ + + + + +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM----LEAVHTIH---Q 173
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-TVVAGTPGYLDPE------ 743
IVH D+KP N L+ + KL DFG++ T V G Y+ PE
Sbjct: 174 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 744 -----YFVTDWLNEKSDVYSFGVVLLEIIT 768
++ KSDV+S G +L +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTY 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
F +VLG G F V+ G A+K + S E E+ +L ++ H N+ L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 633 VGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ + L+ + ++ G L + + +++ AS + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI----QQV----LSAVKYLH 123
Query: 687 IGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
+ IVHRD+KPEN+L EN + + DFGLSK+ + + GTPGY+ PE
Sbjct: 124 ---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPGYVAPE 177
Query: 744 YFVTDWLNEKSDVYSFGVVL 763
++ D +S GV+
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 50/213 (23%), Positives = 83/213 (38%), Gaps = 24/213 (11%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+ +LG+G V+ G G A+K+ + S + E ++L +++H+N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 632 LVGYFIEDNNMGLIY---EYMANGNL-KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
L E+ E+ G+L L A L L + D G+ +L
Sbjct: 72 LFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 688 GCKPPIVHRDIKPENILLTENLEA----KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
+ IVHR+IKP NI+ + KL DFG ++ ++ GT YL P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPD 185
Query: 744 YFVTDWL--------NEKSDVYSFGVVLLEIIT 768
+ L D++S GV T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG----TQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRN 628
K+LG+G FG+V G L +VAVK + +SS + +EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 629 LTNLVGYFIEDNNMG-----LIYEYMANGNLKQLL----SDEKASTLSWERRLQIAMDAA 679
+ L+G IE ++ G +I +M G+L L + + + L+ +D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 680 QGLEYL---HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT 736
G+EYL + +HRD+ N +L +++ +ADFGLSK G
Sbjct: 158 LGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKI----YSGDYYRQGR 207
Query: 737 PGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ E KSDV++FGV + EI T
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ LG G FG V+ GY + T+VAVK L S F AE L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
++ +I EYM NG+L L L+ + L +A A+G+ ++ + +
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 695 HRDIKPENILLTENLEAKLADFGLSKV-------------FPIGGTHVSTVVAGTPGYLD 741
HRD++ NIL+++ L K+ADFGL+++ FPI T A
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT------A------- 178
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE KSDV+SFG++L EI+T
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 29/204 (14%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +GKG FG V G G +VAVK + + + + F AE ++ ++ H NL L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 635 YFIEDN-NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+E+ + ++ EYMA G+L L S L + L+ ++D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKV---------FPIGGTHVSTVVAGTPGYLDPEY 744
VHRD+ N+L++E+ AK++DFGL+K P+ T A PE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------A-------PEA 357
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
+ KSDV+SFG++L EI +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYS 381
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG----TQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRN 628
++LGKG FG+V L +VAVKML + +EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 629 LTNLVG------YFIEDNNMGLIYEYMANGNLKQLL----SDEKASTLSWERRLQIAMDA 678
+ LVG +I +M +G+L L E L + ++ +D
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 679 AQGLEYL---HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
A G+EYL + +HRD+ N +L E++ +ADFGLS+ G
Sbjct: 147 ACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKI----YSGDYYRQG 196
Query: 736 TPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
L E + SDV++FGV + EI+T
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/196 (32%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVHHRNLTNL 632
+ LGKG FG VY +A+K+L + + EV++ + H N+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
GYF + + LI EY G + + L K S +R + A L Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH---SKR 129
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
++HRDIKPEN+LL E K+ADFG S P + T + GT YL PE +E
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 753 KSDVYSFGVVLLEIIT 768
K D++S GV+ E +
Sbjct: 187 KVDLWSLGVLCYEFLV 202
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 579 LGKGGFGTVYHGY---LDDGTQVAVKMLSS--SSGQGFKE-FEAEVKLLMRVHHRNLTNL 632
LG GG TVY L+ +VA+K + + + FE EV ++ H+N+ ++
Sbjct: 19 LGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 633 --VGYFIEDNNMG-LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
V E+++ L+ EY+ L + + LS + + G+++ H
Sbjct: 77 IDVD---EEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAH--- 128
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
IVHRDIKP+NIL+ N K+ DFG++K + V GT Y PE +
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 750 LNEKSDVYSFGVVLLEIIT 768
+E +D+YS G+VL E++
Sbjct: 189 TDECTDIYSIGIVLYEMLV 207
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 61/213 (28%), Positives = 86/213 (40%), Gaps = 41/213 (19%)
Query: 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
LG G +G VY G VAVK L + + +EF E ++ + H NL L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKPP 692
G + +I E+M GNL L + +S L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD---- 748
+HRD+ N L+ EN K+ADFGLS++ Y
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRL-----------------MTGDTYTAHAGAKF 174
Query: 749 ---W-----LNE-----KSDVYSFGVVLLEIIT 768
W L KSDV++FGV+L EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG------TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN 628
LG+G FG V+ + VAVK L +S ++F+ E +LL + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLL-------------SDEKASTLSWERRLQIA 675
+ G E + +++EYM +G+L + L D L + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 676 MDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
A G+ YL + VHRD+ N L+ + L K+ DFG+S+ +
Sbjct: 165 SQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RV 216
Query: 735 GTPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
G L PE + +SDV+SFGVVL EI T
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLS----SSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+ LGKG FG VY + +A+K+L G + E+++ + H N+
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLRREIEIQSHLRHPNILR 78
Query: 632 LVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ YF + + L+ E+ G L +++++T ++A L Y
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELA----DALHYC 130
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H + ++HRDIKPEN+L+ E K+ADFG S P GT YL PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPEMI 184
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
+EK D++ GV+ E +
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLV 207
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 25/216 (11%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVG 634
+VL +GGF VY + G + A+K L S+ + + EV + ++ H N+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 635 YFIEDNNMG-------LIYEYMANGNLKQLLSDEKASTLSWERR-LQIAMDAAQGLEYLH 686
L+ + G L + L ++ L+I + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA-----------G 735
KPPI+HRD+K EN+LL+ KL DFG + + +
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 736 TPGYLDPEYFVTDW---LNEKSDVYSFGVVLLEIIT 768
TP Y PE + EK D+++ G +L +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
F + +G G FG V+ GY + +VA+K + + S + +F E +++M++ H L L
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQL 68
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKP 691
G +E + L+ E+M +G L L ++ + E L + +D +G+ YL
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKV-------------FPIGGTHVSTVVAGTPG 738
+HRD+ N L+ EN K++DFG+++ FP+ +
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------S---- 173
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE F + KSDV+SFGV++ E+ +
Sbjct: 174 ---PEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDG----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
+FN+V+G+G FG VYHG L D AVK L + +F E ++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 629 LTNLVGY-FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH- 686
+ +L+G + + ++ YM +G+L+ + +E + + + + + A+G++YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS 146
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL-----D 741
VHRD+ N +L E K+ADFGL++ + +V T L
Sbjct: 147 KKF----VHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMA 200
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIIT 768
E T KSDV+SFGV+L E++T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRV 624
K +DN++ + LGKG F V G + A K++++ S + F++ E E ++ ++
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDA 678
H N+ L E++ L+++ + G L ++ S+ AS QI
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQIL--- 115
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ + Y H IVHR++KPEN+LL + KLADFGL+ AG
Sbjct: 116 -ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAG 169
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
TPGYL PE D ++ D+++ GV+L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 38/222 (17%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN 628
+ LG+G FG V+ D VAVK L + K+F+ E +LL + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERRLQI 674
+ G + + + +++EYM +G+L + L + L + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 675 AMDAAQGLEYL---HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
A A G+ YL H VHRD+ N L+ NL K+ DFG+S+
Sbjct: 139 ASQIASGMVYLASQH------FVHRDLATRNCLVGANLLVKIGDFGMSRDV----YSTDY 188
Query: 732 VVAGTPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
G L PE + +SDV+SFGV+L EI T
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 24/213 (11%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTN 631
+ +LG+G V+ G G A+K+ ++ S + E ++L +++H+N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 632 LVGYFIEDNNMGLIY---EYMANGNL-KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
L E+ E+ G+L L A L L + D G+ +L
Sbjct: 72 LFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 688 GCKPPIVHRDIKPENILLTENLEA----KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
+ IVHR+IKP NI+ + KL DFG ++ ++ GT YL P+
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPD 185
Query: 744 YFVTDWL--------NEKSDVYSFGVVLLEIIT 768
+ L D++S GV T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
++V+GKG FG VYHG D Q A+K L + Q + F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 630 TNLVGYFIEDNNMGLI-YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HI 687
L+G + + + YM +G+L Q + + + + + + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL-----DP 742
VHRD+ N +L E+ K+ADFGL++ I +V L
Sbjct: 144 KF----VHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTAL 197
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIIT 768
E T KSDV+SFGV+L E++T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 36/234 (15%)
Query: 565 YSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV 624
+ + LK K+LG G GTV G VAVK + E+KLL
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTES 65
Query: 625 -HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL-----SDEKASTLSWERRLQIAMDA 678
H N+ D + + E N NL+ L+ SDE + +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT-------------ENLEAKLADFGLSKVFPIG 725
A G+ +LH I+HRD+KP+NIL++ ENL ++DFGL K G
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 726 GTHVSTV---VAGTPGYLDPEYFVTDW-------LNEKSDVYSFGVVLLEIITS 769
+ T +GT G+ PE L D++S G V I++
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 1e-33
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVH 625
+ + + LG GGFG V D G QVA+K +E + E++++ +++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 626 HRNLTNLVGYFIEDNNMG------LIYEYMANGNLKQLLSD-EKASTLSWERRLQIAMDA 678
H N+ + + L EY G+L++ L+ E L + D
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEA---KLADFGLSKVFPIGGTHVSTVVAG 735
+ L YLH + I+HRD+KPENI+L + K+ D G +K G + V G
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-G 185
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
T YL PE D +SFG + E IT
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG------TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
++ LG+G FG VY G T+VA+K + ++S + EF E ++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------SDEKASTLSWERRLQIAMDAA 679
++ L+G + +I E M G+LK L ++ + S + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
G+ YL+ VHRD+ N ++ E+ K+ DFG+++ + G G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGL 201
Query: 740 L-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
L PE SDV+SFGVVL EI T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDG----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
+FN+V+G+G FG VYHG L D AVK L + +F E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 629 LTNLVGY-FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-H 686
+ +L+G + + ++ YM +G+L+ + +E + + + + A+G+++L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL-----D 741
VHRD+ N +L E K+ADFGL++ + +V T L
Sbjct: 211 KKF----VHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMA 264
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIIT 768
E T KSDV+SFGV+L E++T
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 45/214 (21%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K LG G FG V G VAVKM+ S S EF E + +M++ H L
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKF 68
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKP 691
G ++ + ++ EY++NG L L L + L++ D +G+ +L
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD--- 748
+HRD+ N L+ +L K++DFG+++ LD +Y +
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYV-----------------LDDQYVSSVGTK 166
Query: 749 ----W-----LNE-----KSDVYSFGVVLLEIIT 768
W + KSDV++FG+++ E+ +
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 63/232 (27%), Positives = 94/232 (40%), Gaps = 58/232 (25%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HH 626
F K LG G FG V D +VAVKML S++ + +E+K++ + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL------------SDEKASTLSWERRLQI 674
N+ NL+G + +I EY G+L L ST S L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 675 AMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733
+ AQG+ +L C +HRD+ N+LLT AK+ DFGL++
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDI----------- 214
Query: 734 AGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
D Y V W + + +SDV+S+G++L EI +
Sbjct: 215 -----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
F K LG G FG V +G VA+KM+ S S EF E K++M + H L L
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQL 84
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKP 691
G + + +I EYMANG L L + + ++ L++ D + +EYL
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDPEYF 745
+HRD+ N L+ + K++DFGLS+ + ++ V +P PE
Sbjct: 142 --LHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSP----PEVL 193
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
+ + KSD+++FGV++ EI +
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 576 NKVLGKGGFGTVYHGYL---DDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLT 630
+K LG G FGTV GY VAVK+L ++ E AE ++ ++ + +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGC 689
++G E + L+ E G L + L ++ + + +++ + G++YL
Sbjct: 82 RMIG-ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDPE 743
VHRD+ N+LL AK++DFGLSK + G PE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PE 190
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIIT 768
+ KSDV+SFGV++ E +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 62/232 (26%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG---TQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HHRNL 629
F V+G+G FG V + A+K + +S ++F E+++L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERRLQIA 675
NL+G + L EY +GNL L ++ ASTLS ++ L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 676 MDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
D A+G++YL +HRD+ NIL+ EN AK+ADFGLS+
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 735 GTPGYLDPEYFVTD--------W-----LNE-----KSDVYSFGVVLLEIIT 768
E +V W LN SDV+S+GV+L EI++
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG-----TQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRN 628
KVLG G FGTV+ G V +K++ SG Q F+ + + + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH-I 687
+ L+G + L+ +Y+ G+L + + + L + L + A+G+ YL
Sbjct: 77 IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEH 134
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFV 746
G VHR++ N+LL + ++ADFG++ + P + A TP ++ E
Sbjct: 135 GM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 747 TDWLNEKSDVYSFGVVLLEIIT 768
+SDV+S+GV + E++T
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 37/217 (17%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLS--------SSSGQGFKEFEAEV 618
+ D + K LG G G V + +VA+K++S + E E+
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 619 KLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRL 672
++L +++H + + +F + + ++ E M G L + L +
Sbjct: 67 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----Y 121
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHV 729
Q+ ++YLH + I+HRD+KPEN+LL+ E+ K+ DFG SK+ G T +
Sbjct: 122 QML----LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 730 STVVAGTPGYLDPEYFVTDWL---NEKSDVYSFGVVL 763
+ GTP YL PE V+ N D +S GV+L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS--GQGFKE-FEAEVKLLMRVHHRNLTNL 632
+ LGKGGF + D A K++ S +E E+ + + H+++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIGCK 690
G+F +++ + ++ E +L +L KA T R QI G +YLH +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---R 133
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
++HRD+K N+ L E+LE K+ DFGL+ G + GTP Y+ PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192
Query: 751 NEKSDVYSFGVVL 763
+ + DV+S G ++
Sbjct: 193 SFEVDVWSIGCIM 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 579 LGKGGFGTVYHGYL---DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LG G FG+V G VA+K+L + +E E +++ ++ + + L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCKPPI 693
+ + L+ E G L + L ++ + ++ + G++YL
Sbjct: 78 -VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF---- 131
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDPEYFVT 747
VHRD+ N+LL AK++DFGLSK ++ + AG PE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECINF 187
Query: 748 DWLNEKSDVYSFGVVLLEIIT 768
+ +SDV+S+GV + E ++
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG-----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
KVLG G FGTVY G VA+K L ++S + KE E ++ V + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HI 687
+ L+G + LI + M G L + + K + + L + A+G+ YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP-GYLDPEYFV 746
VHRD+ N+L+ K+ DFGL+K+ P ++ E +
Sbjct: 137 RL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 747 TDWLNEKSDVYSFGVVLLEIIT 768
+SDV+S+GV + E++T
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 64/241 (26%), Positives = 97/241 (40%), Gaps = 67/241 (27%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG------TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
K LG+G FG V T VAVKML ++S ++ +E +L +V+H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL----------------------SDEKAST 665
++ L G +D + LI EY G+L+ L
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 666 LSWERRLQIAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
L+ + A +QG++YL + VHRD+ NIL+ E + K++DFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDV-- 200
Query: 725 GGTHVSTVVAGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEII 767
Y + Y W L + +SDV+SFGV+L EI+
Sbjct: 201 --------------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 768 T 768
T
Sbjct: 247 T 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HH 626
K LG+G FG V VAVKML ++ + +E+K+L+ + HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 627 RNLTNLVGY-FIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERR 671
N+ NL+G + +I E+ GNL L D L+ E
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 672 LQIAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
+ + A+G+E+L C +HRD+ NILL+E K+ DFGL++ I
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARD--IYKDPD- 203
Query: 731 TVVAGTPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
V L PE +SDV+SFGV+L EI +
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS--GQGFKE-FEAEVKLLMRVHHRNLTNL 632
+ LGKGGF + D A K++ S +E E+ + + H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHIGCK 690
G+F +++ + ++ E +L +L KA T R QI G +YLH +
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---R 159
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
++HRD+K N+ L E+LE K+ DFGL+ G + GTP Y+ PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 751 NEKSDVYSFGVVL 763
+ + DV+S G ++
Sbjct: 219 SFEVDVWSIGCIM 231
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRV 624
K +DN++ + LGKG F V G + A K++++ S + F++ E E ++ ++
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDA 678
H N+ L E++ L+++ + G L ++ S+ AS QI
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI----QQIL--- 138
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ + Y H IVHR++KPEN+LL + KLADFGL+ AG
Sbjct: 139 -ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAG 192
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
TPGYL PE D ++ D+++ GV+L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 45/253 (17%), Positives = 79/253 (31%), Gaps = 28/253 (11%)
Query: 575 FNKVLGKGGFGTVYHGYLDD------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN 628
+ +LG+G F VY D + +K+ ++ F ++ L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAST---LSWERRLQIAMDAAQGLEYL 685
+ N L+ E + G L ++ K + + + AM +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA-----------KLADFGLS---KVFPIGGTHVST 731
H I+H DIKP+N +L L D G S K+FP G +
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA- 244
Query: 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI 791
T G+ E N + D + + ++ + V+NE +
Sbjct: 245 -KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 792 AKGDIENIVDSCL 804
L
Sbjct: 304 HLDMWNEFFHVML 316
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
+ LG G FG VY G + QVAVK L S Q +F E ++ + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL-----SDEKASTLSWERRLQIAMDAAQGL 682
N+ +G ++ ++ E MA G+LK L + S+L+ L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 683 EYL---HIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGT 736
+YL H +HRDI N LLT AK+ DFG+++ + G
Sbjct: 154 QYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----GG 203
Query: 737 PGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
L PE F+ K+D +SFGV+L EI +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 62/236 (26%)
Query: 575 FNKVLGKGGFGTVYHGYL--------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV- 624
K LG+G FG V + VAVKML ++ + + +E++++ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWER 670
H+N+ NL+G +D + +I EY + GNL++ L + ++++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 671 RLQIAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
+ A+G+EYL C +HRD+ N+L+TEN K+ADFGL++
Sbjct: 159 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI------- 207
Query: 730 STVVAGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
Y T W L + +SDV+SFGV++ EI T
Sbjct: 208 ---------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-32
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLS--------SSSGQGFKEFEAEVKLLMRV 624
+K LG G G V + +VA++++S + E E+++L ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDA 678
+H + + +F + + ++ E M G L + L + Q+
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF----YQML--- 249
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
++YLH + I+HRD+KPEN+LL+ E+ K+ DFG SK+ G T + + G
Sbjct: 250 -LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 736 TPGYLDPEYFVTDWL---NEKSDVYSFGVVL 763
TP YL PE V+ N D +S GV+L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 17/195 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS--GQGFKE-FEAEVKLLMRVHHRNLTNL 632
+LGKG F VY + G +VA+KM+ + G + + EVK+ ++ H ++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLS-WERR---LQIAMDAAQGLEYLHIG 688
YF + N + L+ E NG + + L + S E R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQII----TGMLYLH-- 129
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
I+HRD+ N+LLT N+ K+ADFGL+ + T + GTP Y+ PE
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRS 187
Query: 749 WLNEKSDVYSFGVVL 763
+SDV+S G +
Sbjct: 188 AHGLESDVWSLGCMF 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKM-----LSSSSGQGFKEFEAEVKLLMRVHHRN 628
+V+GKG F V + G Q AVK+ +SS G ++ + E + + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNL----------KQLLSDEKASTLSWERRLQIAMDA 678
+ L+ + D + +++E+M +L + S+ AS QI
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QIL--- 140
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ L Y H I+HRD+KP +LL + KL FG++ G V G
Sbjct: 141 -EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
TP ++ PE + + DV+ GV+L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
+ LG G FG VY G + QVAVK L S Q +F E ++ + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL-----SDEKASTLSWERRLQIAMDAAQGL 682
N+ +G ++ ++ E MA G+LK L + S+L+ L +A D A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 683 EYL-HIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
+YL +HRDI N LLT AK+ DFG+++ G + G
Sbjct: 195 QYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----GGCA 246
Query: 739 YL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
L PE F+ K+D +SFGV+L EI +
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 570 KITDNFN--KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKE---------FEAE 617
+N+ ++LG+G V + + AVK++ + G F E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 618 VKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWER 670
V +L +V H N+ L + + L+++ M G L K LS+++ +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM--- 130
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
+ + + LH K IVHRD+KPENILL +++ KL DFG S G +
Sbjct: 131 -RALL----EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLR 181
Query: 731 TVVAGTPGYLDPE------YFVTDWLNEKSDVYSFGVVL 763
V GTP YL PE ++ D++S GV++
Sbjct: 182 EVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 55/218 (25%), Positives = 78/218 (35%), Gaps = 44/218 (20%)
Query: 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKML---SSSSGQGFKEFEAEVKLLMRVHHR 627
+ LG G FG V G VAVK L S + +F EV + + HR
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
NL L G + ++ E G+L L + + A+ A+G+ YL
Sbjct: 82 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE- 138
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
+HRD+ N+LL K+ DFGL + P D Y +
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---------------DDHYVMQ 181
Query: 748 D-------W-----LNE-----KSDVYSFGVVLLEIIT 768
+ W L SD + FGV L E+ T
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 26/228 (11%), Positives = 54/228 (23%), Gaps = 43/228 (18%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ L G V+ ++ A+K+ + S + R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 633 VGYF-----------------------IEDNNMGLIYEYM--ANGNLKQLLS-----DEK 662
+D + M A+ +L+ L S
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 663 ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722
+ + L +VH P+N+ + + L D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 723 PIGGTHVSTVVAGTPGYLDPEYFV--TDWLNEKSDVYSFGVVLLEIIT 768
GT Y E+ T + + G+ + +
Sbjct: 245 ---GTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 24/206 (11%)
Query: 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
N++LG+G FG VY G + VAVK + ++F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIG 688
L+G E+ +I E G L L K S L + ++ + + YL I
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESIN 133
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDP 742
C VHRDI NIL+ KL DFGLS+ I P
Sbjct: 134 C----VHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWMS----P 183
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIIT 768
E SDV+ F V + EI++
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 54/217 (24%), Positives = 83/217 (38%), Gaps = 46/217 (21%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
+ +G+G FG V+ G VA+K + +S ++F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIG 688
L+G E+ +I E G L+ L K +L + A + L YL
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR 136
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD 748
VHRDI N+L++ N KL DFGLS+ D Y+
Sbjct: 137 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-----------------EDSTYYKAS 175
Query: 749 -------W-----LNE-----KSDVYSFGVVLLEIIT 768
W +N SDV+ FGV + EI+
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-32
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 62/236 (26%)
Query: 575 FNKVLGKGGFGTVYHGYL--------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV- 624
K LG+G FG V + VAVKML ++ + + +E++++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWER 670
H+N+ NL+G +D + +I EY + GNL++ L + ++++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 671 RLQIAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
+ A+G+EYL C +HRD+ N+L+TEN K+ADFGL++
Sbjct: 205 LVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI------- 253
Query: 730 STVVAGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
Y T W L + +SDV+SFGV++ EI T
Sbjct: 254 ---------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-32
Identities = 32/233 (13%), Positives = 63/233 (27%), Gaps = 45/233 (19%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMR--------- 623
VLG+ + G V + + K+ + EV L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 624 -------------VHHRNLTNLVGYFIEDNNMGLIYEYM----ANGNLKQLLSD-----E 661
V ++ +++ +M ++ + NL+
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 662 KASTLSWERRLQIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720
+L RLQ+ + + L LH G +VH ++P +I+L + L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 721 VFPIGGTHVSTVVAGTPGYLDPE-----YFVTDWLNEKSDVYSFGVVLLEIIT 768
P + D ++ G+ + I
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 62/266 (23%), Positives = 103/266 (38%), Gaps = 56/266 (21%)
Query: 551 NAHGSLEFENRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKM----- 602
+ H S EN +F +L++ ++ +G+G +G V A+K+
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 603 LSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK 662
+ + + + + EV+L+ ++HH N+ L + ++ + L+ E G+L L+
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 663 ASTLSWERRLQIAM-------------------------------DAA-------QGLEY 684
+ + + L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 685 LHIGCKPPIVHRDIKPENILLT--ENLEAKLADFGLSKVFPI---GGTHVSTVVAGTPGY 739
LH I HRDIKPEN L + ++ E KL DFGLSK F G + T AGTP +
Sbjct: 184 LH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 740 LDPE--YFVTDWLNEKSDVYSFGVVL 763
+ PE + K D +S GV+L
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
K++G G G V +G L VA+K L + + + ++F +E ++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIG 688
L G ++ EYM NG+L L + + + + G+ YL +G
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDP 742
VHRD+ N+L+ NL K++DFGLS+V T G T P
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----P 223
Query: 743 E---Y--FVTDWLNEKSDVYSFGVVLLEIIT 768
E + F + SDV+SFGVV+ E++
Sbjct: 224 EAIAFRTFSS-----ASDVWSFGVVMWEVLA 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 40/218 (18%), Positives = 77/218 (35%), Gaps = 34/218 (15%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVK--MLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNL 632
+ +G G FG+V+ DG A+K + + EV + H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKAS--TLSWERRLQIAMDAAQGLEYLHIGCK 690
+ ED++M + EY G+L +S+ + + +GL Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 691 PPIVHRDIKPENILLTEN-------------------LEAKLADFGLSKVFPIGGTHVST 731
+VH DIKP NI ++ + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SSPQV 189
Query: 732 VVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIIT 768
G +L E ++ K+D+++ + ++
Sbjct: 190 EE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 61/236 (25%), Positives = 90/236 (38%), Gaps = 62/236 (26%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HH 626
F K LG G FG V D VAVKML S+ + +E+K+L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL----------------SDEKASTLSWER 670
N+ NL+G +I EY G+L L ++ L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 671 RLQIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
L + A+G+ +L C +HRD+ NILLT K+ DFGL++
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI------- 195
Query: 730 STVVAGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
D Y V W + +SDV+S+G+ L E+ +
Sbjct: 196 ---------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 571 ITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVK------MLSSSSGQGFKEFEAEVKLL 621
+ D++ + LG G F V G + A K + SS G +E E EV +L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 622 MRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIA 675
+ H N+ L F ++ LI E ++ G L K+ L++++A+ QI
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL----KQI- 117
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLT----ENLEAKLADFGLSKVFPIGGTHVST 731
G+ YLH I H D+KPENI+L N KL DFG++ G
Sbjct: 118 ---LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKN 170
Query: 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ GTP ++ PE + L ++D++S GV+
Sbjct: 171 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRV 624
+ T+ + + LGKG F V + G + A ++ S + ++ E E ++ +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDA 678
H N+ L E+ + LI++ + G L ++ S+ AS QI
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI----QQIL--- 120
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ + + H + +VHR++KPEN+LL + KLADFGL+ G
Sbjct: 121 -EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
TPGYL PE D + D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
+ D ++ + LG G FG V+ G K +++ + E+ ++ ++HH
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA------- 679
L NL F + M LI E+++ G L ++ E +S E +
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MS-EA------EVINYMRQAC 159
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLT--ENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
+GL+++H + IVH DIKPENI+ + K+ DFGL+ + V T
Sbjct: 160 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATA 214
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ PE + + +D+++ GV+
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 47/231 (20%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG------TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
+ + +G+G FG V+ T VAVKML +S +F+ E L+ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL----------------------SDEKAST 665
N+ L+G M L++EYMA G+L + L S
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 666 LSWERRLQIAMDAAQGLEYL---HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722
LS +L IA A G+ YL VHRD+ N L+ EN+ K+ADFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRN- 223
Query: 723 PIGGTHVSTVVAGTPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
I A + PE + +SDV+++GVVL EI +
Sbjct: 224 -IYSA--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 563 FTYSEVLKITDNFNK--------VLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE 613
F + V N +LG G FG V+ G ++A K++ + + +E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 614 FEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL-------KQLLSDEKASTL 666
+ E+ ++ ++ H NL L F N++ L+ EY+ G L L++
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 667 SWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEA--KLADFGLSKVFPI 724
QI +G+ ++H + I+H D+KPENIL K+ DFGL++ +
Sbjct: 193 M----KQI----CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY-- 239
Query: 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
V GTP +L PE D+++ +D++S GV+
Sbjct: 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 36/207 (17%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLT 630
N +LGKG FG V + AVK+++ + + EV+LL ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 631 NLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
L + ++ ++ E G L ++ S+ A+ + Q+ G+ Y
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----KQVF----SGITY 136
Query: 685 LHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
+H K IVHRD+KPENILL ++ + K+ DFGLS F GT Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIA 191
Query: 742 PE-----YFVTDWLNEKSDVYSFGVVL 763
PE Y +EK DV+S GV+L
Sbjct: 192 PEVLRGTY------DEKCDVWSAGVIL 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLS------SSSGQGFKEFEAEVKL 620
K+ D ++ + LG G F V G + A K + S G +E E EV +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQI 674
L +V H N+ L + ++ LI E ++ G L K+ LS+E+A++ QI
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI----KQI 124
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLT----ENLEAKLADFGLSKVFPIGGTHVS 730
G+ YLH I H D+KPENI+L KL DFGL+ G
Sbjct: 125 ----LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ GTP ++ PE + L ++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-31
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 576 NKVLGKGGFGTVYHGYL---DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+ LG G FG+V G VA+K+L + +E E +++ ++ + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIGCK 690
L+G + + L+ E G L + L ++ + ++ + G++YL
Sbjct: 401 LIG-VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDPEY 744
VHR++ N+LL AK++DFGLSK ++ + AG PE
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PEC 510
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
+ +SDV+S+GV + E ++
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 60/235 (25%)
Query: 575 FNKVLGKGGFGTVYHGYL--------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV- 624
K LG+G FG V + T+VAVKML S ++ + + +E++++ +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWER 670
H+N+ NL+G +D + +I EY + GNL++ L S LS +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
+ A A+G+EYL +HRD+ N+L+TE+ K+ADFGL++
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-------- 241
Query: 731 TVVAGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
+ Y T W L + +SDV+SFGV+L EI T
Sbjct: 242 --------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-31
Identities = 57/205 (27%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG----TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
+ +G+G FG V+ G VA+K + +S ++F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH-IG 688
L+G E+ +I E G L+ L K S L + A + L YL
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR 511
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL-----DPE 743
VHRDI N+L++ N KL DFGLS+ ST + G L PE
Sbjct: 512 F----VHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPE 562
Query: 744 YFVTDWLNEKSDVYSFGVVLLEIIT 768
SDV+ FGV + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 34/205 (16%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+G+G +G V + A K + + F+ E++++ + H N+ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 633 VGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
F ++ ++ L+ E G L K++ + A+ + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK----DV----LSAVAYCH 123
Query: 687 IGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
K + HRD+KPEN L + KL DFGL+ F + GTP Y+ P+
Sbjct: 124 ---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQ 178
Query: 744 -----YFVTDWLNEKSDVYSFGVVL 763
Y + D +S GV++
Sbjct: 179 VLEGLY------GPECDEWSAGVMM 197
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+G+G FG V+ G Q AVK + + E+ + + L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
E + + E + G+L QL+ ++ L +R L A +GLEYLH I+H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRR---ILH 173
Query: 696 RDIKPENILLTEN-LEAKLADFGLSKVFPIGGTHVSTV----VAGTPGYLDPEYFVTDWL 750
D+K +N+LL+ + A L DFG + G S + + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 751 NEKSDVYSFGVVLLEIIT 768
+ K D++S ++L ++
Sbjct: 234 DAKVDIWSSCCMMLHMLN 251
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 29/226 (12%)
Query: 555 SLEFENRHFTYSEVLKITDNFN---KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSG 608
++ + + + + + K LG+G F V G + A K L
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 609 QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLS 667
E E+ +L + NL + + + LI EY A G + L E A +S
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 668 WERRLQIAMDAA-------QGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFG 717
E D +G+ YLH + IVH D+KP+NILL + K+ DFG
Sbjct: 130 -EN------DVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 718 LSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+S+ G + GTP YL PE D + +D+++ G++
Sbjct: 180 MSRKI--GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLS------SSSGQGFKEFEAEVKL 620
K+ D ++ + LG G F V G + A K + S G +E E EV +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQI 674
L +V H N+ L + ++ LI E ++ G L K+ LS+E+A++ QI
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI----KQI 124
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLT----ENLEAKLADFGLSKVFPIGGTHVS 730
G+ YLH I H D+KPENI+L KL DFGL+ G
Sbjct: 125 ----LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ GTP ++ PE + L ++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 66/240 (27%), Positives = 98/240 (40%), Gaps = 65/240 (27%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HH 626
F KVLG G FG V + QVAVKML + + +E+K++ ++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL---------------------SDEKAST 665
N+ NL+G + LI+EY G+L L +E +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 666 LSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725
L++E L A A+G+E+L VHRD+ N+L+T K+ DFGL++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDI--- 222
Query: 726 GTHVSTVVAGTPGYLDPEYFVTD-------W-----LNE-----KSDVYSFGVVLLEIIT 768
D Y V W L E KSDV+S+G++L EI +
Sbjct: 223 -------------MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKE--------FEAEVKLLMRVH-H 626
V+G+G V + G + AVK++ ++ + E E +L +V H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQ 680
++ L+ + + M L+++ M G L K LS+++ ++ + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM----RSLL----E 211
Query: 681 GLEYLHI-GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+ +LH IVHRD+KPENILL +N++ +L+DFG S G + + GTPGY
Sbjct: 212 AVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELC-GTPGY 265
Query: 740 LDPE------YFVTDWLNEKSDVYSFGVVL 763
L PE ++ D+++ GV+L
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVG 634
+ +GKG FG V+ G VA+K++ + ++ + E+ +L + +T G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGCKP 691
+++D + +I EY+ G+ LL + L E QIA + +GL+YLH
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLL---EPGPLD-ET--QIATILREILKGLDYLH---SE 138
Query: 692 PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN 751
+HRDIK N+LL+E+ E KLADFG++ +T V GTP ++ PE +
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 197
Query: 752 EKSDVYSFGVVLLEIITSQA 771
K+D++S G+ +E+ +
Sbjct: 198 SKADIWSLGITAIELARGEP 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 575 FNKVLGKGGFGTVYHGYLDDG------TQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHR 627
F + LG+ FG VY G+L VA+K L + G +EF E L R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERRLQ 673
N+ L+G +D + +I+ Y ++G+L + L S L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 674 IAMDAAQGLEYL-HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732
+ A G+EYL VH+D+ N+L+ + L K++D GL +
Sbjct: 133 LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREV----YAADYY 184
Query: 733 VAGTPGYL-----DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
L PE + + SD++S+GVVL E+ +
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 34/238 (14%), Positives = 64/238 (26%), Gaps = 54/238 (22%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE---------------------- 613
VLG+ + G V + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 614 ------FEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM-ANGNLKQLLSD-----E 661
F L+ + + + + + + Y NL+
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 662 KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721
+L RLQ+ + + L LH +VH ++P +I+L + L F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 722 FPIGGTHVSTVVAGTPGYLDPEYFVTD-----------WLNEKSDVYSFGVVLLEIIT 768
G VS+ + G+ PE + D ++ G+V+ I
Sbjct: 255 -RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ ++ LG G FG V+ G A K + + + E++ + + H L NL
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA-------QGLEYL 685
F +DN M +IYE+M+ G L + ++DE + +S E +A +GL ++
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMS-ED------EAVEYMRQVCKGLCHM 271
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA--KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
H + VH D+KPENI+ T KL DFGL+ V GT + PE
Sbjct: 272 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPE 326
Query: 744 YFVTDWLNEKSDVYSFGVVL 763
+ +D++S GV+
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRNL 629
+KV+G G FG V G L VA+K L + + ++F E ++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HIG 688
L G + + ++ EYM NG+L L A + + + + A G++YL +G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMG 167
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLDP 742
VHRD+ NIL+ NL K++DFGL +V T G T P
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----P 219
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIIT 768
E SDV+S+G+VL E+++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 575 FNKVLGKGGFGTVYHGYL-----DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRVHHRN 628
KV+G G FG VY G L VA+K L + + + +F E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL-HI 687
+ L G + M +I EYM NG L + L ++ S + + + A G++YL ++
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG------TPGYLD 741
VHRD+ NIL+ NL K++DFGLS+V T G T
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA---- 218
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE SDV+SFG+V+ E++T
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 22/211 (10%)
Query: 577 KVLGKG--GFGTVYHGY-LDDGTQVAVKM--LSSSSGQGFKEFEAEVKLLMRVHHRNLTN 631
V+GKG TV G V V+ L + S + + E+ + +H N+
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 632 LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIG 688
FI DN + ++ +MA G+ K L+ ++ E IA + L+Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-EL--AIAYILQGVLKALDYIH-- 145
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV------VAGTPGYLDP 742
VHR +K +IL++ + + L+ + G V +L P
Sbjct: 146 -HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 743 EYFVTDWL--NEKSDVYSFGVVLLEIITSQA 771
E + + KSD+YS G+ E+
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHV 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 551 NAHGSLEFENRHFTYSEVLKITD--NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS- 606
G L+ F S+ +++ K LG G +G V + A+K++ +
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 607 -SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLS 659
S + EV +L + H N+ L +F + N L+ E G L + +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 660 DEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADF 716
+ A+ + Q+ G+ YLH K IVHRD+KPEN+LL ++ K+ DF
Sbjct: 135 EVDAAVII----KQVL----SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 717 GLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
GLS VF + GT Y+ PE + +EK DV+S GV+L
Sbjct: 184 GLSAVFENQKKMKERL--GTAYYIAPEVLRKKY-DEKCDVWSIGVIL 227
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 573 DNFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLT 630
D +K LG+G F AVK++S + E+ L H N+
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIV 69
Query: 631 NLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
L F + + L+ E + G L K+ S+ +AS I + +
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------YIMRKLVSAVSH 121
Query: 685 LHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
+H +VHRD+KPEN+L T +NLE K+ DFG +++ P + T T Y
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 742 PEYFVTDWLNEKSDVYSFGVVL 763
PE + +E D++S GV+L
Sbjct: 178 PELLNQNGYDESCDLWSLGVIL 199
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
LG G FG VY + G A K++ + S + +++ E+++L H + L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGCKPP 692
+ D + ++ E+ G + ++ E L+ E QI + + L +LH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIM-LELDRGLT-EP--QIQVVCRQMLEALNFLH---SKR 137
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL-- 750
I+HRD+K N+L+T + +LADFG+S + + GTP ++ PE + + +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 751 ---NEKSDVYSFGVVLLEIITSQ 770
+ K+D++S G+ L+E+ +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIE 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 46/220 (20%), Positives = 85/220 (38%), Gaps = 44/220 (20%)
Query: 575 FNKVLGKGGFGTVYHGYL--------DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
FN+ LG+G F ++ G T+V +K+L + + F ++ ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL- 685
++L G + + L+ E++ G+L L K + ++ +L++A A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE 130
Query: 686 HIGCKPPIVHRDIKPENILLT--------ENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
+H ++ +NILL KL+D G+S V
Sbjct: 131 ENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----------TVLPKD 175
Query: 738 GYLDP---------EYFVTDWLNEKSDVYSFGVVLLEIIT 768
+ E LN +D +SFG L EI +
Sbjct: 176 ILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICS 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+V+G G V Y +VA+K ++ E E++ + + HH N+ +
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL---QIAM---DAAQGLEYLHIG 688
F+ + + L+ + ++ G++ ++ A L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFG----LSKVFPIGGTHVSTVVAGTPGYLDPE- 743
K +HRD+K NILL E+ ++ADFG L+ I V GTP ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 744 ------YFVTDWLNEKSDVYSFGVVLLEIITSQA 771
Y + K+D++SFG+ +E+ T A
Sbjct: 198 MEQVRGY------DFKADIWSFGITAIELATGAA 225
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 570 KITD--NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLS---SSSGQGFKEFEAEVKLLMR 623
+D +VLGKG FG V G + AVK++S + EV+LL +
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMD 677
+ H N+ L +F + L+ E G L ++ S+ A+ + Q+
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII----RQVL-- 136
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVA 734
G+ Y+H K IVHRD+KPEN+LL ++ ++ DFGLS F +
Sbjct: 137 --SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI 189
Query: 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
GT Y+ PE + +EK DV+S GV+L
Sbjct: 190 GTAYYIAPEVLHGTY-DEKCDVWSTGVIL 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 28/207 (13%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
+ TD + + +G G + + AVK++ S +E E LL H
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQH 75
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQ 680
N+ L + + + ++ E M G L ++ S+ +AS + +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS--------AVLFTITK 127
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEA----KLADFGLSKVFPIGGTHVSTVVAGT 736
+EYLH +VHRD+KP NIL + ++ DFG +K + T T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
Query: 737 PGYLDPEYFVTDWLNEKSDVYSFGVVL 763
++ PE + D++S GV+L
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVK------MLSSSSGQGFKEFEAEVKL 620
+ D ++ + LG G F V G Q A K SS G ++ E EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQI 674
L + H N+ L + ++ LI E +A G L K+ L++E+A+ QI
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL----KQI 123
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLT----ENLEAKLADFGLSKVFPIGGTHVS 730
G+ YLH I H D+KPENI+L K+ DFGL+ G
Sbjct: 124 ----LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 174
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ GTP ++ PE + L ++D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ +G+G GTVY + G +VA++ ++ + E+ ++ + N+ N +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGCKPP 692
++ + + ++ EY+A G+L ++ + + E QIA + Q LE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV---TETCMD-EG--QIAAVCRECLQALEFLH---SNQ 136
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
++HRDIK +NILL + KL DFG + ST+V GTP ++ PE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGP 195
Query: 753 KSDVYSFGVVLLEIITSQ 770
K D++S G++ +E+I +
Sbjct: 196 KVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 14/198 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+G+G G V G QVAVKM+ Q + EV ++ H N+ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGCKPP 692
++ + ++ E++ G L ++ L+ E QIA Q L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV---SQVRLN-EE--QIATVCEAVLQALAYLH---AQG 161
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
++HRDIK ++ILLT + KL+DFG ++V GTP ++ PE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYAT 220
Query: 753 KSDVYSFGVVLLEIITSQ 770
+ D++S G++++E++ +
Sbjct: 221 EVDIWSLGIMVIEMVDGE 238
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 570 KITDNF---NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV- 624
+ D + VLG+G V L + AVK++ G EV++L +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDA 678
HRN+ L+ +F E++ L++E M G++ ++ ++ +AS + D
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------VVVQDV 120
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVF-------PIGGTH 728
A L++LH I HRD+KPENIL + K+ DF L PI
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 729 VSTVVAGTPGYLDPEYFVTDWLNEKS-----DVYSFGVVL 763
+ T G+ Y+ PE D++S GV+L
Sbjct: 178 LLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 574 NFNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTN 631
F + LG G FG V+ G + +K ++ Q E EAE+++L + H N+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 632 LVGYFIEDNNMGLIYEYMANGNL--KQLLSDEKASTLSWERRLQIAMDAA-------QGL 682
+ F + +NM ++ E G L + + + + LS E A L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS-EG------YVAELMKQMMNAL 137
Query: 683 EYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
Y H +VH+D+KPENIL + K+ DFGL+++F ST AGT Y
Sbjct: 138 AYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALY 192
Query: 740 LDPEYFVTDWLNEKSDVYSFGVVL 763
+ PE F D + K D++S GVV+
Sbjct: 193 MAPEVFKRD-VTFKCDIWSAGVVM 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 570 KITDN--FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRV 624
+ +LGKG FG V + AVK+++ + + EV+LL ++
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDA 678
H N+ L + ++ ++ E G L ++ S+ A+ + Q+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----KQVF--- 131
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
G+ Y+H K IVHRD+KPENILL ++ + K+ DFGLS F G
Sbjct: 132 -SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIG 185
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
T Y+ PE + +EK DV+S GV+L
Sbjct: 186 TAYYIAPEVLRGTY-DEKCDVWSAGVIL 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 55/227 (24%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS--------------------SSSGQGFKEFE 615
+GKG +G V Y +D T A+K+LS + G +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 616 A------EVKLLMRVHHRNLTNLVGYFIEDNNMGLIY---EYMANGNL-----KQLLSDE 661
E+ +L ++ H N+ LV ++D N +Y E + G + + LS++
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 662 KASTLSWERRL--QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719
+A R + G+EYLH I+HRDIKP N+L+ E+ K+ADFG+S
Sbjct: 138 QA------RFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 720 KVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN---EKSDVYSFGVVL 763
F +S GTP ++ PE + DV++ GV L
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 39/219 (17%)
Query: 570 KITDN--FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLS-------------SSSGQGFKE 613
KI ++ + LG G +G V + ++ A+K++ + + +E
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 614 FEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLS 667
E+ LL + H N+ L F + L+ E+ G L + + A+ +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 668 WERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPI 724
QI G+ YLH K IVHRDIKPENILL L K+ DFGLS F
Sbjct: 153 ----KQIL----SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-- 199
Query: 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ GT Y+ PE + NEK DV+S GV++
Sbjct: 200 SKDYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIM 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 42/206 (20%), Positives = 87/206 (42%), Gaps = 26/206 (12%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
++ + + + LG+G FG V+ K + G + E+ +L H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARH 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA------- 679
RN+ +L F + +I+E+++ ++ + ++ L+ ER +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LN-ER------EIVSYVHQVC 112
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLT--ENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
+ L++LH I H DI+PENI+ + K+ +FG ++ ++ P
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAP 167
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVL 763
Y PE D ++ +D++S G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
LG+G VY A+K+L + + K E+ +L+R+ H N+ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114
Query: 634 GYFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
F + L+ E + G L K S+ A+ QI + + YLH
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK----QIL----EAVAYLH- 165
Query: 688 GCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
+ IVHRD+KPEN+L + K+ADFGLSK+ V GTPGY PE
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEI 221
Query: 745 FVTDWLNEKSDVYSFGVVL 763
+ D++S G++
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQG-FKEFEAEVKLLMRVHHRNLTNLVG 634
LG G G V+ + G +A K++ + E+++L + + G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-QIAMDAAQGLEYLHIGCKPPI 693
F D + + E+M G+L Q+L +KA + E+ L ++++ +GL YL K I
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVL--KKAGRIP-EQILGKVSIAVIKGLTYLREKHK--I 153
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRD+KP NIL+ E KL DFG+S + + ++ V GT Y+ PE + +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQ 210
Query: 754 SDVYSFGVVLLEIIT 768
SD++S G+ L+E+
Sbjct: 211 SDIWSMGLSLVEMAV 225
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 572 TDNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN 628
+ F+ + LG+G +G+VY + G VA+K + +E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYL 685
+ G + ++ ++ ++ EY G++ ++ + TL+ E +IA +GLEYL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTLT-ED--EIATILQSTLKGLEYL 141
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H +HRDIK NILL AKLADFG++ +TV+ GTP ++ PE
Sbjct: 142 H---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQ 770
N +D++S G+ +E+ +
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 24/210 (11%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVG 634
+++G G +G VY G + G A+K++ + G +E + E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 635 YFI------EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYL 685
FI D+ + L+ E+ G++ L+ + K +TL E IA + +GL +L
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EE--WIAYICREILRGLSHL 145
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H + ++HRDIK +N+LLTEN E KL DFG+S +T + GTP ++ PE
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 201
Query: 746 VTDWL-----NEKSDVYSFGVVLLEIITSQ 770
D + KSD++S G+ +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVK-MLSSSSGQGFKEFEAEVKLLMR-VHHRNLTNLV 633
LG+G +G V ++ G +AVK + ++ + Q K ++ + MR V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSD--EKASTLSWERRL-QIAMDAAQGLEYLHIGCK 690
G + ++ + E M + +L + +K T+ E L +IA+ + LE+LH
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP-EDILGKIAVSIVKALEHLHSKLS 130
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
++HRD+KP N+L+ + K+ DFG+S + + AG Y+ PE +
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 751 ----NEKSDVYSFGVVLLEIIT 768
+ KSD++S G+ ++E+
Sbjct: 187 QKGYSVKSDIWSLGITMIELAI 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMR-VHHRNLTNLV 633
+G+G +G+V G +AVK + S+ + K+ ++ ++MR +
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSW--ERRL-QIAMDAAQGLEYLHIGCK 690
G + + + E M+ + + + E L +I + + L +L K
Sbjct: 88 GALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
I+HRDIKP NILL + KL DFG+S + + T AG Y+ PE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQ--LVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 751 NE----KSDVYSFGVVLLEIIT 768
+ +SDV+S G+ L E+ T
Sbjct: 203 RQGYDVRSDVWSLGITLYELAT 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 57/209 (27%), Positives = 84/209 (40%), Gaps = 38/209 (18%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA------EVKLLMRVH---- 625
+LGKGGFGTV+ G+ L D QVA+K++ + G+ EV LL +V
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGN-------LKQLLSDEKASTLSWERRL--QIAM 676
H + L+ +F L+ E K L + + R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS------RCFFGQVV- 149
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+++ H +VHRDIK ENIL+ AKL DFG + G
Sbjct: 150 ---AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DG 200
Query: 736 TPGYLDPEYFVTDW-LNEKSDVYSFGVVL 763
T Y PE+ + V+S G++L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILL 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 16/201 (7%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVK-MLSSSSGQGFKEFEAEVKLLMR-VHHRNLTNLV 633
+G G G V+ + G +AVK M S + + K ++ ++++ +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL-QIAMDAAQGLEYLHIGCKPP 692
G FI + ++ + E M K + ER L ++ + + L YL
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKK--RMQGPIP-ERILGKMTVAIVKALYYLKEKHG-- 145
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
++HRD+KP NILL E + KL DFG+S + AG Y+ PE +
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGR--LVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 753 -----KSDVYSFGVVLLEIIT 768
++DV+S G+ L+E+ T
Sbjct: 204 PDYDIRADVWSLGISLVELAT 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 571 ITDNF---NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-H 625
+TD++ +VLG G G V + G + A+K+L S + EV +
Sbjct: 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASG 80
Query: 626 HRNLTNLVGYFIEDNNMG-----LIYEYMANGNL--------KQLLSDEKASTLSWERRL 672
++ ++ + E+ + G +I E M G L Q ++ +A+
Sbjct: 81 GPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-------- 131
Query: 673 QIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTH 728
+I D +++LH I HRD+KPEN+L T ++ KL DFG +K
Sbjct: 132 EIMRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--A 185
Query: 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
+ T TP Y+ PE + ++ D++S GV++
Sbjct: 186 LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS---SSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ +G G FG VY + + VA+K +S S + +++ EV+ L ++ H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAM---DAAQGLEYLHIGC 689
G ++ ++ L+ EY G+ LL K L E +IA A QGL YLH
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQ-EV--EIAAVTHGALQGLAYLH--- 171
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
++HRD+K NILL+E KL DFG + + ++ V GTP ++ PE V
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPE--VILA 224
Query: 750 L-----NEKSDVYSFGVVLLEIITSQ 770
+ + K DV+S G+ +E+ +
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 34/207 (16%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS----SSSGQGFKEFEAEVKLLMRVHHRNLTN 631
+LG+G +G V + + AVK+L G + E++LL R+ H+N+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 632 L--VGYFIEDNNMGLIYEYMANGNL-------KQLLSDEKASTLSWERRL--QIAMDAAQ 680
L V Y E M ++ EY G ++ +A Q+
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA------HGYFCQLI----D 120
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG--GTHVSTVVAGTPG 738
GLEYLH IVH+DIKP N+LLT K++ G+++ T G+P
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPA 176
Query: 739 YLDPEYFVTDWLNE--KSDVYSFGVVL 763
+ PE K D++S GV L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/212 (26%), Positives = 84/212 (39%), Gaps = 46/212 (21%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA------EVKLLMRVHHR-- 627
+LG GGFG+VY G + D VA+K + + E EV LL +V
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 628 NLTNLVGYFIEDNNMGLIYEYMAN-GNL------KQLLSDEKASTLSWERRL--QIAMDA 678
+ L+ +F ++ LI E +L + L +E A R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA------RSFFWQVL--- 159
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
+ + + H ++HRDIK ENIL+ E KL DFG + GT
Sbjct: 160 -EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTR 212
Query: 738 GYLDPEYFVTDWLNEK------SDVYSFGVVL 763
Y PE W+ + V+S G++L
Sbjct: 213 VYSPPE-----WIRYHRYHGRSAAVWSLGILL 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 31/201 (15%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLV 633
K +GKG F V + G +VA+K++ + + ++ EV+++ ++H N+ L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 634 GY-FIEDNNMG-LIYEYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQGLE 683
+ IE LI EY + G + + +++A R QI ++
Sbjct: 80 -FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA------RSKFRQIV----SAVQ 128
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
Y H IVHRD+K EN+LL ++ K+ADFG S F +GG + G P Y PE
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPE 183
Query: 744 YFV-TDWLNEKSDVYSFGVVL 763
F + + DV+S GV+L
Sbjct: 184 LFQGKKYDGPEVDVWSLGVIL 204
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 573 DNFN--KVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMR 623
D+F + +GKG FG V + D A+K ++ E E++++
Sbjct: 15 DHFEILRAIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER-RLQIAMDAAQGL 682
+ H L NL F ++ +M ++ + + G+L+ L + E +L I + L
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFIC-ELVMAL 128
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP 742
+YL I+HRD+KP+NILL E+ + DF ++ + P + +AGT Y+ P
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAP 183
Query: 743 EYFVT----------DWLNEKSDVYSFGVVLLEIIT 768
E F + DW +S GV E++
Sbjct: 184 EMFSSRKGAGYSFAVDW-------WSLGVTAYELLR 212
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 569 LKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMR 623
+ D F K+LG+G F TV L + A+K+L + E ++ R
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER-RL---QIAMDAA 679
+ H L F +D + Y NG L + + K + R +I
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVS--- 141
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV-VAGTPG 738
LEYLH I+HRD+KPENILL E++ ++ DFG +KV GT
Sbjct: 142 -ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
Y+ PE + SD+++ G ++ +++
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 39/208 (18%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNL 632
++VLG G G V + + A+KML + EV+L R ++ +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 633 VGYFIEDNNMG-----LIYEYMANGNL--------KQLLSDEKASTLSWERRLQIAMDAA 679
V + E+ G ++ E + G L Q ++ +AS +I
Sbjct: 121 VDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIG 171
Query: 680 QGLEYLH-IGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ ++YLH I I HRD+KPEN+L T N KL DFG +K ++T
Sbjct: 172 EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-Y 225
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVL 763
TP Y+ PE + ++ D++S GV++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-26
Identities = 64/226 (28%), Positives = 109/226 (48%), Gaps = 31/226 (13%)
Query: 563 FTYSEVLKIT-DNFN--KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE--- 615
+ + E + D F +VLG+GGFG V+ G A K L+ + K ++
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 616 AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK-QLLSDEKASTLSWERRLQI 674
E K+L +VH R + +L F ++ L+ M G+++ + + ++ + E R
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 675 AMDAAQ---GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
AQ GLE+LH + I++RD+KPEN+LL ++ +++D GL+ G T
Sbjct: 294 Y--TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348
Query: 732 VVAGTPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
GTPG++ PE Y F D+ ++ GV L E+I ++
Sbjct: 349 YA-GTPGFMAPELLLGEEYDFSVDY-------FALGVTLYEMIAAR 386
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 51/204 (25%), Positives = 79/204 (38%), Gaps = 30/204 (14%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKML--------SSSSGQGFKEFEAEVKLLMRVHHR 627
LG G FG V+ + +V VK + + E+ +L RV H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGN-------LKQLLSDEKASTLSWERRLQIAMDAAQ 680
N+ ++ F L+ E +G L + AS + Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR----QLV----S 141
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
+ YL + I+HRDIK ENI++ E+ KL DFG + G T GT Y
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTIEYC 196
Query: 741 DPEYFV-TDWLNEKSDVYSFGVVL 763
PE + + + +++S GV L
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTL 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTNLVG 634
+ LG+G +G V VAVK++ E + E+ + ++H N+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 635 YFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQGLEYLH 686
+ E N L EY + G L + + A +R Q+ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLM----AGVVYLH 122
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT--HVSTVVAGTPGYLDPEY 744
I HRDIKPEN+LL E K++DFGL+ VF ++ + GT Y+ PE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 745 FV-TDWLNEKSDVYSFGVVL 763
++ E DV+S G+VL
Sbjct: 179 LKRREFHAEPVDVWSCGIVL 198
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 563 FTYSEVLKIT-DNFN--KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE--- 615
+ + E +T + F +VLGKGGFG V G A K L + K
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 616 AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIA 675
E ++L +V+ R + +L + + + L+ M G+LK + + R + A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
+ GLE LH + IV+RD+KPENILL ++ +++D GL+ P G T + V G
Sbjct: 293 AEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-G 347
Query: 736 TPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
T GY+ PE Y F DW ++ G +L E+I Q
Sbjct: 348 TVGYMAPEVVKNERYTFSPDW-------WALGCLLYEMIAGQ 382
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 569 LKITD-NFNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSSGQGFKE---FEAEVKL 620
L D KV+G+G FG V + + A+K+L+ E F E +
Sbjct: 71 LHREDFEILKVIGRGAFGEVA---VVKLKNADKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDAA 679
L+ + +T L F +DNN+ L+ +Y G+L LLS K E + +
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS--KFEDRLPEEMARFYLAEMV 185
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
++ +H + VHRDIKP+NIL+ N +LADFG GT S+V GTP Y
Sbjct: 186 IAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 740 LDPEYFVTDWLNEKS-----DVYSFGVVLLEIIT 768
+ PE + D +S GV + E++
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 49/263 (18%), Positives = 84/263 (31%), Gaps = 74/263 (28%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +G+GGFG V+ D A+K + + ++ EVK L ++ H +
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSW-------------------------- 668
++E E + +S
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 669 -ERRLQIAMDAAQG-------------------------------LEYLHIGCKPPIVHR 696
+ L I M + +E+LH ++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188
Query: 697 DIKPENILLTENLEAKLADFGLSKVF-----------PIGGTHVSTVVAGTPGYLDPEYF 745
D+KP NI T + K+ DFGL P+ T GT Y+ PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 746 VTDWLNEKSDVYSFGVVLLEIIT 768
+ + K D++S G++L E++
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLY 271
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNLTNLVG 634
+ LG+G +G V VAVK++ E + E+ + ++H N+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 635 YFIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQGLEYLH 686
+ E N L EY + G L + + A +R Q+ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA------QRFFHQLM----AGVVYLH 122
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT--HVSTVVAGTPGYLDPEY 744
I HRDIKPEN+LL E K++DFGL+ VF ++ + GT Y+ PE
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 745 FV-TDWLNEKSDVYSFGVVL 763
++ E DV+S G+VL
Sbjct: 179 LKRREFHAEPVDVWSCGIVL 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 68/249 (27%), Positives = 98/249 (39%), Gaps = 34/249 (13%)
Query: 539 SLKRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGYLDDGT 596
L + K A L + + D+F KV+G+G F V +
Sbjct: 32 ELAQDKYVADFLQWAEPIVVRLKEVRLQR-----DDFEILKVIGRGAFSEVAVVKMKQTG 86
Query: 597 QV-AVKMLSSSSGQGFKE---FEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652
QV A+K+++ E F E +L+ R +T L F ++N + L+ EY G
Sbjct: 87 QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146
Query: 653 NLKQLLSDEKASTLSWERRLQIAMD---AAQ---GLEYLHIGCKPPIVHRDIKPENILLT 706
+L LLS R+ M A+ ++ +H + VHRDIKP+NILL
Sbjct: 147 DLLTLLSKF-------GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLD 196
Query: 707 ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVY-------SF 759
+LADFG GT S V GTP YL PE + Y +
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 760 GVVLLEIIT 768
GV E+
Sbjct: 257 GVFAYEMFY 265
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 43/251 (17%)
Query: 539 SLKRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGYL---- 592
+L++ K+ L+ + + R +++ KV+G+G FG V L
Sbjct: 40 ALRKNKNIDNFLSRYKDTINKIRDLRMK-----AEDYEVVKVIGRGAFGEVQ---LVRHK 91
Query: 593 DDGTQVAVKMLSSSSGQGFKE---FEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649
A+K+LS + F E ++ + + L F +D + ++ EYM
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151
Query: 650 ANGNLKQLLSDEKASTLSWERRLQI-AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708
G+L L+S+ E+ + + L+ +H +HRD+KP+N+LL ++
Sbjct: 152 PGGDLVNLMSNYDVP----EKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS 204
Query: 709 LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT-----------DWLNEKSDVY 757
KLADFG G GTP Y+ PE + DW +
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW-------W 257
Query: 758 SFGVVLLEIIT 768
S GV L E++
Sbjct: 258 SVGVFLYEMLV 268
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 9e-24
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 573 DNFN--KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMRVH- 625
++F+ +++G+GGFG VY D G A+K L + + E +L V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 626 --HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDAAQGL 682
+ + F + + I + M G+L LS + E ++ A + GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 305
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP 742
E++H +V+RD+KP NILL E+ +++D GL+ F H S GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 359
Query: 743 E-------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
E Y DW +S G +L +++
Sbjct: 360 EVLQKGVAYDSSADW-------FSLGCMLFKLLRGH 388
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG G FG V G G +VAVK+L+ S + + E++ L H ++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 633 VGY-FIEDNNMGLIY---EYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQ 680
Y I + EY++ G L + + +A RRL QI
Sbjct: 77 --YQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEA------RRLFQQIL----S 122
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
++Y H + +VHRD+KPEN+LL ++ AK+ADFGLS + G + T G+P Y
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNYA 177
Query: 741 DPEYFV-TDWLNEKSDVYSFGVVL 763
PE + + D++S GV+L
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVIL 201
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 25/198 (12%), Positives = 56/198 (28%), Gaps = 45/198 (22%)
Query: 578 VLGKGGFGTVYHGYLDD---GTQVAVKMLSSSSG--QGFKE-FEAEVKLLMRVHHRNLTN 631
G + D QVA+ + + + L R+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 632 LVGYFIEDNNMGLI-YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
V + GL+ E++ G+L+++ ++ S ++ A + H +
Sbjct: 96 -VLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---R 147
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
+ P + ++ + G VV P +
Sbjct: 148 AGVALSIDHPSRVRVSID-----------------GD----VVLAYPATMPDA------- 179
Query: 751 NEKSDVYSFGVVLLEIIT 768
N + D+ G L ++
Sbjct: 180 NPQDDIRGIGASLYALLV 197
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 28/199 (14%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
K +G G FG VAVK + + + + E+ + H N+
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKEV 84
Query: 636 FIEDNNMGLIYEYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQGLEYLHI 687
+ ++ +I EY + G L S+++A R Q+ G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEA------RFFFQQLL----SGVSYCH- 133
Query: 688 GCKPPIVHRDIKPENILLTENLEA--KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
I HRD+K EN LL + K+ DFG SK + STV GTP Y+ PE
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVL 189
Query: 746 VTDWLN-EKSDVYSFGVVL 763
+ + + +DV+S GV L
Sbjct: 190 LRQEYDGKIADVWSCGVTL 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 554 GSLEFENRHFTYSEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGF 611
G+ E E + + + + K+LGKG FG V G A+K+L
Sbjct: 130 GAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK 189
Query: 612 KEFE---AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSW 668
E E ++L H LT L F + + + EY G L LS E+ +
Sbjct: 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS--- 246
Query: 669 ERRLQI-AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727
E R + + L+YLH + +V+RD+K EN++L ++ K+ DFGL K G
Sbjct: 247 EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 728 HVSTVVAGTPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
+ T GTP YL PE Y DW + GVV+ E++ +
Sbjct: 305 TMKT-FCGTPEYLAPEVLEDNDYGRAVDW-------WGLGVVMYEMMCGR 346
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 37/204 (18%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRVHHRNLTNL 632
+ LG+G FG V +VA+K +S + E+ L + H ++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 633 VGY-FIEDNNMGLIY---EYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQ 680
Y I I EY A G L K+ +++++ RR QI
Sbjct: 75 --YDVITTPTD--IVMVIEY-AGGELFDYIVEKKRMTEDEG------RRFFQQII----C 119
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
+EY H + IVHRD+KPEN+LL +NL K+ADFGLS + G + T G+P Y
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYA 174
Query: 741 DPEYFV-TDWLNEKSDVYSFGVVL 763
PE + + DV+S G+VL
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVL 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 569 LKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMR 623
++ + K LG G FG V + + G A+K+L K+ E E ++L
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ--- 680
V+ L L F +++N+ ++ EY+A G + L + R AAQ
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-----FYAAQIVL 152
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
EYLH +++RD+KPEN+L+ + ++ DFG +K G T T+ GTP L
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTW--TLC-GTPEAL 205
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIIT 768
PE ++ N+ D ++ GV++ E+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 5e-22
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 46/221 (20%)
Query: 569 LKITD-NFNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSSGQGFKEFE---AEVKL 620
+ D + LG G FG V+ L +G A+K+L K+ E E +
Sbjct: 3 YSLQDFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMD--- 677
L V H + + G F + + +I +Y+ G L LL +R +
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFY 111
Query: 678 AAQ---GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
AA+ LEYLH I++RD+KPENILL +N K+ DFG +K P T+ T+
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY--TLC- 164
Query: 735 GTPGYLDPEYFVT-------DWLNEKSDVYSFGVVLLEIIT 768
GTP Y+ PE T DW +SFG+++ E++
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDW-------WSFGILIYEMLA 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 571 ITDNFNKV--LGKGGFGTVYHG-YLDDGTQVAVK-MLSSSSGQGFKEFEA--EVKLLMRV 624
+ + + K+ +G+G +G V+ D G VA+K L S K A E+++L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQL 59
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
H NL NL+ F + L++EY + + L D + I Q + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---TH-VST 731
H K +HRD+KPENIL+T++ KL DFG +++ V+T
Sbjct: 118 CH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-22
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 36/204 (17%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG G FG V G G +VAVK+L+ S + E++ L H ++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 633 VGY-FIEDNNMGLIY---EYMANGNL------KQLLSDEKASTLSWERRL--QIAMDAAQ 680
Y I + I+ EY++ G L L ++++ RRL QI
Sbjct: 82 --YQVISTPSD--IFMVMEYVSGGELFDYICKNGRLDEKES------RRLFQQIL----S 127
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
G++Y H + +VHRD+KPEN+LL ++ AK+ADFGLS + G + T G+P Y
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYA 182
Query: 741 DPEYFV-TDWLNEKSDVYSFGVVL 763
PE + + D++S GV+L
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVIL 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 33/230 (14%)
Query: 557 EFENRHFTYSEVLKIT-DNFN--KVLGKGGFGTVY----HGYLDDGTQVAVKMLSSSSGQ 609
E H K F KVLG+G FG V+ D A+K+L ++ +
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 610 GFKEFE--AEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLS 667
E +L+ V+H + L F + + LI +++ G+L LS E T
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 668 WER--RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725
+ ++A+ L++LH I++RD+KPENILL E KL DFGLSK
Sbjct: 127 DVKFYLAELAL----ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179
Query: 726 GTHVSTVVAGTPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIIT 768
+ GT Y+ PE + DW +SFGV++ E++T
Sbjct: 180 EKKAYSFC-GTVEYMAPEVVNRRGHTQSADW-------WSFGVLMFEMLT 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-22
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 569 LKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKLLMR 623
+ + D ++ K+LGKG FG V G A+K+L E E ++L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDAAQGL 682
H LT L F + + + EY G L LS E+ T E R + + L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARFYGAEIVSAL 118
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP 742
EYLH +V+RDIK EN++L ++ K+ DFGL K G + T GTP YL P
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174
Query: 743 E------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
E Y DW + GVV+ E++ +
Sbjct: 175 EVLEDNDYGRAVDW-------WGLGVVMYEMMCGR 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 16/169 (9%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVK-MLSSSSGQGFKEFEA--EVKLLMRVHH 626
+ + + +G+G +G V D G VA+K L S + K A E+KLL ++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRH 83
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
NL NL+ + L++E++ + + L + + L ++ + G+ + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---TH-VST 731
I+HRDIKPENIL++++ KL DFG ++ G V+T
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 573 DNFN--KVLGKGGFGTVY----HGYLDDGTQVAVKMLSSSS-GQGFKEFE---AEVKLLM 622
+ F +VLGKGG+G V+ + G A+K+L + + K+ AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 623 RVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ-- 680
V H + +L+ F + LI EY++ G L L E E A+
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM---EDTACFY--LAEIS 131
Query: 681 -GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
L +LH + I++RD+KPENI+L KL DFGL K GT T GT Y
Sbjct: 132 MALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEY 187
Query: 740 LDPE------Y-FVTDWLNEKSDVYSFGVVLLEIIT 768
+ PE + DW +S G ++ +++T
Sbjct: 188 MAPEILMRSGHNRAVDW-------WSLGALMYDMLT 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 33/170 (19%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE---FEA--EVKLLMRV 624
+ K+ LG+G F TVY + VA+K + K+ A E+KLL +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ---- 680
H N+ L+ F +N+ L++++M +L+ ++ D + + +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNS-----------LVLTPSHIKAY 117
Query: 681 ------GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
GLEYLH + I+HRD+KP N+LL EN KLADFGL+K F
Sbjct: 118 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 573 DNFNKV--LGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHR 627
+ + K+ LG+G + TVY G VA+K + +G A EV LL + H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHA 60
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR---LQIAMDAAQGLEY 684
N+ L + ++ L++EY+ + +LKQ L D + Q+ +GL Y
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL----RGLAY 115
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
H + ++HRD+KP+N+L+ E E KLADFGL++ I
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE---FEA--EVKLLMRV 624
+NF KV +G+G +G VY G VA+K + + E A E+ LL +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKEL 59
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
+H N+ L+ +N + L++E++ + +LK+ + + + QGL +
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
H ++HRD+KP+N+L+ KLADFGL++ F +
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 69/221 (31%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 573 DNFN--KVLGKGGFGTVY----HGYLDDGTQVAVKMLSSSS-GQGFKEFE---AEVKLLM 622
+NF KVLG G +G V+ D G A+K+L ++ Q K E E ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 623 RV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ- 680
+ L L F + + LI +Y+ G L LS + T E +QI +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIY--VGEI 168
Query: 681 --GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
LE+LH K I++RDIK ENILL N L DFGLSK F T + GT
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 739 YLDPE---------YFVTDWLNEKSDVYSFGVVLLEIITSQ 770
Y+ P+ DW +S GV++ E++T
Sbjct: 226 YMAPDIVRGGDSGHDKAVDW-------WSLGVLMYELLTGA 259
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHR 627
F ++ LG G + TVY G G VA+K + S +G A E+ L+ + H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHE 63
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA------QG 681
N+ L +N + L++E+M + +LK+ + + + + R L++ + QG
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYM--DSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
L + H I+HRD+KP+N+L+ + + KL DFGL++ F I
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-20
Identities = 71/219 (32%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 566 SEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVK- 619
+ K +D +F KV+GKG FG V + + AVK+L + KE + +E
Sbjct: 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 620 LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDA 678
LL V H L L F + + + +Y+ G L L E+ E R + A +
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEI 148
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
A L YLH IV+RD+KPENILL L DFGL K + ST GTP
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPE 204
Query: 739 YLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
YL PE Y DW + G VL E++
Sbjct: 205 YLAPEVLHKQPYDRTVDW-------WCLGAVLYEMLYGL 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 46/162 (28%), Positives = 84/162 (51%), Gaps = 21/162 (12%)
Query: 573 DNFNKV--LGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKE---FEA--EVKLLMRVH 625
+ + K+ +G+G +G VY G VA+K + + E A E+ LL +H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR---LQIAMDAAQGL 682
H N+ +L+ + + L++E+M +LK++L + K + + Q+ +G+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL----RGV 132
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
+ H + I+HRD+KP+N+L+ + KLADFGL++ F I
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 573 DNFNKV--LGKGGFGTVYHGYLDDGTQVAVKMLS-SSSGQGFKEFEA--EVKLLMRVHHR 627
+ ++ + +G+G +G VY + G A+K + +G E+ +L + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-PSTTIREISILKELKHS 60
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR---LQIAMDAAQGLEY 684
N+ L + L++E++ + +LK+LL + S + LQ+ G+ Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLL----NGIAY 115
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
H ++HRD+KP+N+L+ E K+ADFGL++ F I
Sbjct: 116 CH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 18/161 (11%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEA--EVKLLMRVHH 626
+ K+ +G+G +GTV+ + VA+K + +G A E+ LL + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKH 60
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERR---LQIAMDAAQGLE 683
+N+ L D + L++E+ + +LK+ + Q+ +GL
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL----KGLG 115
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724
+ H ++HRD+KP+N+L+ N E KLA+FGL++ F I
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 566 SEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKL 620
+ L + D + +V+G+G + V A+K++ ++ + E +
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 621 LMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDA 678
+ +H L L F ++ + + EY+ G+L + ++ E + + +
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEI 119
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
+ L YLH + I++RD+K +N+LL KL D+G+ K G ST GTP
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPN 175
Query: 739 YLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
Y+ PE Y F DW ++ GV++ E++ +
Sbjct: 176 YIAPEILRGEDYGFSVDW-------WALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 26/227 (11%)
Query: 557 EFENRHFTYSEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEF 614
E + LKI D +K+LGKG FG V+ + A+K L +
Sbjct: 2 ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61
Query: 615 E---AEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER 670
E E ++L H LT++ F N+ + EY+ G+L + R
Sbjct: 62 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSR 119
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
A + GL++LH IV+RD+K +NILL ++ K+ADFG+ K +G +
Sbjct: 120 ATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 731 TVVAGTPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
T GTP Y+ PE Y DW +SFGV+L E++ Q
Sbjct: 177 TFC-GTPDYIAPEILLGQKYNHSVDW-------WSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 2e-19
Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 28/219 (12%)
Query: 566 SEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKL 620
+ +K+TD NF VLGKG FG V AVK+L + E E ++
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 621 LMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDA 678
L LT L F + + + EY+ G+L + E A +
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAVFYAAEI 451
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
A GL +L I++RD+K +N++L K+ADFG+ K G T GTP
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 507
Query: 739 YLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
Y+ PE Y DW ++FGV+L E++ Q
Sbjct: 508 YIAPEIIAYQPYGKSVDW-------WAFGVLLYEMLAGQ 539
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA-EVKLLMRVHHRNLTNLVGY 635
KV+G G FG V+ L + +VA+K + K F+ E++++ V H N+ +L +
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 636 FIEDNNMG------LIYEYMANGNLKQLLSDEKASTLSWERRL------QIAMDAAQGLE 683
F + + L+ EY+ + + + L Q+ + L
Sbjct: 101 FYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLA 155
Query: 684 YLH-IGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
Y+H IG I HRDIKP+N+LL + KL DFG +K+ G +VS + + Y
Sbjct: 156 YIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209
Query: 742 PE-------YFVTDWLNEKSDVYSFGVVLLEIITSQA 771
PE Y D++S G V+ E++ Q
Sbjct: 210 PELIFGATNY------TTNIDIWSTGCVMAELMQGQP 240
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 28/228 (12%)
Query: 557 EFENRHFTYSEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEF 614
E S L I + F +VLGKG FG V + G AVK+L +
Sbjct: 8 EGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV 67
Query: 615 E---AEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER 670
E E ++L +H LT L F + + + E++ G+L + + E
Sbjct: 68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EA 124
Query: 671 RLQI-AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729
R + A + L +LH I++RD+K +N+LL KLADFG+ K G
Sbjct: 125 RARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181
Query: 730 STVVAGTPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
+T GTP Y+ PE Y DW ++ GV+L E++
Sbjct: 182 ATFC-GTPDYIAPEILQEMLYGPAVDW-------WAMGVLLYEMLCGH 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 56/206 (27%)
Query: 575 FNKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNL 632
++VLG G G V + + A+KML + EV+L R ++ +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 633 VGYF----IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA-------QG 681
V + + ++ E + G L + D + ER +A+ +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-ER------EASEIMKSIGEA 129
Query: 682 LEYLH-IGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
++YLH I I HRD+KPEN+L T N KL DFG +K
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----------TTGE-- 173
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVL 763
Y ++ D++S GV++
Sbjct: 174 KY-----------DKSCDMWSLGVIM 188
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 566 SEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE---AEVKL 620
S L + D + +V+G+G + V A++++ ++ + E +
Sbjct: 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV 105
Query: 621 LMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQI-AMDA 678
+ +H L L F ++ + + EY+ G+L + ++ E + + +
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHARFYSAEI 162
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
+ L YLH + I++RD+K +N+LL KL D+G+ K G ST GTP
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPN 218
Query: 739 YLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
Y+ PE Y F DW ++ GV++ E++ +
Sbjct: 219 YIAPEILRGEDYGFSVDW-------WALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 28/226 (12%)
Query: 559 ENRHFTYSEVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFE- 615
+ + + +K+TD NF VLGKG FG V AVK+L + E
Sbjct: 7 KFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC 66
Query: 616 --AEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL 672
E ++L LT L F + + + EY+ G+L + E
Sbjct: 67 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHA 123
Query: 673 QI-AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
A + A GL +L I++RD+K +N++L K+ADFG+ K G T
Sbjct: 124 VFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
Query: 732 VVAGTPGYLDPE------Y-FVTDWLNEKSDVYSFGVVLLEIITSQ 770
GTP Y+ PE Y DW ++FGV+L E++ Q
Sbjct: 181 FC-GTPDYIAPEIIAYQPYGKSVDW-------WAFGVLLYEMLAGQ 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEA-EVKLLMRVHHRNLTNLVG 634
KV+G G FG VY L D G VA+K + K F+ E++++ ++ H N+ L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 635 YFIEDNNMG------LIYEYMANGNLKQLLSDEKASTLSWERRL------QIAMDAAQGL 682
+F L+ +Y+ + ++ + + Q+ + L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----RSL 169
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEA-KLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
Y+H I HRDIKP+N+LL + KL DFG +K G +VS + + Y
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 224
Query: 742 PE-------YFVTDWLNEKSDVYSFGVVLLEIITSQ 770
PE Y DV+S G VL E++ Q
Sbjct: 225 PELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
++L+ + L ++ + + LDL NN + G +P+ L++L+FL LN+ N G
Sbjct: 225 KIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 476 IPVELMEKSKNGSLQ----LSVGDNEELCSSSSDSC 507
IP G+LQ + +N+ LC S +C
Sbjct: 284 IPQG-------GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 28/125 (22%), Positives = 51/125 (40%), Gaps = 33/125 (26%)
Query: 385 RNWQG--DPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGL------------------ 424
+W D C +W G+ C R+ +L+LS L
Sbjct: 25 SSWLPTTDCCN---RTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80
Query: 425 ---------TGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
G I P ++ LT + L +++ ++SG +P+FLS+++ L L+ N +G
Sbjct: 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140
Query: 476 IPVEL 480
+P +
Sbjct: 141 LPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ L ++ + ++G I +LS + + +LD S N+LSG +P +S L L + GN+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 472 FTGPIPVELMEKSKNG-SLQLS 492
+G IP SK S+ +S
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTIS 182
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 19/70 (27%), Positives = 32/70 (45%), Gaps = 1/70 (1%)
Query: 408 GNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNL 467
G+ S+ +S + LTG+I P +NL L +DLS N L G+ + + ++L
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 468 KGNKFTGPIP 477
N +
Sbjct: 229 AKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 19/78 (24%), Positives = 35/78 (44%), Gaps = 7/78 (8%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFL-RVLNLKGNKFTGP 475
L+ S + L+G + P +S+L + + N +SG +P+ L + + N+ TG
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 476 IPVELMEKSKNGSLQLSV 493
IP +L L+
Sbjct: 190 IPPTF------ANLNLAF 201
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 17/82 (20%), Positives = 34/82 (41%), Gaps = 2/82 (2%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLT-LIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P ++ + + ++G I + + L S+ +S N L+G +P + L L ++L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207
Query: 471 KFTGPIPVELMEKSKNGSLQLS 492
G V + L+
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLA 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 19/70 (27%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
+ L+L ++ + G + L+ L + SL++S N+L G +P+ LQ V
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300
Query: 470 NKFT--GPIP 477
NK P+P
Sbjct: 301 NKCLCGSPLP 310
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 22/165 (13%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVKMLS-SSSGQGFKEFEA--EVKLLMRVHH 626
D + ++ LG+G +G VY VA+K + +G A EV LL + H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-PGTAIREVSLLKELQH 92
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRL--QIAMDAAQGLEY 684
RN+ L ++ + LI+EY N +LK+ + ++ + Q+ G+ +
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI----NGVNF 147
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEA-----KLADFGLSKVFPI 724
H +HRD+KP+N+LL+ + + K+ DFGL++ F I
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-18
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 19/111 (17%)
Query: 414 IISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
+ LNL + ++G I + +L + LDLS+N L G +P+ +S L L ++L N +
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 474 GPIPVELMEKSKNGSLQ----LSVGDNEELC--------SSSSDSCKKEKK 512
GPIP + G + +N LC S++D ++
Sbjct: 718 GPIP-------EMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-17
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 16/98 (16%)
Query: 385 RNWQG--DPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLT---GEIAPYLSNLTLIQ 439
+W +PC ++DG+ C ++ S++LSS L ++ L +LT ++
Sbjct: 31 PDWSSNKNPC-----TFDGVTC-----RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80
Query: 440 SLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIP 477
SL LSN+ ++G+V F L L+L N +GP+
Sbjct: 81 SLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVT 117
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-17
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++SL+LS + L+G I L +L+ ++ L L N L G +P+ L ++ L L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
TG IP L S +L +S+ +N
Sbjct: 478 LTGEIPSGL---SNCTNLNWISLSNN 500
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-17
Identities = 35/84 (41%), Positives = 43/84 (51%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
N + L L ++G TG+I P LSN + + SL LS N LSG +P L L LR L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 469 GNKFTGPIPVELMEKSKNGSLQLS 492
N G IP ELM +L L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILD 474
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-17
Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ +L L + LTGEI LSN T + + LSNN L+G +P+++ RL+ L +L L N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
F+G IP EL + SL L + N
Sbjct: 526 FSGNIPAELGDCR---SLIWLDLNTN 548
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-16
Identities = 30/82 (36%), Positives = 49/82 (59%), Gaps = 7/82 (8%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L++SS+ + I P+L + + +Q LD+S N LSG+ +S L++LN+ N+F GP
Sbjct: 204 FLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 476 IPVELMEKSKNGSLQ-LSVGDN 496
IP ++ SLQ LS+ +N
Sbjct: 263 IPPLPLK-----SLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-16
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 397 YSWDGLNCSYKGNDPPRI------ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG 450
G ++G ++ N++S G +P N + LD+S N LSG
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646
Query: 451 NVPEFLSRLQFLRVLNLKGNKFTGPIPVEL 480
+P+ + + +L +LNL N +G IP E+
Sbjct: 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-15
Identities = 23/90 (25%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPY--LSNLTLIQSLDLSNNSLSGNVP-EFLSRLQFLRVLNLK 468
+ SL+LS + L+G + L + + ++ L++S+N+L +L L VL+L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 469 GNKFTGPIPVELMEKSKNGSLQ-LSVGDNE 497
N +G V + G L+ L++ N+
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNK 189
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-15
Identities = 21/86 (24%), Positives = 43/86 (50%), Gaps = 7/86 (8%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L +S + ++G++ +S ++ LD+S+N+ S +P L L+ L++ GNK
Sbjct: 178 GELKHLAISGNKISGDV-D-VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
+G + S L+ L++ N
Sbjct: 235 LSGDFSRAI---STCTELKLLNISSN 257
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-15
Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L++S + L+G+ + +S T ++ L++S+N G +P L+ L+ L+L NK
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENK 280
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
FTG IP L L L + N
Sbjct: 281 FTGEIPDFLSGACDT--LTGLDLSGN 304
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-15
Identities = 30/87 (34%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 408 GNDPPRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRVL 465
N +++L+LSS+ +G I P L +Q L L NN +G +P LS L L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
Query: 466 NLKGNKFTGPIPVELMEKSKNGSLQLS 492
+L N +G IP L SK L+L
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLW 450
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-15
Identities = 23/82 (28%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 405 SYKGNDPPRI------ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSR 458
Y G+ P + L++S + L+G I + ++ + L+L +N +SG++P+ +
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678
Query: 459 LQFLRVLNLKGNKFTGPIPVEL 480
L+ L +L+L NK G IP +
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAM 700
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 9/102 (8%)
Query: 412 PRIISLNLSSSGLTGEI-APYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF-LRVLNLKG 469
+ SL LSS+ +GE+ L + ++ LDLS N SG +PE L+ L L L+L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 470 NKFTGPIPVELMEKSKNGSLQLSVGDN-------EELCSSSS 504
N F+GPI L + KN +L + +N L + S
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-14
Identities = 29/80 (36%), Positives = 43/80 (53%)
Query: 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
++LS++ LTGEI ++ L + L LSNNS SGN+P L + L L+L N F G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 475 PIPVELMEKSKNGSLQLSVG 494
IP + ++S + G
Sbjct: 553 TIPAAMFKQSGKIAANFIAG 572
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-14
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ L+L+ + TGEI +LS + LDLS N G VP F L L L N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
F+G +P++ + K + L+ L + N
Sbjct: 329 NFSGELPMDTLLKMRG--LKVLDLSFN 353
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-13
Identities = 12/80 (15%), Positives = 27/80 (33%)
Query: 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
+ + G + L+ L+ ++++ G+ + L++ N
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 473 TGPIPVELMEKSKNGSLQLS 492
+G IP E+ L L
Sbjct: 645 SGYIPKEIGSMPYLFILNLG 664
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-12
Identities = 21/71 (29%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 412 PRIISLNLSSSGLTGEI-APYLSNLTLIQSLDLSNNSLSGNVPE---FLSRLQFLRVLNL 467
+ LN+SS+ L L ++ LDLS NS+SG L+ L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185
Query: 468 KGNKFTGPIPV 478
GNK +G + V
Sbjct: 186 SGNKISGDVDV 196
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L LS++ +G I L + + LDL+ N +G +P + + + N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANF 569
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNE 497
G V + + E
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLE 595
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 55/179 (30%), Positives = 81/179 (45%), Gaps = 24/179 (13%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVA---VKMLSSSSGQGFKEFEA--EVKLLMRV 624
+ V +G G +GTVY G VA V++ + G G EV LL R+
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 625 H---HRNLTNLVGYFIEDNNMG-----LIYEYMANGNLKQLLSDEKASTLSWERRLQIAM 676
H N+ L+ L++E++ +L+ L L E +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTHVSTVV 733
+GL++LH C IVHRD+KPENIL+T KLADFGL++++ + T V VV
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV 181
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 43/219 (19%)
Query: 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
++ G+G FGTV G G VA+K + +E + ++ L +HH N+ L Y
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSY 87
Query: 636 FI-------EDNNMGLIYEYM---------ANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
F D + ++ EY+ + + Q+
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF----QLI---- 139
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
+ + LH+ + HRDIKP N+L+ + KL DFG +K +V+ + +
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--SRY 196
Query: 739 YLDPE-------YFVTDWLNEKSDVYSFGVVLLEIITSQ 770
Y PE Y D++S G + E++ +
Sbjct: 197 YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 51/230 (22%), Positives = 82/230 (35%), Gaps = 60/230 (26%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKE--FEA---------EVKLLMRVH 625
+ + G +G V G +G VA+K + ++ G E++LL H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 626 HRNLTNLVGYFIEDNNMG-----LIYEYMANGNLKQL-------LSDEKASTLSWERRLQ 673
H N+ L F+ L+ E M +L Q+ +S + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY----H 142
Query: 674 IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733
I GL LH +VHRD+ P NILL +N + + DF L++ T
Sbjct: 143 IL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED--TADANKT-- 191
Query: 734 AGTPGYLDPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQA 771
Y W + K D++S G V+ E+ +A
Sbjct: 192 ---------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 45/237 (18%)
Query: 560 NRHFTYSEVLK----ITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFK 612
+ +F E+ + + K +G G G V Y VA+K L +
Sbjct: 8 DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SR 60
Query: 613 EFEA---------EVKLLMRVHHRNLTNLVGYFIEDNNMG------LIYEYMA---NGNL 654
F+ E+ L+ V+H+N+ L+ F ++ ++ E M +
Sbjct: 61 PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI 120
Query: 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714
+ L E+ S L + Q+ G+++LH I+HRD+KP NI++ + K+
Sbjct: 121 QMELDHERMSYLLY----QML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771
DFGL++ G + + T T Y PE + E D++S G ++ E+I
Sbjct: 170 DFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 8e-17
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 39/214 (18%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
K +G G G V Y VA+K L + F+ E+ L+ V+H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 627 RNLTNLVGYFIEDNNMG------LIYEYMA---NGNLKQLLSDEKASTLSWERRLQIAMD 677
+N+ +L+ F + L+ E M ++ L E+ S L + Q+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY----QML-- 174
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
G+++LH I+HRD+KP NI++ + K+ DFGL++ G + + T T
Sbjct: 175 --CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTR 227
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771
Y PE + E D++S G ++ E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 573 DNFNKV--LGKGGFGTVYHG--YLDDGTQVAVKMLS-SSSGQGFKEFEA--EVKLLMRVH 625
+ V +G+G +G V+ + G VA+K + + +G EV +L +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLE 69
Query: 626 ---HRNLTNL-----VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMD 677
H N+ L V + + L++E++ + +L L + E +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF--PIGGTHVSTVV 733
+GL++LH +VHRD+KP+NIL+T + + KLADFGL++++ + T V VV
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV 181
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 54/257 (21%), Positives = 101/257 (39%), Gaps = 64/257 (24%)
Query: 559 ENRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFE 615
EN +F + + + DN+ ++G+G +G VY Y + VA+K + + FE
Sbjct: 12 ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFE 64
Query: 616 A---------EVKLLMRVHHRNLTNLVGYFIEDNNMG-----LIYEYMANGNLKQL---- 657
E+ +L R+ + L I D+ + ++ E + +LK+L
Sbjct: 65 DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP 123
Query: 658 --LSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715
L++E T+ + + G ++H I+HRD+KP N LL ++ K+ D
Sbjct: 124 IFLTEEHIKTILY----NLL----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCD 172
Query: 716 FGLSKVFPIGGTHVSTVVAGTPGYLDP----------EYFVTDW-------LNEKS---- 754
FGL++ P + VT W L +++
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232
Query: 755 -DVYSFGVVLLEIITSQ 770
D++S G + E++
Sbjct: 233 IDIWSTGCIFAELLNML 249
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 54/227 (23%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
+LG+G +G V G VA+K + F+ E+K+L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKH 68
Query: 627 RNLTNLVGYFI-----EDNNMGLIYEYMANGNL-----KQLLSDEKASTLSWERRLQIAM 676
N+ + N + +I E M +L Q+LSD+ + Q
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIY----QTL- 122
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT 736
+ ++ LH ++HRD+KP N+L+ N + K+ DFGL+++ S
Sbjct: 123 ---RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 737 PGYLDPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQA 771
G E+ T W L DV+S G +L E+ +
Sbjct: 177 SGM--VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 64/226 (28%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
+G G +G+V G +VA+K L + F++ E+ LL + H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 627 RNLTNLVGYFIEDNNMG------LIYEYMA---NGNLKQLLSDEKASTLSWERRLQIAMD 677
N+ L+ F +++ L+ +M + S+EK L + Q+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY----QML-- 136
Query: 678 AAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
+GL+Y+H +VHRD+KP N+ + E+ E K+ DFGL++ T
Sbjct: 137 --KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 181
Query: 738 GYLDPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQA 771
Y VT W L+ D++S G ++ E++T +
Sbjct: 182 -----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 58/235 (24%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVH- 625
K LGKG +G V+ G VAVK + F F+ E+ +L +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSG 67
Query: 626 HRNLTNLVGYFIEDNNMG--LIYEYMANGNLK-----QLLSDEKASTLSWERRLQIAMDA 678
H N+ NL+ DN+ L+++YM +L +L + + Q+
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVY----QLI--- 119
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG 738
+ ++YLH G ++HRD+KP NILL K+ADFGLS+ F + +
Sbjct: 120 -KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 739 YLDP---------EYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQAV 772
+ +Y T W L D++S G +L EI+ + +
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 58/246 (23%), Positives = 102/246 (41%), Gaps = 55/246 (22%)
Query: 573 DNFNKV--LGKGGFGTVYHGY-LDDGTQVAVK-MLSSSSGQGFKEFEA--EVKLLMRVHH 626
+ K+ +G+G FG V+ G +VA+K +L + +GF A E+K+L + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKH 75
Query: 627 RNLTNLVGYFIEDNNMG--------LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDA 678
N+ NL+ + L++++ + +L LL + +I
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLS---EIKRVM 130
Query: 679 AQ---GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
GL Y+H + I+HRD+K N+L+T + KLADFGL++ F
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF------------S 175
Query: 736 TPGYLDPEYF----VTDW-------LNEKS-----DVYSFGVVLLEIITSQAVIV-RNEN 778
P + VT W L E+ D++ G ++ E+ T ++ E
Sbjct: 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235
Query: 779 ENIHII 784
+ +I
Sbjct: 236 HQLALI 241
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 66/247 (26%)
Query: 566 SEVLKITDNFNKV---LGKGGFGTVY---HGYLDDGTQVAVKMLS----SSSGQGFKEFE 615
SE ++ D F +G+G +G VY D A+K + S S
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----- 67
Query: 616 AEVKLLMRVHHRNLTNLVGYFIEDNNMG--LIYEYMANGNLKQLLSDEKASTLSWERRLQ 673
E+ LL + H N+ +L F+ + L+++Y + +L ++ +AS +
Sbjct: 68 -EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK---ANKKP 122
Query: 674 IAMDAAQ----------GLEYLHIGCKPPIVHRDIKPENILLTENLEA----KLADFGLS 719
+ + G+ YLH ++HRD+KP NIL+ K+AD G +
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 720 KVF--PIGG-THVSTVVAGTPGYLDPEYFVTDW-------LNEKS-----DVYSFGVVLL 764
++F P+ + VV VT W L + D+++ G +
Sbjct: 180 RLFNSPLKPLADLDPVV------------VTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227
Query: 765 EIITSQA 771
E++TS+
Sbjct: 228 ELLTSEP 234
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 48/251 (19%), Positives = 94/251 (37%), Gaps = 67/251 (26%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
++G G +G V Y + VA+K + + FE E+ +L R++H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNH 111
Query: 627 RNLTNLVGYFIEDNNMG-----LIYEYMANGNLKQL------LSDEKASTLSWERRLQIA 675
++ ++ I + ++ E + + K+L L++ TL + +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY----NLL 166
Query: 676 MDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAG 735
G++Y+H I+HRD+KP N L+ ++ K+ DFGL++ S +
Sbjct: 167 ----VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 736 TPGYLDP---------------EYFVTDW-------LNEKS-----DVYSFGVVLLEIIT 768
+ VT W L +++ DV+S G + E++
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 769 SQAVIVRNENE 779
V +
Sbjct: 280 MIKENVAYHAD 290
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 57/223 (25%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
+ +G G +G V G +VA+K L ++ F++ E++LL + H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 627 RNLTNLVGYFIEDNNMG------LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ 680
N+ L+ F D + L+ +M +L +L+ K L +R + +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVYQMLK 139
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
GL Y+H I+HRD+KP N+ + E+ E K+ DFGL++ T
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------------- 183
Query: 741 DPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQA 771
Y VT W LN D++S G ++ E+IT +
Sbjct: 184 --GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 61/227 (26%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---------EVKLLMRVHH 626
+G+G +G V Y + +VA+K +S FE E+K+L+R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRH 84
Query: 627 RNLTNLVGYFI-----EDNNMGLIYEYMANGNL-----KQLLSDEKASTLSWERRLQIAM 676
N+ + + ++ ++ + M +L Q LS++ + QI
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLY----QIL- 138
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGT 736
+GL+Y+H ++HRD+KP N+LL + K+ DFGL++V
Sbjct: 139 ---RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA--------DPDHDH 184
Query: 737 PGYLDPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQA 771
G+L EY T W LN K D++S G +L E+++++
Sbjct: 185 TGFL-TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
K LG GG G V+ D +VA+K + + Q K E+K++ R+ H N+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 636 FIEDNNMG--------------LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQG 681
+ ++ EYM +L +L + L E +G
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLFMYQLLRG 132
Query: 682 LEYLHIGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYL 740
L+Y+H ++HRD+KP N+ + TE+L K+ DFGL+++ H S +
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHLS---- 182
Query: 741 DPEYFVTDW-------LNEKS-----DVYSFGVVLLEIITSQA 771
E VT W L+ + D+++ G + E++T +
Sbjct: 183 --EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH---------- 625
+ LG G F TV+ + + T VA+K++ + E E+KLL RV+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 626 -HRNLTNLVGYFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ 680
++ L+ +F G +++E + NL L+ + + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 681 GLEYLHIGCKPPIVHRDIKPENILL------TENLEAKLADFGLSKVFPIGGTHVSTVVA 734
GL+Y+H C I+H DIKPEN+L+ ++ K+AD G + + H + +
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACW--YDEHYTNSIQ 197
Query: 735 GTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIIT 768
T Y PE + W +D++S ++ E+IT
Sbjct: 198 -TREYRSPEVLLGAPW-GCGADIWSTACLIFELIT 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 33/179 (18%), Positives = 62/179 (34%), Gaps = 34/179 (18%)
Query: 577 KVLGKGGFGTVYHGY---------LDDGTQVAVKMLSSSSGQGFKEFE-----------A 616
+ G +Y + ++K L + G+ F E
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 617 EVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA----NGNLKQLLSDEKASTLSWERRL 672
+ K L + +G+ + + Y ++ +L+ L LS L
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 673 QIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK--LADFGLSKVFPIGGTHV 729
Q+A LE+LH + VH ++ ENI + +++ LA +G + + G HV
Sbjct: 163 QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/255 (22%), Positives = 103/255 (40%), Gaps = 63/255 (24%)
Query: 551 NAHGSLEFENRHFTYSEVLK----ITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKML 603
+ H E F E+ K + + + +G G +G+V + G +VAVK L
Sbjct: 3 HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 62
Query: 604 SSSSGQGFKEFEA---------EVKLLMRVHHRNLTNLVGYFIEDNNMG------LIYEY 648
S + F++ E++LL + H N+ L+ F ++ L+
Sbjct: 63 S-------RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708
M +L ++ K L+ + + +GL+Y+H I+HRD+KP N+ + E+
Sbjct: 116 M-GADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED 168
Query: 709 LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW-------LNEKS-----DV 756
E K+ DFGL++ T Y T W LN D+
Sbjct: 169 CELKILDFGLARHTADEMT---------------GYVATRWYRAPEIMLNWMHYNQTVDI 213
Query: 757 YSFGVVLLEIITSQA 771
+S G ++ E++T +
Sbjct: 214 WSVGCIMAELLTGRT 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 31/204 (15%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA--EVKLL--MRVHHRNLTN 631
+ LG+G + V+ + + +V VK+L K+ + E+K+L +R N+
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLR-GGPNIIT 95
Query: 632 LVGYFIEDNNMG--LIYEYMANGNLKQL---LSDEKASTLSWERRLQIAMDAAQGLEYLH 686
L + + L++E++ N + KQL L+D + +I + L+Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY----EIL----KALDYCH 147
Query: 687 IGCKPPIVHRDIKPENILL-TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
I+HRD+KP N+++ E+ + +L D+GL++ + G + V + + PE
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELL 202
Query: 746 VTDWLNEKS-DVYSFGVVLLEIIT 768
V + + S D++S G +L +I
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIF 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 37/144 (25%), Positives = 67/144 (46%), Gaps = 4/144 (2%)
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
R L ++ ++ + + +++ ++ D L+ E + + A+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPG-YLDPEY 744
+HRD+ NILL+E K+ DFGL++ +V A P ++ PE
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 745 FVTDWLNEKSDVYSFGVVLLEIIT 768
+SDV+SFGV+L EI +
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 18/155 (11%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV-HH 626
K LG+G FG V VAVKML ++ + +E+K+L+ + HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 627 RNLTNLVGYFIEDNN-MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
N+ NL+G + + +I E+ GNL L +R + +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFR 136
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720
+ D+K +T + + + F K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 26/175 (14%)
Query: 577 KVLGKGGFGTVYHGYLDDGT------QVAVKMLSSSSGQGFKEFE-----AEVKLLMRVH 625
+G+GGFG +Y ++ VK+ S +G F E + A+ + + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 626 HRNLTNLVG-----YFIEDNNMGLIYEYMA----NGNLKQLLSDEKASTLSWERRLQIAM 676
+G + G Y +M +L+++ + A S + LQ+++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY-EANAKRFSRKTVLQLSL 159
Query: 677 DAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK--LADFGLSKVFPIGGTHV 729
LEY+H + VH DIK N+LL + L D+GL+ + G H
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 18/175 (10%)
Query: 566 SEVLKITDNF--NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLM 622
VL + NF K +G G FG + G L VA+K+ S E +
Sbjct: 2 MGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQL 61
Query: 623 RVHHRNLTNLVGYFIEDNNMGLIYEYMANG-NLKQLLSDEKASTLSWERRLQIAMDAAQG 681
+ + + ++ E + G +L+ L D T S + L IA+
Sbjct: 62 G-SGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLF-DLCDRTFSLKTVLMIAIQLISR 117
Query: 682 LEYLHIGCKPPIVHRDIKPENILL--TENLEAK---LADFGLSKVF--PIGGTHV 729
+EY+H +++RD+KPEN L+ N + + DF L+K + P H+
Sbjct: 118 MEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 50/252 (19%), Positives = 90/252 (35%), Gaps = 83/252 (32%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA-EVKLLMRVHHRNLTNLVG 634
K LG G FG V + ++ G + A+K + ++ E+ ++ + H N+ LV
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 635 YFIEDNNMG--------------------------------------LIYEYM------- 649
YF + +I EY+
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 650 --ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILL- 705
+ + + S + Q+ + + ++H +G I HRDIKP+N+L+
Sbjct: 128 LKSFIRSGRSIPMNLISIYIY----QLF----RAVGFIHSLG----ICHRDIKPQNLLVN 175
Query: 706 TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE-------YFVTDWLNEKSDVYS 758
+++ KL DFG +K V+ + + Y PE Y D++S
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEY------TPSIDLWS 227
Query: 759 FGVVLLEIITSQ 770
G V E+I +
Sbjct: 228 IGCVFGELILGK 239
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVA---VKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
K +G GGFG +Y + + + A VK+ +G F E +K RV ++
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSE----LKFYQRVAKKDCIKK 98
Query: 633 VGYFIEDNNMGLIYEYMANG-------------------NLKQLLSDEKASTLSWERRLQ 673
+ + +G I + +G +L+++ T LQ
Sbjct: 99 WIERKQLDYLG-IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQ 155
Query: 674 IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK--LADFGLSKVFPIGGTHV 729
+ + LEY+H + VH DIK N+LL + LAD+GLS + G H
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR------NL 629
KV+GKG FG V Y VA+KM+ + + ++ E+++L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
+++ F N++ + +E ++ NL +L+ K S + A Q L+ LH
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217
Query: 690 KPPIVHRDIKPENILLTENLEA--KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE-YFV 746
K I+H D+KPENILL + + K+ DFG S V T + + Y PE
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ-SRFYRAPEVILG 273
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTV-----TNMIAKG 794
+ D++S G +L E++T ++ +E + + + + ++
Sbjct: 274 ARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 35/160 (21%), Positives = 71/160 (44%), Gaps = 14/160 (8%)
Query: 577 KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSGQGFKEFEAEV-KLLMRVHHRNLTNLVG 634
+ +G G FG +Y G + G +VA+K+ + E+++ K++ + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG--IPTIRW 72
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
E + ++ E + +L+ L + + S + L +A +EY+H +
Sbjct: 73 CGAEGDYNVMVMELLGP-SLEDLF-NFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 127
Query: 695 HRDIKPENILLTENLEAK---LADFGLSKVF--PIGGTHV 729
HRD+KP+N L+ + + DFGL+K + H+
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 18/163 (11%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEV-KLLMRVHHRNLTNLVG 634
+ +G+G FG ++ G L + QVA+K S E KLL + N+
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--IPNVYY 73
Query: 635 YFIEDNNMGLIYEYMANG-NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+ E + L+ + + G +L+ LL D S + A ++ +H + +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 127
Query: 694 VHRDIKPENILLTENLEAK-----LADFGLSKVF--PIGGTHV 729
V+RDIKP+N L+ + DFG+ K + P+ H+
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 10/102 (9%)
Query: 403 NCSYKGNDPPRIIS-------LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
S++ N P I + L+LS L ++L+ +Q L++S+N+
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 456 LSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L L+VL+ N EL + SL L++ N
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQEL--QHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 18/81 (22%), Positives = 25/81 (30%), Gaps = 6/81 (7%)
Query: 403 NCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFL 456
C N P +L+LS + L + + +Q LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 457 SRLQFLRVLNLKGNKFTGPIP 477
L L L L GN
Sbjct: 73 QSLSHLSTLILTGNPIQSLAL 93
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 16/86 (18%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + L+LS + +L+ + +L L+ N + S L L+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ +L+ L+V N
Sbjct: 112 LASLENFPI---GHLKTLKELNVAHN 134
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 22/95 (23%), Positives = 33/95 (34%), Gaps = 1/95 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRL-QFLRVLNLKGN 470
+ LN+S + L +Q LD S N + + + L L LNL N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 471 KFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSD 505
F + + QL V C++ SD
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 15/76 (19%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
++ L+ S L +L + LD+S+ + L L VL + GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 471 KFTGPIPVELMEKSKN 486
F ++ + +N
Sbjct: 456 SFQENFLPDIFTELRN 471
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 1/67 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ +L L+ + + S L+ +Q L +L+ + L+ L+ LN+ N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 472 FTG-PIP 477
+P
Sbjct: 136 IQSFKLP 142
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 22/98 (22%), Positives = 39/98 (39%), Gaps = 6/98 (6%)
Query: 402 LNCSYKGNDPPRIISLNLSSSGLT--GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRL 459
++ D P + L+LS +GL+ G + T ++ LDLS N + FL L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-L 395
Query: 460 QFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ L L+ + + + +N L L +
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRN--LIYLDISHT 431
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 10/104 (9%)
Query: 412 PRIISLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRV----LN 466
+ LN++ + + ++ Y SNLT ++ LDLS+N + L L + + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 467 LKGNKFTGPIPVELMEKSKNGSLQ-LSVGDNEELCSSSSDSCKK 509
L N P K L L++ +N + + +
Sbjct: 184 LSLNPMNFIQPGAF----KEIRLHKLTLRNNFDSLNVMKTCIQG 223
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKG 469
P +SL+LS + + + L L L NN S NV + + L L V L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRL-HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 470 NKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+F +E +KS L L++ +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEF 262
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 21/94 (22%), Positives = 36/94 (38%), Gaps = 4/94 (4%)
Query: 402 LNCSYKGNDPPRIISL-NLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS--GNVPEFLSR 458
+NC + ++ SL L+ + G A +L ++ LDLS N LS G +
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 459 LQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLS 492
L+ L+L N + + + L
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ 404
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/63 (20%), Positives = 19/63 (30%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ S +L S + S Q L+L N L L+ L + KG
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339
Query: 472 FTG 474
Sbjct: 340 AFS 342
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 8/97 (8%)
Query: 414 IISLNLSS-SGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
I L+ +I + LT + S L + ++ S + L L KF
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 473 TGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKK 509
++L +L+ N+ + S
Sbjct: 317 GQFPTLKL-----KSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 37/160 (23%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEV-KLLMRVHHRNLTNLVG 634
+ +G G FG +Y G + +VA+K+ + + +E+++ ++L + N+
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG--IPNVRW 70
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ +E + L+ + + +L+ L + + LS + L +A +E++H +
Sbjct: 71 FGVEGDYNVLVMDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH---SKSFL 125
Query: 695 HRDIKPENILLTENLEAK---LADFGLSKVF--PIGGTHV 729
HRDIKP+N L+ A + DFGL+K + H+
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 40/243 (16%)
Query: 576 NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHR---- 627
+ ++GKG FG V Y + VA+K++ + Q E V+LL ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEM 114
Query: 628 --NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ +L +F+ N++ L++E ++ NL LL + +S + A L +L
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA--KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
+ I+H D+KPENILL + K+ DFG S G + + + Y PE
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL--GQRIYQYIQ-SRFYRSPE 228
Query: 744 ------YFVTDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTV-----TNMI 791
Y + D++S G +L+E+ T + + NE + ++ I V +++
Sbjct: 229 VLLGMPY------DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282
Query: 792 AKG 794
+
Sbjct: 283 DQA 285
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 26/102 (25%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
+CS+ + P I LNL+ + L A + + + SLD+ N++S PE
Sbjct: 9 ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 456 LSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+L L+VLNL+ N+ + + +L L + N
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTF---AFCTNLTELHLMSN 107
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 19/85 (22%), Positives = 34/85 (40%), Gaps = 1/85 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ LNL S+G +L ++ +DL N+L+ + L+ LNL+ N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDN 496
T +N + +L + N
Sbjct: 596 ITSVEKKVFGPAFRNLT-ELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 22/89 (24%), Positives = 37/89 (41%), Gaps = 2/89 (2%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
+ L+L S+ + + +LDLS+N LS +L+ L+ L L
Sbjct: 94 AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153
Query: 469 GNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
NK + E ++ N SL+ L + N
Sbjct: 154 NNKIQA-LKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
I +L+LS+S L+ L + LDLS N+L+ + + L L L+
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281
Query: 470 NKFTGPIPVELMEKSKNGSLQ-LSVGDNEELCSSSSDSCKKEKKNMF 515
N L +++ L++ + S S S K F
Sbjct: 282 NNIQHLFSHSL---HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
+ L LS++ + + L ++ L+LS+N + P + L L L
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 470 NKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ + +L + N S++ LS+ ++
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNS 232
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 14/87 (16%), Positives = 28/87 (32%), Gaps = 3/87 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ L+L + + E+ L I + LS N + + L+ L L+
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ +L L + +N
Sbjct: 465 ALKN-VDSSPSPFQPLRNLTILDLSNN 490
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 14/66 (21%), Positives = 25/66 (37%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + LNL + L+ + T + L L +NS+ + + L L+L N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 472 FTGPIP 477
+
Sbjct: 133 LSSTKL 138
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ SL++ + ++ L +++ L+L +N LS + + L L+L N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
K +L L + N
Sbjct: 109 IQKIKNNPF---VKQKNLITLDLSHN 131
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 19/86 (22%), Positives = 34/86 (39%)
Query: 405 SYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRV 464
++ G + L+LS + L + L ++ L N++ L L +R
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 465 LNLKGNKFTGPIPVELMEKSKNGSLQ 490
LNLK + I + + K + S Q
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQ 326
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 8/74 (10%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS--------GNVPEFLSRLQFLR 463
+ L+LS++ + L L ++ LDL +N+L+ G FL L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 464 VLNLKGNKFTGPIP 477
+LNL+ N F
Sbjct: 540 ILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 14/71 (19%), Positives = 24/71 (33%), Gaps = 2/71 (2%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG--NVPEFLSRLQFLRVLNLKG 469
I + LS + + + +Q L L +L + P L+ L +L+L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 470 NKFTGPIPVEL 480
N L
Sbjct: 490 NNIANINDDML 500
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 13/70 (18%), Positives = 26/70 (37%), Gaps = 3/70 (4%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF---LRVLNL 467
+ L LSS+ + + + L L+N L ++ E L +R L+L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 468 KGNKFTGPIP 477
++ +
Sbjct: 230 SNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 412 PRIISLNLSSSGLTG--EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
P + L L L L + LDLSNN+++ + L L+ L +L+L+
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513
Query: 470 NKFT 473
N
Sbjct: 514 NNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 17/89 (19%), Positives = 31/89 (34%), Gaps = 8/89 (8%)
Query: 412 PRIISLNLSSSGLT--------GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLR 463
++ L+L + L G +L L+ + L+L +N E L L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 464 VLNLKGNKFTGPIPVELMEKSKNGSLQLS 492
+++L N + SL L
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 2/85 (2%)
Query: 414 IISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
++S + L L ++ L++ +N + G + L L+ L+L + +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 474 -GPIPVELMEKSKNGSLQ-LSVGDN 496
+ E + L L++ N
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKN 391
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 18/90 (20%), Positives = 36/90 (40%), Gaps = 7/90 (7%)
Query: 412 PRIISLNLSSSGLTGEIAP--YLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRVLNL 467
+ L+LS+S + +L + L+L+ N +S + S L L VL+L
Sbjct: 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL 412
Query: 468 KGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
N+ + + +N + + + N
Sbjct: 413 GLNEIGQELTGQEWRGLEN--IFEIYLSYN 440
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 8/91 (8%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLS----RLQFLRVLNL 467
+ LN+ + + G + + L ++ L LSN+ S + L +LNL
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 468 KGNKFTGPIPVELMEKSKNGSLQ-LSVGDNE 497
NK + S G L+ L +G NE
Sbjct: 389 TKNKISKIESDAF---SWLGHLEVLDLGLNE 416
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 9/91 (9%)
Query: 412 PRIISLNLSSSGLTGEIAPYLS---NLTLIQSLDLSNNSLSGNVPEFLSRLQF--LRVLN 466
R+ L L++ L + L T I++L LSN+ LS L++ L +L+
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 467 LKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L N + L+ + N
Sbjct: 255 LSYNNLNVVGNDSF---AWLPQLEYFFLEYN 282
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 3e-11
Identities = 33/211 (15%), Positives = 59/211 (27%), Gaps = 55/211 (26%)
Query: 572 TDNFNKV--LGKGGFGTVYHGYLDDGTQVAVKML--------SSSSGQGFKEFEAEVKLL 621
T+ + +G+G FG V+ D T VA+K++ + S + F+E E+ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 622 MRVH---------HRNLTNLVGYFI------------------------------EDNNM 642
+ L +D+ +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPEN 702
++ E+ G L + S I L HRD+ N
Sbjct: 138 FIVLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGN 192
Query: 703 ILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733
+LL + KL K I + +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 20/99 (20%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 400 DGLNCSYKGNDPPRIISLNLSSSGLTGEIAPY--LSNLTLIQSLDLSNNSLSGNVPEFLS 457
+G N S +G + N + P L++ + L L SG VP+ +
Sbjct: 43 NGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIG 102
Query: 458 RLQFLRVLNLKGNKFTGP----IPVELMEKSKNGSLQLS 492
+L L VL L + P + + Q
Sbjct: 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-11
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 6/83 (7%)
Query: 416 SLNLSSSGL-TGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
+ + + L T + L + + L+ N L G +P F L LNL N+ T
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITE 367
Query: 475 PIPVELMEKSKNGSLQ-LSVGDN 496
IP ++ ++ LS N
Sbjct: 368 -IPANFCGFTEQ--VENLSFAHN 387
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 9/88 (10%), Positives = 27/88 (30%), Gaps = 3/88 (3%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
+ + E ++ + L + +N + + + VL++K N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS---VLDIKDNPNISID 603
Query: 477 PVELMEKSKNGSLQLSVGDNEELCSSSS 504
+ + G L +++ +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIRGCDA 631
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 15/102 (14%), Positives = 28/102 (27%), Gaps = 15/102 (14%)
Query: 412 PRIISLNLSS---SGLTGEIA--PYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
P ++ ++LS S + L + D N PE ++ L L
Sbjct: 513 PYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572
Query: 467 LKGNKFTGPIPVELMEK------SKNGSLQLSVGDNEELCSS 502
+ N + ++ N D +C
Sbjct: 573 IGSNDIRK-VNEKITPNISVLDIKDN---PNISIDLSYVCPY 610
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 13/106 (12%), Positives = 31/106 (29%), Gaps = 9/106 (8%)
Query: 402 LNCSYKGNDPPRIISLN--------LSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVP 453
+ Y+ + ++S I + +N+++ V
Sbjct: 141 MRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VS 199
Query: 454 EFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEEL 499
+ + RL LR + + F E E + Q ++ +
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 15/94 (15%), Positives = 32/94 (34%), Gaps = 6/94 (6%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
N + N + NL + +++ N +P FL L ++++N+
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 469 GNKFTGP-----IPVELMEKSKNGSLQ-LSVGDN 496
N+ L + +Q + +G N
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 21/105 (20%), Positives = 41/105 (39%), Gaps = 20/105 (19%)
Query: 411 PPRIIS-------LNLSSSGLTG-------EIAPYLSNLTLIQSLDLSNNSLSGNVPEF- 455
P + S +NL + LT + N L+ S+DL N L+ +F
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508
Query: 456 LSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDNEEL 499
+ L +L ++L N F+ P + + +L+ + + +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQP---LNSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 16/83 (19%), Positives = 32/83 (38%), Gaps = 4/83 (4%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L + L G++ P + + SL+L+ N ++ F + + L+ NK
Sbjct: 334 MLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY- 391
Query: 476 IPVELMEKSKNGSLQ-LSVGDNE 497
IP + + + + NE
Sbjct: 392 IP-NIFDAKSVSVMSAIDFSYNE 413
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 18/74 (24%), Positives = 31/74 (41%), Gaps = 8/74 (10%)
Query: 416 SLNLSSSGLTG-------EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
+++ S + + + P + S++LSNN +S E S L +NL
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 469 GNKFTGPIPVELME 482
GN T IP ++
Sbjct: 466 GNMLTE-IPKNSLK 478
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 16/106 (15%), Positives = 34/106 (32%), Gaps = 20/106 (18%)
Query: 416 SLNLSSSGLT--------GEIAPYLSNLTLIQSLDLSNNSL-SGNVPEFLSRLQFLRVLN 466
+N++ + + IQ + + N+L + V L +++ L +L
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336
Query: 467 LKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN------EELCSSSSD 505
N+ G +P L L++ N C +
Sbjct: 337 CLYNQLEGKLP-AF---GSEIKLASLNLAYNQITEIPANFCGFTEQ 378
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 15/137 (10%), Positives = 31/137 (22%), Gaps = 34/137 (24%)
Query: 386 NWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAP--------------- 430
NW + + G++ N R+ L+L G +G +
Sbjct: 59 NWNFNKELDMWGAQPGVSL----NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 431 -------------YLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF--LRVLNLKGNKFTGP 475
+S + ++ R F L + +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 476 IPVELMEKSKNGSLQLS 492
I K+ +
Sbjct: 175 IKKSSRITLKDTQIGQL 191
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 12/90 (13%), Positives = 34/90 (37%), Gaps = 12/90 (13%)
Query: 416 SLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSG-------NVPEFLSRLQFLRVLNL 467
+L+ + + L + +++++ ++D S N + + + + +NL
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 468 KGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
N+ + EL L +++ N
Sbjct: 441 SNNQISKFPK-ELFSTGSP--LSSINLMGN 467
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 6/65 (9%), Positives = 15/65 (23%), Gaps = 5/65 (7%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
+ +S E ++ + L+ L + +
Sbjct: 210 QFYMGNSPFVAEN-----ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 476 IPVEL 480
+P L
Sbjct: 265 LPTFL 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 7e-10
Identities = 83/621 (13%), Positives = 180/621 (28%), Gaps = 178/621 (28%)
Query: 261 INGSHALQFYW-------EPKDPTAKYYVYMYFAEVEVLQ-DNQ-LREFNISKDGQILME 311
+ + + + E + P+ +Y+ + + L DNQ ++N+S+ L
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE--QRDRLYNDNQVFAKYNVSRLQPYLK- 139
Query: 312 FIVPEYLFSFSTYRVKPYSGAII-------------EFSLDRTERSTLPPIINAFEVY-M 357
+ + L ++P +I + L + + F+++ +
Sbjct: 140 --LRQAL-----LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD-----FKIFWL 187
Query: 358 EKDFSQSETLHTDVDAVMNMKKMYG-VKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIIS 416
+ ++ + ++K+ + NW + N RI S
Sbjct: 188 --NLKNC---NSPETVLEMLQKLLYQIDPNWTS-------------RSDHSSNIKLRIHS 229
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV--PE----FLSRLQFL---R---V 464
+ L PY + L L+ L NV + F + L R V
Sbjct: 230 IQAELRRLLKS-KPYENCL-LV--LL--------NVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 465 LNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAV 524
+ T I ++ + L+ + + L D C+ + +P
Sbjct: 278 TDFLSAATTTHISLDHHSMT------LTPDEVKSLLLKYLD-CRPQD-----LPREVLTT 325
Query: 525 SLLFFLTALAMIWWSLKRRKDRAAILNAHGSLEFEN-RHFTYSEVLKITDNFNKVLGKGG 583
+ L++I S++ ++N +H ++ I ++ VL
Sbjct: 326 NPR----RLSIIAESIRDGLAT-----------WDNWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 584 FGTVYH--GYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLM-RVHHRNLTNLVGYFIEDN 640
+ ++ + +LS K +V +++ ++H +L +
Sbjct: 371 YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---DVMVVVNKLHKYSLVE------KQP 421
Query: 641 NMGLIYEYMANGNLKQLLSDEKA------------STLSWERRLQIAMDAAQGLEYLHIG 688
I LK L +E A T + + +D Y HIG
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---QYFYSHIG 478
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGL--SKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
H E+ DF K+ H ST + L+
Sbjct: 479 ------HHLKNIEHPERMTLFRMVFLDFRFLEQKI-----RHDSTAWNASGSILN----- 522
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-------IHIIQTVTNMIAKGDIENI 799
L ++ + I N+ + + + + + ++
Sbjct: 523 ---------------TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL 567
Query: 800 VDSCL--RGGFEIESAWRAVE 818
+ L E A + V+
Sbjct: 568 LRIALMAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 93/658 (14%), Positives = 182/658 (27%), Gaps = 239/658 (36%)
Query: 145 TAMEMKEIIHIPTENHVLICLVNTGLGTPFISALELRLLRNSSYETVSRSIALYKRYDYG 204
+ E+ II + L L + E V + + R +Y
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRL--------------FWTLLSKQEEMVQKFVEEVLRINYK 92
Query: 205 SITNQ-----------TIRYKDDAYDRMWT-PREFPK--------TKKLSTSL-PIRS-- 241
+ + T Y + DR++ + F K KL +L +R
Sbjct: 93 FLMSPIKTEQRQPSMMTRMY-IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 242 --------GADDSYLPPSAVMSTAITPINGSHALQFYWEPKDPTAKYYVYMYFAEV---- 289
G+ +++ +S + +W +
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI---FW------------LNLKNCNSPE 196
Query: 290 EVLQDNQLREFNISKDGQILMEFIVPEYLFSFSTY-------RVKPYSGA-IIEFSLDRT 341
VL+ Q + I + + L S + KPY ++ L
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV---LLNV 253
Query: 342 ERSTLPPIINAFEVYMEKDFSQSETLHTDVDA-VMNMKKMYGVKRNWQGDPCAPKAYSWD 400
+ + NAF + + L T V +
Sbjct: 254 QNAK---AWNAFNL-------SCKILLTTRFKQVTDFLSAATTTH--------------- 288
Query: 401 GLNCSYKGNDPPRIISLNLSSSGLT-GEIAPYLSNLTLIQSLDLSNNSLSGN-------- 451
ISL+ S LT E+ L + DL L+ N
Sbjct: 289 --------------ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 452 --VPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKK 509
+ + L+ + +N K T ++E S L+V + E +K
Sbjct: 335 ESIRDGLATWDNWKHVNCD--KLT-----TIIESS------LNVLEPAEY--------RK 373
Query: 510 EKKNMFVIP---LVASAVSLLFFLTALAMIWWSLKRRKDRAAILNAHGSLEFENRHFTYS 566
+ V P + + + L++IW+ + + ++N + YS
Sbjct: 374 MFDRLSVFPPSAHIPTIL--------LSLIWFDVIKSDVM-VVVN-----KLHK----YS 415
Query: 567 EVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
V K + ++ YL+ ++ E E L H
Sbjct: 416 LVEK--QPKESTI------SIPSIYLELKVKL----------------ENEYAL-----H 446
Query: 627 RNLTN----LVGY----FIEDNNMGLIYEYMANGNLKQLLSDEKAST-------LSW-ER 670
R++ + + I Y ++ + +LK + E+ + + E+
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 671 RLQIA----------MDAAQGLE-YL-HIGCKPPIVHRDIKPENILLTENLEAKLADF 716
+++ ++ Q L+ Y +I D P+ E L + DF
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYI--------CDNDPKY----ERLVNAILDF 551
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 80/507 (15%), Positives = 159/507 (31%), Gaps = 130/507 (25%)
Query: 346 LPPIINAFEVYMEKDFSQSETLHTDVDAVMNMK-------KMYGVKRNWQGDPCAPKAYS 398
++ F+ +D +S ++D ++ K +++ + Q + + +
Sbjct: 26 EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE--MVQKFV 83
Query: 399 WDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSR 458
+ L +YK L S T + P + I+ D N +SR
Sbjct: 84 EEVLRINYKF----------LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 459 LQF---LR--VLNLKGNKFTGPIPVELME---KSKNGSLQLSVGDNEELCSSSSDSCKKE 510
LQ LR +L L+ K + ++ + K+ + L V C S CK +
Sbjct: 134 LQPYLKLRQALLELRPAKN---VLIDGVLGSGKT---WVALDV------CLSYKVQCKMD 181
Query: 511 KKNMFVIPL--VASAVSLLFFLTAL-AMIWWSLKRRKDRAA--ILNAHGSLEFENRHFT- 564
+F + L S ++L L L I + R D ++ L H R
Sbjct: 182 -FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240
Query: 565 --YSEVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLM 622
Y L + L + V + + + F K+L+
Sbjct: 241 KPYENCLLV--------------------LLN---V-------QNAKAWNAFNLSCKILL 270
Query: 623 RVHHRNLTNLVG------YFIEDNNMGLIYEYMANGNLKQLLS---DEKASTLSWERR-- 671
+ +T+ + ++ ++M L + +K LL D + L E
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPD-----EVKSLLLKYLDCRPQDLPREVLTT 325
Query: 672 --LQIAMDAAQGLE-------YLHIGCKPPIVHRDIKPE-NILLTENLEAKLADFGLSKV 721
++++ A + + H+ C + I+ N+L V
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLS---V 380
Query: 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN- 780
FP H+ T++ W + V L +++ + E+
Sbjct: 381 FP-PSAHIPTIL-----------LSLIWFDVIKSDVMVVVNKLH---KYSLVEKQPKEST 425
Query: 781 --IHIIQTVTNMIAKGDIE---NIVDS 802
I I + + + +IVD
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDH 452
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 4/89 (4%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
+ + L+LS L L +Q L++S+N+L ++L L L+
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 469 GNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
N+ + SL ++ +N
Sbjct: 530 FNRIETSKGILQ---HFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 19/82 (23%), Positives = 30/82 (36%), Gaps = 6/82 (7%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
C + + P +++LS + L + SN + +Q LDLS + +
Sbjct: 16 YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 456 LSRLQFLRVLNLKGNKFTGPIP 477
L L L L GN P
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSP 97
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 14/76 (18%), Positives = 24/76 (31%), Gaps = 1/76 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ L+ S L +L + LD+S + + L L L + GN
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 471 KFTGPIPVELMEKSKN 486
F + + N
Sbjct: 459 SFKDNTLSNVFANTTN 474
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 13/67 (19%), Positives = 23/67 (34%), Gaps = 1/67 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ +L ++ + +N T + LDLS L L L++LN+ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 471 KFTGPIP 477
Sbjct: 508 NLLFLDS 514
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 14/62 (22%), Positives = 25/62 (40%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
R+ LN+S + L + + + L + +LD S N + + + L NL N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 472 FT 473
Sbjct: 557 VA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+LS + L + +L L+ N + P S L L L K
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ + +L+ L+V N
Sbjct: 116 LASLESFPI---GQLITLKKLNVAHN 138
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 12/63 (19%), Positives = 25/63 (39%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ +L L+ + + S LT +++L L+ + +L L+ LN+ N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 472 FTG 474
Sbjct: 140 IHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 2/76 (2%)
Query: 403 NCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVP-EFLSRLQF 461
CSY + L+LS +G ++ L +Q LD +++L L+
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 462 LRVLNLKGNKFTGPIP 477
L L++
Sbjct: 426 LLYLDISYTNTKIDFD 441
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 14/77 (18%), Positives = 28/77 (36%), Gaps = 3/77 (3%)
Query: 412 PRIISLNLSSSGLT--GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
P + L+LS + L+ G + ++ LDLS N + L+ L+ L+ +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQH 408
Query: 470 NKFTGPIPVELMEKSKN 486
+ +
Sbjct: 409 STLKRVTEFSAFLSLEK 425
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 20/103 (19%), Positives = 37/103 (35%), Gaps = 8/103 (7%)
Query: 412 PRIISLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLR----VLN 466
+ LN++ + + ++ Y SNLT + +DLS N + L L+ L+
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187
Query: 467 LKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKK 509
+ N I + + K L L N + +
Sbjct: 188 MSLNPIDF-IQDQAFQGIKLHELTLR--GNFNSSNIMKTCLQN 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 20/83 (24%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNL 467
+P +SL++S + + + L L L N S N+ + L L L V L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKL-HELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 468 KGNKFTGPIPVELMEKSKNGSLQ 490
+F +E+ E S L
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLC 259
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 11/66 (16%), Positives = 21/66 (31%), Gaps = 5/66 (7%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ +++L+ + + QSL + L L L+ L L NK
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK---SLTLTMNK 339
Query: 472 FTGPIP 477
+
Sbjct: 340 GSISFK 345
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 57/270 (21%), Positives = 95/270 (35%), Gaps = 76/270 (28%)
Query: 570 KITDNFN---KVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSSGQGFKEFEAEVKLLM 622
KI D FN V+ K G+G +L VA+K++ S+ + E++LL
Sbjct: 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLK 88
Query: 623 RVHHRNLTN--------LVGYFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWER 670
V + + + L+ F G +++E + + +L + + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPC 147
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT------------------------ 706
+I QGL+YLH C+ I+H DIKPENILL+
Sbjct: 148 VKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 707 -------------------------ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
E L+ K+AD G + + + T Y
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQ--TRQYRS 261
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771
E + N +D++S + E+ T
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 16/82 (19%), Positives = 21/82 (25%), Gaps = 6/82 (7%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
NC G P L S + L S L + LDL+ + +
Sbjct: 17 YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76
Query: 456 LSRLQFLRVLNLKGNKFTGPIP 477
L L L N
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAE 98
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P++ L+L+ + L + A NL L++ L+LS++ L + + L L+ LNL+GN
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
F + G L+ L +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFC 486
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 18/86 (20%), Positives = 38/86 (44%), Gaps = 2/86 (2%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
+ P + L +G++ L N ++SL L +N +S + L+VL+ +
Sbjct: 102 SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161
Query: 469 GNKFTGPIPVEL--MEKSKNGSLQLS 492
N ++ ++++ N SL L+
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLN 187
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 412 PRIISLNLSS---SGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
P + LNL + L L ++ L LS LS + L+ + ++L
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508
Query: 469 GNKFTGPIPVELMEKSKNGSLQLS 492
N+ T +E + K L L+
Sbjct: 509 HNRLTS-SSIEALSHLKGIYLNLA 531
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 13/66 (19%), Positives = 23/66 (34%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
R+ +L L+++ L LS ++ L +S L + L L L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 472 FTGPIP 477
+
Sbjct: 141 ISSIKL 146
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 23/81 (28%), Positives = 40/81 (49%), Gaps = 1/81 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
R+ L LS L+ ++L ++ +DLS+N L+ + E LS L+ + LNL N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534
Query: 472 FTGPIPVELMEKSKNGSLQLS 492
+ +P L S+ ++ L
Sbjct: 535 ISIILPSLLPILSQQRTINLR 555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 16/72 (22%), Positives = 22/72 (30%), Gaps = 3/72 (4%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV---PEFLSRLQFLRVL 465
+ + LNLS S L L +Q L+L N L L L +L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 466 NLKGNKFTGPIP 477
L +
Sbjct: 482 VLSFCDLSSIDQ 493
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 16/63 (25%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 417 LNLSSSGLT--GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
L+LS + L NL+ +QSL+LS N E L +L+L +
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 475 PIP 477
Sbjct: 415 KDA 417
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+L+ + + + +L L+ N L LS + L+ L
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ + L +L+ L +G N
Sbjct: 117 ISSIDFIPL---HNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 3/87 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV-PEFLSRLQFLRVLNLKGN 470
+ L LS++ SN + L + N+ + L L+ LR L+L +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
++ LQ L++ N
Sbjct: 361 DIET-SDCCNLQLRNLSHLQSLNLSYN 386
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 15/67 (22%), Positives = 23/67 (34%), Gaps = 1/67 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKGN 470
+ SLNLS + ++ LDL+ L + L L+VLNL +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 471 KFTGPIP 477
Sbjct: 436 LLDISSE 442
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 16/66 (24%), Positives = 29/66 (43%), Gaps = 1/66 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+L+++ L+ E+ L L+ ++ L LS N S L L++KGN
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 472 FTGPIP 477
+
Sbjct: 337 KRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 1/63 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ ++LS + LT LS+L I L+L++N +S +P L L R +NL+ N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 472 FTG 474
Sbjct: 559 LDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 12/93 (12%), Positives = 26/93 (27%), Gaps = 7/93 (7%)
Query: 407 KGNDPPRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRV 464
K + + L ++S++L + L+
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282
Query: 465 LNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L+L + +P L +L+ L + N
Sbjct: 283 LDLTATHLSE-LPSGL---VGLSTLKKLVLSAN 311
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 12/86 (13%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF--LRVLNLKGN 470
+SLNL+ + + I P + + QSL+ + + L L + +
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 471 KFTGPIPVELMEKSKNGSLQLSVGDN 496
P + +++ +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKH 264
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 14/71 (19%), Positives = 23/71 (32%), Gaps = 6/71 (8%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSL---SGNVPEFLSRLQFLRVLN 466
SLN + I L N T+ + + S V E L + + +N
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESIN 260
Query: 467 LKGNKFTGPIP 477
L+ + F
Sbjct: 261 LQKHYFFNISS 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 23/65 (35%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P ++ SLNLS +GL + L LDLS N L P L + L+LKGN
Sbjct: 252 PSQLNSLNLSFTGLKQVPKGLPAKL---SVLDLSYNRLDR-NP-SPDELPQVGNLSLKGN 306
Query: 471 KFTGP 475
F
Sbjct: 307 PFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 17/69 (24%), Positives = 25/69 (36%), Gaps = 4/69 (5%)
Query: 409 NDPPRIISLNLSSSGLT---GEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRV 464
P + L L ++G+ G + + +Q LDLS+NSL L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 465 LNLKGNKFT 473
LNL
Sbjct: 258 LNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 17/82 (20%), Positives = 27/82 (32%), Gaps = 7/82 (8%)
Query: 412 PRIISLNLSSSGLTGEI----APYLSNLTLIQSLDLSNN---SLSGNVPEFLSRLQFLRV 464
P + +L+LS + GE A +Q L L N + SG + L+
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 465 LNLKGNKFTGPIPVELMEKSKN 486
L+L N +
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 19/110 (17%), Positives = 35/110 (31%), Gaps = 14/110 (12%)
Query: 402 LNCSYKGNDPPRIISL-----------NLSSSGLTGEIAPYLSNL-TLIQSLDLSNNSLS 449
N G PP ++ N+S + +A L ++ L ++
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 450 GNVPEFLSRLQFLRVLNLKGNKFTGPIPVELM-EKSKNGSLQ-LSVGDNE 497
E + L L+L N G + K +LQ L++ +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 9/82 (10%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQF-----LRV 464
+ L L + +TG P L T + L+L N S + +L+ LQ L+V
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKV 153
Query: 465 LNLKGNKFTGPIPVELMEKSKN 486
L++ E +
Sbjct: 154 LSIAQAHSLN-FSCEQVRVFPA 174
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 16/88 (18%), Positives = 28/88 (31%), Gaps = 7/88 (7%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
N + SNL + ++L N +P+FL L L+ LN+ N+
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 476 IPVELMEKSKNGSL-------QLSVGDN 496
++ +G N
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYN 558
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 20/161 (12%), Positives = 54/161 (33%), Gaps = 15/161 (9%)
Query: 361 FSQSETLHTDVDAVMNMKK-MYGVKRNWQGDPC--APKAYSWDGLN--CSYKG------N 409
++ D A+ + + + G + + +W+ + +
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320
Query: 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
+ R+ L+L+ G G + + LT ++ L +S + + F + +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 470 NKFTGPIPVELMEKSKNGS----LQLSVGDNEELCSSSSDS 506
++ ++ + + LQ ++ N E+ DS
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 17/106 (16%), Positives = 36/106 (33%), Gaps = 10/106 (9%)
Query: 399 WDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS-------GN 451
++CS ++ LS + + + + I ++ LSNN ++
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719
Query: 452 VPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L ++L+ NK T + + + L + V N
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLTS-LSDDF-RATTLPYLSNMDVSYN 763
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 18/111 (16%), Positives = 36/111 (32%), Gaps = 12/111 (10%)
Query: 412 PRIISLNLSS---SGLTGEIA--PYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
P + ++++S S + L + D N + P ++ L L
Sbjct: 753 PYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 467 LKGNKFTGPIPVELMEKSKNGSLQ-LSVGDNEELCSSSSDSCKKEKKNMFV 516
+ N + +L L L + DN + + C + M+V
Sbjct: 813 IGSNDIRK-VDEKLTP-----QLYILDIADNPNISIDVTSVCPYIEAGMYV 857
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 10/88 (11%), Positives = 29/88 (32%), Gaps = 5/88 (5%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT-GP 475
+ + + + ++ + L + +N + V E L L +L++ N
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843
Query: 476 IPVELMEKSKNGSLQLSVGDNEELCSSS 503
+ + + G L +++
Sbjct: 844 VT-SVCPYIEAGMYVLLYDKTQDIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 12/92 (13%)
Query: 416 SLNLSS---SGLTGEIAPYLSNLTLI--QSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
S++ S I+ + + I ++ LS N + E + + + L N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 471 KFTGPIPVELMEKSKNG-----SLQ-LSVGDN 496
T IP ++ L + + N
Sbjct: 708 LMTS-IPENSLKPKDGNYKNTYLLTTIDLRFN 738
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 8/92 (8%)
Query: 408 GNDPPRIISLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF----- 461
++ L S + L ++ ++ S+D S N + +
Sbjct: 615 CAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
Query: 462 LRVLNLKGNKFTGPIPVELMEKSKN-GSLQLS 492
+ L N+ P EL ++ LS
Sbjct: 675 ASTVTLSYNEIQK-FPTELFATGSPISTIILS 705
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 10/79 (12%), Positives = 23/79 (29%), Gaps = 3/79 (3%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE--FLSRLQFLRVLNLKGNKFTG 474
L L + + + + ++ L S+N L +P + + ++ NK
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 475 PIPVELMEKSKNGSLQLSV 493
+ S
Sbjct: 659 EGRNISCSMDDYKGINAST 677
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 14/64 (21%), Positives = 22/64 (34%), Gaps = 2/64 (3%)
Query: 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG-NVPEFLSRLQFLRVLNLKGNK 471
R IS + T +A IQ + N+L L ++ L +L+ NK
Sbjct: 526 RGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK 584
Query: 472 FTGP 475
Sbjct: 585 VRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 24/101 (23%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG-------------------NVPEFL 456
+ ++ +T I+ + LT +Q + +N+ + N
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 457 SRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
S L+ L + L +P L LQ L++ N
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFL---YDLPELQSLNIACN 525
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 11/83 (13%), Positives = 24/83 (28%), Gaps = 5/83 (6%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L+ + + + + L L N + +F + + L NK
Sbjct: 577 LLDCVHNKVR-HL-EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY- 633
Query: 476 IPVELMEKSKNGSLQ-LSVGDNE 497
IP + + + N+
Sbjct: 634 IP-NIFNAKSVYVMGSVDFSYNK 655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 10/91 (10%), Positives = 29/91 (31%), Gaps = 8/91 (8%)
Query: 408 GNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGN------VPEFLSRLQF 461
+ R+ +L + P + + + L + + + + + RL
Sbjct: 392 LDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTK 449
Query: 462 LRVLNLKGNKFTGPIPVELMEKSKNGSLQLS 492
L+++ + FT E + + +
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 64/264 (24%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRV-----HHR 627
+ +G G FG V +D+ AVK++ + K + E +L ++ ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNN 96
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
N+ G F+ ++M LI+E + +L ++++ + E ++ + L YL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR- 154
Query: 688 GCKPPIVHRDIKPENILLTENLEA-------------------------KLADFGLSKVF 722
K + H D+KPENILL + KL DFG F
Sbjct: 155 --KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATF 211
Query: 723 PIGGTHVSTVVAGTPGYLDPE------YFVTDWLNEKSDVYSFGVVLLEIITSQAVIV-R 775
+ +++ T Y PE + + SD++SFG VL E+ T +
Sbjct: 212 --KSDYHGSIIN-TRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 776 NENENIHIIQTV-----TNMIAKG 794
E++ +++++ NM+ +
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEA 286
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 45/238 (18%)
Query: 577 KVLGKGGFGTVYHGY--LDDGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRVHHR---- 627
LG+G FG V +QVA+K++ + K EA E+ +L ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKEN 80
Query: 628 --NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ +F +M + +E + N + L + +A L +L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA-------------------KLADFGLSKVFPIGG 726
H + + H D+KPENIL + ++ADFG S F
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD--H 193
Query: 727 THVSTVVAGTPGYLDPE-YFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHI 783
H +T+VA T Y PE W + DV+S G +L E + + H+
Sbjct: 194 EHHTTIVA-TRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFT-LFQTHENREHL 248
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 19/91 (20%), Positives = 39/91 (42%), Gaps = 3/91 (3%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSL-SGNVPEFLSRLQFLRVLNL 467
+ + L + L + +L ++ L++++N + S +PE+ S L L L+L
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 468 KGNKFTGPIPVEL--MEKSKNGSLQLSVGDN 496
NK +L + + +L L + N
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 14/70 (20%), Positives = 25/70 (35%), Gaps = 1/70 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
++ L+ S L +L + LD+S+ + L L VL + GN
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 471 KFTGPIPVEL 480
F ++
Sbjct: 456 SFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 20/82 (24%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 417 LNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L ++ + P + L + LDLS L P + L L+VLN+ N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS- 508
Query: 476 IPVELMEKSKNGSLQ-LSVGDN 496
+P + ++ SLQ + + N
Sbjct: 509 VPDGIFDRLT--SLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 21/101 (20%), Positives = 32/101 (31%), Gaps = 10/101 (9%)
Query: 403 NCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFL 456
C N P +L+LS + L + + +Q LDLS +
Sbjct: 13 QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 457 SRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L L L L GN + + + LQ L +
Sbjct: 73 QSLSHLSTLILTGNPIQS-LALGAFSGLSS--LQKLVAVET 110
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 12/62 (19%), Positives = 25/62 (40%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ +L L+ + + S L+ +Q L +L+ + L+ L+ LN+ N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 472 FT 473
Sbjct: 136 IQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 13/64 (20%), Positives = 28/64 (43%), Gaps = 1/64 (1%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV-PEFLSRLQFLRVLNLKG 469
+I L++S + + L+ ++ L ++ NS N P+ + L+ L L+L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 470 NKFT 473
+
Sbjct: 480 CQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 3/59 (5%)
Query: 417 LNLSSSGLT--GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L+LS +GL+ G + T ++ LDLS N + + L+ L L+ + +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 4/86 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + L+LS + +L+ + +L L+ N + S L L+ L
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ + K L+ L+V N
Sbjct: 112 LAS-LENFPIGHLKT--LKELNVAHN 134
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 14/56 (25%), Positives = 26/56 (46%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
L+LS L ++L+ +Q L++++N L RL L+ + L N +
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 48/243 (19%), Positives = 95/243 (39%), Gaps = 55/243 (22%)
Query: 577 KVLGKGGFGTVYHGY--LDDGTQVAVKMLSSSSGQGFKEFEA---EVKLLMRVHHRNLTN 631
LG+G FG V G VAVK++ + + EA E+++L ++ + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNS 75
Query: 632 ------LVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
++ +F ++ +++E + + + + + ++A + + +L
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 686 HIGCKPPIVHRDIKPENILLTENLEA-------------------KLADFGLSKVFPIGG 726
H + H D+KPENIL ++ K+ DFG S +
Sbjct: 135 H---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD--D 188
Query: 727 THVSTVVAGTPGYLDPE------YFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN 780
H ST+V+ T Y PE + ++ DV+S G +L+E + +
Sbjct: 189 EHHSTLVS-TRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGFT-VFPTHDSK 240
Query: 781 IHI 783
H+
Sbjct: 241 EHL 243
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 20/97 (20%), Positives = 41/97 (42%), Gaps = 3/97 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ +L+LSS+ L + P + + + L NN L + + L Q L +L+GN
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCK 508
F + K+ ++ ++L + + C
Sbjct: 249 FHCGTLRDFFSKN-QRVQTVAKQTVKKLTGQNEEECT 284
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 17/67 (25%), Positives = 28/67 (41%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
++ S L +A + ++ LDLS N LS L+ L +LNL N +
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 477 PVELMEK 483
+E +
Sbjct: 75 DLESLST 81
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 1/59 (1%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG-NVPEFLSRLQFLRVLNLKGNKFT 473
++ L+++ +T + +Q LDL N + N E + L LNL+ N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+LS + L+ A L+ T ++ L+LS+N L + L LR L+L N
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNY 91
Query: 472 FT 473
Sbjct: 92 VQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 4/77 (5%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
LNL + + ++ +++LDLS+N L+ + + ++L+ NK
Sbjct: 173 HLNLQYNFIY-DV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL- 228
Query: 476 IPVELMEKSKNGSLQLS 492
I L L
Sbjct: 229 IEKALRFSQNLEHFDLR 245
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 10/77 (12%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
LNLSS+ L E L +L+ +++LDL+NN + L + L+ N +
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 476 IPVELMEKSKNGSLQLS 492
+ + KN + L+
Sbjct: 114 VSCSRGQGKKN--IYLA 128
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 7/40 (17%), Positives = 17/40 (42%)
Query: 434 NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
N + ++++SL + ++ L+L GN +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 20/97 (20%), Positives = 42/97 (43%), Gaps = 3/97 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ +L+LSS+ L + P + + + L NN L + + L Q L +L+GN
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCK 508
F + K++ ++ ++L + + C
Sbjct: 249 FHCGTLRDFFSKNQR-VQTVAKQTVKKLTGQNEEECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 16/61 (26%), Positives = 25/61 (40%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
++ S L +A + ++ LDLS N LS L+ L +LNL N +
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74
Query: 477 P 477
Sbjct: 75 D 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 18/62 (29%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+LS + L+ A L+ T ++ L+LS+N L + L LR L+L N
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNY 91
Query: 472 FT 473
Sbjct: 92 VQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 8/47 (17%), Positives = 19/47 (40%)
Query: 434 NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVEL 480
N + ++++SL + ++ L+L GN + +L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL 54
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 412 PRIISLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
R+ L+L + + A ++ ++ L+L N + +V + L+ L+L N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSN 201
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
K + E + +S+ +N
Sbjct: 202 KLAF-MGPEF---QSAAGVTWISLRNN 224
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 13/56 (23%), Positives = 28/56 (50%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
L + +T + P LS LT + LD+S+++ ++ ++ L + ++L N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 16/77 (20%), Positives = 34/77 (44%), Gaps = 2/77 (2%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L +++ T P +S L+ ++ L + ++ + LS L L +L++ +
Sbjct: 70 DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 476 IPVELMEKSKNGSLQLS 492
I ++ K S+ LS
Sbjct: 128 ILTKINTLPKVNSIDLS 144
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 1/68 (1%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L++S S I ++ L + S+DLS N ++ L L L+ LN++ +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174
Query: 476 IPVELMEK 483
+E K
Sbjct: 175 RGIEDFPK 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/85 (18%), Positives = 32/85 (37%), Gaps = 8/85 (9%)
Query: 414 IISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
+ + L++ +T ++ + I+ L ++N + +S L L L + G T
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT 101
Query: 474 GPIPVELMEKSKNGSLQ-LSVGDNE 497
L S SL L + +
Sbjct: 102 SDKIPNL---SGLTSLTLLDISHSA 123
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P++ S++LS +G +I P L L ++SL++ + + + L L
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQT 192
Query: 472 FTG 474
G
Sbjct: 193 IGG 195
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 7/105 (6%)
Query: 416 SLNLSSSGLTGEIAP--YLSNLTLIQSLDLSNNSLSG-NVPEFLSRLQFLRVLNLKGNKF 472
L L GL+ + Y NL + LDLS N + + +L L+ ++ N+
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 473 TGPIPVELMEKSKNGSLQ-LSVGDN--EELCSSSSDSCKKEKKNM 514
+ +E + +L S+ N S C +NM
Sbjct: 161 FL-VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 15/78 (19%), Positives = 25/78 (32%), Gaps = 6/78 (7%)
Query: 402 LNCSYKG-----NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV-PEF 455
+ L LS + + A L +Q L+L + + E
Sbjct: 9 AFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 456 LSRLQFLRVLNLKGNKFT 473
L LR+L+L +K
Sbjct: 69 FRNLPNLRILDLGSSKIY 86
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 5/70 (7%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYL-----SNLTLIQSLDLSNNSLSGNVPEFLSRLQFLR 463
++ P + L L + L L L+ +Q L L++N L+ P S L LR
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 464 VLNLKGNKFT 473
L+L N+ T
Sbjct: 508 GLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 16/72 (22%), Positives = 29/72 (40%), Gaps = 2/72 (2%)
Query: 403 NCSYKGNDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQF 461
++ G + L+LS + + L ++ L+L+ N ++ E L
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 462 LRVLNLKGNKFT 473
L+VLNL N
Sbjct: 316 LQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 14/66 (21%), Positives = 24/66 (36%), Gaps = 1/66 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
++ L L S I NL ++ LDL ++ + P+ L L L L
Sbjct: 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107
Query: 471 KFTGPI 476
+ +
Sbjct: 108 GLSDAV 113
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 4/65 (6%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNV--PEFLSRLQFLRVLNLK 468
P + L+L SS + + P L + L L LS V + L+ L L+L
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 469 GNKFT 473
N+
Sbjct: 132 KNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 7/104 (6%)
Query: 412 PRIISLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF--LRVLNLK 468
+ L+LS + + + P L ++S+D S+N + L LQ L +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 469 GNKFTGPIPV---ELMEKSKNGSLQ-LSVGDNEELCSSSSDSCK 508
N + V + M +N L+ L V N + +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 15/62 (24%), Positives = 27/62 (43%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ LNLS + L + L + +DL N ++ + L+ L+ L+L+ N
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 472 FT 473
T
Sbjct: 374 LT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 17/67 (25%), Positives = 26/67 (38%), Gaps = 2/67 (2%)
Query: 416 SLNLSSSGLTG-EIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKGNKFT 473
++LS + L +I +L + +Q L L+ N S + S L L L N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464
Query: 474 GPIPVEL 480
EL
Sbjct: 465 LAWETEL 471
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 15/74 (20%), Positives = 23/74 (31%), Gaps = 10/74 (13%)
Query: 404 CSYKGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLR 463
CS+ G LT ++ L+ L LS N + L+ L+
Sbjct: 2 CSFDGR------IAFYRFCNLT-QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQ 51
Query: 464 VLNLKGNKFTGPIP 477
+L L I
Sbjct: 52 LLELGSQYTPLTID 65
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 15/63 (23%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ LNL+ + + +IA L +Q L+LS N L L + ++L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 471 KFT 473
Sbjct: 349 HIA 351
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
LN+ S+ ++ +I+ L+NL+ + SL L+NN L E + L L L L N T
Sbjct: 269 MLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 476 IPVELMEK 483
P+ + K
Sbjct: 327 RPLASLSK 334
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 9/82 (10%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L L+ ++ L+NLT + SL+L N + LS + L L + +K
Sbjct: 114 ELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDV 170
Query: 476 IPVELMEKSKNGSLQ-LSVGDN 496
P+ + L LS+ N
Sbjct: 171 TPIANLT-----DLYSLSLNYN 187
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 4/72 (5%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
I L + +T + L I L ++ ++ + + L L LNL GN+
Sbjct: 22 AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQ 77
Query: 472 FTGPIPVELMEK 483
T P+ + K
Sbjct: 78 ITDISPLSNLVK 89
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 15/83 (18%), Positives = 33/83 (39%), Gaps = 8/83 (9%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L + ++ ++ + +LT ++ L++ +N +S L+ L L L L N+
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNE 302
Query: 476 IPVELMEKSKNGSLQ-LSVGDNE 497
+ +L L + N
Sbjct: 303 DMEVI---GGLTNLTTLFLSQNH 322
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 4/71 (5%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
+ I L ++ + I + LT ++ L+L+ N ++ LS L L L +
Sbjct: 41 EELESITKLVVAGEKVA-SI-QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIG 96
Query: 469 GNKFTGPIPVE 479
NK T ++
Sbjct: 97 TNKITDISALQ 107
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 10/83 (12%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
+ +T ++N+T + SL + NN ++ L+ L L L + N+ +
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDI 258
Query: 476 IPVELMEKSKNGSLQ-LSVGDNE 497
V L+ L+VG N+
Sbjct: 259 NAV-----KDLTKLKMLNVGSNQ 276
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 2/58 (3%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
SL L+++ L E + LT + +L LS N ++ P L+ L + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 10/87 (11%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L ++ S + ++NLT + SL L+ N + L+ L L N+
Sbjct: 155 TGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQ 210
Query: 472 FTGPIPVELMEKSKNGSLQ-LSVGDNE 497
T PV + L L +G+N+
Sbjct: 211 ITDITPV-----ANMTRLNSLKIGNNK 232
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
+L + ++ +T L NLT ++ L L+ +++S L+ L + LNL N
Sbjct: 92 NLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD 147
Query: 476 IP 477
+
Sbjct: 148 LS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 11/68 (16%), Positives = 24/68 (35%), Gaps = 4/68 (5%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
+L + + +I P ++L L S++ L+ + L + G K
Sbjct: 4 TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI 59
Query: 476 IPVELMEK 483
+E +
Sbjct: 60 QGIEYLTN 67
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 24/82 (29%), Positives = 37/82 (45%), Gaps = 9/82 (10%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L+L+ LT + +L L L+ LDLS+N L +P L+ L+ L VL N
Sbjct: 446 LHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--- 499
Query: 477 PVELMEKSKNGSLQ-LSVGDNE 497
+ + LQ L + +N
Sbjct: 500 --NVDGVANLPRLQELLLCNNR 519
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 5/64 (7%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF--LSRLQFLRVLNLKG 469
+ L S + L + ++NL +Q L L NN L L L +LNL+G
Sbjct: 486 RCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQG 542
Query: 470 NKFT 473
N
Sbjct: 543 NSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 21/89 (23%), Positives = 35/89 (39%), Gaps = 7/89 (7%)
Query: 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469
DP R L+ S E + ++ L L++ L+ V L +L + L+L
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSH 472
Query: 470 NKFTGPIPVELMEKSKNGSLQ-LSVGDNE 497
N+ +P L + L+ L DN
Sbjct: 473 NRLRA-LPPAL---AALRCLEVLQASDNA 497
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 17/88 (19%), Positives = 34/88 (38%), Gaps = 9/88 (10%)
Query: 392 CAPKAYSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSN 445
C+ + + + C K P L+L + + ++ ++ L+L+
Sbjct: 9 CSAQDRA---VLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNE 65
Query: 446 NSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
N +S P + L LR L L+ N+
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 17/63 (26%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ SL + + L I+ S L ++ L L +L+ E LS L L VL L+
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 471 KFT 473
Sbjct: 187 NIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P + L L+ + ++ + P +NL +++L L +N L + L L L++ N
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN 114
Query: 471 KFT 473
K
Sbjct: 115 KIV 117
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 18/71 (25%), Positives = 30/71 (42%), Gaps = 5/71 (7%)
Query: 407 KGNDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
+ + L L++ GL+ + +L +SL S NSL+ +PE L+ L V N
Sbjct: 66 RDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 467 LKGNKFTGPIP 477
+ P
Sbjct: 121 NNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 23/107 (21%), Positives = 42/107 (39%), Gaps = 30/107 (28%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF--------- 461
PP + L +S++ L ++ P L N + ++ +D+ NNSL +P+ L+F
Sbjct: 130 PPLLEYLGVSNNQLE-KL-PELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLE 186
Query: 462 ----------LRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDNE 497
L + N +P SL+ + G+N
Sbjct: 187 ELPELQNLPFLTAIYADNNSLKK-LPDLP------LSLESIVAGNNI 226
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 27/118 (22%), Positives = 46/118 (38%), Gaps = 33/118 (27%)
Query: 402 LNCSYKG-----NDPPRIISLNLSSSGLTGEIAPYLSNLT-----------------LIQ 439
L + G PP + SL S + LT E+ +L L++
Sbjct: 76 LELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLE 134
Query: 440 SLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L +SNN L +PE FL+++++ N +P SL+ ++ G+N
Sbjct: 135 YLGVSNNQLE-KLPEL-QNSSFLKIIDVDNNSLKK-LPDLP------PSLEFIAAGNN 183
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 16/87 (18%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
PP + LN SS+ + + +L L++SNN L +P RL+ L N
Sbjct: 296 PPNLYYLNASSNEIR-SLCDLPPSLE---ELNVSNNKLI-ELPALPPRLE---RLIASFN 347
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+P +L+ L V N
Sbjct: 348 HLAE-VPELP------QNLKQLHVEYN 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 11/70 (15%), Positives = 28/70 (40%), Gaps = 4/70 (5%)
Query: 414 IISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
+ L + +T ++ ++L + +L + + + L L +N N+ T
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 81
Query: 474 GPIPVELMEK 483
P++ + K
Sbjct: 82 DITPLKNLTK 91
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 8e-06
Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 10/83 (12%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
SL +++ ++ L LT + L L+ N L L+ L L L+L N+ +
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 258
Query: 476 IPVELMEKSKNGSLQ-LSVGDNE 497
P+ S L L +G N+
Sbjct: 259 APL-----SGLTKLTELKLGANQ 276
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 15/68 (22%), Positives = 30/68 (44%), Gaps = 4/68 (5%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L L + ++ +S+LT +Q L NN +S L+ L + L+ N+ +
Sbjct: 313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDL 368
Query: 476 IPVELMEK 483
P+ + +
Sbjct: 369 TPLANLTR 376
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 18/68 (26%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L L ++ ++ L+ LT + +L+L+ N L +S L+ L L L N +
Sbjct: 269 ELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI 324
Query: 476 IPVELMEK 483
PV + K
Sbjct: 325 SPVSSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 17/72 (23%), Positives = 31/72 (43%), Gaps = 4/72 (5%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+L+++ ++ LS LT + L L N +S L+ L L L L N+
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQ 298
Query: 472 FTGPIPVELMEK 483
P+ ++
Sbjct: 299 LEDISPISNLKN 310
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 4/68 (5%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
+N S++ LT L NLT + + ++NN ++ L+ L L L L N+ T
Sbjct: 72 QINFSNNQLTD--ITPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDI 127
Query: 476 IPVELMEK 483
P++ +
Sbjct: 128 DPLKNLTN 135
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-05
Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 11/82 (13%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L L ++ +T L NLT + L+LS+N++S LS L L+ L+ GN+ T
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDL 170
Query: 476 IPVELMEKSKNGSLQ-LSVGDN 496
P+ + +L+ L + N
Sbjct: 171 KPLANLT-----TLERLDISSN 187
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 17/72 (23%), Positives = 34/72 (47%), Gaps = 5/72 (6%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+ + +T L+NLT ++ LD+S+N +S L++L L L N+
Sbjct: 156 TSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQ 210
Query: 472 FTGPIPVELMEK 483
+ P+ ++
Sbjct: 211 ISDITPLGILTN 222
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 18/84 (21%), Positives = 31/84 (36%), Gaps = 8/84 (9%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
L ++ ++ L+NLT I L +N +S P L+ L + L L +T
Sbjct: 335 RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390
Query: 476 IPVELMEKSKNGSLQLSVGDNEEL 499
N S+ +V +
Sbjct: 391 PV----NYKANVSIPNTVKNVTGA 410
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 16/78 (20%), Positives = 28/78 (35%), Gaps = 11/78 (14%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
LN G P I +L + + LT + L +L++S N L+ ++P
Sbjct: 45 LNVGESGLTTLPDCLPAHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLT-SLPVL 99
Query: 456 LSRLQFLRVLNLKGNKFT 473
L L + +
Sbjct: 100 PPGLLELSIFSNPLTHLP 117
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
P + L +S + LT + S L SL + N L+ +PE L L +NL+
Sbjct: 238 VLPSELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 469 GNKFT 473
GN +
Sbjct: 293 GNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 25/88 (28%), Positives = 38/88 (43%), Gaps = 16/88 (18%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P + L + + LT + L Q L +S+N L+ ++P S L L N N
Sbjct: 120 PSGLCKLWIFGNQLT-SLPVLPPGL---QELSVSDNQLA-SLPALPSELCKLWAYN---N 171
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDNE 497
+ T +P+ LQ LSV DN+
Sbjct: 172 QLTS-LPMLP------SGLQELSVSDNQ 192
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 16/89 (17%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
P + L ++ LT + S L + L +S N L+ ++P S L+ L +
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSE---LKELMVS 249
Query: 469 GNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
GN+ T +P+ L LSV N
Sbjct: 250 GNRLTS-LPMLP------SGLLSLSVYRN 271
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 16/90 (17%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468
P + L ++ LT + S L Q L +S+N L+ ++P S L L N
Sbjct: 158 ALPSELCKLWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKLWAYN-- 210
Query: 469 GNKFTGPIPVELMEKSKNGSLQ-LSVGDNE 497
N+ T +P L+ L V N
Sbjct: 211 -NRLT-SLPALP------SGLKELIVSGNR 232
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 21/164 (12%), Positives = 48/164 (29%), Gaps = 24/164 (14%)
Query: 417 LNLSSSGLTG---EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L++S++ L + N ++ ++PE + L + L+ N +
Sbjct: 185 LDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243
Query: 474 GPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLFFLTAL 533
I L +++ + G S + +
Sbjct: 244 SRIRESLSQQT---AQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA-------------- 286
Query: 534 AMIWWSLKRRKDRAAILNAHGSLEFENRHFTYSEVLKITDNFNK 577
W+ ++ D + I +A E N + + L T +
Sbjct: 287 ---WFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARN 327
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 22/102 (21%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
L + N PP+I L ++ + L + ++L + LD +N LS +PE
Sbjct: 64 LQLNRLNLSSLPDNLPPQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPEL 118
Query: 456 LSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ L+ L++ N+ T +P L+ ++ +N
Sbjct: 119 PASLK---HLDVDNNQLTM-LPELP------ALLEYINADNN 150
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 3/67 (4%)
Query: 409 NDPPRIISLNLSSSGLT--GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
P + +L LS + L + L L + SLD+S N+ +P+ + +R LN
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 467 LKGNKFT 473
L
Sbjct: 417 LSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 15/79 (18%), Positives = 29/79 (36%), Gaps = 8/79 (10%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPE 454
+ + + SL+LS + +T I L +Q L L ++ ++ +
Sbjct: 10 CDGRSRSFTSIPSGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGD 68
Query: 455 FLSRLQFLRVLNLKGNKFT 473
L L L+L N +
Sbjct: 69 AFYSLGSLEHLDLSDNHLS 87
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 11/65 (16%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV---PEFLSRLQFLRVLNLK 468
++ + + +S + + +L ++ LDLS N + L+ L L
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 469 GNKFT 473
N
Sbjct: 370 QNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 1/82 (1%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L++ L +++ S L ++ + + N+ + F L+ L L+L N
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 477 PVELMEKSKNGSLQ-LSVGDNE 497
K SLQ L + N
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNH 372
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 20/63 (31%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ L L SS + I +L ++ LDLS+N LS + L L+ LNL GN
Sbjct: 50 ANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108
Query: 471 KFT 473
+
Sbjct: 109 PYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 18/103 (17%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE- 454
LN S G P + L++S++ L + +L L Q L +S N L +P+
Sbjct: 415 LNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLK-TLPDA 469
Query: 455 -FLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDN 496
L V+ + N+ +P + ++ + ++ + N
Sbjct: 470 SLFPVLL---VMKISRNQLKS-VPDGIFDRLTSLQ-KIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 15/105 (14%), Positives = 31/105 (29%), Gaps = 2/105 (1%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ L + + L L ++ I L L + + + F L +R L L+
Sbjct: 148 TSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 471 KFTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMF 515
L + ++ L S + K + +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 9/86 (10%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPE 454
+ CS G + PP L+L ++ +T EI NL + +L L NN +S P
Sbjct: 36 VQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPG 94
Query: 455 FLSRLQFLRVLNLKGNKFTGPIPVEL 480
+ L L L L N+ +P ++
Sbjct: 95 AFAPLVKLERLYLSKNQLKE-LPEKM 119
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 16/63 (25%), Positives = 32/63 (50%), Gaps = 3/63 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ L LS + ++ + L+N ++ L L+NN L VP L+ ++++V+ L N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 471 KFT 473
+
Sbjct: 274 NIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 14/66 (21%), Positives = 31/66 (46%), Gaps = 7/66 (10%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG------NVPEFLSRLQFLRVL 465
P + L+L+++ L ++ L++ IQ + L NN++S P + ++ +
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 466 NLKGNK 471
+L N
Sbjct: 299 SLFSNP 304
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 15/57 (26%), Positives = 25/57 (43%), Gaps = 2/57 (3%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L +S++ L + Y + ++ LDLS+N L +V + L L L N
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 15/58 (25%), Positives = 24/58 (41%), Gaps = 2/58 (3%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L L + LT +L N + +DLS N L + ++Q L L + N+
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 9/67 (13%), Positives = 25/67 (37%), Gaps = 2/67 (2%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
N + ++ T ++ ++TL + + N+++ L + + +LN
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81
Query: 467 LKGNKFT 473
L +
Sbjct: 82 LNDLQIE 88
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
++ LNL+ + EI Y + IQ L + N++ P + L VL L+ N
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 471 KFT 473
+
Sbjct: 134 DLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYL-SNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P + L L + L+ + + N + +L +SNN+L + L+ L L N
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 471 KFT 473
+ T
Sbjct: 182 RLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 6/63 (9%), Positives = 22/63 (34%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ +S + ++ L + ++ L+L++ + + ++ L + N
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 471 KFT 473
Sbjct: 110 AIR 112
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 8/90 (8%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + L+LS + L + +++L L +NS+ + LS L+ L L N
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 356
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNEELCS 501
+ L + +V D ++ C
Sbjct: 357 WDCNSLRALFRN----VARPAVDDADQHCK 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 15/58 (25%), Positives = 25/58 (43%), Gaps = 2/58 (3%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L +S++ L + Y + ++ LDLS+N L +V + L L L N
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 15/58 (25%), Positives = 25/58 (43%), Gaps = 2/58 (3%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L L + LT + +L N + +DLS N L + ++Q L L + N+
Sbjct: 230 ILKLQHNNLT-DT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
++ LNL+ + EI Y + IQ L + N++ P + L VL L+ N
Sbjct: 69 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 127
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDN 496
+ +P + L LS+ +N
Sbjct: 128 DLSS-LPRGIF--HNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 9/67 (13%), Positives = 25/67 (37%), Gaps = 2/67 (2%)
Query: 409 NDPPRIISLNLSSSGLTGEIAPYLSNLTL--IQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
N + ++ T ++ ++TL + + N+++ L + + +LN
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 75
Query: 467 LKGNKFT 473
L +
Sbjct: 76 LNDLQIE 82
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYL-SNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P + L L + L+ + + N + +L +SNN+L + L+ L L N
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 471 KFT 473
+ T
Sbjct: 176 RLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
P + L+LS + L + +++L L +NS+ + LS L+ L L N
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 350
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNEELCSSSS 504
+ L + +V D ++ C
Sbjct: 351 WDCNSLRALF----RNVARPAVDDADQHCKIDY 379
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 6/59 (10%), Positives = 22/59 (37%), Gaps = 2/59 (3%)
Query: 416 SLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
+ +S + ++ L + ++ L+L++ + + ++ L + N
Sbjct: 49 IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 9/86 (10%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPE 454
+ CS G P L+L ++ ++ E+ L + +L L NN +S +
Sbjct: 38 VQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEK 96
Query: 455 FLSRLQFLRVLNLKGNKFTGPIPVEL 480
S L+ L+ L + N IP L
Sbjct: 97 AFSPLRKLQKLYISKNHLVE-IPPNL 121
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 13/89 (14%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG-NKFTG 474
SL + +S L+ + P + +L ++ LDL + N P L+ L LK +
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 475 PIPVELMEKSKNGSLQ----LSVGDNEEL 499
+P+++ L L + L
Sbjct: 269 -LPLDI------HRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 17/94 (18%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLI--QSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
+ L A L + T +L+L + L P+ RL L+ + +
Sbjct: 61 ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME 118
Query: 475 PIPVELMEKSKNGSLQ----LSVGDN--EELCSS 502
+P + L++ N L +S
Sbjct: 119 -LPDTM------QQFAGLETLTLARNPLRALPAS 145
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 15/76 (19%), Positives = 28/76 (36%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L+L P ++ L L + S +P + RL L L+L+G +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 477 PVELMEKSKNGSLQLS 492
P + + N + +
Sbjct: 294 PSLIAQLPANCIILVP 309
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 14/63 (22%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P ++ L+L I+ L ++ L+L ++ ++P + L L L + GN
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGN 228
Query: 471 KFT 473
F
Sbjct: 229 HFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 19/89 (21%), Positives = 31/89 (34%), Gaps = 11/89 (12%)
Query: 392 CAPKAYSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLS 444
C+ + + C+ +G P LNL + + I +L ++ L L
Sbjct: 52 CSNQFSK---VVCTRRGLSEVPQGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLG 107
Query: 445 NNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
NS+ + L L L L N T
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLT 136
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 22/63 (34%), Positives = 36/63 (57%), Gaps = 3/63 (4%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
I+ LNLSS+ LTG + L ++ LDL NN + ++P+ ++ LQ L+ LN+ N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483
Query: 471 KFT 473
+
Sbjct: 484 QLK 486
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 15/63 (23%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
P + L+L I+ L+ ++ L+L+ +L +P + L L L+L GN
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGN 217
Query: 471 KFT 473
+
Sbjct: 218 HLS 220
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 18/89 (20%), Positives = 29/89 (32%), Gaps = 11/89 (12%)
Query: 392 CAPKAYSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLS 444
C+ + + C K LNL + + I +L ++ L LS
Sbjct: 41 CSNQFSK---VICVRKNLREVPDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLS 96
Query: 445 NNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
N + + L L L L N+ T
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLT 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 29/117 (24%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 375 MNMKKMYGVKRNWQGDPCAPKAYSWDGLNCS-----YKGNDPPRIISLNLSSSGLTGEIA 429
M M + ++ + P K D + ++ + L+ + GLT IA
Sbjct: 1 MEMGRRIHLELRNR-TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA 58
Query: 430 PYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486
L L ++ L+LS+N +SG + + L LNL GNK +E ++K +N
Sbjct: 59 N-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 16/99 (16%), Positives = 44/99 (44%), Gaps = 10/99 (10%)
Query: 407 KGNDPPRIISLNLSSSGLTGEIAPYLSN---LTLIQSLDLSNNSLSGN----VPEFLSRL 459
+ P + L + + + L ++++D+S L+ + + + ++
Sbjct: 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKI 306
Query: 460 QFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEE 498
+ L+ +N+K N + + EL K+ +++ V D++E
Sbjct: 307 KHLKFINMKYNYLSDEMKKEL---QKSLPMKIDVSDSQE 342
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 20/63 (31%), Positives = 36/63 (57%), Gaps = 3/63 (4%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
++SLN+SS+ LT I L I+ LDL +N + ++P+ + +L+ L+ LN+ N
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454
Query: 471 KFT 473
+
Sbjct: 455 QLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 17/57 (29%), Positives = 23/57 (40%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
N + SG S ++ LD SNN L+ V E L L L L+ N+
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 15/78 (19%), Positives = 32/78 (41%), Gaps = 6/78 (7%)
Query: 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF 455
++ S G + + LN+S + ++ + +L+ ++ L +S+N +
Sbjct: 5 VDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64
Query: 456 LSRLQFLRVLNLKGNKFT 473
Q L L+L NK
Sbjct: 65 FKFNQELEYLDLSHNKLV 82
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 18/64 (28%), Positives = 31/64 (48%), Gaps = 3/64 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS--GNVPEFLSRLQFLRVLNLKG 469
P++ L LS + + G + L + L+LS N L + E L +L+ L+ L+L
Sbjct: 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFN 129
Query: 470 NKFT 473
+ T
Sbjct: 130 CEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 19/62 (30%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ L+L + GL ++ L L ++ L+LS N + G + +L L LNL GNK
Sbjct: 49 VNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106
Query: 472 FT 473
Sbjct: 107 LK 108
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 20/62 (32%), Positives = 36/62 (58%), Gaps = 4/62 (6%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ SL+L +G++ +I L +L ++SL L NN ++ LSRL L L+L+ N+
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 167
Query: 472 FT 473
+
Sbjct: 168 IS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 26/117 (22%), Positives = 53/117 (45%), Gaps = 4/117 (3%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
++ +L+L + ++ +I P L+ LT +Q+L LS N +S ++ L+ L+ L VL L +
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQE 211
Query: 472 FTGPIPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKKEKKNMFVIPLVASAVSLLF 528
+++ + G S D ++ + +P + VS +F
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIF 268
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 15/58 (25%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 417 LNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473
L+LS L +++P ++L+ +Q L++S+N+ L L+VL+ N
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 12/64 (18%), Positives = 26/64 (40%), Gaps = 3/64 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPY-LSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKG 469
+I L++S + + L+ ++ L ++ NS N + L+ L L+L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 470 NKFT 473
+
Sbjct: 185 CQLE 188
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 10/81 (12%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
+ + G +++ T + LD ++ + LS+ L L L + T +
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L 333
Query: 477 PVELMEKSKNGSLQ-LSVGDN 496
V S N L+ LS +
Sbjct: 334 DV-----SHNTKLKSLSCVNA 349
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 16/64 (25%), Positives = 31/64 (48%), Gaps = 3/64 (4%)
Query: 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS--GNVPEFLSRLQFLRVLNLKG 469
R+ +L ++++ + L + L L+NNSL G++ + L+ L+ L L +
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILR 122
Query: 470 NKFT 473
N T
Sbjct: 123 NPVT 126
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 858 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.55 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.48 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.44 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.39 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.32 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.27 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.24 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.21 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.17 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.14 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.12 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.12 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.11 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.97 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 98.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.95 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.92 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.91 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 98.91 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.89 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.88 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 98.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.86 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.79 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.79 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 98.78 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.76 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 98.75 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 98.73 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.71 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.7 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.69 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.69 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.68 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 98.68 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.67 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.66 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.66 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.64 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.63 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.62 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 98.62 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.62 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 98.6 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 98.58 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.58 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.57 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.57 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.56 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.55 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.55 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.55 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.55 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.53 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 98.53 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.51 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.5 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.5 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 98.5 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.48 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.48 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.48 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.48 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.45 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.43 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.42 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.42 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.41 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.4 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.39 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.39 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.38 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.36 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.34 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.33 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.31 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.29 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.26 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.2 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.2 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.2 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.11 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.11 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.1 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.06 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.06 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.06 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.04 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.03 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.01 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.0 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 97.99 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.99 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.98 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 97.98 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.96 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.95 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.95 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.93 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.89 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 97.87 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 97.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 97.83 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.82 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.82 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 97.8 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 97.79 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 97.71 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.67 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.58 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.52 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.37 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.35 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.22 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.03 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 96.97 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.82 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.7 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.4 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.24 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.23 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.19 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.18 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.93 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.83 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 95.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.22 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 94.89 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 94.74 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 94.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 91.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 89.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.34 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 86.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 83.78 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.33 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.39 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=440.66 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=211.6
Q ss_pred HHHhhccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCee
Q 043526 570 KITDNFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 570 ~~t~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 642 (858)
..+..|.+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 344567789999999999999863 578899999975533 3457899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 643 GLIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
++|||||++|+|.++|+... ...++|.++++|+.|||+||+||| +.+|+||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCC
Confidence 99999999999999996532 246899999999999999999999 8899999999999999999
Q ss_pred CCEEEeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHH
Q 043526 709 LEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQT 786 (858)
Q Consensus 709 ~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~ 786 (858)
+.+||+|||+++....... .......||+.|||||.+.++.++.++|||||||++|||+| |+.||..... .++.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~-- 257 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVV-- 257 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHH--
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHH--
Confidence 9999999999987643322 22334578999999999999999999999999999999999 8999975432 1222
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..+.++... ..+......+.+|+.+||+.||++||||+||+++|+.
T Consensus 258 --~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 258 --EMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp --HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --HHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 223333211 1233445678899999999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=441.74 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=206.0
Q ss_pred ccccccccCceEEEEEEEC------CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999864 4789999999877666778899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcc-------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEee
Q 043526 649 MANGNLKQLLSDEK-------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLAD 715 (858)
Q Consensus 649 ~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~D 715 (858)
|++|+|.++++... ...++|.++++|+.|||+||+||| +.+|+||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcc
Confidence 99999999997643 236999999999999999999999 88999999999999999999999999
Q ss_pred ecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhc
Q 043526 716 FGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAK 793 (858)
Q Consensus 716 FGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~ 793 (858)
||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+.. .+.+
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~----~i~~ 275 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAID----CITQ 275 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHH----HHHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHc
Confidence 999987654332 22334679999999999999999999999999999999999 8999975432 11222 2222
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+.. ...+.....++.+|+.+||+.||++||||+||+++|+.+.+
T Consensus 276 g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 GRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 211 11223344578899999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=438.91 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=212.0
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||+||+|++. +|+.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 35688999999999999864 478899999987766677889999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcc-----------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeee
Q 043526 648 YMANGNLKQLLSDEK-----------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716 (858)
Q Consensus 648 y~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DF 716 (858)
||++|+|.++|+... ...++|.++++|+.|||+||+||| +++|+||||||+||||++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCc
Confidence 999999999997642 346999999999999999999999 889999999999999999999999999
Q ss_pred cCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcC
Q 043526 717 GLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKG 794 (858)
Q Consensus 717 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~ 794 (858)
|+|+........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||..... .++. ..+.++
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~----~~i~~~ 246 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVI----ECITQG 246 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHH----HHHHHT
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHH----HHHHcC
Confidence 999876543322 2233468999999999999999999999999999999999 8999976432 1222 222222
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
... ..+.....++.+|+.+||+.||++||||+||++.|+++.+
T Consensus 247 ~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 RVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 211 1223345578899999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=427.56 Aligned_cols=254 Identities=28% Similarity=0.496 Sum_probs=200.6
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||+||+|++++ .||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+||||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 356789999999999999753 59999987543 3345789999999999999999999998865 568999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC-ccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~-~~~~ 730 (858)
|+|.++|+..+ ..++|.+++.|+.|||+||+||| +.+|+||||||+||||++++.+||+|||+|+...... ....
T Consensus 116 GsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 116 SSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99999997543 46999999999999999999999 8899999999999999999999999999998765332 2233
Q ss_pred ecccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TVVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
....||+.|||||++.. +.++.++|||||||+||||+||+.||...... ..+...+..+.. .+.+ ..
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----~~~~~~~~~~~~----~p~~-~~ 261 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----DQIIFMVGRGYA----SPDL-SK 261 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHTTCC----CCCS-TT
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcCCC----CCCc-cc
Confidence 45679999999999863 46899999999999999999999999754321 112222222211 1111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
.+......+.+|+.+||+.+|++||||+||+++|+.+
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2233456788999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=418.26 Aligned_cols=267 Identities=25% Similarity=0.374 Sum_probs=200.8
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC----eeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN----NMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~Ey~ 649 (858)
.+.+.||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++++|.+++ .++||||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 3467899999999999998 6899999999654221 122345666667889999999999998764 579999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC-----CCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG-----CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
++|+|.++|+.. .++|.++++++.|+++||+|||+. ..++|+||||||+||||++++.+||+|||+++....
T Consensus 84 ~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 84 EHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999999754 589999999999999999999943 134999999999999999999999999999988754
Q ss_pred CCcce---eecccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHhCCCccccCCCccc---------cHHHH
Q 043526 725 GGTHV---STVVAGTPGYLDPEYFVTD------WLNEKSDVYSFGVVLLEIITSQAVIVRNENENI---------HIIQT 786 (858)
Q Consensus 725 ~~~~~---~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~---------~l~~~ 786 (858)
..... .....||+.|||||++.+. .++.++|||||||++|||+||++|+........ .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 43322 2235799999999998754 367899999999999999999887754322111 01122
Q ss_pred HHHHHhcCCchhhhchhhcCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 787 VTNMIAKGDIENIVDSCLRGG-FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+...+.++.. ++.+... .+.+....+.+|+.+||+.||++||||+||++.|+++.+++.
T Consensus 241 ~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 241 MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 2222222111 1111111 123456678899999999999999999999999999776543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=416.74 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=205.9
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.+.||+|+||.||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+++..+||||||++|+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 3467999999999999965 799999999975432 2579999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCcc----
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTH---- 728 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~---- 728 (858)
|.++|+... .+++.++..++.||+.||+||| +.+|+||||||+||||+.++ .+||+|||+|+.+......
T Consensus 137 L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 137 LGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999997653 6999999999999999999999 89999999999999999987 5999999999987543221
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|||||.+.+..++.++|||||||++|||+||+.||....... +...+. .+... + ...
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~----~~~~~------~-~~~ 278 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIA----SEPPP------I-REI 278 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHH----HSCCG------G-GGS
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHH----cCCCC------c-hhc
Confidence 1233579999999999999999999999999999999999999997644322 111111 11110 0 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+......+.+++.+||+.||++|||++|++++|.+.++...
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 22344578899999999999999999999999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=423.60 Aligned_cols=259 Identities=26% Similarity=0.377 Sum_probs=211.6
Q ss_pred hhccccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhccc-ceeeeeeeeeeeC-CeeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHH-RNLTNLVGYFIED-NNMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~-~~~~ 643 (858)
..+.+.||+|+||+||+|.+. .++.||||++...... ..++|.+|+++|.+++| ||||+++|+|.+. +..+
T Consensus 66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~ 145 (353)
T 4ase_A 66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 145 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence 355689999999999999864 2468999999765433 45679999999999965 8999999999765 5689
Q ss_pred EEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 644 LIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
+|||||++|+|.++|+..+ ...++|.+++.++.|||+||+||| +++|+||||||+|||+++++
T Consensus 146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCC
Confidence 9999999999999997643 235899999999999999999999 89999999999999999999
Q ss_pred CEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||....... .+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-----~~ 297 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EF 297 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence 9999999999977544333 3344578999999999999999999999999999999998 899997544221 12
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
...+.++.. ...+.....++.+++.+||+.||++|||++||+++|+++++..
T Consensus 298 ~~~i~~g~~---------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 298 CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHcCCC---------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 222333221 1122233457889999999999999999999999999987643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=422.92 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=201.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||||+
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 44578999999999999964 79999999997553 2345679999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.++|...+...+++.+++.|+.||+.||+||| +.+|+||||||+||||++++.+||+|||+|+...... ...
T Consensus 107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 182 (350)
T 4b9d_A 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELA 182 (350)
T ss_dssp TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-HHH
T ss_pred CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-ccc
Confidence 999999998766667899999999999999999999 8999999999999999999999999999998764221 122
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....||+.|||||.+.+..++.++|||||||++|||+||+.||..... .+.+.... .+... ..+.
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~-~~~~~---------~~~~ 247 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLKII-SGSFP---------PVSL 247 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH-HTCCC---------CCCT
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHH-cCCCC---------CCCc
Confidence 345799999999999999999999999999999999999999975431 12222221 22111 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....++.+|+.+||+.||++|||++|++++
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 334578899999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=416.58 Aligned_cols=246 Identities=20% Similarity=0.328 Sum_probs=206.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++|+
T Consensus 78 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 78 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred EeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 3467999999999999975 799999999987666667789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++... .+++.++..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus 158 L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~ 230 (346)
T 4fih_A 158 LTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 230 (346)
T ss_dssp HHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccc
Confidence 99999653 5899999999999999999999 89999999999999999999999999999987754332 23456
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.||+.|||||.+.+..++.++|||||||++|||++|+.||.... ...+...+ .++.. +.+ .......
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i----~~~~~-----~~~--~~~~~~s 297 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMI----RDNLP-----PRL--KNLHKVS 297 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHH----HHSSC-----CCC--SCGGGSC
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHH----HcCCC-----CCC--CccccCC
Confidence 79999999999999999999999999999999999999997533 11222211 11110 001 0112334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.++.+++.+||+.||++|||++|++++
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 578899999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=404.36 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=197.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~ 646 (858)
.+.+.||+|+||+||+|... +|+.||||++.... ....+.|.+|++++++++|||||+++++|.. ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999965 78999999996542 3345679999999999999999999999875 34589999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEc-CCCCEEEeeecCccccc
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLT-ENLEAKLADFGLSKVFP 723 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~ 723 (858)
|||++|+|.+++... ..+++..+..|+.||+.||+||| +.+ |+||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999764 36899999999999999999999 666 99999999999998 47999999999998643
Q ss_pred CCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
. .......||+.|||||.+.+ .++.++|||||||++|||+||+.||...... ..+...+..+.....++
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~-- 252 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPASFD-- 252 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCGGGG--
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHcCCCCCCCC--
Confidence 2 22345679999999998864 6999999999999999999999999654321 11222222221111111
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+||+.||++|||++|++++
T Consensus 253 ------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123468899999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=409.37 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=206.3
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 455689999999999999964 7999999999743 234457899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 114 ~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 114 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999997643 6999999999999999999999 89999999999999999999999999999998754332
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.......||+.|||||.+.+..++.++||||+||++|||+||+.||..... ..+.. .+..+.. .
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~----~i~~~~~----------~ 252 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFA----KIIKLEY----------D 252 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHTCC----------C
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHHcCCC----------C
Confidence 234456899999999999999999999999999999999999999975431 11111 1222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
++.....++.+++.+||+.||++|||++|+..
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 12233457889999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=417.82 Aligned_cols=247 Identities=20% Similarity=0.336 Sum_probs=207.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++.++||||||++|
T Consensus 154 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG 233 (423)
T 4fie_A 154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 233 (423)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCC
Confidence 34578999999999999975 79999999998776667788999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 234 ~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 234 ALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp EHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred cHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 999999643 5899999999999999999999 89999999999999999999999999999987754332 2345
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.+||+.|||||.+.+..++.++|||||||++|||++|+.||.... ...+... +..+.. +.+. .....
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~----i~~~~~-----~~~~--~~~~~ 373 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKM----IRDNLP-----PRLK--NLHKV 373 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHH----HHHSCC-----CCCS--CTTSS
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHH----HHcCCC-----CCCc--ccccC
Confidence 679999999999999999999999999999999999999996533 1122221 221111 1111 11223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..++.+|+.+||+.||++|||++|++++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4578899999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=394.90 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=189.6
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++++++|||||++++++.+++..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 34568899999999999996 479999999997542 23456799999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+ +|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 95 A-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp C-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred C-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 9 67999999754 36999999999999999999999 8999999999999999999999999999998764332
Q ss_pred eeecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......||+.|||||.+.+..+ +.++||||+||++|||+||+.||..... .... ..+..+.. .
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~-~~i~~~~~----------~ 230 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLF-KNISNGVY----------T 230 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-HHHHHTCC----------C
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHH-HHHHcCCC----------C
Confidence 2234679999999999988765 5799999999999999999999975331 1111 12222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.....++.+++.+|++.||++|||++|++++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 122234568899999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=402.22 Aligned_cols=245 Identities=28% Similarity=0.343 Sum_probs=194.8
Q ss_pred hhccccccccCceEEEEEEEC----CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
+++.+.||+|+||+||+|+.. +++.||||+++... .....++.+|++++++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 455689999999999999852 57899999997542 223456889999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 106 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp CCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999997654 6999999999999999999999 8999999999999999999999999999998654332
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
. ......||+.|||||.+.+..++.++||||+||++|||+||+.||..... ..+. .. +.++..
T Consensus 181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~---~~-i~~~~~---------- 243 (304)
T 3ubd_A 181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETM---TM-ILKAKL---------- 243 (304)
T ss_dssp C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HH-HHHCCC----------
T ss_pred c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHH---HH-HHcCCC----------
Confidence 2 23346799999999999999999999999999999999999999975431 1111 11 112211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPN-----MNEVVT 839 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~ 839 (858)
..+.....++.+++.+||+.||++||| ++|+++
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112233457889999999999999998 466665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=388.18 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=186.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCC-----------
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN----------- 640 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----------- 640 (858)
++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 44578999999999999965 7999999999755433 4467899999999999999999999987654
Q ss_pred -eeEEEEeeccCCChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 641 -NMGLIYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 641 -~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
..++||||+++|+|.+++.... ....++..++.|+.||++||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 3689999999999999997654 224566778999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-----------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHH
Q 043526 719 SKVFPIGGTH-----------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 719 a~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v 787 (858)
|+.+...... ......||+.|||||.+.+..++.++|||||||++|||++ ||... .+....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHHHHH
Confidence 9887543221 1123569999999999999999999999999999999997 66421 1111111
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. .+......... ......+.+++.+||+.||++|||+.|++++
T Consensus 238 ~-~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 T-DVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-HHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H-HHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 11222111111 1223456789999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=380.27 Aligned_cols=284 Identities=39% Similarity=0.697 Sum_probs=245.8
Q ss_pred ccccCHHHHHHHHhhcc--ccccccCceEEEEEEECCCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeee
Q 043526 560 NRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYF 636 (858)
Q Consensus 560 ~~~~~~~el~~~t~~f~--~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 636 (858)
.+.+++.++...+++|. +.||+|+||.||+|...+|+.||||++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 35678888888877774 78999999999999988899999999976533 2345789999999999999999999999
Q ss_pred eeCCeeEEEEeeccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 637 IEDNNMGLIYEYMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 637 ~~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
...+..++||||+++|+|.+++.... ...++|..+..++.|++.||+|||..+..+|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997654 3359999999999999999999994434499999999999999999999999
Q ss_pred eecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCcccc---CCCccccHHHHHHHHH
Q 043526 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVR---NENENIHIIQTVTNMI 791 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~---~~~~~~~l~~~v~~~~ 791 (858)
|||+++..............||+.|+|||.+.+..++.++||||||++++||++|+.||.. .......+..|+....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999988765555555556799999999999888899999999999999999999999963 2234556778888777
Q ss_pred hcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 792 AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 792 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.......+.+..+....+.+....+.+++.+|++.+|.+|||++||+++|++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 7777888888888888888899999999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=375.47 Aligned_cols=269 Identities=45% Similarity=0.720 Sum_probs=235.0
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
.+.||+|+||.||+|..++|+.||||++........+.+.+|++++++++||||+++++++..++..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 47899999999999998889999999998777777788999999999999999999999999999999999999999999
Q ss_pred HHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC-cceeec
Q 043526 656 QLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVSTV 732 (858)
Q Consensus 656 ~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~ 732 (858)
+++.... ...++|.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 200 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence 9996544 235899999999999999999999 8899999999999999999999999999998654322 222334
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCC-ccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN-ENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~-~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..||+.|+|||.+.+..++.++||||||++++||++|+.||..... +......|.......+.+...+++.+......+
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHH
Confidence 4689999999999988999999999999999999999999976543 334566676666666777777777776677788
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
....+.+++.+|++.+|++||+++|++++|+.++..
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 889999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=378.47 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=195.7
Q ss_pred hccccccccCceEEEEEEEC----CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++.+ +|||||++++++.+++..++||||
T Consensus 24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 44688999999999999853 57889999986543 346788999999998 699999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCcccccCCCc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~~~~~ 727 (858)
+++|+|.+++. .+++.++..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 102 ~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 102 LEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred CCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999999983 4889999999999999999999 8999999999999999977 7999999999986533211
Q ss_pred ---------------------------ceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCc
Q 043526 728 ---------------------------HVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENE 779 (858)
Q Consensus 728 ---------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~ 779 (858)
......+||+.|+|||.+.+. .++.++||||+||+++||+||+.||....++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 111234799999999998765 5899999999999999999999999765543
Q ss_pred cccHHHHHHHHHhc----------------------CCchhhhchh---------hc----C-----CCCHHHHHHHHHH
Q 043526 780 NIHIIQTVTNMIAK----------------------GDIENIVDSC---------LR----G-----GFEIESAWRAVEL 819 (858)
Q Consensus 780 ~~~l~~~v~~~~~~----------------------~~~~~~~d~~---------l~----~-----~~~~~~~~~l~~l 819 (858)
...+..... .... .......... +. . ........++++|
T Consensus 254 ~~~l~~I~~-~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 254 LTALAQIMT-IRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHH-HHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHH-hcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 322222111 0000 0000000000 00 0 0001123467899
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 043526 820 AVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 820 ~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.+||+.||++|||++|++++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=382.63 Aligned_cols=259 Identities=21% Similarity=0.346 Sum_probs=198.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeee------CCeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIE------DNNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~~l 644 (858)
.+.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+..++
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 44578999999999999964 799999999975432 234678899999999999999999998764 357899
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
|||||+ |+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 137 vmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999996 6899999654 47999999999999999999999 89999999999999999999999999999987643
Q ss_pred CC---cceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch---
Q 043526 725 GG---THVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE--- 797 (858)
Q Consensus 725 ~~---~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~--- 797 (858)
.. ........||+.|||||.+.+. .++.++||||+||+++||++|+.||.... ..+....+..........
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCCCCGGGTC
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhcCCCChHHhh
Confidence 21 1223456899999999998764 56899999999999999999999997543 222222222221111000
Q ss_pred --------hhhchhh-cCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 --------NIVDSCL-RGGFEI-----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 --------~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.... ....+. ....++++|+.+||+.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000011 123568899999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=392.95 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=206.2
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..++|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 345688999999999999965 7999999999876655667889999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC--CCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN--LEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~--~~~kL~DFGla~~~~~~~~~~ 729 (858)
|+|.++|.... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+++.+.... .
T Consensus 239 g~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~ 312 (573)
T 3uto_A 239 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312 (573)
T ss_dssp CBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence 99999996433 46999999999999999999999 8999999999999999854 899999999999875433 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|||||.+.+..++.++||||+||++|||++|+.||...... .. .. .+..+... +.+.. .
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~---~~-~i~~~~~~-~~~~~-----~ 380 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ET---LR-NVKSCDWN-MDDSA-----F 380 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HH---HH-HHHTTCCC-CCSGG-----G
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HH---HH-HHHhCCCC-CCccc-----c
Confidence 33457999999999999999999999999999999999999999754321 11 11 11121110 00000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+|+.+||+.||++||+++|++++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1224567899999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.11 Aligned_cols=279 Identities=34% Similarity=0.603 Sum_probs=227.9
Q ss_pred ccccCHHHHHHHHhhcc--------ccccccCceEEEEEEECCCCEEEEEEeccCC----CcchHhHHHHHHHHHhcccc
Q 043526 560 NRHFTYSEVLKITDNFN--------KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRVHHR 627 (858)
Q Consensus 560 ~~~~~~~el~~~t~~f~--------~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~Hp 627 (858)
...|++.++.+++.+|. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 36789999999999886 4699999999999987 68899999987532 23456789999999999999
Q ss_pred eeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc
Q 043526 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT 706 (858)
Q Consensus 628 nIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~ 706 (858)
||+++++++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999999997543 346899999999999999999999 88999999999999999
Q ss_pred CCCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 707 ENLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 707 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
+++.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||++++||++|+.||....... .+..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence 9999999999999876543222 2234568999999998764 57899999999999999999999997654322 1222
Q ss_pred HHHHHHh-cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 786 TVTNMIA-KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 786 ~v~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
+...... ...+.+.+++.+ ...+......+.+++.+|++.+|.+||++++|+++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2222211 122344444444 2345667788999999999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=388.09 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=197.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHH---HHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEA---EVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~---E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|+.. +|+.||||++.+.. ........+ ++++++.++|||||++++++.+++.+++||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 44589999999999999965 79999999996431 122233333 456677789999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||++||+|.++|.... .+++..+..++.||+.||+||| +.+|+||||||+||||+.+|.+||+|||+|+.+....
T Consensus 272 Ey~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp CCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 9999999999997643 6999999999999999999999 9999999999999999999999999999998765432
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
....+||+.|||||++.. ..++.++|+||+||++|||++|+.||....... ..... ..+....
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~-~~i~~~~---------- 410 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID-RMTLTMA---------- 410 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHH-HHHHHCC----------
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH-HhhcCCC----------
Confidence 234679999999999974 578999999999999999999999997543222 11111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
..++.....++.+|+.+||+.||.+|++ ++||.+|
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1122334457889999999999999998 6777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=358.19 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=210.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 34578999999999999975 79999999997766667788999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce---
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV--- 729 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--- 729 (858)
+|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 93 TLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp BHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 9999997643 46899999999999999999999 8899999999999999999999999999998764332211
Q ss_pred ----------eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh
Q 043526 730 ----------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 730 ----------~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~ 799 (858)
.....||+.|+|||.+.+..++.++||||||++++||++|..|+.............. ...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~---------~~~ 239 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---------RGF 239 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH---------HHH
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh---------hcc
Confidence 1145689999999999999999999999999999999999998865433221110001 111
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.+... +......+.+++.+|++.+|++|||++|+++.|+++...
T Consensus 240 ~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 LDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 112223578999999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.80 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=210.4
Q ss_pred hccccccccCceEEEEEEE--------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeE
Q 043526 574 NFNKVLGKGGFGTVYHGYL--------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~--------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 643 (858)
.+.+.||+|+||.||+|.. .++..||||+++.... ...+++.+|+++++++ +||||++++++|..++..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 4457899999999999985 2456799999976533 3456799999999999 8999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 644 LIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
+||||+++|+|.+++.... ...+++.+++.++.||++||+||| +.+|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCC
Confidence 9999999999999997653 235889999999999999999999 88999999999999999999
Q ss_pred CEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+..
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~~~-- 316 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELFK-- 316 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH--
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH--
Confidence 9999999999876443221 2223456789999999999999999999999999999999 99998754322 1211
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.+..+. ....+.....++.+++.+|++.+|++||+++|+++.|++++....
T Consensus 317 --~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 317 --LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp --HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 112211 111223344578899999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=352.11 Aligned_cols=265 Identities=22% Similarity=0.350 Sum_probs=214.4
Q ss_pred ccccccccCHHHHHHHHhh------------ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHH
Q 043526 556 LEFENRHFTYSEVLKITDN------------FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLM 622 (858)
Q Consensus 556 ~~~~~~~~~~~el~~~t~~------------f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~ 622 (858)
+.+....++++++..++.. ..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++
T Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~ 97 (321)
T 2c30_A 18 LYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97 (321)
T ss_dssp -------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred eeecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHH
Confidence 3445567888888888764 2357999999999999976 79999999998776677788999999999
Q ss_pred hcccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcc
Q 043526 623 RVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPEN 702 (858)
Q Consensus 623 ~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~N 702 (858)
+++||||+++++++...+..++||||+++|+|.+++... .+++.++..++.|+++||+||| +.+|+||||||+|
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~N 171 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDS 171 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHH
Confidence 999999999999999999999999999999999998643 5899999999999999999999 8899999999999
Q ss_pred eEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc
Q 043526 703 ILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782 (858)
Q Consensus 703 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~ 782 (858)
||++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.||..... ..
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~ 248 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQ 248 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH
T ss_pred EEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH
Confidence 9999999999999999987654322 22345799999999999999999999999999999999999999965431 11
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... +....... +. ........+.+++.+|++.+|++||+++|++++
T Consensus 249 ~~~~----~~~~~~~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 249 AMKR----LRDSPPPK-----LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHH----HHHSSCCC-----CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHH----HhcCCCCC-----cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11111100 00 111234468899999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=354.44 Aligned_cols=258 Identities=31% Similarity=0.491 Sum_probs=200.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|+. +|+.||||++..... ...+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 3457899999999999987 688999999976543 2346789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
|+|.+++.... ...+++.+++.++.|+++||+||| +.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 119 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~ 194 (309)
T 3p86_A 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-L 194 (309)
T ss_dssp CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-c
Confidence 99999997643 234899999999999999999999 778 9999999999999999999999999998653321 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+. .... ....
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~---~~~~---------~~~~ 260 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVG---FKCK---------RLEI 260 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHH---HSCC---------CCCC
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---hcCC---------CCCC
Confidence 223456899999999999999999999999999999999999999754321 1111111 1110 1112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
+.....++.+++.+|++.+|++|||++|+++.|+.+++....
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 223345688999999999999999999999999998876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.71 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=209.8
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|...+++.||||++.... ...+++.+|++++++++||||+++++++.+++..++||||+++++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 4457899999999999999889999999997543 345789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++.............
T Consensus 92 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 92 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 999996543 46899999999999999999999 88999999999999999999999999999987644322223334
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.+++.|+|||.+.+..++.++||||||++++||++ |+.||...... ... ..+..+. ....+...
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~-~~~~~~~---------~~~~~~~~ 232 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVV-EDISTGF---------RLYKPRLA 232 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-HHHHTTC---------CCCCCTTS
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHH-HHHhcCc---------cCCCCCcC
Confidence 56778999999998899999999999999999999 89998654321 111 1111110 11112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.+++.+|++.+|++||+++|++++|+++.+.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 45688999999999999999999999999997654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.28 Aligned_cols=261 Identities=26% Similarity=0.361 Sum_probs=203.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC----eeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN----NMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++||||+
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 34578999999999999875 7999999996542 23345667888999999999999999998754 369999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC----------CeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP----------PIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~----------~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
++|+|.++++.. .++|.+++.++.|+++||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 105 EKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999653 4899999999999999999999 77 9999999999999999999999999999
Q ss_pred ccccCCCcc-eeecccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCccc-----------c
Q 043526 720 KVFPIGGTH-VSTVVAGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI-----------H 782 (858)
Q Consensus 720 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~-----------~ 782 (858)
+........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||........ .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 876543322 2233568999999999876 3456788999999999999999999975432211 1
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
...+... ...+.....+.... .......++.+++.+||+.||++|||++||++.|+++.+
T Consensus 259 ~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 259 LEDMQEV-VVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHH-HTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhh-hhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11111111111111 122455679999999999999999999999999999654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.31 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=207.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|...++..||||++.... ...+++.+|++++.+++||||+++++++..++..++||||+++++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 3457899999999999999989999999997553 335789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 106 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 106 LLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp HHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 999997643 36899999999999999999999 88999999999999999999999999999987643322222334
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.+++.|+|||.+.+..++.++||||||++++||+| |+.||...... ... ..+.++. ....+...
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~----~~~~~~~---------~~~~~~~~ 246 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA----EHIAQGL---------RLYRPHLA 246 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH----HHHHTTC---------CCCCCTTC
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHH----HHHhccc---------CCCCCCcC
Confidence 56778999999998889999999999999999998 99998754321 111 1111110 11112222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
...+.+++.+|++.+|++||+++|++++|++++.++
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 356889999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=348.02 Aligned_cols=246 Identities=21% Similarity=0.371 Sum_probs=204.9
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+++.++||||+++++++..++..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 357899999999999995 5899999999987666667789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ .....
T Consensus 104 L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 176 (297)
T 3fxz_A 104 LTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (297)
T ss_dssp HHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred HHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence 99999654 5889999999999999999999 88999999999999999999999999999987654332 23345
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .........+.. ....+....
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~--------~~~~~~~~~ 243 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTP--------ELQNPEKLS 243 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSC--------CCSCGGGSC
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC--------CCCCccccC
Confidence 7999999999999999999999999999999999999999654311 111111111110 001122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 568899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.86 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=207.9
Q ss_pred hhccccccccCceEEEEEEEC----CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 344578999999999999974 44569999997653 3345679999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.++++... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 131 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 131 YMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp CCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999996543 46899999999999999999999 88999999999999999999999999999987654322
Q ss_pred c--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 H--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 ~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
. ......+|+.|+|||.+.+..++.++||||||++++||++ |+.||...... .+. ..+.++ .
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~----~~~~~~---------~ 271 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVI----SSVEEG---------Y 271 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH----HHHHTT---------C
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHH----HHHHcC---------C
Confidence 2 2223345778999999998899999999999999999999 99998654321 111 111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
....+......+.+++.+|+..+|++||+++||++.|++++....
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111223344578899999999999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.55 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=209.5
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|..+++..||||++..... ..+++.+|++++++++||||+++++++..++..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 44578999999999999999888999999975533 35779999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..............
T Consensus 90 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 90 LLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp HHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 999997643 46899999999999999999999 88999999999999999999999999999987655443333444
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.+++.|+|||.+.+..++.++||||||++++||++ |+.||....... .... +..+. ....+...
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~-~~~~~---------~~~~~~~~ 230 (268)
T 3sxs_A 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLK-VSQGH---------RLYRPHLA 230 (268)
T ss_dssp CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHH-HHTTC---------CCCCCTTS
T ss_pred CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHH-HHcCC---------CCCCCCcC
Confidence 56778999999998889999999999999999999 999986543211 1111 11111 00111222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
...+.+++.+|++.+|++|||++|++++|+.+.+
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 3468899999999999999999999999988643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=376.70 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=209.6
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 4467899999999999999889999999997643 45688999999999999999999999986 667899999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.++++......+++.+++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 345 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence 999998665556889999999999999999999 88999999999999999999999999999987643222222233
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+....++.++|||||||++|||+| |+.||...... .+... +..+. ....+...
T Consensus 346 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~----i~~~~---------~~~~~~~~ 410 (454)
T 1qcf_A 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA----LERGY---------RMPRPENC 410 (454)
T ss_dssp SSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH----HHHTC---------CCCCCTTS
T ss_pred cccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCC---------CCCCCCCC
Confidence 46778999999998899999999999999999999 99999754321 11111 11111 11112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.+++.+|++.+|++|||+++|++.|+++...
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 45788999999999999999999999999986543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.21 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=201.5
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHh--cccceeeeeeeeeeeC----CeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMR--VHHRNLTNLVGYFIED----NNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~~lV~E 647 (858)
.+.+.||+|+||.||+|+. +|+.||||++... ....+..|.+++.. ++||||+++++++... ...++|||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 3457899999999999998 7899999998643 34566677777776 7999999999987653 45889999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCC-----CCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC-----KPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
|+++|+|.++++. ..+++..++.++.|++.||+|||... +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 87 YHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp CCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred hccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 9999999999954 35899999999999999999999422 678999999999999999999999999999876
Q ss_pred cCCCcce---eecccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHhC----------CCccccCCCccccH
Q 043526 723 PIGGTHV---STVVAGTPGYLDPEYFVTD------WLNEKSDVYSFGVVLLEIITS----------QAVIVRNENENIHI 783 (858)
Q Consensus 723 ~~~~~~~---~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~ElltG----------~~p~~~~~~~~~~l 783 (858)
....... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.||..........
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 5443322 2234689999999999876 455799999999999999999 77876544333322
Q ss_pred HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 784 IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 784 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
................... ..+......+.+++.+|++.+|++|||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222222111111111111 01234567899999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=378.53 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=212.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|.+. ++..||||+++... ...++|.+|++++++++||||++++++|..++..++||||+++|
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 45688999999999999986 48899999997653 34678999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.++++......+++..++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++............
T Consensus 302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 378 (495)
T 1opk_A 302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378 (495)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence 9999998766667999999999999999999999 8899999999999999999999999999998765433222333
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||.+....++.++|||||||++|||+| |+.||...... .+... +..+ .....+..
T Consensus 379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~---------~~~~~~~~ 443 (495)
T 1opk_A 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL----LEKD---------YRMERPEG 443 (495)
T ss_dssp CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH----HHTT---------CCCCCCTT
T ss_pred CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcC---------CCCCCCCC
Confidence 446778999999998899999999999999999999 88998754422 12221 1111 11112233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
....+.+++.+||+.+|++||++++|++.|+.+++.
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 445788999999999999999999999999986543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.11 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=198.1
Q ss_pred hccccccccCceEEEEEEEC----CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.. ++..||||+++... ....++|.+|++++++++||||+++++++.+.+..++||||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence 44578999999999999864 57789999997653 33456799999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.++++... ..+++.+++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 128 ~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 128 MENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp CTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999997543 46899999999999999999999 889999999999999999999999999999876543222
Q ss_pred e--eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 729 V--STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 729 ~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+. ..+.++ ..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~----~~i~~~---------~~ 268 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVI----KAVDEG---------YR 268 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHH----HHHHTT---------EE
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcC---------CC
Confidence 1 122335678999999999999999999999999999998 99998654321 111 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
...+......+.+++.+|++.+|++||+++||++.|++++...
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1122334567889999999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=347.02 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=204.7
Q ss_pred hhccccccccCceEEEEEEE-----CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 645 (858)
+.+.+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++||||+++++++... ...++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 34568899999999999985 36899999999877666667899999999999999999999998654 558999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 99999999999997653 35899999999999999999999 889999999999999999999999999999876543
Q ss_pred Ccc--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc----------cccHHHHHHHHHhc
Q 043526 726 GTH--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE----------NIHIIQTVTNMIAK 793 (858)
Q Consensus 726 ~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~----------~~~l~~~v~~~~~~ 793 (858)
... ......++..|+|||.+.+..++.++||||||++++||+||..|+.....+ .......+...+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 221 122344677899999999999999999999999999999999887532110 00001111111111
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
+ .....+.....++.+++.+|++.+|++|||++|+++.|+++..
T Consensus 248 ~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 248 N---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1 1111233445678899999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=353.28 Aligned_cols=244 Identities=23% Similarity=0.425 Sum_probs=202.6
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 3457899999999999997 589999999997542 3345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 98 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~ 170 (328)
T 3fe3_A 98 GGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--L 170 (328)
T ss_dssp TCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--G
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--c
Confidence 999999997653 6899999999999999999999 88999999999999999999999999999987654332 3
Q ss_pred ecccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWLN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....||+.|+|||.+.+..+. .++|||||||+++||++|+.||..... .. +...+..+.. ..+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~-~~~~i~~~~~----------~~p 234 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KE-LRERVLRGKY----------RIP 234 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH-HHHHHHHCCC----------CCC
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HH-HHHHHHhCCC----------CCC
Confidence 345799999999999887765 799999999999999999999975431 11 1111211111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|+..||.+|||++|++++
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2234567899999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=346.40 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=206.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 44578999999999999964 789999999865432 23467899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.... .+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 94 ~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 94 EGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 9999999997653 6899999999999999999999 8899999999999999999999999999998765443333
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ......+... .... .... .
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~-~~~~-~~~~----~ 237 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDS-VPNV-TTDV----R 237 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSC-CCCH-HHHS----C
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhcc-CCCc-chhc----c
Confidence 44457999999999999999999999999999999999999999754321 1111222211 1111 0111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHHHhh
Q 043526 810 IESAWRAVELAVKCASRTSSERP-NMNEVVTELKECLMMELA 850 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~~~~ 850 (858)
......+.+++.+|++.+|.+|| +++++.+.|++++....+
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 22335688999999999999999 999999999987665543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=346.03 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=215.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 44578999999999999976 5889999999754 334578999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.............
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 95 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp EHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred cHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 9999998766667999999999999999999999 8899999999999999999999999999998776544444444
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..+++.|+|||.+.+..++.++||||||++++||++ |+.||...... .+...+. .. .....+..
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~----~~---------~~~~~~~~ 236 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLE----KD---------YRMERPEG 236 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHH----TT---------CCCCCCTT
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh----cc---------CCCCCCCC
Confidence 557889999999998899999999999999999999 88888654322 1111111 11 11112223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
....+.+++.+|+..+|++||+++|+++.|++++.....
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 345788999999999999999999999999998776553
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=363.13 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=206.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|... +|+.||||+++.... ...++|.+|++++++++||||+++++++..++..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 34578999999999999986 799999999875432 2345789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee-
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS- 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 730 (858)
|+|.++++... ..+++.+++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus 197 g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 197 GDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999997543 46899999999999999999999 88999999999999999999999999999986433211111
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....++..|+|||.+....++.++|||||||++|||+| |+.||...... .+...+..+. ....+
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~ 337 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QTREFVEKGG---------RLPCP 337 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------HHHHHHHTTC---------CCCCC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC---------CCCCC
Confidence 11224668999999998889999999999999999998 99998654321 1122222221 11112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
......+.+++.+|++.+|++|||++++++.|+++..
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 2234578899999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=359.88 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=210.8
Q ss_pred hhccccccccCceEEEEEEEC--------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 642 (858)
..+.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++++++ +||||+++++++..++..
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 345688999999999999852 346799999976533 3457789999999999 999999999999999999
Q ss_pred EEEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 643 GLIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
++||||+++|+|.+++.... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++++
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCC
Confidence 99999999999999997654 235899999999999999999999 8899999999999999999
Q ss_pred CCEEEeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHH
Q 043526 709 LEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQT 786 (858)
Q Consensus 709 ~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~ 786 (858)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||+++||++ |+.||...... +
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-----~- 301 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----E- 301 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----H-
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H-
Confidence 9999999999987654322 22233456789999999999999999999999999999999 99998654311 1
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+...+.++. ....+.....++.+++.+|++.+|++||+++||+++|++++....
T Consensus 302 ~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 112222221 111122334578899999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=364.87 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=206.9
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC-eeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN-NMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||||+++|
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 34578999999999999985 7899999997653 4578999999999999999999999987765 789999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++..++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 345 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 345 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccC
Confidence 9999998766556899999999999999999999 889999999999999999999999999999864322 122
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ ... .+..+. ....+..
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~---------~~~~p~~ 410 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGY---------KMDAPDG 410 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH----HHHTTC---------CCCCCTT
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCC---------CCCCCCc
Confidence 356889999999999999999999999999999998 999997654322 111 122221 1112233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
....+.+++.+||+.+|++||+++++++.|+++...+
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 4457889999999999999999999999999976543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=344.03 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=197.6
Q ss_pred hhccccccccCceEEEEEEEC----CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+.+.+.||+|+||.||+|... .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 345688999999999999864 355799999876433 34567899999999999999999999984 567889999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 96 LCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp CCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999997543 46899999999999999999999 88999999999999999999999999999987654433
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......+++.|+|||.+....++.++||||||++++||++ |+.||...... .....+ ..+.. .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i----~~~~~---------~ 236 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI----ENGER---------L 236 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTCC---------C
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH----HcCCC---------C
Confidence 33334456789999999998899999999999999999997 89998754422 222211 11110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
..+......+.+++.+|++.+|++||++.|++++|+++++++.+
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 280 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 11223345788999999999999999999999999998877653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=371.23 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=204.9
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 4457899999999999999888899999997653 345789999999999999999999999876 67899999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......+++.+++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 341 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence 999998655557899999999999999999999 88999999999999999999999999999987654332223334
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+....++.++|||||||++|||+| |+.||...... .+ ...+..+. ....+...
T Consensus 342 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~----~~~i~~~~---------~~~~~~~~ 406 (452)
T 1fmk_A 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV----LDQVERGY---------RMPCPPEC 406 (452)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTC---------CCCCCTTS
T ss_pred cccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCC---------CCCCCCCC
Confidence 56788999999998899999999999999999999 89998654321 11 11122221 11122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
...+.+++.+|++.+|++|||++++++.|+++....
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 457889999999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.26 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=209.2
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 4457899999999999999888899999997543 34678999999999999999999999986 456899999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......+++.+++.++.|+++||+||| +.+|+||||||+||++++++.+||+|||++..............
T Consensus 94 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 999997655456899999999999999999999 88999999999999999999999999999987754433333344
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+.+..++.++||||||++++||++ |+.||...... .+.. .+..+. ....+...
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~~~ 235 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ----NLERGY---------RMVRPDNC 235 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTC---------CCCCCTTC
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHH----HHhccc---------CCCCcccc
Confidence 56789999999998889999999999999999999 88888654321 1111 111111 01112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.+++.+|+..+|++||+++++++.|++++..
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 45788999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=357.11 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=207.1
Q ss_pred hccccccccCceEEEEEEE------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCe-eEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNN-MGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~-~~l 644 (858)
.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+. .++
T Consensus 25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i 104 (359)
T 3vhe_A 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 104 (359)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence 3457899999999999974 2568999999976533 3346799999999999 79999999999987654 899
Q ss_pred EEeeccCCChHHHhhhccc-------------------------------------------------------------
Q 043526 645 IYEYMANGNLKQLLSDEKA------------------------------------------------------------- 663 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~------------------------------------------------------------- 663 (858)
||||+++|+|.++++....
T Consensus 105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3vhe_A 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184 (359)
T ss_dssp EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence 9999999999999976532
Q ss_pred ---CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-ceeecccCCCCc
Q 043526 664 ---STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVSTVVAGTPGY 739 (858)
Q Consensus 664 ---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y 739 (858)
..+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 185 ~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 185 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 12899999999999999999999 88999999999999999999999999999987644322 223345678899
Q ss_pred cCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHH
Q 043526 740 LDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVE 818 (858)
Q Consensus 740 ~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 818 (858)
+|||.+.+..++.++|||||||+++||+| |+.||....... . +...+..+.. ...+.....++.+
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~----~~~~~~~~~~---------~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E----FCRRLKEGTR---------MRAPDYTTPEMYQ 327 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H----HHHHHHHTCC---------CCCCTTCCHHHHH
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-H----HHHHHHcCCC---------CCCCCCCCHHHHH
Confidence 99999999999999999999999999999 999987544222 1 1111111111 1112223456889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 819 LAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 819 l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
++.+|++.+|.+||+++|++++|+++++..
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.81 Aligned_cols=268 Identities=19% Similarity=0.267 Sum_probs=209.3
Q ss_pred hccccccccCceEEEEEEECC------CCEEEEEEeccCCCcc-----------hHhHHHHHHHHHhcccceeeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD------GTQVAVKMLSSSSGQG-----------FKEFEAEVKLLMRVHHRNLTNLVGYF 636 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~~~~ 636 (858)
.+.+.||+|+||.||+|...+ ++.||||++....... ...+..|+..++.++||||+++++++
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 117 (364)
T 3op5_A 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG 117 (364)
T ss_dssp EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence 445789999999999999764 4789999987553211 12234455566777899999999999
Q ss_pred eeC----CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc--CCCC
Q 043526 637 IED----NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT--ENLE 710 (858)
Q Consensus 637 ~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~--~~~~ 710 (858)
... ...++||||+ +++|.+++... ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++ .++.
T Consensus 118 ~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 118 LHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTTC
T ss_pred eeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCCe
Confidence 875 4589999999 99999999764 346999999999999999999999 88999999999999999 8899
Q ss_pred EEEeeecCcccccCCCcce------eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHH
Q 043526 711 AKLADFGLSKVFPIGGTHV------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII 784 (858)
Q Consensus 711 ~kL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~ 784 (858)
+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-KYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-HHH
Confidence 9999999998764332211 123459999999999999899999999999999999999999998543222 222
Q ss_pred HHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 043526 785 QTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851 (858)
Q Consensus 785 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~ 851 (858)
....... ...+.+++++++... ....++.+++..|++.+|++||++++|++.|++++.....+
T Consensus 272 ~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 272 RDSKIRY-RENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHH-HHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHh-hhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 2222222 224566677766422 22346889999999999999999999999999988765543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.99 Aligned_cols=260 Identities=16% Similarity=0.199 Sum_probs=209.6
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|++.+.++ +|+|++++++++......++||||+ +
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 3457899999999999996 589999999986543 335688999999999 7999999999999999999999999 9
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC-----EEEeeecCcccccCCC
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE-----AKLADFGLSKVFPIGG 726 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~-----~kL~DFGla~~~~~~~ 726 (858)
++|.+++.... ..+++.+++.++.||++||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 90 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 90 PSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99999997543 46899999999999999999999 899999999999999988776 9999999998765432
Q ss_pred cc------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc-ccHHHHHHHHHhcCCchhh
Q 043526 727 TH------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-IHIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 727 ~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~-~~l~~~v~~~~~~~~~~~~ 799 (858)
.. ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ......+..........+.
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 21 1234568999999999999899999999999999999999999997644221 1122222211111111111
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.. .....+.+++.+|++.+|++||++++|++.|++++....
T Consensus 246 -----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 246 -----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp -----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11 123478899999999999999999999999999876544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.07 Aligned_cols=267 Identities=21% Similarity=0.289 Sum_probs=210.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC--eeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--NMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 34578999999999999976 59999999997543 334577889999999999999999999998765 789999999
Q ss_pred cCCChHHHhhhccc-CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE----cCCCCEEEeeecCcccccC
Q 043526 650 ANGNLKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL----TENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 650 ~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl----~~~~~~kL~DFGla~~~~~ 724 (858)
++|+|.+++..... ..+++.+++.++.|+++||+||| +.+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 99999999976542 34899999999999999999999 8899999999999999 7888899999999987654
Q ss_pred CCcceeecccCCCCccCccccc--------cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC--
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFV--------TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG-- 794 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~-- 794 (858)
... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||......... ...+.......
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~p~ 245 (319)
T 4euu_A 169 DEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITGKPS 245 (319)
T ss_dssp TCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-HHHHHHHHHHCCT
T ss_pred CCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-HHHHHHHhcCCCc
Confidence 332 23356899999999886 577899999999999999999999999754432221 12222222111
Q ss_pred -Cchhhh---c------hh--hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 795 -DIENIV---D------SC--LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 795 -~~~~~~---d------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.+..+. . .. ............+.+++.+|++.||++||+++|++++..+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111100 0 00 0112345667788999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=345.27 Aligned_cols=259 Identities=17% Similarity=0.227 Sum_probs=208.2
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|.. .+|+.||||++..... ..++.+|+++++++ +||||+++++++..++..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 3457899999999999996 5899999999875532 35789999999999 9999999999999999999999999 9
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC-----EEEeeecCcccccCCC
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE-----AKLADFGLSKVFPIGG 726 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~-----~kL~DFGla~~~~~~~ 726 (858)
++|.+++... ...+++.+++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++......
T Consensus 89 ~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 89 PSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999999764 347999999999999999999999 889999999999999999887 9999999998764432
Q ss_pred cc------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccc-cHHHHHHHHHhcCCchhh
Q 043526 727 TH------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI-HIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 727 ~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~-~l~~~v~~~~~~~~~~~~ 799 (858)
.. ......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ .....+.........
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--- 241 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI--- 241 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH---
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH---
Confidence 21 12346799999999999999999999999999999999999999976543221 111111111111000
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
..+... .. ++.+++..|++.+|.+||++++|++.|+++.....
T Consensus 242 --~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 242 --EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp --HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 011111 12 78899999999999999999999999998765543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.46 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=209.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++..++..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34578999999999999998899999999976543 34789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++..............
T Consensus 90 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 90 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 999997543 46899999999999999999999 88999999999999999999999999999987643222222334
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+.+..++.++||||||++++||++ |+.||...... ... ..+..+. ....+...
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~-~~i~~~~---------~~~~~~~~ 230 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVV-EDISTGF---------RLYKPRLA 230 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-HHHHTTC---------CCCCCTTS
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHH-HHHhcCC---------cCCCCccC
Confidence 56778999999998889999999999999999999 89898654311 111 1111111 01112223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.+++.+|++.+|++||+++|++++|+++.+.
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 45688999999999999999999999999997653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.54 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=209.2
Q ss_pred hccccccccCceEEEEEEE------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 3457899999999999985 2458899999975432 34577899999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhccc----------------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 647 EYMANGNLKQLLSDEKA----------------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
||+++|+|.+++..... ..+++.+++.++.||++||+||| +.+|+||||||+|||
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNIL 182 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEE
Confidence 99999999999976432 34899999999999999999999 889999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCcccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIH 782 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~ 782 (858)
+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||++++||++ |+.||.....+.
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 260 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-- 260 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999876443322 2223456788999999998889999999999999999999 999987544221
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
+... +..+. ....+......+.+++.+|++.+|++||+++|++++|++++..
T Consensus 261 ~~~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LFNL----LKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH----hhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2111 11111 1111223345788999999999999999999999999997753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.56 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=210.7
Q ss_pred hhccccccccCceEEEEEEE------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 644 (858)
+.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++..++..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34568899999999999985 3578999999976543 3457789999999999 99999999999999999999
Q ss_pred EEeeccCCChHHHhhhccc----------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 645 IYEYMANGNLKQLLSDEKA----------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
||||+++|+|.+++..... ..+++.+++.++.|+++||+||| +.+|+||||||+|||++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCC
Confidence 9999999999999976542 24899999999999999999999 8899999999999999999
Q ss_pred CCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHH
Q 043526 709 LEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQT 786 (858)
Q Consensus 709 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~ 786 (858)
+.+||+|||+++........ ......|++.|+|||.+.+..++.++||||||++++||+| |+.||....... ....
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~- 259 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KFYK- 259 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HHHH-
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-HHHH-
Confidence 99999999999876544322 2223456788999999998899999999999999999999 999986544221 1111
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
.+.++ .....+......+.+++.+|++.+|.+||+++|++++|++++...
T Consensus 260 ---~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 260 ---MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp ---HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---HhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111 111112233457889999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.00 Aligned_cols=270 Identities=25% Similarity=0.364 Sum_probs=209.0
Q ss_pred hccccccccCceEEEEEEEC-----CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-----DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 645 (858)
...+.||+|+||.||++.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 34578999999999998753 688999999976533 3456789999999999999999999999884 578999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.+++... .+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999654 4899999999999999999999 889999999999999999999999999999887544
Q ss_pred Ccc--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GTH--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
... ......|+..|+|||.+.+..++.++||||||++++||+||+.||............+.........+.+.++..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 322 123345788899999999888999999999999999999999998643211100000000000000011112222
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.....+......+.+++.+|++.+|++||+++|+++.|+++.+.-.
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 2222233445678999999999999999999999999999765543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=347.57 Aligned_cols=245 Identities=28% Similarity=0.399 Sum_probs=202.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.. +|+.||+|+++.. .......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 34578999999999999975 7999999999753 2344567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 88 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 161 (337)
T 1o6l_A 88 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp TTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-c
Confidence 9999999997543 6899999999999999999999 88999999999999999999999999999986432222 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .+ ... +..+.. .++
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~---~~~-i~~~~~----------~~p 225 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL---FEL-ILMEEI----------RFP 225 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHH-HHHCCC----------CCC
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HH---HHH-HHcCCC----------CCC
Confidence 33457899999999999989999999999999999999999999654311 11 111 111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....++.+++.+|++.+|++|| +++|++++
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 23345788999999999999999 89999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.50 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=199.8
Q ss_pred hccccccccCceEEEEEEEC-CCCE----EEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQ----VAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
...+.||+|+||.||+|+.. +|+. ||+|.+... .....+++.+|++++++++||||++++++|..+. .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e 96 (327)
T 3poz_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEE
T ss_pred ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 34578999999999999964 4544 588887644 3345678999999999999999999999998765 779999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 97 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999997643 46899999999999999999999 88999999999999999999999999999987754332
Q ss_pred c-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 H-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
. ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||....... +... +..+ ..
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~---------~~ 237 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI----LEKG---------ER 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTT---------CC
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHH----HHcC---------CC
Confidence 2 2233456889999999999999999999999999999999 999997544222 1111 1111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+......+.+++.+|++.+|++||+++|++++|+++...
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 112233455788999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.20 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=207.4
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|.+. +++.||||++.... .....++.+|+.++++++||||+++++++......++||
T Consensus 74 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 153 (367)
T 3l9p_A 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153 (367)
T ss_dssp EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEE
Confidence 45678999999999999853 46789999997543 334567899999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc-----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---CEEEeeecC
Q 043526 647 EYMANGNLKQLLSDEK-----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL---EAKLADFGL 718 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DFGl 718 (858)
||+++|+|.+++...+ ...+++.+++.++.||++||+||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999999999997654 235899999999999999999999 88999999999999999554 599999999
Q ss_pred cccccCCC-cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGG-THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++...... ........||+.|+|||.+.+..++.++|||||||+++||++ |+.||...... .+. ..+..+..
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~----~~i~~~~~ 304 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL----EFVTSGGR 304 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHHHTTCC
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCC
Confidence 98653221 122233567899999999999999999999999999999998 99998654321 111 11222110
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
...+......+.+++.+|++.+|++||+++||+++|+.+.+...
T Consensus 305 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 305 ---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 11122334568899999999999999999999999998765543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.72 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=206.1
Q ss_pred hccccccccCceEEEEEEE------CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 4467999999999999996 246689999997542 34457899999999999 899999999999999999999
Q ss_pred EeeccCCChHHHhhhccc---------------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 646 YEYMANGNLKQLLSDEKA---------------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
|||+++|+|.+++..... ..+++.+++.++.||++||+||| +.+|+||||||+|||
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVL 204 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEE
Confidence 999999999999976532 24799999999999999999999 889999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCcccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIH 782 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~ 782 (858)
++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||++++||+| |+.||....... .
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-N 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH-H
Confidence 999999999999999876543322 2233457889999999998899999999999999999998 999987654221 1
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
....+..+ .....+......+.+++.+|++.+|.+||++.|++++|+.++....
T Consensus 284 ----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 284 ----FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp ----HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ----HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 11112221 1111122334578899999999999999999999999999765433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.47 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=207.5
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence 34578999999999999974 358899999976543 33567999999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc----------------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 647 EYMANGNLKQLLSDEK----------------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
||+++|+|.+++.... ...+++.+++.++.||++||+||| +.+|+||||||+|||
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCL 206 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEE
Confidence 9999999999997642 146899999999999999999999 889999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCcccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIH 782 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~ 782 (858)
+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--- 283 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--- 283 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH---
Confidence 99999999999999987643221 12233457889999999998889999999999999999999 99998654321
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.+...+.++... ..+......+.+++.+|++.+|++||++++++++|+++.+.
T Consensus 284 ---~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 284 ---EVIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp ---HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ---HHHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 111222222211 11223345788999999999999999999999999997643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=353.19 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=209.1
Q ss_pred hccccccccCceEEEEEEE-----CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeee--eCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI--EDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 105 (327)
T 3lxl_A 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 105 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence 4457899999999999984 368899999998776666678999999999999999999999887 456689999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++++|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 106 EYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred eecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 9999999999997643 36899999999999999999999 8899999999999999999999999999998775443
Q ss_pred cc--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc---------ccHHHHHHHHHhcCC
Q 043526 727 TH--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN---------IHIIQTVTNMIAKGD 795 (858)
Q Consensus 727 ~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~---------~~l~~~v~~~~~~~~ 795 (858)
.. ......|+..|+|||.+.+..++.++||||||++++||++|+.||.....+. ......+...
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 256 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL----- 256 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH-----
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH-----
Confidence 22 1223457888999999998889999999999999999999999986432110 0000111111
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+........+......+.+++.+|++.+|++||+++|++++|+++.....
T Consensus 257 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 ----LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp ----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ----hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111122233445678999999999999999999999999998765544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=346.97 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=205.5
Q ss_pred hhccccccccCceEEEEEEE-----CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 644 (858)
....+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 34457899999999999984 378999999997543 34457899999999999999999999999877 66899
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 103 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 999999999999996543 46899999999999999999999 88999999999999999999999999999987754
Q ss_pred CCcc--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCC---------ccccHHHHHHHHHhc
Q 043526 725 GGTH--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNEN---------ENIHIIQTVTNMIAK 793 (858)
Q Consensus 725 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~---------~~~~l~~~v~~~~~~ 793 (858)
.... ......||..|+|||.+.+..++.++||||||++++||+||+.|+..... ........+...+..
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 4322 22334678889999999988899999999999999999999988643210 000011111111111
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
+ .....+......+.+++.+|++.+|.+|||++|+++.|++++
T Consensus 259 ~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 259 G---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1 111122334567889999999999999999999999999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.72 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=202.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence 45688999999999999975 7999999999765322 3467899999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC----CEEEeeecCcccc
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL----EAKLADFGLSKVF 722 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~----~~kL~DFGla~~~ 722 (858)
||+++|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 95 ELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp ECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999654 36899999999999999999999 88999999999999998877 7999999999876
Q ss_pred cCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|..||...... .+.. .+..+... +++
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~----~i~~~~~~--~~~ 239 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA----NITAVSYD--FDE 239 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH----HHHTTCCC--CCH
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHhcCCC--CCc
Confidence 5432 223456999999999999889999999999999999999999999754311 1111 11111100 000
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... ......+.+++.+|+..||++|||++|++++
T Consensus 240 ~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 240 EFF----SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 1123468899999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.10 Aligned_cols=248 Identities=20% Similarity=0.341 Sum_probs=202.9
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC--CeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED--NNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.+ |+.||||++.... ....+.+.+|++++++++||||+++++++... +..++||||+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 44578999999999999985 8999999997653 23456799999999999999999999999887 7789999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
++|+|.+++.......+++.+++.++.|+++||+||| +.+ |+||||||+|||++.++.++|+|||+......
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--- 165 (271)
T 3kmu_A 92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--- 165 (271)
T ss_dssp TTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence 9999999998766557999999999999999999999 777 99999999999999999999999988765322
Q ss_pred ceeecccCCCCccCccccccCCCCC---chhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNE---KSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~---ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
....||+.|+|||.+.+...+. ++||||||++++||++|+.||...... .........+.
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~--------- 228 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGMKVALEGL--------- 228 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHHHHHHHSCC---------
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHHHHHHhcCC---------
Confidence 2245789999999998765444 799999999999999999999754321 11112211211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
....+......+.+++.+|++.+|++|||++|+++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11122233457889999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=363.64 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||+|+||+||+|+.. +|+.||||+++.. .......+.+|..++..++||||++++++|.+++..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 478999999999999976 5889999999642 122345589999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus 159 g~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 234 (437)
T 4aw2_A 159 GDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234 (437)
T ss_dssp CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECC
T ss_pred CcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccc
Confidence 9999999753 246899999999999999999999 899999999999999999999999999999877655544455
Q ss_pred cccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 732 VVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 732 ~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
...||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+......-. + .
T Consensus 235 ~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~--------~-p 303 (437)
T 4aw2_A 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKERFQ--------F-P 303 (437)
T ss_dssp SCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHHCC--------C-C
T ss_pred cccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhhcccccc--------C-C
Confidence 568999999999987 567899999999999999999999999754321 11111111000000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSE--RPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 840 (858)
.........+.+++.+|++.+|++ ||+++|++++
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 001123456889999999888888 9999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=336.68 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=210.8
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
+.||+|+||.||+|... ++..||||+++.... ...+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999853 678899999986533 3457789999999999999999999999 566789999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce--e
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV--S 730 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--~ 730 (858)
+|.+++... ...+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......... .
T Consensus 95 ~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 95 PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 999999654 346899999999999999999999 8899999999999999999999999999998775433222 1
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....+++.|+|||.+.+..++.++||||||++++||+| |+.||...... .+.. .+..+.. ...+
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~----~i~~~~~---------~~~~ 235 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA----FIEQGKR---------MECP 235 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHH----HHHTTCC---------CCCC
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HHhcCCc---------CCCC
Confidence 23346789999999988889999999999999999999 99999754422 1111 1222111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhccc
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKK 854 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~~~ 854 (858)
......+.+++.+|+..+|++||++.|++++|++++.........
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 334457889999999999999999999999999998887755443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=338.99 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=199.8
Q ss_pred HhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc--ccceeeeeeeeeeeC----CeeEEE
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV--HHRNLTNLVGYFIED----NNMGLI 645 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~----~~~~lV 645 (858)
.+.+.+.||+|+||.||+|+.. |+.||||++... ....+..|.+++... +||||+++++++... ...++|
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 4455689999999999999985 899999998643 234455566665554 899999999999887 789999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC--------CeEecCCCCcceEEcCCCCEEEeeec
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP--------PIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~--------~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
|||+++|+|.++++.. .+++.+++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 114 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp ECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999653 5899999999999999999999 66 99999999999999999999999999
Q ss_pred CcccccCCCcce---eecccCCCCccCccccccCCCCCc------hhHHHHHHHHHHHHhC----------CCccccCCC
Q 043526 718 LSKVFPIGGTHV---STVVAGTPGYLDPEYFVTDWLNEK------SDVYSFGVVLLEIITS----------QAVIVRNEN 778 (858)
Q Consensus 718 la~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k------sDVwSfGvll~ElltG----------~~p~~~~~~ 778 (858)
+++......... .....||+.|+|||.+.+.....+ +|||||||++|||+|| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 998764332221 124568999999999987766655 9999999999999999 555544332
Q ss_pred ccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 779 ENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 779 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
........ ................+ .......++.+++.+|++.+|.+||+++||+++|+++.+..
T Consensus 268 ~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDPSYEDM-REIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSCCHHHH-HHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCchhhh-HHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 22222222 11111111111111000 01256678999999999999999999999999999976543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=344.33 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=194.9
Q ss_pred hccccccccCceEEEEEEECC-C---CEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCee-----
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD-G---TQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNM----- 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~----- 642 (858)
.+.+.||+|+||.||+|.... + ..||||+++.. .....+++.+|++++++++||||+++++++...+..
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 445789999999999998653 3 27999999765 344567899999999999999999999999887665
Q ss_pred -EEEEeeccCCChHHHhhhcc----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 643 -GLIYEYMANGNLKQLLSDEK----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 643 -~lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
++||||+++|+|.+++.... ...+++.+++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 89999999999999996543 225899999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCC
Q 043526 718 LSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGD 795 (858)
Q Consensus 718 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~ 795 (858)
+++........ ......+++.|+|||.+.+..++.++|||||||+++||++ |+.||...... .+...+ ..+.
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~----~~~~ 256 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYL----IGGN 256 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTC
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHH----hcCC
Confidence 99876433221 2223456788999999999999999999999999999999 89998754422 111111 1111
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
....+......+.+++.+|++.+|++||++.++++.|++++...
T Consensus 257 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 257 ---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01112233457889999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.70 Aligned_cols=246 Identities=27% Similarity=0.479 Sum_probs=191.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCC----cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG----QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... |+.||||++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 44578999999999999974 89999999875432 33567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC---eEecCCCCcceEEcC--------CCCEEEeeecC
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP---IVHRDIKPENILLTE--------NLEAKLADFGL 718 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~---IvH~DLk~~NILl~~--------~~~~kL~DFGl 718 (858)
++++|.+++.. ..+++.+++.++.|+++||+||| +.+ |+||||||+|||++. ++.+||+|||+
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 89 RGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp TTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999853 36899999999999999999999 555 999999999999986 67899999999
Q ss_pred cccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 719 SKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 719 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
++...... .....|++.|+|||.+.+..++.++||||||++++||++|+.||....... .........
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~---- 230 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMNK---- 230 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTSC----
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcCC----
Confidence 98654322 223468999999999998889999999999999999999999997543211 111111111
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.....+......+.+++.+|++.+|++||+++|++++|++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 -----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111223334578899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=341.06 Aligned_cols=273 Identities=24% Similarity=0.347 Sum_probs=211.4
Q ss_pred HHHHHHhhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHh--cccceeeeeeeeeeeCC----
Q 043526 567 EVLKITDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMR--VHHRNLTNLVGYFIEDN---- 640 (858)
Q Consensus 567 el~~~t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~---- 640 (858)
+...-.+.+.+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 33344556678999999999999998 5899999999643 34677889988887 78999999999998876
Q ss_pred eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCC-----CCCeEecCCCCcceEEcCCCCEEEee
Q 043526 641 NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC-----KPPIVHRDIKPENILLTENLEAKLAD 715 (858)
Q Consensus 641 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~IvH~DLk~~NILl~~~~~~kL~D 715 (858)
..++||||+++|+|.+++... .+++.+++.++.|++.||+|||... +.+|+||||||+|||++.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 789999999999999999653 5899999999999999999999321 46899999999999999999999999
Q ss_pred ecCcccccCCCcc---eeecccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHhC----------CCccccC
Q 043526 716 FGLSKVFPIGGTH---VSTVVAGTPGYLDPEYFVTD------WLNEKSDVYSFGVVLLEIITS----------QAVIVRN 776 (858)
Q Consensus 716 FGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDVwSfGvll~ElltG----------~~p~~~~ 776 (858)
||++......... ......||+.|+|||.+.+. .++.++|||||||+++||+|| +.||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9999876544322 12345689999999998765 233689999999999999999 6677654
Q ss_pred CCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 777 ENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 777 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
.........+.... ..+....-+.... ...+....+.+++.+|++.+|++||+++||+++|+++.+++..
T Consensus 271 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 271 VPSDPSVEEMRKVV-CEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp SCSSCCHHHHHHHH-TTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred CcCcccHHHHHHHH-HHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 43332333322222 1111111111110 1235567899999999999999999999999999998776543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.36 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=200.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 34578999999999999976 899999999875432 3346789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-cee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~ 730 (858)
|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 90 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 90 GELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp EEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999654 36899999999999999999999 89999999999999999999999999999987643322 122
Q ss_pred ecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....||+.|+|||.+.+..+ +.++|||||||+++||++|+.||............+... ... . ...
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~---~------~~~ 231 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTY---L------NPW 231 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT----CTT---S------TTG
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc----ccc---C------Ccc
Confidence 34578999999999987665 778999999999999999999997654332222222111 000 0 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 2234467899999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.29 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=203.2
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEE
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 644 (858)
.+.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++..++..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3455689999999999999975 7999999999754322 35779999999999999999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC----CEEEeeecCcc
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL----EAKLADFGLSK 720 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~----~~kL~DFGla~ 720 (858)
||||+++|+|.+++... ..+++.+++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999654 46899999999999999999999 88999999999999999887 79999999998
Q ss_pred cccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 721 VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 721 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
....... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .....+ ..... ...
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~----~~~~~-~~~ 237 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANV----SAVNY-EFE 237 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH----HHTCC-CCC
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHH----HhcCC-CcC
Confidence 7653322 23356899999999999889999999999999999999999999654311 111111 11110 000
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+... ......+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYF-----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHH-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 1123467899999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=336.26 Aligned_cols=256 Identities=27% Similarity=0.387 Sum_probs=203.5
Q ss_pred hccccccccCceEEEEEEECC----CCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|...+ +..||||.+.... ....+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence 345789999999999998642 3469999997653 2345779999999999999999999999865 456899999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++++|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 94 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 94 YPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999997543 46899999999999999999999 889999999999999999999999999999876544333
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......+++.|+|||.+.+..++.++||||||++++||+| |+.||....... ....+. .+.. ..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~----~~~~---------~~ 234 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLE----KGDR---------LP 234 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHH----HTCC---------CC
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHh----cCCC---------CC
Confidence 3344557889999999998899999999999999999998 999997544322 222111 1110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.+......+.+++.+|+..+|++||++.|++++|+++.+.+.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 112233568899999999999999999999999999877654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.63 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=195.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC-----------
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN----------- 640 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----------- 640 (858)
...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 44578999999999999976 89999999997543 335578999999999999999999999986654
Q ss_pred ----------------------------------------------eeEEEEeeccCCChHHHhhhcc-cCchhHHHHHH
Q 043526 641 ----------------------------------------------NMGLIYEYMANGNLKQLLSDEK-ASTLSWERRLQ 673 (858)
Q Consensus 641 ----------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~ 673 (858)
..++||||+++|+|.+++.... .....+..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 2789999999999999997644 23456778899
Q ss_pred HHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-----------ceeecccCCCCccCc
Q 043526 674 IAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-----------HVSTVVAGTPGYLDP 742 (858)
Q Consensus 674 i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~y~AP 742 (858)
++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 9999999999999 88999999999999999999999999999987754321 112334689999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHH
Q 043526 743 EYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVK 822 (858)
Q Consensus 743 E~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 822 (858)
|.+.+..++.++|||||||+++||++|..|+... .. ............. .......+.+++.+
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~-~~~~~~~~~~~~~---------~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VR-IITDVRNLKFPLL---------FTQKYPQEHMMVQD 308 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HH-HHHHhhccCCCcc---------cccCChhHHHHHHH
Confidence 9999999999999999999999999987764311 11 1111111111111 11233467899999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 043526 823 CASRTSSERPNMNEVVTE 840 (858)
Q Consensus 823 Cl~~dP~~RPsm~eVl~~ 840 (858)
|++.+|++||+++|++++
T Consensus 309 ~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHCSSGGGSCCHHHHHHS
T ss_pred HccCCCCcCCCHHHHhhc
Confidence 999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.75 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=202.4
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccC-----CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-----SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4556789999999999999965 7999999998532 223467899999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---EEEeeecCcc
Q 043526 646 YEYMANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE---AKLADFGLSK 720 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~---~kL~DFGla~ 720 (858)
|||+++|+|.+.+.... ...+++..+..++.||++||+||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999998886543 335899999999999999999999 889999999999999987655 9999999998
Q ss_pred cccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 721 VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 721 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
....... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||.... ..+. ..+..+... .
T Consensus 182 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~----~~i~~~~~~--~ 251 (351)
T 3c0i_A 182 QLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLF----EGIIKGKYK--M 251 (351)
T ss_dssp ECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHH----HHHHHTCCC--C
T ss_pred EecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHH----HHHHcCCCC--C
Confidence 7654322 2234569999999999998889999999999999999999999997532 1111 111111110 0
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+... ......+.+++.+|++.||++||++.|++++
T Consensus 252 ~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 252 NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 1123468899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=374.78 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=209.6
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 4567899999999999999888899999997654 345789999999999999999999999876 67899999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......+++.+++.|+.||++||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 424 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence 999998655557899999999999999999999 88999999999999999999999999999987643221122234
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.++..|+|||.+....++.++|||||||++|||++ |+.||...... .+ ...+..+. ....+...
T Consensus 425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~----~~~i~~~~---------~~~~~~~~ 489 (535)
T 2h8h_A 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV----LDQVERGY---------RMPCPPEC 489 (535)
T ss_dssp TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HH----HHHHHTTC---------CCCCCTTC
T ss_pred cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCC---------CCCCCCCC
Confidence 46788999999998899999999999999999999 89998654321 11 11222221 11112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
...+.+++.+||+.+|++||++++|++.|++++...
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 457889999999999999999999999999876443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=344.92 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=208.9
Q ss_pred hhccccccccCceEEEEEEE--------CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCee
Q 043526 573 DNFNKVLGKGGFGTVYHGYL--------DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~--------~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 642 (858)
+.+.+.||+|+||.||+|.. .+++.||||++..... ...+++.+|+++++++ +||||+++++++...+..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 34568899999999999986 3577899999976533 3456789999999999 899999999999999999
Q ss_pred EEEEeeccCCChHHHhhhccc--------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 643 GLIYEYMANGNLKQLLSDEKA--------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
++||||+++|+|.+++..... ..+++.+++.++.||++||+||| +.+|+||||||+|||++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCC
Confidence 999999999999999976432 34899999999999999999999 8899999999999999999
Q ss_pred CCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHH
Q 043526 709 LEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQT 786 (858)
Q Consensus 709 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~ 786 (858)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||++++||++ |+.||...... .+.
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~-- 269 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELF-- 269 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH--
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HHH--
Confidence 99999999999876543222 1223456788999999998889999999999999999999 99998654311 111
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
..+..+.. ...+......+.+++.+|++.+|.+||+++|+++.|++++.....
T Consensus 270 --~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 --KLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp --HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --HHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11122111 111223345788999999999999999999999999998776543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.01 Aligned_cols=248 Identities=32% Similarity=0.546 Sum_probs=200.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcc-------hHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQG-------FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||.||+|... +++.||||++....... .+.+.+|++++++++||||+++++++.... ++|
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence 44578999999999999974 89999999986543322 267899999999999999999999987655 699
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEcCCCC-----EEEeeecC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLTENLE-----AKLADFGL 718 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~~~~~-----~kL~DFGl 718 (858)
|||+++|+|.+.+.... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++. +||+|||+
T Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 99999999999886543 46899999999999999999999 778 999999999999988776 99999999
Q ss_pred cccccCCCcceeecccCCCCccCccccc--cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTHVSTVVAGTPGYLDPEYFV--TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++.... ......|++.|+|||.+. ...++.++|||||||+++||++|+.||.............+. ..+
T Consensus 176 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~-- 246 (287)
T 4f0f_A 176 SQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---EEG-- 246 (287)
T ss_dssp CBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH---HSC--
T ss_pred cccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh---ccC--
Confidence 975432 233456899999999984 456789999999999999999999999765443322222211 111
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
.....+......+.+++.+|++.+|++||+++|+++.|++
T Consensus 247 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 -------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111223334578899999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.27 Aligned_cols=248 Identities=20% Similarity=0.346 Sum_probs=202.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|... +|+.+|+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 44578999999999999975 6889999998744 334567889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC--CCCEEEeeecCcccccCCCccee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE--NLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~--~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 87 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 160 (321)
T 1tki_A 87 DIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF 160 (321)
T ss_dssp BHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--cc
Confidence 9999996542 36899999999999999999999 889999999999999997 7899999999998775433 23
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .+ ..... .+... .+.... .
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~---~~~i~-~~~~~--~~~~~~----~ 228 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QI---IENIM-NAEYT--FDEEAF----K 228 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH---HHHHH-HTCCC--CCHHHH----T
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HH---HHHHH-cCCCC--CChhhh----c
Confidence 3456899999999999888899999999999999999999999754321 11 11111 11110 000000 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....++.+++.+|+..||++|||++|++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123468899999999999999999999885
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=347.85 Aligned_cols=264 Identities=17% Similarity=0.216 Sum_probs=208.5
Q ss_pred hccccccccCceEEEEEEECC---------CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeee-------------
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD---------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTN------------- 631 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~------------- 631 (858)
.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 445789999999999999763 889999998754 56889999999999999998
Q ss_pred --eeeeeee-CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 632 --LVGYFIE-DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 632 --l~~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
+++++.. ++..++||||+ +++|.+++.......+++.+++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETT
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCC
Confidence 5677766 67889999999 999999998765567999999999999999999999 8899999999999999999
Q ss_pred C--CEEEeeecCcccccCCCcc------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc
Q 043526 709 L--EAKLADFGLSKVFPIGGTH------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN 780 (858)
Q Consensus 709 ~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~ 780 (858)
+ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||+++||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 8999999999876432211 1133478999999999999899999999999999999999999998654333
Q ss_pred ccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 043526 781 IHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851 (858)
Q Consensus 781 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~ 851 (858)
..+.......... ...+.+.... ......++.+++.+|++.+|++||+++++++.|++++......
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 276 EDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 2233322221111 1111111110 0112357889999999999999999999999999987665533
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=344.22 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=201.9
Q ss_pred hhccccccccCceEEEEEEEC-CC-------CEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DG-------TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g-------~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 644 (858)
+.+.+.||+|+||.||+|... ++ ..||+|++........+.+.+|++++++++||||+++++++..++..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 345678999999999999864 33 5799999977666667889999999999999999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC--------EEEeee
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE--------AKLADF 716 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~--------~kL~DF 716 (858)
||||+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999999997643 34899999999999999999999 889999999999999998887 999999
Q ss_pred cCcccccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC
Q 043526 717 GLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795 (858)
Q Consensus 717 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~ 795 (858)
|++...... ....|++.|+|||.+.+ ..++.++||||||++++||++|+.|+....... .... .....
T Consensus 166 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----~~~~-~~~~~- 234 (289)
T 4fvq_A 166 GISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ----RKLQ-FYEDR- 234 (289)
T ss_dssp CSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHH-HHHTT-
T ss_pred cccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH----HHHH-Hhhcc-
Confidence 998754321 23457889999999987 778999999999999999999765554332111 1111 11110
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARK 852 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~ 852 (858)
...+.....++.+++.+|++.+|++|||++|++++|++++....+..
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 235 ----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp ----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 00111112357899999999999999999999999999877665443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=344.34 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=209.3
Q ss_pred hccccccccCceEEEEEEEC-CC-----CEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DG-----TQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g-----~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||.||+|... ++ +.||||.+..... ...+.+.+|+++++++ +||||+++++++..++..++|
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 128 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence 44578999999999999964 23 4899999976533 3456789999999999 899999999999999999999
Q ss_pred EeeccCCChHHHhhhcc------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEE
Q 043526 646 YEYMANGNLKQLLSDEK------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKL 713 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL 713 (858)
|||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEEE
Confidence 99999999999997543 235789999999999999999999 889999999999999999999999
Q ss_pred eeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHH
Q 043526 714 ADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMI 791 (858)
Q Consensus 714 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~ 791 (858)
+|||+++........ ......|++.|+|||.+.+..++.++||||||++++||+| |..||....... .+... .
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~----~ 280 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL----V 280 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHH----H
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHH----H
Confidence 999999866433222 2223456788999999998899999999999999999999 888986543221 11111 1
Q ss_pred hcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 043526 792 AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851 (858)
Q Consensus 792 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~ 851 (858)
..+ .....+......+.+++.+|++.+|.+||+++|++++|+++......+
T Consensus 281 ~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 281 KDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred hcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 111 111112223456889999999999999999999999999987665443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.33 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=205.0
Q ss_pred HHHhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee----------
Q 043526 570 KITDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE---------- 638 (858)
Q Consensus 570 ~~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------- 638 (858)
...+...+.||+|+||.||+|... +|+.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 334455689999999999999976 79999999997543 467889999999999999999998864
Q ss_pred ------CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEE
Q 043526 639 ------DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAK 712 (858)
Q Consensus 639 ------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~k 712 (858)
....++||||+++|+|.+++.......+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence 445889999999999999998766668999999999999999999999 88999999999999999999999
Q ss_pred EeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHh
Q 043526 713 LADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIA 792 (858)
Q Consensus 713 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~ 792 (858)
|+|||++........ .....|++.|+|||.+.+..++.++||||||++++||++|..|+.... .. ...+.
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~-~~~~~ 232 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KF-FTDLR 232 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HH-HHHHH
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HH-HHHhh
Confidence 999999987654322 233468999999999998889999999999999999999998874211 11 11111
Q ss_pred cCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 793 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.+.+ +......+.+++.+|++.+|++||++.|++++|+.+.+
T Consensus 233 ~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 233 DGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp TTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred cccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 2111 11123357799999999999999999999999998543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.64 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=196.8
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||.||+|... ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+++|+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 34578999999999999984 789999998643 34578999999999999999999999887 34789999999999
Q ss_pred hHHHhhhccc-CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC-EEEeeecCcccccCCCcceee
Q 043526 654 LKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE-AKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 654 L~~~L~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~ 731 (858)
|.+++..... ..+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++...... ..
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~ 161 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MT 161 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cc
Confidence 9999976442 24788999999999999999999432389999999999999998887 799999999765422 12
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
...||+.|+|||.+.+..++.++||||||++++||++|+.||.........+.. ....+.... ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~---------~~~~ 228 (307)
T 2eva_A 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW----AVHNGTRPP---------LIKN 228 (307)
T ss_dssp ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH----HHHTTCCCC---------CBTT
T ss_pred cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH----HHhcCCCCC---------cccc
Confidence 345899999999999989999999999999999999999999754433221111 111111111 1112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
....+.+++.+|++.+|++|||++|++++|+.+...
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 234688999999999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=348.82 Aligned_cols=245 Identities=20% Similarity=0.338 Sum_probs=197.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++.++ +||||+++++++..++..++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 44579999999999999976 68899999997542 23345688899999887 899999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 135 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 208 (396)
T 4dc2_A 135 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 208 (396)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence 99999999997643 6899999999999999999999 8899999999999999999999999999998633222 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc---ccHHHHHHHHHhcCCchhhhchhhc
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN---IHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~---~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... ......+...+..+.+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 279 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 279 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---------
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---------
Confidence 2344679999999999999999999999999999999999999996432211 1111222222222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
.++.....++.+++.+||+.||.+||++
T Consensus 280 -~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1223344578899999999999999995
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=349.55 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=197.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.. +|+.||||+++.. .......+..|.+++..+ +||||+++++++...+..++||||
T Consensus 26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 105 (353)
T 3txo_A 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEF 105 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeC
Confidence 44578999999999999975 6899999999753 223456688899999988 699999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 106 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 179 (353)
T 3txo_A 106 VNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-V 179 (353)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-c
Confidence 99999999997653 6899999999999999999999 8899999999999999999999999999998643222 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+. .. +..+. ..+
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~---~~-i~~~~----------~~~ 243 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLF---EA-ILNDE----------VVY 243 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HH-HHHCC----------CCC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHH---HH-HHcCC----------CCC
Confidence 233457999999999999888999999999999999999999999754321 111 11 11111 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNM------NEVVT 839 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm------~eVl~ 839 (858)
+......+.+++.+|++.+|++||++ +|+++
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22234568899999999999999998 67765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.92 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=199.4
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||+||+|...+|+.||||++..... .....+.+|++++++++||||+++++++..++..++||||+++
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 3578999999999999998999999999975432 2346788999999999999999999999999999999999985
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+.+.... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 104 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 178 (311)
T 3niz_A 104 DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTH 178 (311)
T ss_dssp EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----C
T ss_pred CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cccC
Confidence 8888886543 45899999999999999999999 88999999999999999999999999999987643322 2233
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch---hhh------ch
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE---NIV------DS 802 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~---~~~------d~ 802 (858)
..||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... ....+.......... ... +.
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 468999999999876 568999999999999999999999997654322 222222222111110 000 00
Q ss_pred hhc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLR--GGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... ...+ .....++.+++.+|++.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 0000 1123467899999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.23 Aligned_cols=246 Identities=25% Similarity=0.398 Sum_probs=193.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--------------------------cchHhHHHHHHHHHhccc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--------------------------QGFKEFEAEVKLLMRVHH 626 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--------------------------~~~~~~~~E~~~l~~l~H 626 (858)
.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++|
T Consensus 16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 34578999999999999964 789999999875421 123568999999999999
Q ss_pred ceeeeeeeeeee--CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 627 RNLTNLVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 627 pnIv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
|||+++++++.. .+..++||||+++++|.+++.. ..+++.+++.++.|+++||+||| +.+|+||||||+|||
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLL 169 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEE
Confidence 999999999987 5678999999999999987643 36899999999999999999999 889999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHhCCCccccCCCccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW---LNEKSDVYSFGVVLLEIITSQAVIVRNENENI 781 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~ 781 (858)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||+++||++|+.||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--- 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI--- 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence 99999999999999987654322 223457899999999987654 47889999999999999999999965431
Q ss_pred cHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 782 HIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 782 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... ...+..+... ..........+.+++.+|++.||++||+++|++++
T Consensus 246 --~~~-~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 --MCL-HSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp --HHH-HHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred --HHH-HHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111 1111111110 00111233568899999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=338.89 Aligned_cols=242 Identities=27% Similarity=0.415 Sum_probs=201.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.. +|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 34578999999999999975 7999999999753 2234567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 89 EGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 9999999997543 6899999999999999999999 899999999999999999999999999999875432
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ......... +.. .++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~-~~~----------~~p 223 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILN-AEL----------RFP 223 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHH-CCC----------CCC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-CCC----------CCC
Confidence 2345799999999999999999999999999999999999999965431 111111111 110 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....++.+++.+|++.+|++|| +++|++++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 22345688999999999999999 88888864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.82 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=208.3
Q ss_pred hccccccccCceEEEEEEE------CCCCEEEEEEeccCCCc-chHhHHHHHHHHHhc-ccceeeeeeeeeeeCC-eeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDN-NMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~-~~~l 644 (858)
.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++...+ ..++
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 4457899999999999984 35689999999765432 346789999999999 7999999999988765 4899
Q ss_pred EEeeccCCChHHHhhhcccC--------------chhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC
Q 043526 645 IYEYMANGNLKQLLSDEKAS--------------TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE 710 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~--------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~ 710 (858)
||||+++|+|.+++...... .+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCC
Confidence 99999999999999765421 2899999999999999999999 889999999999999999999
Q ss_pred EEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHH
Q 043526 711 AKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVT 788 (858)
Q Consensus 711 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~ 788 (858)
+||+|||+++........ ......|++.|+|||.+.+..++.++||||||++++||+| |+.||....... .+ .
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~----~ 261 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF----C 261 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH----H
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-HH----H
Confidence 999999999876443322 2233457889999999999999999999999999999998 999986544221 11 1
Q ss_pred HHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 789 NMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 789 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
..+..+.. ...+......+.+++.+|++.+|.+||+++|++++|+++++...
T Consensus 262 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 262 RRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111111 11112234468899999999999999999999999999886554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.41 Aligned_cols=263 Identities=18% Similarity=0.290 Sum_probs=201.9
Q ss_pred hcccccccc--CceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKG--GFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence 445789999 99999999976 79999999997543 23346788899999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||.+.........
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 99999999998765567999999999999999999999 889999999999999999999999999988754322111
Q ss_pred ------eeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc-------
Q 043526 729 ------VSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK------- 793 (858)
Q Consensus 729 ------~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~------- 793 (858)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||........ +..........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC--------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCCcccccccc
Confidence 1122468899999999987 6789999999999999999999999976443221 11111000000
Q ss_pred --C-------------Cchhhhch---h------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 794 --G-------------DIENIVDS---C------LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 794 --~-------------~~~~~~d~---~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ...+.... . ............+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00000000 0 0000112234568899999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=343.89 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=202.0
Q ss_pred ccccccccCceEEEEEEEC-CCCE----EEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQ----VAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..+.||+|+||.||+|... +|+. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++||||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 4578999999999999964 4554 8888876443 344567889999999999999999999886 5668899999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++...+ ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 96 LPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp CTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred CCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999997643 46899999999999999999999 889999999999999999999999999999987544322
Q ss_pred -eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 729 -VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 729 -~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
......|+..|+|||.+.+..++.++|||||||++|||+| |+.||....... +.. .+..+.. .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~---------~ 236 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPD----LLEKGER---------L 236 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHH----HHHTTCB---------C
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHH----HHHcCCC---------C
Confidence 2334567889999999998999999999999999999999 999997644221 111 1111110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
..+......+.+++.+|++.+|.+||+++|++++|+++....
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111122335778999999999999999999999999976543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=355.72 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=201.2
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.||+|+||.||+|+.. +|+.||+|+++.. .......+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 3478999999999999976 6899999998642 22334568899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|+|.++++.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 153 gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 153 GGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp TEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 99999999653 5889999999999999999999 88999999999999999999999999999987765444344
Q ss_pred ecccCCCCccCccccccCC----CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 731 TVVAGTPGYLDPEYFVTDW----LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~----~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...... .....+..... .+.-
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~----------~~~~ 294 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKN----------SLTF 294 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHH----------HCCC
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhccc----------cccC
Confidence 4567999999999997654 789999999999999999999999754311 11111111000 0000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSE--RPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~--RPsm~eVl~~ 840 (858)
........++.+++.+|++.+|.+ ||+++||+++
T Consensus 295 p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011123457889999999999988 9999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.70 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=198.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence 34578999999999999998899999999865432 2346788999999999999999999999999999999999986
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... ..+++.++..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 -~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (288)
T 1ob3_A 85 -DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (288)
T ss_dssp -EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred -CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence 9999986543 46889999999999999999999 88999999999999999999999999999987643221 223
Q ss_pred cccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---chhh-----hch
Q 043526 732 VVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IENI-----VDS 802 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~~~-----~d~ 802 (858)
...||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+........ .... .++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 3468999999999875 4589999999999999999999999975432 111222222111110 0000 000
Q ss_pred hhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRG-------GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... ........++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0011234577899999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=369.80 Aligned_cols=254 Identities=22% Similarity=0.382 Sum_probs=204.5
Q ss_pred cccccCceEEEEEEEC---CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 578 VLGKGGFGTVYHGYLD---DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 56789999998653 3356789999999999999999999999976 56899999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee--e
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS--T 731 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~ 731 (858)
|.+++... ...+++.+++.++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.......... .
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999754 346899999999999999999999 88999999999999999999999999999987654322221 2
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...+++.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +. ..+..+.. ...+.
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~~---------~~~p~ 562 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGKR---------MECPP 562 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH----HHHHTTCC---------CCCCT
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCC---------CCCCC
Confidence 2345689999999999999999999999999999998 999997654321 11 22222211 11223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~ 851 (858)
....++.+++.+||+.+|++||++++|++.|+.+......+
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 34467889999999999999999999999999987665443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=345.62 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=202.3
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 455688999999999999975 789999999975532 34567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---CEEEeeecCcccccCCC
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL---EAKLADFGLSKVFPIGG 726 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DFGla~~~~~~~ 726 (858)
++|+|.+++... ..+++.++..++.||++||+||| +.+|+||||||+|||++.++ .+||+|||++.......
T Consensus 111 ~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 111 TGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999654 36899999999999999999999 88999999999999998654 59999999998765332
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.. .+..+... ...+.
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~----~i~~~~~~-~~~~~--- 253 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYA----QIKAGAYD-YPSPE--- 253 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHTCCC-CCTTG---
T ss_pred --ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHhCCCC-CCccc---
Confidence 22345799999999999998999999999999999999999999975431 11111 11221110 00000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......++.+++.+|++.||++||++.|++++
T Consensus 254 --~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 --WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01234568899999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.14 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=199.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||+||+|... +|+.||||++..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 34578999999999999975 789999999975433 234678899999999999999999999999999999999998
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+ +|.+.+... ...+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 85 ~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 158 (292)
T 3o0g_A 85 Q-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp E-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred C-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence 6 666665443 246899999999999999999999 88999999999999999999999999999987643322 22
Q ss_pred ecccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---chhhhc---hh
Q 043526 731 TVVAGTPGYLDPEYFVTDW-LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IENIVD---SC 803 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~~~~d---~~ 803 (858)
....||+.|+|||.+.+.. ++.++|||||||+++||++|+.|+........ ....+........ ...... ..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhccccccc
Confidence 3456899999999998665 79999999999999999999988755443222 2222222211110 000000 00
Q ss_pred h---------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 L---------RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ...........+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000112234578899999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.73 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+.||+|+||.||+|... +|+.||||+++.......+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 357999999999999964 7999999999876656677899999999999999999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE--cCCCCEEEeeecCcccccCCCcceeec
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL--TENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
.+++.... ..+++.+++.++.||++||+||| +.+|+||||||+|||+ ++++.+||+|||+++....... ...
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 99986543 46899999999999999999999 8899999999999999 5678899999999987654322 233
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..||+.|+|||.+....++.++|||||||+++||++|+.||...... ........... . ...... ...
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~~~~-~-~~~~~~-----~~~ 315 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----ETLNNILACRW-D-LEDEEF-----QDI 315 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCC-C-SCSGGG-----TTS
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhccC-C-CChhhh-----ccC
Confidence 46899999999999889999999999999999999999999754321 11111111111 0 000000 122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..++.+++.+|++.+|.+||+++|++++
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 3578899999999999999999999983
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.99 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=205.2
Q ss_pred cccccCceEEEEEEE---CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 578 VLGKGGFGTVYHGYL---DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~---~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.||+|+||.||+|.+ .+++.||||+++.... ...+++.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 899999999999964 2578899999975532 2357799999999999999999999999 667789999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee--
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS-- 730 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~-- 730 (858)
+|.+++.... .+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++...........
T Consensus 103 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (291)
T 1xbb_A 103 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177 (291)
T ss_dssp EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccccc
Confidence 9999997643 6899999999999999999999 88999999999999999999999999999987754433222
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....+++.|+|||.+.+..++.++||||||++++||++ |+.||...... . +...+..+.. ...+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~----~~~~~~~~~~---------~~~~ 242 (291)
T 1xbb_A 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E----VTAMLEKGER---------MGCP 242 (291)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTTCC---------CCCC
T ss_pred ccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHHcCCC---------CCCC
Confidence 22345788999999998888999999999999999999 99998754321 1 1122222211 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhcc
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKK 853 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~~ 853 (858)
......+.+++.+|++.+|++||++.++++.|++++.......+
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 23345788999999999999999999999999998877654443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.56 Aligned_cols=262 Identities=19% Similarity=0.280 Sum_probs=207.0
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeee-eeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF-IEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|+. .+|+.||||++..... ..++.+|+++++.++|+++++.+..+ ...+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 3457899999999999996 5899999999875533 35789999999999998877777666 5567789999999 8
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
++|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 89 ~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 89 PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99999997433 46899999999999999999999 8899999999999999 48889999999999876544321
Q ss_pred ------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc-cccHHHHHHHHHhcCCchhhhc
Q 043526 729 ------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE-NIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 729 ------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~-~~~l~~~v~~~~~~~~~~~~~d 801 (858)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .......+..........
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 240 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE---- 240 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH----
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH----
Confidence 123457899999999999989999999999999999999999999764322 222222222211111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~ 851 (858)
.+... ...++.+++.+|++.+|++||+++++++.|+++.......
T Consensus 241 -~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 241 -VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -HHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 11111 2346889999999999999999999999999987665543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=331.94 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=203.6
Q ss_pred cccccccCceEEEEEEEC-CC---CEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCee-EEEEeec
Q 043526 576 NKVLGKGGFGTVYHGYLD-DG---TQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNM-GLIYEYM 649 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~lV~Ey~ 649 (858)
.+.||+|+||.||+|... ++ ..||+|.+..... ...+.+.+|++++++++||||+++++++...+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 478999999999999853 33 3799999976443 3457789999999999999999999999877665 9999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc--
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-- 727 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-- 727 (858)
.+|+|.+++... ...+++.+++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 106 ~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 106 CHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred cCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999999753 346899999999999999999999 88999999999999999999999999999986543211
Q ss_pred -ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 -HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......++..|+|||.+.+..++.++||||||++++||++|+.|+..... ...+...+. .+. ..
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~----~~~---------~~ 247 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLA----QGR---------RL 247 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHH----TTC---------CC
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhh----cCC---------CC
Confidence 122234578899999999999999999999999999999997666543332 222222211 111 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
..+......+.+++.+|++.+|.+|||++++++.|++++..-
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 112223456889999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.37 Aligned_cols=245 Identities=24% Similarity=0.254 Sum_probs=192.3
Q ss_pred HHhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEE
Q 043526 571 ITDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 571 ~t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
-.+...+.||+|+||+||+|... +|+.||||++...... ...++..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 34455678999999999999976 7999999998654332 334455666666555 8999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+ +++|.+++.... ..++|.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 669999987653 46999999999999999999999 7899999999999999999999999999998764322
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
......||+.|+|||.+.+ .++.++|||||||+++||++|..++.... . ...+..+... +.+.
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~-----~~~~~~~~~~----~~~~- 274 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G-----WQQLRQGYLP----PEFT- 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H-----HHHHTTTCCC----HHHH-
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H-----HHHHhccCCC----cccc-
Confidence 2334568999999998875 68999999999999999999977664321 0 1111222111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.+|++|||++|++++
T Consensus 275 ---~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 ---AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1223578899999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=342.23 Aligned_cols=260 Identities=21% Similarity=0.257 Sum_probs=198.4
Q ss_pred hccccccccCceEEEEEEEC----CCCEEEEEEeccCCCc-----------chHhHHHHHHHHHhcccceeeeeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSGQ-----------GFKEFEAEVKLLMRVHHRNLTNLVGYFIE 638 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 638 (858)
.+.+.||+|+||.||+|... ++..+|||++...... ....+.+|+..++.++||||+++++++..
T Consensus 40 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~ 119 (345)
T 2v62_A 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLT 119 (345)
T ss_dssp EEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEE
T ss_pred EEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccc
Confidence 44578999999999999975 6788999998765332 12346678888999999999999999988
Q ss_pred ----CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC--CEE
Q 043526 639 ----DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL--EAK 712 (858)
Q Consensus 639 ----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~--~~k 712 (858)
....++||||+ +++|.+++.... .+++.+++.++.||+.||+||| +.+|+||||||+|||++.++ .+|
T Consensus 120 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 120 EFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp ESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEE
Confidence 67899999999 999999997654 7899999999999999999999 88999999999999999887 999
Q ss_pred EeeecCcccccCCCcc------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHH
Q 043526 713 LADFGLSKVFPIGGTH------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT 786 (858)
Q Consensus 713 L~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~ 786 (858)
|+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~- 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT- 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH-
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH-
Confidence 9999999876432211 113456899999999999989999999999999999999999999654322222222
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
........ +...+..... ......++.+++.+|++.+|++||++++|++.|+++
T Consensus 273 ~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 273 AKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 22211111 1111111111 112334788999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.15 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=205.9
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeee-eeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF-IEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~Ey~~ 650 (858)
+.+.+.||+|+||.||+|.. .+|+.||||++..... ..++.+|+++++.++|++++..+..+ ...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 34468899999999999996 5889999998765432 35688999999999988887777666 5667789999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~~~~ 727 (858)
+++|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999999997433 36899999999999999999999 8899999999999999 7889999999999987654332
Q ss_pred c------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc-cccHHHHHHHHHhcCCchhhh
Q 043526 728 H------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE-NIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 728 ~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~-~~~l~~~v~~~~~~~~~~~~~ 800 (858)
. ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .......+..........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 240 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE--- 240 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH---
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh---
Confidence 1 123457899999999999989999999999999999999999999764432 122222222111111111
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
.+... ....+.+++.+|++.+|++||+++++++.|++++.....
T Consensus 241 --~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 241 --VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp --HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred --hhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 01111 134688999999999999999999999999998766543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.74 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=201.4
Q ss_pred ccccccccCceEEEEEEECC-----CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLDD-----GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..+.||+|+||.||+|.... +..||||++..... ....++.+|++++++++||||+++++++...+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 34789999999999998642 24699999975533 3345789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 128 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 128 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999997542 46899999999999999999999 889999999999999999999999999999876433221
Q ss_pred --eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 729 --VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 729 --~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
......++..|+|||.+.+..++.++||||||++++||++ |+.||...... . +...+.++. .
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~----~~~~~~~~~---------~ 268 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E----VMKAINDGF---------R 268 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H----HHHHHHTTC---------C
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--H----HHHHHHCCC---------c
Confidence 1122345778999999998899999999999999999999 99998654321 1 111222211 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
...+......+.+++.+|++.+|++||++.|++++|++++.....
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 111223345788999999999999999999999999998765443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.77 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=180.7
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+.||+|+||.||+|... +|+.||||++... ....+.+|++++..++ ||||+++++++.++...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999975 7899999999643 3467889999999997 99999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---CEEEeeecCcccccCCCcceee
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL---EAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~ 731 (858)
.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 94 FERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 9999764 46899999999999999999999 88999999999999998765 799999999987644322 223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc--ccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN--IHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~--~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
...||+.|+|||.+.+..++.++|||||||+++||++|+.||....... ....+ +...+..+.... .... .
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~-~~~~-----~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF-EGEA-----W 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC-CSHH-----H
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC-Cccc-----c
Confidence 4568999999999999999999999999999999999999997543211 11111 222222221100 0000 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.||++||+++|++++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1234578899999999999999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.60 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=198.1
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC-CeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-NNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|.. +|+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|
T Consensus 24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 4457899999999999987 48899999997543 457899999999999999999999997655 4789999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++...... ...
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~ 173 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 173 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc----ccC
Confidence 9999997665445889999999999999999999 889999999999999999999999999998765432 122
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||.+.+..++.++||||||++++||+| |+.||...... .+.. .+..+. ....+..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~----~~~~~~---------~~~~~~~ 238 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP----RVEKGY---------KMDAPDG 238 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHH----HHTTTC---------CCCCCTT
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHhcCC---------CCCCccc
Confidence 357889999999998899999999999999999998 99998654322 1111 111111 1111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
....+.+++.+|++.+|++||+++|+++.|+++...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 345788999999999999999999999999997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=344.07 Aligned_cols=264 Identities=22% Similarity=0.364 Sum_probs=195.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHH--HHhcccceeeeeeeeeee-----CCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKL--LMRVHHRNLTNLVGYFIE-----DNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~-----~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|+. +|+.||||++.... ...+..|.++ +..++||||+++++.+.. ....++||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 3457899999999999987 68999999996432 3444445544 455899999999986543 23578999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC---------CeEecCCCCcceEEcCCCCEEEeeec
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP---------PIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~---------~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
||+++|+|.+++.... .++..++.++.||++||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 92 e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp CCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred ecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 9999999999996543 589999999999999999999 66 99999999999999999999999999
Q ss_pred CcccccCCCc-------ceeecccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccc-c
Q 043526 718 LSKVFPIGGT-------HVSTVVAGTPGYLDPEYFVT-------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI-H 782 (858)
Q Consensus 718 la~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~-~ 782 (858)
+++.+..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........ .
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987643211 11223468999999999876 4566789999999999999999888755432111 0
Q ss_pred H-----------HHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 783 I-----------IQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 783 l-----------~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
. ................+.... .........+.+++.+||+.||++|||++|+++.|++++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 0 001111111111000000000 0123456679999999999999999999999999999875543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=345.52 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=204.4
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 344578999999999999975 7899999999866555567889999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC--CCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE--NLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~--~~~~kL~DFGla~~~~~~~~~~ 729 (858)
|+|.+++.... ..+++.+++.++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 133 g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 133 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 99999996542 46899999999999999999999 889999999999999984 47799999999987654322
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ......+ ...... ......
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i----~~~~~~------~~~~~~ 274 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNV----KRCDWE------FDEDAF 274 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH----HHCCCC------CCSSTT
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCCC------CCcccc
Confidence 2334689999999999998999999999999999999999999975431 1111111 111100 000111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.||++||+++|++++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1234578899999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=352.46 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=201.5
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+.+.+.||+|+||.||+|... +|+.+|+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 445689999999999999864 799999999976532 23467899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc---CCCCEEEeeecCcccccCCC
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~---~~~~~kL~DFGla~~~~~~~ 726 (858)
++|+|.+.+.... .+++.++..++.||+.||+||| +.+|+||||||+|||++ +++.+||+|||+++......
T Consensus 93 ~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 93 TGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp BCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999997643 6899999999999999999999 88999999999999998 46789999999998765432
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
. ......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ..+.. .+..+... ...+.
T Consensus 168 ~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~----~i~~~~~~-~~~~~--- 236 (444)
T 3soa_A 168 Q-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQ----QIKAGAYD-FPSPE--- 236 (444)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----HHHHTCCC-CCTTT---
T ss_pred c-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHH----HHHhCCCC-CCccc---
Confidence 2 22345799999999999998999999999999999999999999965431 11111 12222110 00000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......++.+++.+|++.||++|||++|++++
T Consensus 237 --~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 237 --WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01234568899999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=326.97 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=202.8
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 345688999999999999975 6789999999876666778899999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
++|.+++.... .+++.+++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||++........
T Consensus 91 ~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~- 164 (277)
T 3f3z_A 91 GELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164 (277)
T ss_dssp CBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC-
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc-
Confidence 99999987643 6899999999999999999999 8899999999999999 7889999999999987654322
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....||+.|+|||.+.+. ++.++||||||++++||++|+.||...... . ....+.++.... .....
T Consensus 165 -~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~----~~~~~~~~~~~~-~~~~~---- 231 (277)
T 3f3z_A 165 -MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--E----VMLKIREGTFTF-PEKDW---- 231 (277)
T ss_dssp -BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--H----HHHHHHHCCCCC-CHHHH----
T ss_pred -hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--H----HHHHHHhCCCCC-Cchhh----
Confidence 2335689999999988654 899999999999999999999999754321 1 111111211100 00000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++||++.|++++
T Consensus 232 -~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 232 -LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0123578899999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.15 Aligned_cols=243 Identities=26% Similarity=0.407 Sum_probs=199.3
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 4457899999999999996 58999999998643 2233467899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++....... .
T Consensus 92 -~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~ 163 (336)
T 3h4j_B 92 -GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163 (336)
T ss_dssp -CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--T
T ss_pred -CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--c
Confidence 689999986643 6899999999999999999999 8899999999999999999999999999998764432 2
Q ss_pred eecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....||+.|+|||.+.+..+ +.++|||||||+++||++|+.||........ ...+.... ...
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~-~~~ 227 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCV-YVM 227 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSC-CCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCC-CCC
Confidence 234569999999999987765 6899999999999999999999975432211 00000000 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+......+.+++.+|++.||.+|||++|++++
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22334568899999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.23 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=192.5
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++..++..++||||++ |
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 3478999999999999964 79999999997543 3345778999999999999999999999999999999999998 5
Q ss_pred ChHHHhhhcc----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 653 NLKQLLSDEK----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 653 sL~~~L~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+|.+++.... ...+++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 163 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN- 163 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-
Confidence 9999986543 235889999999999999999999 88999999999999999999999999999987643322
Q ss_pred eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhhh----
Q 043526 729 VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENIV---- 800 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~~---- 800 (858)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+....... ......
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 2233468999999999876 46899999999999999999999999754321 1222222211110 000000
Q ss_pred -c------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 -D------------SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 -d------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ..+...........+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000000011223478899999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.84 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=200.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.+ +|+.||||+++... ......+..|.+++..+ +||||+++++++..++..++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 34578999999999999975 78999999997532 33456778899999887 899999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 173 (345)
T 1xjd_A 100 LNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 173 (345)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-C
Confidence 99999999997643 6899999999999999999999 8899999999999999999999999999998643222 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ..+.. .+..+. ..+
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~----~i~~~~----------~~~ 237 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFH----SIRMDN----------PFY 237 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCC----------CCC
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHH----HHHhCC----------CCC
Confidence 23446799999999999999999999999999999999999999975431 11111 111111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMN-EVVT 839 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~ 839 (858)
+.....++.+++.+|++.+|++||++. |+.+
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 222345788999999999999999997 6654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.14 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=192.4
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|+..+ .||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~ 103 (289)
T 3og7_A 27 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEG 103 (289)
T ss_dssp EEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCE
T ss_pred eeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCC
Confidence 445789999999999998643 599999975533 3456789999999999999999999965 55668999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC-Cccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG-GTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~-~~~~~ 730 (858)
++|.+++.... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++...... .....
T Consensus 104 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 104 SSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp EEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred CcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 99999996543 46899999999999999999999 889999999999999999999999999999865432 12222
Q ss_pred ecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
....||+.|+|||.+. ...++.++||||||++++||++|+.||....... . +...+..+....... .
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~----~~~~~~~~~~~~~~~-----~ 249 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-Q----IIEMVGRGSLSPDLS-----K 249 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-H----HHHHHHHTSCCCCTT-----S
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-H----HHHHhcccccCcchh-----h
Confidence 3456899999999986 5678889999999999999999999997544221 1 122222221111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
........+.+++.+|++.+|++||+++|+++.|+++.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11233457889999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=337.54 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=207.9
Q ss_pred hccccccccCceEEEEEEE-----CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCC--eeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-----DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--NMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 646 (858)
.+.+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 4457899999999999984 368999999998776666788999999999999999999999987654 689999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++++|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 124 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred ECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999997653 46899999999999999999999 8899999999999999999999999999998775443
Q ss_pred cce--eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCc----------cccHHHHHHHHHhcC
Q 043526 727 THV--STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENE----------NIHIIQTVTNMIAKG 794 (858)
Q Consensus 727 ~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~----------~~~l~~~v~~~~~~~ 794 (858)
... .....++..|+|||.+.+..++.++||||||++++||+||+.|+.....+ .......+...+..+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 221 12345677899999999888999999999999999999999987532100 000011111111111
Q ss_pred CchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 795 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.....+.....++.+++.+|++.+|++||+++|+++.|+++..+
T Consensus 280 ---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 280 ---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11112233456788999999999999999999999999997543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=339.05 Aligned_cols=245 Identities=28% Similarity=0.413 Sum_probs=191.5
Q ss_pred hccccccccCceEEEEEEE----CCCCEEEEEEeccCC----CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++++.++||||+++++++..++..++|
T Consensus 20 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 99 (327)
T 3a62_A 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLI 99 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEE
T ss_pred EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEE
Confidence 4467899999999999996 479999999997542 23445678899999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 100 LEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999999997543 6889999999999999999999 889999999999999999999999999999764332
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~-~~~---------- 237 (327)
T 3a62_A 175 GT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KTIDKIL-KCK---------- 237 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH-HTC----------
T ss_pred Cc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-hCC----------
Confidence 22 223456899999999999888999999999999999999999999754321 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
...+......+.+++.+|++.+|.+|| +++|++++
T Consensus 238 ~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011223345788999999999999999 77787764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.04 Aligned_cols=251 Identities=20% Similarity=0.329 Sum_probs=200.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|..++.++ +||||+++++++..++..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 34578999999999999975 689999999975432 2345678899999988 899999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 92 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~ 165 (345)
T 3a8x_A 92 VNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 165 (345)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-C
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-C
Confidence 99999999997543 6899999999999999999999 8899999999999999999999999999998643222 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccc---cHHHHHHHHHhcCCchhhhchhhc
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI---HIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~---~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ .....+...+..+..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------- 236 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------- 236 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---------
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---------
Confidence 23345799999999999999999999999999999999999999965322110 111112222222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNM------NEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm------~eVl~~ 840 (858)
..+......+.+++.+|++.||++||++ +|++++
T Consensus 237 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1222334578899999999999999995 566543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=342.71 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=194.9
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCC--cchHhHHHHHHHHHhccc--ceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHH--RNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||++...+++.||||++..... ...+.+.+|++++.+++| |||+++++++..++..++||| +
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 90 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 90 (343)
T ss_dssp EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence 34578999999999999988999999999875432 344678999999999986 999999999999999999999 5
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH- 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~- 728 (858)
.+|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus 91 ~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 91 GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 678999999764 36899999999999999999999 88999999999999997 578999999999876543222
Q ss_pred eeecccCCCCccCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 729 VSTVVAGTPGYLDPEYFVT-----------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ......
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~-------- 232 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHA-------- 232 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHHHHH--------
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHHHHH--------
Confidence 2234579999999999864 67889999999999999999999999653321 111111
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
++++......+......+.+++.+|++.||.+|||++|++++-
T Consensus 233 -~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 233 -IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1122122222222335688999999999999999999998763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=370.82 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=201.4
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++||||++++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 56889999997543 234578999999999999999999999996 4568899999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc--e
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH--V 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~--~ 729 (858)
|+|.+++... ..+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999654 36899999999999999999999 889999999999999999999999999999877543322 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....+++.|+|||.+....++.++|||||||+++||++ |+.||......+ +...+..+. ....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~---------~~~~ 593 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGE---------RMGC 593 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTC---------CCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC---------CCCC
Confidence 223346788999999999999999999999999999998 999997644211 222222221 1112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
+.....++.+++.+||+.+|++||++++|++.|+++...
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 233446788999999999999999999999999997653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.18 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=193.9
Q ss_pred hccccccccCceEEEEEEEC--CC--CEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeee-CCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--DG--TQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-DNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--~g--~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 647 (858)
.+.+.||+|+||.||+|.+. ++ ..||||.++... ....+++.+|++++++++||||++++++|.+ ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999863 32 368999987543 3456789999999999999999999998764 457899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++.+++.++.||++||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 172 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999996543 46889999999999999999999 88999999999999999999999999999986643221
Q ss_pred c---eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 728 H---VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 728 ~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
. ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||...... .+...+ ..+..
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~----~~~~~------- 314 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRR------- 314 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHH----HTTCC-------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHH----HcCCC-------
Confidence 1 1223456788999999999999999999999999999999 56666543322 222211 11110
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+......+.+++.+|++.+|++||+++|+++.|++++..
T Consensus 315 --~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 --LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 011122345688999999999999999999999999997754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=341.14 Aligned_cols=251 Identities=19% Similarity=0.239 Sum_probs=203.2
Q ss_pred hccccccccCceEEEEEE------ECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc---cceeeeeeeeeeeCCeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGY------LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH---HRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 644 (858)
.+.+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++.+++ |+||+++++++..++..++
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 345789999999999994 457899999999754 3456777888777776 9999999999999999999
Q ss_pred EEeeccCCChHHHhhhcc---cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-----------CCC
Q 043526 645 IYEYMANGNLKQLLSDEK---ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-----------NLE 710 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-----------~~~ 710 (858)
||||+++|+|.+++.... ...+++.+++.|+.||++||+||| +.+|+||||||+|||++. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCC
Confidence 999999999999997532 356999999999999999999999 899999999999999998 899
Q ss_pred EEEeeecCcccccCC-CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHH
Q 043526 711 AKLADFGLSKVFPIG-GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTN 789 (858)
Q Consensus 711 ~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~ 789 (858)
+||+|||+++.+... .........||+.|+|||.+.+..++.++|||||||++|||+||+.||.........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------- 294 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------- 294 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------
Confidence 999999999765422 223344567999999999999999999999999999999999999998654322110
Q ss_pred HHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHHHHhh
Q 043526 790 MIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSER-PNMNEVVTELKECLMMELA 850 (858)
Q Consensus 790 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Psm~eVl~~L~~~~~~~~~ 850 (858)
+...+.. + .....+.+++..|+..+|.+| |+++++.+.|++.+.....
T Consensus 295 ----------~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 295 ----------PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp ----------ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred ----------echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 1111111 1 123356688999999999988 6889999999988776543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=333.14 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=198.7
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.+.||+|+||.||+|.. .+|+.||||++.... .....++.+|++++++++||||+++++++..++..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 34568899999999999996 479999999997532 23456789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 649 MANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
+++|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999996532 446899999999999999999999 8899999999999999999999999999998764332
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
. ......|+..|+|||.+.+..++.++||||||++++||++|+.||.........+ .. .+........
T Consensus 191 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~~~------- 258 (310)
T 2wqm_A 191 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CK-KIEQCDYPPL------- 258 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH---HH-HHHTTCSCCC-------
T ss_pred c-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH---HH-HhhcccCCCC-------
Confidence 2 2223468999999999999899999999999999999999999986543222111 11 1222111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
.......++.+++.+|+..||++||++++|++.|+++......
T Consensus 259 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 259 -PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0112234688999999999999999999999999997665543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=338.81 Aligned_cols=256 Identities=30% Similarity=0.475 Sum_probs=204.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEE--EEEEeccC-CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQV--AVKMLSSS-SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~v--AVK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|... +|..+ |||.+... .....+.+.+|+++++++ +||||+++++++..++..++||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 45678999999999999964 66654 99998753 333456789999999999 899999999999999999999999
Q ss_pred ccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 649 MANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
+++|+|.+++.... ...+++.+++.++.||++||+||| +.+|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999997543 246899999999999999999999 8899999999999999999999999
Q ss_pred eecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhc
Q 043526 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAK 793 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~ 793 (858)
|||+++..... .......+++.|+|||.+.+..++.++||||||++++||+| |+.||...... . ....+..
T Consensus 185 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~-~~~~~~~ 256 (327)
T 1fvr_A 185 DFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E-LYEKLPQ 256 (327)
T ss_dssp CTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H-HHHHGGG
T ss_pred ccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----H-HHHHhhc
Confidence 99998743221 11223456889999999998889999999999999999998 99998654311 1 1112222
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+. ....+......+.+++.+|++.+|.+||+++|++++|++++....
T Consensus 257 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11 111222334578899999999999999999999999999876554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.23 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=186.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 34578999999999999976 68899999997543 3467889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCcce
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+|.+++... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 134 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~ 206 (349)
T 2w4o_A 134 ELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VL 206 (349)
T ss_dssp BHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--cc
Confidence 999999654 36899999999999999999999 889999999999999975 889999999999876432 12
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ....+...... ... ...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~~-~~~-----~~~ 275 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEYY-FIS-----PWW 275 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCCC-CCT-----TTT
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCCc-cCC-----chh
Confidence 2345689999999999998999999999999999999999999975443211 11111111110 000 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.||++||++.|++++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234578899999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=340.35 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=201.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999975 7999999998643 2234567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 124 AGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 9999999997643 6899999999999999999999 899999999999999999999999999999876432
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... . +.. ..+..+.. .++
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~---~~~-~~i~~~~~----------~~p 258 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--I---QIY-EKIVSGKV----------RFP 258 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHH-HHHHHCCC----------CCC
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--H---HHH-HHHHcCCC----------CCC
Confidence 2235689999999999999999999999999999999999999975431 1 111 11112211 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
......+.+++.+|++.||.+||+ ++|++++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 233457889999999999999998 8888764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=342.76 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=192.5
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.+.||+|+||.||+++.. +|+.||||++..... ..+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 345688999999999999976 899999999975433 346788999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC--EEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE--AKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~--~kL~DFGla~~~~~~~~~~ 729 (858)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||+++...... .
T Consensus 101 ~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~ 173 (361)
T 3uc3_A 101 GELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 173 (361)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence 99999996543 6899999999999999999999 899999999999999987766 9999999997543222 2
Q ss_pred eecccCCCCccCccccccCCCCCc-hhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEK-SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~k-sDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....||+.|+|||.+.+..++.+ +|||||||++|||++|+.||...... ......+....... .....
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~---------~~~~~ 243 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVK---------YSIPD 243 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTC---------CCCCT
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCC---------CCCCC
Confidence 233468999999999988777655 89999999999999999999754422 12222222221111 00001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......+.+++.+|++.+|++|||++|++++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11234568899999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=331.67 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=199.4
Q ss_pred hccccccccCceEEEEEEECC----CCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeee-eCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFI-EDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E 647 (858)
.+.+.||+|+||.||+|...+ +..+|+|.+..... ...+.+.+|++++++++||||+++++++. .++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 445889999999999998642 23689999876433 34567899999999999999999999865 4567899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++... ...+++.+++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 108 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp CCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999653 346889999999999999999999 88999999999999999999999999999987643221
Q ss_pred ---ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCC-ccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 728 ---HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA-VIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 728 ---~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~-p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.......|++.|+|||.+.+..++.++||||||++++||++|+. |+...... .....+ .++.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~----~~~~-------- 249 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGR-------- 249 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH----HTTC--------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH----hcCC--------
Confidence 11223456788999999999999999999999999999999554 54433221 111111 1111
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
....+......+.+++.+|++.+|++||+++|+++.|++++..
T Consensus 250 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011122234688999999999999999999999999997753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=339.01 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=187.9
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeee--------eCCee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFI--------EDNNM 642 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--------~~~~~ 642 (858)
+.+.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.++. ||||+++++++. .....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 345688999999999999964 79999999997666666678999999999996 999999999984 33458
Q ss_pred EEEEeeccCCChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 643 GLIYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
++||||+. |+|.+++.... ...+++.+++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 89999996 69999886532 346999999999999999999999 777 999999999999999999999999999
Q ss_pred ccccCCCcce-----------eecccCCCCccCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 720 KVFPIGGTHV-----------STVVAGTPGYLDPEYF---VTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 720 ~~~~~~~~~~-----------~~~~~gt~~y~APE~~---~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
+......... .....||+.|+|||.+ .+..++.++|||||||+++||++|+.||.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----- 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence 8765432211 1134589999999998 56678899999999999999999999986432110
Q ss_pred HHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 786 TVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.. ...............+.+++.+|++.+|++||+++|++++|+++.....
T Consensus 261 ~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 IV-------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hh-------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 00 0001001111122347789999999999999999999999999765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.04 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=194.0
Q ss_pred hccccccccCceEEEEEEEC----CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe-----e
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN-----M 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~ 642 (858)
.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+. .
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence 34578999999999999854 34589999987543 2345678999999999999999999999987653 5
Q ss_pred EEEEeeccCCChHHHhhhc----ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 643 GLIYEYMANGNLKQLLSDE----KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
++||||+++|+|.+++... ....+++.+++.++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 8999999999999998542 2356899999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++....... .......+++.|+|||.+.+..++.++||||||++++||++ |+.||...... .+...+ ..+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~----~~~~~ 267 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL----LHGHR 267 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH----HTTCC
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH----HcCCC
Confidence 987643322 12233457889999999999999999999999999999999 88888654322 111111 11110
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
...+......+.+++.+|+..+|.+||++++++++|++++.
T Consensus 268 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 268 ---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122334578899999999999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=337.24 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+.||+|+||.||+|.. .+|+.||||++..........+.+|++++.++ +||||+++++++..++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 6799999999999995 47999999999877666678899999999985 799999999999999999999999999999
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---EEEeeecCcccccCCCc----
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE---AKLADFGLSKVFPIGGT---- 727 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~---~kL~DFGla~~~~~~~~---- 727 (858)
.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++........
T Consensus 99 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 99 LSHIHKRR--HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 99997653 6899999999999999999999 889999999999999998776 99999999986543211
Q ss_pred --ceeecccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc---------HHHHHHHHH
Q 043526 728 --HVSTVVAGTPGYLDPEYFVT-----DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH---------IIQTVTNMI 791 (858)
Q Consensus 728 --~~~~~~~gt~~y~APE~~~~-----~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~---------l~~~v~~~~ 791 (858)
.......||+.|+|||.+.. ..++.++|||||||+++||++|+.||......... ....+...+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 11123458999999999875 55789999999999999999999999765422100 001111112
Q ss_pred hcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 792 AKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 792 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.++... ...... ......+.+++.+|++.||++|||++|++++
T Consensus 254 ~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 254 QEGKYE-FPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHCCCC-CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccCcc-cCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 221110 000000 0123468899999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=355.47 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=192.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 34578999999999999964 7999999999743 3344567888999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
++|+|.+++.... .+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 231 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 304 (446)
T 4ejn_A 231 NGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 304 (446)
T ss_dssp SSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-
Confidence 9999999996643 6899999999999999999999 6 8999999999999999999999999999986433222
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .+.. .. ..+. ..+
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~---~i-~~~~----------~~~ 368 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE---LI-LMEE----------IRF 368 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HH-HHCC----------CCC
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH---HH-HhCC----------CCC
Confidence 233467999999999999999999999999999999999999999654321 1111 11 1111 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
+.....++.+++.+|++.||.+|| +++|++++
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 223345788999999999999999 99999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=344.96 Aligned_cols=268 Identities=21% Similarity=0.285 Sum_probs=210.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCC--eeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN--NMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 34578999999999999976 69999999997543 334577889999999999999999999998765 679999999
Q ss_pred cCCChHHHhhhccc-CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE----cCCCCEEEeeecCcccccC
Q 043526 650 ANGNLKQLLSDEKA-STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL----TENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 650 ~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl----~~~~~~kL~DFGla~~~~~ 724 (858)
++|+|.+++..... ..+++.+++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 99999999976542 33899999999999999999999 8899999999999999 7788899999999987643
Q ss_pred CCcceeecccCCCCccCcccccc--------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC-
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVT--------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD- 795 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~- 795 (858)
.. ......||..|+|||.+.. ..++.++|||||||++|||++|+.||......... .+.+........
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~p~ 245 (396)
T 4eut_A 169 DE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITGKPS 245 (396)
T ss_dssp GG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHHHHSCCT
T ss_pred CC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHHhcCCCc
Confidence 32 2233568999999998864 56778999999999999999999999764432221 122222222111
Q ss_pred --chhhh---c------hhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 796 --IENIV---D------SCL--RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 796 --~~~~~---d------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
+..+. + ..+ ...........+.+++.+|++.||++||+++|+++.+++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 10000 0 000 1122356677888999999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=338.28 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=198.9
Q ss_pred hccccccccCceEEEEEEEC-CCCE----EEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQ----VAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~----vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
...+.||+|+||.||+|... +|+. ||+|.+... .....+++.+|++++++++||||+++++++..+. .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence 34578999999999999964 5554 577777543 3445678999999999999999999999998765 789999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 97 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999999997643 46899999999999999999999 88999999999999999999999999999987643322
Q ss_pred c-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 H-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
. ......+++.|+|||.+.+..++.++|||||||+++||++ |+.||....... +...+ ..+. .
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~----~~~~---------~ 237 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----EKGE---------R 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH----HTTC---------C
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCC---------C
Confidence 2 2223456778999999999999999999999999999999 999997644322 22211 1111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
...+......+.+++.+|++.+|.+||+++|+++.|+++....
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1122334457889999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=343.44 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=201.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 44578999999999999965 6899999998643 2344577899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 98 ~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~ 170 (384)
T 4fr4_A 98 LGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--Q 170 (384)
T ss_dssp TTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--c
Confidence 999999999754 36899999999999999999999 8899999999999999999999999999998765432 2
Q ss_pred eecccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 730 STVVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.....||+.|+|||.+.. ..++.++|||||||++|||++|+.||........ ....... ... ..
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~-~~~----------~~ 237 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTF-ETT----------VV 237 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHH-HHC----------CC
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHH-hhc----------cc
Confidence 334679999999999874 4588999999999999999999999975432221 1111111 111 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPN-MNEVVT 839 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-m~eVl~ 839 (858)
.++......+.+++.+|++.+|.+||+ ++++.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122334457889999999999999998 777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=342.00 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=200.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+..|.+++..+ +||||+++++++...+..++||||
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence 44578999999999999976 5889999999753 233456788899999887 899999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 103 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 103 VNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 99999999997643 6899999999999999999999 8899999999999999999999999999998643222 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ..+.+ . +..+.. .+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~---~-i~~~~~----------~~ 240 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQ---S-IMEHNV----------AY 240 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---H-HHHCCC----------CC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHH---H-HHhCCC----------CC
Confidence 23345799999999999999999999999999999999999999975431 11111 1 111111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
+.....++.+++.+|++.+|.+||+ ++|++++
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2233457889999999999999995 5677654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.80 Aligned_cols=258 Identities=19% Similarity=0.262 Sum_probs=197.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 44578999999999999975 7899999999754322 2467899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.... .+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 117 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 117 NGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 9999999997643 6899999999999999999999 8899999999999999999999999999998765433333
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||..... ..+...+...... . ... +
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-~--~~~----~ 258 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMGAHINQAIPR-P--STV----R 258 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHHHHHHSCCCC-G--GGT----S
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHHHHhccCCCC-c--ccc----C
Confidence 3345689999999999988999999999999999999999999965321 1122222221100 0 001 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHHHh
Q 043526 810 IESAWRAVELAVKCASRTSSERP-NMNEVVTELKECLMMEL 849 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~~~ 849 (858)
......+.+++.+|++.+|++|| +++++++.|++++....
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 12234688999999999999999 99999999998765544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=338.88 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=197.2
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccC-----CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-----SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
+.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 444689999999999999964 7889999998643 3445678999999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc--------------------------------------cCchhHHHHHHHHHHHHHHHHHhhcC
Q 043526 647 EYMANGNLKQLLSDEK--------------------------------------ASTLSWERRLQIAMDAAQGLEYLHIG 688 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~--------------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~ 688 (858)
||+++|+|.+++.... ...+++..+..++.||++||+|||
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-- 185 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-- 185 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence 9999999999985211 123577888999999999999999
Q ss_pred CCCCeEecCCCCcceEEcCCC--CEEEeeecCcccccCCCc---ceeecccCCCCccCcccccc--CCCCCchhHHHHHH
Q 043526 689 CKPPIVHRDIKPENILLTENL--EAKLADFGLSKVFPIGGT---HVSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGV 761 (858)
Q Consensus 689 ~~~~IvH~DLk~~NILl~~~~--~~kL~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGv 761 (858)
+.+|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++|||||||
T Consensus 186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 88999999999999998776 899999999987643221 12334568999999999865 67889999999999
Q ss_pred HHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 762 VLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 762 ll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+++||++|+.||...... +........... ...+. .......+.+++.+|++.+|.+||++.|++++
T Consensus 265 il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDA-----DTISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHCCCCCCCCChH-----HHHHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999654321 112222111100 00000 01234578899999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=331.96 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=202.9
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.+.||+|+||.||+|... +|+.||||++...... ..+++.+|++++++++||||+++++++..++..++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 455689999999999999975 7999999999754322 356799999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC----CEEEeeecCccc
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL----EAKLADFGLSKV 721 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~----~~kL~DFGla~~ 721 (858)
|||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||++..
T Consensus 94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 94 LELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp ECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999654 36899999999999999999999 88999999999999999888 799999999987
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||...... +.... +..... ..+
T Consensus 169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-i~~~~~--~~~ 238 (321)
T 2a2a_A 169 IEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLAN-ITSVSY--DFD 238 (321)
T ss_dssp CCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHH-HHTTCC--CCC
T ss_pred cCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH-HHhccc--ccC
Confidence 654322 23356899999999999889999999999999999999999999654311 11111 111110 001
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.... .....+.+++.+|++.+|++|||++|++++
T Consensus 239 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111 123467899999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.01 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHh-cccceeeeeeeeeee----CCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMR-VHHRNLTNLVGYFIE----DNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~~lV~Ey~~ 650 (858)
+.||+|+||.||+|... +|+.||||++... ..+.+|++++.+ .+||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 57999999999999965 7899999999632 567788888754 589999999999875 567899999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~ 727 (858)
+|+|.+++.......+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~- 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence 999999998765557999999999999999999999 889999999999999997 7889999999998754322
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccc--cHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI--HIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~--~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+ ..+... ...+
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~~-~~~~--- 289 (400)
T 1nxk_A 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQYE-FPNP--- 289 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCCC-CCTT---
T ss_pred -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCccc-CCCc---
Confidence 22345689999999999999999999999999999999999999976443221 111111 111110 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......++.+++.+||+.||++|||++|++++
T Consensus 290 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 --EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001234578899999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=350.94 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=199.6
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||+|+||.||+|+.. +|+.||||++++.. ......+.+|..++..++||||+++++++.+++..++||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 478999999999999975 79999999996431 22345688999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus 146 g~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 221 (412)
T 2vd5_A 146 GDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221 (412)
T ss_dssp CBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECS
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccc
Confidence 99999997542 36899999999999999999999 889999999999999999999999999999887655444444
Q ss_pred cccCCCCccCccccc-------cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 732 VVAGTPGYLDPEYFV-------TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 732 ~~~gt~~y~APE~~~-------~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
...||+.|+|||.+. ...++.++|||||||++|||++|+.||...... .....+......-. -+
T Consensus 222 ~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~~-----~p-- 292 (412)
T 2vd5_A 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGKIVHYKEHLS-----LP-- 292 (412)
T ss_dssp SCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHHHCC-----CC--
T ss_pred eeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccCcC-----CC--
Confidence 567999999999987 356899999999999999999999999754321 11111111000000 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSER---PNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Psm~eVl~~ 840 (858)
..+.....++.+++.+|++ +|++| |+++|++++
T Consensus 293 --~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 --LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0112234578899999999 99998 589888764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.64 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=201.4
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 4457899999999999996 5899999999977665667789999999999999999999999973 3478899999
Q ss_pred ccCCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 649 MANGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 649 ~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
+++|+|.+++... ....+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 9999999999763 2356899999999999999999999 8899999999999999999999999999987643211
Q ss_pred cc--------eeecccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC
Q 043526 727 TH--------VSTVVAGTPGYLDPEYFVTDW---LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD 795 (858)
Q Consensus 727 ~~--------~~~~~~gt~~y~APE~~~~~~---~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~ 795 (858)
.. ......|++.|+|||.+.... ++.++||||||++++||++|+.||.........+...+. .
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~-- 262 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----N-- 262 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----C--
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----c--
Confidence 00 011235799999999987543 689999999999999999999998642211111111111 1
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
.............+.+++.+|++.+|.+||+++|++++|+.+.
T Consensus 263 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 -------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0111111223457889999999999999999999999998853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=337.46 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=205.8
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +++.||||.+..... ....++.+|++++++++||||+++++++...+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 44688999999999999854 478899999975433 33457899999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhccc--------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 647 EYMANGNLKQLLSDEKA--------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 99999999999976431 35689999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++........ ......+++.|+|||.+.+..++.++||||||++++||++ |+.||...... + ....+.++..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~-~~~~~~~~~~ 258 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----Q-VLRFVMEGGL 258 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----H-HHHHHHTTCC
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----H-HHHHHHcCCc
Confidence 9865432211 1223346788999999998889999999999999999999 78888654311 1 1111222211
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
. ..+......+.+++.+|++.+|++||++.|++++|++.+.
T Consensus 259 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 1122334568899999999999999999999999988654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=346.12 Aligned_cols=247 Identities=22% Similarity=0.347 Sum_probs=195.2
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcc--cceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVH--HRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|++++.+++ ||||+++++++..++..++||| +
T Consensus 59 ~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~ 137 (390)
T 2zmd_A 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 137 (390)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-C
T ss_pred EEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-c
Confidence 4457899999999999998889999999997543 234577899999999996 5999999999999999999999 6
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH- 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~- 728 (858)
.+++|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus 138 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 138 GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 7889999997654 6889999999999999999999 89999999999999996 578999999999876543222
Q ss_pred eeecccCCCCccCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 729 VSTVVAGTPGYLDPEYFVT-----------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~~~------- 280 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISKLHAI------- 280 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----HHHHHHH-------
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----HHHHHHH-------
Confidence 2334579999999999864 46889999999999999999999999653321 1111111
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
++.......+......+.+++.+||..+|++||+++|++++
T Consensus 281 --~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 --IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111222224568899999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=332.88 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=200.8
Q ss_pred HhhccccccccCceEEEEEEE-CCCCEEEEEEeccCC-----CcchHhHHHHHHHHHhcc---cceeeeeeeeeeeCC--
Q 043526 572 TDNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS-----GQGFKEFEAEVKLLMRVH---HRNLTNLVGYFIEDN-- 640 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-----~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~-- 640 (858)
.+.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++++++ ||||+++++++....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 345568899999999999995 579999999986432 122356778888777775 999999999998765
Q ss_pred ---eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 641 ---NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 641 ---~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
..++||||+. |+|.+++.......+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4789999997 59999998776566999999999999999999999 8899999999999999999999999999
Q ss_pred CcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 718 LSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 718 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ......+..........
T Consensus 166 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 166 LARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH--HHHHHHHHHHHCCCCTT
T ss_pred cccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChh
Confidence 998764332 22345789999999999999999999999999999999999999975432 12222222221111000
Q ss_pred hh------hchhhcCC--C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NI------VDSCLRGG--F-----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~------~d~~l~~~--~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ....+... . ..+....+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 00000000 0 01234578899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=341.72 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=202.2
Q ss_pred hccccccccCceEEEEEEE----CCCCEEEEEEeccCC----CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 644 (858)
.+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++..++..++
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 4457899999999999997 478999999986432 23446678899999999 69999999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++|+|.+++.... .+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 137 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 999999999999997643 6899999999999999999999 88999999999999999999999999999987644
Q ss_pred CCcceeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
..........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... ............
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~--------- 281 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS--------- 281 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC---------
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc---------
Confidence 33333445679999999999985 357899999999999999999999997543221 122222221111
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERP-----NMNEVVTEL 841 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~L 841 (858)
...++......+.+++.+|+..||.+|| +++|++++.
T Consensus 282 --~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0112233345688999999999999999 999998865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=336.62 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=193.3
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCe----eEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN----MGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~~lV 645 (858)
.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|++++++++||||+++++++..... .++|
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 4467899999999999996 58899999999765332 24578899999999999999999999876654 3899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.++++... .+++.+++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 99999999999997643 6899999999999999999999 889999999999999999999999999999876443
Q ss_pred Ccc--eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GTH--VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .............. ..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~---~~ 241 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIPP---SA 241 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCCH---HH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCCCCc---cc
Confidence 221 223356899999999999999999999999999999999999999654321 11222222211110 00
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVV-TELKEC 844 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl-~~L~~~ 844 (858)
. .......+.+++.+|++.||++||+..+++ +.|.+.
T Consensus 242 ~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 242 R----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 011234688999999999999999666555 455443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.07 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=202.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (276)
T 2yex_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (276)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCC
Confidence 44578999999999999975 79999999987543 33457789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-cee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~ 730 (858)
++|.+++... ..+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........ ...
T Consensus 90 ~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 90 GELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp EEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999653 36899999999999999999999 88999999999999999999999999999987643322 122
Q ss_pred ecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....|+..|+|||.+.+..+ +.++||||||++++||++|+.||.........+..+.. .... . ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~---~------~~~ 231 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTY---L------NPW 231 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTT---S------TTG
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----cccc---c------Cch
Confidence 34568999999999987664 77899999999999999999999765433222222211 1000 0 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++|||++|++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1233467899999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.86 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=201.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 44578999999999999976 79999999996432 233567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 99 ~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~ 171 (476)
T 2y94_A 99 SGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 171 (476)
T ss_dssp SSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--C
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--c
Confidence 999999999654 36899999999999999999999 8999999999999999999999999999998765432 2
Q ss_pred eecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....||+.|+|||.+.+..+ +.++|||||||+++||++|+.||...... .+ ...+..+.. ..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~----~~~i~~~~~----------~~ 235 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TL----FKKICDGIF----------YT 235 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HH----HHHHHTTCC----------CC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HH----HHHHhcCCc----------CC
Confidence 234569999999999987765 68999999999999999999999754321 11 111122110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+......+.+++.+|++.||++|||++|++++
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 12233468899999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.73 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
..||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4899999999999996 478999999998776666788999999999999999999999999999999999999999999
Q ss_pred HHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccccCCCcceeecc
Q 043526 656 QLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 656 ~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
+++.... ...+++..+..++.|+++||+||| +.+|+||||||+||+++. ++.+||+|||++....... ......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccccc
Confidence 9997653 335678999999999999999999 889999999999999997 8999999999998764322 122345
Q ss_pred cCCCCccCccccccC--CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 734 AGTPGYLDPEYFVTD--WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 734 ~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
.|++.|+|||.+.+. .++.++||||||++++||++|+.||........... ...... .....+..
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~----------~~~~~~~~ 250 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFK----------VHPEIPES 250 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HHHHHC----------CCCCCCTT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hhcccc----------cccccccc
Confidence 689999999998764 378999999999999999999999975432211111 100000 01112223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...++.+++.+|++.+|++||+++|++++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 34578899999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=355.66 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=205.7
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++... .......+.+|++++++++||||+++++++..++..++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999975 7999999999643 2334567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.......+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~-- 341 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCcc--
Confidence 9999999997765556999999999999999999999 88999999999999999999999999999987654332
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. ..+...+.... ..++
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~-~~i~~~i~~~~----------~~~p 409 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KR-EEVERLVKEVP----------EEYS 409 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CH-HHHHHHHHHCC----------CCCC
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hH-HHHHHHhhccc----------ccCC
Confidence 233579999999999999889999999999999999999999997644211 11 11111111111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
......+.+++.+|++.||.+|| +++||+++
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 23345788999999999999999 78888764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.49 Aligned_cols=246 Identities=26% Similarity=0.438 Sum_probs=181.0
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 3457899999999999996 489999999986432 233477899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++... ...+++.+++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 94 ~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 168 (278)
T 3cok_A 94 HNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-K 168 (278)
T ss_dssp TTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-c
Confidence 999999999754 246899999999999999999999 88999999999999999999999999999987643222 1
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||........ ... +..... ..+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~---------~~~~~~--~~~ 232 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNK---------VVLADY--EMP 232 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSCC--CCC
T ss_pred ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHH---------Hhhccc--CCc
Confidence 2235689999999999988899999999999999999999999975432211 000 000000 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.+|++||+++|++++
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 2234578899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=340.39 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=197.5
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
...+.||+|+||.||+|.. .+|+.||||++...... ..+++.+|++++++++||||+++++++..++..++||||+
T Consensus 57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 136 (348)
T 1u5q_A 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136 (348)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence 3457899999999999996 58999999999754332 3457899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
+ |+|.+++.... ..+++.++..++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 137 ~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 137 L-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp S-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred C-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 8 58888886443 46899999999999999999999 889999999999999999999999999999875432
Q ss_pred eecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 730 STVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
....||+.|+|||.+. ...++.++|||||||+++||++|+.||..... ...+........ .. +
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~-~~-----~-- 273 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES-PA-----L-- 273 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC-CC-----C--
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC-CC-----C--
Confidence 2346899999999984 56789999999999999999999999865431 111222211111 10 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|++.+|++|||+++++++
T Consensus 274 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111223467899999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.92 Aligned_cols=244 Identities=30% Similarity=0.421 Sum_probs=198.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
...+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence 34578999999999999865 67899999986431 223467889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++...... .
T Consensus 92 ~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~ 163 (279)
T 3fdn_A 92 PLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 163 (279)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---c
Confidence 9999999997643 6899999999999999999999 899999999999999999999999999988654322 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||...... .... .+... ....+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~-~~~~~----------~~~~~ 227 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYK-RISRV----------EFTFP 227 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH-HHHHT----------CCCCC
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHH-HHHhC----------CCCCC
Confidence 23456899999999999989999999999999999999999999754311 1111 11111 01112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
......+.+++.+|++.+|++||+++|++++-
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 22345678999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.00 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=200.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 34578999999999999975 68999999987543 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---EEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE---AKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~---~kL~DFGla~~~~~~~~ 727 (858)
+++|.+.+.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||++........
T Consensus 89 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 89 GGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999986543 6899999999999999999999 889999999999999987655 99999999987653322
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||...... ..... +..+... ...+
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~-~~~~----- 229 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ----IKAGAYD-YPSP----- 229 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHTCCC-CCTT-----
T ss_pred --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHH----HHhcccc-CCch-----
Confidence 23356899999999999999999999999999999999999999654321 11111 1111110 0000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|++.+|++||+++|++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011223468899999999999999999999885
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.05 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=196.1
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+...+.||+|+||.||+|... +|+.||||++.... .....++.+|+..+..+ +||||+++++++.+++..++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 344578999999999999976 79999999997643 33456788999999999 999999999999999999999999
Q ss_pred ccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC------------------
Q 043526 649 MANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN------------------ 708 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~------------------ 708 (858)
+++|+|.+++.... ...+++.+++.++.||++||+||| +.+|+||||||+|||++.+
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999997653 256899999999999999999999 8899999999999999844
Q ss_pred -CCEEEeeecCcccccCCCcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHH
Q 043526 709 -LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT 786 (858)
Q Consensus 709 -~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~ 786 (858)
..+||+|||++....... ...|++.|+|||.+.+. .++.++|||||||+++||++|.+++.... .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~--- 236 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----Q--- 236 (289)
T ss_dssp CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----H---
T ss_pred ceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----H---
Confidence 479999999998764322 23589999999999765 56689999999999999999988764321 1
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.++... ..+......+.+++.+|++.||++||+++|++++
T Consensus 237 -~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111222111 1122234578899999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.51 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=195.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 34578999999999999975 6999999998655332 24668899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 86 ~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (311)
T 4agu_A 86 HTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159 (311)
T ss_dssp EEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-cc
Confidence 99999988654 36899999999999999999999 88999999999999999999999999999987653322 22
Q ss_pred ecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch--------hhhc
Q 043526 731 TVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE--------NIVD 801 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~--------~~~d 801 (858)
....|+..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+.......... ....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhcccccccccccccccccc
Confidence 33468999999999875 66799999999999999999999999754422 1111222111110000 0000
Q ss_pred -hhhcCC---CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 -SCLRGG---FE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 -~~l~~~---~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+... .+ ......+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00 1234468899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.90 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=200.7
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++...+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3455689999999999999975 799999999986655555778999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~~~~ 727 (858)
+++|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++ ++++.+||+|||+++.....
T Consensus 90 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 90 GGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp SCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 999999996543 6899999999999999999999 8899999999999999 78899999999998764322
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......|++.|+|||.+.+..++.++||||||++++||++|+.||..... ..+. ..+.++... ....
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~----~~i~~~~~~------~~~~ 229 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLF----EKIKEGYYE------FESP 229 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH----HHHHHCCCC------CCTT
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH----HHHHcCCCC------CCcc
Confidence 12234689999999999998999999999999999999999999865431 1111 112222110 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|++.+|++||+++|++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112234578899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=335.85 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=200.4
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-----cceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-----HRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.||+|+||.||+|+. .+|+.||||++... ....+.+..|+++++.++ ||||+++++++...+..++|||
T Consensus 38 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 3457899999999999997 47899999999643 233466788999999986 9999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC--------------------
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-------------------- 707 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-------------------- 707 (858)
|+ +++|.+++.......+++.++..++.||+.||+||| +.+|+||||||+|||++.
T Consensus 117 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 117 PL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99 899999998776667999999999999999999999 899999999999999976
Q ss_pred -----CCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcccc
Q 043526 708 -----NLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782 (858)
Q Consensus 708 -----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~ 782 (858)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ..
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~ 266 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH--ME 266 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HH
T ss_pred ccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH--HH
Confidence 788999999999865432 2235689999999999999999999999999999999999999975432 11
Q ss_pred HHHHHHHHHhcCCchhhhchh-----------------hcCCC----------------CHHHHHHHHHHHHHccccCCC
Q 043526 783 IIQTVTNMIAKGDIENIVDSC-----------------LRGGF----------------EIESAWRAVELAVKCASRTSS 829 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~-----------------l~~~~----------------~~~~~~~l~~l~~~Cl~~dP~ 829 (858)
....+...... ......... +.... +......+.+++.+|++.||+
T Consensus 267 ~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 267 HLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 22222221111 000000000 00000 001124677999999999999
Q ss_pred CCCCHHHHHHH
Q 043526 830 ERPNMNEVVTE 840 (858)
Q Consensus 830 ~RPsm~eVl~~ 840 (858)
+|||++|++++
T Consensus 346 ~Rpta~elL~h 356 (360)
T 3llt_A 346 LRPSPAELLKH 356 (360)
T ss_dssp GSCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=335.70 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=203.2
Q ss_pred hhccccccccCceEEEEEEE------CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.++++++||||+++++++...+..++|
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 34568899999999999984 357899999997543 33456789999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhccc-----CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeec
Q 043526 646 YEYMANGNLKQLLSDEKA-----STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFG 717 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFG 717 (858)
|||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.+|+||||||+|||++. +..+||+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 999999999999976542 35899999999999999999999 889999999999999994 4569999999
Q ss_pred CcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCC
Q 043526 718 LSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGD 795 (858)
Q Consensus 718 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~ 795 (858)
+++....... .......|++.|+|||.+.+..++.++||||||++++||+| |+.||...... .+. ..+..+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----~~~~~~~ 262 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL----EFVTSGG 262 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHHHTTC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH----HHHhcCC
Confidence 9986543222 12233467889999999998899999999999999999998 88888654311 111 1122211
Q ss_pred chhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 796 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
. ...+......+.+++.+|++.+|.+||++.|++++|+.+....
T Consensus 263 ~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 263 R---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred C---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1 1112233457889999999999999999999999999876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.93 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=195.9
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 455689999999999999965 78999999987553 3456789999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccCC
Q 043526 651 NGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 651 ~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~~ 725 (858)
+|+|.+++.... ...+++..++.++.|+++||+||| +.+|+||||||+|||+ +.++.+||+|||++......
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 999999986542 357999999999999999999999 8899999999999999 45678999999999876433
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
. ......|++.|+|||.+. ..++.++||||||++++||++|+.||....... .... ....... ..
T Consensus 181 ~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-----~~~~-~~~~~~~------~~ 245 (285)
T 3is5_A 181 E--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-----VQQK-ATYKEPN------YA 245 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH-HHHCCCC------CC
T ss_pred c--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-----HHhh-hccCCcc------cc
Confidence 2 223456899999999875 567899999999999999999999997543211 1111 1111000 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.........+.+++.+|++.||++||+++|++++
T Consensus 246 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 -VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001123467899999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=342.45 Aligned_cols=244 Identities=27% Similarity=0.363 Sum_probs=190.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHH-HHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKL-LMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+..|..+ ++.++||||+++++++...+..++||||
T Consensus 41 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 120 (373)
T 2r5t_A 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120 (373)
T ss_dssp EEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeC
Confidence 45689999999999999975 688999999975432 233456667766 5778999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 121 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~ 194 (373)
T 2r5t_A 121 INGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S 194 (373)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence 99999999997643 6889999999999999999999 8899999999999999999999999999998643322 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +...... .+. + .+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~-~~~--------~--~~ 258 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNIL-NKP--------L--QL 258 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-----HHHHHHH-HSC--------C--CC
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH-hcc--------c--CC
Confidence 234467999999999999999999999999999999999999999654311 1111111 111 1 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+......+.+++.+|++.||.+||++.+.++
T Consensus 259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred CCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 2223456889999999999999999864333
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.61 Aligned_cols=249 Identities=21% Similarity=0.361 Sum_probs=198.0
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.+.||+|+||.||+|... +|+.||||++..... ...+|++++.++ +||||+++++++.+++..++||||++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 345689999999999999975 789999999976532 345688888888 79999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC----CCEEEeeecCcccccCCC
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN----LEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~----~~~kL~DFGla~~~~~~~ 726 (858)
+|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||+.++ +.+||+|||+++......
T Consensus 100 gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 100 GGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp SCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999654 36899999999999999999999 8899999999999998543 349999999998765432
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+. ..+ +...+..+... +..
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~-~~~~i~~~~~~------~~~ 244 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEE-ILARIGSGKFS------LSG 244 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHH-HHHHHHHCCCC------CCS
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHH-HHHHHccCCcc------cCc
Confidence 2 2234568999999999988778899999999999999999999997543221 111 11222222211 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........++.+++.+|+..||++||+++|++++
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112334578899999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=329.93 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=195.2
Q ss_pred hccccccccCceEEEEEEEC--CCC--EEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--DGT--QVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|.+. +++ .||||+++... ....+++.+|++++++++||||+++++++..+. .++||
T Consensus 21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 99 (291)
T 1u46_A 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVT 99 (291)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEE
T ss_pred eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeE
Confidence 44578999999999999863 333 68999987542 334578899999999999999999999998765 88999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++++|.+++.... ..+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 100 ELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp ECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999997643 46899999999999999999999 8899999999999999999999999999998775443
Q ss_pred cce--eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 727 THV--STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 727 ~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
... .....++..|+|||.+.+..++.++||||||++++||++ |+.||...... +........+..
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~------- 243 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGER------- 243 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCC-------
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCC-------
Confidence 221 223457788999999998888999999999999999999 99998654321 112221111110
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
...+......+.+++.+|+..+|++||+++++++.|+++...+.
T Consensus 244 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 244 --LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred --CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 01122334578899999999999999999999999999765544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.05 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=202.0
Q ss_pred HHHHHHhhcc-ccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCe
Q 043526 567 EVLKITDNFN-KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNN 641 (858)
Q Consensus 567 el~~~t~~f~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 641 (858)
+...-.+.+. +.||+|+||.||+|... +|+.||||++.... .....++.+|+.++.+++ ||||+++++++...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3333333333 78999999999999975 79999999987543 234578899999999995 6999999999999999
Q ss_pred eEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecC
Q 043526 642 MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGL 718 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGl 718 (858)
.++||||+++|+|.+++.......+++.+++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 999999999999999997665567999999999999999999999 889999999999999998 78999999999
Q ss_pred cccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 719 SKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 719 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ....+. ....
T Consensus 181 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~----~~~~-- 250 (327)
T 3lm5_A 181 SRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNIS----QVNV-- 250 (327)
T ss_dssp CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH----HTCC--
T ss_pred ccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHH----hccc--
Confidence 98764332 2233568999999999999999999999999999999999999996543211 111111 1100
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.............+.+++.+|++.+|++||+++|++++
T Consensus 251 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 ----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00001112234568899999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=321.62 Aligned_cols=244 Identities=26% Similarity=0.429 Sum_probs=195.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEEe
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIYE 647 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E 647 (858)
+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.. +...++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 4568999999999999964 78899999987542 3345678999999999999999999999875 355899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEc-CCCCEEEeeecCcccccC
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLT-ENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~~ 724 (858)
|+++|+|.+++... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++ +++.+||+|||++.....
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 110 LMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999764 36899999999999999999999 777 99999999999998 789999999999976543
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
. ......|++.|+|||.+. +.++.++||||||++++||++|+.||...... .... ..+..+......+
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~-~~~~~~~~~~~~~--- 252 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIY-RRVTSGVKPASFD--- 252 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHH-HHHTTTCCCGGGG---
T ss_pred c---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHH-HHHhccCCccccC---
Confidence 2 223456899999999876 45899999999999999999999999654321 1111 1122211111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|.+|||++|++++
T Consensus 253 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122468899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.19 Aligned_cols=238 Identities=23% Similarity=0.361 Sum_probs=198.5
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCC--------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 644 (858)
...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++...+..++
T Consensus 27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 106 (335)
T 3dls_A 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL 106 (335)
T ss_dssp EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence 4457899999999999995 4789999999976532 134567889999999999999999999999999999
Q ss_pred EEeeccCC-ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 645 IYEYMANG-NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 645 V~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
||||+.+| +|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 107 v~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 107 VMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999777 9999996543 6899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcceeecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
.... .....||+.|+|||.+.+..+ +.++|||||||+++||++|+.||..... ....
T Consensus 182 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------------~~~~ 239 (335)
T 3dls_A 182 RGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------------TVEA 239 (335)
T ss_dssp TTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------GTTT
T ss_pred CCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------HHhh
Confidence 4332 233568999999999987776 7899999999999999999999864211 0111
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... .+.....++.+++.+|++.+|++||+++|++++
T Consensus 240 ~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111234468899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=344.86 Aligned_cols=235 Identities=17% Similarity=0.183 Sum_probs=185.5
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccC---CCcchHhHHHHH---HHHHhcccceeeeee-------eeeeeCC-
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS---SGQGFKEFEAEV---KLLMRVHHRNLTNLV-------GYFIEDN- 640 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~~~~~~- 640 (858)
.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ +++..++
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 57899999999999995 57999999999743 334457889999 555566899999998 5554443
Q ss_pred ----------------eeEEEEeeccCCChHHHhhhcc-----cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 043526 641 ----------------NMGLIYEYMANGNLKQLLSDEK-----ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIK 699 (858)
Q Consensus 641 ----------------~~~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk 699 (858)
..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+||| +.+|+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 278999999 679999997543 224567899999999999999999 8899999999
Q ss_pred CcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccC-----------CCCCchhHHHHHHHHHHHHh
Q 043526 700 PENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD-----------WLNEKSDVYSFGVVLLEIIT 768 (858)
Q Consensus 700 ~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDVwSfGvll~Ellt 768 (858)
|+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++|||||||++|||++
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 9999999999999999999986322 2334567 999999999877 89999999999999999999
Q ss_pred CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 769 SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 769 G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
|+.||....... ....+... . ......+.+++.+||+.||++||++.|+++
T Consensus 309 g~~Pf~~~~~~~--------------~~~~~~~~-~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 309 ADLPITKDAALG--------------GSEWIFRS-C-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp SSCCC------C--------------CSGGGGSS-C-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred CCCCCccccccc--------------chhhhhhh-c-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999986533111 01111110 0 112346889999999999999999999997
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=319.72 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=199.6
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 455689999999999999976 799999999875422 2357799999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC----CEEEeeecCccc
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL----EAKLADFGLSKV 721 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~----~~kL~DFGla~~ 721 (858)
|||+++++|.+++... ..+++.+++.++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||++..
T Consensus 87 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 87 LELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999654 36899999999999999999999 88999999999999999877 799999999987
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
...... .....|++.|+|||.+.+..++.++||||||++++||++|+.||...... . ... .+...... ..
T Consensus 162 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~-~~~~~~~~--~~ 231 (283)
T 3bhy_A 162 IEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--E---TLT-NISAVNYD--FD 231 (283)
T ss_dssp CC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHH-HHHTTCCC--CC
T ss_pred ccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--H---HHH-HhHhcccC--Cc
Confidence 643322 23346899999999999889999999999999999999999999754311 1 111 11111100 00
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... ......+.+++.+|++.+|++||+++|++++
T Consensus 232 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 232 EEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred chhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000 1123468899999999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=325.68 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=201.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 34578999999999999976 68899999986542 234567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.... .+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 98 ~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 171 (294)
T 2rku_A 98 RRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER- 171 (294)
T ss_dssp TTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc-
Confidence 9999999986543 6899999999999999999999 889999999999999999999999999999876433222
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||...... +.... +..+.. ..+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~----------~~~ 235 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLR-IKKNEY----------SIP 235 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH-HHTTCC----------CCC
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HhhccC----------CCc
Confidence 23456899999999999888999999999999999999999999654321 11111 111110 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2233467899999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.01 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=188.6
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCC--eeEEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDN--NMGLIY 646 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~~lV~ 646 (858)
+.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.++.++. ||||+++++++..++ ..++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 344578999999999999964 7999999998644 2234567889999999997 999999999997654 689999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||++ |+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 91 e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 91 DYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp ECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred cccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9998 5899998653 5889999999999999999999 8899999999999999999999999999998653211
Q ss_pred --------------------cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 727 --------------------THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 727 --------------------~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~ 241 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST--MNQLE 241 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 111233578999999999876 6789999999999999999999999975432 11112
Q ss_pred HHHHHHhcCCchh-----------hhch----------hhcC------------CCCHHHHHHHHHHHHHccccCCCCCC
Q 043526 786 TVTNMIAKGDIEN-----------IVDS----------CLRG------------GFEIESAWRAVELAVKCASRTSSERP 832 (858)
Q Consensus 786 ~v~~~~~~~~~~~-----------~~d~----------~l~~------------~~~~~~~~~l~~l~~~Cl~~dP~~RP 832 (858)
.+...+....... .++. .... ........++.+++.+|++.||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 1111111100000 0000 0000 00012234688999999999999999
Q ss_pred CHHHHHHH
Q 043526 833 NMNEVVTE 840 (858)
Q Consensus 833 sm~eVl~~ 840 (858)
|++|++++
T Consensus 322 t~~e~l~H 329 (388)
T 3oz6_A 322 SANDALKH 329 (388)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhCC
Confidence 99999876
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.65 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=201.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 115 (360)
T 3eqc_A 36 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115 (360)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCC
Confidence 34578999999999999976 789999999976533 3356789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++|.+++.... .+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 116 ~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 116 GSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 99999997653 6899999999999999999999 64 8999999999999999999999999999765321 22
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHH------------------------
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT------------------------ 786 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~------------------------ 786 (858)
....||+.|+|||.+.+..++.++|||||||+++||++|+.||.............
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 33568999999999999999999999999999999999999997544221110000
Q ss_pred HHHHHhcCCchhhhchhhcCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGG----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...........+..+...... ........+.+++.+|++.||++|||++|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000111111111111 111234578899999999999999999999885
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=327.35 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=198.6
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeee--CCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIE--DNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|.. .+|+.||||++... ..+.+.+|++++++++ ||||+++++++.. ....++||||+
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 4457899999999999986 57999999999743 3577899999999997 9999999999988 56789999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCcc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~ 728 (858)
++++|.+++. .+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 116 ~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 116 NNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred CchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 9999999984 3788999999999999999999 88999999999999999776 899999999987654322
Q ss_pred eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc------
Q 043526 729 VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD------ 801 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d------ 801 (858)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||.........+...... .......+.++
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV-LGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH-HCHHHHHHHHHHTTCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh-cCCchhhhHHHHhcccc
Confidence 233468999999999876 678999999999999999999999996554332222221111 11000000000
Q ss_pred -----------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 -----------------SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 -----------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.............++.+++.+|++.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000111111235678999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=341.80 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=205.9
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhccc-ceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH-RNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|.. .+|+.||||++..... ..++..|+++++.++| +++..+..++...+..++||||+ +
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 3457899999999999996 5799999999875533 3568899999999987 55556666677788899999999 8
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
++|.+++.... ..+++.+++.|+.||+.||+||| +.+|+||||||+|||| +.++.+||+|||+++.+......
T Consensus 87 ~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 87 PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99999997533 46999999999999999999999 8899999999999999 68899999999999877544322
Q ss_pred e------eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc-ccHHHHHHHHHhcCCchhhhc
Q 043526 729 V------STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-IHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 729 ~------~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~-~~l~~~v~~~~~~~~~~~~~d 801 (858)
. .....||..|+|||.+.+..++.++|||||||++|||++|+.||....... ......+........+..+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~- 241 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC- 241 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH-
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh-
Confidence 1 224579999999999999999999999999999999999999997654322 11222222111111111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
..+ ..++.+++..|++.+|++||++++|++.|++++....
T Consensus 242 ----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 242 ----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp ----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 112 2468899999999999999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=350.16 Aligned_cols=248 Identities=24% Similarity=0.415 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.||+|+||.||+|+.. +|+.||||++.... ......+..|++++++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 468999999999999975 79999999996432 23456788999999999999999999999999999999999999
Q ss_pred CChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-K 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-C
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-c
Confidence 99999997643 346999999999999999999999 88999999999999999999999999999987654332 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... +..+. ..++
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~-i~~~~----------~~~p 413 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQR-VLEQA----------VTYP 413 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHH-HHHCC----------CCCC
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHH-Hhhcc----------cCCC
Confidence 23357999999999999999999999999999999999999999764321 111111111 11111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNM-----NEVVT 839 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~ 839 (858)
......+.+++.+|++.+|++||++ +++.+
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 3334578899999999999999975 55654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.67 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=199.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.. +...++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 34578999999999999975 79999999997543 2345678999999999999999999998854 5678999999
Q ss_pred ccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCCCCC-----eEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 649 MANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGCKPP-----IVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
+++++|.+++.... ...+++.+++.++.|++.||+||| +.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999997643 335899999999999999999999 666 99999999999999999999999999987
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
...... ......|+..|+|||.+.+..++.++||||||++++||++|+.||..... ..+ ...+.++...
T Consensus 166 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~----~~~i~~~~~~---- 234 (279)
T 2w5a_A 166 LNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KEL----AGKIREGKFR---- 234 (279)
T ss_dssp C---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH----HHHHHHTCCC----
T ss_pred eccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHH----HHHHhhcccc----
Confidence 643322 12234689999999999988899999999999999999999999875431 111 1222222211
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~ 842 (858)
..+.....++.+++.+|++.+|++||+++|+++++.
T Consensus 235 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 -----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 112223457889999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.82 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=201.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 44578999999999999975 6889999998643 2233567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 97 PRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 9999999997653 6899999999999999999999 8999999999999999999999999999987654322
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|++.|+|||.+.+..++.++||||||++++||++|+.||...... ..... +.... ...+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-~~~~~----------~~~~ 232 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRR-IVNVD----------LKFP 232 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH-HHTTC----------CCCC
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHH-Hhccc----------cCCC
Confidence 23356899999999999988999999999999999999999999754321 11111 11111 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|.+||+++|++++
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 2234568899999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.01 Aligned_cols=248 Identities=20% Similarity=0.364 Sum_probs=195.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++..++..++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 44578999999999999976 68999999998776677789999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++....... .....
T Consensus 102 ~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 176 (302)
T 2j7t_A 102 AVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDS 176 (302)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC---
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccccc
Confidence 9999986533 46899999999999999999999 8899999999999999999999999999876432110 11223
Q ss_pred ccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 733 VAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 733 ~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
..|+..|+|||.+. ...++.++||||||++++||++|+.||...... ........... ... .
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~-------~ 243 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSDP-PTL-------L 243 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCC-CCC-------S
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccCC-ccc-------C
Confidence 46899999999983 567889999999999999999999998754311 11111111111 100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.+......+.+++.+|++.+|++||+++|+++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11223456889999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.27 Aligned_cols=245 Identities=26% Similarity=0.444 Sum_probs=202.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 3578999999999999864 78999999997553 345678999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.. ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 178 (303)
T 3a7i_A 106 SALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT 178 (303)
T ss_dssp EHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCC
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCc
Confidence 99999864 35899999999999999999999 8899999999999999999999999999998764332 12234
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+.+..++.++||||||++++||++|+.||...... .... .+..+.. +.+ +...
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~~~~-----~~~----~~~~ 243 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLF----LIPKNNP-----PTL----EGNY 243 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH----HHHHSCC-----CCC----CSSC
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHH----HhhcCCC-----CCC----cccc
Confidence 56899999999999999999999999999999999999998654311 1111 1111111 111 1222
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
...+.+++.+|++.+|++||+++|++++.
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 34688999999999999999999998854
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=340.48 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=189.5
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCC--------CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--------GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 642 (858)
.+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++. .+..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 3445688999999999999965 78999999986431 122346889999999999999999999975 4568
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCc
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLS 719 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla 719 (858)
++||||+++|+|.+++... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.+ ..+||+|||++
T Consensus 215 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999999998654 36899999999999999999999 8899999999999999754 45999999999
Q ss_pred ccccCCCcceeecccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 720 KVFPIGGTHVSTVVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 720 ~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
+..... .......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ..+...+ ..+..
T Consensus 290 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i----~~~~~ 362 (419)
T 3i6u_A 290 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQI----TSGKY 362 (419)
T ss_dssp TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHH----HTTCC
T ss_pred eecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHH----hcCCC
Confidence 876432 22334578999999999853 56788999999999999999999999754322 1222211 11111
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ..... ......+.+++.+|++.+|++||+++|++++
T Consensus 363 ~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 363 NF-IPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CC-CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CC-Cchhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 1123468899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.99 Aligned_cols=245 Identities=23% Similarity=0.385 Sum_probs=201.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 34578999999999999975 68899999987542 234567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++... ..+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 124 ~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (335)
T 2owb_A 124 RRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 197 (335)
T ss_dssp TTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-c
Confidence 999999998654 36899999999999999999999 88999999999999999999999999999987653322 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||...... +.... +..+.. ..+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~-~~~~~~----------~~~ 261 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLR-IKKNEY----------SIP 261 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH-HHHTCC----------CCC
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHH-HhcCCC----------CCC
Confidence 23456899999999999888999999999999999999999999654311 11111 111110 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.||++||+++|++++
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2223467899999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.85 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=199.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--------chHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--------GFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--------~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 643 (858)
...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 176 (365)
T 2y7j_A 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176 (365)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEE
T ss_pred ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEE
Confidence 33478999999999999985 7999999998755321 135678899999999 7999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+||||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 177 lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999754 36899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcceeecccCCCCccCcccccc------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVT------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..... .+..+...
T Consensus 252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~----~i~~~~~~ 323 (365)
T 2y7j_A 252 PGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLR----MIMEGQYQ 323 (365)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHTCCC
T ss_pred CCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHhCCCC
Confidence 4322 234578999999999863 3578899999999999999999999965331 11111 11111110
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+ ......+.+++.+|++.+|++||+++|++++
T Consensus 324 -~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 -FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000001 0123468899999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=330.44 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=182.7
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++..++..++||||+++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 3457899999999999985 478999999986543 33456788999999999999999999999999999999999999
Q ss_pred CChHHHhhhc------ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 652 GNLKQLLSDE------KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 652 gsL~~~L~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
++|.+++... ....+++..++.++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9999999642 2345899999999999999999999 889999999999999999999999999999876433
Q ss_pred Cc----ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 726 GT----HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 726 ~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
.. .......|++.|+|||.+.. ..++.++||||||++++||++|+.||....... ... ..... ......
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~~~~~-~~~~~~ 248 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLM---LTLQN-DPPSLE 248 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHH---HHHTS-SCCCTT
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHH---HHhcc-CCCccc
Confidence 21 11233568999999999875 568899999999999999999999997654222 111 11111 111110
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...............+.+++.+|++.+|.+||+++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000001111223468899999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=330.38 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=190.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence 34578999999999999854 789999999975432 234567899999999999999999999999999999999998
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-----CCCCEEEeeecCcccccCC
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-----ENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-----~~~~~kL~DFGla~~~~~~ 725 (858)
+ +|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 117 ~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 117 N-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp E-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred C-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 5 9999997654 5899999999999999999999 88999999999999994 5556999999999876433
Q ss_pred CcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---chhhh-
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IENIV- 800 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~~~~- 800 (858)
.. ......||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... .....+........ .....
T Consensus 191 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 191 IR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhhhhhhhh
Confidence 22 22334679999999999864 5899999999999999999999999754321 11111111111000 00000
Q ss_pred chhhcCC------------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGG------------FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~------------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+..... .+.....++.+++.+|++.||++|||++|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000000 001123577899999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.85 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=195.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 34578999999999999975 6999999998655333 24567899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 108 ~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 181 (331)
T 4aaa_A 108 HTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 181 (331)
T ss_dssp EEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred cchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-cc
Confidence 99999887543 36899999999999999999999 88999999999999999999999999999987643322 22
Q ss_pred ecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc-----------CC-ch
Q 043526 731 TVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK-----------GD-IE 797 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~-----------~~-~~ 797 (858)
....|+..|+|||.+.+. .++.++|||||||+++||++|+.||....... .+ ..+...... .. ..
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QL-YHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH-HHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HH-HHHHHHhCCCChhhhhHhhhccccc
Confidence 335689999999999865 78999999999999999999999997544211 11 111111000 00 00
Q ss_pred hhhchhhcCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSCLRGGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....+.+....+ ......+.+++.+|++.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000001 1234578899999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=318.70 Aligned_cols=244 Identities=23% Similarity=0.378 Sum_probs=192.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++.++.++||||+++++++...+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 34578999999999999976 7999999998643 2334567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++++|.+++.... .+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....... .
T Consensus 94 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 94 SGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 9999999997653 6899999999999999999999 8899999999999999999999999999998764332 2
Q ss_pred eecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....|++.|+|||.+.+... +.++||||||++++||++|+.||...... .+ ...+..+.. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~----~~~~~~~~~----------~~ 230 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TL----FKKIRGGVF----------YI 230 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHHHHHCCC----------CC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HH----HHHhhcCcc----------cC
Confidence 233468999999999987655 68999999999999999999998653311 11 111111110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+......+.+++.+|++.+|++||+++|++++
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12223468899999999999999999999885
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=336.25 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=200.4
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc--------cceeeeeeeeee----eC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH--------HRNLTNLVGYFI----ED 639 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~----~~ 639 (858)
+.+.+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+++++.++ |+||+++++++. ..
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 445678999999999999864 7899999999643 234567889999999986 888999999987 45
Q ss_pred CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCC---------
Q 043526 640 NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENL--------- 709 (858)
Q Consensus 640 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~--------- 709 (858)
...++||||+ +++|.+.+.......+++.+++.++.||+.||+||| +. +|+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred ceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 6789999999 567777776555567999999999999999999999 76 999999999999999775
Q ss_pred ----------------------------------------CEEEeeecCcccccCCCcceeecccCCCCccCccccccCC
Q 043526 710 ----------------------------------------EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749 (858)
Q Consensus 710 ----------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 749 (858)
.+||+|||+++..... .....||+.|+|||.+.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCC
Confidence 7999999999876432 23346899999999999988
Q ss_pred CCCchhHHHHHHHHHHHHhCCCccccCCCcccc----HHHHHHHHHhcC--------Cc-hhhhch--------------
Q 043526 750 LNEKSDVYSFGVVLLEIITSQAVIVRNENENIH----IIQTVTNMIAKG--------DI-ENIVDS-------------- 802 (858)
Q Consensus 750 ~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~----l~~~v~~~~~~~--------~~-~~~~d~-------------- 802 (858)
++.++|||||||+++||+||+.||......... ....+......- .. .+.+..
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 999999999999999999999999765433221 111111111110 00 000000
Q ss_pred ---hh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 ---CL--RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ---~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+ ....+......+.+|+.+||+.||++|||++|++++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 011245667789999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=360.20 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=203.5
Q ss_pred hccccccccCceEEEEEEEC----CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD----DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|+.++++++||||+++++++. ++..++||||
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 44578999999999999974 356799999875433 33467999999999999999999999985 4668999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 472 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 472 CTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp CTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred CCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 99999999997543 46899999999999999999999 889999999999999999999999999999876544333
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ..... +..+.. ..
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~----i~~~~~---------~~ 612 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGER---------LP 612 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHHTCC---------CC
T ss_pred eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCCC---------CC
Confidence 3334456789999999998899999999999999999997 89998654321 11111 111110 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.+......+.+++.+|+..+|++||++.|+++.|++++..+.
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 122334578899999999999999999999999999886653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=342.77 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=191.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 644 (858)
...+.||+|+||.||+|... +|+.||||++... .....+++.+|+++++.++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 33578999999999999865 7899999999754 233456788999999999999999999999654 35799
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++ +|.+.+.. .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 145 v~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999986 56666632 4889999999999999999999 88999999999999999999999999999987643
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC------c--
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD------I-- 796 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~------~-- 796 (858)
. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..... .+....+...+.... +
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHHcch
Confidence 2 223345789999999999999999999999999999999999999965431 111111111111000 0
Q ss_pred -----------------hhhhchhhcCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 -----------------ENIVDSCLRGGFE---IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 -----------------~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+...+..... .....++.+|+.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 1125678999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=330.85 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=197.6
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeee--------CCee
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--------DNNM 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~~~~ 642 (858)
...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.++||||+++++++.. .+..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence 4457899999999999997 4899999999865432 234678899999999999999999999987 4468
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
++||||+++ +|.+.+.... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 100 YLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 999999986 7777775443 36899999999999999999999 889999999999999999999999999999876
Q ss_pred cCCCc---ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---C
Q 043526 723 PIGGT---HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---D 795 (858)
Q Consensus 723 ~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~ 795 (858)
..... .......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+....... .
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhh
Confidence 43221 12234568999999999875 5679999999999999999999999976432 12222222221111 0
Q ss_pred chhhhchhhcC--------CCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 IENIVDSCLRG--------GFEIE-------SAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 ~~~~~d~~l~~--------~~~~~-------~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........... ..... ....+.+++.+|++.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11110000000 00000 13457899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.60 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=202.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCc---c--------------hHhHHHHHHHHHhcccceeeeeeeee
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ---G--------------FKEFEAEVKLLMRVHHRNLTNLVGYF 636 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---~--------------~~~~~~E~~~l~~l~HpnIv~l~~~~ 636 (858)
.+.+.||+|+||.||+|.. +|+.||||++...... . .+.+.+|++++++++||||+++++++
T Consensus 34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3457899999999999999 9999999998643211 1 17899999999999999999999999
Q ss_pred eeCCeeEEEEeeccCCChHHH------hhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCC
Q 043526 637 IEDNNMGLIYEYMANGNLKQL------LSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENL 709 (858)
Q Consensus 637 ~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~ 709 (858)
...+..++||||+++|+|.++ +.......+++..++.++.|++.||+||| + .+|+||||||+|||++.++
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTTS
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCCC
Confidence 999999999999999999999 65544567999999999999999999999 6 8999999999999999999
Q ss_pred CEEEeeecCcccccCCCcceeecccCCCCccCccccccC-CCCC-chhHHHHHHHHHHHHhCCCccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD-WLNE-KSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||...... ..+..
T Consensus 190 ~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~-- 263 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELFN-- 263 (348)
T ss_dssp CEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHHH--
T ss_pred cEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH--
Confidence 9999999999876433 23445689999999999876 5665 999999999999999999999764431 11111
Q ss_pred HHHHhcCCchhh------hchhhc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 788 TNMIAKGDIENI------VDSCLR---GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 788 ~~~~~~~~~~~~------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+..+....- ..+... ..........+.+++.+|++.+|.+||+++|++++
T Consensus 264 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 264 --NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1222211100 000000 00012234578899999999999999999999883
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=344.87 Aligned_cols=249 Identities=27% Similarity=0.367 Sum_probs=197.0
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3455689999999999999975 78999999997543 33467889999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCcccccCC
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLSKVFPIG 725 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla~~~~~~ 725 (858)
+++|+|.+.+.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 118 ~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 118 YKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999986543 6899999999999999999999 8899999999999999764 55999999999876543
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
. ......||+.|+|||.+. ..++.++||||+||++|||++|+.||...... .+.. .+..+... ...+.+
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~----~i~~~~~~-~~~~~~- 261 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILR----KVEKGKYT-FDSPEW- 261 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHTCCC-CCSGGG-
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHhCCCC-CCchhc-
Confidence 2 223456999999999876 56899999999999999999999999754321 1111 12221110 000111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+.+++.+|++.+|.+|||++|++++
T Consensus 262 ----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 262 ----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1223468899999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.37 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=197.0
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-----cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-----QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
+...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 344578999999999999965 699999999875322 12357889999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++ +|.+++.... ..+++.++..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 92 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp ECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 99986 8988886543 46889999999999999999999 8899999999999999999999999999998764332
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---chhh---
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IENI--- 799 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~~~--- 799 (858)
. ......||+.|+|||.+.+ ..++.++|||||||+++||++|.+||..... ......+........ +.+.
T Consensus 167 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 167 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred c-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhhhhhhccC
Confidence 2 2234568999999999875 4578999999999999999999998865432 111111111111100 0000
Q ss_pred hchhhcC---CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 VDSCLRG---GFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ~d~~l~~---~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+..... ..+ ......+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 001 1223578999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.31 Aligned_cols=191 Identities=24% Similarity=0.411 Sum_probs=150.8
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 644 (858)
+.+.+.||+|+||.||+|... +|+.||||++..... ...+++.+|++++++++||||+++++++... ...++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 345688999999999999865 799999999965422 2456789999999999999999999999543 56899
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+. |+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 135 v~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 135 VLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 999985 6999998654 46999999999999999999999 88999999999999999999999999999987643
Q ss_pred CCc--------------------------ceeecccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHhC
Q 043526 725 GGT--------------------------HVSTVVAGTPGYLDPEYF-VTDWLNEKSDVYSFGVVLLEIITS 769 (858)
Q Consensus 725 ~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSfGvll~ElltG 769 (858)
... .......||+.|+|||.+ ....++.++|||||||+++||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 211 112335689999999976 466799999999999999999994
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=327.18 Aligned_cols=247 Identities=27% Similarity=0.476 Sum_probs=193.1
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeee------CCeeEEEE
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIE------DNNMGLIY 646 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~------~~~~~lV~ 646 (858)
+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+++++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 457899999999999997 479999999997543 3457889999999999 79999999999987 46789999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++|+|.+++.......+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp ECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred EcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 9999999999998766567899999999999999999999 8899999999999999999999999999998764321
Q ss_pred cceeecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
. ......|++.|+|||.+. ...++.++|||||||+++||++|+.||...... ..... +........
T Consensus 184 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~~-- 254 (326)
T 2x7f_A 184 G-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL-IPRNPAPRL-- 254 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH-HHHSCCCCC--
T ss_pred c-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHH-hhcCccccC--
Confidence 1 223346899999999987 567889999999999999999999998654311 11111 111111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|+..+|.+||+++|++++
T Consensus 255 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 255 ------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111223468899999999999999999999883
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.93 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=193.2
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||.||+|... +|+.||||++...... ....+.+|++++++++||||+++++++..++..++||||++ |
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 4578999999999999976 7899999999754322 22355679999999999999999999999999999999998 4
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 85 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 159 (324)
T 3mtl_A 85 DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYDN 159 (324)
T ss_dssp EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cccc
Confidence 9999887543 46899999999999999999999 88999999999999999999999999999986543222 2233
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhhhchh-h---
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENIVDSC-L--- 804 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~~d~~-l--- 804 (858)
..||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+....... .+....... .
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 467999999999876 56899999999999999999999999764322 2222222222111 111111000 0
Q ss_pred -cCCC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 -RGGF--------EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 -~~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... .......+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 01223567899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.67 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=196.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC----CcchHhHHHHHHHHHhcccceeeeeeeeee--eCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS----GQGFKEFEAEVKLLMRVHHRNLTNLVGYFI--EDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++. +.+..++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 44578999999999999964 78999999996432 344578999999999999999999999984 456789999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||++++ |.+++.......+++.++..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 88 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp ECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred hhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999986 888877665667999999999999999999999 8899999999999999999999999999998764322
Q ss_pred -cceeecccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 727 -THVSTVVAGTPGYLDPEYFVTDW--LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 727 -~~~~~~~~gt~~y~APE~~~~~~--~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
........|+..|+|||.+.+.. .+.++||||||++++||++|+.||..... .... ..+..+..
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-~~i~~~~~------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLF-ENIGKGSY------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH-HHHHHCCC-------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHH-HHHhcCCC-------
Confidence 22233456899999999987643 37799999999999999999999975331 1111 11122111
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+......+.+++.+|++.||.+||+++|++++
T Consensus 231 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122234567899999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=345.91 Aligned_cols=249 Identities=28% Similarity=0.387 Sum_probs=202.7
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4455689999999999999975 89999999996543 3356779999999999999999999999999999999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE---cCCCCEEEeeecCcccccC
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL---TENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl---~~~~~~kL~DFGla~~~~~ 724 (858)
|+.+|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 107 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 107 VYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999996543 6899999999999999999999 8899999999999999 5678999999999987654
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
... .....||+.|+|||.+.+ .++.++||||+||++|||++|+.||..... ..+.. .+..+....- .+.
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~----~i~~~~~~~~-~~~- 250 (484)
T 3nyv_A 182 SKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILK----KVEKGKYTFE-LPQ- 250 (484)
T ss_dssp CCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHHHCCCCCC-SGG-
T ss_pred ccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHcCCCCCC-Ccc-
Confidence 322 233568999999998865 689999999999999999999999975432 11112 1222211100 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......+.+++.+|++.+|++|||++|++++
T Consensus 251 ----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 251 ----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 01234568899999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=336.52 Aligned_cols=250 Identities=10% Similarity=0.021 Sum_probs=178.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---cchHhHHHHHHHHHhc--ccceeeeee-------eeeeeC-
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRV--HHRNLTNLV-------GYFIED- 639 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l--~HpnIv~l~-------~~~~~~- 639 (858)
...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 34578999999999999965 799999999987543 2345677785555555 699988755 333332
Q ss_pred ----------------CeeEEEEeeccCCChHHHhhhcccCchhHHHH------HHHHHHHHHHHHHhhcCCCCCeEecC
Q 043526 640 ----------------NNMGLIYEYMANGNLKQLLSDEKASTLSWERR------LQIAMDAAQGLEYLHIGCKPPIVHRD 697 (858)
Q Consensus 640 ----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~IvH~D 697 (858)
...++||||++ |+|.+++..... .+.+..+ +.++.||++||+||| +.+|+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrD 219 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCc
Confidence 33799999999 899999976532 3455666 788899999999999 88999999
Q ss_pred CCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCcccc
Q 043526 698 IKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVIVR 775 (858)
Q Consensus 698 Lk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~~~ 775 (858)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986532 1223456799999999987 6789999999999999999999999976
Q ss_pred CCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 776 NENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 776 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
........ .............+...........+.+++.+||+.||++||+++|+++
T Consensus 296 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 53221100 0000000000001111111233557889999999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=343.70 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=200.4
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.+.||+|+||+||+|... +|+.||||++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 4556789999999999999975 7999999998643 233467899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc---CCCCEEEeeecCcccccCC
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~---~~~~~kL~DFGla~~~~~~ 725 (858)
+++|+|.+.+.... .+++.++..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 103 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999986653 6899999999999999999999 88999999999999995 4567999999999876543
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
. ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||..... ..+... +..+..... .+.
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~----i~~~~~~~~-~~~-- 245 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKR----VETGKYAFD-LPQ-- 245 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHTCCCSC-SGG--
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCCCCCC-Ccc--
Confidence 2 2234569999999999875 589999999999999999999999965432 111111 122111100 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......+.+++.+|++.+|.+|||+.|++++
T Consensus 246 ---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 ---WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01234568899999999999999999999885
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=358.06 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=201.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+..|.+++..+ +||+|+++++++...+..++||||
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~ 423 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423 (674)
T ss_dssp EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEEC
T ss_pred EEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeC
Confidence 44578999999999999965 7889999999743 233456788899999887 799999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.++++... .+++.+++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 424 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~- 497 (674)
T 3pfq_A 424 VNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 497 (674)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence 99999999997653 6899999999999999999999 88999999999999999999999999999986433222
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ .. .+.++. ..+
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~---~~-~i~~~~----------~~~ 561 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DEL---FQ-SIMEHN----------VAY 561 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HH-HHHSSC----------CCC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHH---HH-HHHhCC----------CCC
Confidence 23456799999999999999999999999999999999999999975431 111 11 111111 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNM-----NEVVT 839 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm-----~eVl~ 839 (858)
+.....++.+|+.+||+.||++||++ +||++
T Consensus 562 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 33345578899999999999999997 66655
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=336.86 Aligned_cols=196 Identities=28% Similarity=0.392 Sum_probs=170.0
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhc------ccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV------HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~~~lV 645 (858)
+.+.+.||+|+||.||+|... +++.||||++... .....++.+|+++++.+ .|+||+++++++...+..++|
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 344688999999999999865 6899999999753 22345677888888887 567999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC--EEEeeecCccccc
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE--AKLADFGLSKVFP 723 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~--~kL~DFGla~~~~ 723 (858)
|||+. ++|.+++.......+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+++...
T Consensus 178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99996 69999998776667999999999999999999999 889999999999999999987 9999999997643
Q ss_pred CCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCC
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~ 777 (858)
.. .....||+.|+|||.+.+..++.++|||||||+++||++|+.||....
T Consensus 254 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 254 QR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 22 223568999999999999899999999999999999999999997543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=337.03 Aligned_cols=194 Identities=25% Similarity=0.409 Sum_probs=162.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 645 (858)
.+.+.||+|+||.||+|... +|+.||||++..... ...+++.+|++++++++||||+++++++... +..++|
T Consensus 29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 44678999999999999965 688999999975422 2456789999999999999999999999876 578999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||++ |+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 ~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 99987 5999999654 46899999999999999999999 889999999999999999999999999999876433
Q ss_pred Ccc---------------------eeecccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHhCCCcc
Q 043526 726 GTH---------------------VSTVVAGTPGYLDPEYF-VTDWLNEKSDVYSFGVVLLEIITSQAVI 773 (858)
Q Consensus 726 ~~~---------------------~~~~~~gt~~y~APE~~-~~~~~s~ksDVwSfGvll~ElltG~~p~ 773 (858)
... ......||+.|+|||.+ ....++.++|||||||+++||++|..|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 211 12445789999999986 4667999999999999999999865544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=322.29 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=183.9
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc-c-hHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ-G-FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~-~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
.+.+.||+|+||.||+|.. .+|+.||||++...... . .+.+.++...++.++||||+++++++..++..++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 3457899999999999996 48999999999754322 2 2334445556788899999999999999999999999998
Q ss_pred CCChHHHhhhc--ccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDE--KASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
+ +|.+++... ....+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 164 (290)
T 3fme_A 90 T-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV- 164 (290)
T ss_dssp E-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence 5 888887642 2457999999999999999999999 76 99999999999999999999999999998764332
Q ss_pred ceeecccCCCCccCcccc----ccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 728 HVSTVVAGTPGYLDPEYF----VTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~----~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
......||+.|+|||.+ ....++.++||||||++++||++|+.||......... ..........
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~------- 232 (290)
T 3fme_A 165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----LKQVVEEPSP------- 232 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH----HHHHHHSCCC-------
T ss_pred -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH----HHHHhccCCC-------
Confidence 22334689999999996 4567889999999999999999999999754322211 1122221110
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..........+.+++.+|++.+|++|||++|++++
T Consensus 233 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 --QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 00111234568899999999999999999999884
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=322.63 Aligned_cols=256 Identities=18% Similarity=0.316 Sum_probs=202.0
Q ss_pred hhccccccccCceEEEEEEE--CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccce------eeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL--DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN------LTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~~~l 644 (858)
+.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+..++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 34567899999999999986 36889999999643 233567889999999998776 9999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-----------------
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE----------------- 707 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~----------------- 707 (858)
||||+ +++|.+++.......+++.++..++.|+++||+||| +.+|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999 889999998766567899999999999999999999 889999999999999987
Q ss_pred --CCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 708 --NLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 708 --~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||......+ ...
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~ 244 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE--HLA 244 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH--HHH
T ss_pred ccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--HHH
Confidence 668999999999865432 223568999999999999899999999999999999999999997543211 111
Q ss_pred HHHHHHhcCCchhhhc------------------------------hhh-cCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 043526 786 TVTNMIAKGDIENIVD------------------------------SCL-RGGFEIESAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d------------------------------~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
.+...... ....... +.. ....+......+.+++.+|++.||.+|||+
T Consensus 245 ~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 MMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11111110 0000000 000 001123456788999999999999999999
Q ss_pred HHHHHH
Q 043526 835 NEVVTE 840 (858)
Q Consensus 835 ~eVl~~ 840 (858)
+|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.09 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=198.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
...+.||+|+||.||+|... +|+.||||.+.... ..+++.+|++++++++||||+++++++...+..++||||++++
T Consensus 32 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 44578999999999999975 69999999997543 4578899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... ...+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 110 ~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~ 184 (314)
T 3com_A 110 SVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNT 184 (314)
T ss_dssp EHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCC
T ss_pred CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCc
Confidence 999999643 346899999999999999999999 8899999999999999999999999999998764322 12234
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+.+..++.++||||||++++||++|+.||...... ..... ......... ..+...
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~~~-------~~~~~~ 251 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFM-IPTNPPPTF-------RKPELW 251 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH-HHHSCCCCC-------SSGGGS
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHH-HhcCCCccc-------CCcccC
Confidence 56899999999999888999999999999999999999999654311 11111 111110000 011122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+++.+|+..+|.+||++.+++++
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4568899999999999999999999873
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=343.28 Aligned_cols=247 Identities=28% Similarity=0.356 Sum_probs=196.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-------------cchHhHHHHHHHHHhcccceeeeeeeeeeeC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-------------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED 639 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 639 (858)
.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++..+
T Consensus 39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 118 (504)
T 3q5i_A 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118 (504)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34578999999999999975 689999999875421 2356789999999999999999999999999
Q ss_pred CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC---CEEEeee
Q 043526 640 NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL---EAKLADF 716 (858)
Q Consensus 640 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~---~~kL~DF 716 (858)
...++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+||
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999996643 6899999999999999999999 88999999999999999775 6999999
Q ss_pred cCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 717 GLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 717 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
|+++...... ......||+.|+|||.+. +.++.++||||+||++|||++|+.||...... .+. ..+..+..
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~----~~i~~~~~ 264 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DII----KKVEKGKY 264 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHCCC
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHcCCC
Confidence 9998765432 223456999999999876 46899999999999999999999999754321 111 11222211
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..-. +.+ .....++.+++.+|++.+|.+|||++|++++
T Consensus 265 ~~~~-~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YFDF-NDW-----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCH-HHH-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCc-ccc-----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 000 1123468899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=335.07 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=192.6
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC-------------
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------------- 639 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------------- 639 (858)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 4458999999999999996 5899999999865432 234799999999999999999998543
Q ss_pred -------------------------CeeEEEEeeccCCChHHHhhh--cccCchhHHHHHHHHHHHHHHHHHhhcCCCCC
Q 043526 640 -------------------------NNMGLIYEYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692 (858)
Q Consensus 640 -------------------------~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 692 (858)
...++||||+++ +|.+.+.. .....+++..+..++.||++||+||| +.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLG 161 (383)
T ss_dssp ------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTT
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCc
Confidence 348899999984 88888764 23457999999999999999999999 899
Q ss_pred eEecCCCCcceEEc-CCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCC
Q 043526 693 IVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQ 770 (858)
Q Consensus 693 IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~ 770 (858)
|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||+++||++|+
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 99999999999998 688999999999987644332 2334689999999998764 5899999999999999999999
Q ss_pred CccccCCCccccHHHHHHHHHhcCCchhhhc---------------hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 043526 771 AVIVRNENENIHIIQTVTNMIAKGDIENIVD---------------SCLRGGFEIESAWRAVELAVKCASRTSSERPNMN 835 (858)
Q Consensus 771 ~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d---------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 835 (858)
.||..... .+....+...........+.. ..+....+......+.+++.+|++.+|++|||+.
T Consensus 240 ~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 240 PLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp CSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99975432 111111111111111111000 0000001222345688999999999999999999
Q ss_pred HHHHH
Q 043526 836 EVVTE 840 (858)
Q Consensus 836 eVl~~ 840 (858)
|++++
T Consensus 318 e~l~h 322 (383)
T 3eb0_A 318 EAMAH 322 (383)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=339.05 Aligned_cols=259 Identities=22% Similarity=0.353 Sum_probs=182.5
Q ss_pred cccccccCceEEEEEEEC---CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEeecc
Q 043526 576 NKVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEYMA 650 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey~~ 650 (858)
.+.||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 357999999999999975 57899999997542 23578899999999999999999999954 678999999997
Q ss_pred CCChHHHhhhcc-------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE----cCCCCEEEeeecCc
Q 043526 651 NGNLKQLLSDEK-------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL----TENLEAKLADFGLS 719 (858)
Q Consensus 651 ~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl----~~~~~~kL~DFGla 719 (858)
+ +|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 8888875432 224899999999999999999999 8899999999999999 77889999999999
Q ss_pred ccccCCCc--ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCcc-------ccHHHHHHH
Q 043526 720 KVFPIGGT--HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-------IHIIQTVTN 789 (858)
Q Consensus 720 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~-------~~l~~~v~~ 789 (858)
+....... .......||+.|+|||.+.+ ..++.++|||||||+++||++|+.||.....+. ......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87643221 12234578999999999886 458999999999999999999999996543210 111111111
Q ss_pred HHhc---CCchhhh---------ch---hhcCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 790 MIAK---GDIENIV---------DS---CLRGGFE---------IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 790 ~~~~---~~~~~~~---------d~---~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.. ..+..+. .. ....... ......+.+|+.+||+.||.+|||++|++++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1110 0000000 00 0000000 0113467899999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.35 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=194.8
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccCC--------CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--------GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 642 (858)
.+.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++..++ .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 4556689999999999999975 68999999986532 122356889999999999999999999987655 8
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---EEEeeecCc
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE---AKLADFGLS 719 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~---~kL~DFGla 719 (858)
++||||+++++|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999999998654 36899999999999999999999 889999999999999987665 999999999
Q ss_pred ccccCCCcceeecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 720 KVFPIGGTHVSTVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 720 ~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
+..... .......|++.|+|||.+. ...++.++|||||||+++||++|+.||...... ..+...+. .+..
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~----~~~~ 237 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQIT----SGKY 237 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHH----HTCC
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHH----hCcc
Confidence 876432 1223356899999999974 567889999999999999999999999754422 12222221 1111
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. .+... ......+.+++.+|++.||++||+++|++++
T Consensus 238 ~~--~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 NF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cc--Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00 00000 1123468899999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.80 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=198.4
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC---------cchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG---------QGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~---------~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 643 (858)
..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++ ||||+++++++..++..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 3578999999999999975 789999999975432 12356789999999996 999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+||||+++++|.+++... ..+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 101 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 999999999999999764 36899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCcceeecccCCCCccCccccc------cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFV------TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
.... .....|++.|+|||.+. ...++.++||||||++++||++|+.||..... ... .. .+..+...
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~---~~-~~~~~~~~ 247 (298)
T 1phk_A 176 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLM---LR-MIMSGNYQ 247 (298)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HH-HHHHTCCC
T ss_pred CCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHH---HH-HHhcCCcc
Confidence 4322 23356899999999885 45678999999999999999999999865431 111 11 11111110
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
. ...........+.+++.+|++.+|++||+++|+++
T Consensus 248 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 00001223457889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=329.25 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=190.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 644 (858)
...+.||+|+||.||+|... +|+.||||++..... ...+++.+|+++++.++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 34578999999999999974 799999999865422 23467889999999999999999999997653 4699
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+ +++|.+++.. ..+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 99999 7899999865 35899999999999999999999 88999999999999999999999999999987543
Q ss_pred CCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch-
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS- 802 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~- 802 (858)
. .....||+.|+|||.+.+ ..++.++||||+||+++||++|+.||..... .+....+...... ...+....
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~-~~~~~~~~~ 253 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGT-PPAEFVQRL 253 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCC-CCHHHHHTC
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCC-CCHHHHHHh
Confidence 2 233568999999999886 6789999999999999999999999975432 1111111111110 00110000
Q ss_pred ----------hhc----C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 ----------CLR----G---GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ----------~l~----~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+. . .........+.+++.+|++.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 0 0011224578899999999999999999999884
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=336.60 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=191.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~ 646 (858)
...+.||+|+||.||+|+.. +|+.||||++.... ....+|++++++++||||+++++++... ...++||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 44578999999999999975 69999999986542 2235799999999999999999998642 2367999
Q ss_pred eeccCCChHHHhhh--cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCccccc
Q 043526 647 EYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFP 723 (858)
Q Consensus 647 Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~~~ 723 (858)
||+++ +|.+.+.. .....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 133 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99986 67666643 22457899999999999999999999 8999999999999999965 568999999998764
Q ss_pred CCCcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh--
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV-- 800 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~-- 800 (858)
.... .....||+.|+|||.+.+. .++.++|||||||+++||++|+.||..... ...+...++ .+.......+.
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~-~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIK-VLGTPTREQIREM 284 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-HHCSCCHHHHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-HhCCCCHHHHHhh
Confidence 4322 2335689999999998764 789999999999999999999999975432 112222221 11111000000
Q ss_pred c--------hhhc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 D--------SCLR-----GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d--------~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+ +.+. ..++.....++.+|+.+||+.||++||++.|++++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000 00112234578999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.06 Aligned_cols=259 Identities=22% Similarity=0.370 Sum_probs=198.7
Q ss_pred hccccccccCceEEEEEEE--CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhc---ccceeeeeeeeee-----eCCe
Q 043526 574 NFNKVLGKGGFGTVYHGYL--DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRV---HHRNLTNLVGYFI-----EDNN 641 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~--~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~-----~~~~ 641 (858)
.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++.+ +||||+++++++. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3457899999999999997 468899999986432 22345677788777766 8999999999987 4567
Q ss_pred eEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 642 MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
.++||||++ |+|.+++.......+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 899999998 69999998766566999999999999999999999 88999999999999999999999999999986
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh--
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI-- 799 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~-- 799 (858)
..... ......|+..|+|||.+.+..++.++||||||++++||++|+.||..... ......+............
T Consensus 170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 170 YSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCGGGSCT
T ss_pred ccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCcccCcc
Confidence 54321 22345689999999999988999999999999999999999999975432 1122222221111000000
Q ss_pred --h--chhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 --V--DSCLR-------GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 --~--d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ..... ..........+.+++.+|++.+|++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000 00112234578899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.04 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=191.6
Q ss_pred hhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe------eEEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN------MGLIY 646 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~lV~ 646 (858)
+...+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++...+. .++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 3456889999999999999887777999988654322 2469999999999999999999965443 78999
Q ss_pred eeccCCChHHHhhh-cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeecCcccccC
Q 043526 647 EYMANGNLKQLLSD-EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 647 Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~~ 724 (858)
||++++.+...... .....+++..+..++.||++||+||| +.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99987544433321 12457899999999999999999999 88999999999999999 799999999999987644
Q ss_pred CCcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh--hc
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI--VD 801 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~--~d 801 (858)
... .....||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ..+...+ ..........+ .+
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~-~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEII-KVLGTPSREQIKTMN 270 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH-HHHCCCCHHHHHHHC
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHhCCCCHHHHHhhC
Confidence 332 2334689999999998754 5899999999999999999999999764321 1111111 11111100000 00
Q ss_pred hh-----h--------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SC-----L--------RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~-----l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+. + ...+......++.+++.+|++.||.+|||+.|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0 000111234578999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=325.53 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=195.4
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||.||+|..++ .+|+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 113 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence 345789999999999999854 49999987542 33456788899999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC----c
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG----T 727 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~----~ 727 (858)
++|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+|||++ ++.+||+|||+++...... .
T Consensus 114 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 114 RTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp EEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 99999997543 46899999999999999999999 88999999999999998 6799999999987653211 1
Q ss_pred ceeecccCCCCccCcccccc---------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchh
Q 043526 728 HVSTVVAGTPGYLDPEYFVT---------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~---------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~ 798 (858)
.......|++.|+|||.+.. ..++.++||||||++++||++|+.||.....+. +...+..+....
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~ 262 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMGTGMKPN 262 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHHHTTCCCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHhccCCCCC
Confidence 12223458899999999864 357889999999999999999999997543211 111112211111
Q ss_pred hhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 799 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.. ......++.+++.+|+..+|++||+++++++.|+++.....
T Consensus 263 ~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 263 LS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11 11122357899999999999999999999999998665443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.04 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=193.6
Q ss_pred HHHHHHhhc--cccccccCceEEEEEEECCCCEEEEEEeccCCCcc-----------hHhHHHHHHHHHhcccceeeeee
Q 043526 567 EVLKITDNF--NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQG-----------FKEFEAEVKLLMRVHHRNLTNLV 633 (858)
Q Consensus 567 el~~~t~~f--~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~ 633 (858)
++.....++ .+.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 344444444 47899999999999998889999999986432221 26789999999999999999999
Q ss_pred eeeeeC-----CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC
Q 043526 634 GYFIED-----NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN 708 (858)
Q Consensus 634 ~~~~~~-----~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~ 708 (858)
+++... ...++||||++ |+|.+.+... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCC
Confidence 998543 35899999998 5888888644 346899999999999999999999 8899999999999999999
Q ss_pred CCEEEeeecCcccccCCCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHH
Q 043526 709 LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 709 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v 787 (858)
+.+||+|||+++...... ......|++.|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+
T Consensus 171 ~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i 246 (362)
T 3pg1_A 171 NDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--YNQLNKI 246 (362)
T ss_dssp CCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred CCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 999999999997543322 2233568899999999876 6789999999999999999999999975432 1112222
Q ss_pred HHHHhcCCchh-----------hhchhhcCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 788 TNMIAKGDIEN-----------IVDSCLRGG-------FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 788 ~~~~~~~~~~~-----------~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........... .+...+... ........+.+++.+|++.+|++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 22111111110 000000000 011224468899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.64 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=193.2
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcc--cceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVH--HRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
.+.+.||+|+||.||++...+|+.||||++.... ....+.+.+|++++.+++ ||||+++++++..++..++||| +
T Consensus 31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 109 (313)
T 3cek_A 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 109 (313)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence 3457899999999999998889999999997543 234577899999999997 4999999999999999999999 6
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc-
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH- 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~- 728 (858)
.+++|.+++.... .+++.+++.++.|+++||+||| +.+|+||||||+|||+++ +.+||+|||+++........
T Consensus 110 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 110 GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 6789999997643 6899999999999999999999 889999999999999975 89999999999876443221
Q ss_pred eeecccCCCCccCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 729 VSTVVAGTPGYLDPEYFVT-----------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~-----------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
......|++.|+|||.+.+ ..++.++||||||++++||++|+.||....... .......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~~~~------ 253 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAII------ 253 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHH------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH----HHHHHHH------
Confidence 2234468999999999865 467889999999999999999999996543211 1111111
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTEL 841 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L 841 (858)
+.......+......+.+++.+|++.+|++||+++|++++-
T Consensus 254 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 ---DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ---CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11111112222235688999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.48 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=197.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~ 646 (858)
...+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++... ...++||
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence 44578999999999999965 7889999999754332 346789999999999999999999999765 3689999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++ +|.+++... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 110 e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 110 DLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp ECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred cccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99985 999998653 5899999999999999999999 8899999999999999999999999999998764332
Q ss_pred cce--eecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh----
Q 043526 727 THV--STVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI---- 799 (858)
Q Consensus 727 ~~~--~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~---- 799 (858)
... .....||+.|+|||.+. ...++.++|||||||+++||++|+.||...... .....+...........+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHHHHHHHHCSCCHHHHHTCC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhh
Confidence 211 23357899999999875 455899999999999999999999999754422 222222221111110000
Q ss_pred -------hchhh-cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 -------VDSCL-RGGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 -------~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..... ....+ ......+.+++.+|++.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00001 1123568899999999999999999999873
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=327.30 Aligned_cols=255 Identities=25% Similarity=0.328 Sum_probs=188.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 644 (858)
...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 34578999999999999865 789999999975422 33467889999999999999999999997665 6899
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++ +|.+.+. ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 108 VMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 9999985 7888874 24889999999999999999999 88999999999999999999999999999986543
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHH--------------
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM-------------- 790 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~-------------- 790 (858)
. .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .....+...
T Consensus 180 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 180 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHHTTSCH
T ss_pred c--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHHhhh
Confidence 2 1223456899999999999989999999999999999999999999754321 111111000
Q ss_pred -----HhcC------CchhhhchhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 791 -----IAKG------DIENIVDSCLRGGF---EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 791 -----~~~~------~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.... .....+........ .......+.+++.+|++.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 00000000000000 01235678999999999999999999999885
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=326.86 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=198.0
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-----------cceeeeeeeeeeeCC
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-----------HRNLTNLVGYFIEDN 640 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~~~ 640 (858)
+.+.+.||+|+||.||+|.. .+|+.||||++... ......+.+|++++++++ ||||+++++++...+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 34568899999999999996 47899999999743 223467888999998886 899999999998654
Q ss_pred ----eeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEc------CCC
Q 043526 641 ----NMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLT------ENL 709 (858)
Q Consensus 641 ----~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~------~~~ 709 (858)
..++||||+ +++|.+++.......+++..+..++.||+.||+||| +. +|+||||||+|||++ ..+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcc
Confidence 789999999 889999998766667999999999999999999999 76 999999999999994 445
Q ss_pred CEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc----ccHHH
Q 043526 710 EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN----IHIIQ 785 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~----~~l~~ 785 (858)
.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||+||+.||....... .....
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 7999999999876432 223468999999999999999999999999999999999999997544211 11111
Q ss_pred HHHHHHhc--------CCc----------------------hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 043526 786 TVTNMIAK--------GDI----------------------ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMN 835 (858)
Q Consensus 786 ~v~~~~~~--------~~~----------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~ 835 (858)
.+...... +.. .+.... ....+.....++.+++.+|++.||++|||++
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11111110 000 000000 1123456677899999999999999999999
Q ss_pred HHHHH
Q 043526 836 EVVTE 840 (858)
Q Consensus 836 eVl~~ 840 (858)
|++++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=316.71 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=189.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee-------------C
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-------------D 639 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-------------~ 639 (858)
...+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 44578999999999999964 7999999999643 2345678999999999999999999998865 3
Q ss_pred CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCc
Q 043526 640 NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLS 719 (858)
Q Consensus 640 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla 719 (858)
+..++||||+++|+|.+++.... ..+++.+++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred CceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 56889999999999999997543 46788999999999999999999 889999999999999999999999999999
Q ss_pred ccccCCC-------------cceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 720 KVFPIGG-------------THVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 720 ~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
....... ........|+..|+|||.+.+. .++.++|||||||+++||++ |+.... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----~~~~ 236 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----ERVN 236 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----hHHH
Confidence 8754221 1112334689999999998754 78999999999999999998 433211 1111
Q ss_pred HHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 786 TVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ..+.... ..+....+......+.+++.+|++.||.+|||++|++++
T Consensus 237 ~~-~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 IL-KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH-HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HH-Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11 1111111 111122233445568899999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.16 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=190.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeee--------------eC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFI--------------ED 639 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--------------~~ 639 (858)
..+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++. +.
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3578999999999999976 58999999998766666788999999999999999999998873 34
Q ss_pred CeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeecC
Q 043526 640 NNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGL 718 (858)
Q Consensus 640 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGl 718 (858)
...++||||++ |+|.+++.. ..+++..++.++.|+++||+||| +.+|+||||||+|||++ +++.+||+|||+
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 67899999998 599999864 35889999999999999999999 88999999999999997 567999999999
Q ss_pred cccccCCCc--ceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC-
Q 043526 719 SKVFPIGGT--HVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG- 794 (858)
Q Consensus 719 a~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~- 794 (858)
++....... .......++..|+|||.+.. ..++.++||||||++++||++|+.||...... .....+.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILESIPVVH 245 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHSCCCC
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCc
Confidence 987643211 11233457899999998865 67899999999999999999999999754321 1111111110000
Q ss_pred ---------CchhhhchhhcCC-CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 795 ---------DIENIVDSCLRGG-FE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 795 ---------~~~~~~d~~l~~~-~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+...+....... .+ .....++.+++.+|++.||++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000011111000 01 1234578899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=323.15 Aligned_cols=197 Identities=26% Similarity=0.400 Sum_probs=167.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cc-----eeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HR-----NLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +|+.||||+++.. .....++..|+++++.++ |+ +++++++++...+..++||
T Consensus 57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 34578999999999999965 7889999999743 223466778888888875 44 4999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc--CCCCEEEeeecCcccccC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT--ENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~--~~~~~kL~DFGla~~~~~ 724 (858)
||++ |+|.+++.......+++..+..++.|++.||+|||.. ..+|+||||||+|||++ .++.+||+|||+++....
T Consensus 136 e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp ECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred ecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 9996 5999999876656799999999999999999999932 47899999999999995 578899999999987643
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCC
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNE 777 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~ 777 (858)
. .....||+.|+|||.+.+..++.++|||||||+++||+||+.||....
T Consensus 214 ~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 214 R----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp C----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 223568999999999999899999999999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=322.48 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=170.2
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~~ 651 (858)
+.||+|+||.||+|... +|+.||||++... .....+....++.++||||+++++++.. +...++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 57999999999999976 7999999999643 1222233344667799999999999976 4458999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCcc
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~~ 728 (858)
|+|.+++.......+++.+++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~--- 184 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--- 184 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc---
Confidence 99999998766667999999999999999999999 889999999999999986 455999999999865432
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+....++.++||||||++++||++|+.||........ .......+..+.. ......
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~------~~~~~~ 256 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--SPGMKRRIRLGQY------GFPNPE 256 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------CCCTTT
T ss_pred ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--hhhHHHhhhcccc------ccCchh
Confidence 22334689999999999888899999999999999999999999965442211 0000111110000 000001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......+.+++.+|++.+|++|||++|++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12234578899999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.21 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=199.5
Q ss_pred HhhccccccccCceEEEEEEEC-CCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence 4455689999999999999975 7999999998654 234567899999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC---CCEEEeeecCcccccCC
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN---LEAKLADFGLSKVFPIG 725 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~---~~~kL~DFGla~~~~~~ 725 (858)
+++++|.+.+.... .+++.+++.++.|++.||+||| +.+|+||||||+||+++.+ +.+||+|||++......
T Consensus 103 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999986543 6899999999999999999999 8899999999999999764 46999999999876433
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.. .....|++.|+|||.+.+ .++.++||||||++++||++|+.||..... ..+. ..+..+...... +..
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~----~~~~~~~~~~~~-~~~- 246 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDIL----KRVETGKYAFDL-PQW- 246 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHCCCCCCS-GGG-
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHH----HHHHcCCCCCCc-hhh-
Confidence 22 123357889999998865 488999999999999999999999975431 1111 112222111000 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.+|++||+++|++++
T Consensus 247 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 247 ----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1123468899999999999999999999884
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.98 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=199.7
Q ss_pred hhccccccccCceEEEEEEEC-CC-CEEEEEEeccCCCcchHhHHHHHHHHHhcccce------eeeeeeeeeeCCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DG-TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN------LTNLVGYFIEDNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g-~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~~~l 644 (858)
+.+.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+.+++...+..++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 345678999999999999964 44 68999999643 234567888999999998877 8999999999999999
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEE-------------------
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILL------------------- 705 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl------------------- 705 (858)
||||+ +++|.+++.......+++.+++.++.||+.||+||| +.+|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999 668888887665567999999999999999999999 8999999999999999
Q ss_pred cCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHH
Q 043526 706 TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785 (858)
Q Consensus 706 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~ 785 (858)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||...... ....
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~ 249 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR--EHLV 249 (355)
T ss_dssp ESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH
T ss_pred cCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 66789999999999865432 23356899999999999989999999999999999999999999754421 1112
Q ss_pred HHHHHHhcCCchhhhch--------------------------h-----hcCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 043526 786 TVTNMIAKGDIENIVDS--------------------------C-----LRGGFEIESAWRAVELAVKCASRTSSERPNM 834 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d~--------------------------~-----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm 834 (858)
.+...... ........ . ............+.+++.+|++.||++|||+
T Consensus 250 ~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 250 MMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 22211110 00000000 0 0001123345678999999999999999999
Q ss_pred HHHHHH
Q 043526 835 NEVVTE 840 (858)
Q Consensus 835 ~eVl~~ 840 (858)
+|++++
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=333.47 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=185.4
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++..++..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 3689999999998777778999999998643 235678899999886 89999999999999999999999996 699
Q ss_pred HHHhhhcccC-----chhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-------------CCEEEeee
Q 043526 655 KQLLSDEKAS-----TLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-------------LEAKLADF 716 (858)
Q Consensus 655 ~~~L~~~~~~-----~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-------------~~~kL~DF 716 (858)
.+++...... ..++..++.++.||+.||+||| +.+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999765421 1234456789999999999999 8899999999999999754 48999999
Q ss_pred cCcccccCCCcc---eeecccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHH
Q 043526 717 GLSKVFPIGGTH---VSTVVAGTPGYLDPEYFVT-------DWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQ 785 (858)
Q Consensus 717 Gla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~ 785 (858)
|+++........ ......||+.|+|||.+.+ ..++.++|||||||+++||+| |+.||....... ..
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~ 249 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---SN 249 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---HH
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---HH
Confidence 999887543222 1223569999999999865 678999999999999999999 899986543221 11
Q ss_pred HHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 786 TVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 786 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
...... ... .+....+.....++.+++.+|++.||.+||++.||++
T Consensus 250 i~~~~~---~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIRGIF---SLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTCC---CCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCC---Ccc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111100 000 0111123455678899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=326.15 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=179.7
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 644 (858)
...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 3457899999999999985 479999999996542 23456788999999999999999999998754 56799
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
|+|++ +++|.+++.. ..+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred Eeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 99999 6799999864 35899999999999999999999 88999999999999999999999999999987542
Q ss_pred CCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch-
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS- 802 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~- 802 (858)
. .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+...+... ..+.+..
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p-~~~~~~~~ 257 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTP-GAELLKKI 257 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSC-CHHHHTTC
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC-CHHHHHHh
Confidence 2 233568999999999876 6789999999999999999999999965432 12222222211110 0000000
Q ss_pred ----------hhc--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 ----------CLR--GGFEI-----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ----------~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+. ...+. .....+.+|+.+|++.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 00011 123468899999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=318.96 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=185.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCe-------eEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN-------MGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-------~~lV 645 (858)
.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|++.+..++||||+++++++...+. .++|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp EEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 33578999999999999975 79999999986543 334567788889999999999999999976443 7899
Q ss_pred EeeccCCChHHHhhh--cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-CCCEEEeeecCcccc
Q 043526 646 YEYMANGNLKQLLSD--EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-NLEAKLADFGLSKVF 722 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-~~~~kL~DFGla~~~ 722 (858)
|||+++ +|.+.+.. .....+++..+..++.|++.||+|||. .+.+|+||||||+|||++. ++.+||+|||+++..
T Consensus 105 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred eecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 999987 55554432 234468899999999999999999993 3679999999999999997 899999999999876
Q ss_pred cCCCcceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
..... .....||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... . ....+....... ..+...
T Consensus 183 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~-~~~~~~~~~~~~-~~~~~~ 257 (360)
T 3e3p_A 183 SPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-G-QLHEIVRVLGCP-SREVLR 257 (360)
T ss_dssp CTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-HHHHHHHHHCCC-CHHHHH
T ss_pred CCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-H-HHHHHHHHcCCC-CHHHHH
Confidence 54322 2345689999999998654 4899999999999999999999999764321 1 111111111110 001100
Q ss_pred h-------------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 S-------------------CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. .............+.+++.+|++.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00011122245688999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.05 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=191.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCee------EEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNM------GLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~------~lV 645 (858)
..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+++++.++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 4578999999999999965 7999999999764322 346788999999999999999999999877654 999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+. ++|.+.+. ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 126 MPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp EECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred Ecccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 99998 58888873 24899999999999999999999 889999999999999999999999999999865422
Q ss_pred CcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh----
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV---- 800 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~---- 800 (858)
.....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+....... ..+..
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~-~~~~~~~~~ 270 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVP-GTEFVQKLN 270 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC-CHHHHTTCS
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC-cHHHHHHhh
Confidence 233568999999999886 6789999999999999999999999975431 11111111111000 00000
Q ss_pred --------chhhcCC-C-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 --------DSCLRGG-F-----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 --------d~~l~~~-~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....... . .......+.+++.+|++.||++|||++|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 0 01224578899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=322.80 Aligned_cols=258 Identities=21% Similarity=0.333 Sum_probs=195.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~ 646 (858)
.+.+.||+|+||.||+|... +|+.||||++..... ....++.+|++++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 34578999999999999975 789999999975432 2346788999999999999999999988764 6789999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||++ |+|.+++.. ..+++.++..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 94 ELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred eccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 9998 599999865 35899999999999999999999 8899999999999999999999999999998764322
Q ss_pred cc---------eeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC-
Q 043526 727 TH---------VSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD- 795 (858)
Q Consensus 727 ~~---------~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~- 795 (858)
.. ......||+.|+|||.+.. ..++.++|||||||+++||++|+.||...... .....+........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLIFGIIGTPHS 244 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCS
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCch
Confidence 11 1123468999999998764 77899999999999999999999999754321 11111111111100
Q ss_pred ---ch--------hhhchhhc-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 ---IE--------NIVDSCLR-GGF-----EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 ---~~--------~~~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. +.+..... ... ......++.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 000 01234567899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.16 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=190.2
Q ss_pred HhhccccccccCceEEEEEEE-CCCCEEEEEEeccCCC------cchHhHHHHHHHHHhc----ccceeeeeeeeeeeCC
Q 043526 572 TDNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG------QGFKEFEAEVKLLMRV----HHRNLTNLVGYFIEDN 640 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l----~HpnIv~l~~~~~~~~ 640 (858)
.+.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++.++ +||||+++++++...+
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~ 111 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE 111 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence 345568999999999999986 4789999999975432 1234567799999998 8999999999999999
Q ss_pred eeEEEEee-ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeecC
Q 043526 641 NMGLIYEY-MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGL 718 (858)
Q Consensus 641 ~~~lV~Ey-~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGl 718 (858)
..++|+|+ +.+++|.+++.... .+++.+++.++.||++||+||| +.+|+||||||+||+++ +++.+||+|||+
T Consensus 112 ~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 112 GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp -CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred eEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 99999999 78999999997643 6899999999999999999999 88999999999999999 889999999999
Q ss_pred cccccCCCcceeecccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch
Q 043526 719 SKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797 (858)
Q Consensus 719 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~ 797 (858)
++...... .....|+..|+|||.+.+.... .++||||||++++||++|+.||.... . . ...
T Consensus 187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~----~-~~~--- 248 (312)
T 2iwi_A 187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E----I-LEA--- 248 (312)
T ss_dssp CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----H-HHT---
T ss_pred hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H----H-hhh---
Confidence 98765432 2345689999999998866654 58999999999999999999985321 0 0 000
Q ss_pred hhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. ..+......+.+++.+|++.+|++||+++|++++
T Consensus 249 -----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 -----EL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----CC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1122234467899999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.58 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=175.4
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHH-HHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVK-LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++..++..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 478999999999999975 799999999976533 23345566665 67778999999999999999999999999986
Q ss_pred ChHHHhhh---cccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 653 NLKQLLSD---EKASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 653 sL~~~L~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+|.+++.. .....+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 180 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-- 180 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc--
Confidence 88887753 12457899999999999999999999 66 99999999999999999999999999998764322
Q ss_pred eeecccCCCCccCcccc----ccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 729 VSTVVAGTPGYLDPEYF----VTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~----~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
......|++.|+|||.+ .+..++.++||||||++++||++|+.||....... +.... ...+. .+.+
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~-~~~~~-----~~~~ 250 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQ-VVKGD-----PPQL 250 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CC-CCCSC-----CCCC
T ss_pred ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHH-HhcCC-----CCCC
Confidence 12234689999999998 45678999999999999999999999996532110 00000 00010 0111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...........+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111112234578899999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=317.37 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=192.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc--chHhHHHHHHHHHhcccceeeeeeeeeeeCCe------eEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ--GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN------MGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~~lV 645 (858)
..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+. .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 4578999999999999975 7999999999754322 34678899999999999999999999987654 4999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||++ ++|.+++.. .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 108 ~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp EECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred ecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 99998 588888742 4899999999999999999999 889999999999999999999999999999865322
Q ss_pred CcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC------c--
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD------I-- 796 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~------~-- 796 (858)
.....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||..... ......+........ +
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHHHhh
Confidence 233468999999999876 6789999999999999999999999975432 111111111110000 0
Q ss_pred ---hhhhchh---hcC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 ---ENIVDSC---LRG---GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ---~~~~d~~---l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+... ... .........+.+++.+|++.||++||+++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 000 0112335678899999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.17 Aligned_cols=237 Identities=26% Similarity=0.410 Sum_probs=194.4
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc------chHhHHHHHHHHHhcc--cceeeeeeeeeeeCCeeEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ------GFKEFEAEVKLLMRVH--HRNLTNLVGYFIEDNNMGL 644 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~l 644 (858)
.+.+.||+|+||.||+|.. .+|+.||||++...... ....+..|++++++++ ||||+++++++..++..++
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l 125 (320)
T 3a99_A 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125 (320)
T ss_dssp EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence 4467899999999999985 47899999999754322 2356778999999996 5999999999999999999
Q ss_pred EEeeccC-CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc-CCCCEEEeeecCcccc
Q 043526 645 IYEYMAN-GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVF 722 (858)
Q Consensus 645 V~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~-~~~~~kL~DFGla~~~ 722 (858)
|+|++.+ ++|.+++... ..+++..++.++.|+++||+||| +.+|+||||||+|||++ +++.+||+|||+++..
T Consensus 126 v~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 126 ILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 9999986 8999999764 36899999999999999999999 88999999999999999 7899999999999876
Q ss_pred cCCCcceeecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
.... .....||+.|+|||.+.+... +.++||||||++++||++|+.||.... . .. .+..
T Consensus 201 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~----~~-~~~~----- 260 (320)
T 3a99_A 201 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----II-RGQV----- 260 (320)
T ss_dssp CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HH-HCCC-----
T ss_pred cccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------h----hh-cccc-----
Confidence 5322 233568999999999886665 688999999999999999999985421 0 00 1100
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.....++.+++.+|++.+|++||+++|++++
T Consensus 261 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 -----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223468899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.91 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=175.8
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-ch-HhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-GF-KEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|+||.||+|... +|+.||||++...... .. +.+.++..+++.++||||+++++++..++..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 3478999999999999975 7999999999765332 22 33444555788889999999999999999999999999 4
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKP-PIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~-~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+.+..+. ......+++..++.++.|+++||+||| +. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 108 ~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (318)
T 2dyl_A 108 TCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AK 181 (318)
T ss_dssp EEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cc
Confidence 4554444 333457899999999999999999999 64 99999999999999999999999999997664322 22
Q ss_pred ecccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 731 TVVAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
....|++.|+|||.+. ...++.++||||||++++||++|+.||....... ........... .. +.
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~-~~-----~~ 251 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF----EVLTKVLQEEP-PL-----LP 251 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHHSCC-CC-----CC
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----HHHHHHhccCC-CC-----CC
Confidence 3346899999999984 4568899999999999999999999997533211 11122211111 00 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
........+.+++.+|++.+|.+||+++|++++
T Consensus 252 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 252 --GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011223468899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=324.93 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=184.2
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
..+.||+|+||+||.....+|+.||||++.... ...+.+|+++++.+ +||||+++++++.+.+..++||||+. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 347899999999766556689999999996532 23467899999999 79999999999999999999999997 59
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-----CCCEEEeeecCcccccCCCc-
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-----NLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-----~~~~kL~DFGla~~~~~~~~- 727 (858)
|.+++.... ..+.+.+++.++.||++||+||| +.+|+||||||+|||++. ...+||+|||+++.......
T Consensus 104 L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 104 LQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 999997654 23455667899999999999999 889999999999999953 34688999999987653321
Q ss_pred -ceeecccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhch
Q 043526 728 -HVSTVVAGTPGYLDPEYFV---TDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802 (858)
Q Consensus 728 -~~~~~~~gt~~y~APE~~~---~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~ 802 (858)
.......||+.|+|||.+. ...++.++|||||||+++||++ |+.||....... .......... ..
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~~-~~--- 249 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANILLGACSL-DC--- 249 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------HHHHTTCCCC-TT---
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------HHHHhccCCc-cc---
Confidence 1223457999999999997 4567889999999999999999 888885432211 1111111110 00
Q ss_pred hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 803 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
+ .........+.+++.+|++.||.+||+++|+++
T Consensus 250 -~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 -L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 012234556789999999999999999999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=340.54 Aligned_cols=240 Identities=22% Similarity=0.305 Sum_probs=193.0
Q ss_pred hhccccccccCceEEEEEEEC--CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCe-----eEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD--DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN-----MGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-----~~l 644 (858)
+.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++...+. .++
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 345678999999999999975 689999999865432 344678999999999999999999999988765 799
Q ss_pred EEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 645 IYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
||||+++++|.+++.. .++|.+++.++.||+.||+||| +.+|+||||||+|||++++ .+||+|||+++....
T Consensus 162 v~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 9999999999988743 6899999999999999999999 8899999999999999986 899999999987643
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
. ....||++|+|||.+.+.. +.++|||||||+++||++|..|+........ .
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~------- 285 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------P------- 285 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------C-------
T ss_pred C-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------c-------
Confidence 2 3356899999999987654 8899999999999999999988754221110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERP-NMNEVVTELKECLMME 848 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~~~~ 848 (858)
...........+.+++.+|++.+|++|| +++++.+.|...+...
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0000012234678999999999999999 5777778887766443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=317.90 Aligned_cols=236 Identities=17% Similarity=0.154 Sum_probs=177.7
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCCC---cchHhHHHHHHHHHhccc-ceeeee---------eee------
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRVHH-RNLTNL---------VGY------ 635 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~---~~~~~~~~E~~~l~~l~H-pnIv~l---------~~~------ 635 (858)
.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+++.++| +|.... ...
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 47899999999999995 4799999999874332 336789999999999977 221111 111
Q ss_pred ------eee-----CCeeEEEEeeccCCChHHHhhh-----cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 043526 636 ------FIE-----DNNMGLIYEYMANGNLKQLLSD-----EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIK 699 (858)
Q Consensus 636 ------~~~-----~~~~~lV~Ey~~~gsL~~~L~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk 699 (858)
+.. ....+++|+++ +++|.+++.. .....+++..++.++.||++||+||| +.+|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcc
Confidence 111 12356677755 5799999852 22456899999999999999999999 8999999999
Q ss_pred CcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCcccc----------ccCCCCCchhHHHHHHHHHHHHhC
Q 043526 700 PENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF----------VTDWLNEKSDVYSFGVVLLEIITS 769 (858)
Q Consensus 700 ~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDVwSfGvll~ElltG 769 (858)
|+|||++.++.+||+|||+++..... .....| +.|+|||.+ ....++.++|||||||++|||+||
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred cceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999998865322 334567 999999999 555688899999999999999999
Q ss_pred CCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 770 QAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 770 ~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.||....... ....++.. .. .....+.+++.+|++.+|++||++.|++++
T Consensus 314 ~~Pf~~~~~~~--------------~~~~~~~~----~~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 314 DLPNTDDAALG--------------GSEWIFRS----CK--NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp SCCCCTTGGGS--------------CSGGGGSS----CC--CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcchhh--------------hHHHHHhh----cc--cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99996543211 11111111 11 123568899999999999999998888653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=299.50 Aligned_cols=221 Identities=24% Similarity=0.338 Sum_probs=176.4
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHH-Hhcccceeeeeeeeeee----CCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLL-MRVHHRNLTNLVGYFIE----DNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~ 650 (858)
+.||+|+||.||+|.. .+|+.||||++.. ...+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999996 4789999999964 25678888887 55689999999999987 677899999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~ 727 (858)
+|+|.+++.......+++.+++.++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999998766667999999999999999999999 889999999999999998 7889999999986532
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
+..++.++|||||||+++||++|+.||........ .......+.... ..
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~~~~~~~~~--~~ 220 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKTRIRMGQ--YE 220 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSSCTTC--CS
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHHHHHHhhcc--cc
Confidence 23457899999999999999999999965432110 000000000000 00
Q ss_pred CC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FE----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+ .....++.+++.+|++.+|++||+++|++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 1234578899999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.67 Aligned_cols=231 Identities=10% Similarity=0.096 Sum_probs=179.9
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++.+.+++||||+++++++..++..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 345688999999999999975 5899999999765432 246789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++++|.+++... ....++.+|+.|++.||+||| +.+|+||||||+|||++.++.+||+++|
T Consensus 113 ~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred cCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999999542 244568899999999999999 8899999999999999999999998443
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
|++| ++.++|||||||++|||+||+.||......... . ...... .+.... ...+
T Consensus 175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-~-~~~~~~-~~~~~~--~~~~---- 228 (286)
T 3uqc_A 175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-A-PAERDT-AGQPIE--PADI---- 228 (286)
T ss_dssp ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-E-ECCBCT-TSCBCC--HHHH----
T ss_pred ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-H-HHHHHh-ccCCCC--hhhc----
Confidence 3333 578999999999999999999999764422100 0 000000 000000 0001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
......++.+++.+|++.||++| |++|+++.|+++...+
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 11223468899999999999999 9999999999976544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=334.58 Aligned_cols=266 Identities=26% Similarity=0.315 Sum_probs=202.5
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeee------CCeeEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE------DNNMGL 644 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~~l 644 (858)
+.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. ++..++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 45568999999999999996 47999999998754 23345678999999999999999999998765 667899
Q ss_pred EEeeccCCChHHHhhhcc-cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---EEEeeecCcc
Q 043526 645 IYEYMANGNLKQLLSDEK-ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE---AKLADFGLSK 720 (858)
Q Consensus 645 V~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~---~kL~DFGla~ 720 (858)
||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++.
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999997643 336899999999999999999999 889999999999999997765 9999999998
Q ss_pred cccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 721 VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 721 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
....... .....|++.|+|||.+.+..++.++||||||++++||++|+.||..... ...|..............
T Consensus 173 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 173 ELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp BTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------CCS
T ss_pred ccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchhhhh
Confidence 7654322 2345789999999999999999999999999999999999999965421 111111000000000000
Q ss_pred c----------hhh--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHHHH
Q 043526 801 D----------SCL--RGGFEIESAWRAVELAVKCASRTSSERPNMNE-----VVTELKECLMM 847 (858)
Q Consensus 801 d----------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~e-----Vl~~L~~~~~~ 847 (858)
. ..+ ...........+.+++.+|+..||++||+++| ..+.+++++..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0 000 11123446778999999999999999999988 55666665543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=302.14 Aligned_cols=240 Identities=16% Similarity=0.167 Sum_probs=179.4
Q ss_pred HhhccccccccCceEEEEEEECCCCEEEEEEeccCC--------CcchHhHHHHHHHHHhcc---------c--------
Q 043526 572 TDNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--------GQGFKEFEAEVKLLMRVH---------H-------- 626 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H-------- 626 (858)
.+...+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+++++.++ |
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred cchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 345568999999999999998 78999999997553 223477899999999886 4
Q ss_pred ---------ceeeeeeeeeee-------------CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHH
Q 043526 627 ---------RNLTNLVGYFIE-------------DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684 (858)
Q Consensus 627 ---------pnIv~l~~~~~~-------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~y 684 (858)
|||+++++++.. ++..++||||+++|++.+.+.. ..+++.++..++.||+.||+|
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHH
Confidence 555555555443 6789999999999987777643 358999999999999999999
Q ss_pred hhcCCCCCeEecCCCCcceEEcCCC--------------------CEEEeeecCcccccCCCcceeecccCCCCccCccc
Q 043526 685 LHIGCKPPIVHRDIKPENILLTENL--------------------EAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744 (858)
Q Consensus 685 LH~~~~~~IvH~DLk~~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~ 744 (858)
||+ +.+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||.
T Consensus 177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 993 36899999999999999887 8999999999876532 2468999999999
Q ss_pred cccCCCCCchhHHHHHHH-HHHHHhCCCccccCCCccccHHHHHHHHHh-cCCchhhhchhhcCCCCHHHHHHHHHHHHH
Q 043526 745 FVTDWLNEKSDVYSFGVV-LLEIITSQAVIVRNENENIHIIQTVTNMIA-KGDIENIVDSCLRGGFEIESAWRAVELAVK 822 (858)
Q Consensus 745 ~~~~~~s~ksDVwSfGvl-l~ElltG~~p~~~~~~~~~~l~~~v~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 822 (858)
+.+.. +.++||||+|++ .+++++|..||.... ........+. ...... ............++.+++.+
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTFKT----KCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCCSS----CCCSHHHHHHHHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhccCc----ccchhhhhhcCHHHHHHHHH
Confidence 98766 889999998776 778889999884210 0011111111 100000 00000112456789999999
Q ss_pred ccccCCCCCCCHHHHH
Q 043526 823 CASRTSSERPNMNEVV 838 (858)
Q Consensus 823 Cl~~dP~~RPsm~eVl 838 (858)
|++.+ |++|++
T Consensus 319 ~L~~d-----sa~e~l 329 (336)
T 2vuw_A 319 MLNFS-----SATDLL 329 (336)
T ss_dssp GGGSS-----SHHHHH
T ss_pred HhccC-----CHHHHH
Confidence 99976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-27 Score=279.03 Aligned_cols=186 Identities=17% Similarity=0.101 Sum_probs=131.2
Q ss_pred cccccCceEEEEEE-ECCCCEEEEEEeccCC----------CcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 578 VLGKGGFGTVYHGY-LDDGTQVAVKMLSSSS----------GQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~----------~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
..+.|+.|.+..++ .-.|+.+|||++.... ....++|.+|+++|+++ .|+||+++++++++++..+||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45666666665544 3368999999997542 12346799999999999 799999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||++|++|.++|.... .++.. +|+.||+.||+|+| +.+||||||||+|||+++++.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997654 45543 58999999999999 899999999999999999999999999999876543
Q ss_pred CcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCcc
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVI 773 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~ 773 (858)
.. ......||++|||||.+.+. ...++|+||+|+++++|.++..++
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred Cc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 32 23345799999999998754 567899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-24 Score=252.06 Aligned_cols=182 Identities=18% Similarity=0.237 Sum_probs=147.2
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCc--------chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ--------GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
.+.||+|+||.||+|.. .++.+|+|+....... ..+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 6788999987543221 13458999999999999999988888888888999999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++++|.+++.. +..++.|+++||+||| +.+|+||||||+|||+++ .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999964 5689999999999999 889999999999999999 999999999998754322
Q ss_pred ce------eecccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCcc
Q 043526 728 HV------STVVAGTPGYLDPEYFVT--DWLNEKSDVYSFGVVLLEIITSQAVI 773 (858)
Q Consensus 728 ~~------~~~~~gt~~y~APE~~~~--~~~s~ksDVwSfGvll~ElltG~~p~ 773 (858)
.. .....||+.|||||++.. ..++.+.|+|+..+-..+.+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 134579999999999976 56778899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-21 Score=206.45 Aligned_cols=140 Identities=16% Similarity=0.173 Sum_probs=115.3
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCC------------------cchHhHHHHHHHHHhcccceeeeeeeeee
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG------------------QGFKEFEAEVKLLMRVHHRNLTNLVGYFI 637 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 637 (858)
.+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 478999999999999998899999999964321 12456899999999999 5 77777554
Q ss_pred eCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 638 EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 638 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
. +..++||||+++|+|.+ +.. .+...++.|+++||+||| +.+|+||||||+|||++ ++.+||+|||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred c-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 4 55699999999999998 522 234579999999999999 89999999999999999 9999999999
Q ss_pred CcccccCCCcceeecccCCCCccCccccc
Q 043526 718 LSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746 (858)
Q Consensus 718 la~~~~~~~~~~~~~~~gt~~y~APE~~~ 746 (858)
+++. +..++|||++.
T Consensus 238 ~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TCEE--------------TTSTTHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHH
Confidence 9864 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.7e-17 Score=173.16 Aligned_cols=135 Identities=21% Similarity=0.267 Sum_probs=105.0
Q ss_pred ccccccccCceEEEEEEE-CCCCE--EEEEEeccCCCc------------------------chHhHHHHHHHHHhcccc
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQ--VAVKMLSSSSGQ------------------------GFKEFEAEVKLLMRVHHR 627 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~l~~~~~~------------------------~~~~~~~E~~~l~~l~Hp 627 (858)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.+.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999997 68999 999997543111 013678899999999988
Q ss_pred eee--eeeeeeeeCCeeEEEEeeccC-C----ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 043526 628 NLT--NLVGYFIEDNNMGLIYEYMAN-G----NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKP 700 (858)
Q Consensus 628 nIv--~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~ 700 (858)
++. .++++ +..++||||+.+ | +|.+.... .++.++..++.|++.||+|||. +.+|+||||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp 199 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSE 199 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCST
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCH
Confidence 652 33322 356899999953 4 66665432 3456778999999999999994 46899999999
Q ss_pred cceEEcCCCCEEEeeecCcccc
Q 043526 701 ENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 701 ~NILl~~~~~~kL~DFGla~~~ 722 (858)
.|||+++ .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.55 E-value=4.5e-15 Score=161.66 Aligned_cols=126 Identities=27% Similarity=0.429 Sum_probs=109.6
Q ss_pred CCchhHHHHHHHHHHHcC---CCCCCCC--CCCCCCCCCccceeccCCCCCCCcEEEEEecCCCCcc--cccchhccccc
Q 043526 365 ETLHTDVDAVMNMKKMYG---VKRNWQG--DPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTG--EIAPYLSNLTL 437 (858)
Q Consensus 365 ~~~~~~~~al~~~k~~~~---~~~~w~~--dpc~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g--~ip~~~~~l~~ 437 (858)
.+.+.|..||++||+.++ .+.+|.. |||. +.|.||.|+.. ....+|+.|+|++|+|+| .+|+.|++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~---~~w~gv~C~~~-~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCc---CCCcceEeCCC-CCCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 367789999999999985 3568963 4552 25999999742 123689999999999999 99999999999
Q ss_pred cccccCCC-CCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 438 IQSLDLSN-NSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 438 L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
|++|+|++ |++.|.+|..++++++|++|+|++|+++|.+|..+..+++|+.|+++.+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 135 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC
Confidence 99999995 9999999999999999999999999999999999999999998887654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-15 Score=166.27 Aligned_cols=137 Identities=14% Similarity=0.095 Sum_probs=96.3
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCC--------------cchHhHHHHHHHHHhcccceeeeeeeeeee-
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSG--------------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIE- 638 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~--------------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 638 (858)
.+.+.||+|++|.||+|...+|+.||||+++.... ........+.++.....|+|++++......
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 44578999999999999998999999999763210 011122233333333344444444322111
Q ss_pred -----CCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC---
Q 043526 639 -----DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE--- 710 (858)
Q Consensus 639 -----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~--- 710 (858)
....+|||||+++++|.++... .....++.|++.+|.+|| ..+||||||||.|||+++++.
T Consensus 178 p~p~~~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 178 PEPIAQSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CCEEEEETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSC
T ss_pred CeeeeccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCccc
Confidence 1223699999999888765421 234578899999999999 789999999999999988763
Q ss_pred -------EEEeeecCccc
Q 043526 711 -------AKLADFGLSKV 721 (858)
Q Consensus 711 -------~kL~DFGla~~ 721 (858)
+.|+||+-+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 89999997754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-14 Score=175.57 Aligned_cols=126 Identities=18% Similarity=0.281 Sum_probs=107.8
Q ss_pred CCchhHHHHHHHHHHHcCCCCCCCCCC----CCCCCCCc------------cceeccCCCCCCCcEEEEEecCCCCcccc
Q 043526 365 ETLHTDVDAVMNMKKMYGVKRNWQGDP----CAPKAYSW------------DGLNCSYKGNDPPRIISLNLSSSGLTGEI 428 (858)
Q Consensus 365 ~~~~~~~~al~~~k~~~~~~~~w~~dp----c~~~~~~w------------~gv~C~~~~~~~~~l~~L~L~~n~l~g~i 428 (858)
.+..+|..||++||+.++.. +|+.+. +.|..|.| .||.|+. ..+|+.|+|++|+|+|.+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~----~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN----NGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT----TSCEEEEECTTTCCEEEE
T ss_pred ccchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecC----CCCEEEEECccCCCCCcC
Confidence 45677999999999998654 895432 22223589 9999975 369999999999999999
Q ss_pred cchhccccccccccC-CCCCCccC--------------------------------------------------------
Q 043526 429 APYLSNLTLIQSLDL-SNNSLSGN-------------------------------------------------------- 451 (858)
Q Consensus 429 p~~~~~l~~L~~L~L-s~N~l~g~-------------------------------------------------------- 451 (858)
|++|++|++|+.||| ++|.|+|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 88877666
Q ss_pred --------------------CCcccccccccceeeccCCcCcC-----------------CCChhhh--ccCcCCCcccc
Q 043526 452 --------------------VPEFLSRLQFLRVLNLKGNKFTG-----------------PIPVELM--EKSKNGSLQLS 492 (858)
Q Consensus 452 --------------------iP~~l~~l~~L~~L~L~~N~l~g-----------------~iP~~~~--~~~~l~~l~l~ 492 (858)
||..|++|++|+.|+|++|+|+| .+|..++ ++++|+.|+++
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 89999999999999999999999 4999988 99999998887
Q ss_pred ccC
Q 043526 493 VGD 495 (858)
Q Consensus 493 ~~~ 495 (858)
.+.
T Consensus 500 ~N~ 502 (876)
T 4ecn_A 500 NCP 502 (876)
T ss_dssp SCT
T ss_pred CCC
Confidence 654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.8e-13 Score=133.24 Aligned_cols=145 Identities=11% Similarity=0.085 Sum_probs=98.1
Q ss_pred eEEeccCCCCCCCCcCCCCceeeecCccccccCcccccccc----cccCCcccccccccccCCCCCceeeeCCCCCCCce
Q 043526 31 FISIDCGIPAASSYNDETTDLKYISDTTFVETGINKNISSE----FQISTLPKQFYNVRTFPQGMRNCYTLNPTEGKGSK 106 (858)
Q Consensus 31 ~~~idCG~~~~~~~~~~~~~~~~~~D~~~~~~g~~~~~~~~----~~~~~~~~~~~tlR~Fp~~~~ncy~l~~~~~~~~~ 106 (858)
-+.||||++.. +| ..+++|.+|..|...|........ .........|+|.|+||+ .-+|.+|.. ++|+
T Consensus 7 ~~~INcGg~~~---~d-~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~--~~tY~f~v~--~~G~ 78 (174)
T 2jwp_A 7 IWAVNAGGESH---VD-VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED--SFGYDIPIK--EEGE 78 (174)
T ss_dssp EEEEEETSSSE---EE-TTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS--CEEEEEECC--SCEE
T ss_pred EEEEECCCCCc---cC-CCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC--CeEEEEEeC--CCeE
Confidence 37899997442 33 468999999888644432211100 001112456999999995 679999876 7899
Q ss_pred EEEEEEeeeccCCCCCCCCeeeEEeccee-EEEEecCCc---cccceeEEEEe-------------cCCCeeEEEEeecC
Q 043526 107 YSIRASFMYGNYDAANKPPQFDLYLGVNL-WDSIKLDNA---TAMEMKEIIHI-------------PTENHVLICLVNTG 169 (858)
Q Consensus 107 ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~-w~~v~~~~~---~~~~~~e~i~~-------------~~~~~~~vcl~~~~ 169 (858)
|+||++|.--.|.. .....||++++|.. ...+++... ..+...|+.+. +.++.+.|.|.+..
T Consensus 79 Y~VrLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~ 157 (174)
T 2jwp_A 79 YVLVLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGY 157 (174)
T ss_dssp EEEEEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSS
T ss_pred EEEEEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccC
Confidence 99999996655543 46689999999977 455554221 12334555543 35677999998654
Q ss_pred CCCceeeeEEeeecc
Q 043526 170 LGTPFISALELRLLR 184 (858)
Q Consensus 170 ~~~pfis~lEl~~l~ 184 (858)
.+.||||+||+.+-.
T Consensus 158 ~~~a~inaIEI~~~~ 172 (174)
T 2jwp_A 158 YDNPKVCALFIMKGT 172 (174)
T ss_dssp SCSSSEEEEEEESSC
T ss_pred CCCcEEEEEEEEeCc
Confidence 567999999999743
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.8e-13 Score=163.73 Aligned_cols=122 Identities=18% Similarity=0.263 Sum_probs=103.8
Q ss_pred CCchhHHHHHHHHHHHcCC------------CCCCCCC-CCCCCCCCc---cceeccCCCCCCCcEEEEEecCCCCcccc
Q 043526 365 ETLHTDVDAVMNMKKMYGV------------KRNWQGD-PCAPKAYSW---DGLNCSYKGNDPPRIISLNLSSSGLTGEI 428 (858)
Q Consensus 365 ~~~~~~~~al~~~k~~~~~------------~~~w~~d-pc~~~~~~w---~gv~C~~~~~~~~~l~~L~L~~n~l~g~i 428 (858)
.....|..||.+|++..+. ..+|+.+ +| |.| .||+|+.. .+|+.|+|++|+|+|.+
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~----c~w~~~~GV~C~~~----~~V~~L~L~~~~l~g~l 97 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL----DMWGAQPGVSLNSN----GRVTGLSLEGFGASGRV 97 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG----GGTTCCTTEEECTT----CCEEEEECTTSCCEEEE
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc----ccccCCCCeEEcCC----CCEEEEEecCcccCCcC
Confidence 3455799999999998732 1267532 33 389 99999753 69999999999999999
Q ss_pred cchhccccccccccCCCC--------------------------------------------------------------
Q 043526 429 APYLSNLTLIQSLDLSNN-------------------------------------------------------------- 446 (858)
Q Consensus 429 p~~~~~l~~L~~L~Ls~N-------------------------------------------------------------- 446 (858)
|++|++|++|+.|||++|
T Consensus 98 p~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~ 177 (636)
T 4eco_A 98 PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177 (636)
T ss_dssp CGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC
T ss_pred ChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccc
Confidence 999999999999999998
Q ss_pred ----------------CCccCCCcccccccccceeeccCCcCcCC-----------------CChhhh--ccCcCCCccc
Q 043526 447 ----------------SLSGNVPEFLSRLQFLRVLNLKGNKFTGP-----------------IPVELM--EKSKNGSLQL 491 (858)
Q Consensus 447 ----------------~l~g~iP~~l~~l~~L~~L~L~~N~l~g~-----------------iP~~~~--~~~~l~~l~l 491 (858)
+|+| ||+++++|++|+.|+|++|+|+|. +|..++ ++++|+.|++
T Consensus 178 ~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L 256 (636)
T 4eco_A 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256 (636)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEe
Confidence 4556 999999999999999999999997 999999 9999998888
Q ss_pred cccC
Q 043526 492 SVGD 495 (858)
Q Consensus 492 ~~~~ 495 (858)
+.+.
T Consensus 257 ~~n~ 260 (636)
T 4eco_A 257 YNCP 260 (636)
T ss_dssp ECCT
T ss_pred cCCc
Confidence 7654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=7e-13 Score=162.14 Aligned_cols=121 Identities=26% Similarity=0.401 Sum_probs=92.5
Q ss_pred CCchhHHHHHHHHHHHcC---CCCCCC-CCCCCCCCCCccceeccCCCCCCCcEEEEEecCCCCccc---ccc-------
Q 043526 365 ETLHTDVDAVMNMKKMYG---VKRNWQ-GDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGE---IAP------- 430 (858)
Q Consensus 365 ~~~~~~~~al~~~k~~~~---~~~~w~-~dpc~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g~---ip~------- 430 (858)
...++|.+||++||+.+. .+.+|+ +++|| .|.||+|+ ..+|+.|+|+++.++|. +|+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C----~w~gv~C~-----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC----TFDGVTCR-----DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG----GSTTEEEE-----TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred cCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc----CCcceEEC-----CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence 446789999999999773 577996 44453 89999997 25899999999999887 554
Q ss_pred ----------------hhccccccccccCCCCCCccCCCc--ccccccccceeeccCCcCcCCCChhh-hccCcCCCccc
Q 043526 431 ----------------YLSNLTLIQSLDLSNNSLSGNVPE--FLSRLQFLRVLNLKGNKFTGPIPVEL-MEKSKNGSLQL 491 (858)
Q Consensus 431 ----------------~~~~l~~L~~L~Ls~N~l~g~iP~--~l~~l~~L~~L~L~~N~l~g~iP~~~-~~~~~l~~l~l 491 (858)
.|++|++|++|||++|+++|.+|. .+++|++|++|+|++|+++|.+|..+ .++++|+.|++
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 566677788888888888887777 77888888888888888877777765 66666666665
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+.+
T Consensus 159 s~n 161 (768)
T 3rgz_A 159 SAN 161 (768)
T ss_dssp CSS
T ss_pred CCC
Confidence 543
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.5e-12 Score=126.26 Aligned_cols=145 Identities=12% Similarity=0.102 Sum_probs=92.1
Q ss_pred eEEeeccCCcCCcccccCCCCCCcccccCCCCC-Ccccc-cccccccCCCCCCCChHHhhhcceecCCCCcceEEecC-C
Q 043526 197 LYKRYDYGSITNQTIRYKDDAYDRMWTPREFPK-TKKLS-TSLPIRSGADDSYLPPSAVMSTAITPINGSHALQFYWE-P 273 (858)
Q Consensus 197 ~~~r~~~g~~~~~~~ryp~D~~dR~W~~~~~~~-~~~~~-t~~~i~~~~~~~~~~P~~v~~tA~t~~~~~~~l~~~~~-~ 273 (858)
...|.|||+.. +. |..+|.|.+|.... ....+ ....+. ....+..|+.|+|||..... +++|. |
T Consensus 6 ~~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~~~~~~~~~--~~~~~~~~~~lY~TaR~~~~-----~~tY~f~ 72 (174)
T 2jwp_A 6 VIWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRASDYGMKLP--ILRSNPEDQVLYQTERYNED-----SFGYDIP 72 (174)
T ss_dssp EEEEEEETSSS---EE---ETTTEEECSSCSSTTCCCCCCCCTTSC--CSSSCHHHHHTTTCCCCCCS-----CEEEEEE
T ss_pred EEEEEECCCCC---cc---CCCCCEEcCCcCcccCCcccccccceE--ecccCCCCchhhhhhccCCC-----CeEEEEE
Confidence 46899999754 22 67899999885421 00001 001111 11224578999999988432 34555 5
Q ss_pred CCCCCceEEEEEeeeccccccCcceEEEEEECCceeeeecccccce----eee-EEee------------eecCCceEEE
Q 043526 274 KDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLF----SFS-TYRV------------KPYSGAIIEF 336 (858)
Q Consensus 274 ~~~~~~y~v~lhFae~~~~~~~~~R~F~i~~ng~~~~~~~~p~~~~----~~~-~~~~------------~~~~~~~~~i 336 (858)
++++..|.|.|||||+.. ...++|+|||++||+.+.+.+.+.... +.. .|.. +....+.++|
T Consensus 73 v~~~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I 151 (174)
T 2jwp_A 73 IKEEGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSV 151 (174)
T ss_dssp CCSCEEEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEE
T ss_pred eCCCeEEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEE
Confidence 677789999999999974 446899999999999887755432211 111 1111 1123446799
Q ss_pred EEEecCCCCCChhhhhhhhhh
Q 043526 337 SLDRTERSTLPPIINAFEVYM 357 (858)
Q Consensus 337 ~L~~t~~S~LpPi~~a~e~~~ 357 (858)
++.+.. .-.|++||+|++.
T Consensus 152 ~f~p~~--~~~a~inaIEI~~ 170 (174)
T 2jwp_A 152 EFVKGY--YDNPKVCALFIMK 170 (174)
T ss_dssp EEECSS--SCSSSEEEEEEES
T ss_pred EEeccC--CCCcEEEEEEEEe
Confidence 998743 3469999999984
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=3e-12 Score=156.57 Aligned_cols=98 Identities=27% Similarity=0.458 Sum_probs=86.7
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.+.++.|+|++|+|+|.+|.+|++|++|+.|+|++|+|+|.||..+++|++|+.|||++|+|+|.+|..+..++.|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999888877
Q ss_pred cc---------------------ccCcccccCCCCCccc
Q 043526 491 LS---------------------VGDNEELCSSSSDSCK 508 (858)
Q Consensus 491 l~---------------------~~~n~~lc~~s~~~~~ 508 (858)
++ |.||+++||.....|.
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~ 749 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCD 749 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCC
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCC
Confidence 54 4579999997543443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-12 Score=142.41 Aligned_cols=128 Identities=16% Similarity=0.301 Sum_probs=106.6
Q ss_pred CCchhHHHHHHHHHHHcC-----CCCCCC-CCCCCCCCCCccceeccCC-----CCCCCcEEEEEecCCCCcccccchhc
Q 043526 365 ETLHTDVDAVMNMKKMYG-----VKRNWQ-GDPCAPKAYSWDGLNCSYK-----GNDPPRIISLNLSSSGLTGEIAPYLS 433 (858)
Q Consensus 365 ~~~~~~~~al~~~k~~~~-----~~~~w~-~dpc~~~~~~w~gv~C~~~-----~~~~~~l~~L~L~~n~l~g~ip~~~~ 433 (858)
..+.+|..||++||..+. ...+|. ...|.+..|.|.|+.|... .....+|+.|+|++|+|+ .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 567889999999999762 234562 1223344458999999631 123478999999999999 9999999
Q ss_pred cccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccccccC
Q 043526 434 NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 434 ~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
+|++|++|+|++|+++ .+|..++++++|+.|+|++|+|+ .+|..+..+++|+.|+++.++
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~ 161 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEET
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCC
Confidence 9999999999999999 99999999999999999999999 999999999999998887643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=121.22 Aligned_cols=103 Identities=23% Similarity=0.211 Sum_probs=87.7
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|+.|.|+..+ ..+.+++.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 589999998743 34568899999999999888999999999999999999999666667899999999999999
Q ss_pred cCcCCCChhhhccCcCCCccccccCcccccC
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~~n~~lc~ 501 (858)
+|++..|..+..+++|+.|++ .+|+..|.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L--~~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWL--LNNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEEC--CSSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEe--CCCCCCCC
Confidence 999776767999999987655 56666554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=2.8e-11 Score=121.94 Aligned_cols=97 Identities=26% Similarity=0.227 Sum_probs=85.5
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|..|.|+..+ ..+++++.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 578999998743 34568999999999998 89999999999999999999999877788999999999999999
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+|++..|..+..+++|+.|+++.|
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N 112 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGN 112 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCC
Confidence 999888888999999988777654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.14 E-value=4.2e-11 Score=124.05 Aligned_cols=97 Identities=21% Similarity=0.171 Sum_probs=83.4
Q ss_pred CccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCc
Q 043526 398 SWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471 (858)
Q Consensus 398 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~ 471 (858)
+|.+|+|+..+ ..+++++.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 20 s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 20 SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 89999998643 355789999999999999889999999999999999999985444667999999999999999
Q ss_pred CcCCCChhhhccCcCCCcccccc
Q 043526 472 FTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 472 l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
|++..|..+..+++|+.|+++.|
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N 122 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCN 122 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCccChhHhCcchhhCeEeccCC
Confidence 99776667888999988877654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.12 E-value=4.6e-11 Score=120.19 Aligned_cols=98 Identities=19% Similarity=0.247 Sum_probs=79.5
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccc-hhccccccccccCCCCCCccCCCcccccccccceeeccC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAP-YLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~ 469 (858)
|.|..|.|+..+ ..+.+++.|+|++|+|++..|. .|+++++|+.|+|++|+|++.+|..|..+++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 589999998743 2345788899999999865554 488899999999999999988888888899999999999
Q ss_pred CcCcCCCChhhhccCcCCCcccccc
Q 043526 470 NKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 470 N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
|+|++..|..+..+++|+.|+++.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N 112 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDN 112 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCC
Confidence 9998888877888888887776654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.12 E-value=7e-11 Score=116.96 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=83.8
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|.+|+|+..+ ..+++++.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..+..+++|+.|+|++|
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 589999998743 34568999999999999766667899999999999999999666667899999999999999
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+|++..|..+..+++|+.|+++.|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N 110 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTN 110 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CccccCHHHhhCCcccCEEECcCC
Confidence 999777777888999998877654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=115.58 Aligned_cols=103 Identities=18% Similarity=0.161 Sum_probs=84.7
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|...-|.|+..+ ..+++++.|+|++|+|++..|..|++|++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 12 C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 12 CDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp ECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 456778898643 34568999999999999888999999999999999999999654555789999999999999
Q ss_pred cCcCCCChhhhccCcCCCccccccCcccccC
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~~n~~lc~ 501 (858)
+|++..|..+..+++|+.|++ .+|+..|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L--~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYL--YNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEEC--CSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEe--CCCCcccc
Confidence 999655556889999987655 56665554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=2.8e-10 Score=120.00 Aligned_cols=138 Identities=14% Similarity=0.084 Sum_probs=107.9
Q ss_pred cccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 576 NKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
...++.|+.+.||+.... |+.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+|
T Consensus 19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 456777888999999754 6899999987532233457899999999885 67788899999988899999999999998
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG---------------------------------------------- 688 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------------- 688 (858)
.+.+. +..+...++.+++++|+.||..
T Consensus 98 ~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 98 SEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred hhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 87642 1123457888999999999951
Q ss_pred ----------CCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 689 ----------CKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 689 ----------~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
....++|+|+++.|||++++..+.|.||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766667999997643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=127.62 Aligned_cols=102 Identities=20% Similarity=0.166 Sum_probs=82.3
Q ss_pred CCccceeccCC-C-------CCCCcEEEEEecC-CCCcccccchhccccccccccCCCCCCccCCCcccccccccceeec
Q 043526 397 YSWDGLNCSYK-G-------NDPPRIISLNLSS-SGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNL 467 (858)
Q Consensus 397 ~~w~gv~C~~~-~-------~~~~~l~~L~L~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L 467 (858)
|.|.+|.|+.. + ....+|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|
T Consensus 8 C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred ccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 58999999875 1 1234689999996 9999888889999999999999999999999999999999999999
Q ss_pred cCCcCcCCCChhhhccCcCCCccccccCcccccC
Q 043526 468 KGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501 (858)
Q Consensus 468 ~~N~l~g~iP~~~~~~~~l~~l~l~~~~n~~lc~ 501 (858)
++|+|++..|..+..++ |+.|+ +.+|+..|.
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~--l~~N~~~c~ 118 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELV--LSGNPLHCS 118 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEE--CCSSCCCCC
T ss_pred CCCccceeCHHHcccCC-ceEEE--eeCCCccCC
Confidence 99999954444444443 76554 456666663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=117.22 Aligned_cols=98 Identities=21% Similarity=0.238 Sum_probs=83.0
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|.+|+|+..+ ..+++++.|+|++|+|++..+..|+++++|++|+|++|+|++..+..+..+++|++|+|++|
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 589999998744 34568999999999999766667899999999999999999655566799999999999999
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++++..|..+..+++|+.|+++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N 110 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTN 110 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCccCHhHhcCccCCCEEEcCCC
Confidence 999766667889999998877654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.04 E-value=1.7e-10 Score=118.67 Aligned_cols=98 Identities=27% Similarity=0.258 Sum_probs=83.2
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|..|.|+..+ ..+++++.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.+|++|+.|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 689999998643 24468999999999999777778999999999999999999888999999999999999999
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+|++..+..+..+++|+.|+++.|
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N 114 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNAN 114 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCccCHhHccCCCCCCEEECCCC
Confidence 999544445678899988877655
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=8.9e-10 Score=115.43 Aligned_cols=129 Identities=17% Similarity=0.099 Sum_probs=97.8
Q ss_pred cccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccccee--eeeeeeeeeCCeeEEEEeeccCCChHHH
Q 043526 580 GKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL--TNLVGYFIEDNNMGLIYEYMANGNLKQL 657 (858)
Q Consensus 580 G~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 657 (858)
+.|..+.||+....+|+.+++|+.... ....+..|+++++.+++.++ .+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 356669999998878889999997643 23568899999999875554 45888888777889999999998884
Q ss_pred hhhcccCchhHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------
Q 043526 658 LSDEKASTLSWERRLQIAMDAAQGLEYLHIGC------------------------------------------------ 689 (858)
Q Consensus 658 L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------------------ 689 (858)
... . ....++.++++.|+.||...
T Consensus 104 ~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 1 12356777888888888421
Q ss_pred -------CCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 690 -------KPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 690 -------~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
...++|+|++|.|||++++..+.|.||+.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.97 E-value=5.1e-10 Score=115.14 Aligned_cols=99 Identities=15% Similarity=0.153 Sum_probs=82.1
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccc-hhccccccccccCCCCCCccCCCcccccccccceeeccC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAP-YLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~ 469 (858)
|.|..++|+... ..+..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 589999998743 2345678999999999977654 588999999999999999977777899999999999999
Q ss_pred CcCcCCCChhhhccCcCCCccccccC
Q 043526 470 NKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 470 N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|+|++..|..+..+++|+.|+++.|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~ 116 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNR 116 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSC
T ss_pred CccCccCHhHhcCCcCCCEEECCCCc
Confidence 99998777788889999888776553
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=98.97 E-value=3.2e-10 Score=114.04 Aligned_cols=90 Identities=26% Similarity=0.343 Sum_probs=80.9
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++++.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+..+++|+.|
T Consensus 52 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred cCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 34689999999999999999999999999999999999998888889999999999999999999999999999999876
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
++ .+|+..|.
T Consensus 132 ~L--~~N~l~c~ 141 (192)
T 1w8a_A 132 NL--ASNPFNCN 141 (192)
T ss_dssp EC--TTCCBCCS
T ss_pred Ee--CCCCccCc
Confidence 55 55665553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.95 E-value=6.3e-10 Score=128.56 Aligned_cols=82 Identities=17% Similarity=0.150 Sum_probs=57.3
Q ss_pred CCcEEEEEecCCCCcccccchhc-cccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.++|+.|+|++|.|+|.+|..+. +|++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+| +|+.+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L 219 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEE
Confidence 35677777777777777777765 677777777777777754 33 3357778888888888875 45557777888777
Q ss_pred cccccC
Q 043526 490 QLSVGD 495 (858)
Q Consensus 490 ~l~~~~ 495 (858)
+++.|.
T Consensus 220 ~Ls~N~ 225 (487)
T 3oja_A 220 SLRNNK 225 (487)
T ss_dssp ECTTSC
T ss_pred EecCCc
Confidence 766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=5.6e-10 Score=127.34 Aligned_cols=105 Identities=20% Similarity=0.193 Sum_probs=87.5
Q ss_pred CCCCCCCCCccc--eeccCCC-----CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCC-cccccccc
Q 043526 390 DPCAPKAYSWDG--LNCSYKG-----NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVP-EFLSRLQF 461 (858)
Q Consensus 390 dpc~~~~~~w~g--v~C~~~~-----~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~ 461 (858)
|||. ..|.|.+ |.|+..+ ..+++++.|+|++|+|++..|..|++|++|++|+|++|.+.+.+| ..|.++++
T Consensus 2 ~p~~-~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~ 80 (455)
T 3v47_A 2 DPGT-SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80 (455)
T ss_dssp ------CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT
T ss_pred CCcc-ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc
Confidence 5764 4566666 9998643 245789999999999998889999999999999999999998885 57899999
Q ss_pred cceeeccCCcCcCCCChhhhccCcCCCccccccC
Q 043526 462 LRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 462 L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|++|+|++|++++..|..+..+++|+.|+++.+.
T Consensus 81 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 114 (455)
T 3v47_A 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCN 114 (455)
T ss_dssp CCEEECTTCTTCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCEEeCCCCccCccChhhccCcccCCEEeCCCCC
Confidence 9999999999999999999999999988876553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.91 E-value=4.3e-10 Score=122.11 Aligned_cols=109 Identities=24% Similarity=0.465 Sum_probs=90.4
Q ss_pred CCCCCCCCCCC--CCccceeccCCC-----------CCCCcEEEEEecC-CCCcccccchhccccccccccCCCCCCccC
Q 043526 386 NWQGDPCAPKA--YSWDGLNCSYKG-----------NDPPRIISLNLSS-SGLTGEIAPYLSNLTLIQSLDLSNNSLSGN 451 (858)
Q Consensus 386 ~w~~dpc~~~~--~~w~gv~C~~~~-----------~~~~~l~~L~L~~-n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 451 (858)
+|.|-.|.... ..-..+..+... ...++|+.|+|++ |+++|.+|..|++|++|++|+|++|+++|.
T Consensus 37 ~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 116 (313)
T 1ogq_A 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred CCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc
Confidence 39998886422 233333333211 1236789999995 999999999999999999999999999999
Q ss_pred CCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 452 VPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 452 iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+|..++++++|++|+|++|+++|.+|..+..+++|+.|+++.+
T Consensus 117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred CCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 9999999999999999999999999999999999998887654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.91 E-value=3.5e-09 Score=115.75 Aligned_cols=82 Identities=20% Similarity=0.241 Sum_probs=74.7
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|++.|.+|..++++++|+.|+|++|++.|.+|..++++++|+.|+|++|++.|.+|..++++++|..+.
T Consensus 228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~ 307 (328)
T 4fcg_A 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL 307 (328)
T ss_dssp CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEE
T ss_pred CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEe
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999888776
Q ss_pred cc
Q 043526 491 LS 492 (858)
Q Consensus 491 l~ 492 (858)
+.
T Consensus 308 l~ 309 (328)
T 4fcg_A 308 VP 309 (328)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=7.9e-10 Score=131.14 Aligned_cols=94 Identities=21% Similarity=0.098 Sum_probs=78.7
Q ss_pred ceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC
Q 043526 401 GLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474 (858)
Q Consensus 401 gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g 474 (858)
-|+|+..+ +.|+.++.|+|++|+|++..|.+|.+|++|++|||++|+|++..|..|.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 47898643 456789999999999997666789999999999999999997667789999999999999999996
Q ss_pred CCChhhhccCcCCCcccccc
Q 043526 475 PIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 475 ~iP~~~~~~~~l~~l~l~~~ 494 (858)
..|..+..+++|+.|+++.+
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N 134 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVET 134 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTS
T ss_pred CCHHHhcCCCCCCEEECCCC
Confidence 66667888888888777654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-09 Score=108.97 Aligned_cols=89 Identities=26% Similarity=0.315 Sum_probs=78.0
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L- 131 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHL- 131 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE-
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEE-
Confidence 4689999999999998878889999999999999999998888889999999999999999996666678888888865
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
.+.+|+..|.
T Consensus 132 -~L~~N~~~C~ 141 (193)
T 2wfh_A 132 -AIGANPLYCD 141 (193)
T ss_dssp -ECCSSCEECS
T ss_pred -EeCCCCeecC
Confidence 4567777774
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.86 E-value=2e-09 Score=110.58 Aligned_cols=90 Identities=20% Similarity=0.207 Sum_probs=79.7
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 79 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 158 (220)
T 2v70_A 79 GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158 (220)
T ss_dssp TCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEE
Confidence 34689999999999998888889999999999999999998889999999999999999999998889999999998866
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
++ .+|+..|.
T Consensus 159 ~L--~~N~l~c~ 168 (220)
T 2v70_A 159 NL--LANPFNCN 168 (220)
T ss_dssp EC--CSCCEECS
T ss_pred Ee--cCcCCcCC
Confidence 54 56666664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.4e-09 Score=114.10 Aligned_cols=96 Identities=22% Similarity=0.207 Sum_probs=82.4
Q ss_pred ccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcC
Q 043526 399 WDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472 (858)
Q Consensus 399 w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l 472 (858)
|..|+|+..+ ..+++++.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|
T Consensus 16 ~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 95 (251)
T 3m19_A 16 KKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL 95 (251)
T ss_dssp GTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcc
Confidence 4555555422 3456899999999999988888999999999999999999988888899999999999999999
Q ss_pred cCCCChhhhccCcCCCcccccc
Q 043526 473 TGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 473 ~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++..|..+..+++|+.|+++.+
T Consensus 96 ~~~~~~~~~~l~~L~~L~L~~N 117 (251)
T 3m19_A 96 ASLPLGVFDHLTQLDKLYLGGN 117 (251)
T ss_dssp CCCCTTTTTTCTTCCEEECCSS
T ss_pred cccChhHhcccCCCCEEEcCCC
Confidence 9777778899999998887655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=2.3e-09 Score=125.41 Aligned_cols=98 Identities=19% Similarity=0.098 Sum_probs=83.6
Q ss_pred CCccceeccCCC--------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeecc
Q 043526 397 YSWDGLNCSYKG--------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLK 468 (858)
Q Consensus 397 ~~w~gv~C~~~~--------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~ 468 (858)
|.|.|+ |+..+ ..+++++.|+|++|+|++..|..|++|++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 478888 75422 234689999999999998888999999999999999999998888899999999999999
Q ss_pred CCcCcCCCChhhhccCcCCCccccccC
Q 043526 469 GNKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 469 ~N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
+|++++..|..++.+++|+.|+++.+.
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 109 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNP 109 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred CCccCccCHHHhccCCCCcEEECCCCc
Confidence 999998777779999999988876553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.79 E-value=3.9e-09 Score=117.00 Aligned_cols=107 Identities=24% Similarity=0.212 Sum_probs=81.3
Q ss_pred CCCCCCCCC-CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhc-cccccccccCCCCCCccCCCcccccc
Q 043526 388 QGDPCAPKA-YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLSRL 459 (858)
Q Consensus 388 ~~dpc~~~~-~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l 459 (858)
....|...+ |.|.-|.|+..+ ..+..++.|+|++|+|++..+..+. +|++|+.|+|++|+|++..|..|.+|
T Consensus 8 ~~~~Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l 87 (361)
T 2xot_A 8 SVVSCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV 87 (361)
T ss_dssp CCTTCCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred cCCCCCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCC
Confidence 344563322 578899998743 3445678899999999876666676 88889999999998887666778888
Q ss_pred cccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 460 QFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 460 ~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++|+.|+|++|+|++..|..+..+++|+.|+++.|
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 122 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN 122 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCC
Confidence 88888888888888666667888888887776554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.7e-09 Score=103.55 Aligned_cols=79 Identities=23% Similarity=0.267 Sum_probs=43.5
Q ss_pred CcEEEEEecCCCCc-ccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 412 PRIISLNLSSSGLT-GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 412 ~~l~~L~L~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
++++.|+|++|+++ |.+|..+..+++|+.|+|++|++++. ..++++++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555555555555 55555555555555555555555533 4455555555555555555555555555555555554
Q ss_pred cc
Q 043526 491 LS 492 (858)
Q Consensus 491 l~ 492 (858)
++
T Consensus 95 ls 96 (149)
T 2je0_A 95 LS 96 (149)
T ss_dssp CT
T ss_pred CC
Confidence 43
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.79 E-value=4.8e-09 Score=119.83 Aligned_cols=98 Identities=22% Similarity=0.176 Sum_probs=86.5
Q ss_pred CccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCc
Q 043526 398 SWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471 (858)
Q Consensus 398 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~ 471 (858)
.|..|.|+..+ ..+++++.|+|++|+|++..|..|.+|++|+.|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 46789998643 355789999999999999889999999999999999999998888999999999999999999
Q ss_pred CcCCCChhhhccCcCCCccccccC
Q 043526 472 FTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 472 l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|++..|..+..+++|+.|+++.|.
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~ 158 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNP 158 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCC
T ss_pred CCccChhhhcccCCCCEEECCCCC
Confidence 997777778899999988876553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=98.78 E-value=5.2e-09 Score=107.52 Aligned_cols=87 Identities=20% Similarity=0.178 Sum_probs=49.4
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 80 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-- 157 (220)
T 2v9t_B 80 RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM-- 157 (220)
T ss_dssp SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE--
T ss_pred cCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEE--
Confidence 456666666666663322334556666666666666665555566666666666666666665555555555555543
Q ss_pred cccCccccc
Q 043526 492 SVGDNEELC 500 (858)
Q Consensus 492 ~~~~n~~lc 500 (858)
.+.+|+..|
T Consensus 158 ~L~~N~~~c 166 (220)
T 2v9t_B 158 HLAQNPFIC 166 (220)
T ss_dssp ECCSSCEEC
T ss_pred EeCCCCcCC
Confidence 334455544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.77 E-value=3e-09 Score=104.09 Aligned_cols=84 Identities=23% Similarity=0.254 Sum_probs=64.6
Q ss_pred CCCCcEEEEEecCCCCc-ccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCC
Q 043526 409 NDPPRIISLNLSSSGLT-GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNG 487 (858)
Q Consensus 409 ~~~~~l~~L~L~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~ 487 (858)
..+++++.|+|++|+|+ |.+|..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++.+|..+..+++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 44567888888888887 77887778888888888888888754 6677788888888888888877777777778877
Q ss_pred Ccccccc
Q 043526 488 SLQLSVG 494 (858)
Q Consensus 488 ~l~l~~~ 494 (858)
.|+++.+
T Consensus 99 ~L~Ls~N 105 (168)
T 2ell_A 99 HLNLSGN 105 (168)
T ss_dssp EEECBSS
T ss_pred EEeccCC
Confidence 7766554
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-08 Score=112.84 Aligned_cols=140 Identities=14% Similarity=0.151 Sum_probs=105.0
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEec--cCC-CcchHhHHHHHHHHHhcc--cceeeeeeeeeeeC---CeeEEEEee
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLS--SSS-GQGFKEFEAEVKLLMRVH--HRNLTNLVGYFIED---NNMGLIYEY 648 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~lV~Ey 648 (858)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468899999999988754 678888875 322 123457888999999997 45678888888766 448899999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC--------------------------------------- 689 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 689 (858)
++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 123 VSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred cCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9998775422 123667888899999999999999520
Q ss_pred ----------------CCCeEecCCCCcceEEcCCCC--EEEeeecCccc
Q 043526 690 ----------------KPPIVHRDIKPENILLTENLE--AKLADFGLSKV 721 (858)
Q Consensus 690 ----------------~~~IvH~DLk~~NILl~~~~~--~kL~DFGla~~ 721 (858)
...++|||+++.|||+++++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997754 68999998865
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.76 E-value=6.9e-09 Score=119.21 Aligned_cols=98 Identities=19% Similarity=0.194 Sum_probs=84.3
Q ss_pred CccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCc
Q 043526 398 SWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471 (858)
Q Consensus 398 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~ 471 (858)
.|..|.|+..+ ..+.+++.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.+|++|+.|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 57899998643 356688999999999998888899999999999999999998889999999999999999999
Q ss_pred CcCCCChhhhccCcCCCccccccC
Q 043526 472 FTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 472 l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
+++..+..+..+++|+.|+++.+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~ 115 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENK 115 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSC
T ss_pred CCccCcccccCCCCCCEEECCCCc
Confidence 996555567888999888776553
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.76 E-value=6.2e-09 Score=110.31 Aligned_cols=108 Identities=22% Similarity=0.245 Sum_probs=83.7
Q ss_pred CCCCCCCCCCCCCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccc
Q 043526 386 NWQGDPCAPKAYSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRL 459 (858)
Q Consensus 386 ~w~~dpc~~~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l 459 (858)
.|.|..|.+. ..|..|+|+..+ ..++.++.|+|++|+|++..+..|+++++|++|+|++|++++..+..+.++
T Consensus 6 ~~~~~~C~c~-~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l 84 (270)
T 2o6q_A 6 KKDGGVCSCN-NNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL 84 (270)
T ss_dssp GGGTCSBEEE-TTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSC
T ss_pred CCCCCCCEeC-CCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCC
Confidence 4666665321 146667776532 345678999999999997666789999999999999999994444556889
Q ss_pred cccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 460 QFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 460 ~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++|+.|+|++|++++..|..+..+++|+.|+++.+
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 119 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC
Confidence 99999999999999766667788999998877654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.75 E-value=9.7e-09 Score=106.14 Aligned_cols=89 Identities=20% Similarity=0.191 Sum_probs=74.9
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++..+..|..|++|+.|+|++|+|+ .||..+..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 3468999999999999666667899999999999999999 899999999999999999999996666678888888865
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
+ +.+|+..|.
T Consensus 165 ~--l~~N~~~c~ 174 (229)
T 3e6j_A 165 Y--LFGNPWDCE 174 (229)
T ss_dssp E--CTTSCBCTT
T ss_pred E--eeCCCccCC
Confidence 4 456776654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=8.2e-09 Score=122.33 Aligned_cols=90 Identities=22% Similarity=0.203 Sum_probs=79.3
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhcc-CcCCC
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEK-SKNGS 488 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~-~~l~~ 488 (858)
..++++.|+|++|+|++.+|..|++|++|+.|+|++|+|++..|..|..|++|+.|||++|+|++..|..+..+ ++|+.
T Consensus 492 ~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~ 571 (635)
T 4g8a_A 492 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 571 (635)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCE
T ss_pred hccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCE
Confidence 34689999999999999889999999999999999999998888889999999999999999999999999887 56775
Q ss_pred ccccccCcccccC
Q 043526 489 LQLSVGDNEELCS 501 (858)
Q Consensus 489 l~l~~~~n~~lc~ 501 (858)
| ...+|+..|.
T Consensus 572 L--~L~~Np~~C~ 582 (635)
T 4g8a_A 572 L--NLTQNDFACT 582 (635)
T ss_dssp E--ECTTCCBCCS
T ss_pred E--EeeCCCCccc
Confidence 4 5567888875
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.72 E-value=4.3e-09 Score=100.74 Aligned_cols=80 Identities=20% Similarity=0.198 Sum_probs=43.8
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCcc-CCCcccccccccceeeccCCcCcCCCC---hhhhccCcCC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSG-NVPEFLSRLQFLRVLNLKGNKFTGPIP---VELMEKSKNG 487 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L~L~~N~l~g~iP---~~~~~~~~l~ 487 (858)
++++.|+|++|+|++.+|..+.++++|+.|+|++|++++ ..|..++.+++|+.|+|++|++++..+ ..+..+++|+
T Consensus 64 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~ 143 (149)
T 2je0_A 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLT 143 (149)
T ss_dssp TTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCC
T ss_pred CCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcc
Confidence 455555666666655555555555556666666665554 133555555566666666665554443 3455555555
Q ss_pred Cccc
Q 043526 488 SLQL 491 (858)
Q Consensus 488 ~l~l 491 (858)
.|++
T Consensus 144 ~L~l 147 (149)
T 2je0_A 144 YLDG 147 (149)
T ss_dssp EETT
T ss_pred cccC
Confidence 4443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.2e-08 Score=100.72 Aligned_cols=88 Identities=19% Similarity=0.168 Sum_probs=73.6
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++..+..++++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 46899999999999966666789999999999999999977777789999999999999999965555567888888765
Q ss_pred ccccCccccc
Q 043526 491 LSVGDNEELC 500 (858)
Q Consensus 491 l~~~~n~~lc 500 (858)
+ .+|+..|
T Consensus 131 l--~~N~~~~ 138 (177)
T 2o6r_A 131 L--HTNPWDC 138 (177)
T ss_dssp C--CSSCBCC
T ss_pred e--cCCCeec
Confidence 5 4555544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=9.4e-09 Score=120.75 Aligned_cols=81 Identities=25% Similarity=0.256 Sum_probs=73.3
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCC-ChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI-PVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~i-P~~~~~~~~l~~l 489 (858)
.++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ || .+++|++|+.|+|++|+|++.+ |..++.+++|+.|
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 457999999999999 999999999999999999999996 88 7999999999999999999887 9999999999987
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.|
T Consensus 539 ~L~~N 543 (567)
T 1dce_A 539 NLQGN 543 (567)
T ss_dssp ECTTS
T ss_pred EecCC
Confidence 77644
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=8.9e-09 Score=109.29 Aligned_cols=104 Identities=21% Similarity=0.126 Sum_probs=85.7
Q ss_pred CCCCCCCCCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccc
Q 043526 390 DPCAPKAYSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLR 463 (858)
Q Consensus 390 dpc~~~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~ 463 (858)
|||... .....|.|...+ ..+++++.|+|++|+|++..+..|+++++|+.|+|++|++++..|..+.++++|+
T Consensus 1 ~~C~~~-~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 79 (276)
T 2z62_A 1 EPCVEV-VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79 (276)
T ss_dssp CCSEEE-ETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCceec-cCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCC
Confidence 567421 122357887643 2456799999999999977777999999999999999999977777899999999
Q ss_pred eeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 464 VLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 464 ~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
.|+|++|++++..|..+..+++|+.|+++.+
T Consensus 80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 110 (276)
T 2z62_A 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVET 110 (276)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCccCccChhhhcCCccccEEECCCC
Confidence 9999999999888889999999998877654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.1e-08 Score=121.14 Aligned_cols=96 Identities=21% Similarity=0.143 Sum_probs=80.9
Q ss_pred cceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCc
Q 043526 400 DGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 400 ~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
..|.|+..+ ..+++++.|+|++|++++..|..|+++++|++|+|++|++++..|..|++|++|++|+|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 458887633 34578899999999999888889999999999999999999877888999999999999999999
Q ss_pred CCCChhhhccCcCCCccccccC
Q 043526 474 GPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 474 g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
+..|..++.+++|+.|+++.+.
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n~ 115 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVETK 115 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTSC
T ss_pred ccChhhcCCcccCCEEEccCCc
Confidence 8888889999888888776553
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=7.7e-09 Score=122.47 Aligned_cols=108 Identities=19% Similarity=0.098 Sum_probs=88.4
Q ss_pred CCCCCCCCCCCCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCccccccc
Q 043526 387 WQGDPCAPKAYSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQ 460 (858)
Q Consensus 387 w~~dpc~~~~~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~ 460 (858)
|.+.+|... ..+.-|+|+..+ ..+..++.|+|++|+|++..|..|++|++|++|+|++|++++..|..|++++
T Consensus 3 ~~~~~C~~~-~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 3 SSDQKCIEK-EVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ---CCCEEE-ETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred cccCceecc-cCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 445556321 135568898643 3567899999999999988889999999999999999999988899999999
Q ss_pred ccceeeccCCcCcCCCChhhhccCcCCCccccccC
Q 043526 461 FLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 461 ~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
+|+.|+|++|++++..|..++.+++|+.|+++.+.
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 116 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSC
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccC
Confidence 99999999999999889999999999888776553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.68 E-value=1e-08 Score=113.06 Aligned_cols=99 Identities=21% Similarity=0.123 Sum_probs=81.3
Q ss_pred CCccce-eccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccC
Q 043526 397 YSWDGL-NCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469 (858)
Q Consensus 397 ~~w~gv-~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~ 469 (858)
|.|.|+ .|+..+ ..+++++.|+|++|+|++..+..|.++++|+.|+|++|++++..|..++++++|+.|+|++
T Consensus 30 C~~~~~c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 30 CDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp ECTTSEEECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCCCeEeeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 378887 333321 2345899999999999976666899999999999999999988888999999999999999
Q ss_pred CcCcCCCChhhhccCcCCCccccccC
Q 043526 470 NKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 470 N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|++++..+..+..+++|+.|+++.+.
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~ 135 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNP 135 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCC
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCC
Confidence 99995444458899999988876553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=98.68 E-value=2e-08 Score=105.19 Aligned_cols=90 Identities=21% Similarity=0.207 Sum_probs=73.4
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 105 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 34688999999999996666668899999999999999996666678999999999999999997777788888888865
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
++ .+|+..|.
T Consensus 185 ~l--~~N~~~c~ 194 (251)
T 3m19_A 185 TL--FGNQFDCS 194 (251)
T ss_dssp EC--CSCCBCTT
T ss_pred Ee--eCCceeCC
Confidence 54 56665553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.67 E-value=8.4e-09 Score=107.05 Aligned_cols=93 Identities=19% Similarity=0.139 Sum_probs=77.4
Q ss_pred eeccCCCC---CCCcEEEEEecCCCCcccccchhccccccccccCCCCC-CccCCCcccccccccceeeccC-CcCcCCC
Q 043526 402 LNCSYKGN---DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNS-LSGNVPEFLSRLQFLRVLNLKG-NKFTGPI 476 (858)
Q Consensus 402 v~C~~~~~---~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~l~~l~~L~~L~L~~-N~l~g~i 476 (858)
|.|..-.. .+.+++.|+|++|+|++..+..|+++++|+.|+|++|+ +++..|..|.++++|+.|+|++ |++++..
T Consensus 18 v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 18 VTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp EEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred eEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 45975222 44689999999999997766789999999999999997 8855556899999999999999 9999766
Q ss_pred ChhhhccCcCCCcccccc
Q 043526 477 PVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 477 P~~~~~~~~l~~l~l~~~ 494 (858)
|..+..+++|+.|+++.+
T Consensus 98 ~~~f~~l~~L~~L~l~~n 115 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNT 115 (239)
T ss_dssp TTSEECCTTCCEEEEEEE
T ss_pred HHHhCCCCCCCEEeCCCC
Confidence 678889999998877654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.6e-08 Score=107.75 Aligned_cols=96 Identities=18% Similarity=0.177 Sum_probs=81.8
Q ss_pred cceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCc-C
Q 043526 400 DGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK-F 472 (858)
Q Consensus 400 ~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~-l 472 (858)
..|.|+..+ ..+++++.|+|++|+|++..+..|+++++|+.|+|++|++++..|..+..+++|+.|+|++|+ +
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l 93 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (285)
T ss_dssp CEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred eEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCc
Confidence 447887643 356789999999999997777889999999999999999998889999999999999999998 7
Q ss_pred cCCCChhhhccCcCCCccccccC
Q 043526 473 TGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 473 ~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
++..|..+..+++|+.|+++.+.
T Consensus 94 ~~~~~~~~~~l~~L~~L~l~~n~ 116 (285)
T 1ozn_A 94 RSVDPATFHGLGRLHTLHLDRCG 116 (285)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccCHHHhcCCcCCCEEECCCCc
Confidence 76668889999999988776543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.1e-08 Score=114.03 Aligned_cols=98 Identities=20% Similarity=0.136 Sum_probs=84.5
Q ss_pred CccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCc
Q 043526 398 SWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471 (858)
Q Consensus 398 ~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~ 471 (858)
.|..|.|...+ ..+++++.|+|++|+|++..+..|.+|++|+.|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 46789998643 345678999999999998888999999999999999999997777889999999999999999
Q ss_pred CcCCCChhhhccCcCCCccccccC
Q 043526 472 FTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 472 l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|++..+..+..+++|+.|+++.|.
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~ 147 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNP 147 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCC
T ss_pred CCeeCHhHhhccccCceeeCCCCc
Confidence 996666678999999988776553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=2.2e-08 Score=109.14 Aligned_cols=95 Identities=24% Similarity=0.297 Sum_probs=81.4
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|+.+.|+..+ ..++.++.|+|++|+|++..+..|+++++|++|+|++|++++..|..++++++|+.|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 589999998633 24578999999999999777779999999999999999999888999999999999999999
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+++ .+|..+. ++|+.|+++.+
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n 131 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHEN 131 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSS
T ss_pred cCC-ccChhhc--ccccEEECCCC
Confidence 998 7887665 57777666543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.3e-08 Score=109.19 Aligned_cols=95 Identities=23% Similarity=0.250 Sum_probs=81.9
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.|..+.|+..+ ..+++++.|+|++|+|++..|..|.++++|+.|+|++|++++..|..++++++|+.|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 579999998643 23568999999999999777889999999999999999999888999999999999999999
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+++ .+|..+. ++|+.|+++.+
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n 133 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDN 133 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSS
T ss_pred cCC-ccCcccc--ccCCEEECCCC
Confidence 998 7887766 67777666543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.7e-08 Score=108.99 Aligned_cols=186 Identities=20% Similarity=0.209 Sum_probs=119.1
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cce--eeeeeeeeeeCC---eeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRN--LTNLVGYFIEDN---NMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~Ey~~ 650 (858)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999863 56888886432 33567889999998884 333 233444433332 2478999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG------------------------------------------ 688 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------ 688 (858)
|.+|.+... ..++..++..++.++++.++.||..
T Consensus 100 G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 100 GVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 988875432 1356667778888888888888841
Q ss_pred -------------CCCCeEecCCCCcceEEcC--CCCEEEeeecCcccccCCCcceeec-------------ccCCCCcc
Q 043526 689 -------------CKPPIVHRDIKPENILLTE--NLEAKLADFGLSKVFPIGGTHVSTV-------------VAGTPGYL 740 (858)
Q Consensus 689 -------------~~~~IvH~DLk~~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~-------------~~gt~~y~ 740 (858)
....++|+|+++.||++++ ...+.|.||+.+............. .....+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 1245899999999999998 4568899999887542210000000 00000111
Q ss_pred C-ccccccCCCCCchhHHHHHHHHHHHHhCCCccc
Q 043526 741 D-PEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV 774 (858)
Q Consensus 741 A-PE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~ 774 (858)
. |+.... .....+.|+++.+++++.+|..++.
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 221111 1123689999999999999988764
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.63 E-value=2.2e-08 Score=97.89 Aligned_cols=85 Identities=22% Similarity=0.245 Sum_probs=70.1
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCC--cccccccccceeeccCCcCcCCCC---hhhhccC
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVP--EFLSRLQFLRVLNLKGNKFTGPIP---VELMEKS 484 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP--~~l~~l~~L~~L~L~~N~l~g~iP---~~~~~~~ 484 (858)
..++++.|+|++|+|++.+|..+.++++|+.|+|++|++++ +| ..+..+++|+.|+|++|.+++..+ ..+..++
T Consensus 69 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~ 147 (168)
T 2ell_A 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP 147 (168)
T ss_dssp CCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCS
T ss_pred cCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCc
Confidence 34688999999999998888888889999999999999985 44 778899999999999999986555 4788888
Q ss_pred cCCCccccccC
Q 043526 485 KNGSLQLSVGD 495 (858)
Q Consensus 485 ~l~~l~l~~~~ 495 (858)
+|+.|+++.+.
T Consensus 148 ~L~~L~l~~n~ 158 (168)
T 2ell_A 148 QLTYLDGYDRE 158 (168)
T ss_dssp SCCEETTEETT
T ss_pred cCcEecCCCCC
Confidence 88887776543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.62 E-value=9.7e-09 Score=110.69 Aligned_cols=96 Identities=24% Similarity=0.298 Sum_probs=81.7
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccc-hhccccccccccCCCCCCc--cCCCcccccccccceeec
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAP-YLSNLTLIQSLDLSNNSLS--GNVPEFLSRLQFLRVLNL 467 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~--g~iP~~l~~l~~L~~L~L 467 (858)
|.|.+|+|+..+ ..+++++.|+|++|+|+ .+|+ .|.++++|+.|+|++|+++ |.+|..+..+++|+.|+|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 689999998743 34568999999999999 5665 4799999999999999998 445777888999999999
Q ss_pred cCCcCcCCCChhhhccCcCCCcccccc
Q 043526 468 KGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 468 ~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++|.++ .+|..+..+++|+.|+++.+
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n 111 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHS 111 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTS
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCC
Confidence 999998 68888889999998877654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.62 E-value=4e-08 Score=99.61 Aligned_cols=88 Identities=23% Similarity=0.209 Sum_probs=72.1
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 46899999999999966666689999999999999999976666789999999999999999976666688888888765
Q ss_pred ccccCccccc
Q 043526 491 LSVGDNEELC 500 (858)
Q Consensus 491 l~~~~n~~lc 500 (858)
++ +|+..|
T Consensus 155 l~--~N~~~~ 162 (208)
T 2o6s_A 155 LH--DNPWDC 162 (208)
T ss_dssp CC--SCCBCC
T ss_pred ec--CCCeec
Confidence 54 555444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.62 E-value=1.6e-08 Score=122.44 Aligned_cols=80 Identities=26% Similarity=0.313 Sum_probs=62.3
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++|+.|+|++|.|+ .||..|++|++|+.|||++|+|+ .||..|++|++|+.|+|++|.|+ .||..++.+++|+.|++
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 56777888888887 77877888888888888888888 77888888888888888888876 77777877877777766
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+.|
T Consensus 324 ~~N 326 (727)
T 4b8c_D 324 EGN 326 (727)
T ss_dssp TTS
T ss_pred CCC
Confidence 544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.61 E-value=2e-08 Score=101.07 Aligned_cols=81 Identities=21% Similarity=0.250 Sum_probs=48.8
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|++++..|..|++|++|+.|+|++|++++..|..++.+++|+.|+|++|++.+.+| .+..+++|+.|++
T Consensus 88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l 166 (197)
T 4ezg_A 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNI 166 (197)
T ss_dssp TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEEC
T ss_pred CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEEC
Confidence 456666666666666566666666666666666666666566666666666666666665333554 4556666665555
Q ss_pred cc
Q 043526 492 SV 493 (858)
Q Consensus 492 ~~ 493 (858)
+.
T Consensus 167 ~~ 168 (197)
T 4ezg_A 167 QF 168 (197)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=98.60 E-value=3.7e-08 Score=97.23 Aligned_cols=77 Identities=22% Similarity=0.182 Sum_probs=68.5
Q ss_pred EEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 415 ~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|+++.|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57999999997 8998875 89999999999999888999999999999999999999755556789999998888655
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.59 E-value=4.7e-08 Score=103.62 Aligned_cols=89 Identities=24% Similarity=0.205 Sum_probs=74.4
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++..|..++++++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 132 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 211 (272)
T 3rfs_A 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211 (272)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEE
Confidence 46899999999999977777789999999999999999977777789999999999999999988887788888888765
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
+ .+|+..|.
T Consensus 212 l--~~N~~~~~ 220 (272)
T 3rfs_A 212 L--HDNPWDCT 220 (272)
T ss_dssp C--CSSCBCCC
T ss_pred c--cCCCcccc
Confidence 5 45555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=98.58 E-value=4.3e-08 Score=96.32 Aligned_cols=78 Identities=22% Similarity=0.232 Sum_probs=69.3
Q ss_pred EEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 415 ~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+++.|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 57999999999 6898774 89999999999999888999999999999999999999766667789999998887665
Q ss_pred C
Q 043526 495 D 495 (858)
Q Consensus 495 ~ 495 (858)
.
T Consensus 89 ~ 89 (170)
T 3g39_A 89 Q 89 (170)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.58 E-value=1e-08 Score=122.44 Aligned_cols=84 Identities=17% Similarity=0.268 Sum_probs=69.2
Q ss_pred CCcEEEEEecCCCCccc-----------------ccchhc--cccccccccCCCCCCccCCCcccccccccceeeccCCc
Q 043526 411 PPRIISLNLSSSGLTGE-----------------IAPYLS--NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~-----------------ip~~~~--~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~ 471 (858)
.++++.|+|++|+|+|. +|++++ +|++|++|+|++|++.|.+|..+++|++|+.|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 46788888888888886 888888 88888888888888888888888888888888888887
Q ss_pred -CcC-CCChhhhcc------CcCCCcccccc
Q 043526 472 -FTG-PIPVELMEK------SKNGSLQLSVG 494 (858)
Q Consensus 472 -l~g-~iP~~~~~~------~~l~~l~l~~~ 494 (858)
|+| .+|..++.+ ++|+.|+++.+
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 888 888888776 77777766544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.57 E-value=3.3e-08 Score=117.06 Aligned_cols=83 Identities=19% Similarity=0.160 Sum_probs=57.5
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++|+.|+|++|.|++..|..|++|++|+.|+|++|.|++..|..|++|++|+.|+|++|+|++..|..+..+++|+.|++
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 35667777777777666667777777777777777777666666777777777777777777443344567777776666
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+.+
T Consensus 155 s~N 157 (597)
T 3oja_B 155 SNN 157 (597)
T ss_dssp CSS
T ss_pred eCC
Confidence 544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.57 E-value=5.8e-08 Score=104.11 Aligned_cols=88 Identities=23% Similarity=0.232 Sum_probs=58.3
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+..+.+|+.
T Consensus 123 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~-- 199 (290)
T 1p9a_G 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF-- 199 (290)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE--
T ss_pred CCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCe--
Confidence 356777777777777555555677777777777777777333344566777777777777777 67777766666654
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
+.+.+|+..|.
T Consensus 200 l~L~~Np~~C~ 210 (290)
T 1p9a_G 200 AFLHGNPWLCN 210 (290)
T ss_dssp EECCSCCBCCS
T ss_pred EEeCCCCccCc
Confidence 34456776664
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.57 E-value=5.1e-08 Score=103.37 Aligned_cols=84 Identities=19% Similarity=0.153 Sum_probs=64.9
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++..|..|+++++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 46788888888888866666678888888888888888866666678888888888888888876666677788887776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 188 L~~N 191 (272)
T 3rfs_A 188 LYQN 191 (272)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 6544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=5e-08 Score=117.19 Aligned_cols=98 Identities=27% Similarity=0.318 Sum_probs=74.3
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
|.++-|.|+..+ ..+++++.|+|++|+|++..|..|+++++|++|+|++|++++..|..+++|++|+.|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 456778887632 34567888899988888777777888888888888888888877888888888888888888
Q ss_pred cCcCCCChhhhccCcCCCcccccc
Q 043526 471 KFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 471 ~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++++..+..++.+++|+.|+++.+
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n 107 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSN 107 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSS
T ss_pred ccCccChhhhccCCCCCEEECCCC
Confidence 887444446777777777666544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=4e-08 Score=115.42 Aligned_cols=78 Identities=28% Similarity=0.390 Sum_probs=71.8
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLS 492 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~ 492 (858)
.++.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .||..+++|++|+.|+|++|+|++ +| .++.+++|+.|+++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57899999999996 787 999999999999999999 999999999999999999999996 78 89999999988876
Q ss_pred ccC
Q 043526 493 VGD 495 (858)
Q Consensus 493 ~~~ 495 (858)
.|.
T Consensus 517 ~N~ 519 (567)
T 1dce_A 517 NNR 519 (567)
T ss_dssp SSC
T ss_pred CCC
Confidence 553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.55 E-value=2.1e-08 Score=108.60 Aligned_cols=82 Identities=22% Similarity=0.197 Sum_probs=66.7
Q ss_pred CcEEEEEecCCCCcccccchh--ccccccccccCCCCCCccCCCcccccc-----cccceeeccCCcCcCCCChhhhccC
Q 043526 412 PRIISLNLSSSGLTGEIAPYL--SNLTLIQSLDLSNNSLSGNVPEFLSRL-----QFLRVLNLKGNKFTGPIPVELMEKS 484 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~--~~l~~L~~L~Ls~N~l~g~iP~~l~~l-----~~L~~L~L~~N~l~g~iP~~~~~~~ 484 (858)
++++.|+|++|+|+|.+|..+ +++++|+.|+|++|++++. |..++.+ ++|+.|+|++|++++..|..++.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 578888888888888888876 7888888888888888866 8777777 8888888888888877778888888
Q ss_pred cCCCcccccc
Q 043526 485 KNGSLQLSVG 494 (858)
Q Consensus 485 ~l~~l~l~~~ 494 (858)
+|+.|+++.|
T Consensus 174 ~L~~L~Ls~N 183 (312)
T 1wwl_A 174 ALSTLDLSDN 183 (312)
T ss_dssp SCCEEECCSC
T ss_pred CCCEEECCCC
Confidence 8887776644
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.55 E-value=3.5e-08 Score=109.20 Aligned_cols=81 Identities=27% Similarity=0.164 Sum_probs=42.9
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..|++|+.|+|++|+|++..|..+..+++|+.|++
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 34555555555555444445555555555555555555444444555555555555555555444555555555554444
Q ss_pred c
Q 043526 492 S 492 (858)
Q Consensus 492 ~ 492 (858)
+
T Consensus 144 ~ 144 (361)
T 2xot_A 144 S 144 (361)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.55 E-value=5.4e-08 Score=117.83 Aligned_cols=82 Identities=27% Similarity=0.337 Sum_probs=76.9
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
....|+.|+|++|.|. .||..+.+|++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|+ .||..++.+++|+.|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 3467999999999999 99999999999999999999999 99999999999999999999999 899999999999988
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+|+.|
T Consensus 299 ~L~~N 303 (727)
T 4b8c_D 299 YFFDN 303 (727)
T ss_dssp ECCSS
T ss_pred ECCCC
Confidence 87655
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.53 E-value=6.8e-08 Score=103.55 Aligned_cols=81 Identities=27% Similarity=0.219 Sum_probs=43.0
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|++
T Consensus 100 ~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 179 (290)
T 1p9a_G 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179 (290)
T ss_dssp TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEEC
Confidence 45555566666555444445555556666666666555443444555555666666666555332233344555555444
Q ss_pred c
Q 043526 492 S 492 (858)
Q Consensus 492 ~ 492 (858)
+
T Consensus 180 ~ 180 (290)
T 1p9a_G 180 Q 180 (290)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=98.53 E-value=4.2e-08 Score=107.75 Aligned_cols=78 Identities=19% Similarity=0.146 Sum_probs=71.3
Q ss_pred EEEecCC-CCcccccchhccccccccccCCC-CCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccccc
Q 043526 416 SLNLSSS-GLTGEIAPYLSNLTLIQSLDLSN-NSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSV 493 (858)
Q Consensus 416 ~L~L~~n-~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~ 493 (858)
.++++++ +|+ .||. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..+..+++|+.|+|+.
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4699998 999 6999 99999999999996 999987778999999999999999999999999999999999988876
Q ss_pred cC
Q 043526 494 GD 495 (858)
Q Consensus 494 ~~ 495 (858)
|.
T Consensus 90 N~ 91 (347)
T 2ifg_A 90 NA 91 (347)
T ss_dssp SC
T ss_pred Cc
Confidence 54
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=5.9e-08 Score=103.38 Aligned_cols=90 Identities=21% Similarity=0.204 Sum_probs=76.2
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++++.|+|++|+|++..+..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 151 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 230 (285)
T 1ozn_A 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (285)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEE
Confidence 34689999999999996666679999999999999999998889999999999999999999997666678888888865
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
++ .+|+..|.
T Consensus 231 ~l--~~N~~~c~ 240 (285)
T 1ozn_A 231 RL--NDNPWVCD 240 (285)
T ss_dssp EC--CSSCEECS
T ss_pred ec--cCCCccCC
Confidence 54 56666664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.52 E-value=1.7e-08 Score=123.74 Aligned_cols=85 Identities=20% Similarity=0.240 Sum_probs=70.7
Q ss_pred CCCcEEEEEecCCCCcc-----------------cccchhc--cccccccccCCCCCCccCCCcccccccccceeeccCC
Q 043526 410 DPPRIISLNLSSSGLTG-----------------EIAPYLS--NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g-----------------~ip~~~~--~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
..++|+.|+|++|+|+| .||+.++ +|++|+.|+|++|++.|.+|..|++|++|+.|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 34678889999999998 4888887 8999999999999988899988899999999999999
Q ss_pred c-CcC-CCChhhhccC-------cCCCcccccc
Q 043526 471 K-FTG-PIPVELMEKS-------KNGSLQLSVG 494 (858)
Q Consensus 471 ~-l~g-~iP~~~~~~~-------~l~~l~l~~~ 494 (858)
+ |+| .+|..++.+. +|+.|+++.+
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N 558 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSS
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCC
Confidence 8 888 8888887776 7777666544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.51 E-value=4.1e-08 Score=96.85 Aligned_cols=78 Identities=15% Similarity=0.087 Sum_probs=56.9
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCCh--hhhccCcCCCc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPV--ELMEKSKNGSL 489 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~--~~~~~~~l~~l 489 (858)
++++.|+|++|+|++. +.|++|++|+.|+|++|+|++..|..+..+++|+.|+|++|+++ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4778888888888854 67788888888888888888433343478888888888888885 6676 67777777765
Q ss_pred ccc
Q 043526 490 QLS 492 (858)
Q Consensus 490 ~l~ 492 (858)
+++
T Consensus 119 ~l~ 121 (176)
T 1a9n_A 119 CIL 121 (176)
T ss_dssp ECC
T ss_pred Eec
Confidence 554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.51 E-value=5.9e-08 Score=113.94 Aligned_cols=92 Identities=24% Similarity=0.255 Sum_probs=73.3
Q ss_pred cceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCc
Q 043526 400 DGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 400 ~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
.-++|+..+ ..+++++.|+|++|+|++..|..|+++++|++|+|++|++++..|+.|+++++|++|+|++|+|+
T Consensus 34 ~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 113 (562)
T 3a79_B 34 SMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113 (562)
T ss_dssp CEEECTTSCCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred cEEEcCCCCCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC
Confidence 557777532 24568899999999999777788999999999999999999877888888888888888888887
Q ss_pred CCCChhhhccCcCCCcccccc
Q 043526 474 GPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 474 g~iP~~~~~~~~l~~l~l~~~ 494 (858)
.+|.. .+++|+.|+++.+
T Consensus 114 -~lp~~--~l~~L~~L~Ls~N 131 (562)
T 3a79_B 114 -NISCC--PMASLRHLDLSFN 131 (562)
T ss_dssp -EECSC--CCTTCSEEECCSS
T ss_pred -ccCcc--ccccCCEEECCCC
Confidence 67766 6777777666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.50 E-value=8e-08 Score=109.64 Aligned_cols=90 Identities=17% Similarity=0.063 Sum_probs=80.2
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 216 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 295 (452)
T 3zyi_A 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295 (452)
T ss_dssp TCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEE
T ss_pred ccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEE
Confidence 34689999999999999999999999999999999999999889999999999999999999997777778888888865
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
.+.+|+..|.
T Consensus 296 --~L~~Np~~Cd 305 (452)
T 3zyi_A 296 --HLHHNPWNCD 305 (452)
T ss_dssp --ECCSSCEECS
T ss_pred --EccCCCcCCC
Confidence 4567787775
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.50 E-value=7.6e-08 Score=109.43 Aligned_cols=90 Identities=18% Similarity=0.098 Sum_probs=80.4
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|
T Consensus 205 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 284 (440)
T 3zyj_A 205 PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284 (440)
T ss_dssp TCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEE
T ss_pred CCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEE
Confidence 34689999999999999889999999999999999999999889999999999999999999997777778888888865
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
.+.+|+..|.
T Consensus 285 --~L~~Np~~Cd 294 (440)
T 3zyj_A 285 --HLHHNPWNCN 294 (440)
T ss_dssp --ECCSSCEECS
T ss_pred --EcCCCCccCC
Confidence 4567888775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.3e-07 Score=100.06 Aligned_cols=90 Identities=21% Similarity=0.211 Sum_probs=74.4
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 131 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 210 (270)
T 2o6q_A 131 SLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210 (270)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred cCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEE
Confidence 35689999999999996655668999999999999999997666678999999999999999996666668888888765
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
.+.+|+..|.
T Consensus 211 --~l~~N~~~c~ 220 (270)
T 2o6q_A 211 --QLQENPWDCT 220 (270)
T ss_dssp --ECCSSCBCCS
T ss_pred --EecCCCeeCC
Confidence 4567777665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.1e-07 Score=108.37 Aligned_cols=89 Identities=24% Similarity=0.185 Sum_probs=64.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++..|..|+++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 401 (455)
T 3v47_A 322 LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIW 401 (455)
T ss_dssp CTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEE
Confidence 35677888888888777777777888888888888888777777777888888888888888765555566777777554
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
+ .+|+..|.
T Consensus 402 l--~~N~l~~~ 410 (455)
T 3v47_A 402 L--HTNPWDCS 410 (455)
T ss_dssp C--CSSCBCCC
T ss_pred c--cCCCcccC
Confidence 4 45554443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.3e-07 Score=100.21 Aligned_cols=84 Identities=19% Similarity=0.181 Sum_probs=68.8
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC-CCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG-PIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g-~iP~~~~~~~~l~~l 489 (858)
.++++.|+|++|+|++..|..|.++++|+.|+|++|++++..+..++++++|+.|+|++|++++ .+|..+..+++|+.|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred CcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 4678888888888887777888888888888888888887666678888888888888888886 468888888888877
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 155 ~Ls~N 159 (276)
T 2z62_A 155 DLSSN 159 (276)
T ss_dssp ECCSS
T ss_pred ECCCC
Confidence 76544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.48 E-value=6.4e-08 Score=119.42 Aligned_cols=82 Identities=22% Similarity=0.111 Sum_probs=41.5
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCC-CcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNV-PEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i-P~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
+++++.|+|++|+|++..|..|++|++|++|||++|++.+.| |..|.+|++|++|+|++|++++..|..+..+++|+.|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 455666666666666555555555555555555555444444 3444445555555555555444444444444444444
Q ss_pred ccc
Q 043526 490 QLS 492 (858)
Q Consensus 490 ~l~ 492 (858)
+++
T Consensus 103 ~Ls 105 (844)
T 3j0a_A 103 RLY 105 (844)
T ss_dssp ECT
T ss_pred eCc
Confidence 443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.48 E-value=1e-07 Score=102.53 Aligned_cols=90 Identities=22% Similarity=0.204 Sum_probs=69.1
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccC-cCCC
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS-KNGS 488 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~-~l~~ 488 (858)
..++++.|+|++|+|++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|+.
T Consensus 173 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 252 (306)
T 2z66_A 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252 (306)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCE
T ss_pred hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCE
Confidence 346788888888888877788888888888888888888866666778888888888888888888888887774 6765
Q ss_pred ccccccCcccccC
Q 043526 489 LQLSVGDNEELCS 501 (858)
Q Consensus 489 l~l~~~~n~~lc~ 501 (858)
|++ .+|+..|.
T Consensus 253 L~L--~~N~~~~~ 263 (306)
T 2z66_A 253 LNL--TQNDFACT 263 (306)
T ss_dssp EEC--TTCCEECS
T ss_pred EEc--cCCCeecc
Confidence 544 45555543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.46 E-value=4.6e-08 Score=107.76 Aligned_cols=98 Identities=18% Similarity=0.145 Sum_probs=81.7
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccc-hhccccccccccCCCCCCccCCCc-ccccccccce-eec
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAP-YLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRV-LNL 467 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~-L~L 467 (858)
|.|..|.|+..+ +.+.+++.|+|++|+|+ .||+ .|.+|++|+.|+|++|++.+.||. .|.+|++|+. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 689999998643 34568999999999999 5664 799999999999999999888885 5788988765 777
Q ss_pred cCCcCcCCCChhhhccCcCCCccccccC
Q 043526 468 KGNKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 468 ~~N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
++|+|++..|..+..+++|+.|+++.+.
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~ 115 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTG 115 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEEC
T ss_pred cCCcccccCchhhhhccccccccccccc
Confidence 8899997778889999999988776543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.45 E-value=1e-07 Score=93.93 Aligned_cols=83 Identities=19% Similarity=0.106 Sum_probs=71.0
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCc--ccccccccceeeccCCcCcCCCChh----hhcc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE--FLSRLQFLRVLNLKGNKFTGPIPVE----LMEK 483 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~--~l~~l~~L~~L~L~~N~l~g~iP~~----~~~~ 483 (858)
..++++.|+|++|+|++..|..++++++|+.|+|++|+++ .+|. .+..+++|+.|+|++|.++ .+|.. +..+
T Consensus 62 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l 139 (176)
T 1a9n_A 62 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKV 139 (176)
T ss_dssp CCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHC
T ss_pred cCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHC
Confidence 3468999999999999544445599999999999999996 7887 8999999999999999998 67775 8899
Q ss_pred CcCCCcccccc
Q 043526 484 SKNGSLQLSVG 494 (858)
Q Consensus 484 ~~l~~l~l~~~ 494 (858)
++|+.|+++.+
T Consensus 140 ~~L~~Ld~~~n 150 (176)
T 1a9n_A 140 PQVRVLDFQKV 150 (176)
T ss_dssp TTCSEETTEEC
T ss_pred CccceeCCCcC
Confidence 99998877544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.44 E-value=6.5e-08 Score=97.27 Aligned_cols=83 Identities=19% Similarity=0.212 Sum_probs=73.0
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|.++ .++.+.++++|+.|+|++|++++..|..++.|++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 457999999999775 345899999999999999999988899999999999999999999998899999999999888
Q ss_pred ccccC
Q 043526 491 LSVGD 495 (858)
Q Consensus 491 l~~~~ 495 (858)
++.+.
T Consensus 143 L~~n~ 147 (197)
T 4ezg_A 143 LSYNG 147 (197)
T ss_dssp CCSCT
T ss_pred ccCCC
Confidence 76553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-07 Score=111.04 Aligned_cols=85 Identities=21% Similarity=0.072 Sum_probs=67.6
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.+++++.|+|++|+|++..+..|.++++|++|||++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|
T Consensus 26 l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (570)
T ss_dssp SCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred ccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccc
Confidence 45678888888888887777788888888888888888887667778888888888888888887777778888777777
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 106 ~L~~n 110 (570)
T 2z63_A 106 VAVET 110 (570)
T ss_dssp ECTTS
T ss_pred ccccc
Confidence 66554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.42 E-value=1.3e-07 Score=109.77 Aligned_cols=81 Identities=25% Similarity=0.180 Sum_probs=61.3
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC-CCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG-PIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g-~iP~~~~~~~~l~~l 489 (858)
.++++.|+|++|+|++..|..|++|++|++|||++|+|+ .||.. .+++|++|+|++|++++ .+|..++.+++|+.|
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 356777888888888777777888888888888888887 67766 77788888888888876 577778777777777
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 121 ~L~~n 125 (520)
T 2z7x_B 121 GLSTT 125 (520)
T ss_dssp EEEES
T ss_pred EecCc
Confidence 66543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.9e-07 Score=110.55 Aligned_cols=83 Identities=18% Similarity=0.162 Sum_probs=48.8
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC-CCChhhhccCcCCCcc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG-PIPVELMEKSKNGSLQ 490 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g-~iP~~~~~~~~l~~l~ 490 (858)
++++.|+|++|+|++..|..|++|++|++|+|++|++++..|..++++++|+.|+|++|++++ .+|..++++++|+.|+
T Consensus 80 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~ 159 (606)
T 3vq2_A 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD 159 (606)
T ss_dssp TTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEE
T ss_pred hhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEE
Confidence 455666666666665555566666666666666666664444556666666666666666654 4566666666665555
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 160 Ls~n 163 (606)
T 3vq2_A 160 LSYN 163 (606)
T ss_dssp CCSS
T ss_pred ccCC
Confidence 5443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.6e-07 Score=102.28 Aligned_cols=82 Identities=28% Similarity=0.305 Sum_probs=70.0
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 67888999999998888888889999999999999998777778888899999999999988 88888888888887776
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+.+
T Consensus 271 ~~N 273 (330)
T 1xku_A 271 HNN 273 (330)
T ss_dssp CSS
T ss_pred CCC
Confidence 544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.40 E-value=9.7e-08 Score=110.80 Aligned_cols=83 Identities=20% Similarity=0.153 Sum_probs=75.4
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.+++++.|+|++|+|++..|..|.+|++|++|+|++|++++..|..|++|++|++|+|++|+++ .+|.. .+++|+.|
T Consensus 19 ~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L 95 (520)
T 2z7x_B 19 LSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHL 95 (520)
T ss_dssp CCTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEE
T ss_pred ccccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEE
Confidence 3478999999999999888899999999999999999999888999999999999999999999 68877 78889988
Q ss_pred cccccC
Q 043526 490 QLSVGD 495 (858)
Q Consensus 490 ~l~~~~ 495 (858)
+++.+.
T Consensus 96 ~L~~N~ 101 (520)
T 2z7x_B 96 DLSFNA 101 (520)
T ss_dssp ECCSSC
T ss_pred eccCCc
Confidence 876653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.39 E-value=6.1e-08 Score=104.93 Aligned_cols=84 Identities=19% Similarity=0.198 Sum_probs=71.8
Q ss_pred CCCcEEEEEecCCCCcccccchhccc-----cccccccCCCCCCccCCCcccccccccceeeccCCcCcCC--CChhh--
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNL-----TLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP--IPVEL-- 480 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~--iP~~~-- 480 (858)
..++++.|+|++|+|++. |..++++ ++|++|+|++|++++..|..++.+++|+.|+|++|++.|. +|..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 356899999999999977 8889888 9999999999999988889999999999999999999876 44555
Q ss_pred hccCcCCCcccccc
Q 043526 481 MEKSKNGSLQLSVG 494 (858)
Q Consensus 481 ~~~~~l~~l~l~~~ 494 (858)
..+++|+.|+++.+
T Consensus 198 ~~l~~L~~L~L~~N 211 (312)
T 1wwl_A 198 LKFPTLQVLALRNA 211 (312)
T ss_dssp TSCTTCCEEECTTS
T ss_pred ccCCCCCEEECCCC
Confidence 78888888777544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.5e-07 Score=101.74 Aligned_cols=82 Identities=22% Similarity=0.124 Sum_probs=55.4
Q ss_pred cEEEEEecCCCCcccccchh--ccccccccccCCCCCCccCCC----cccccccccceeeccCCcCcCCCChhhhccCcC
Q 043526 413 RIISLNLSSSGLTGEIAPYL--SNLTLIQSLDLSNNSLSGNVP----EFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~--~~l~~L~~L~Ls~N~l~g~iP----~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l 486 (858)
+++.|+|++|+++|.+|..+ +++++|++|+|++|++++.+| ..+..+++|+.|+|++|++++..|..+..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 36677777777777777666 677777777777777776555 233456777777777777776666667777777
Q ss_pred CCcccccc
Q 043526 487 GSLQLSVG 494 (858)
Q Consensus 487 ~~l~l~~~ 494 (858)
+.|+++.|
T Consensus 172 ~~L~Ls~N 179 (310)
T 4glp_A 172 TSLDLSDN 179 (310)
T ss_dssp CEEECCSC
T ss_pred CEEECCCC
Confidence 76666544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.4e-07 Score=110.21 Aligned_cols=82 Identities=24% Similarity=0.296 Sum_probs=47.3
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC-CCChhhhccCcCCCcc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG-PIPVELMEKSKNGSLQ 490 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g-~iP~~~~~~~~l~~l~ 490 (858)
++++.|+|++|+|++..|..|++|++|++|||++|++++..|..+++|++|++|+|++|++++ .+|..+..+++|+.|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 455666666666665555556666666666666666665444455666666666666666654 3455555555555555
Q ss_pred ccc
Q 043526 491 LSV 493 (858)
Q Consensus 491 l~~ 493 (858)
++.
T Consensus 130 L~~ 132 (549)
T 2z81_A 130 IGN 132 (549)
T ss_dssp EEE
T ss_pred CCC
Confidence 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.5e-07 Score=111.44 Aligned_cols=88 Identities=27% Similarity=0.305 Sum_probs=66.4
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|++++..|..|+++++|+.|+|++|++++.+|..+.++++| .|+|++|++++.+|..+..+++|+.|+
T Consensus 475 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~ 553 (606)
T 3t6q_A 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTIN 553 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEE
T ss_pred CCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEe
Confidence 3567788888888887777778888888888888888887777778888888 888888888877777777777776544
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
+.+|+..|.
T Consensus 554 --l~~N~~~c~ 562 (606)
T 3t6q_A 554 --LRQNPLDCT 562 (606)
T ss_dssp --CTTCCEECS
T ss_pred --CCCCCcccc
Confidence 456666653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.38 E-value=1.5e-07 Score=102.66 Aligned_cols=82 Identities=22% Similarity=0.201 Sum_probs=67.8
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 57888888888888777788888888888888888888777778888888888888888888 78888888888887766
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+.|
T Consensus 272 ~~N 274 (332)
T 2ft3_A 272 HTN 274 (332)
T ss_dssp CSS
T ss_pred CCC
Confidence 544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.38 E-value=2.4e-07 Score=109.63 Aligned_cols=84 Identities=19% Similarity=0.158 Sum_probs=62.7
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|.|++..|..|++|++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 45778888888888876667778888888888888888843334457788888888888888877777777777777776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 178 L~~N 181 (597)
T 3oja_B 178 LSSN 181 (597)
T ss_dssp CTTS
T ss_pred CcCC
Confidence 6544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.36 E-value=2.1e-07 Score=108.97 Aligned_cols=89 Identities=20% Similarity=0.219 Sum_probs=67.3
Q ss_pred CCcEEEEEecCCCCc-ccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLT-GEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.++++.|+|++|.++ |.+|..+..+++|+.|+|++|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 457788888888887 6788888888888888888888887778788888888888888888887777777777777755
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
++ .+|+..|.
T Consensus 524 ~l--~~N~~~~~ 533 (570)
T 2z63_A 524 WL--HTNPWDCS 533 (570)
T ss_dssp EC--CSSCBCCC
T ss_pred Ee--cCCcccCC
Confidence 44 45555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-07 Score=108.33 Aligned_cols=81 Identities=26% Similarity=0.210 Sum_probs=60.3
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC-CCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG-PIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g-~iP~~~~~~~~l~~l 489 (858)
.++++.|+|++|+|++..|..|++|++|++|||++|+|+ .||.. .+++|+.|+|++|++++ ++|..++++++|+.|
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L 151 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFL 151 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEE
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEE
Confidence 356777888888887777777777888888888888877 67766 67778888888888776 456777777777776
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 152 ~L~~n 156 (562)
T 3a79_B 152 GLSAA 156 (562)
T ss_dssp EEECS
T ss_pred ecCCC
Confidence 66543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.34 E-value=2.6e-07 Score=105.97 Aligned_cols=82 Identities=20% Similarity=0.182 Sum_probs=47.7
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++|+.|+|++|+|++..|..|++|++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..+..+++|+.|++
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 45666666666666555566666666666666666666333334556666666666666666555555666666555554
Q ss_pred cc
Q 043526 492 SV 493 (858)
Q Consensus 492 ~~ 493 (858)
+.
T Consensus 136 ~~ 137 (477)
T 2id5_A 136 GD 137 (477)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.33 E-value=1.4e-07 Score=110.59 Aligned_cols=67 Identities=24% Similarity=0.352 Sum_probs=33.9
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
+|+.|+|++|+|+ .|| ..+++|+.|+|++|+|++ ||. +.+ +|+.|+|++|+|++ +|. .+++|+.|++
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 4455555555555 444 334555555555555554 555 433 55555555555554 444 3344444444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.32 E-value=3.5e-07 Score=112.87 Aligned_cols=81 Identities=21% Similarity=0.244 Sum_probs=40.8
Q ss_pred CcEEEEEecCCCCcccccch--hccccccccccCCCCCCccCCC-cccccccccceeeccCCcCcCCCChhhhcc--CcC
Q 043526 412 PRIISLNLSSSGLTGEIAPY--LSNLTLIQSLDLSNNSLSGNVP-EFLSRLQFLRVLNLKGNKFTGPIPVELMEK--SKN 486 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~--~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~--~~l 486 (858)
++|+.|+|++|+|++.+|.. |++|++|++|||++|++++..| ..|++|++|+.|+|++|++++..|..+..+ ++|
T Consensus 97 ~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L 176 (844)
T 3j0a_A 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL 176 (844)
T ss_dssp SSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSS
T ss_pred cccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCcc
Confidence 34555555555555544443 5555555555555555554333 345555555555555555555555555444 444
Q ss_pred CCcccc
Q 043526 487 GSLQLS 492 (858)
Q Consensus 487 ~~l~l~ 492 (858)
+.|+++
T Consensus 177 ~~L~L~ 182 (844)
T 3j0a_A 177 SFFSLA 182 (844)
T ss_dssp CCCEEC
T ss_pred ceEECC
Confidence 444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.32 E-value=2.7e-07 Score=97.13 Aligned_cols=78 Identities=26% Similarity=0.305 Sum_probs=66.0
Q ss_pred CCcEEEEEecCCCCcc--cccchhccccccccccCCCCCCccCCCccccccc--ccceeeccCCcCcCCCCh-------h
Q 043526 411 PPRIISLNLSSSGLTG--EIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQ--FLRVLNLKGNKFTGPIPV-------E 479 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~--~L~~L~L~~N~l~g~iP~-------~ 479 (858)
.++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..++ +|+.|+|++|.+++.+|. .
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 4689999999999998 7778899999999999999999965 4466666 999999999999998883 3
Q ss_pred hhccCcCCCcc
Q 043526 480 LMEKSKNGSLQ 490 (858)
Q Consensus 480 ~~~~~~l~~l~ 490 (858)
+..+++|..|+
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 56777777654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.31 E-value=4.7e-07 Score=100.96 Aligned_cols=83 Identities=20% Similarity=0.202 Sum_probs=66.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcc-cccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEF-LSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.++++.|+|++|++++..|..|+++++|++|+|++|+++ .+|.. +.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence 467888888888888777777888888888888888888 56654 5788888888888888887777778888888877
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 171 ~l~~n 175 (390)
T 3o6n_A 171 QLSSN 175 (390)
T ss_dssp ECCSS
T ss_pred ECCCC
Confidence 76544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.2e-07 Score=104.85 Aligned_cols=85 Identities=20% Similarity=0.154 Sum_probs=71.9
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|.|++. | .+..+++|+.|+|++|+|+| +|..+..+++|+.|+|++|+|++ +|..+..+++|..|+
T Consensus 168 l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~ 243 (487)
T 3oja_A 168 SDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFD 243 (487)
T ss_dssp TTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEE
T ss_pred CCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEE
Confidence 47899999999999966 3 34579999999999999996 56669999999999999999995 888898888888655
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
+ .+|+..|+
T Consensus 244 l--~~N~l~c~ 252 (487)
T 3oja_A 244 L--RGNGFHCG 252 (487)
T ss_dssp C--TTCCBCHH
T ss_pred c--CCCCCcCc
Confidence 4 56776665
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.28 E-value=5e-07 Score=100.76 Aligned_cols=79 Identities=22% Similarity=0.261 Sum_probs=39.1
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChh-hhccCcCCCccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVE-LMEKSKNGSLQL 491 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~-~~~~~~l~~l~l 491 (858)
+|+.|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|+.|+|++|+++ .+|.. +..+++|+.|++
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEEC
Confidence 3445555555555444445555555555555555555444444555555555555555555 33332 344555554444
Q ss_pred c
Q 043526 492 S 492 (858)
Q Consensus 492 ~ 492 (858)
+
T Consensus 149 ~ 149 (390)
T 3o6n_A 149 S 149 (390)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.26 E-value=4.3e-07 Score=99.86 Aligned_cols=82 Identities=27% Similarity=0.304 Sum_probs=66.6
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCc-ccccccccceeeccCCcCcCCCCh--hhhccCcCC
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKGNKFTGPIPV--ELMEKSKNG 487 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~g~iP~--~~~~~~~l~ 487 (858)
.++++.|+|++|+|++..|..|+++++|++|+|++|++++ +|. .+.++++|+.|+|++|+++ .+|. .+..+++|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 4678899999999997777888999999999999999984 554 4888899999999999988 5555 678888888
Q ss_pred Ccccccc
Q 043526 488 SLQLSVG 494 (858)
Q Consensus 488 ~l~l~~~ 494 (858)
.|+++.+
T Consensus 153 ~L~l~~n 159 (353)
T 2z80_A 153 ILRVGNM 159 (353)
T ss_dssp EEEEEES
T ss_pred EEECCCC
Confidence 7776654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.24 E-value=5.3e-07 Score=97.32 Aligned_cols=75 Identities=32% Similarity=0.407 Sum_probs=43.6
Q ss_pred CcEEEEEecCCCCcccccchhccc---cccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNL---TLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGS 488 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l---~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~ 488 (858)
++++.|+|++|+|++.+|+.++.+ ++|+.|+|++|+|+ .||..+. ++|+.|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 456666666666666656665555 46666666666666 5666553 5666666666666642 22 344455554
Q ss_pred ccc
Q 043526 489 LQL 491 (858)
Q Consensus 489 l~l 491 (858)
|++
T Consensus 299 L~L 301 (310)
T 4glp_A 299 LTL 301 (310)
T ss_dssp EEC
T ss_pred EEC
Confidence 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=6.8e-07 Score=107.29 Aligned_cols=84 Identities=20% Similarity=0.138 Sum_probs=72.7
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++..+..|++|++|++|+|++|++++..|..|++|++|++|+|++|++++..|..+..+++|+.|+
T Consensus 72 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 151 (680)
T 1ziw_A 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELL 151 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEE
T ss_pred ccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEE
Confidence 36789999999999954444799999999999999999977778899999999999999999998898899999999887
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 152 L~~n 155 (680)
T 1ziw_A 152 LSNN 155 (680)
T ss_dssp CCSS
T ss_pred ccCC
Confidence 7654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.7e-07 Score=93.73 Aligned_cols=81 Identities=20% Similarity=0.262 Sum_probs=58.8
Q ss_pred CCcEEEEEecCCC-CcccccchhccccccccccCCC-CCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCC-
Q 043526 411 PPRIISLNLSSSG-LTGEIAPYLSNLTLIQSLDLSN-NSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNG- 487 (858)
Q Consensus 411 ~~~l~~L~L~~n~-l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~- 487 (858)
.++++.|+|++|+ +++..+..|.++++|+.|+|++ |+|++..|..|.++++|+.|+|++|++++ +|. +..+.+|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4578888888886 7744445778888888888887 88885555677888888888888888875 676 66666666
Q ss_pred --Cccccc
Q 043526 488 --SLQLSV 493 (858)
Q Consensus 488 --~l~l~~ 493 (858)
.|+++.
T Consensus 132 L~~L~l~~ 139 (239)
T 2xwt_C 132 FFILEITD 139 (239)
T ss_dssp EEEEEEES
T ss_pred ccEEECCC
Confidence 555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.20 E-value=4.4e-08 Score=98.60 Aligned_cols=79 Identities=18% Similarity=0.187 Sum_probs=65.7
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++ +| .+.++++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 3578899999999986 77 8889999999999999998 788888888999999999999985 55 688888888777
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 122 l~~N 125 (198)
T 1ds9_A 122 MSNN 125 (198)
T ss_dssp ESEE
T ss_pred CCCC
Confidence 6544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.18 E-value=6.4e-08 Score=97.42 Aligned_cols=79 Identities=27% Similarity=0.302 Sum_probs=69.5
Q ss_pred cEEEEEecCCCCcccccc------hhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcC
Q 043526 413 RIISLNLSSSGLTGEIAP------YLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~------~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l 486 (858)
+++.++|+.+.|+|.+|+ .++++++|+.|+|++|++++ +| .+..+++|+.|+|++|+++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 556667777777777776 99999999999999999996 88 8999999999999999999 899988888999
Q ss_pred CCcccccc
Q 043526 487 GSLQLSVG 494 (858)
Q Consensus 487 ~~l~l~~~ 494 (858)
+.|+++.+
T Consensus 96 ~~L~L~~N 103 (198)
T 1ds9_A 96 EELWISYN 103 (198)
T ss_dssp SEEEEEEE
T ss_pred CEEECcCC
Confidence 98887654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-06 Score=95.54 Aligned_cols=80 Identities=31% Similarity=0.340 Sum_probs=63.9
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++++.|+|++|++++. +.+..+++|+.|+|++|++++..|..++.+++|+.|+|++|++++..| +..+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 338 (347)
T 4fmz_A 263 DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338 (347)
T ss_dssp TCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEE
T ss_pred cCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcccee
Confidence 346788888888888853 468888888888888888888888888888888888888888886655 7778888776
Q ss_pred cccc
Q 043526 490 QLSV 493 (858)
Q Consensus 490 ~l~~ 493 (858)
+++.
T Consensus 339 ~l~~ 342 (347)
T 4fmz_A 339 DFAN 342 (347)
T ss_dssp SSSC
T ss_pred ehhh
Confidence 6543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.6e-06 Score=91.31 Aligned_cols=76 Identities=28% Similarity=0.325 Sum_probs=66.1
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|+|++ +| .++++++|+.|+|++|++++ +| .++.+++|+.|+|++|++++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 689999999999996 44 69999999999999999995 56 699999999999999999976 67888888887766
Q ss_pred cc
Q 043526 492 SV 493 (858)
Q Consensus 492 ~~ 493 (858)
+.
T Consensus 180 ~~ 181 (263)
T 1xeu_A 180 TG 181 (263)
T ss_dssp EE
T ss_pred CC
Confidence 53
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.11 E-value=2.3e-06 Score=91.65 Aligned_cols=75 Identities=32% Similarity=0.410 Sum_probs=45.1
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|+|++. +.++++++|+.|+|++|++++..| +..+++|+.|+|++|++++ +| .+..+++|+.|++
T Consensus 134 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l 207 (291)
T 1h6t_A 134 PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL 207 (291)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEE
T ss_pred CCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4566666666666643 456666666666666666664333 6666666666666666663 33 2555666655544
Q ss_pred c
Q 043526 492 S 492 (858)
Q Consensus 492 ~ 492 (858)
+
T Consensus 208 ~ 208 (291)
T 1h6t_A 208 F 208 (291)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.1e-06 Score=103.96 Aligned_cols=74 Identities=24% Similarity=0.305 Sum_probs=52.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
+++++.|+|++|+|++ +| ..+++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 220 ~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 220 PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 3567777777777774 66 45577777777777777 5666 5567777777777777 7777777777777665
Q ss_pred ccc
Q 043526 491 LSV 493 (858)
Q Consensus 491 l~~ 493 (858)
++.
T Consensus 291 L~~ 293 (622)
T 3g06_A 291 LEG 293 (622)
T ss_dssp CCS
T ss_pred ecC
Confidence 543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-06 Score=94.66 Aligned_cols=76 Identities=20% Similarity=0.153 Sum_probs=46.3
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|+|++. | ....+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 169 ~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l 244 (317)
T 3o53_A 169 DTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244 (317)
T ss_dssp TTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEEC
T ss_pred CcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEc
Confidence 4566666666666633 3 2334666666666666666 34545666666666666666666 45666666666665443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.6e-06 Score=92.21 Aligned_cols=82 Identities=18% Similarity=0.179 Sum_probs=69.7
Q ss_pred CCcEEEEEecCCCCcccccchhc-cccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.++++.|+|++|+|++..|..+. ++++|+.|+|++|++++ +|. ...+++|+.|+|++|+++ .+|..+..+++|+.|
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 219 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCC-cchhhhcccCcccEE
Confidence 46899999999999988888774 79999999999999995 454 445999999999999999 466679999999988
Q ss_pred cccccC
Q 043526 490 QLSVGD 495 (858)
Q Consensus 490 ~l~~~~ 495 (858)
+++.|.
T Consensus 220 ~L~~N~ 225 (317)
T 3o53_A 220 SLRNNK 225 (317)
T ss_dssp ECTTSC
T ss_pred ECcCCc
Confidence 887654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.6e-05 Score=83.51 Aligned_cols=135 Identities=18% Similarity=0.147 Sum_probs=96.2
Q ss_pred cccccCce-EEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 578 VLGKGGFG-TVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 578 ~LG~G~fG-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.+..|..| .||+.... ++..+.+|+-... ....+.+|...|+.+. +-.+-++++++...+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34556555 68987754 5678899986532 3456888999988874 33466788889889999999999999888
Q ss_pred HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 043526 655 KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG---------------------------------------------- 688 (858)
Q Consensus 655 ~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------------------- 688 (858)
.+..... ......++.++++.|+.||..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7765321 122344566666666666631
Q ss_pred ---------CCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 689 ---------CKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 689 ---------~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
....++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999887778999997754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.06 E-value=3.1e-06 Score=90.60 Aligned_cols=78 Identities=29% Similarity=0.355 Sum_probs=55.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++. ++ ++++++|+.|+|++|++++ +|. +..+++|+.|+|++|++++ + ..+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 35777888888888754 33 7778888888888888774 444 7777888888888888775 3 4567777777666
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 141 l~~n 144 (291)
T 1h6t_A 141 LGNN 144 (291)
T ss_dssp CCSS
T ss_pred ccCC
Confidence 6543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.04 E-value=2.6e-06 Score=100.60 Aligned_cols=77 Identities=31% Similarity=0.380 Sum_probs=59.5
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++|+.|+|++|+|++. +.|+.|++|+.|+|++|+|++..| +..|++|+.|+|++|+|++ + +.+..+++|+.|+
T Consensus 130 l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~ 203 (605)
T 1m9s_A 130 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLE 203 (605)
T ss_dssp CTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEE
T ss_pred CCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEE
Confidence 45788888888888854 678888888888888888886655 7888888888888888885 3 3577777777766
Q ss_pred ccc
Q 043526 491 LSV 493 (858)
Q Consensus 491 l~~ 493 (858)
++.
T Consensus 204 L~~ 206 (605)
T 1m9s_A 204 LFS 206 (605)
T ss_dssp CCS
T ss_pred ccC
Confidence 654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.5e-05 Score=85.94 Aligned_cols=135 Identities=21% Similarity=0.211 Sum_probs=89.9
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccc---eeeeeeeeee-eCCeeEEEEeeccCC
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR---NLTNLVGYFI-EDNNMGLIYEYMANG 652 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~Ey~~~g 652 (858)
+.++.|....||+. |..+++|+-. .......+..|.++++.+.+. .+.+++.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 5678888842 223346789999999999753 2445566664 345578999999998
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG-------------------------------------------- 688 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------------- 688 (858)
.|.+.... .++..++..++.++++.|+.||..
T Consensus 99 ~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 99 ILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp ECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred ECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88653210 122333344444444444444421
Q ss_pred -------------CCCCeEecCCCCcceEEcC---CCC-EEEeeecCccc
Q 043526 689 -------------CKPPIVHRDIKPENILLTE---NLE-AKLADFGLSKV 721 (858)
Q Consensus 689 -------------~~~~IvH~DLk~~NILl~~---~~~-~kL~DFGla~~ 721 (858)
....++|+|+++.|||+++ ++. +.|.||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999997 455 48999997754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.03 E-value=3.5e-06 Score=99.60 Aligned_cols=80 Identities=34% Similarity=0.446 Sum_probs=70.1
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|+|++ + +.+.+|++|+.|+|++|+|++. ..++.|++|+.|+|++|+|++..| +..+++|+.|
T Consensus 107 ~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L 180 (605)
T 1m9s_A 107 DLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 180 (605)
T ss_dssp TCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred cCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEE
Confidence 35789999999999996 4 5699999999999999999964 669999999999999999997766 8999999988
Q ss_pred cccccC
Q 043526 490 QLSVGD 495 (858)
Q Consensus 490 ~l~~~~ 495 (858)
+++.+.
T Consensus 181 ~Ls~N~ 186 (605)
T 1m9s_A 181 YLSKNH 186 (605)
T ss_dssp ECCSSC
T ss_pred ECcCCC
Confidence 876653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.01 E-value=3.9e-06 Score=90.49 Aligned_cols=73 Identities=23% Similarity=0.387 Sum_probs=34.1
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
++++.|+|++|+|++ +|+ +.++++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 151 ~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 223 (308)
T 1h6u_A 151 TNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEE
T ss_pred CCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEE
Confidence 344555555555553 222 4555555555555555542 222 4455555555555555543321 44444444433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.00 E-value=4.4e-06 Score=90.12 Aligned_cols=77 Identities=26% Similarity=0.312 Sum_probs=47.1
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|++++. |+ ++++++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 128 l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~ 201 (308)
T 1h6u_A 128 LSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201 (308)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEE
Confidence 45666667776666643 32 6666667777777776663 444 6666667777777776664322 56666666555
Q ss_pred ccc
Q 043526 491 LSV 493 (858)
Q Consensus 491 l~~ 493 (858)
++.
T Consensus 202 L~~ 204 (308)
T 1h6u_A 202 LKN 204 (308)
T ss_dssp CTT
T ss_pred ccC
Confidence 543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.8e-06 Score=87.70 Aligned_cols=75 Identities=23% Similarity=0.345 Sum_probs=46.0
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
++++.|+|++|+|++ +|+ +++|++|+.|+|++|++++ +|.... ++|+.|+|++|++++ +| .+..+++|+.|++
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 567777777777774 333 7777777777777777763 554222 666666666666664 22 4556666665555
Q ss_pred cc
Q 043526 492 SV 493 (858)
Q Consensus 492 ~~ 493 (858)
+.
T Consensus 136 s~ 137 (263)
T 1xeu_A 136 RN 137 (263)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.99 E-value=5.6e-07 Score=97.95 Aligned_cols=81 Identities=26% Similarity=0.283 Sum_probs=51.6
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccC-CCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGN-VPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
++++.|+|++|.+++.+|. +.++++|+.|+|++|++++. +|..+..+++|+.|+|++|++++.+|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4566666666666655443 45566666666666666654 666666666666666666666666666666666666655
Q ss_pred ccc
Q 043526 491 LSV 493 (858)
Q Consensus 491 l~~ 493 (858)
++.
T Consensus 149 L~~ 151 (336)
T 2ast_B 149 LSG 151 (336)
T ss_dssp CTT
T ss_pred CCC
Confidence 543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.5e-05 Score=87.48 Aligned_cols=79 Identities=4% Similarity=-0.065 Sum_probs=55.6
Q ss_pred ccc-cccCceEEEEEEEC-------CCCEEEEEEeccCC---CcchHhHHHHHHHHHhcccc---eeeeeeeeeeeC---
Q 043526 577 KVL-GKGGFGTVYHGYLD-------DGTQVAVKMLSSSS---GQGFKEFEAEVKLLMRVHHR---NLTNLVGYFIED--- 639 (858)
Q Consensus 577 ~~L-G~G~fG~Vy~~~~~-------~g~~vAVK~l~~~~---~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~--- 639 (858)
+.| +.|....+|+.... +|+.+++|+..... ......+..|+++++.+... .+.++++++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998764 26788999865432 11235678899999888532 456677777655
Q ss_pred CeeEEEEeeccCCChH
Q 043526 640 NNMGLIYEYMANGNLK 655 (858)
Q Consensus 640 ~~~~lV~Ey~~~gsL~ 655 (858)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999987654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=97.98 E-value=4e-06 Score=98.15 Aligned_cols=67 Identities=16% Similarity=0.223 Sum_probs=32.6
Q ss_pred CcEEEEEecCCCCcccccchhcccccc-------ccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhcc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLI-------QSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEK 483 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L-------~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~ 483 (858)
++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .||..+.++++|+.|+|++|+|+|.+|..+..+
T Consensus 180 ~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 180 ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 34555555555555 4444 333 44 55555555555 455555555555555555555555555554443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.96 E-value=5.6e-06 Score=94.47 Aligned_cols=76 Identities=24% Similarity=0.382 Sum_probs=59.8
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
+++++.|+|++|+|++ +| +|+++++|++|+|++|++++ +|..+ .+|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 130 ~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 130 PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEE
Confidence 3578888888888885 77 58888888888888888885 77654 488888888888886 66 578888887776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 202 l~~N 205 (454)
T 1jl5_A 202 ADNN 205 (454)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 6544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.95 E-value=8.9e-07 Score=98.61 Aligned_cols=84 Identities=20% Similarity=0.167 Sum_probs=65.0
Q ss_pred CCcEEEEEecCCCCc----ccccchhccccccccccCCCCCCccC----CCcccc--cccccceeeccCCcCcC----CC
Q 043526 411 PPRIISLNLSSSGLT----GEIAPYLSNLTLIQSLDLSNNSLSGN----VPEFLS--RLQFLRVLNLKGNKFTG----PI 476 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~----g~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~--~l~~L~~L~L~~N~l~g----~i 476 (858)
.++|+.|+|++|.|+ +.+|..+.++++|+.|+|++|++++. +|..+. .+++|+.|+|++|++++ .+
T Consensus 215 ~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l 294 (386)
T 2ca6_A 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 294 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHH
T ss_pred CCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHH
Confidence 357888888888886 67888888888888888888888866 666663 38888888888888887 48
Q ss_pred Chhh-hccCcCCCcccccc
Q 043526 477 PVEL-MEKSKNGSLQLSVG 494 (858)
Q Consensus 477 P~~~-~~~~~l~~l~l~~~ 494 (858)
|..+ .++++|+.|+++.|
T Consensus 295 ~~~l~~~l~~L~~L~l~~N 313 (386)
T 2ca6_A 295 KTVIDEKMPDLLFLELNGN 313 (386)
T ss_dssp HHHHHHHCTTCCEEECTTS
T ss_pred HHHHHhcCCCceEEEccCC
Confidence 8777 55788887766543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.95 E-value=2.3e-06 Score=94.48 Aligned_cols=82 Identities=28% Similarity=0.257 Sum_probs=50.6
Q ss_pred CcEEEEEecCCCCccccc----chhcccc-ccccccCCCCCCccCCCcccccc-----cccceeeccCCcCcCCCChhhh
Q 043526 412 PRIISLNLSSSGLTGEIA----PYLSNLT-LIQSLDLSNNSLSGNVPEFLSRL-----QFLRVLNLKGNKFTGPIPVELM 481 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip----~~~~~l~-~L~~L~Ls~N~l~g~iP~~l~~l-----~~L~~L~L~~N~l~g~iP~~~~ 481 (858)
.+++.|+|++|+|++..+ ..+.+++ +|+.|+|++|++++..+..++.+ ++|+.|+|++|++++..+..++
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 446666676666665554 4555666 66666776666666656666654 6666666766666666655544
Q ss_pred cc-----CcCCCccccc
Q 043526 482 EK-----SKNGSLQLSV 493 (858)
Q Consensus 482 ~~-----~~l~~l~l~~ 493 (858)
.. ++|+.|+++.
T Consensus 102 ~~l~~~~~~L~~L~Ls~ 118 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGW 118 (362)
T ss_dssp HHHHTSCTTCCEEECCS
T ss_pred HHHHhCCCCccEEECcC
Confidence 43 5566555543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.93 E-value=6.3e-06 Score=94.14 Aligned_cols=75 Identities=23% Similarity=0.229 Sum_probs=56.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++ +| ++++++|++|+|++|+|++ +| ++++++|+.|+|++|++++ +| ++.+++|+.|+
T Consensus 63 l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~ 133 (457)
T 3bz5_A 63 LTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLN 133 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEE
Confidence 4577888888888886 44 7788888888888888885 44 7788888888888888886 55 77777777776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 134 l~~N 137 (457)
T 3bz5_A 134 CARN 137 (457)
T ss_dssp CTTS
T ss_pred CCCC
Confidence 6544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.89 E-value=6.5e-06 Score=94.11 Aligned_cols=76 Identities=24% Similarity=0.244 Sum_probs=57.8
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|++++..| ++.+++|+.|+|++|++++. ..+.++++|+.|+|++|+++|.+| +..+++|+.|+
T Consensus 308 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 381 (466)
T 1o6v_A 308 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381 (466)
T ss_dssp CTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEE
T ss_pred CCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEe
Confidence 4577888888888886655 77888888888888888854 357788888888888888887776 77777777665
Q ss_pred cc
Q 043526 491 LS 492 (858)
Q Consensus 491 l~ 492 (858)
++
T Consensus 382 l~ 383 (466)
T 1o6v_A 382 LN 383 (466)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=97.87 E-value=7.9e-06 Score=89.23 Aligned_cols=81 Identities=20% Similarity=0.264 Sum_probs=69.5
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++++.|+|++|.+++ + +.+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 241 NLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp TCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred cCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 45689999999999985 4 578999999999999999995 44 48899999999999999998888999999999887
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 317 ~L~~n 321 (347)
T 4fmz_A 317 FLSQN 321 (347)
T ss_dssp ECCSS
T ss_pred EccCC
Confidence 77654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=97.86 E-value=8.5e-06 Score=92.94 Aligned_cols=76 Identities=26% Similarity=0.348 Sum_probs=55.8
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcC--CCChhhhcc-----
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG--PIPVELMEK----- 483 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g--~iP~~~~~~----- 483 (858)
+++++.|+|++|+|++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|+|++|+++| .+|.++..+
T Consensus 316 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~ 387 (454)
T 1jl5_A 316 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSH 387 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-
T ss_pred cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhccc
Confidence 4688999999999996 7765 588999999999999 6888 47899999999999998 889888877
Q ss_pred --------CcCCCcccccc
Q 043526 484 --------SKNGSLQLSVG 494 (858)
Q Consensus 484 --------~~l~~l~l~~~ 494 (858)
++|+.|+++.|
T Consensus 388 ~~~i~~~~~~L~~L~ls~N 406 (454)
T 1jl5_A 388 LAEVPELPQNLKQLHVETN 406 (454)
T ss_dssp -------------------
T ss_pred ccccccccCcCCEEECCCC
Confidence 56776666543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=97.83 E-value=2.8e-06 Score=94.51 Aligned_cols=81 Identities=17% Similarity=0.243 Sum_probs=45.8
Q ss_pred cEEEEEecCCCCc--c---cccchhccccccccccCCCCCCc----cCCCcccccccccceeeccCCcCcCC----CChh
Q 043526 413 RIISLNLSSSGLT--G---EIAPYLSNLTLIQSLDLSNNSLS----GNVPEFLSRLQFLRVLNLKGNKFTGP----IPVE 479 (858)
Q Consensus 413 ~l~~L~L~~n~l~--g---~ip~~~~~l~~L~~L~Ls~N~l~----g~iP~~l~~l~~L~~L~L~~N~l~g~----iP~~ 479 (858)
+|+.|+|++|+|+ | .+|..+.++++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++. +|..
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 267 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHH
Confidence 5566666666665 2 23335666666666666666664 45566666666666666666666544 4444
Q ss_pred hhc--cCcCCCccccc
Q 043526 480 LME--KSKNGSLQLSV 493 (858)
Q Consensus 480 ~~~--~~~l~~l~l~~ 493 (858)
+.. +++|+.|+++.
T Consensus 268 l~~~~~~~L~~L~L~~ 283 (386)
T 2ca6_A 268 FSKLENIGLQTLRLQY 283 (386)
T ss_dssp HHTCSSCCCCEEECCS
T ss_pred HhhccCCCeEEEECcC
Confidence 422 55555555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.82 E-value=3.3e-06 Score=91.80 Aligned_cols=83 Identities=23% Similarity=0.270 Sum_probs=49.7
Q ss_pred CcEEEEEecCC-CCccc-ccchhcccc-ccccccCCCC--CCc-cCCCcccccccccceeeccCCc-CcCCCChhhhccC
Q 043526 412 PRIISLNLSSS-GLTGE-IAPYLSNLT-LIQSLDLSNN--SLS-GNVPEFLSRLQFLRVLNLKGNK-FTGPIPVELMEKS 484 (858)
Q Consensus 412 ~~l~~L~L~~n-~l~g~-ip~~~~~l~-~L~~L~Ls~N--~l~-g~iP~~l~~l~~L~~L~L~~N~-l~g~iP~~~~~~~ 484 (858)
++++.|+|++| ++++. +|..+.+++ +|+.|+|++| .++ +.+|..+.++++|+.|+|++|. +++..+..+..++
T Consensus 168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~ 247 (336)
T 2ast_B 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247 (336)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence 35666666666 66653 555566666 6666666666 444 4555556666666666666666 5555555666666
Q ss_pred cCCCcccccc
Q 043526 485 KNGSLQLSVG 494 (858)
Q Consensus 485 ~l~~l~l~~~ 494 (858)
+|+.|+++.+
T Consensus 248 ~L~~L~l~~~ 257 (336)
T 2ast_B 248 YLQHLSLSRC 257 (336)
T ss_dssp TCCEEECTTC
T ss_pred CCCEeeCCCC
Confidence 6665555443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=97.80 E-value=1e-05 Score=92.49 Aligned_cols=78 Identities=29% Similarity=0.364 Sum_probs=55.5
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|++++. |+ +++|++|++|+|++|++++..| ++++++|+.|+|++|++++. |. +..+++|+.|+
T Consensus 67 l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~ 140 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLE 140 (466)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred hcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEE
Confidence 35777888888888744 33 7788888888888888875433 77788888888888887744 33 67777777766
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 141 l~~n 144 (466)
T 1o6v_A 141 LSSN 144 (466)
T ss_dssp EEEE
T ss_pred CCCC
Confidence 6543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=97.79 E-value=1.1e-05 Score=92.27 Aligned_cols=76 Identities=26% Similarity=0.173 Sum_probs=37.1
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCccccccc-------ccceeeccCCcCcCCCChhhhccC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQ-------FLRVLNLKGNKFTGPIPVELMEKS 484 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~-------~L~~L~L~~N~l~g~iP~~~~~~~ 484 (858)
++++.|+|++|+|++ +| ++.+++|+.|+|++|+|+|..+..+.+|+ +|+.|+|++|++.|.+| ++.++
T Consensus 212 ~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 212 IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCT
T ss_pred CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccc
Confidence 345555555555554 44 55555555555555555544333333333 34445555555555544 23444
Q ss_pred cCCCcccc
Q 043526 485 KNGSLQLS 492 (858)
Q Consensus 485 ~l~~l~l~ 492 (858)
+|+.|+++
T Consensus 287 ~L~~L~Ls 294 (457)
T 3bz5_A 287 KIKELDVT 294 (457)
T ss_dssp TCCCCCCT
T ss_pred cCCEEECC
Confidence 45544443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.77 E-value=5.8e-06 Score=91.25 Aligned_cols=82 Identities=29% Similarity=0.286 Sum_probs=57.1
Q ss_pred cEEEEEecCCCCcccccchhccc-----cccccccCCCCCCccCCCcccccc-----cccceeeccCCcCcCCCChhhhc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNL-----TLIQSLDLSNNSLSGNVPEFLSRL-----QFLRVLNLKGNKFTGPIPVELME 482 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l-----~~L~~L~Ls~N~l~g~iP~~l~~l-----~~L~~L~L~~N~l~g~iP~~~~~ 482 (858)
+|+.|+|++|+|++..+..++.+ ++|++|+|++|++++..+..++.+ ++|+.|+|++|++++..+..++.
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 67778888888877777777775 778888888888877666655544 77888888888877666555544
Q ss_pred c-----CcCCCcccccc
Q 043526 483 K-----SKNGSLQLSVG 494 (858)
Q Consensus 483 ~-----~~l~~l~l~~~ 494 (858)
. .+|+.|+++.+
T Consensus 132 ~l~~~~~~L~~L~Ls~N 148 (362)
T 3goz_A 132 AFSNLPASITSLNLRGN 148 (362)
T ss_dssp HHTTSCTTCCEEECTTS
T ss_pred HHHhCCCceeEEEccCC
Confidence 2 46666665543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00012 Score=79.54 Aligned_cols=138 Identities=16% Similarity=0.208 Sum_probs=80.9
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccc--eeeeeee------eeeeCCeeEEEEeec
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR--NLTNLVG------YFIEDNNMGLIYEYM 649 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~------~~~~~~~~~lV~Ey~ 649 (858)
.|+.|..+.||+...++| .+++|+.... ..+...|.+++..+... .+.+++. +....+..+++|||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 466677889999988665 4899998652 23444566666655421 2233332 123456788999999
Q ss_pred cCCChH--------------HHhhhccc------------CchhHHHHH-------------------------------
Q 043526 650 ANGNLK--------------QLLSDEKA------------STLSWERRL------------------------------- 672 (858)
Q Consensus 650 ~~gsL~--------------~~L~~~~~------------~~l~~~~~~------------------------------- 672 (858)
+|..+. ..+|.... ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11221110 001232110
Q ss_pred HHHHHHHHHHHHhhc----------CCCCCeEecCCCCcceEEcCCCCEEEeeecCcc
Q 043526 673 QIAMDAAQGLEYLHI----------GCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720 (858)
Q Consensus 673 ~i~~~ia~aL~yLH~----------~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~ 720 (858)
.+...+.+++++|+. .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446666652 125789999999999999888899999999764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=97.71 E-value=1.1e-05 Score=95.65 Aligned_cols=71 Identities=27% Similarity=0.316 Sum_probs=65.0
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcC
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l 486 (858)
+++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .||..+.+|++|+.|+|++|.|+|.+|..+..+...
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~~ 310 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHHS
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcccc
Confidence 468999999999999 7887 6799999999999999 899999999999999999999999999988877643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.70 E-value=8.5e-06 Score=85.69 Aligned_cols=80 Identities=26% Similarity=0.384 Sum_probs=58.8
Q ss_pred EEecCCCC---cccccchhccccccccccCCCCCCcc--CCCcccccccccceeeccCCcCcCCCChhhhccC--cCCCc
Q 043526 417 LNLSSSGL---TGEIAPYLSNLTLIQSLDLSNNSLSG--NVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS--KNGSL 489 (858)
Q Consensus 417 L~L~~n~l---~g~ip~~~~~l~~L~~L~Ls~N~l~g--~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~--~l~~l 489 (858)
++++.|.+ .+.++....+|++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~- 224 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE- 224 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE-
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce-
Confidence 45566643 33333334678999999999999998 7788889999999999999999965 5566666 4554
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
|.+.+|+ +|+
T Consensus 225 -L~L~~Np-l~~ 234 (267)
T 3rw6_A 225 -LWLDGNS-LCD 234 (267)
T ss_dssp -EECTTST-TGG
T ss_pred -EEccCCc-Ccc
Confidence 4555665 454
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00021 Score=79.71 Aligned_cols=74 Identities=15% Similarity=0.192 Sum_probs=49.4
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCC-------cchHhHHHHHHHHHhccc--ceee-eeeeeeeeCCeeEEE
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-------QGFKEFEAEVKLLMRVHH--RNLT-NLVGYFIEDNNMGLI 645 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-------~~~~~~~~E~~~l~~l~H--pnIv-~l~~~~~~~~~~~lV 645 (858)
+.||.|..+.||++... +++.++||....... ....++..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 578899998653211 234567789988888742 4444 44433 34556899
Q ss_pred EeeccCC
Q 043526 646 YEYMANG 652 (858)
Q Consensus 646 ~Ey~~~g 652 (858)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.58 E-value=7.8e-06 Score=92.92 Aligned_cols=83 Identities=24% Similarity=0.264 Sum_probs=65.3
Q ss_pred CcEEEEEecCCCCccc----ccchhccccccccccCCCCCCccCCCccccc-----ccccceeeccCCcCcC----CCCh
Q 043526 412 PRIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGNVPEFLSR-----LQFLRVLNLKGNKFTG----PIPV 478 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~-----l~~L~~L~L~~N~l~g----~iP~ 478 (858)
++++.|+|++|.+++. +|..+.++++|+.|||++|++++..+..+.. +++|+.|+|++|++++ .+|.
T Consensus 313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 5788888888888865 6777778888888888888888765655554 5688888888888886 7888
Q ss_pred hhhccCcCCCcccccc
Q 043526 479 ELMEKSKNGSLQLSVG 494 (858)
Q Consensus 479 ~~~~~~~l~~l~l~~~ 494 (858)
.+..+++|+.|+++.+
T Consensus 393 ~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 393 TLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHCCCCCEEECCSS
T ss_pred HHHhCCCccEEECCCC
Confidence 8888888887766543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.52 E-value=5.3e-05 Score=83.06 Aligned_cols=77 Identities=21% Similarity=0.238 Sum_probs=61.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCc-ccccccccceeeccCCcCcCCCCh-hhhccCcCCC
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKGNKFTGPIPV-ELMEKSKNGS 488 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~g~iP~-~~~~~~~l~~ 488 (858)
...++.|+|++|+|+ .||+.+...++|+.|+|++|+.-+.||. .|..+++|+.|||++|+|+ .+|. .+.++.+|..
T Consensus 153 ~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~ 230 (350)
T 4ay9_X 153 SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA 230 (350)
T ss_dssp BSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEEC
T ss_pred chhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhh
Confidence 346889999999999 7888888889999999986554448885 5799999999999999999 5654 4555555544
Q ss_pred c
Q 043526 489 L 489 (858)
Q Consensus 489 l 489 (858)
+
T Consensus 231 l 231 (350)
T 4ay9_X 231 R 231 (350)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00061 Score=72.30 Aligned_cols=74 Identities=22% Similarity=0.206 Sum_probs=54.3
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccc---eeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR---NLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.+|.|..+.||+.++.+|+.+.||+-..........|..|++.|+.+.-. .+.+++++ . .-++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 458999999999999999999999987655444445688899999888422 23333333 2 3478999998764
Q ss_pred h
Q 043526 654 L 654 (858)
Q Consensus 654 L 654 (858)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.37 E-value=2.1e-05 Score=89.29 Aligned_cols=83 Identities=23% Similarity=0.259 Sum_probs=55.1
Q ss_pred CcEEEEEecCCCCccc----ccchhccccccccccCCCCCCccCCCcccccc-----cccceeeccCCcCcCC----CCh
Q 043526 412 PRIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRL-----QFLRVLNLKGNKFTGP----IPV 478 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l-----~~L~~L~L~~N~l~g~----iP~ 478 (858)
++++.|+|++|+|++. +|..+.++++|+.|+|++|++++.-+..+... ++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5677777777777754 66667777777777777777765544444433 5777777777777755 455
Q ss_pred hhhccCcCCCcccccc
Q 043526 479 ELMEKSKNGSLQLSVG 494 (858)
Q Consensus 479 ~~~~~~~l~~l~l~~~ 494 (858)
.+..+++|+.|+++.+
T Consensus 336 ~l~~~~~L~~L~Ls~n 351 (461)
T 1z7x_W 336 VLAQNRFLLELQISNN 351 (461)
T ss_dssp HHHHCSSCCEEECCSS
T ss_pred HHhhCCCccEEEccCC
Confidence 6666677776665543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.35 E-value=2.4e-05 Score=86.80 Aligned_cols=83 Identities=24% Similarity=0.203 Sum_probs=58.1
Q ss_pred CcEEEEEecCCCCcc----cccchhccccccccccCCCCCCcc----CCCcccccccccceeeccCCcCcCC----CChh
Q 043526 412 PRIISLNLSSSGLTG----EIAPYLSNLTLIQSLDLSNNSLSG----NVPEFLSRLQFLRVLNLKGNKFTGP----IPVE 479 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g----~iP~~l~~l~~L~~L~L~~N~l~g~----iP~~ 479 (858)
++|+.|+|++|.|+. .++..+..+++|++|||++|+|+. .++..+..+++|+.|+|++|+++.. ++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 467888888888864 355566778888888888888874 2455667777888888888888742 3444
Q ss_pred hhccCcCCCcccccc
Q 043526 480 LMEKSKNGSLQLSVG 494 (858)
Q Consensus 480 ~~~~~~l~~l~l~~~ 494 (858)
+...++|+.|+++.|
T Consensus 235 L~~~~~L~~L~Ls~N 249 (372)
T 3un9_A 235 AREHPSLELLHLYFN 249 (372)
T ss_dssp HHHCSSCCEEECTTS
T ss_pred HHhCCCCCEEeccCC
Confidence 555677777766554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0013 Score=70.82 Aligned_cols=136 Identities=19% Similarity=0.160 Sum_probs=90.6
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc---cceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH---HRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
+.|+.|....+|+... ++..++||+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4588999999999876 4678889987543 3466888999988884 2567788888887888999999999876
Q ss_pred hHH-----------Hhhhccc-C-------------------chhHHHH-----HHHHH--------------HHH-HHH
Q 043526 654 LKQ-----------LLSDEKA-S-------------------TLSWERR-----LQIAM--------------DAA-QGL 682 (858)
Q Consensus 654 L~~-----------~L~~~~~-~-------------------~l~~~~~-----~~i~~--------------~ia-~aL 682 (858)
+.. .||.... . .-+|... +.-.. .++ ...
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 521 2232211 0 0135432 11111 111 112
Q ss_pred HHhh-cCCCCCeEecCCCCcceEEcCCCCEEEeeec
Q 043526 683 EYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFG 717 (858)
Q Consensus 683 ~yLH-~~~~~~IvH~DLk~~NILl~~~~~~kL~DFG 717 (858)
..|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2342 12356799999999999999887 8888874
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.03 E-value=9.8e-05 Score=73.23 Aligned_cols=61 Identities=18% Similarity=0.241 Sum_probs=26.9
Q ss_pred cEEEEEecCCCCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeec--cCCcCc
Q 043526 413 RIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNL--KGNKFT 473 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L--~~N~l~ 473 (858)
.|+.|+|++|+|... +...+...+.|++|+|++|+++.. |...+...++|+.|+| ++|.++
T Consensus 66 ~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 66 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred CcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 344455555554421 223333334455555555554432 3333444444555555 444444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00012 Score=81.22 Aligned_cols=83 Identities=22% Similarity=0.114 Sum_probs=43.0
Q ss_pred CcEEEEEecCCCCcccccchhc-cccccccccCCCCCCccCCCcccc-----cccccceeeccCCcCcC----CCChhhh
Q 043526 412 PRIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNNSLSGNVPEFLS-----RLQFLRVLNLKGNKFTG----PIPVELM 481 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~-----~l~~L~~L~L~~N~l~g----~iP~~~~ 481 (858)
.+|+.|+|++|.|+..-...+. .|++|+.|+|++|+|+..-...++ ..++|+.|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4566666666666543333332 355666666666666533222221 23556666666666653 2333344
Q ss_pred ccCcCCCcccccc
Q 043526 482 EKSKNGSLQLSVG 494 (858)
Q Consensus 482 ~~~~l~~l~l~~~ 494 (858)
.+++|+.|+++.|
T Consensus 181 ~~~~L~~L~Ls~N 193 (372)
T 3un9_A 181 GNTSVTHLSLLHT 193 (372)
T ss_dssp TCSSCCEEECTTS
T ss_pred cCCCcCEEeCCCC
Confidence 4555555555443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00013 Score=72.29 Aligned_cols=85 Identities=18% Similarity=0.249 Sum_probs=66.7
Q ss_pred CcEEEEEecCC-CCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCcCcCC----CCh
Q 043526 412 PRIISLNLSSS-GLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFTGP----IPV 478 (858)
Q Consensus 412 ~~l~~L~L~~n-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g~----iP~ 478 (858)
+.|+.|+|++| .|... +...+...++|++|+|++|+|... |...+...++|+.|+|++|+++.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 57899999999 98753 556677789999999999999742 455566678999999999999843 456
Q ss_pred hhhccCcCCCccccccCc
Q 043526 479 ELMEKSKNGSLQLSVGDN 496 (858)
Q Consensus 479 ~~~~~~~l~~l~l~~~~n 496 (858)
.+.....|+.|+++..+|
T Consensus 116 ~L~~n~~L~~L~L~~~~N 133 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQ 133 (185)
T ss_dssp GGGGCSSCCEEECCCCSS
T ss_pred HHHhCCCceEEEecCCCC
Confidence 667778888888854444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0029 Score=70.97 Aligned_cols=80 Identities=11% Similarity=0.103 Sum_probs=48.1
Q ss_pred CCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccC---CCCCchhHHHHHHHHHHH
Q 043526 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTD---WLNEKSDVYSFGVVLLEI 766 (858)
Q Consensus 690 ~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDVwSfGvll~El 766 (858)
...++|||+++.|||+++++ ++|.||+.+..-............-...|.+|+..... .-....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 67899999999999999876 99999998875321100000000001235555544311 111234566778888887
Q ss_pred HhCC
Q 043526 767 ITSQ 770 (858)
Q Consensus 767 ltG~ 770 (858)
.+++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0035 Score=66.80 Aligned_cols=70 Identities=6% Similarity=0.114 Sum_probs=44.4
Q ss_pred ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceee-eeeeeeeeCCeeEEEEeec-cCCCh
Q 043526 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT-NLVGYFIEDNNMGLIYEYM-ANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~-~~gsL 654 (858)
+.|+.|....+|+. ..+++|+....... ..+...|+..++.+....+. +++++ ..+.-++++||+ ++.+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999998 56888887654222 23346688888777543443 44443 333456899999 55444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00015 Score=85.03 Aligned_cols=78 Identities=8% Similarity=0.069 Sum_probs=35.4
Q ss_pred cEEEEEecCCCCccc----ccchhccccccccccCCCCCCc----cCCCcccccccccceeeccCCcCcCCCChhhhccC
Q 043526 413 RIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLS----GNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS 484 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~----g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~ 484 (858)
+|+.|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+..++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 444455555544433 3333444455555555555544 2233333444555555555554443 444444444
Q ss_pred cCCCccc
Q 043526 485 KNGSLQL 491 (858)
Q Consensus 485 ~l~~l~l 491 (858)
+|+.|.+
T Consensus 244 ~L~~L~l 250 (592)
T 3ogk_B 244 NLEEFCG 250 (592)
T ss_dssp TCCEEEE
T ss_pred HHHhhcc
Confidence 4444433
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0093 Score=64.42 Aligned_cols=140 Identities=15% Similarity=0.143 Sum_probs=72.3
Q ss_pred cccccCceE-EEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccce--eeeeeeeeeeCCeeEEEEeeccCCCh
Q 043526 578 VLGKGGFGT-VYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN--LTNLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 578 ~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
.|+.|.... +|+....+|..+++|....... .++..|+.+++.+.... +.+++.+....+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455555544 6676654477787776543321 33455666666664322 445555533332 689999987666
Q ss_pred HHHhhhccc------------------------CchhHHHH---------------H-----HHHHHHHHHHHHhh---c
Q 043526 655 KQLLSDEKA------------------------STLSWERR---------------L-----QIAMDAAQGLEYLH---I 687 (858)
Q Consensus 655 ~~~L~~~~~------------------------~~l~~~~~---------------~-----~i~~~ia~aL~yLH---~ 687 (858)
.+.+..... ..++.... + .....+.+.++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 554422110 00111000 0 00011112222221 1
Q ss_pred CCCCCeEecCCCCcceEEcCC----CCEEEeeecCcccc
Q 043526 688 GCKPPIVHRDIKPENILLTEN----LEAKLADFGLSKVF 722 (858)
Q Consensus 688 ~~~~~IvH~DLk~~NILl~~~----~~~kL~DFGla~~~ 722 (858)
.....++|||+.+.|||++.+ ..+.|.||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124679999999999999875 67999999988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.006 Score=65.48 Aligned_cols=141 Identities=10% Similarity=0.116 Sum_probs=80.9
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccccee--eeeeee------eeeCCeeEEEEeec
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL--TNLVGY------FIEDNNMGLIYEYM 649 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~~~------~~~~~~~~lV~Ey~ 649 (858)
.|+.|....+|+....+| .+++|+.... ....++..|++++..+....+ .+++.. ....+..+++++|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 466788889999988766 5889988653 123456677777777753222 333321 12345678999999
Q ss_pred cCCChHH--------------Hhhhcc-----c-----CchhHHHHHHH------------HHHHHHHHHHhhcC----C
Q 043526 650 ANGNLKQ--------------LLSDEK-----A-----STLSWERRLQI------------AMDAAQGLEYLHIG----C 689 (858)
Q Consensus 650 ~~gsL~~--------------~L~~~~-----~-----~~l~~~~~~~i------------~~~ia~aL~yLH~~----~ 689 (858)
+|..+.. .+|... . ....|.....- ...+.+.++.++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 9864321 112110 0 01234332110 11234455555421 2
Q ss_pred CCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 690 ~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
...++|+|+++.|||++++..+.|.||+.+..
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 35789999999999999876668999997653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0035 Score=70.57 Aligned_cols=72 Identities=19% Similarity=0.307 Sum_probs=49.7
Q ss_pred ccccccCceEEEEEEECC--------CCEEEEEEeccCCCcchHhHHHHHHHHHhccccee-eeeeeeeeeCCeeEEEEe
Q 043526 577 KVLGKGGFGTVYHGYLDD--------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL-TNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 647 (858)
+.|+.|....+|+....+ ++.+++|+.... .....+..|..+++.+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 457888889999998753 578999998432 112566689999888864444 45555543 2 38999
Q ss_pred eccCCCh
Q 043526 648 YMANGNL 654 (858)
Q Consensus 648 y~~~gsL 654 (858)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00021 Score=83.85 Aligned_cols=83 Identities=17% Similarity=0.143 Sum_probs=56.5
Q ss_pred CcEEEEEecCC--CCcccccchhcc-ccccccccCCCCCCcc-CCCcccccccccceeeccCCcCcCC-CChhhhccCcC
Q 043526 412 PRIISLNLSSS--GLTGEIAPYLSN-LTLIQSLDLSNNSLSG-NVPEFLSRLQFLRVLNLKGNKFTGP-IPVELMEKSKN 486 (858)
Q Consensus 412 ~~l~~L~L~~n--~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g-~iP~~l~~l~~L~~L~L~~N~l~g~-iP~~~~~~~~l 486 (858)
++++.|+|+.+ .+++..+..++. +++|+.|+|++|++++ .+|..+..+++|+.|+|++|.|++. ++..+..+++|
T Consensus 436 ~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L 515 (592)
T 3ogk_B 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515 (592)
T ss_dssp TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence 46777787643 367666666655 7778888888888776 4566667778888888888887654 34444567777
Q ss_pred CCcccccc
Q 043526 487 GSLQLSVG 494 (858)
Q Consensus 487 ~~l~l~~~ 494 (858)
+.|+++.+
T Consensus 516 ~~L~ls~n 523 (592)
T 3ogk_B 516 RYLWVQGY 523 (592)
T ss_dssp CEEEEESC
T ss_pred CeeECcCC
Confidence 76665433
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.40 E-value=0.021 Score=61.34 Aligned_cols=140 Identities=11% Similarity=0.132 Sum_probs=81.7
Q ss_pred cccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccce--eeeeeee-----eeeCCeeEEEEeecc
Q 043526 578 VLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRN--LTNLVGY-----FIEDNNMGLIYEYMA 650 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~Ey~~ 650 (858)
.++ |....||+....+|+.+++|+..... .....+..|..++..+.... +.+++.. ....+..+++||+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789999887778889999986432 23456777888888775322 3444443 123455678999998
Q ss_pred CCChH-----H---------Hhhhcc-------cCchhHHHH----HHH---------------HHHHHHHHHHhhc---
Q 043526 651 NGNLK-----Q---------LLSDEK-------ASTLSWERR----LQI---------------AMDAAQGLEYLHI--- 687 (858)
Q Consensus 651 ~gsL~-----~---------~L~~~~-------~~~l~~~~~----~~i---------------~~~ia~aL~yLH~--- 687 (858)
|..+. . .+|... ...+++... ..+ ...+.+.++.+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 1 011110 011122110 001 1111122223221
Q ss_pred -CCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 688 -GCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 688 -~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
.....++|||+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1245689999999999999 4 899999987754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0037 Score=58.03 Aligned_cols=55 Identities=25% Similarity=0.394 Sum_probs=38.8
Q ss_pred EEEecCCCCc-ccccchhccccccccccCCCCCCccCCC-cccccccccceeeccCCcCc
Q 043526 416 SLNLSSSGLT-GEIAPYLSNLTLIQSLDLSNNSLSGNVP-EFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 416 ~L~L~~n~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~ 473 (858)
.++.++++|+ ..+|..|. ++|+.|+|++|+|+ .|| ..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 5677777776 45665432 46788888888888 555 45677888888888888764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.01 Score=65.52 Aligned_cols=140 Identities=19% Similarity=0.243 Sum_probs=82.3
Q ss_pred ccccccCceEEEEEEEC--------CCCEEEEEEeccCCCcchHhHHHHHHHHHhccccee-eeeeeeeeeCCeeEEEEe
Q 043526 577 KVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL-TNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 647 (858)
+.|..|-...+|+.... +++.+++|+.... ........+|.++++.+.-.++ .++++++. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 34667778889998864 3578999986432 2345667789999988853333 34555543 2 39999
Q ss_pred eccCCChHHH-----------------hhhcc---cCch--hHHHHHHHHHHHHH-------------------HHHHhh
Q 043526 648 YMANGNLKQL-----------------LSDEK---ASTL--SWERRLQIAMDAAQ-------------------GLEYLH 686 (858)
Q Consensus 648 y~~~gsL~~~-----------------L~~~~---~~~l--~~~~~~~i~~~ia~-------------------aL~yLH 686 (858)
|++|..|..- ||... .... -|.+..++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 11111 1111 24455555443321 223332
Q ss_pred ----c-CCCCCeEecCCCCcceEEcCC----CCEEEeeecCccc
Q 043526 687 ----I-GCKPPIVHRDIKPENILLTEN----LEAKLADFGLSKV 721 (858)
Q Consensus 687 ----~-~~~~~IvH~DLk~~NILl~~~----~~~kL~DFGla~~ 721 (858)
. .....++|+|+.+.|||++++ +.+.+.||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123468999999999999876 7899999997754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.019 Score=65.06 Aligned_cols=73 Identities=16% Similarity=0.249 Sum_probs=48.1
Q ss_pred ccccccCceEEEEEEECC-CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceee-eeeeeeeeCCeeEEEEeeccCCCh
Q 043526 577 KVLGKGGFGTVYHGYLDD-GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT-NLVGYFIEDNNMGLIYEYMANGNL 654 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~~gsL 654 (858)
+.|+.|-...+|+....+ +..+++|+....... ..+...|..++..+...++. ++++.+ .+ .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457888889999998865 578889987543322 22336888888888755553 566655 22 359999997544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0084 Score=65.84 Aligned_cols=73 Identities=16% Similarity=0.238 Sum_probs=44.6
Q ss_pred ccccccCceEEEEEEECC---------CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceee-eeeeeeeeCCeeEEEE
Q 043526 577 KVLGKGGFGTVYHGYLDD---------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT-NLVGYFIEDNNMGLIY 646 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~ 646 (858)
+.|+.|....+|+....+ ++.+++|+...... ...+...|.++++.+...+++ ++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457788888999998754 26888888754322 222346788888888544443 555433 2 36899
Q ss_pred eeccCCCh
Q 043526 647 EYMANGNL 654 (858)
Q Consensus 647 Ey~~~gsL 654 (858)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.00047 Score=80.78 Aligned_cols=81 Identities=20% Similarity=0.158 Sum_probs=56.6
Q ss_pred CcEEEEEecCCCCcccccchhcc-ccccccccCCCCCCccCCCccc-ccccccceeeccCCcCcCCCChhh-hccCcCCC
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSN-LTLIQSLDLSNNSLSGNVPEFL-SRLQFLRVLNLKGNKFTGPIPVEL-MEKSKNGS 488 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~L~L~~N~l~g~iP~~~-~~~~~l~~ 488 (858)
++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+..+ ..+++|+.
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 510 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence 4678888866 777776677766 7888888888888876555545 567888888888888865444333 34677776
Q ss_pred ccccc
Q 043526 489 LQLSV 493 (858)
Q Consensus 489 l~l~~ 493 (858)
|+++.
T Consensus 511 L~l~~ 515 (594)
T 2p1m_B 511 LWMSS 515 (594)
T ss_dssp EEEES
T ss_pred EeeeC
Confidence 66643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.00073 Score=79.11 Aligned_cols=66 Identities=14% Similarity=0.173 Sum_probs=33.2
Q ss_pred cEEEEEecCCCCcccccchhc-cccccccccCCCC-CCccC-CCcccccccccceeeccCCcCcCCCCh
Q 043526 413 RIISLNLSSSGLTGEIAPYLS-NLTLIQSLDLSNN-SLSGN-VPEFLSRLQFLRVLNLKGNKFTGPIPV 478 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N-~l~g~-iP~~l~~l~~L~~L~L~~N~l~g~iP~ 478 (858)
+|+.|+|++|.+++..+..+. ++++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++..+.
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~ 174 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGH 174 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGG
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchH
Confidence 455555555555555555554 4555555555555 33321 333334555555555555555544333
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0017 Score=71.33 Aligned_cols=64 Identities=16% Similarity=0.324 Sum_probs=52.5
Q ss_pred CCCcEEEEEecCCCCcccccchhc---cccccccccCCCCCCccC----CCcccccccccceeeccCCcCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLS---NLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~---~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
..++|+.|+|++|.+++..+..+. .+++|++|||+.|+|++. ++..+.++++|+.|+|++|.++
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 357899999999999876666655 488999999999999863 5666678899999999999876
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0061 Score=56.49 Aligned_cols=50 Identities=22% Similarity=0.318 Sum_probs=40.1
Q ss_pred cceeccCCC--------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCc
Q 043526 400 DGLNCSYKG--------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLS 449 (858)
Q Consensus 400 ~gv~C~~~~--------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 449 (858)
.-|.|+..+ ..+.+++.|+|++|+|+..-+..|..|++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 348888754 24558999999999999444456889999999999999876
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.048 Score=54.73 Aligned_cols=102 Identities=15% Similarity=0.126 Sum_probs=67.0
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
-||.+.|... ..++++.+++.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 3899999754 4689999999999999999887721 01111233456999999999998764 1110
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA 771 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~ 771 (858)
.....+.|||... ...+.+.-|||+|+++|.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122456888764 345788999999999999886443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.0049 Score=66.57 Aligned_cols=76 Identities=20% Similarity=0.222 Sum_probs=50.3
Q ss_pred CcEEEEEecCCCCccccc-chhccccccccccCCCCCCccCCC-cccccccccc-eeeccCCcCcCCCChhhhccCcCCC
Q 043526 412 PRIISLNLSSSGLTGEIA-PYLSNLTLIQSLDLSNNSLSGNVP-EFLSRLQFLR-VLNLKGNKFTGPIPVELMEKSKNGS 488 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~-~L~L~~N~l~g~iP~~~~~~~~l~~ 488 (858)
++++.|+|++|+++ .|| ..|.+|++|+.|+|++| ++ .|+ ..|.+|++|+ .|+|++ +++..-+..+..+.+|+.
T Consensus 226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp TTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred CCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 35777777777777 444 35777777777777776 65 444 4567777777 777777 565333456666777766
Q ss_pred ccc
Q 043526 489 LQL 491 (858)
Q Consensus 489 l~l 491 (858)
+++
T Consensus 302 l~l 304 (329)
T 3sb4_A 302 VLA 304 (329)
T ss_dssp EEE
T ss_pred EEe
Confidence 554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.45 E-value=0.059 Score=58.41 Aligned_cols=68 Identities=10% Similarity=0.111 Sum_probs=43.9
Q ss_pred cccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccc---ceeeeeeee------eeeCCeeEEEEeecc
Q 043526 580 GKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH---RNLTNLVGY------FIEDNNMGLIYEYMA 650 (858)
Q Consensus 580 G~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~------~~~~~~~~lV~Ey~~ 650 (858)
|.|....||+....+| .+++|+...... ..|+..+..+.. |.+.+++.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444679999988777 899998765432 345555555532 224444432 234567789999999
Q ss_pred CCCh
Q 043526 651 NGNL 654 (858)
Q Consensus 651 ~gsL 654 (858)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.012 Score=63.41 Aligned_cols=77 Identities=16% Similarity=0.076 Sum_probs=62.6
Q ss_pred CcEEEEEecCCCCcccccchhccccccc-cccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQ-SLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~-~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.+|+.|+|++| ++..-+..|.+|++|+ .|+|++ +++-.-+..|.+|++|+.|+|++|+++..-+..+..+++|+.+.
T Consensus 250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 47999999998 7744445799999999 999998 78733357899999999999999999955555788888887653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=94.74 E-value=0.0057 Score=59.74 Aligned_cols=81 Identities=16% Similarity=0.123 Sum_probs=58.8
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCC-CccCCCcccccc----cccceeeccCCc-CcCCCChhhhccCc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNS-LSGNVPEFLSRL----QFLRVLNLKGNK-FTGPIPVELMEKSK 485 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~l~~l----~~L~~L~L~~N~-l~g~iP~~~~~~~~ 485 (858)
.+|+.|||+++.++..=-..+.+|++|+.|+|+++. ++..==..++.+ ++|+.|+|+++. +|..==..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999886544668899999999999985 664222235543 479999999975 66322235667788
Q ss_pred CCCcccc
Q 043526 486 NGSLQLS 492 (858)
Q Consensus 486 l~~l~l~ 492 (858)
|+.|+++
T Consensus 141 L~~L~L~ 147 (176)
T 3e4g_A 141 LKYLFLS 147 (176)
T ss_dssp CCEEEEE
T ss_pred CCEEECC
Confidence 8877664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.0059 Score=67.09 Aligned_cols=83 Identities=12% Similarity=0.147 Sum_probs=55.0
Q ss_pred CCcEEEEEecC--CCCccc-----ccchh--ccccccccccCCCCCCccCCCcccc---cccccceeeccCCcCcCC---
Q 043526 411 PPRIISLNLSS--SGLTGE-----IAPYL--SNLTLIQSLDLSNNSLSGNVPEFLS---RLQFLRVLNLKGNKFTGP--- 475 (858)
Q Consensus 411 ~~~l~~L~L~~--n~l~g~-----ip~~~--~~l~~L~~L~Ls~N~l~g~iP~~l~---~l~~L~~L~L~~N~l~g~--- 475 (858)
.|+|+.|+|+. |...|. +.+.+ ..+++|+.|+|++|++++..+..+. .+++|+.|+|+.|+|++.
T Consensus 218 lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~ 297 (362)
T 2ra8_A 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297 (362)
T ss_dssp CTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHH
T ss_pred CCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHH
Confidence 35677777753 222111 12222 2578999999999998865554444 478999999999998863
Q ss_pred -CChhhhccCcCCCccccc
Q 043526 476 -IPVELMEKSKNGSLQLSV 493 (858)
Q Consensus 476 -iP~~~~~~~~l~~l~l~~ 493 (858)
++..+..+++|+.|+++.
T Consensus 298 ~L~~~L~~l~~L~~L~L~~ 316 (362)
T 2ra8_A 298 LLLDHVDKIKHLKFINMKY 316 (362)
T ss_dssp HHHTTHHHHTTCSEEECCS
T ss_pred HHHhhcccCCcceEEECCC
Confidence 455556677888777753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.77 E-value=0.42 Score=53.35 Aligned_cols=73 Identities=16% Similarity=0.297 Sum_probs=48.3
Q ss_pred ccccccCceEEEEEEECC--------CCEEEEEEeccCCCcchHhHHHHHHHHHhcccceee-eeeeeeeeCCeeEEEEe
Q 043526 577 KVLGKGGFGTVYHGYLDD--------GTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT-NLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E 647 (858)
+.+..|-...+|+....+ ++.+++|+...... ...+..+|.++++.+.-.+++ ++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 356678888999998763 68899998754432 223456788888888543343 444432 2 268999
Q ss_pred eccCCCh
Q 043526 648 YMANGNL 654 (858)
Q Consensus 648 y~~~gsL 654 (858)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=91.88 E-value=0.026 Score=56.02 Aligned_cols=61 Identities=23% Similarity=0.354 Sum_probs=30.5
Q ss_pred cEEEEEecCC-CCcc----cccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCcCc
Q 043526 413 RIISLNLSSS-GLTG----EIAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 413 ~l~~L~L~~n-~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
.|+.|+|++| +|.. .|-..+..=+.|+.|+|++|++... |-..|..-+.|+.|+|++|+|.
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 4555666553 4432 1333444445566666666665421 2223334455666666666655
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=89.16 E-value=0.064 Score=53.22 Aligned_cols=83 Identities=10% Similarity=0.153 Sum_probs=57.1
Q ss_pred CcEEEEEecCCCCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCc---CcC----CC
Q 043526 412 PRIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNK---FTG----PI 476 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~---l~g----~i 476 (858)
..|+.|+|++|+|... |...+..=+.|+.|+|++|+|+.. |-..+..-+.|+.|+|++|. +.. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 4789999999999843 444555678999999999999843 33345555789999998753 321 13
Q ss_pred ChhhhccCcCCCcccccc
Q 043526 477 PVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 477 P~~~~~~~~l~~l~l~~~ 494 (858)
-..+...+.|..|+++++
T Consensus 150 a~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFA 167 (197)
T ss_dssp HHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCCcCeEeccCC
Confidence 334455566666666544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.34 E-value=2.1 Score=47.17 Aligned_cols=30 Identities=37% Similarity=0.482 Sum_probs=25.0
Q ss_pred CeEecCCCCcceEE------cCCCCEEEeeecCccc
Q 043526 692 PIVHRDIKPENILL------TENLEAKLADFGLSKV 721 (858)
Q Consensus 692 ~IvH~DLk~~NILl------~~~~~~kL~DFGla~~ 721 (858)
.++|+|+.+.|||+ +++..+++.||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999988764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=86.57 E-value=0.47 Score=52.57 Aligned_cols=76 Identities=11% Similarity=0.082 Sum_probs=50.7
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
+|+.|.|.+ .++-.-+..|.+|++|+.|+|++|+++ .||.....+.+|+.+.|.+| ++-.-...+..+.+|+.+.+
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 467777775 666333457888888888888888888 66655444678888888744 55233345666777776655
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=83.78 E-value=0.73 Score=50.99 Aligned_cols=79 Identities=10% Similarity=0.067 Sum_probs=51.4
Q ss_pred CcEEEEEecCCCCc-----ccccchhccccccccccCCCCCCccCCC-cccccccccceeeccCCcCcCCCChhhhccCc
Q 043526 412 PRIISLNLSSSGLT-----GEIAPYLSNLTLIQSLDLSNNSLSGNVP-EFLSRLQFLRVLNLKGNKFTGPIPVELMEKSK 485 (858)
Q Consensus 412 ~~l~~L~L~~n~l~-----g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~ 485 (858)
.+|+.|+|.+|.+. -.-+..|.+|++|+.|+|. |+++ .|+ ..|.+|++|+.|+|.+| ++..-+..+..+ +
T Consensus 271 ~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~ 346 (401)
T 4fdw_A 271 PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-G 346 (401)
T ss_dssp TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-C
T ss_pred CCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-C
Confidence 46777888777665 2233467888888888888 4466 554 46777888888888655 552223455566 7
Q ss_pred CCCcccccc
Q 043526 486 NGSLQLSVG 494 (858)
Q Consensus 486 l~~l~l~~~ 494 (858)
|+.+.+.-+
T Consensus 347 L~~l~l~~n 355 (401)
T 4fdw_A 347 IKEVKVEGT 355 (401)
T ss_dssp CCEEEECCS
T ss_pred CCEEEEcCC
Confidence 776655443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.33 E-value=3.3 Score=41.26 Aligned_cols=116 Identities=10% Similarity=0.141 Sum_probs=78.5
Q ss_pred ccceeeeeeeeeeeCCeeEEEEeeccCC-ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcce
Q 043526 625 HHRNLTNLVGYFIEDNNMGLIYEYMANG-NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENI 703 (858)
Q Consensus 625 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NI 703 (858)
.||++++. ..-..++...+.|+.-+.+ ++.. + ..++...+++++.+|+....+++ . =+|--|.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~---~--r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNR---T--RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGG---S--SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhc---C--ceEEEEecceE
Confidence 58888866 4555666666666644322 2222 2 24678899999999998886666 2 37889999999
Q ss_pred EEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCcccc
Q 043526 704 LLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVR 775 (858)
Q Consensus 704 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~ 775 (858)
+++.++.+++.-.|+-..++ |.- .++..=.-.+=+++..+++++..|..
T Consensus 111 ~f~~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999998777543322 221 11222234577899999999888753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.39 E-value=17 Score=36.26 Aligned_cols=115 Identities=9% Similarity=0.130 Sum_probs=76.8
Q ss_pred ccceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHH-HhhcCCCCCeEecCCCCcce
Q 043526 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE-YLHIGCKPPIVHRDIKPENI 703 (858)
Q Consensus 625 ~HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~IvH~DLk~~NI 703 (858)
.||.+ -...-.+++.+.+.|+.-+++-=...+ ..++...+++++.+|+.... +++ .-+|--|.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 57777 444446677777777755443222233 24678899999999988777 555 347888999999
Q ss_pred EEcCCCCEEEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccc
Q 043526 704 LLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV 774 (858)
Q Consensus 704 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~ 774 (858)
++|.++.+++.-.|+-..+ +|.-+ ++.-=.-.+=+++..++.++..|.
T Consensus 116 ~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877754433 23221 111123356788888888877664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 858 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 6e-67
Identities = 77/275 (28%), Positives = 130/275 (47%), Gaps = 23/275 (8%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
+ +G G FGTVY G VAVKML ++ + Q + F+ EV +L + H N+
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+GY + ++ ++ +L L + + + + IA AQG++YLH
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFP-IGGTHVSTVVAGTPGYLDPEYFVT---D 748
I+HRD+K NI L E+L K+ DFGL+ V G+H ++G+ ++ PE +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 749 WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808
+ +SDVY+FG+VL E++T Q + N N II V D+ + +C +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ-LPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK--- 240
Query: 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
L +C + ERP +++ ++
Sbjct: 241 ------AMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 5e-65
Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 19/269 (7%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ LG G FG V+ GY + T+VAVK L S F AE L+ ++ H+ L L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
++ +I EYM NG+L L L+ + L +A A+G+ ++ + +
Sbjct: 76 VVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
HRD++ NIL+++ L K+ADFGL+++ + PE KS
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 755 DVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814
DV+SFG++L EI+T + V + +G D+C
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGYRMVRPDNCPE--------- 237
Query: 815 RAVELAVKCASRTSSERPNMNEVVTELKE 843
+L C +RP + + + L++
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-63
Identities = 62/272 (22%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
F + +G G FG V+ GY + +VA+K + + ++F E +++M++ H L L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
G +E + L++E+M +G L + + E L + +D +G+ YL + +
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYL---EEACV 122
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRD+ N L+ EN K++DFG+++ ST + PE F + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 754 SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813
SDV+SFGV++ E+ + + N + + ++ + + R ++
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS--------------EVVEDISTGFRLYKPRLAS 228
Query: 814 WRAVELAVKCASRTSSERPNMNEVVTELKECL 845
++ C +RP + ++ +L E
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-63
Identities = 69/296 (23%), Positives = 128/296 (43%), Gaps = 29/296 (9%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYF 636
+ +GKG FG V+ G G +VAVK+ SS + + EAE+ + + H N+ +
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAAD 66
Query: 637 IEDNN----MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC--- 689
+DN + L+ +Y +G+L L+ ++ E +++A+ A GL +LH+
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 690 --KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS---TVVAGTPGYLDPEY 744
KP I HRD+K +NIL+ +N +AD GL+ + GT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 745 FVTD------WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTN-----MIAK 793
+++D+Y+ G+V EI ++ +E+ + V + + K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 794 GDIENIVDSCLRGGFEIESAWRAV-ELAVKCASRTSSERPNMNEVVTELKECLMME 848
E + + ++ A R + ++ +C + R + L + E
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-63
Identities = 65/270 (24%), Positives = 112/270 (41%), Gaps = 19/270 (7%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
F K LG G FG V +G VA+KM+ S EF E K++M + H L L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
G + + +I EYMANG L L + + ++ L++ D + +EYL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRD+ N L+ + K++DFGLS+ S + PE + + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 754 SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813
SD+++FGV++ EI + + + + + LR ++
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNS--------------ETAEHIAQGLRLYRPHLAS 227
Query: 814 WRAVELAVKCASRTSSERPNMNEVVTELKE 843
+ + C + ERP +++ + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-61
Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 25/276 (9%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +GKG FG V G G +VAVK + + + + F AE ++ ++ H NL L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 67
Query: 635 YFIEDNN-MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
+E+ + ++ EYMA G+L L S L + L+ ++D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
VHRD+ N+L++E+ AK++DFGL+K + PE + K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKFSTK 180
Query: 754 SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813
SDV+SFG++L EI + V ++ V + KG + D C
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGYKMDAPDGCPP-------- 227
Query: 814 WRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849
E+ C ++ RP+ ++ +L+ EL
Sbjct: 228 -AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 19/271 (7%)
Query: 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
LG+G FG V+ G + T+VA+K L + + F E +++ ++ H L L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ + ++ EYM+ G+L L E L + + +A A G+ Y+ V
Sbjct: 80 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
HRD++ NIL+ ENL K+ADFGL+++ + PE + KS
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 755 DVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAW 814
DV+SFG++L E+ T V + V + + +G C
Sbjct: 196 DVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYRMPCPPECPE--------- 241
Query: 815 RAVELAVKCASRTSSERPNMNEVVTELKECL 845
+L +C + ERP + L++
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 4e-60
Identities = 69/273 (25%), Positives = 108/273 (39%), Gaps = 19/273 (6%)
Query: 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNL 632
LG G +G VY G VAVK L + + +EF E ++ + H NL L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
+G + +I E+M GNL L + +S L +A + +EYL K
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 135
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNE 752
+HRD+ N L+ EN K+ADFGLS++ + PE + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 753 KSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812
KSDV++FGV+L EI T + + + +++ R
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYELLEKDYRMERPEGC 241
Query: 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
+ EL C S+RP+ E+ +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 29/296 (9%)
Query: 572 TDNF---NKVLGKGGFGTVYHGYL---DDGTQVAVKMLSSSSGQGF-KEFEAEVKLLMRV 624
DN + LG G FG+V G VA+K+L + + +E E +++ ++
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEY 684
+ + L+G + + L+ E G L + L ++ + ++ + G++Y
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKY 124
Query: 685 LHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH--VSTVVAGTPGYLDP 742
L VHRD+ N+LL AK++DFGLSK ++ + + P
Sbjct: 125 LEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802
E + +SDV+S+GV + E ++ + V I +G
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMECPPE 236
Query: 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKKELWH 858
C L C +RP+ V ++ C LA K + H
Sbjct: 237 CPP---------ELYALMSDCWIYKWEDRPDFLTVEQRMRACY-YSLASKVEGHHH 282
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 2e-59
Identities = 66/303 (21%), Positives = 124/303 (40%), Gaps = 38/303 (12%)
Query: 563 FTYSEVLKITDNFN-----------KVLGKGGFGTVYHGYL----DDGTQVAVKMLSSS- 606
FT+ + + F +V+G G FG V G+L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 607 SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTL 666
+ + ++F +E ++ + H N+ +L G + + +I E+M NG+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQF 125
Query: 667 SWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726
+ + + + A G++YL VHRD+ NIL+ NL K++DFGLS+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 727 THVSTVVA----GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIH 782
+ + A + PE SDV+S+G+V+ E+++ +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-- 240
Query: 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELK 842
D+ N ++ R ++ +L + C + + RP ++V L
Sbjct: 241 ------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 843 ECL 845
+ +
Sbjct: 289 KMI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (513), Expect = 3e-59
Identities = 75/305 (24%), Positives = 121/305 (39%), Gaps = 49/305 (16%)
Query: 573 DNFN--KVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGF-KEFEAEVKLLMR 623
+N + +G+G FG V+ + T VAVKML + +F+ E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKAST------------------ 665
+ N+ L+G M L++EYMA G+L + L T
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 666 ----LSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK- 720
LS +L IA A G+ YL + VHRD+ N L+ EN+ K+ADFGLS+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 721 VFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN 780
++ A ++ PE + +SDV+++GVVL EI +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248
Query: 781 IHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840
+ V + G+I ++C L C S+ ++RP+ +
Sbjct: 249 ----EEVIYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 841 LKECL 845
L+
Sbjct: 296 LQRMC 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-59
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 572 TDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGF-KEFEAEVKLLMRVHHR 627
D+F LG G G V+ G +A K++ + E+++L +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
+ G F D + + E+M G+L Q+L +KA + + ++++ +GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR- 121
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
K I+HRD+KP NIL+ E KL DFG+S ++ GT Y+ PE
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQG 177
Query: 748 DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHII 784
+ +SD++S G+ L+E+ + I + + + ++
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-58
Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 27/285 (9%)
Query: 570 KITDNFNKVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSSGQGF-KEFEAEVKLLMRV 624
+ +FN+V+G+G FG VYHG L D AVK L+ + G +F E ++
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 625 HHRNLTNLVGYFIE-DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
H N+ +L+G + + + ++ YM +G+L+ + +E + + + + A+G+
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGM- 143
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG---THVSTVVAGTPGYL 740
VHRD+ N +L E K+ADFGL++ H T ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 741 DPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800
E T KSDV+SFGV+L E++T A + N +T + +G
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGRRLLQP 256
Query: 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
+ C E+ +KC + RP+ +E+V+ +
Sbjct: 257 EYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-58
Identities = 68/275 (24%), Positives = 109/275 (39%), Gaps = 27/275 (9%)
Query: 576 NKVLGKGGFGTVYHGYLDD---GTQVAVKMLSSSSGQG--FKEFEAEVKLLMRVHHRNLT 630
+K LG G FGTV GY VAVK+L + + E AE ++ ++ + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
++G ++ M L+ E G L + L + + + +++ + G++YL
Sbjct: 72 RMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST--VVAGTPGYLDPEYFVTD 748
VHRD+ N+LL AK++DFGLSK + + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 749 WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808
+ KSDV+SFGV++ E + R VT M+ KG+ C R
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGERMGCPAGCPR--- 237
Query: 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843
+L C + RP V L+
Sbjct: 238 ------EMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-58
Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQ-----VAVKMLSSSSGQGFK-EFEAEVKLLMRVHHR 627
KV+G G FG VY G L + VA+K L + + + +F E ++ + H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
N+ L G + M +I EYM NG L + EK S + + + A G++YL
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG--THVSTVVAGTPGYLDPEYF 745
VHRD+ NIL+ NL K++DFGLS+V T+ ++ + PE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805
SDV+SFG+V+ E++T + + ++ ++ R
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------------EVMKAINDGFR 231
Query: 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
++ +L ++C + + RP ++V+ L + +
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 65/296 (21%), Positives = 110/296 (37%), Gaps = 41/296 (13%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRV-HH 626
F K LG G FG V D VAVKML S+ +E +E+K+L + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL----------------SDEKASTLSWER 670
N+ NL+G +I EY G+L L ++ L E
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH-V 729
L + A+G+ +L +HRD+ NILLT K+ DFGL++ + V
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTN 789
++ PE +SDV+S+G+ L E+ + + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--------- 254
Query: 790 MIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
++ R + ++ C +RP ++V +++ +
Sbjct: 255 ----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 60/277 (21%), Positives = 106/277 (38%), Gaps = 27/277 (9%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHR 627
+++ +G G +G DG + K L S + + +EV LL + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 628 NLTNLVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKAS--TLSWERRLQIAMDAAQGLE 683
N+ I+ + + ++ EY G+L +++ L E L++ L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 684 YLH--IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
H ++HRD+KP N+ L KL DFGL+++ T + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801
PE NEKSD++S G +L E+ + + I +G I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------GKIREGKFRRIPY 236
Query: 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVV 838
E+ + + RP++ E++
Sbjct: 237 RYSD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-56
Identities = 71/325 (21%), Positives = 125/325 (38%), Gaps = 49/325 (15%)
Query: 551 NAHGSLEFENRHFTYSEVLKIT-DNFN--KVLGKGGFGTVYHGYL------DDGTQVAVK 601
+ + + R + Y + +N KVLG G FG V + QVAVK
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73
Query: 602 MLSSSSGQGFKE-FEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL- 658
ML + +E +E+K++ ++ H N+ NL+G + LI+EY G+L L
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 659 --------------------SDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDI 698
+E + L++E L A A+G+E+L VHRD+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190
Query: 699 KPENILLTENLEAKLADFGLSKVFPIGGTHVS-TVVAGTPGYLDPEYFVTDWLNEKSDVY 757
N+L+T K+ DFGL++ +V ++ PE KSDV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 758 SFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAV 817
S+G++L EI + + + ++ + + +
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVD-------------ANFYKLIQNGFKMDQPFYATEEIY 297
Query: 818 ELAVKCASRTSSERPNMNEVVTELK 842
+ C + S +RP+ + + L
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-56
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 569 LKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH 625
L D + LG G FG VY + A K++ + S + +++ E+ +L
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
H N+ L+ F +NN+ ++ E+ A G + ++ + + L+ + + L YL
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYL 126
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H I+HRD+K NIL T + + KLADFG+S + + GTP ++ PE
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182
Query: 746 VTDWL-----NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800
+ + + K+DV+S G+ L+E+ + + IAK +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKSEPPT-- 234
Query: 801 DSCLRGGFEIESAW--RAVELAVKCASRTSSERPNMNEV 837
S W + KC + R +++
Sbjct: 235 -------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-56
Identities = 66/272 (24%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTN 631
F+ +G+G F TVY G + +VA L + + F+ E ++L + H N+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 632 LVGYFIE----DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
+ + L+ E M +G LK L K + + +GL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT 130
Query: 688 GCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
PPI+HRD+K +NI +T K+ D GL+ + + V GTP ++ PE +
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY- 185
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806
+ +E DVY+FG+ +LE+ TS+ +N I + VT+ + + + ++
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKPASFDKVAIPEVK- 243
Query: 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVV 838
E+ C + ER ++ +++
Sbjct: 244 -----------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 38/291 (13%)
Query: 574 NFNKVLGKGGFGTVYHGYLDDGTQ---VAVKMLS-SSSGQGFKEFEAEVKLLMRV-HHRN 628
F V+G+G FG V + A+K + +S ++F E+++L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWERRLQI 674
+ NL+G + L EY +GNL L ++ ASTLS ++ L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 675 AMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVA 734
A D A+G++YL + +HRD+ NIL+ EN AK+ADFGLS+ + T+
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 735 GTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG 794
++ E SDV+S+GV+L EI++
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------------- 233
Query: 795 DIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
++ + R + +L +C ERP+ +++ L L
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 24/282 (8%)
Query: 575 FNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRNL 629
+ +G+G FG V+ G + VA+K + + +E F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 630 TNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGC 689
L+G +N + +I E G L+ + +L + A + L YL
Sbjct: 71 VKLIGVI-TENPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE--- 125
Query: 690 KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW 749
VHRDI N+L++ N KL DFGLS+ + ++ ++ PE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 750 LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809
SDV+ FGV + EI+ + V I G+ + +C
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENGERLPMPPNCPP---- 236
Query: 810 IESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851
L KC + S RP E+ +L L E A+
Sbjct: 237 -----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-54
Identities = 74/272 (27%), Positives = 114/272 (41%), Gaps = 30/272 (11%)
Query: 573 DNFN--KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHH 626
++F + LGKG FG VY +A+K+L + + EV++ + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
N+ L GYF + + LI EY G + + L +K S +R + A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
++HRDIKPEN+LL E K+ADFG S P + GT YL PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806
+EK D++S GV+ E + + N + + I++ +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISRVEFT--------- 222
Query: 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVV 838
F A +L + S+RP + EV+
Sbjct: 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-54
Identities = 62/271 (22%), Positives = 104/271 (38%), Gaps = 24/271 (8%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKLLMRVHHRN 628
++++ + LG+G +G V VAVK++ E + E+ + ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 629 LTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG 688
+ G+ E N L EY + G L + + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 689 CKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVSTVVAGTPGYLDPEYFVT 747
I HRDIKPEN+LL E K++DFGL+ VF + + GT Y+ PE
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 748 DWLN-EKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806
+ E DV+S G+VL ++ + + + + I + L
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237
Query: 807 GFEIESAWRAVELAVKCASRTSSERPNMNEV 837
L K S R + ++
Sbjct: 238 -----------ALLHKILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 1e-53
Identities = 68/295 (23%), Positives = 122/295 (41%), Gaps = 37/295 (12%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQG---FKEFEAEVKLLMRVHHRNLTNL 632
+ +G G FG VY + + VA+K +S S Q +++ EV+ L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 633 VGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP 692
G ++ ++ L+ EY L +K L + A QGL YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 693 IVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDW--- 749
++HRD+K NILL+E KL DFG + + + V GTP ++ PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQ 190
Query: 750 LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809
+ K DV+S G+ +E+ + + N++ + + + IA+ + + F
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL-----FNMNAMSALYH-IAQNESPALQSGHWSEYFR 244
Query: 810 IESAWRAVELAVKCASRTSSERPNMNEVV------TELKECLMMELARKKKELWH 858
C + +RP ++ E ++M+L ++ K+
Sbjct: 245 --------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-53
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 27/287 (9%)
Query: 567 EVLKITD-NFNKVLGKGGFGTVYHG-YLDDGTQ----VAVKMLS-SSSGQGFKEFEAEVK 619
+LK T+ KVLG G FGTVY G ++ +G + VA+K L ++S + KE E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 620 LLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
++ V + ++ L+G + LI + M G L + + K + + L + A
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIA 121
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVSTVVAGTPG 738
+G+ YL +VHRD+ N+L+ K+ DFGL+K+ + +
Sbjct: 122 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798
++ E + +SDV+S+GV + E++T + + +I +
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------------EISS 224
Query: 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
I++ R + VKC + RP E++ E +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 6e-53
Identities = 67/283 (23%), Positives = 103/283 (36%), Gaps = 29/283 (10%)
Query: 573 DNFN--KVLGKGGFGTVYHGYLD----DGTQVAVKMLSS---SSGQGFKEFEAEVKLLMR 623
+ + LG G FG V G D VAVK L S + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
+ HRNL L G M ++ E G+L L + + A+ A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMG 125
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH--VSTVVAGTPGYLD 741
YL +HRD+ N+LL K+ DFGL + P H + +
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 742 PEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801
PE T + SD + FGV L E+ T N + Q + + +G+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGERLPRPE 238
Query: 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844
C + + V+C + +RP + L E
Sbjct: 239 DCPQ---------DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 9e-53
Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 21/262 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ +G+G GTVY + G +VA++ ++ + E+ ++ + N+ N +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
++ + + ++ EY+A G+L ++++ + + + Q LE+LH ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 696 RDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSD 755
RDIK +NILL + KL DFG + ST+V GTP ++ PE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 756 VYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWR 815
++S G++ +E+I + NEN + TN + + + R
Sbjct: 199 IWSLGIMAIEMIEGEP-PYLNENPLRALYLIATNGTPELQNPEKLSAIFR---------- 247
Query: 816 AVELAVKCASRTSSERPNMNEV 837
+ +C +R + E+
Sbjct: 248 --DFLNRCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 68/287 (23%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 575 FNKVLGKGGFGTVYHGYL------DDGTQVAVKMLS-SSSGQGFKEFEAEVKLLMRVHHR 627
++ LG+G FG VY G + T+VA+K ++ ++S + EF E ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------SDEKASTLSWERRLQIAMDAA 679
++ L+G + +I E M G+LK L ++ + S + +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG-THVSTVVAGTPG 738
G+ YL VHRD+ N ++ E+ K+ DFG+++
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 739 YLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIEN 798
++ PE SDV+SFGVVL EI T + + + V + +G + +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFVMEGGLLD 255
Query: 799 IVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
D+C EL C RP+ E+++ +KE +
Sbjct: 256 KPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 71/295 (24%), Positives = 115/295 (38%), Gaps = 40/295 (13%)
Query: 575 FNKVLGKGGFGTVYHGY------LDDGTQVAVKMLSSSSGQG-FKEFEAEVKLLMR-VHH 626
K LG+G FG V VAVKML + + +E+K+L+ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 627 RNLTNLVGYFIEDNN-MGLIYEYMANGNLKQLLSDEK--------------ASTLSWERR 671
N+ NL+G + + +I E+ GNL L ++ L+ E
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-S 730
+ + A+G+E+L +HRD+ NILL+E K+ DFGL++ +V
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNM 790
++ PE +SDV+SFGV+L EI + + + I +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG----ASPYPGVKIDEEFCRR 249
Query: 791 IAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
+ +G D + + C S+RP +E+V L L
Sbjct: 250 LKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 42/298 (14%)
Query: 575 FNKVLGKGGFGTVYHGYL--------DDGTQVAVKML-SSSSGQGFKEFEAEVKLLMRV- 624
K LG+G FG V + T+VAVKML S ++ + + +E++++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 625 HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLL--------------SDEKASTLSWER 670
H+N+ NL+G +D + +I EY + GNL++ L S LS +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
+ A A+G+EYL +HRD+ N+L+TE+ K+ADFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 731 T-VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTN 789
T ++ PE +SDV+SFGV+L EI T ++ +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VEELFK 248
Query: 790 MIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847
++ +G + +C + C S+RP ++V +L + +
Sbjct: 249 LLKEGHRMDKPSNCTN---------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 9e-49
Identities = 61/273 (22%), Positives = 117/273 (42%), Gaps = 25/273 (9%)
Query: 571 ITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHR 627
+ D+++ + LG G FG V+ G A K + + + E++ + + H
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
L NL F +DN M +IYE+M+ G L + ++DE + +S + ++ +GL ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 688 GCKPPIVHRDIKPENILLT--ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
VH D+KPENI+ T + E KL DFGL+ + T GT + PE
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAVI-VRNENENIHIIQTVTNMIAKGDIENIVDSCL 804
+ +D++S GV+ +++ + N++E + +++ + I +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED-- 255
Query: 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
+ K + R +++
Sbjct: 256 -----------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 61/275 (22%), Positives = 106/275 (38%), Gaps = 28/275 (10%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMR 623
K ++F K+LG+G F TV L + A+K+L E ++ R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
+ H L F +D + Y NG L + + + A+ +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDET---CTRFYTAEIVS 119
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDP 742
L I+HRD+KPENILL E++ ++ DFG +KV + GT Y+ P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS 802
E + SD+++ G ++ +++ R NE + I K + +
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGL-PPFRAGNE-----YLIFQKIIKLEYD----- 228
Query: 803 CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
F + +A +L K +++R E+
Sbjct: 229 -----FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (426), Expect = 1e-46
Identities = 54/275 (19%), Positives = 110/275 (40%), Gaps = 27/275 (9%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH 626
+ D ++ + LG G FG V+ G K +++ + E+ ++ ++HH
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
L NL F + M LI E+++ G L ++ E +S + A +GL+++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH 144
Query: 687 IGCKPPIVHRDIKPENILL--TENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEY 744
+ IVH DIKPENI+ + K+ DFGL+ T T + PE
Sbjct: 145 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEI 199
Query: 745 FVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804
+ + +D+++ GV+ +++ + ++ ++N+
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--------------LQNVKRCDW 245
Query: 805 RGGFEIESAW--RAVELAVKCASRTSSERPNMNEV 837
+ S+ A + + +R +++
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 6e-46
Identities = 65/285 (22%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 570 KITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQG---FKEFEAEVKLLMR 623
++D + ++LG GG V+ L VAVK+L + + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 624 VHHRNLTNLVGYFIEDNNMG----LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
++H + + + G ++ EY+ L+ ++ E ++ +R +++ DA
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADAC 121
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV--STVVAGTP 737
Q L + + I+HRD+KP NI+++ K+ DFG+++ G V + V GT
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797
YL PE D ++ +SDVYS G VL E++T + + ++ + D
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP- 231
Query: 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERP-NMNEVVTEL 841
I S G + + +K ++ R E+ +L
Sbjct: 232 -IPPSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 52/266 (19%), Positives = 106/266 (39%), Gaps = 26/266 (9%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ LG+G FG V+ K + G + E+ +L HRN+ +L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
F + +I+E+++ ++ + + + A L+ + + L++LH I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125
Query: 696 RDIKPENILLT--ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
DI+PENI+ + K+ +FG ++ G ++ P Y PE D ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 754 SDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813
+D++S G ++ +++ + N+ I IENI+++ E
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQI--------------IENIMNAEYTFDEEAFKE 229
Query: 814 W--RAVELAVKCASRTSSERPNMNEV 837
A++ + + R +E
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-44
Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 565 YSEVLKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-FEAEVKL 620
+ + I D ++ VLG G F V VA+K ++ + +G + E E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 621 LMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ 680
L ++ H N+ L + ++ LI + ++ G L + ++ + ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
++YL IVHRD+KPEN+L E+ + ++DFGLSK+ V + GTP
Sbjct: 119 AVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTP 173
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797
GY+ PE ++ D +S GV+ ++ + + E
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--------------FE 219
Query: 798 NIVDSCLRGGFEIESAW--RAVELAVKCASRTSSERPNMNEV 837
I+ + A + + +R +
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (400), Expect = 5e-44
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 40/285 (14%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGF---------KEFEAEVKL 620
+N+ ++LG+G V + AVK++ + G F + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 621 LMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAA 679
L +V H N+ L + + L+++ M G L L+++ TLS + +I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 120
Query: 680 QGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGY 739
+ + LH K IVHRD+KPENILL +++ KL DFG S V GTP Y
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSY 175
Query: 740 LDPEYFVTDWL------NEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTVTNMIA 792
L PE ++ D++S GV++ ++ R + + +I +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 793 KGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
+ ++ D+ +L + +R E
Sbjct: 236 SPEWDDYSDTV-------------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (400), Expect = 8e-44
Identities = 44/282 (15%), Positives = 93/282 (32%), Gaps = 28/282 (9%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
+ +G+G FG ++ G L + QVA+K S + E + + V Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 636 FIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVH 695
F ++ ++ + +L+ LL D S + A ++ +H + +V+
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 696 RDIKPENILLTENLE-----AKLADFGLSKVFPIGGTHV------STVVAGTPGYLDPEY 744
RDIKP+N L+ + DFG+ K + T ++GT Y+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 745 FVTDWLNEKSDVYSFGVVLLEIITSQAVI-VRNENENIHIIQTVTNMIAKGDIENIVDSC 803
+ + + D+ + G V + + N + + + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845
+ + P+ + + + L
Sbjct: 245 PE---------EFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 9e-43
Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 17/244 (6%)
Query: 573 DNFN--KVLGKGGFGTVYHG-YLDDGTQVAVKMLSSSSG---QGFKEFEAEVKLLMRV-H 625
++F K+LGKG FG V+ + A+K L + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
H LT++ F N+ + EY+ G+L + R A + GL++L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFL 119
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
IV+RD+K +NILL ++ K+ADFG+ K +G +T GTP Y+ PE
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTVTNMIAKG---DIENIVD 801
+ N D +SFGV+L E++ Q+ ++E E H I+ + + ++++
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235
Query: 802 SCLR 805
Sbjct: 236 KLFV 239
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (396), Expect = 1e-42
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 18/223 (8%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQG------FKEFEAEVKLLMR 623
++F+ +++G+GGFG VY D G A+K L + + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 624 VHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLE 683
+ + F + + I + M G+L LS + A + GLE
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLE 121
Query: 684 YLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPE 743
++H +V+RD+KP NILL E+ +++D GL+ F H S GT GY+ PE
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 175
Query: 744 YFVTDW-LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQ 785
+ +D +S G +L +++ + +++ ++ H I
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-42
Identities = 48/293 (16%), Positives = 103/293 (35%), Gaps = 28/293 (9%)
Query: 569 LKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH 625
L++ + + + +G G FG +Y G + G +VA+K+ + + E K+ +
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60
Query: 626 HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
+ + + + ++ + +L+ L + + S + L +A +EY+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDL-FNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 686 HIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGTHV------STVVAGT 736
H +HRD+KP+N L+ + DFGL+K + TH + + GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 737 PGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVI-VRNENENIHIIQTVTNMIAKGD 795
Y + + + D+ S G VL+ + ++
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 796 IENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848
IE + C S ++P+ + + + +
Sbjct: 237 IEVLCKGYPS---------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-42
Identities = 61/297 (20%), Positives = 124/297 (41%), Gaps = 32/297 (10%)
Query: 567 EVLKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGF-KEFEAEVKLLM 622
+V + + +G+G +G V Y + +VA+K +S Q + + E+K+L+
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 623 RVHHRNLTNLVGYF----IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDA 678
R H N+ + IE + ++ +L +LL + LS +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQI 118
Query: 679 AQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS--TVVAGT 736
+GL+Y+H ++HRD+KP N+LL + K+ DFGL++V H T T
Sbjct: 119 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 737 PGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAV-IVRNENENIHIIQTVTNMIAKG 794
Y PE + + D++S G +L E+++++ + ++ + ++ I + ++
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 795 DIENIVDSCLRGGFEIESAWR--------------AVELAVKCASRTSSERPNMNEV 837
D+ I++ R A++L K + +R + +
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-42
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 30/280 (10%)
Query: 570 KITDNF---NKVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV- 624
I D++ ++VLG G G V + + A+KML + EV+L R
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRAS 62
Query: 625 HHRNLTNLVGYF----IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQ 680
++ +V + + ++ E + G L + D + +I +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 681 GLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
++YLH I HRD+KPEN+L T N KL DFG +K + + TP
Sbjct: 123 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TP 177
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE 797
Y+ PE + ++ D++S GV++ ++ N + I + I G E
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQYE 235
Query: 798 NIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
E + L ++R + E
Sbjct: 236 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-42
Identities = 63/280 (22%), Positives = 106/280 (37%), Gaps = 25/280 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE-----FEAEVKLLMRVHHRNLT 630
LG+G F TVY + VA+K + K+ E+KLL + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 631 NLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK 690
L+ F +N+ L++++M + + L+ + QGLEYLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH---Q 118
Query: 691 PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWL 750
I+HRD+KP N+LL EN KLADFGL+K F T T Y PE +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 751 -NEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808
D+++ G +L E++ + ++ + + I + ++ F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 809 EIESAWR-----------AVELAVKCASRTSSERPNMNEV 837
+ ++L R +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 8e-42
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLS---SSSGQGFKEFEAEVKLLMRVHH 626
+F + LG G FG V+ +G A+K+L + + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ + G F + + +I +Y+ G L LL + + AA+ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVCLALE 118
Query: 687 IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
I++RD+KPENILL +N K+ DFG +K P V+ + GTP Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVS 174
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQ 770
T N+ D +SFG+++ E++
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 60/300 (20%), Positives = 113/300 (37%), Gaps = 30/300 (10%)
Query: 577 KVLGKGGFGTVYHGY--LDDGTQVAVKMLSSSSGQG-----FKEFEAEVKLLMRVHHRNL 629
+G+G +G V+ + G VA+K + +G+ A ++ L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 630 TNLVGYFIEDNNMGLIYEYM----ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
L + + +L L + E + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
H +VHRD+KP+NIL+T + + KLADFGL++++ S V T Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 746 VTDWLNEKSDVYSFGVVLLEIITSQAVI-VRNENENIHIIQTVTNMIAKGDIENIVDSCL 804
+ D++S G + E+ + + ++ + + I V + + D V
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 805 RGGFEIESAWR----------AVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKK 854
+ + +L +KC + ++R + L +L R K+
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSHPYFQDLERCKE 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 51/284 (17%), Positives = 110/284 (38%), Gaps = 24/284 (8%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHR 627
+NF + +G+G +G VY G VA+K + + + E+ LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
N+ L+ +N + L++E++ + +LK+ + + + QGL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-- 118
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
++HRD+KP+N+L+ KLADFGL++ F + + V
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 748 DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807
+ + D++S G + E++T +A + ++E + + + ++ + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 808 FEIESAWR--------------AVELAVKCASRTSSERPNMNEV 837
W L + ++R +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (369), Expect = 8e-40
Identities = 50/276 (18%), Positives = 101/276 (36%), Gaps = 20/276 (7%)
Query: 577 KVLGKGGFGTVYHGYLDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG 634
+ +G+G +G VY + G A+K + E+ +L + H N+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 635 YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIV 694
+ L++E++ K L E L + G+ Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 695 HRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKS 754
HRD+KP+N+L+ E K+ADFGL++ F I + + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 755 DVYSFGVVLLEIITSQAVIV-RNENENIHIIQTVTNMIAKGDIENIVD-------SCLRG 806
D++S G + E++ + +E + + I + + N+ + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 807 GFEIESAWR-----AVELAVKCASRTSSERPNMNEV 837
ES + ++L K ++R +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 27/252 (10%)
Query: 570 KIT-DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQGFKEFEAEVKLLM 622
K+T ++F+ K+LGKG FG V G A+K+L + E ++L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 623 RVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGL 682
H LT L F + + + EY G L LS + + ER A+ +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYG---AEIV 115
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP 742
L +V+RDIK EN++L ++ K+ DFGL K G + T GTP YL P
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174
Query: 743 EYFVTDWLNEKSDVYSFGVVLLEIITS---------QAVIVRNENENIHIIQTVTNMIAK 793
E + D + GVV+ E++ + + E I +T++
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP---- 230
Query: 794 GDIENIVDSCLR 805
+ ++++ L+
Sbjct: 231 -EAKSLLAGLLK 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 60/292 (20%), Positives = 116/292 (39%), Gaps = 36/292 (12%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+G+G FG V+ G +VA+K + + E+K+L + H N+ NL+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 634 G--------YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYL 685
Y ++ L++++ + L + TLS +R+ L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGL 130
Query: 686 HIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT---HVSTVVAGTPGYLDP 742
+ + I+HRD+K N+L+T + KLADFGL++ F + + T T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 743 EYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTVTNMIAKGDIENIV 800
E + + D++ G ++ E+ T ++ E + +I + I N+
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 801 DSCLRGGFEIESAWR---------------AVELAVKCASRTSSERPNMNEV 837
+ L E+ + A++L K ++R + ++
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 7e-39
Identities = 66/284 (23%), Positives = 105/284 (36%), Gaps = 32/284 (11%)
Query: 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGY 635
KV+G G FG VY L D G VA+K + + E++++ ++ H N+ L +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYF 81
Query: 636 FIE------DNNMGLIYEYMANGNLKQLLSDEKAS-TLSWERRLQIAMDAAQGLEYLHIG 688
F + + L+ +Y+ + +A TL + L Y+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 689 CKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDP-EYFV 746
I HRDIKP+N+LL + KL DFG +K G +VS + + Y P F
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFG 196
Query: 747 TDWLNEKSDVYSFGVVLLEIITSQ-------------AVIVRNENENIHIIQTVTNMIAK 793
DV+S G VL E++ Q +I I+ + +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
I F + A+ L + T + R E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-39
Identities = 51/278 (18%), Positives = 98/278 (35%), Gaps = 22/278 (7%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKEFEAEVKLLMRVHHRNLTNLV 633
+ +G+G +GTV+ + VA+K + E+ LL + H+N+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 634 GYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPI 693
D + L++E+ K S + Q L+ L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 694 VHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEK 753
+HRD+KP+N+L+ N E KLA+FGL++ F I S V F +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 754 SDVYSFGVVLLEIITSQAVIV--RNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811
D++S G + E+ + + + ++ + I + + ++ + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 812 SAWR------------AVELAVKCASRTSSERPNMNEV 837
A +L +R + E
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 20/240 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKE------FEAEVKLLMRVH--HR 627
+LG GGFG+VY G + D VA+K + + E EV LL +V
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 628 NLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
+ L+ +F ++ LI E E+ L E + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHC-- 126
Query: 688 GCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFV 746
++HRDIK ENIL+ N E KL DFG + V T GT Y PE+
Sbjct: 127 -HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIR 182
Query: 747 TD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805
+ + V+S G++L +++ I +E I Q + ++++ CL
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-38
Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 34/281 (12%)
Query: 571 ITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKML------SSSSGQGFKEFEAEVKLL 621
+ D ++ + LG G F V G Q A K + SS G ++ E EV +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 622 MRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQG 681
+ H N+ L + ++ LI E +A G L L++++ +L+ E + G
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNG 125
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTEN----LEAKLADFGLSKVFPIGGTHVSTVVAGTP 737
+ YLH I H D+KPENI+L + K+ DFGL+ G + GTP
Sbjct: 126 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 180
Query: 738 GYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTVTNMIAKGDI 796
++ PE + L ++D++S GV+ +++ + + + E + + V
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEV 837
N A + + + +R + +
Sbjct: 241 SNTSAL-------------AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 1e-35
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 15/220 (6%)
Query: 557 EFENRHFTYSEVLKITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS---SGQG 610
+F + T S+ D F+ K LG G FG V + G A+K+L +
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 611 FKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWER 670
+ E ++L V+ L L F +++N+ ++ EY+A G + L S
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPH 142
Query: 671 RLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730
A EYLH +++RD+KPEN+L+ + ++ DFG +K +
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRT 195
Query: 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQ 770
+ GTP L PE ++ N+ D ++ GV++ E+
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 573 DNFN--KVLGKGGFGTVYHGYL----DDGTQVAVKMLS----SSSGQGFKEFEAEVKLLM 622
+NF KVLG G +G V+ D G A+K+L + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 623 RV-HHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQG 681
+ L L F + + LI +Y+ G L LS + T + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLD 741
+ L K I++RDIK ENILL N L DFGLSK F T + GT Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 742 PEYFVTDW--LNEKSDVYSFGVVLLEIIT 768
P+ ++ D +S GV++ E++T
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLT 227
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 6e-33
Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 573 DNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRN 628
D++ + LG+G + V+ + + +V VK+L K+ + E+K+L + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 629 LTNLVGYFIE--DNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLH 686
+ L + L++E++ N + KQL TL+ + + L+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH 146
Query: 687 IGCKPPIVHRDIKPENILLT-ENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYF 745
I+HRD+KP N+++ E+ + +L D+GL++ + G + V + + PE
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELL 201
Query: 746 VTDWL-NEKSDVYSFGVVLLEIIT 768
V + + D++S G +L +I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIF 225
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-33
Identities = 60/301 (19%), Positives = 107/301 (35%), Gaps = 32/301 (10%)
Query: 563 FTYSEVLKITDNFN------KVLGKGGFGTVYHGY-LDDGTQVAVKML--SSSSGQGFKE 613
F EV K + +G G +G V G +VA+K L S K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 614 FEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDE--KASTLSWERR 671
E++LL + H N+ L+ F D + ++ + K L +R
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 672 LQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731
+ +GL Y+H I+HRD+KP N+ + E+ E K+ DFGL++ + ++
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAV-IVRNENENIHIIQTVTNM 790
V + D++S G ++ E+IT + + + + + I VT
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 791 IAKGDIENIVDSCLRGGFEIESAWR--------------AVELAVKCASRTSSERPNMNE 836
++ + + + AV L K + +R E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 837 V 837
Sbjct: 298 A 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-31
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 20/237 (8%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLV 633
K +G G G V Y VA+K LS + K E+ L+ V+H+N+ +L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 634 GYFI------EDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHI 687
F E ++ L+ E M + + + ER + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLH- 136
Query: 688 GCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVT 747
I+HRD+KP NI++ + K+ DFGL++ G + + T T Y PE +
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILG 192
Query: 748 DWLNEKSDVYSFGVVLLEIITSQA-VIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803
E D++S G ++ E++ + R+ + + + ++ + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 6e-29
Identities = 63/304 (20%), Positives = 123/304 (40%), Gaps = 38/304 (12%)
Query: 563 FTYSEVLK----ITDNFN--KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSS--SGQGFKE 613
F E+ K + + + +G G +G+V + G +VAVK LS S K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 614 FEAEVKLLMRVHHRNLTNLVGYF-----IEDNNMGLIYEYMANGNLKQLLSDEKASTLSW 668
E++LL + H N+ L+ F +E+ N + ++ +L ++ +K L+
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTD 120
Query: 669 ERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728
+ + +GL+Y+H I+HRD+KP N+ + E+ E K+ DFGL++
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE 174
Query: 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIV-RNENENIHIIQTV 787
++ VA N+ D++S G ++ E++T + + + + + +I +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 788 TNMIAKGDIENIVDSCLRGGFEIESAWR--------------AVELAVKCASRTSSERPN 833
++ I R + + AV+L K S +R
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 834 MNEV 837
+
Sbjct: 295 AAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 3e-26
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 577 KVLGKGGFGTVYHGY-LDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVG- 634
+ LG G F TV+ + + T VA+K++ + E E+KLL RV+ + T
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 77
Query: 635 -------------YFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQG 681
+ + ++ + NL L+ + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 682 LEYLHIGCKPPIVHRDIKPENILLTEN------LEAKLADFGLSKVFPIGGTHVSTVVAG 735
L+Y+H + I+H DIKPEN+L+ ++ K+AD G + + T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----Q 191
Query: 736 TPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQ 770
T Y PE + +D++S ++ E+IT
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.0 bits (238), Expect = 3e-23
Identities = 30/158 (18%), Positives = 54/158 (34%), Gaps = 19/158 (12%)
Query: 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS----------GQGFKEFEAEVKLLM 622
D K++G+G V++ Y + + VK G F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 623 RVHHRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGL 682
R R L L G + Y + N L +L+ ++ + E ++ + +
Sbjct: 62 RNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 683 EYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSK 720
+ IVH D+ N+L++E + DF S
Sbjct: 117 AKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 26/158 (16%), Positives = 47/158 (29%), Gaps = 5/158 (3%)
Query: 351 NAFEVYMEKDFSQSETLHTDVDAVMNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGND 410
N + + L T + N + +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ + + + LDL NN + G +P+ L++L+FL LN+ N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 471 KFTGPIPVELMEKSKNGSLQ-LSVGDNEELCSSSSDSC 507
G IP + + +N+ LC S +C
Sbjct: 279 NLCGEIP----QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 35/111 (31%)
Query: 369 TDVDAVMNMKKMYG---VKRNWQ--GDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSG 423
D A++ +KK G +W D C +W G+ C R+ +L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCD-TDTQTYRVNNL------ 55
Query: 424 LTGEIAPYLSNLTLIQSLDLSNNSLSGN--VPEFLSRLQFLRVLNLKGNKF 472
DLS +L +P L+ L +L L + G
Sbjct: 56 ------------------DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 1e-09
Identities = 19/122 (15%), Positives = 45/122 (36%), Gaps = 8/122 (6%)
Query: 375 MNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSN 434
+ ++ + + + L ++ + L L + ++ +S+
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 435 LTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494
LT +Q L +NN +S L+ L + L+ N+ + P+ + + QL +
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRIT----QLGLN 381
Query: 495 DN 496
D
Sbjct: 382 DQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 1e-05
Identities = 11/69 (15%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
+ L + +T + ++L + +L + + + L L +N N+ T
Sbjct: 25 MKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD 80
Query: 475 PIPVELMEK 483
P++ + K
Sbjct: 81 ITPLKNLTK 89
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 22/95 (23%), Positives = 38/95 (40%), Gaps = 7/95 (7%)
Query: 398 SWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGN 451
+ CS G + PP L+L ++ +T NL + +L L NN +S
Sbjct: 11 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 452 VPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKN 486
P + L L L L N+ +P ++ + +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQE 104
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 27/146 (18%), Positives = 45/146 (30%), Gaps = 4/146 (2%)
Query: 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475
+ S GL ++ L LDL NN ++ L+ L L L NK +
Sbjct: 14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 476 IPVELMEKSKNGSLQLSVGDNEELCSSSSDSCKK-EKKNMFVIPLVASAVSLLFFLTALA 534
P K L LS +EL + ++ + + S + L + +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 535 MIWWSLKRRKDRAAILNAHGSLEFEN 560
+ LK L +
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIR 156
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 15/81 (18%), Positives = 31/81 (38%), Gaps = 5/81 (6%)
Query: 416 SLNLSSSGLTGEIAPYL-SNLTLIQSLDLSNNSLSG----NVPEFLSRLQFLRVLNLKGN 470
SL++ L+ L L Q + L + L+ ++ L L LNL+ N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 471 KFTGPIPVELMEKSKNGSLQL 491
+ +++ + S ++
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 19/93 (20%), Positives = 30/93 (32%), Gaps = 9/93 (9%)
Query: 403 NCSYKGNDPPRIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGNVPEFLSR 458
C G + L L+ ++ +A L ++ LDLSNN L L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 459 -----LQFLRVLNLKGNKFTGPIPVELMEKSKN 486
L L L ++ + L K+
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 19/63 (30%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 438 IQSLDLSNNSLSGN-VPEFLSRLQFLRVLNLKGNKFTGPIPVELMEK-SKNGSLQ-LSVG 494
IQSLD+ LS E L LQ +V+ L T ++ N +L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 495 DNE 497
NE
Sbjct: 64 SNE 66
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 10/130 (7%)
Query: 375 MNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSN 434
+ VK C S N +I + L +G+
Sbjct: 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL---QISNNRLEDAGVRELCQGLGQP 367
Query: 435 LTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFTGPIPVELME--KSKNGS 488
++++ L L++ +S + + L LR L+L N ++L+E +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 489 LQ-LSVGDNE 497
L+ L + D
Sbjct: 428 LEQLVLYDIY 437
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 14/63 (22%), Positives = 25/63 (39%), Gaps = 9/63 (14%)
Query: 412 PRIISLNLSSSGLTGEIAPYLS-----NLTLIQSLDLSNNSLSGNVPEFLSRLQF----L 462
+ L+LS++ L L L++ L L + S + + L L+ L
Sbjct: 397 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
Query: 463 RVL 465
RV+
Sbjct: 457 RVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 10/61 (16%), Positives = 20/61 (32%), Gaps = 4/61 (6%)
Query: 412 PRIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNL 467
+ + L GLT I+ L + L+L +N L + + +
Sbjct: 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86
Query: 468 K 468
+
Sbjct: 87 Q 87
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 19/100 (19%), Positives = 34/100 (34%), Gaps = 8/100 (8%)
Query: 375 MNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYLSN 434
+ + P + + PP + LN+S++ L E+
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR 305
Query: 435 LTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
L + L S N L+ VPE L + L+++ N
Sbjct: 306 L---ERLIASFNHLA-EVPELPQNL---KQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLN 466
PPR+ L S + L E+ NL + L + N L P+ ++ LR+ +
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQNL---KQLHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 5/61 (8%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI 476
L L++ GL+ + +L +SL S NSL+ +PE L+ L V N +
Sbjct: 43 LELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 97
Query: 477 P 477
P
Sbjct: 98 P 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 5e-06
Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 6/104 (5%)
Query: 414 IISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGN-VPEFLSRLQFLRVLNLKGNKF 472
+I+ S + +A + S + Q +DLSN+ + + + LS+ L+ L+L+G +
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 473 TGPIPVELMEKSKNGSLQ-LSVGDNEELCSSSSDSCKKEKKNMF 515
+ PI L +KN +L L++ + + +
Sbjct: 84 SDPIVNTL---AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 7e-06
Identities = 43/242 (17%), Positives = 78/242 (32%), Gaps = 12/242 (4%)
Query: 268 QFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIVPEYLFSFSTYRVK 327
F ++P + E L +N L +K + L E V + + R
Sbjct: 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163
Query: 328 PYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAVMNMKKMYGVKRNW 387
+E + T V M ++ + E + + + + V
Sbjct: 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 223
Query: 388 QGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLT--GEIAPYLSNLTLIQSLDLSN 445
+ + S+ + LS+ G + L N+ L Q+L L
Sbjct: 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL-QTLRLQY 282
Query: 446 NSLSGNVPEFL-----SRLQFLRVLNLKGNKFT--GPIPVELME-KSKNGSLQLS-VGDN 496
N + + L ++ L L L GN+F+ + E+ E S G +L + D
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 342
Query: 497 EE 498
EE
Sbjct: 343 EE 344
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 45/341 (13%), Positives = 97/341 (28%), Gaps = 22/341 (6%)
Query: 138 SIKLDNATAMEMKEIIHIPTENHVL--ICLVNTGLGTPFISALELRLLRNSSYETVSRSI 195
S+KLD T + K + + E+ + I L +GT L + E S
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS- 67
Query: 196 ALYKRYDYGSITNQTIRYKDDAYDRMWT-PREFPKTKKLSTSLPIRSGADDSYLPPSAVM 254
T R KD+ + + + K KL T + + P
Sbjct: 68 -----------DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 116
Query: 255 STAITPINGSHALQFYWEPKDPTAKYYVYMYFAEVEVLQDNQLREFNISKDGQILMEFIV 314
+ TP+ + P+ A + ++ I ++ +
Sbjct: 117 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 176
Query: 315 PEYLFSFSTYRVKPYSGAIIEFSLDRTERSTLPPIINAFEVYMEKDFSQSETLHTDVDAV 374
S + + E L + E+ + + T +
Sbjct: 177 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA-L 235
Query: 375 MNMKKMYGVKRNWQGDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTGEIAPYL-- 432
K + R + C A + ++ + + +L L + + + L
Sbjct: 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295
Query: 433 ---SNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN 470
+ + L+L+ N S + + ++ + +G
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 10/67 (14%), Positives = 23/67 (34%), Gaps = 8/67 (11%)
Query: 414 IISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVL 465
I +L +T E + L ++ + LS N++ + E ++ + L +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 466 NLKGNKF 472
Sbjct: 65 EFSDIFT 71
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTG 474
I NL +T + + L I + +N+ + + L + L L GNK T
Sbjct: 27 IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82
Query: 475 PIPVELM 481
P+ +
Sbjct: 83 IKPLANL 89
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 15/58 (25%), Positives = 19/58 (32%), Gaps = 3/58 (5%)
Query: 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
+ +N LT + P L L LS N L L L LNL +
Sbjct: 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 8/40 (20%), Positives = 13/40 (32%)
Query: 432 LSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNK 471
+ LD+S + L L+ LR + K
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 10/39 (25%), Positives = 18/39 (46%), Gaps = 2/39 (5%)
Query: 439 QSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIP 477
+ L L++ L+ V L +L + L+L N+ P
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP 37
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 22/102 (21%), Positives = 36/102 (35%), Gaps = 26/102 (25%)
Query: 417 LNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLS------------------- 457
L+L+ LT + +L L L+ LDLS+N L P +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 458 --RLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ-LSVGDN 496
L L+ L L N+ ++ + L L++ N
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPR--LVLLNLQGN 100
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.002
Identities = 13/37 (35%), Positives = 16/37 (43%), Gaps = 1/37 (2%)
Query: 439 QSLDLSNNSL-SGNVPEFLSRLQFLRVLNLKGNKFTG 474
Q L L NN L + L L +LNL+GN
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 4/52 (7%)
Query: 424 LTGEI---APYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKF 472
LT E+ A +N + LDL + + + L ++ N+
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 858 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.1 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.07 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.97 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.79 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.74 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.65 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.57 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.51 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.49 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.3 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.23 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.23 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.17 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.04 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.03 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.01 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 97.98 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.83 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.83 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 97.82 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.78 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 97.62 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.44 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.43 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 97.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 96.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 96.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.47 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.12 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.04 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.66 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.21 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 94.68 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 94.48 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 94.22 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.88 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 89.91 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 80.95 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=413.01 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=200.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..++..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 345789999999999999999999999999754 3445789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..++|..++.++.|||+||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 87 L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 87 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 999987543 46899999999999999999999 88999999999999999999999999999988765544444456
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.||+.|+|||.+.+..++.++|||||||++|||+|++.|+..... ...+...+ ..+. ....+....
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i----~~~~---------~~~~p~~~~ 228 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDI----STGF---------RLYKPRLAS 228 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHH----HHTC---------CCCCCTTSC
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHH----HhcC---------CCCCccccC
Confidence 789999999999999999999999999999999996555443221 11222222 2211 111122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
.++.+++.+||+.+|++||||+||+++|+++.+
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 578899999999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=411.86 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=211.6
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 4567899999999999999988999999997543 445789999999999999999999998754 56789999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.......++|.++++|+.||++||+||| +.+|+||||||+||||++++.+||+|||+|+.............
T Consensus 94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence 999987766667999999999999999999999 88999999999999999999999999999998765554445556
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIESA 813 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~ 813 (858)
.||+.|+|||.+.++.++.++|||||||++|||+||+.|+..... ...+.+ .+..+. ....+....
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~----~i~~~~---------~~~~p~~~~ 236 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQ----NLERGY---------RMVRPDNCP 236 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHH----HHHTTC---------CCCCCTTCC
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHH----HHHhcC---------CCCCcccCh
Confidence 789999999999989999999999999999999997766544322 111222 222221 111122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 814 WRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 814 ~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
.++.+++.+||+.+|++||||+||++.|++....
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 5688999999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-48 Score=416.16 Aligned_cols=267 Identities=25% Similarity=0.421 Sum_probs=205.4
Q ss_pred cCHHHHHHHHhhc-----------cccccccCceEEEEEEEC-CC---CEEEEEEeccCC-CcchHhHHHHHHHHHhccc
Q 043526 563 FTYSEVLKITDNF-----------NKVLGKGGFGTVYHGYLD-DG---TQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHH 626 (858)
Q Consensus 563 ~~~~el~~~t~~f-----------~~~LG~G~fG~Vy~~~~~-~g---~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~H 626 (858)
++|++..+++.+| .+.||+|+||+||+|.++ +| ..||||++.... ....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555566666555 358999999999999975 33 368999986543 3345689999999999999
Q ss_pred ceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc
Q 043526 627 RNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT 706 (858)
Q Consensus 627 pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~ 706 (858)
||||+++|+|..++..++||||+++|+|.+++.... ..++|.++++++.|||+||+||| +.+|+||||||+||||+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEEC
Confidence 999999999999999999999999999999887543 46899999999999999999999 88999999999999999
Q ss_pred CCCCEEEeeecCcccccCCCcce----eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccc
Q 043526 707 ENLEAKLADFGLSKVFPIGGTHV----STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENI 781 (858)
Q Consensus 707 ~~~~~kL~DFGla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~ 781 (858)
.++.+||+|||+++......... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||..... .
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~ 240 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--Q 240 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--H
Confidence 99999999999998775432221 122457899999999999999999999999999999998 8999865432 1
Q ss_pred cHHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHH
Q 043526 782 HIIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMME 848 (858)
Q Consensus 782 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~ 848 (858)
.+.. .+.++. +...+.....++.+++.+||+.+|++||||+||++.|+++++..
T Consensus 241 ~~~~----~i~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 241 DVIN----AIEQDY---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHH----HHHcCC---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 2222 222211 11123344567889999999999999999999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-48 Score=413.70 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=215.2
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||||+++|
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence 45688999999999999976 68899999997543 45678999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......++|..++.|+.||++||+||| +.+|+||||||+|||+++++.+||+|||+++............
T Consensus 99 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 175 (287)
T d1opja_ 99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175 (287)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred chHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence 9999998776678999999999999999999999 8899999999999999999999999999999876554444445
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..|++.|+|||.+.++.++.++|||||||++|||++|+.|+..... ... +...+..+ .....+...
T Consensus 176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~----~~~~i~~~---------~~~~~~~~~ 241 (287)
T d1opja_ 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQ----VYELLEKD---------YRMERPEGC 241 (287)
T ss_dssp EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHH----HHHHHHTT---------CCCCCCTTC
T ss_pred ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHH----HHHHHhcC---------CCCCCCccc
Confidence 5688999999999999999999999999999999998777654332 111 11222222 111222334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
..++.+|+.+||+.||++||||+||++.|+.+.++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 45788999999999999999999999999886543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=403.92 Aligned_cols=255 Identities=28% Similarity=0.488 Sum_probs=200.0
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence 345789999999999998743 5999998754 34456789999999999999999999998754 568999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-cee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~ 730 (858)
|+|.++++..+ ..++|.+++.|+.|||+||+||| +.+|+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 88 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 88 SSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 99999997543 46999999999999999999999 88999999999999999999999999999987654322 233
Q ss_pred ecccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 731 TVVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
....||+.|||||.+.+ ..++.++|||||||++|||+||+.||....... . +...+..+....... .
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~----~~~~~~~~~~~p~~~-----~ 233 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-Q----IIFMVGRGYLSPDLS-----K 233 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-H----HHHHHHHTSCCCCGG-----G
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-H----HHHHHhcCCCCCcch-----h
Confidence 45679999999999864 357899999999999999999999997543211 1 122222221111000 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
.+.....++.+++.+||+.+|++||||+||+++|+.+.
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12233457889999999999999999999999998854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=398.72 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=211.5
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.+.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 3568899999999999999989999999998653 345789999999999999999999999999999999999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeecc
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTVV 733 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 733 (858)
|.+++.... ..+++..+++++.|+++||+||| +.+|+||||||+|||+++++.+||+|||+++.............
T Consensus 86 l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 86 LLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp HHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred HHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 999976544 46889999999999999999999 88999999999999999999999999999987765544444456
Q ss_pred cCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 734 AGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 734 ~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
.||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ + ...+.++. +...+...
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~----~~~i~~~~---------~~~~p~~~ 226 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--T----AEHIAQGL---------RLYRPHLA 226 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--H----HHHHHTTC---------CCCCCTTC
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--H----HHHHHhCC---------CCCCcccc
Confidence 78999999999999999999999999999999998 788987554221 1 22222221 11112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
..++.+++.+||+.+|++|||++|++++|.+
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 4578899999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=402.12 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=211.3
Q ss_pred cccccCceEEEEEEEC---CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCCC
Q 043526 578 VLGKGGFGTVYHGYLD---DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANGN 653 (858)
Q Consensus 578 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~gs 653 (858)
.||+|+||+||+|.++ ++..||||+++.... ...++|.+|++++++++|||||+++|+|.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999864 456899999976543 345789999999999999999999999864 56889999999999
Q ss_pred hHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce--ee
Q 043526 654 LKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV--ST 731 (858)
Q Consensus 654 L~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~ 731 (858)
|.+++...+ ..+++.++++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 95 L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 95 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence 999986543 46899999999999999999999 8899999999999999999999999999999875443322 23
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
...||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... ++. ..+.++... ..+.
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~----~~i~~~~~~---------~~p~ 235 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGKRM---------ECPP 235 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTCCC---------CCCT
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCCC---------CCCC
Confidence 4468899999999999999999999999999999998 89999764422 222 223332211 1223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhcccccC
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARKKKELW 857 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~~~~~~ 857 (858)
....++.+|+.+||+.+|++||||.+|++.|+.....-.++.+....
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~~~~ 282 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccchhhc
Confidence 34457889999999999999999999999999977655555554443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=397.58 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=201.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
++.+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|++++++++|||||++++++.+++..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 34578999999999999975 79999999997543 33456799999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-cee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT-HVS 730 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~-~~~ 730 (858)
|+|.+++... ..+++.++..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+|+....... ...
T Consensus 88 g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 88 GELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp EEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999654 47999999999999999999999 88999999999999999999999999999997754332 223
Q ss_pred ecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 731 TVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
....||+.|+|||.+.+..+ +.++|||||||++|||+||+.||.........+... ...... ....
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~~--------~~~~ 229 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY--------LNPW 229 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCTT--------STTG
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCC--------CCcc
Confidence 45679999999999987765 578999999999999999999997654322221111 111000 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.||++|||++|++++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1224567899999999999999999999763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=398.02 Aligned_cols=250 Identities=27% Similarity=0.394 Sum_probs=202.7
Q ss_pred ccccccCceEEEEEEEC---CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 577 KVLGKGGFGTVYHGYLD---DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.||+|+||+||+|.++ .++.||||+++... ....++|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 35689999996542 2345679999999999999999999999864 567899999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce--
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV-- 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~-- 729 (858)
|+|.++++... .++|.++++++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999997543 6999999999999999999999 8899999999999999999999999999998775443332
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +...+.++.. ...
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~----~~~~i~~~~~---------~~~ 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E----VTAMLEKGER---------MGC 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTTCC---------CCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--H----HHHHHHcCCC---------CCC
Confidence 234568999999999999999999999999999999998 89999754321 1 2222333221 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
+.....++.+|+.+||+.||++||||++|++.|+....+
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 233345788999999999999999999999999886543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=398.36 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=202.3
Q ss_pred ccccccccCceEEEEEEECCC-----CEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYLDDG-----TQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
..++||+|+||.||+|.+++. ..||||+++.... ....+|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 457899999999999997532 3799999975433 3345799999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+.+|++.+.+.... ..++|.++++++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.......
T Consensus 91 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 91 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred cccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999886543 46999999999999999999999 88999999999999999999999999999987654322
Q ss_pred -ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 -HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 -~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......||+.|+|||.+.++.++.++|||||||++|||++|+.|+...... ..+. ..+.++. +.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~----~~i~~~~---------~~ 232 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVM----KAINDGF---------RL 232 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHH----HHHHTTC---------CC
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHH----HHHhccC---------CC
Confidence 2223456899999999999999999999999999999999977665443221 1122 2222221 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
..+.....++.+|+.+||+.+|++||+|+||++.|+++++...
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 2233345678899999999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=394.35 Aligned_cols=244 Identities=30% Similarity=0.424 Sum_probs=204.4
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 345689999999999999975 7899999998643 234457789999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 88 APLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 99999999997543 6899999999999999999999 8999999999999999999999999999998764332
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+ ...+.++.. ..
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~----~~~i~~~~~----------~~ 223 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QET----YKRISRVEF----------TF 223 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHH----HHHHHTTCC----------CC
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHH----HHHHHcCCC----------CC
Confidence 2345799999999999999999999999999999999999999965431 111 111222111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.....++.+++.+|++.||++|||++|++++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 22234578899999999999999999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=400.26 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=205.0
Q ss_pred hhccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++|||||+++++|.+ +..++||||+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 3556889999999999999998889999999654 3456789999999999999999999999854 5688999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......++|.+++.++.||++||+||| +.+|+||||||+||||++++.+||+|||+++............
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 9999998766667999999999999999999999 8899999999999999999999999999998775544444445
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..||+.|+|||++..+.++.++|||||||++|||+||+.|+...... ..+...+ ..+. ....+...
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i----~~~~---------~~~~~~~~ 239 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV----ERGY---------RMPCPPEC 239 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH----HTTC---------CCCCCTTS
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHH----HhcC---------CCCCCccc
Confidence 67899999999999999999999999999999999987776554322 1122222 1111 11122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTELKECLM 846 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~ 846 (858)
..++.+++.+||+.+|++||+|++|+++|++...
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 4578899999999999999999999999988653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=393.73 Aligned_cols=247 Identities=21% Similarity=0.382 Sum_probs=206.2
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+++|
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence 3457899999999999995 479999999998766666778999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 103 ~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp BHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred cHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 999987643 5899999999999999999999 88999999999999999999999999999987754332 2344
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIES 812 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~ 812 (858)
..||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .+.+......+... -..+...
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~--------~~~~~~~ 242 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTPE--------LQNPEKL 242 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSCC--------CSSGGGS
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCCC--------CCCcccC
Confidence 5799999999999999999999999999999999999999965331 11122222221100 0112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 813 AWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 813 ~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.+++.+|++.||++|||++|++++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 4578899999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=392.94 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=191.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeee--CCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--DNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey 648 (858)
++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+ ++..++||||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 34578999999999999964 799999999976532 335678999999999999999999999865 4568999999
Q ss_pred ccCCChHHHhhhcc--cCchhHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCcceEEcCCCCEEEeeecCcccccC
Q 043526 649 MANGNLKQLLSDEK--ASTLSWERRLQIAMDAAQGLEYLHIGC--KPPIVHRDIKPENILLTENLEAKLADFGLSKVFPI 724 (858)
Q Consensus 649 ~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~ 724 (858)
+++|+|.+++.... ...+++.+++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999996532 457999999999999999999999421 23599999999999999999999999999998754
Q ss_pred CCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .. +...+.++....
T Consensus 167 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~----~~~~i~~~~~~~------ 233 (269)
T d2java1 167 DTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KE----LAGKIREGKFRR------ 233 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH----HHHHHHHTCCCC------
T ss_pred CCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HH----HHHHHHcCCCCC------
Confidence 322 23346799999999999999999999999999999999999999975431 11 122222222211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.....++.+++.+||+.||++|||++|++++
T Consensus 234 ---~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 ---IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 122234578899999999999999999999763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=394.76 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=205.0
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 34578999999999999965 79999999998877777889999999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.... ..+++.++..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 95 ~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~ 169 (288)
T d2jfla1 95 AVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 169 (288)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence 9999986543 46999999999999999999999 8899999999999999999999999999997653221 11234
Q ss_pred ccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 733 VAGTPGYLDPEYFV-----TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 733 ~~gt~~y~APE~~~-----~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
..||+.|+|||.+. ...++.++|||||||++|||+||+.||...... .....+ . .+....+ .
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i---~-~~~~~~~-------~ 236 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKI---A-KSEPPTL-------A 236 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHH---H-HSCCCCC-------S
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHH---H-cCCCCCC-------C
Confidence 57999999999984 456789999999999999999999999754322 221111 1 1111110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.+.....++.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334578899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=401.46 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=204.6
Q ss_pred hccccccccCceEEEEEEECC-C-----CEEEEEEeccC-CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLDD-G-----TQVAVKMLSSS-SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~-g-----~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 645 (858)
.+.+.||+|+||+||+|+... + ..||||++... .......+.+|+.++.++ +|||||+++++|.+.+..++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 456899999999999998642 2 36999998654 334557899999999998 899999999999999999999
Q ss_pred EeeccCCChHHHhhhccc---------------------CchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 646 YEYMANGNLKQLLSDEKA---------------------STLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
|||+++|+|.++|+..+. ..++|.+++.++.||++||+||| +.+|+||||||+|||
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVL 196 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhccc
Confidence 999999999999976432 35899999999999999999999 889999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCcccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIH 782 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~ 782 (858)
++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||....... .
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~-~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-N 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-H
Confidence 999999999999999876544333 2234568999999999999999999999999999999998 899987543221 1
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKE 843 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~ 843 (858)
+ ...+..+. +...+.....++.+|+.+||+.+|++||||+||+++|..
T Consensus 276 ~----~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 276 F----YKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp H----HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1 12222221 111223344578899999999999999999999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=385.01 Aligned_cols=245 Identities=26% Similarity=0.430 Sum_probs=196.8
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeee----CCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE----DNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~ 646 (858)
.|.+.||+|+||+||+|... +++.||+|++.... ....+.|.+|++++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45578999999999999975 78999999987542 3345678999999999999999999999875 34578999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCcceEEc-CCCCEEEeeecCccccc
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPP--IVHRDIKPENILLT-ENLEAKLADFGLSKVFP 723 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--IvH~DLk~~NILl~-~~~~~kL~DFGla~~~~ 723 (858)
||+++|+|.+++.... .+++.++..++.||++||+||| +.+ |+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999997643 6899999999999999999999 666 99999999999997 57899999999998653
Q ss_pred CCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.. ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... .+...+..+.....++
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~-- 235 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVKPASFD-- 235 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCCCGGGG--
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHHHcCCCCcccC--
Confidence 32 2334679999999998865 58999999999999999999999996543211 1122222221111111
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+|++.||++|||++|++++
T Consensus 236 ------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1123468899999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=392.54 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=200.0
Q ss_pred hhccccccccCceEEEEEEECC----CCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 573 DNFNKVLGKGGFGTVYHGYLDD----GTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
+++.+.||+|+||.||+|++.. +..||||.++..... ..+.|.+|++++++++|||||++++++. ++..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence 3456899999999999998642 457899998754433 3567999999999999999999999985 567899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.+++.... ..+++.+++.++.||++||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp CCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred eccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999999876543 46899999999999999999999 89999999999999999999999999999988765444
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
.......||+.|+|||.+.+..++.++|||||||++|||+| |.+||...... .+... +.++...
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~----i~~~~~~--------- 228 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGERL--------- 228 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCCC---------
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCCC---------
Confidence 44455678999999999999999999999999999999998 78888654422 22222 2222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhh
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELAR 851 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~ 851 (858)
..+.....++.+++.+||+.||++|||++||+++|+++++++.++
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~q 273 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhCC
Confidence 122334457889999999999999999999999999988776553
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=387.86 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=199.4
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeee-CCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE-DNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||.||+|.+ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.+ ++..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 4567899999999999998 5789999999654 345789999999999999999999999865 45689999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
+|.+++.......++|..+++|+.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~ 159 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT 159 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----Ccc
Confidence 9999998766567999999999999999999999 889999999999999999999999999999875432 223
Q ss_pred ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCHH
Q 043526 733 VAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEIE 811 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~ 811 (858)
..++..|+|||++.++.++.++|||||||++|||+| |+.|+.... ..++..++ .++. +...+..
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i----~~~~---------~~~~~~~ 224 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRV----EKGY---------KMDAPDG 224 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHH----TTTC---------CCCCCTT
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HcCC---------CCCCCcc
Confidence 457899999999999999999999999999999998 677765433 22333332 2221 1112233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 812 SAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 812 ~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...++.+++.+||+.||.+||||+|++++|+++...
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 345788999999999999999999999999997554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=401.85 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=202.6
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCC-CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS-GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||+||+|+.. +|+.||+|+++... .....++.+|+++|++++|||||+++++|.+++..++||||+++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3478999999999999964 79999999997653 334567899999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCK-PPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
+|.+++.... .+++..+..++.|+++||+||| + .+|+||||||+|||+++++.+||+|||+|+..... ...
T Consensus 90 ~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~ 161 (322)
T d1s9ja_ 90 SLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 161 (322)
T ss_dssp EHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---TC-
T ss_pred cHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---ccc
Confidence 9999997653 6899999999999999999999 5 48999999999999999999999999999876432 223
Q ss_pred cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHH--HHH------------------
Q 043526 732 VVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVT--NMI------------------ 791 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~--~~~------------------ 791 (858)
...||+.|+|||++.+..++.++||||+||+++||++|+.||............... ...
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 457999999999999999999999999999999999999999765432211110000 000
Q ss_pred ----hcCCchhhhchhhcCC---C-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 792 ----AKGDIENIVDSCLRGG---F-EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 792 ----~~~~~~~~~d~~l~~~---~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......+..+...... . ......++.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000011111111100 0 11124578899999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=391.42 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=205.6
Q ss_pred hccccccccCceEEEEEEECCC----CEEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeC-CeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDG----TQVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-NNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g----~~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E 647 (858)
+|.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|+|.+. +..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 5567899999999999997532 36899999753 344567899999999999999999999998764 57899999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+++|+|.++++... ..+++..+++++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999987543 46788999999999999999999 88999999999999999999999999999987654322
Q ss_pred c---eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhh
Q 043526 728 H---VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCL 804 (858)
Q Consensus 728 ~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l 804 (858)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+...... .++... +.++...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~----i~~g~~~------- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVY----LLQGRRL------- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTCCC-------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHH----HHcCCCC-------
Confidence 2 222356899999999999999999999999999999999988887643311 111121 2222111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 805 RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 805 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
..+.....++.+++.+||+.||++||+|+||+++|+++++.
T Consensus 254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11222345788999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=391.19 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=202.6
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEee
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
+.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 345689999999999999974 7999999998643 234457799999999999999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc-
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT- 727 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~- 727 (858)
+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 90 ~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999987654 6999999999999999999999 89999999999999999999999999999998754332
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..+ ...+..+.. .
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~----~~~i~~~~~----------~ 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLI----FQKIIKLEY----------D 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH----HHHHHTTCC----------C
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHH----HHHHHcCCC----------C
Confidence 223345799999999999999999999999999999999999999975431 111 111222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
++.....++.+++.+||+.||++|||++|++++
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 122334578899999999999999999997553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=385.72 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=202.7
Q ss_pred hccccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHH--HHHHHHhcccceeeeeeeeeeeCC----eeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEA--EVKLLMRVHHRNLTNLVGYFIEDN----NMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~--E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~E 647 (858)
-+.+.||+|+||.||+|++ +|+.||||+++... .+++.. |+..+..++|||||+++++|.+++ .+++|||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3457899999999999997 68999999996442 234444 455556789999999999998764 5789999
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcC-----CCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIG-----CKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
|+++|+|.+++++. .++|.++++++.|+|.||+|||+. .+++|+||||||+||||++++.+||+|||+++..
T Consensus 82 y~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999754 589999999999999999999942 1369999999999999999999999999999987
Q ss_pred cCCCcce---eecccCCCCccCccccccCC------CCCchhHHHHHHHHHHHHhCCCccccCCCccc---------cHH
Q 043526 723 PIGGTHV---STVVAGTPGYLDPEYFVTDW------LNEKSDVYSFGVVLLEIITSQAVIVRNENENI---------HII 784 (858)
Q Consensus 723 ~~~~~~~---~~~~~gt~~y~APE~~~~~~------~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~---------~l~ 784 (858)
....... .....||+.|+|||++.... ++.++|||||||++|||+||..|+........ ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5543322 23467999999999987542 56789999999999999999988754332110 111
Q ss_pred HHHHHHHhcCCchhhhchhhcCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhh
Q 043526 785 QTVTNMIAKGDIENIVDSCLRGGF-EIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELA 850 (858)
Q Consensus 785 ~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~ 850 (858)
.........+.. ++.+.... +.+....+.+++.+||+.||++||||.||++.|+++.+++..
T Consensus 239 ~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 222222222111 11111111 234566789999999999999999999999999998777654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-44 Score=387.45 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=188.6
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
+++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|++++++++|||||++++++.+++..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 455689999999999999975 799999999975432 334568899999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc---CCCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT---ENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~---~~~~~kL~DFGla~~~~~~~~ 727 (858)
+|+|.+++... ..+++.++..++.||+.||+||| +.+|+||||||+|||+. +++.+||+|||+++......
T Consensus 91 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 91 GGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp SCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999654 46999999999999999999999 89999999999999995 57899999999998764332
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+..+... ....
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~----~i~~~~~~------~~~~ 231 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFE----QILKAEYE------FDSP 231 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH----HHHTTCCC------CCTT
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHH----HHhccCCC------CCCc
Confidence 223457999999999999999999999999999999999999999754311 1111 11111110 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......++.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 112334578899999999999999999999884
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-44 Score=389.84 Aligned_cols=242 Identities=24% Similarity=0.405 Sum_probs=198.3
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
...+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|++++++++|||||++++++.+++..++||||+
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence 3457899999999999996 47899999999765432 3456899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|..++... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 98 LGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 999998776543 47999999999999999999999 889999999999999999999999999999875432
Q ss_pred eecccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcC
Q 043526 730 STVVAGTPGYLDPEYFVT---DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRG 806 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~---~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~ 806 (858)
....||+.|+|||.+.+ +.++.++|||||||++|||++|+.||..... .+........ .....
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~~~-~~~~~------- 234 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQN-ESPAL------- 234 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHS-CCCCC-------
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhC-CCCCC-------
Confidence 33569999999999863 4689999999999999999999999965331 1112222111 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043526 807 GFEIESAWRAVELAVKCASRTSSERPNMNEVVT 839 (858)
Q Consensus 807 ~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~ 839 (858)
.+......+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223457889999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-44 Score=387.31 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=206.4
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCCc-chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|++++++++||||++++++|...+..++||
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 34578999999999999863 4678999999765433 3567999999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc----------------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceE
Q 043526 647 EYMANGNLKQLLSDEK----------------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENIL 704 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NIL 704 (858)
||+++|+|.++++... ...++|.+++.|+.|++.||+||| +.+|+||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceE
Confidence 9999999999996432 234889999999999999999999 899999999999999
Q ss_pred EcCCCCEEEeeecCcccccCCCc-ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCC-ccccCCCcccc
Q 043526 705 LTENLEAKLADFGLSKVFPIGGT-HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA-VIVRNENENIH 782 (858)
Q Consensus 705 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~-p~~~~~~~~~~ 782 (858)
++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|.. ||..... ..
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--~e 250 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--EE 250 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--HH
Confidence 99999999999999987644322 22334568899999999999999999999999999999999964 5554321 12
Q ss_pred HHHHHHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 043526 783 IIQTVTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECL 845 (858)
Q Consensus 783 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~ 845 (858)
+. ..+.++.... .+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 251 ~~----~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VI----YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH----HHHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22 2233332211 12233457889999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=387.97 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=201.7
Q ss_pred hccccccccCceEEEEEEEC-CCC----EEEEEEeccC-CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEe
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGT----QVAVKMLSSS-SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 647 (858)
++.+.||+|+||+||+|.+. +|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++|
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence 34579999999999999964 454 5899988653 345568899999999999999999999999865 5678899
Q ss_pred eccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCc
Q 043526 648 YMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 648 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~ 727 (858)
|+.+|+|.+.+... ...+++..+++++.|||+||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 91 LMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp CCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred eccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999999988754 357899999999999999999999 88999999999999999999999999999998754433
Q ss_pred ce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 728 HV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 728 ~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.. .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+...+ ..+. +
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i----~~~~---------~ 231 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL----EKGE---------R 231 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHH----HHTC---------C
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCC---------C
Confidence 32 334568999999999999999999999999999999999 77887654322 222222 2221 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.....++.+++.+||+.+|++|||++||+++|+.+...
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 112233445788999999999999999999999999887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=385.36 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=197.5
Q ss_pred hhccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeC-CeeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIED-NNMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~~~ 643 (858)
+.+.+.||+|+||.||+|.+. +++.||||+++.... ...+++.+|.+.+.++ +|+||+.+++++.+. +..+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 345689999999999999853 356899999975433 3456788888888877 689999999998765 4689
Q ss_pred EEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 644 LIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
+||||+++|+|.++++..+ ...++|.+++.++.||++||+||| +.+|+||||||+||||++++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCC
Confidence 9999999999999997543 235889999999999999999999 89999999999999999999
Q ss_pred CEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCC-CccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQ-AVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~-~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||...... .. +
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~----~ 246 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EE----F 246 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HH----H
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HH----H
Confidence 9999999999876543332 233457999999999999999999999999999999999975 466543321 11 2
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.++... ..+.....++.+++.+||+.||++|||++||+++|+++++.
T Consensus 247 ~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 CRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2222222211 11223345788999999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-43 Score=390.58 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=205.8
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 455689999999999999964 7999999999876655667899999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC--CCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE--NLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~--~~~~kL~DFGla~~~~~~~~~~ 729 (858)
|+|.+++.... ..+++.++..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 108 g~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 181 (350)
T d1koaa2 108 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 181 (350)
T ss_dssp CBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--C
T ss_pred CCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--c
Confidence 99999996443 36999999999999999999999 899999999999999964 6789999999998765432 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|||||.+.+..++.++|||||||++|||+||+.||..... ..+ .... ..+... +.....
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~---~~~i-~~~~~~------~~~~~~ 249 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DET---LRNV-KSCDWN------MDDSAF 249 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHH-HHTCCC------SCCGGG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHH---HHHH-HhCCCC------CCcccc
Confidence 3446799999999999999999999999999999999999999965431 111 1111 111110 000001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+++.+||+.||++|||++|++++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234568899999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=379.61 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=203.0
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC------cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG------QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 645 (858)
+++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 355688999999999999974 799999999864321 2357799999999999999999999999999999999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC----CEEEeeecCccc
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL----EAKLADFGLSKV 721 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~----~~kL~DFGla~~ 721 (858)
|||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus 92 ~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999997653 6999999999999999999999 89999999999999999876 499999999987
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ... ..+..+... . .
T Consensus 167 ~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~----~~i~~~~~~-~-~ 236 (293)
T d1jksa_ 167 IDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL----ANVSAVNYE-F-E 236 (293)
T ss_dssp CTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHTTCCC-C-C
T ss_pred cCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHH----HHHHhcCCC-C-C
Confidence 654322 23456899999999999999999999999999999999999999754311 111 111221110 0 0
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... .......+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 01123467899999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-43 Score=389.07 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=206.5
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
+++.+.||+|+||.||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 345689999999999999964 7999999999876555567789999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEc--CCCCEEEeeecCcccccCCCcce
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLT--ENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~--~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
|+|.+++... ...+++.+++.|+.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+...... .
T Consensus 111 g~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 111 GELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp CBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred ChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 9999987643 346999999999999999999999 89999999999999998 67899999999999875433 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++||||+||++|||+||+.||..... ..+... +..+... ......
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~----i~~~~~~------~~~~~~ 252 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQN----VKRCDWE------FDEDAF 252 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH----HHHCCCC------CCSSTT
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCCCC------CCcccc
Confidence 3445789999999999999999999999999999999999999965432 111111 1111110 011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.....++.+|+.+||+.||++|||++|++++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234578899999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=385.94 Aligned_cols=256 Identities=30% Similarity=0.463 Sum_probs=203.8
Q ss_pred hccccccccCceEEEEEEEC-CCC--EEEEEEeccC-CCcchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGT--QVAVKMLSSS-SGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~--~vAVK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
++.+.||+|+||+||+|+++ +|. .||||+++.. .....++|.+|+++++++ +|||||+++++|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 44688999999999999975 454 5788887643 344567899999999998 799999999999999999999999
Q ss_pred ccCCChHHHhhhc--------------ccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEe
Q 043526 649 MANGNLKQLLSDE--------------KASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLA 714 (858)
Q Consensus 649 ~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~ 714 (858)
+++|+|.++|+.. ....++|.++++++.|||+||.||| +.+|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence 9999999999754 2357999999999999999999999 8899999999999999999999999
Q ss_pred eecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCC-ccccCCCccccHHHHHHHHHhc
Q 043526 715 DFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQA-VIVRNENENIHIIQTVTNMIAK 793 (858)
Q Consensus 715 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~-p~~~~~~~~~~l~~~v~~~~~~ 793 (858)
|||+++...... ......||..|+|||.+..+.++.++|||||||++|||++|.. ||.... .. + +...+.+
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~---~-~~~~i~~ 241 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CA---E-LYEKLPQ 241 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HH---H-HHHHGGG
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HH---H-HHHHHHh
Confidence 999998654222 1223468999999999999999999999999999999999865 454322 11 1 1122222
Q ss_pred CCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 794 GDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 794 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+. +...+.....++.+|+.+||+.||++||||+||+++|++++++..
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 242 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 21 111223344578899999999999999999999999999876543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=383.11 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=211.6
Q ss_pred HhhccccccccCceEEEEEEE------CCCCEEEEEEeccCCCc-chHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeE
Q 043526 572 TDNFNKVLGKGGFGTVYHGYL------DDGTQVAVKMLSSSSGQ-GFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 572 t~~f~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 643 (858)
...+.+.||+|+||.||+|++ .+++.||||+++..... ...+|.+|+.+++++ +|||||+++++|.+++..+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 345678999999999999985 35678999999765433 445789999999999 6999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcc----------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC
Q 043526 644 LIYEYMANGNLKQLLSDEK----------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE 707 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~ 707 (858)
+||||+++|+|.++++... ...+++..+++++.||++||+||| +++|+||||||+|||++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccc
Confidence 9999999999999997543 235889999999999999999999 899999999999999999
Q ss_pred CCCEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHH
Q 043526 708 NLEAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQT 786 (858)
Q Consensus 708 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~ 786 (858)
++.+|++|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+|++.|+.........+...
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999987654333 3344678999999999999999999999999999999999655544333222222222
Q ss_pred HHHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 787 VTNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 787 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
+. ++ .+...+......+.+|+.+||+.||++||||+||+++|++.+.+
T Consensus 261 i~----~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 261 IK----EG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----HT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hh----cC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22 21 11122233345788999999999999999999999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=378.51 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=194.4
Q ss_pred hccccccccCceEEEEEEEC--CC--CEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--DG--TQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--~g--~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
++.+.||+|+||.||+|++. ++ ..||||++... .....++|.+|++++++++||||++++|+|.+ +..++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 34578999999999999864 23 37899998754 23345789999999999999999999999965 4678999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++|+|.+++.... ..+++..++.++.|||+||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp ECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887543 46999999999999999999999 8899999999999999999999999999999875543
Q ss_pred cce--eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 727 THV--STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 727 ~~~--~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+.......++..
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----~~~~~~i~~~~~~------- 233 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGER------- 233 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCCC-------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----HHHHHHHHhCCCC-------
Confidence 322 233457889999999999999999999999999999998 8999865431 1122222222211
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKEC 844 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~ 844 (858)
...+......+.+++.+||..||++||||+||++.|+++
T Consensus 234 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 --LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111222335788999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=383.06 Aligned_cols=245 Identities=28% Similarity=0.406 Sum_probs=204.5
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
++.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 4568999999999999996 48999999999743 2334677899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 88 ~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~ 161 (337)
T d1o6la_ 88 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp TTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred CCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc-c
Confidence 9999999997654 6889999999999999999999 89999999999999999999999999999987643322 2
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .+. ..+..+.+ .++
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~----~~i~~~~~----------~~p 225 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF----ELILMEEI----------RFP 225 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHCCC----------CCC
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHH----HHHhcCCC----------CCC
Confidence 33467999999999999999999999999999999999999999764421 111 11222211 122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
.....++.+++.+||+.||++||+ ++|++++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 233456889999999999999995 7888774
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-43 Score=379.71 Aligned_cols=242 Identities=27% Similarity=0.407 Sum_probs=202.6
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 44688999999999999974 7999999999643 2344678999999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
++|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 87 EGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999987654 6788899999999999999999 899999999999999999999999999999876532
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|+|||.+.+..++.++||||+||++|||+||+.||...... +.... +..+.. ..+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~-i~~~~~----------~~p 221 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KTYEK-ILNAEL----------RFP 221 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH-HHHCCC----------CCC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-----HHHHH-HHcCCC----------CCC
Confidence 23467999999999999999999999999999999999999999754311 11111 111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....++.+++.+|+..||.+|| +++|++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 22345688999999999999996 89999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=380.00 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=204.7
Q ss_pred hccccccccCceEEEEEEEC--------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhc-ccceeeeeeeeeeeCCeeE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD--------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRV-HHRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 643 (858)
.+.+.||+|+||.||+|+.. ++..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 45688999999999999853 235799999976543 3457889999999888 7999999999999999999
Q ss_pred EEEeeccCCChHHHhhhcc--------------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC
Q 043526 644 LIYEYMANGNLKQLLSDEK--------------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL 709 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~ 709 (858)
+||||+++|+|.+++.... ...+++.++++++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTC
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCC
Confidence 9999999999999997543 246899999999999999999999 89999999999999999999
Q ss_pred CEEEeeecCcccccCCCcc-eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHh-CCCccccCCCccccHHHHH
Q 043526 710 EAKLADFGLSKVFPIGGTH-VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIIT-SQAVIVRNENENIHIIQTV 787 (858)
Q Consensus 710 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~Ellt-G~~p~~~~~~~~~~l~~~v 787 (858)
.+||+|||+++........ ......|++.|+|||.+.++.++.++|||||||++|||++ |.+||..... ..+
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------~~~ 246 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EEL 246 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------HHH
Confidence 9999999999977544322 2344568899999999999999999999999999999998 6777754331 112
Q ss_pred HHHHhcCCchhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHH
Q 043526 788 TNMIAKGDIENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMM 847 (858)
Q Consensus 788 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~ 847 (858)
...+.++.. ...+.....++.+++.+|++.+|++|||+.||++.|++++..
T Consensus 247 ~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 FKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 222323211 111223345788999999999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=379.32 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=207.8
Q ss_pred hccccccccCceEEEEEEEC------CCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD------DGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++||||++++++|..++..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 44578999999999999863 367899999975432 34456899999999999999999999999999999999
Q ss_pred eeccCCChHHHhhhcc--------cCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecC
Q 043526 647 EYMANGNLKQLLSDEK--------ASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGL 718 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGl 718 (858)
||+++|+|.+++...+ ...+++.++.+++.|+|+||+||| +.+|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999987543 134689999999999999999999 88999999999999999999999999999
Q ss_pred cccccCCCcce-eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCC-CccccCCCccccHHHHHHHHHhcCCc
Q 043526 719 SKVFPIGGTHV-STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQ-AVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 719 a~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~-~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
++......... .....||+.|+|||.+.+..++.++|||||||++|||+||+ .|+.... . .+... .+.++..
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~---~~~~~-~i~~~~~ 253 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--N---EQVLR-FVMEGGL 253 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--H---HHHHH-HHHTTCC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--H---HHHHH-HHHhCCC
Confidence 98765433222 23346899999999999999999999999999999999986 5554332 1 12222 2222221
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
.. .+......+.+++.+||+.+|++||||+||+++|++.++...
T Consensus 254 ~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 254 LD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred CC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 11 122233578999999999999999999999999988665443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-42 Score=369.09 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=199.9
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc---chHhHHHHHHHHHhcccceeeeeeeeeeeCCe----eEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ---GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNN----MGLI 645 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~~lV 645 (858)
.+.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++||||+++++++...+. .++|
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence 4568999999999999996 48999999999765332 34578999999999999999999999987543 7899
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+++|+|.+++.... .+++.+++.++.||++||+||| +.+|+||||||+|||++.++..+++|||.++.....
T Consensus 90 mE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999986554 6899999999999999999999 899999999999999999999999999998765432
Q ss_pred Cc--ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchh
Q 043526 726 GT--HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSC 803 (858)
Q Consensus 726 ~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~ 803 (858)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..... .+.....+..+.... ..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~~---~~ 236 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIPP---SA 236 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCG---GG
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCCC---ch
Confidence 22 223445799999999999999999999999999999999999999965431 122222233222110 00
Q ss_pred hcCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 043526 804 LRGGFEIESAWRAVELAVKCASRTSSERP-NMNEVVTELKECL 845 (858)
Q Consensus 804 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-sm~eVl~~L~~~~ 845 (858)
.......++.+++.+|++.||++|| |++++.+.|.++.
T Consensus 237 ----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 237 ----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1112235788999999999999999 8999999888753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-42 Score=366.77 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=202.0
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCc---------chHhHHHHHHHHHhcc-cceeeeeeeeeeeCCee
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQ---------GFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNM 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~---------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 642 (858)
++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 4468999999999999996 47999999999765322 1245889999999997 99999999999999999
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
++||||+++|+|.++++... .+++.+++.++.||++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999997643 6999999999999999999999 889999999999999999999999999999887
Q ss_pred cCCCcceeecccCCCCccCcccccc------CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCc
Q 043526 723 PIGGTHVSTVVAGTPGYLDPEYFVT------DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDI 796 (858)
Q Consensus 723 ~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~ 796 (858)
.... ......||..|+|||.+.+ ..++.++||||+||+++||+||+.||...... .+...+.++..
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i~~~~~ 232 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMIMSGNY 232 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHHHhCCC
Confidence 5432 2344679999999999853 35688999999999999999999999754311 11122222211
Q ss_pred hhhhchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 ENIVDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. +..........++.+++.+|++.+|++|||++||+++
T Consensus 233 ~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 0111112334578899999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=376.25 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhc-ccceeeeeeeeeee----CCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRV-HHRNLTNLVGYFIE----DNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~~~lV~Ey~~ 650 (858)
+.||+|+||+||+|+. .+|+.||||+++.. ..+.+|++++.++ +|||||++++++.. +...++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5799999999999996 57999999999643 5678899987655 89999999999875 456899999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~ 727 (858)
+|+|.+++.......+++.++..|+.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence 999999998765567999999999999999999999 899999999999999985 46799999999987654332
Q ss_pred ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCC
Q 043526 728 HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGG 807 (858)
Q Consensus 728 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~ 807 (858)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ....+...+..+.. .+...
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~~~------~~~~~ 239 (335)
T d2ozaa1 170 --LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMGQY------EFPNP 239 (335)
T ss_dssp --CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSS------SCCTT
T ss_pred --cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcCCC------CCCCc
Confidence 234579999999999999999999999999999999999999997643221 11111111111110 00000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.......++.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 012335578999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=374.33 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=200.3
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHH-hcccceeeeeeeeeeeCCeeEEEEee
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLM-RVHHRNLTNLVGYFIEDNNMGLIYEY 648 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~Ey 648 (858)
.+.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+..|..++. .++|||||++++++.+++..++||||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy 84 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 84 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEee
Confidence 45689999999999999975 7999999999643 2334556777777765 68999999999999999999999999
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 85 ~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 85 LNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred cCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 99999999997654 6889999999999999999999 8899999999999999999999999999998764332 2
Q ss_pred eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCC
Q 043526 729 VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGF 808 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~ 808 (858)
......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... . +...+..+.. .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~----~~~~i~~~~~----------~~ 222 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--E----LFHSIRMDNP----------FY 222 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H----HHHHHHHCCC----------CC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--H----HHHHHHcCCC----------CC
Confidence 233457999999999999999999999999999999999999999754311 1 1222222211 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043526 809 EIESAWRAVELAVKCASRTSSERPNMN-EVVT 839 (858)
Q Consensus 809 ~~~~~~~l~~l~~~Cl~~dP~~RPsm~-eVl~ 839 (858)
+.....++.+|+.+|++.||++||+++ |+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 222345688999999999999999995 6754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-42 Score=375.85 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=202.4
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccC---CCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS---SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 649 (858)
+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++++.++|||||++++++...+..++||||+
T Consensus 44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence 34578999999999999975 7999999998643 2344567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcce
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHV 729 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~ 729 (858)
.+|+|.+++.... .+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 124 ~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 124 AGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999997654 6899999999999999999999 899999999999999999999999999999876432
Q ss_pred eecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCC
Q 043526 730 STVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFE 809 (858)
Q Consensus 730 ~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~ 809 (858)
.....||+.|||||.+.+..++.++|||||||++|||+||+.||.... ...+. ..+..+.. ..+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~----~~i~~~~~----------~~p 258 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIY----EKIVSGKV----------RFP 258 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH----HHHHHCCC----------CCC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHH----HHHhcCCC----------CCC
Confidence 234579999999999999999999999999999999999999996532 11111 11222111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043526 810 IESAWRAVELAVKCASRTSSERP-----NMNEVVTE 840 (858)
Q Consensus 810 ~~~~~~l~~l~~~Cl~~dP~~RP-----sm~eVl~~ 840 (858)
.....++.+++.+||+.||.+|+ +++|++++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 23345788999999999999994 89999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=369.53 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccCCCc-----chHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeecc
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQ-----GFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 650 (858)
++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||++++++..++..++||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 57999999999999964 7999999998654221 23568999999999999999999999999999999999999
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCccee
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 730 (858)
++++..+... ...+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++........ .
T Consensus 84 ~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 84 TDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp EEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred chHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 9887777643 346889999999999999999999 899999999999999999999999999999876543322 2
Q ss_pred ecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhch-------
Q 043526 731 TVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDS------- 802 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~------- 802 (858)
....||+.|+|||.+.. ..++.++|||||||+++||+||+.||.... ..+....+.............+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 33568999999999875 467999999999999999999999986543 22222222222111100000000
Q ss_pred hhc--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 803 CLR--GGFEI-----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 803 ~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... ...+. .....+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 00011 224578899999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-41 Score=377.33 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=196.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCC---CcchHhHHH---HHHHHHhcccceeeeeeeeeeeCCeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSS---GQGFKEFEA---EVKLLMRVHHRNLTNLVGYFIEDNNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~~---E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 646 (858)
.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+ |+++++.++|||||++++++..++..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 34589999999999999965 79999999986421 122233444 466777778999999999999999999999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 87 E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp CCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999999997653 6889999999999999999999 8999999999999999999999999999998765432
Q ss_pred cceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhc
Q 043526 727 THVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLR 805 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~ 805 (858)
.....||+.|+|||.+.. ..++.++|||||||++|||+||+.||........ .. +........
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~-~~~~~~~~~---------- 225 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLTMA---------- 225 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HH-HHHHSSSCC----------
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHhcccCC----------
Confidence 234579999999999874 5689999999999999999999999976543221 11 111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 806 GGFEIESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 806 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
...+.....++.+++.+||+.||++||+ ++|++++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1112233456889999999999999999 6888763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=370.29 Aligned_cols=248 Identities=20% Similarity=0.332 Sum_probs=201.5
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|+.++|||||++++++.+++..++||||+++|
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 45678999999999999975 78999999997653 33456889999999999999999999999999999999999999
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC--CCEEEeeecCcccccCCCccee
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN--LEAKLADFGLSKVFPIGGTHVS 730 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~--~~~kL~DFGla~~~~~~~~~~~ 730 (858)
+|.+++.... ..+++.++..++.||++||+||| +.+|+||||||+|||++.+ ..+||+|||+++...... ..
T Consensus 87 ~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~ 160 (321)
T d1tkia_ 87 DIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF 160 (321)
T ss_dssp BHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC--cc
Confidence 9999996543 36899999999999999999999 8999999999999999854 579999999998764432 23
Q ss_pred ecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhchhhcCCCCH
Q 043526 731 TVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVDSCLRGGFEI 810 (858)
Q Consensus 731 ~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~ 810 (858)
....|++.|+|||...+..++.++||||+||++|||++|+.||...... +.... +..+... ++.....
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~-i~~~~~~--~~~~~~~---- 228 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIEN-IMNAEYT--FDEEAFK---- 228 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH-HHHTCCC--CCHHHHT----
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHhCCCC--CChhhcc----
Confidence 3456899999999999999999999999999999999999999754321 11111 1111110 0000000
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 811 ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 811 ~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....++.+++.+|+..||++|||++|++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123467899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-41 Score=361.36 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=197.3
Q ss_pred cccccccCceEEEEEEE-CCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 576 NKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++++++.+++..++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 47899999999999996 579999999996543 23457899999999999999999999999999999999999976
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
++.+++.......+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~~~ 161 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTH 161 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CTTC
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-ccee
Confidence 5555555555567999999999999999999999 89999999999999999999999999999987654322 2334
Q ss_pred ccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhc---CCchhhhc-hhhcCC
Q 043526 733 VAGTPGYLDPEYFVTDW-LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAK---GDIENIVD-SCLRGG 807 (858)
Q Consensus 733 ~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~---~~~~~~~d-~~l~~~ 807 (858)
..||+.|+|||.+.... .+.++||||+||++|||++|+.||...... ..+.. +...... ........ +.....
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFR-IFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH-HHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHH-HHHhcCCCchhhccccccccccccc
Confidence 56899999999877554 588999999999999999999999754321 11111 1111111 00000000 000000
Q ss_pred C------C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 808 F------E-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 808 ~------~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. + .....++.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 1223578899999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=359.60 Aligned_cols=238 Identities=27% Similarity=0.402 Sum_probs=194.0
Q ss_pred hhccccccccCceEEEEEEEC-CCCEEEEEEeccCCC------cchHhHHHHHHHHHhcc--cceeeeeeeeeeeCCeeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG------QGFKEFEAEVKLLMRVH--HRNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~ 643 (858)
+.+.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|++++++++ |||||++++++.+++..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 345689999999999999964 799999999875321 12345778999999996 899999999999999999
Q ss_pred EEEeeccC-CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCC-CCEEEeeecCccc
Q 043526 644 LIYEYMAN-GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTEN-LEAKLADFGLSKV 721 (858)
Q Consensus 644 lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~-~~~kL~DFGla~~ 721 (858)
+||||+.+ +++.+++... ..+++.++..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 86 lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 99999986 6788888654 36899999999999999999999 8999999999999999854 7899999999987
Q ss_pred ccCCCcceeecccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWL-NEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV 800 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~ 800 (858)
.... ......||+.|+|||.+.+..+ +.++||||+||++|||+||+.||.... . +..+..
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~-i~~~~~---- 221 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------E-IIRGQV---- 221 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------H-HHHCCC----
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------H-Hhhccc----
Confidence 5432 2334679999999999987655 577999999999999999999986421 0 111110
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
..+.....++.+++.+|++.||++|||++|++++
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1112233568899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-40 Score=354.52 Aligned_cols=258 Identities=20% Similarity=0.294 Sum_probs=197.8
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeccCC--CcchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccCC
Q 043526 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSS--GQGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMANG 652 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~g 652 (858)
..+.||+|+||+||+|+.++|+.||||+++... ....+++.+|+.++++++||||+++++++..++..++++||+.++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence 347899999999999999999999999996543 233578999999999999999999999999999999999999987
Q ss_pred ChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceeec
Q 043526 653 NLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVSTV 732 (858)
Q Consensus 653 sL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 732 (858)
.+..+.... ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||.+........ ....
T Consensus 86 ~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 159 (286)
T d1ob3a_ 86 LKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH 159 (286)
T ss_dssp HHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred hHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccce
Confidence 777776443 47999999999999999999999 88999999999999999999999999999987654322 2234
Q ss_pred ccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCC---ch---hhh--chh
Q 043526 733 VAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGD---IE---NIV--DSC 803 (858)
Q Consensus 733 ~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~---~~---~~~--d~~ 803 (858)
..|++.|+|||.+.+ ..++.++||||+||+++||++|+.||..... .+....+........ .. ... +..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 468999999999875 5678999999999999999999999975432 111222211111110 00 000 000
Q ss_pred hc--CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 804 LR--GG-----FEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 804 l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
.. .. ........+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 011224578899999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.6e-39 Score=344.03 Aligned_cols=263 Identities=17% Similarity=0.220 Sum_probs=207.9
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhccc-ceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH-RNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+|++.+..++| +|++.+++++..+...++||||+ +
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 45688999999999999964 79999999986543 23567889999999975 89999999999999999999998 6
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC-----CCCEEEeeecCcccccCCC
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE-----NLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~-----~~~~kL~DFGla~~~~~~~ 726 (858)
++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 85 ~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 85 PSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 79999886543 46899999999999999999999 999999999999999974 5679999999999865332
Q ss_pred c------ceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccc-cHHHHHHHHHhcCCchhh
Q 043526 727 T------HVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENI-HIIQTVTNMIAKGDIENI 799 (858)
Q Consensus 727 ~------~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~-~l~~~v~~~~~~~~~~~~ 799 (858)
. .......||+.|+|||.+.+..++.++|||||||+++||+||+.||........ .....+..........+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE- 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH-
Confidence 1 122345799999999999999999999999999999999999999976543221 11122222111111111
Q ss_pred hchhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHhhhc
Q 043526 800 VDSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMELARK 852 (858)
Q Consensus 800 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~~~~ 852 (858)
+.... ..++.+++..|+..+|++||+++.+.+.|+++++......
T Consensus 240 ----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 240 ----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp ----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred ----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 11122 2468889999999999999999999999999876554443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=351.33 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=193.9
Q ss_pred hccccccccCceEEEEEEE-CC-CCEEEEEEeccC--CCcchHhHHHHHHHHHhc---ccceeeeeeeeeee-----CCe
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DD-GTQVAVKMLSSS--SGQGFKEFEAEVKLLMRV---HHRNLTNLVGYFIE-----DNN 641 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~-g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~~~ 641 (858)
+..+.||+|+||+||+|+. ++ ++.||||+++.. .......+.+|+.+++.+ +||||++++++|.. ...
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 3457899999999999996 34 667999998643 223345677788777766 79999999999863 346
Q ss_pred eEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 642 MGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 642 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
.+++|||++++.+..... .....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.
T Consensus 90 ~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 889999999877654443 33457899999999999999999999 89999999999999999999999999999886
Q ss_pred ccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhh--
Q 043526 722 FPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENI-- 799 (858)
Q Consensus 722 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~-- 799 (858)
.... .......||+.|+|||.+.+..++.++||||+||+++||+||+.||..... ......+............
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCGGGSCT
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCchhcccc
Confidence 5432 233456799999999999999999999999999999999999999975432 1222222221111000000
Q ss_pred ----hchhhc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 800 ----VDSCLR-------GGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 800 ----~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...... ..........+.+|+.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00111234567899999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-39 Score=345.98 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=198.8
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeee-eeeeeCCeeEEEEeecc
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLV-GYFIEDNNMGLIYEYMA 650 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~-~~~~~~~~~~lV~Ey~~ 650 (858)
+.+.+.||+|+||.||+|+. .+|+.||||++..... ..++..|+++++.++|+|++..+ ++..+++..++||||+.
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 34568899999999999996 4789999999876533 35688999999999877766554 55567788899999985
Q ss_pred CCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcC---CCCEEEeeecCcccccCCCc
Q 043526 651 NGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTE---NLEAKLADFGLSKVFPIGGT 727 (858)
Q Consensus 651 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~---~~~~kL~DFGla~~~~~~~~ 727 (858)
++|.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 87 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 -PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp -CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred -Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 5676666443 346899999999999999999999 899999999999999864 55799999999998754332
Q ss_pred c------eeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccH-HHHHHHHHhcCCchhhh
Q 043526 728 H------VSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHI-IQTVTNMIAKGDIENIV 800 (858)
Q Consensus 728 ~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l-~~~v~~~~~~~~~~~~~ 800 (858)
. ......||+.|+|||.+.+..++.++|||||||+++||+||+.||.......... .............
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---- 237 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 237 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH----
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh----
Confidence 2 2234579999999999999999999999999999999999999997654322111 1111111001111
Q ss_pred chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHHHh
Q 043526 801 DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTELKECLMMEL 849 (858)
Q Consensus 801 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~L~~~~~~~~ 849 (858)
+.+... ...++.+++..|++.+|++||+++++.+.|+++.....
T Consensus 238 -~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 238 -EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp -HHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -hHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 111111 22468899999999999999999999999998766544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=357.04 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=191.1
Q ss_pred hccccccccCceEEEEEEEC-CCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEEE
Q 043526 574 NFNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLIY 646 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~ 646 (858)
...++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... ...++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34578999999999999975 799999999975432 234799999999999999999998643 3478999
Q ss_pred eeccCCChHHHhhh-cccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccC
Q 043526 647 EYMANGNLKQLLSD-EKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPI 724 (858)
Q Consensus 647 Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~ 724 (858)
||++++.+....+. .....+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99987644444332 22457999999999999999999999 89999999999999999775 899999999987654
Q ss_pred CCcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh---
Q 043526 725 GGTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV--- 800 (858)
Q Consensus 725 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~--- 800 (858)
... .....|+..|+|||.+.+ ..++.++||||+||+++||++|+.||...... ..+.... ....... .+..
T Consensus 176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~-~~~g~~~-~~~~~~~ 250 (350)
T d1q5ka_ 176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEII-KVLGTPT-REQIREM 250 (350)
T ss_dssp TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHH-HHHCCCC-HHHHHHH
T ss_pred Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHH-HHhCCCh-HHhhhhh
Confidence 332 233568999999998875 57899999999999999999999999754321 1111111 1111000 0000
Q ss_pred -----chh--------hcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 -----DSC--------LRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 -----d~~--------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
+.. +..........++.+|+.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000112234568899999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=350.65 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=193.5
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccC--CCcchHhHHHHHHHHHhcccceeeeeeeeeee--------CCee
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSS--SGQGFKEFEAEVKLLMRVHHRNLTNLVGYFIE--------DNNM 642 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~~~~ 642 (858)
...+.||+|+||+||+|+. ++|+.||||++... .....+++.+|+++|++++|||++++++.+.. ++..
T Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 3457899999999999996 48999999998644 33456778999999999999999999998865 3468
Q ss_pred EEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccc
Q 043526 643 GLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVF 722 (858)
Q Consensus 643 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~ 722 (858)
++||||++++.+...... ...++...+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 999999998777655543 346888899999999999999999 899999999999999999999999999999876
Q ss_pred cCCCc---ceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---C
Q 043526 723 PIGGT---HVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---D 795 (858)
Q Consensus 723 ~~~~~---~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~ 795 (858)
..... .......||+.|+|||.+.+. .++.++||||+||+++||++|+.||..... ......+......- .
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSITPEV 245 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCCChhh
Confidence 53321 122234689999999998754 689999999999999999999999975432 22222222222110 0
Q ss_pred chhhhchhh--------cCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 796 IENIVDSCL--------RGGFEI-------ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 796 ~~~~~d~~l--------~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
......... ...... .....+++|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000 000011 113356789999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-39 Score=349.97 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=201.6
Q ss_pred hhccccccccCceEEEEEEE----CCCCEEEEEEeccC----CCcchHhHHHHHHHHHhccc-ceeeeeeeeeeeCCeeE
Q 043526 573 DNFNKVLGKGGFGTVYHGYL----DDGTQVAVKMLSSS----SGQGFKEFEAEVKLLMRVHH-RNLTNLVGYFIEDNNMG 643 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~----~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~ 643 (858)
+++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|++++++++| |||+++++++......+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 45568999999999999985 25899999998643 22345678899999999977 89999999999999999
Q ss_pred EEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCccccc
Q 043526 644 LIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFP 723 (858)
Q Consensus 644 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~ 723 (858)
+||||+.+|+|.+++...+ .++......++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999997654 5678888999999999999999 8899999999999999999999999999998775
Q ss_pred CCCcceeecccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhhc
Q 043526 724 IGGTHVSTVVAGTPGYLDPEYFVTD--WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIVD 801 (858)
Q Consensus 724 ~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~d 801 (858)
...........|++.|+|||.+... .++.++|||||||+||||+||+.||........ ...........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~-------- 251 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS-------- 251 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC--------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccC--------
Confidence 4444444556799999999998754 468899999999999999999999976543321 11111111111
Q ss_pred hhhcCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043526 802 SCLRGGFEIESAWRAVELAVKCASRTSSERPN-----MNEVVTE 840 (858)
Q Consensus 802 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----m~eVl~~ 840 (858)
....+.....++.+++.+|++.||.+||| ++|++++
T Consensus 252 ---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 ---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 01122344567889999999999999995 7888763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=341.45 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=201.6
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCCeeEEEEeeccC
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDNNMGLIYEYMAN 651 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~~ 651 (858)
..+.||+|+||+||+|+. .+|+.||||+++.... ....++.+|+.+++.++||||+++++++...+..++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 347899999999999996 4889999999965432 3457889999999999999999999999999999999999999
Q ss_pred CChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcceee
Q 043526 652 GNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTHVST 731 (858)
Q Consensus 652 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 731 (858)
++|..++... ..+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||+|||.++........ ..
T Consensus 86 ~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~ 159 (292)
T d1unla_ 86 DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YS 159 (292)
T ss_dssp EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CC
T ss_pred cccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-ce
Confidence 9998887654 36889999999999999999999 889999999999999999999999999999887543322 22
Q ss_pred cccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcC---Cchhh---hchhh
Q 043526 732 VVAGTPGYLDPEYFVTDW-LNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKG---DIENI---VDSCL 804 (858)
Q Consensus 732 ~~~gt~~y~APE~~~~~~-~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~---~~~~~---~d~~l 804 (858)
...++..|+|||.+.... ++.++||||+||+++||++|+.||....+... ....+....... ..... .+...
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 345678899999887654 68999999999999999999999865443222 222222221111 00000 00000
Q ss_pred ---------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 805 ---------RGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 805 ---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...........+.+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112234578899999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-38 Score=346.41 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=192.3
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCC-cchHhHHHHHHHHHhcccceeeeeeeeeeeCC----eeEEEEee
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG-QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN----NMGLIYEY 648 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~Ey 648 (858)
..+.||+|+||+||+|+. .+|+.||||++..... ...+++++|+++|+.++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 347899999999999986 4899999999975433 33567899999999999999999999997653 23455667
Q ss_pred ccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCCcc
Q 043526 649 MANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 649 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~~~ 728 (858)
+.+|+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 92 ~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 92 LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred ecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 7899999999643 5899999999999999999999 889999999999999999999999999999876433221
Q ss_pred --eeecccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCch--------
Q 043526 729 --VSTVVAGTPGYLDPEYFV-TDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIE-------- 797 (858)
Q Consensus 729 --~~~~~~gt~~y~APE~~~-~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~-------- 797 (858)
......||+.|+|||.+. ...++.++||||+||+++||++|+.||...... +...............
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HHHHHHhhhccCCChhhhhhhhhh
Confidence 123456899999999985 456789999999999999999999999754321 1111111111110000
Q ss_pred ---hhhchhh-cCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 798 ---NIVDSCL-RGGFEI-----ESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 798 ---~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
....... ....+. ....++++++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000111 123468899999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-38 Score=343.56 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=194.4
Q ss_pred hccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeC--CeeEEEEeec
Q 043526 574 NFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIED--NNMGLIYEYM 649 (858)
Q Consensus 574 ~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~Ey~ 649 (858)
.+.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|+.++ ||||+++++++... ...++||||+
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 4457899999999999996 47999999999643 3567899999999995 99999999998754 5689999999
Q ss_pred cCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCC-CEEEeeecCcccccCCCcc
Q 043526 650 ANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENL-EAKLADFGLSKVFPIGGTH 728 (858)
Q Consensus 650 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~-~~kL~DFGla~~~~~~~~~ 728 (858)
++++|.... +.+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 115 ~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 115 NNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred CCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence 999998764 25889999999999999999999 89999999999999998655 599999999987654322
Q ss_pred eeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH---------hcCCc--
Q 043526 729 VSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI---------AKGDI-- 796 (858)
Q Consensus 729 ~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~---------~~~~~-- 796 (858)
.....||+.|+|||.+.+. .++.++||||+||+++||++|+.||............ +.... .....
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~-i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR-IAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH-HHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH-HHHHHCCchhhhhhhhccccc
Confidence 2345689999999998764 5799999999999999999999999765432211111 11100 00000
Q ss_pred -hhh---h--------chhhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 797 -ENI---V--------DSCLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 797 -~~~---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... . ..............++.+|+.+|++.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 0000001112234578899999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-38 Score=346.31 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=188.1
Q ss_pred ccccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeCC------eeEEE
Q 043526 575 FNKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIEDN------NMGLI 645 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~lV 645 (858)
..+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|+++|+.++|||||+++++|...+ ..++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 3478999999999999964 799999999975432 23467889999999999999999999997654 57999
Q ss_pred EeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCC
Q 043526 646 YEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIG 725 (858)
Q Consensus 646 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~ 725 (858)
|||+ +.+|..+++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 102 ~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~ 174 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174 (346)
T ss_dssp EECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred Eecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCCc
Confidence 9999 5577777653 35999999999999999999999 899999999999999999999999999999876432
Q ss_pred CcceeecccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh----
Q 043526 726 GTHVSTVVAGTPGYLDPEYFVT-DWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV---- 800 (858)
Q Consensus 726 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~---- 800 (858)
.....||+.|+|||.+.+ ..++.++||||+||+++||++|+.||...... ............ ...+..
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~ 247 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGT-PPAEFVQRLQ 247 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCC-CCHHHHHTCS
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHHHhccCC-CcHHHHhhhc
Confidence 234568999999999875 46789999999999999999999999765321 111111110000 000000
Q ss_pred -------chhhcC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 -------DSCLRG-------GFEIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 -------d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
...+.. .........+.+|+.+|++.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0011223467899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-37 Score=337.22 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=185.3
Q ss_pred cccccccCceEEEEEEEC-CCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeC------CeeEEEE
Q 043526 576 NKVLGKGGFGTVYHGYLD-DGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED------NNMGLIY 646 (858)
Q Consensus 576 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~ 646 (858)
.+.||+|+||+||+|... +|+.||||++..... ....++.+|++++++++||||+++++++... ...++||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 478999999999999965 799999999975432 2345688999999999999999999999643 6789999
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
||+.++.+. .+. ..+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||+++......
T Consensus 102 Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 102 ELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp ECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccccc
Confidence 999775544 442 35889999999999999999999 8999999999999999999999999999988764332
Q ss_pred cceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHH---------------
Q 043526 727 THVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMI--------------- 791 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~--------------- 791 (858)
......||+.|+|||.+.+..++.++||||+||+++||++|+.||..... ......+....
T Consensus 174 --~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred --ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 23345689999999999999999999999999999999999999965431 11111111100
Q ss_pred ----hcC------CchhhhchhhcCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 792 ----AKG------DIENIVDSCLRGGF---EIESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 792 ----~~~------~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
... .............. .......+.+|+.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00011111111111 12345678999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-37 Score=337.53 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=190.1
Q ss_pred ccccccccCceEEEEEEE-CCCCEEEEEEeccCCC--cchHhHHHHHHHHHhcccceeeeeeeeeeeC-----CeeEEEE
Q 043526 575 FNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSG--QGFKEFEAEVKLLMRVHHRNLTNLVGYFIED-----NNMGLIY 646 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~ 646 (858)
..+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++|++++|||+|++++++... ...++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 347899999999999995 5899999999975533 2345788999999999999999999998643 3456777
Q ss_pred eeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeeecCcccccCCC
Q 043526 647 EYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADFGLSKVFPIGG 726 (858)
Q Consensus 647 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~~~~~~ 726 (858)
+|+.+|+|.+++... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||++.....
T Consensus 102 ~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp EECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred EeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc--
Confidence 888999999999643 5999999999999999999999 88999999999999999999999999999876432
Q ss_pred cceeecccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHhCCCccccCCCccccHHHHHHHHHhcCCchhhh-----
Q 043526 727 THVSTVVAGTPGYLDPEYFVTD-WLNEKSDVYSFGVVLLEIITSQAVIVRNENENIHIIQTVTNMIAKGDIENIV----- 800 (858)
Q Consensus 727 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~~~l~~~v~~~~~~~~~~~~~----- 800 (858)
......|++.|+|||...+. ..+.++||||+||+++||++|+.||..... ......+....... ..+..
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~-~~~~~~~~~~ 248 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTP-GAELLKKISS 248 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC-CHHHHTTCCC
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCC-ChHHhhhccc
Confidence 22345688899999987664 568999999999999999999999975431 11122221111110 00000
Q ss_pred ---c---hhhc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043526 801 ---D---SCLR--GGFE-----IESAWRAVELAVKCASRTSSERPNMNEVVTE 840 (858)
Q Consensus 801 ---d---~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl~~ 840 (858)
. ..+. ...+ ......+.+|+.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 0000 0000 1123467899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-33 Score=306.30 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=190.5
Q ss_pred hhccccccccCceEEEEEEE-CCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-----------cceeeeeeeeeeeC-
Q 043526 573 DNFNKVLGKGGFGTVYHGYL-DDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-----------HRNLTNLVGYFIED- 639 (858)
Q Consensus 573 ~~f~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~~- 639 (858)
+.+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 45568999999999999996 489999999997542 23456788998888875 57899999888653
Q ss_pred -CeeEEEEeeccCCCh-HHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCC------E
Q 043526 640 -NNMGLIYEYMANGNL-KQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLE------A 711 (858)
Q Consensus 640 -~~~~lV~Ey~~~gsL-~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~------~ 711 (858)
....++++++..+.. ...........+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 456677776655543 333334445678899999999999999999993 378999999999999986653 9
Q ss_pred EEeeecCcccccCCCcceeecccCCCCccCccccccCCCCCchhHHHHHHHHHHHHhCCCccccCCCcc-c----cHHHH
Q 043526 712 KLADFGLSKVFPIGGTHVSTVVAGTPGYLDPEYFVTDWLNEKSDVYSFGVVLLEIITSQAVIVRNENEN-I----HIIQT 786 (858)
Q Consensus 712 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSfGvll~ElltG~~p~~~~~~~~-~----~l~~~ 786 (858)
+++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||....... . .+...
T Consensus 172 kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999999865432 234568999999999999999999999999999999999999987543211 1 11111
Q ss_pred HHHHHhc--------C-Cchhhhch-------------------hhcCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043526 787 VTNMIAK--------G-DIENIVDS-------------------CLRGGFEIESAWRAVELAVKCASRTSSERPNMNEVV 838 (858)
Q Consensus 787 v~~~~~~--------~-~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPsm~eVl 838 (858)
+. .+.. + ......+. ............++.+|+.+|++.||++|||++|++
T Consensus 248 ~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 248 IE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 11 1100 0 00000000 001122345677899999999999999999999998
Q ss_pred HH--HHHH
Q 043526 839 TE--LKEC 844 (858)
Q Consensus 839 ~~--L~~~ 844 (858)
++ +++.
T Consensus 327 ~Hp~f~~~ 334 (362)
T d1q8ya_ 327 NHPWLKDT 334 (362)
T ss_dssp TCGGGTTC
T ss_pred cCcccCCC
Confidence 85 5543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=5.6e-21 Score=190.73 Aligned_cols=162 Identities=17% Similarity=0.214 Sum_probs=118.6
Q ss_pred ccccccccCceEEEEEEECCCCEEEEEEeccCCCc------------------chHhHHHHHHHHHhcccceeeeeeeee
Q 043526 575 FNKVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQ------------------GFKEFEAEVKLLMRVHHRNLTNLVGYF 636 (858)
Q Consensus 575 f~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~~~~ 636 (858)
..+.||+|+||+||+|...+|+.||||+++..... .......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45789999999999999989999999987532110 012345678889999999998877553
Q ss_pred eeCCeeEEEEeeccCCChHHHhhhcccCchhHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCcceEEcCCCCEEEeee
Q 043526 637 IEDNNMGLIYEYMANGNLKQLLSDEKASTLSWERRLQIAMDAAQGLEYLHIGCKPPIVHRDIKPENILLTENLEAKLADF 716 (858)
Q Consensus 637 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IvH~DLk~~NILl~~~~~~kL~DF 716 (858)
..+++|||+++..+.+ ++......++.|++++|+||| +.+|+||||||+|||++++ .++|+||
T Consensus 84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence 2379999999865433 344556789999999999999 8899999999999999975 5899999
Q ss_pred cCcccccCCCcceeecccCCCCccC------ccccccCCCCCchhHHHHHHHH
Q 043526 717 GLSKVFPIGGTHVSTVVAGTPGYLD------PEYFVTDWLNEKSDVYSFGVVL 763 (858)
Q Consensus 717 Gla~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~s~ksDVwSfGvll 763 (858)
|+|.......... |.. .|. ..+.++.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9997654222110 111 011 135567889999976443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.68 E-value=1.2e-17 Score=179.26 Aligned_cols=125 Identities=27% Similarity=0.441 Sum_probs=109.4
Q ss_pred CchhHHHHHHHHHHHcC---CCCCCC--CCCCCCCCCCccceeccCCCCCCCcEEEEEecCCCCcc--cccchhcccccc
Q 043526 366 TLHTDVDAVMNMKKMYG---VKRNWQ--GDPCAPKAYSWDGLNCSYKGNDPPRIISLNLSSSGLTG--EIAPYLSNLTLI 438 (858)
Q Consensus 366 ~~~~~~~al~~~k~~~~---~~~~w~--~dpc~~~~~~w~gv~C~~~~~~~~~l~~L~L~~n~l~g--~ip~~~~~l~~L 438 (858)
+.++|.+||++||+.+. .+.+|. +|||. +.|.||+|+.. +...||+.|+|++|+++| .||++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~~-~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCS-SSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC---CcCCCeEEeCC-CCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 67899999999999884 467895 35552 36999999853 345689999999999998 589999999999
Q ss_pred ccccCCC-CCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 439 QSLDLSN-NSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 439 ~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
++|||++ |+|+|.||++|++|++|++|+|++|+|+|..|..+..+.+|+.++++.+
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N 135 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccc
Confidence 9999997 9999999999999999999999999999999999999999988776554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.10 E-value=3.1e-11 Score=119.04 Aligned_cols=99 Identities=19% Similarity=0.244 Sum_probs=85.3
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCccccc-chhccccccccccCCCCCCccCCCcccccccccceeeccC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIA-PYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~ 469 (858)
|.|..|.|+..+ +.+++++.|+|++|+|++.++ ..|+++++|+.|+|++|++++..|..+..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 479999998653 355689999999999997664 5679999999999999999988889999999999999999
Q ss_pred CcCcCCCChhhhccCcCCCccccccC
Q 043526 470 NKFTGPIPVELMEKSKNGSLQLSVGD 495 (858)
Q Consensus 470 N~l~g~iP~~~~~~~~l~~l~l~~~~ 495 (858)
|+|++..|..+..+++|+.|+++.|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~ 113 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQ 113 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred ccccccCHHHHhCCCcccccccCCcc
Confidence 99997777788899999988776553
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.07 E-value=2.6e-11 Score=129.04 Aligned_cols=94 Identities=26% Similarity=0.403 Sum_probs=81.7
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..+.++.|++++|.++|.+| .++.+++|+.|+|++|+|+|.||+.|++|++|+.|||++|+|+|.||. ++++++|+.
T Consensus 219 ~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~- 295 (313)
T d1ogqa_ 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV- 295 (313)
T ss_dssp TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCG-
T ss_pred cccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCH-
Confidence 34678999999999998765 799999999999999999999999999999999999999999999995 577777764
Q ss_pred cccccCcccccCCCCCcc
Q 043526 490 QLSVGDNEELCSSSSDSC 507 (858)
Q Consensus 490 ~l~~~~n~~lc~~s~~~~ 507 (858)
+++.+|+.+||.....|
T Consensus 296 -l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 296 -SAYANNKCLCGSPLPAC 312 (313)
T ss_dssp -GGTCSSSEEESTTSSCC
T ss_pred -HHhCCCccccCCCCCCC
Confidence 55678889999755444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=4.8e-10 Score=106.55 Aligned_cols=106 Identities=21% Similarity=0.280 Sum_probs=83.7
Q ss_pred CCCCCCCCccceeccCCC--------CCCCcEEEEEecCCC-CcccccchhccccccccccCCCCCCccCCCcccccccc
Q 043526 391 PCAPKAYSWDGLNCSYKG--------NDPPRIISLNLSSSG-LTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQF 461 (858)
Q Consensus 391 pc~~~~~~w~gv~C~~~~--------~~~~~l~~L~L~~n~-l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~ 461 (858)
.|++ ..+.+|+|+..+ ...++++.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+..-|..|..+++
T Consensus 4 ~C~c--~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~ 81 (156)
T d2ifga3 4 ACCP--HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81 (156)
T ss_dssp SSCC--SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSC
T ss_pred CCCc--CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccc
Confidence 4543 268899998743 223578999998765 88544567999999999999999999666788999999
Q ss_pred cceeeccCCcCcCCCChhhhccCcCCCccccccCcccccC
Q 043526 462 LRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVGDNEELCS 501 (858)
Q Consensus 462 L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~~n~~lc~ 501 (858)
|+.|+|++|+|+ .+|.......++.. +.+.+|+..|.
T Consensus 82 L~~L~Ls~N~l~-~l~~~~~~~~~l~~--L~L~~Np~~C~ 118 (156)
T d2ifga3 82 LSRLNLSFNALE-SLSWKTVQGLSLQE--LVLSGNPLHCS 118 (156)
T ss_dssp CCEEECCSSCCS-CCCSTTTCSCCCCE--EECCSSCCCCC
T ss_pred ccceeccCCCCc-ccChhhhccccccc--cccCCCcccCC
Confidence 999999999999 78877766666664 55677887764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.79 E-value=2e-09 Score=97.96 Aligned_cols=79 Identities=27% Similarity=0.307 Sum_probs=61.6
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCC-ChhhhccCcCCCc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPI-PVELMEKSKNGSL 489 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~i-P~~~~~~~~l~~l 489 (858)
..+++.|+|++|+|+ .+|+.++.+++|+.|+|++|+|+ .+|. ++++++|+.|++++|+++..- +..+..+++|+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCccCCCCCchhhcCCCCCCEE
Confidence 357888888888888 77888888888888888888888 5664 888888888888888887432 2467777777766
Q ss_pred ccc
Q 043526 490 QLS 492 (858)
Q Consensus 490 ~l~ 492 (858)
+++
T Consensus 96 ~l~ 98 (124)
T d1dcea3 96 NLQ 98 (124)
T ss_dssp ECT
T ss_pred ECC
Confidence 554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.76 E-value=3.7e-09 Score=96.15 Aligned_cols=75 Identities=29% Similarity=0.390 Sum_probs=66.6
Q ss_pred EEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 415 ISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 415 ~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
+.|+|++|+|+ .+| .+.+|++|++|||++|+|+ .+|+.++.+++|+.|+|++|+|+ .+| .+..+++|+.|+++.|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46999999999 666 5999999999999999999 79999999999999999999999 565 5889999998877654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.74 E-value=2.7e-09 Score=104.79 Aligned_cols=90 Identities=26% Similarity=0.343 Sum_probs=79.0
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
..++|+.|+|++|++.+..+..+..+++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l 131 (192)
T d1w8aa_ 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccc
Confidence 34689999999999999999999999999999999999997777789999999999999999998778888899998866
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
++ .+|+..|.
T Consensus 132 ~L--~~N~~~~~ 141 (192)
T d1w8aa_ 132 NL--ASNPFNCN 141 (192)
T ss_dssp EC--TTCCBCCS
T ss_pred cc--cccccccc
Confidence 54 56666553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.65 E-value=1e-08 Score=105.87 Aligned_cols=94 Identities=21% Similarity=0.234 Sum_probs=79.3
Q ss_pred eeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCC
Q 043526 402 LNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGP 475 (858)
Q Consensus 402 v~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~ 475 (858)
|.|++.+ +.+++++.|+|++|+|++..+..|.+|++|++|+|++|+|+ .||. ++.+++|+.|+|++|+++ .
T Consensus 15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~ 91 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-S 91 (266)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-S
T ss_pred EEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-c
Confidence 7897643 34568999999999999666678999999999999999999 6775 588999999999999999 5
Q ss_pred CChhhhccCcCCCccccccCccc
Q 043526 476 IPVELMEKSKNGSLQLSVGDNEE 498 (858)
Q Consensus 476 iP~~~~~~~~l~~l~l~~~~n~~ 498 (858)
+|..+..+++|+.|+++.+....
T Consensus 92 ~~~~~~~l~~L~~L~l~~~~~~~ 114 (266)
T d1p9ag_ 92 LPLLGQTLPALTVLDVSFNRLTS 114 (266)
T ss_dssp CCCCTTTCTTCCEEECCSSCCCC
T ss_pred cccccccccccccccccccccce
Confidence 67788899999988887665443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=1.8e-08 Score=96.03 Aligned_cols=81 Identities=17% Similarity=0.142 Sum_probs=63.1
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
+.+++.|+|++|+|+ .||..+..+++|+.|||++|+|+ .++. +..|++|+.|+|++|+++...|..+..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCcchhhhhcccccccCCCccccccccccccce
Confidence 457888999999998 67777788889999999999988 6654 78888999999999998844444456688888776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.|
T Consensus 94 L~~N 97 (162)
T d1a9na_ 94 LTNN 97 (162)
T ss_dssp CCSC
T ss_pred eccc
Confidence 6543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=5.3e-08 Score=100.43 Aligned_cols=89 Identities=22% Similarity=0.229 Sum_probs=78.9
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
...++..|++++|.+++..+..+..+++|+.|++++|+|++..|..|..+++|+.|+|++|+|+ .||..+..+++|+.|
T Consensus 122 ~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L 200 (266)
T d1p9ag_ 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200 (266)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred cccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEE
Confidence 4568899999999999666677889999999999999999877788999999999999999999 999999999988854
Q ss_pred cccccCcccccC
Q 043526 490 QLSVGDNEELCS 501 (858)
Q Consensus 490 ~l~~~~n~~lc~ 501 (858)
.+.||+..|.
T Consensus 201 --~L~~Np~~Cd 210 (266)
T d1p9ag_ 201 --FLHGNPWLCN 210 (266)
T ss_dssp --ECCSCCBCCS
T ss_pred --EecCCCCCCC
Confidence 5578898885
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.49 E-value=6.6e-08 Score=101.48 Aligned_cols=82 Identities=29% Similarity=0.398 Sum_probs=71.1
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCccccc-chhccccccccccCCCCCCccCCCcccccccccceeeccC
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIA-PYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKG 469 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~ 469 (858)
|.|++|+|+..+ +.++.++.|+|++|+|+ .+| ..|.+|++|+.|++++|.+....|..|.+|++|+.|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 589999998642 34578999999999999 555 5799999999999999999977788899999999999999
Q ss_pred CcCcCCCChhh
Q 043526 470 NKFTGPIPVEL 480 (858)
Q Consensus 470 N~l~g~iP~~~ 480 (858)
|+++ .+|..+
T Consensus 89 n~l~-~l~~~~ 98 (305)
T d1xkua_ 89 NQLK-ELPEKM 98 (305)
T ss_dssp SCCS-BCCSSC
T ss_pred CccC-cCccch
Confidence 9999 677654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.47 E-value=4.6e-08 Score=101.82 Aligned_cols=89 Identities=19% Similarity=0.174 Sum_probs=78.8
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.||+++|++++..|..+..+.+|+.|
T Consensus 152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L- 230 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL- 230 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE-
T ss_pred ccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE-
Confidence 3578999999999998778889999999999999999999889999999999999999999998888889999988865
Q ss_pred ccccCcccccC
Q 043526 491 LSVGDNEELCS 501 (858)
Q Consensus 491 l~~~~n~~lc~ 501 (858)
.+++|+..|.
T Consensus 231 -~l~~N~l~C~ 240 (284)
T d1ozna_ 231 -RLNDNPWVCD 240 (284)
T ss_dssp -ECCSSCEECS
T ss_pred -EecCCCCCCC
Confidence 4568887774
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=1.3e-07 Score=89.86 Aligned_cols=79 Identities=15% Similarity=0.111 Sum_probs=64.6
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCCh--hhhccCcCCC
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPV--ELMEKSKNGS 488 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~--~~~~~~~l~~ 488 (858)
.++++.|+|++|+|+ .++ .|..|++|+.|+|++|+++..-|..+..+++|+.|+|++|+++ .++. .+..+++|+.
T Consensus 40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 116 (162)
T ss_dssp TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence 357999999999999 674 5899999999999999999433444578999999999999998 5553 5777888886
Q ss_pred cccc
Q 043526 489 LQLS 492 (858)
Q Consensus 489 l~l~ 492 (858)
|+++
T Consensus 117 L~l~ 120 (162)
T d1a9na_ 117 LCIL 120 (162)
T ss_dssp EECC
T ss_pred hhcC
Confidence 6554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=3.2e-07 Score=95.16 Aligned_cols=85 Identities=19% Similarity=0.136 Sum_probs=76.8
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
....++.|++++|+|++..+..|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..|..+..+++++.|
T Consensus 127 ~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 35678999999999996667789999999999999999998778889999999999999999999999999999999988
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 207 ~l~~N 211 (284)
T d1ozna_ 207 YLFAN 211 (284)
T ss_dssp ECCSS
T ss_pred ccccc
Confidence 77654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.23 E-value=4.1e-07 Score=95.26 Aligned_cols=78 Identities=28% Similarity=0.297 Sum_probs=36.1
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
+++.|+|++|.+++.++..+.+++.++.|++++|.+++..|..+.++++|++|+|++|+|+ .+|..+..+++|+.|++
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 4444444444444444444444444444444444444433444444444444444444444 34444444444444433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.17 E-value=4.7e-07 Score=97.40 Aligned_cols=77 Identities=25% Similarity=0.273 Sum_probs=66.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.+.++.|+|++|+|++. + .+..|++|+.|+|++|+|+ .+| .+++|++|+.|+|++|+|++..| +.++++|+.|+
T Consensus 306 ~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~ 379 (384)
T d2omza2 306 LKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379 (384)
T ss_dssp CTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred hcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence 45788999999999965 3 3899999999999999999 466 59999999999999999997655 88889998877
Q ss_pred ccc
Q 043526 491 LSV 493 (858)
Q Consensus 491 l~~ 493 (858)
++-
T Consensus 380 L~~ 382 (384)
T d2omza2 380 LND 382 (384)
T ss_dssp CCC
T ss_pred CCC
Confidence 653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.04 E-value=1.3e-06 Score=87.17 Aligned_cols=76 Identities=21% Similarity=0.305 Sum_probs=64.2
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|++++|.+++.. .+++|++|+.|||++|++++ +|. ++++++|+.|+|++|++++ +| .+.++++|+.|+
T Consensus 150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ 223 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVT 223 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEE
T ss_pred ccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEE
Confidence 457899999999998543 38999999999999999994 665 8999999999999999994 55 378888888776
Q ss_pred cc
Q 043526 491 LS 492 (858)
Q Consensus 491 l~ 492 (858)
++
T Consensus 224 ls 225 (227)
T d1h6ua2 224 LT 225 (227)
T ss_dssp EE
T ss_pred ee
Confidence 64
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.03 E-value=1.3e-05 Score=81.25 Aligned_cols=131 Identities=16% Similarity=0.141 Sum_probs=91.0
Q ss_pred CceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcc-cceeeeeeeeeeeCCeeEEEEeeccCCChHHHhhhc
Q 043526 583 GFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVH-HRNLTNLVGYFIEDNNMGLIYEYMANGNLKQLLSDE 661 (858)
Q Consensus 583 ~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~ 661 (858)
+.+.||+... +++.+.||+...........+.+|...+..+. +--+.+++.++..++..++||+++++..+.+.....
T Consensus 26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~ 104 (263)
T d1j7la_ 26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE 104 (263)
T ss_dssp SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence 3468998865 55667889887665555567888988888774 333567778888888899999999998876554211
Q ss_pred ccCchhHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 043526 662 KASTLSWERRLQIAMDAAQGLEYLHIG----------------------------------------------------- 688 (858)
Q Consensus 662 ~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------------------- 688 (858)
.....++.++++.++.||..
T Consensus 105 -------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 105 -------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp -------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred -------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 11223444555555555521
Q ss_pred ---CCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 689 ---CKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 689 ---~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
....++|+|+.+.|||++++...-|.||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 122378999999999999877677999997753
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.01 E-value=1.2e-06 Score=88.10 Aligned_cols=98 Identities=16% Similarity=0.147 Sum_probs=79.4
Q ss_pred CCccceeccCCC------CCCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCc-ccccccccceeecc-
Q 043526 397 YSWDGLNCSYKG------NDPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLK- 468 (858)
Q Consensus 397 ~~w~gv~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~- 468 (858)
|....|.|+..+ ..+..++.|+|++|+|+...+..|.+|++|++|+|++|.+...+|. .|..+++++.|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 578889998643 3345799999999999943344789999999999999999877764 57889999999976
Q ss_pred CCcCcCCCChhhhccCcCCCcccccc
Q 043526 469 GNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 469 ~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
.|++....|..+..+++|+.+.++.+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~ 113 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNT 113 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESC
T ss_pred cccccccccccccccccccccccchh
Confidence 57888777788899999998777543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=2.1e-06 Score=80.62 Aligned_cols=80 Identities=19% Similarity=0.111 Sum_probs=68.5
Q ss_pred EEEecCCCCcccccchhccccccccccCCCCC-CccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcccccc
Q 043526 416 SLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNS-LSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQLSVG 494 (858)
Q Consensus 416 ~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l~~~ 494 (858)
.++.+++++. .+|..+..+++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|++.-|..+..+++|+.|+++.|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 4889999998 789999999999999998764 88433467999999999999999999777788999999998888766
Q ss_pred Cc
Q 043526 495 DN 496 (858)
Q Consensus 495 ~n 496 (858)
.=
T Consensus 91 ~l 92 (156)
T d2ifga3 91 AL 92 (156)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.83 E-value=7.1e-06 Score=80.08 Aligned_cols=72 Identities=21% Similarity=0.323 Sum_probs=34.0
Q ss_pred cEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 413 RIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
+++.|+|++|+++ .++ .+..|++|++|+|++|++++ +|. +++|++|+.|++++|.+. .+| .+..++.|+.|+
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 4445555555554 332 34455555555555555553 222 455555555555555544 233 244444444433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.83 E-value=4.6e-07 Score=88.92 Aligned_cols=79 Identities=18% Similarity=0.191 Sum_probs=61.3
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
..+++.|+|++|+|+ .++ .|.+|++|+.|+|++|+|+ .||.....+++|+.|+|++|+++ .+ +.+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CH-HHHHHHHHSSEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cc-ccccccccccccc
Confidence 457888888888888 665 5888888899999888887 77876667778888888888887 34 3477777787776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.|
T Consensus 122 L~~N 125 (198)
T d1m9la_ 122 MSNN 125 (198)
T ss_dssp ESEE
T ss_pred cccc
Confidence 6543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=97.82 E-value=6.3e-06 Score=88.24 Aligned_cols=76 Identities=20% Similarity=0.281 Sum_probs=60.8
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
.+|+.|+|++|+|+ .+ +.|..|++|++|||++|+|+ .+|. +++|++|+.|+|++|++++. + .+..+++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccc-c-ccccccccccccc
Confidence 46889999999988 45 46888999999999999999 4554 88999999999999999853 3 3777888877765
Q ss_pred cc
Q 043526 492 SV 493 (858)
Q Consensus 492 ~~ 493 (858)
+.
T Consensus 118 ~~ 119 (384)
T d2omza2 118 FN 119 (384)
T ss_dssp CS
T ss_pred cc
Confidence 43
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.80 E-value=7.9e-06 Score=80.48 Aligned_cols=58 Identities=31% Similarity=0.421 Sum_probs=28.3
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
++|+.|+|++|+|++ ++ .+++|++|+.|+|++|+++ .+|. +..+++|+.|++++|.+.
T Consensus 68 ~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~~-l~~l~~L~~L~l~~~~~~ 125 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125 (210)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGGG-GTTCTTCCEEECTTSCCC
T ss_pred CCCCEEeCCCccccC-cc-ccccCcccccccccccccc-cccc-cccccccccccccccccc
Confidence 345555555555553 22 2445555555555555555 2442 444555555555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.78 E-value=7.1e-06 Score=80.84 Aligned_cols=76 Identities=29% Similarity=0.367 Sum_probs=63.6
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.+.++.+++++|.+++ +..+.+|++|+.|++++|++++ +++ +++|++|+.|+|++|+++ .+| .+..+++|+.|+
T Consensus 133 l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~ 206 (210)
T d1h6ta2 133 LPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLE 206 (210)
T ss_dssp CTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEE
T ss_pred cccccccccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEE
Confidence 3578899999999984 3467889999999999999995 554 889999999999999998 566 588888888887
Q ss_pred cc
Q 043526 491 LS 492 (858)
Q Consensus 491 l~ 492 (858)
++
T Consensus 207 Ls 208 (210)
T d1h6ta2 207 LF 208 (210)
T ss_dssp EE
T ss_pred cc
Confidence 64
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.75 E-value=5.8e-07 Score=88.18 Aligned_cols=80 Identities=24% Similarity=0.235 Sum_probs=66.5
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCC--hhhhccCcCCCc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIP--VELMEKSKNGSL 489 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP--~~~~~~~~l~~l 489 (858)
++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|+++ .++ .+..+++|+.|+|++|+++ .++ ..+..+++|+.|
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 145 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDL 145 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEE
T ss_pred ccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhc-cccccccccCCCcccee
Confidence 57999999999998 78887788889999999999999 565 4889999999999999998 454 367788888866
Q ss_pred cccccCcc
Q 043526 490 QLSVGDNE 497 (858)
Q Consensus 490 ~l~~~~n~ 497 (858)
++ .+|+
T Consensus 146 ~L--~~N~ 151 (198)
T d1m9la_ 146 LL--AGNP 151 (198)
T ss_dssp EE--CSSH
T ss_pred ec--CCCc
Confidence 55 4554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=5.1e-06 Score=78.46 Aligned_cols=65 Identities=28% Similarity=0.323 Sum_probs=34.4
Q ss_pred CcEEEEEecCCCCccc--ccchhccccccccccCCCCCCccCCCc-ccccccccceeeccCCcCcCCCC
Q 043526 412 PRIISLNLSSSGLTGE--IAPYLSNLTLIQSLDLSNNSLSGNVPE-FLSRLQFLRVLNLKGNKFTGPIP 477 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~--ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~g~iP 477 (858)
++++.|+|++|+|+.. ++..+..|++|+.|||++|+++ .+++ ......+|+.|+|++|.+++...
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 3556666666666532 2334555666666666666666 3433 12223345666666666654443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=8.2e-05 Score=74.74 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=53.6
Q ss_pred ccccCc-eEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccc--ceeeeeeeeeeeCCeeEEEEeeccCCChH
Q 043526 579 LGKGGF-GTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHH--RNLTNLVGYFIEDNNMGLIYEYMANGNLK 655 (858)
Q Consensus 579 LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~~gsL~ 655 (858)
+..|.. +.||+...++|..+.+|.-.... ...+..|++.++.+.. -.+.++++++.+++..++|||+++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 445543 68999998888889999865443 3456778888877743 23456777778888899999999986553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=97.62 E-value=1.9e-05 Score=76.94 Aligned_cols=78 Identities=28% Similarity=0.360 Sum_probs=62.8
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCcc
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQ 490 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~ 490 (858)
.++++.|+|++|+|++. ++ +++|++|+.|++++|.+. .+|. ++++++|+.|++++|.+... ..+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCc-cc-ccCCcccccccccccccc-cccc-cccccccccccccccccccc--cccchhhhhHHhh
Confidence 46899999999999954 43 899999999999999988 5664 88999999999999988743 3477788888776
Q ss_pred cccc
Q 043526 491 LSVG 494 (858)
Q Consensus 491 l~~~ 494 (858)
++.+
T Consensus 135 l~~n 138 (199)
T d2omxa2 135 LSSN 138 (199)
T ss_dssp CCSS
T ss_pred hhhh
Confidence 6543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.44 E-value=4.6e-05 Score=79.94 Aligned_cols=75 Identities=25% Similarity=0.359 Sum_probs=55.0
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCc
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSL 489 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l 489 (858)
.+++++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .|+.- .+.|++|+|++|+++ .+|. ++.+++|+.|
T Consensus 56 ~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L 125 (353)
T d1jl5a_ 56 LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKII 125 (353)
T ss_dssp CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEE
T ss_pred CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceee
Confidence 3567888888888888 788664 46777788888887 55542 146888999999988 6774 5677888877
Q ss_pred ccccc
Q 043526 490 QLSVG 494 (858)
Q Consensus 490 ~l~~~ 494 (858)
+++.+
T Consensus 126 ~l~~~ 130 (353)
T d1jl5a_ 126 DVDNN 130 (353)
T ss_dssp ECCSS
T ss_pred ccccc
Confidence 76544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.43 E-value=3.7e-05 Score=80.75 Aligned_cols=66 Identities=29% Similarity=0.340 Sum_probs=53.9
Q ss_pred CCCcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccC
Q 043526 410 DPPRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKS 484 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~ 484 (858)
.+++++.|+|++|+|+ .+|.. +++|+.|+|++|+|+ .||.. +++|+.|+|++|+|+ .+|.....+.
T Consensus 282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~ 347 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVE 347 (353)
T ss_dssp CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCC
T ss_pred cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccC
Confidence 4578999999999999 78864 578889999999999 88874 568999999999998 7776444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=97.33 E-value=8.5e-05 Score=73.51 Aligned_cols=77 Identities=23% Similarity=0.352 Sum_probs=62.3
Q ss_pred CcEEEEEecCCCCcccccchhccccccccccCCCCCCccCCCcccccccccceeeccCCcCcCCCChhhhccCcCCCccc
Q 043526 412 PRIISLNLSSSGLTGEIAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGNKFTGPIPVELMEKSKNGSLQL 491 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N~l~g~iP~~~~~~~~l~~l~l 491 (858)
.+|+.|+|.+|+|+ .++ .|.+|++|+.|+|++|++++..| +..+++|+.|++++|.++ .++ .+..+++|+.+.+
T Consensus 41 ~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 46889999999998 564 68999999999999999995443 889999999999999987 555 4777777776665
Q ss_pred ccc
Q 043526 492 SVG 494 (858)
Q Consensus 492 ~~~ 494 (858)
+.+
T Consensus 115 ~~~ 117 (227)
T d1h6ua2 115 TST 117 (227)
T ss_dssp TTS
T ss_pred ccc
Confidence 443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.04 E-value=0.0016 Score=69.73 Aligned_cols=75 Identities=15% Similarity=0.187 Sum_probs=47.8
Q ss_pred ccccccCceEEEEEEEC-CCCEEEEEEeccC-------CCcchHhHHHHHHHHHhcc-c-ce-eeeeeeeeeeCCeeEEE
Q 043526 577 KVLGKGGFGTVYHGYLD-DGTQVAVKMLSSS-------SGQGFKEFEAEVKLLMRVH-H-RN-LTNLVGYFIEDNNMGLI 645 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-------~~~~~~~~~~E~~~l~~l~-H-pn-Iv~l~~~~~~~~~~~lV 645 (858)
+.||.|....||+.... +|+.++||.-... ......+...|.+.|+.+. + |. +.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 46899999999999865 4678999964321 1223345566888887663 2 33 334443 355567899
Q ss_pred EeeccCCC
Q 043526 646 YEYMANGN 653 (858)
Q Consensus 646 ~Ey~~~gs 653 (858)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.95 E-value=0.00013 Score=68.41 Aligned_cols=69 Identities=25% Similarity=0.290 Sum_probs=50.6
Q ss_pred cccchhccccccccccCCCCCCccC--CCcccccccccceeeccCCcCcCCCCh-hhhccCcCCCccccccCccc
Q 043526 427 EIAPYLSNLTLIQSLDLSNNSLSGN--VPEFLSRLQFLRVLNLKGNKFTGPIPV-ELMEKSKNGSLQLSVGDNEE 498 (858)
Q Consensus 427 ~ip~~~~~l~~L~~L~Ls~N~l~g~--iP~~l~~l~~L~~L~L~~N~l~g~iP~-~~~~~~~l~~l~l~~~~n~~ 498 (858)
.++....+++.|++|+|++|+|+.. ++..+..+++|+.|+|++|+++ .+++ ......+++. +.+.||+-
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~--L~L~~Npl 127 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEE--LWLDGNSL 127 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSS--CCCTTSTT
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccce--eecCCCCc
Confidence 5566667899999999999999942 3456788999999999999998 5554 2233334554 45567764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.90 E-value=0.00034 Score=69.47 Aligned_cols=78 Identities=21% Similarity=0.226 Sum_probs=60.6
Q ss_pred CCcEEEEEecCCCCcccccchhccccccccc-cCCCCCCccCCCc-ccccccccceeeccCCcCcCCCCh-hhhccCcCC
Q 043526 411 PPRIISLNLSSSGLTGEIAPYLSNLTLIQSL-DLSNNSLSGNVPE-FLSRLQFLRVLNLKGNKFTGPIPV-ELMEKSKNG 487 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L-~Ls~N~l~g~iP~-~l~~l~~L~~L~L~~N~l~g~iP~-~~~~~~~l~ 487 (858)
+..++.|++++|+++ .++..+.+.++++.+ ++++|+|+ .||. .|.++++|+.|+|++|+|+ .+|. .+.++.+|+
T Consensus 152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 152 SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLR 228 (242)
T ss_dssp BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEE
T ss_pred cccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccc
Confidence 457889999999999 666666666665555 67888999 6765 5789999999999999999 5554 577777776
Q ss_pred Cccc
Q 043526 488 SLQL 491 (858)
Q Consensus 488 ~l~l 491 (858)
.+++
T Consensus 229 ~l~~ 232 (242)
T d1xwdc1 229 ARST 232 (242)
T ss_dssp SSSE
T ss_pred cCcC
Confidence 6543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.0067 Score=62.90 Aligned_cols=134 Identities=11% Similarity=0.127 Sum_probs=78.5
Q ss_pred eEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhccccee--eeee-----eeeeeCCeeEEEEeeccCCChH--
Q 043526 585 GTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNL--TNLV-----GYFIEDNNMGLIYEYMANGNLK-- 655 (858)
Q Consensus 585 G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~-- 655 (858)
-.||+...++|+.+++|+.+.. ....+++..|...+..+....+ +..+ .....++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998654 2345778889988888753322 1111 1234456678899999874321
Q ss_pred ---H---------Hhhhc----c---cCchhHH-------------------HHHHHHHHHHHHHHHhh----cCCCCCe
Q 043526 656 ---Q---------LLSDE----K---ASTLSWE-------------------RRLQIAMDAAQGLEYLH----IGCKPPI 693 (858)
Q Consensus 656 ---~---------~L~~~----~---~~~l~~~-------------------~~~~i~~~ia~aL~yLH----~~~~~~I 693 (858)
. .+|.. . ...+++. .+..+...+.+.++.+. .....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 11110 0 0111111 11112222222333332 2234578
Q ss_pred EecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 694 VHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 694 vH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
+|+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45889997764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.47 E-value=0.00014 Score=74.67 Aligned_cols=84 Identities=29% Similarity=0.297 Sum_probs=66.9
Q ss_pred CCCcEEEEEecCCCCccc-ccchhccccccccccCCCCCCccCCCcccccccccceeeccCC-cCcCC-CChhhhccCcC
Q 043526 410 DPPRIISLNLSSSGLTGE-IAPYLSNLTLIQSLDLSNNSLSGNVPEFLSRLQFLRVLNLKGN-KFTGP-IPVELMEKSKN 486 (858)
Q Consensus 410 ~~~~l~~L~L~~n~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L~~N-~l~g~-iP~~~~~~~~l 486 (858)
.+.+++.|+|+++.+++. ++..+.++++|++|+|+++++++..+..++++++|+.|+|+++ .++.. +..-...+++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 346899999999998865 4566789999999999999999999999999999999999994 55521 22223467888
Q ss_pred CCccccc
Q 043526 487 GSLQLSV 493 (858)
Q Consensus 487 ~~l~l~~ 493 (858)
+.|+++.
T Consensus 124 ~~L~ls~ 130 (284)
T d2astb2 124 DELNLSW 130 (284)
T ss_dssp CEEECCC
T ss_pred ccccccc
Confidence 8887754
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.12 E-value=0.00035 Score=75.54 Aligned_cols=79 Identities=24% Similarity=0.262 Sum_probs=36.7
Q ss_pred cEEEEEecCCCCc----ccccchhccccccccccCCCCCCccC----CCcccc-cccccceeeccCCcCcCC----CChh
Q 043526 413 RIISLNLSSSGLT----GEIAPYLSNLTLIQSLDLSNNSLSGN----VPEFLS-RLQFLRVLNLKGNKFTGP----IPVE 479 (858)
Q Consensus 413 ~l~~L~L~~n~l~----g~ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~-~l~~L~~L~L~~N~l~g~----iP~~ 479 (858)
+++.|+|++|+|+ ..|+..+..+++|+.|||++|+|+.. +...+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 3445555555555 13344445555566666666655310 111111 123456666666655432 2333
Q ss_pred hhccCcCCCccc
Q 043526 480 LMEKSKNGSLQL 491 (858)
Q Consensus 480 ~~~~~~l~~l~l 491 (858)
+..+++|+.|++
T Consensus 108 l~~~~~L~~L~L 119 (460)
T d1z7xw1 108 LRTLPTLQELHL 119 (460)
T ss_dssp TTSCTTCCEEEC
T ss_pred hhcccccccccc
Confidence 444455554444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.04 E-value=0.00036 Score=75.44 Aligned_cols=64 Identities=20% Similarity=0.248 Sum_probs=44.8
Q ss_pred CcEEEEEecCCCCccc----ccchhc-cccccccccCCCCCCcc----CCCcccccccccceeeccCCcCcCC
Q 043526 412 PRIISLNLSSSGLTGE----IAPYLS-NLTLIQSLDLSNNSLSG----NVPEFLSRLQFLRVLNLKGNKFTGP 475 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~----ip~~~~-~l~~L~~L~Ls~N~l~g----~iP~~l~~l~~L~~L~L~~N~l~g~ 475 (858)
++|+.|+|++|+|+.. ++..+. ..+.|+.|+|++|+|+. .|++.+..+++|+.|||++|+|+..
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 3577888888888643 444444 35678888888888863 2556666778888888888887743
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.97 E-value=0.0017 Score=66.17 Aligned_cols=58 Identities=24% Similarity=0.280 Sum_probs=29.5
Q ss_pred cEEEEEecCC-CCcccccchhccccccccccCCC-CCCccCCCcccccccccceeeccCC
Q 043526 413 RIISLNLSSS-GLTGEIAPYLSNLTLIQSLDLSN-NSLSGNVPEFLSRLQFLRVLNLKGN 470 (858)
Q Consensus 413 ~l~~L~L~~n-~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~L~~N 470 (858)
+++.|+|++| .+++.....++++++|++|+|++ +++++.-...++++++|+.|+++++
T Consensus 176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 4555555543 34544555555555555555555 3444444444555555555555544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.66 E-value=0.034 Score=56.76 Aligned_cols=156 Identities=10% Similarity=0.073 Sum_probs=82.6
Q ss_pred cCHHHHHHHHhhcc-------ccccccCceEEEEEEECCCCEEEEEEeccCCCcchHhHHHHHHHHHhcccceee--eee
Q 043526 563 FTYSEVLKITDNFN-------KVLGKGGFGTVYHGYLDDGTQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT--NLV 633 (858)
Q Consensus 563 ~~~~el~~~t~~f~-------~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv--~l~ 633 (858)
++-+|+.....++. +.|..|---+.|+.+.++|+ +++|++.... ..++...|++++..+...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 44556666555442 23455666778999887765 8999986542 234555667777777533221 111
Q ss_pred e------eeeeCCeeEEEEeeccCCChHH--------------Hhhhcc---------cCchh----------------H
Q 043526 634 G------YFIEDNNMGLIYEYMANGNLKQ--------------LLSDEK---------ASTLS----------------W 668 (858)
Q Consensus 634 ~------~~~~~~~~~lV~Ey~~~gsL~~--------------~L~~~~---------~~~l~----------------~ 668 (858)
. +.........++.++.+..... .++... ..... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1223445666777776642211 011000 00000 0
Q ss_pred HHHHHHHHHHHHHHHHhh-cCCCCCeEecCCCCcceEEcCCCCEEEeeecCccc
Q 043526 669 ERRLQIAMDAAQGLEYLH-IGCKPPIVHRDIKPENILLTENLEAKLADFGLSKV 721 (858)
Q Consensus 669 ~~~~~i~~~ia~aL~yLH-~~~~~~IvH~DLk~~NILl~~~~~~kL~DFGla~~ 721 (858)
......+..+...+.-.+ .....+++|+|+.++||+++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222233333333333 22356899999999999999987778999997753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.35 E-value=0.0013 Score=68.92 Aligned_cols=64 Identities=19% Similarity=0.248 Sum_probs=45.8
Q ss_pred CcEEEEEecCCCCccc-----ccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCcCcCC
Q 043526 412 PRIISLNLSSSGLTGE-----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFTGP 475 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~-----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g~ 475 (858)
..++.|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|++++.
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 3577888888887632 345567778888888888887532 445567778888888888887744
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.21 E-value=0.037 Score=58.71 Aligned_cols=72 Identities=19% Similarity=0.288 Sum_probs=48.9
Q ss_pred ccccccCceEEEEEEECCC--------CEEEEEEeccCCCcchHhHHHHHHHHHhcccceee-eeeeeeeeCCeeEEEEe
Q 043526 577 KVLGKGGFGTVYHGYLDDG--------TQVAVKMLSSSSGQGFKEFEAEVKLLMRVHHRNLT-NLVGYFIEDNNMGLIYE 647 (858)
Q Consensus 577 ~~LG~G~fG~Vy~~~~~~g--------~~vAVK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E 647 (858)
+.|+.|-.-.+|+....++ +.|.+++... . .......+|.++++.+.-.++. ++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577888889999987543 4577777653 2 2334567888888888644554 56666532 68999
Q ss_pred eccCCCh
Q 043526 648 YMANGNL 654 (858)
Q Consensus 648 y~~~gsL 654 (858)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=94.68 E-value=0.0037 Score=58.30 Aligned_cols=61 Identities=10% Similarity=0.169 Sum_probs=27.6
Q ss_pred cEEEEEecCCCCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCcCc
Q 043526 413 RIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFT 473 (858)
Q Consensus 413 ~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~ 473 (858)
.|+.|+|++|.|... +...+...+.|+.|+|++|.++.. +=..+...+.|+.|+|++|.+.
T Consensus 45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 355555555555422 222333445555555555555432 1112333445555555555443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=94.48 E-value=0.0034 Score=65.54 Aligned_cols=83 Identities=24% Similarity=0.297 Sum_probs=63.4
Q ss_pred CCcEEEEEecCCCCcc----cccchhccccccccccCCCCCCccC-----CCcccccccccceeeccCCcCcCC----CC
Q 043526 411 PPRIISLNLSSSGLTG----EIAPYLSNLTLIQSLDLSNNSLSGN-----VPEFLSRLQFLRVLNLKGNKFTGP----IP 477 (858)
Q Consensus 411 ~~~l~~L~L~~n~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~-----iP~~l~~l~~L~~L~L~~N~l~g~----iP 477 (858)
.+.++.|++++|.++. .+...+..++.|+.|+|++|+++.. +...+..+++|+.|+|++|+++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 3578899999999873 3555677889999999999998742 445578899999999999998633 44
Q ss_pred hhhhccCcCCCccccc
Q 043526 478 VELMEKSKNGSLQLSV 493 (858)
Q Consensus 478 ~~~~~~~~l~~l~l~~ 493 (858)
..+...++|+.|+++.
T Consensus 237 ~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 237 IALKSWPNLRELGLND 252 (344)
T ss_dssp HHGGGCTTCCEEECTT
T ss_pred ccccccccchhhhhhc
Confidence 5566777888776643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=94.22 E-value=0.0054 Score=57.09 Aligned_cols=82 Identities=18% Similarity=0.249 Sum_probs=58.0
Q ss_pred CCcEEEEEecCC-CCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCcCcCCCC----
Q 043526 411 PPRIISLNLSSS-GLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFTGPIP---- 477 (858)
Q Consensus 411 ~~~l~~L~L~~n-~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g~iP---- 477 (858)
.++++.|+|+++ .++.. +-..+...+.|+.|+|++|.+... +-..+...+.|+.|+|++|.++..--
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 368999999974 56542 444677789999999999999742 33445667899999999999884321
Q ss_pred hhhhccCcCCCcccc
Q 043526 478 VELMEKSKNGSLQLS 492 (858)
Q Consensus 478 ~~~~~~~~l~~l~l~ 492 (858)
..+...+.|+.|+++
T Consensus 94 ~aL~~n~sL~~L~l~ 108 (167)
T d1pgva_ 94 RSTLVTQSIVEFKAD 108 (167)
T ss_dssp HHTTTTCCCSEEECC
T ss_pred HHHHhCCcCCEEECC
Confidence 233444566666654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.88 E-value=0.016 Score=53.53 Aligned_cols=85 Identities=18% Similarity=0.251 Sum_probs=52.2
Q ss_pred CcEEEEEecC-CCCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeeccCCcCcCC----CCh
Q 043526 412 PRIISLNLSS-SGLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNLKGNKFTGP----IPV 478 (858)
Q Consensus 412 ~~l~~L~L~~-n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L~~N~l~g~----iP~ 478 (858)
+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++.. |-..+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5778888887 456532 334455678888888888887643 223355567888888888887632 223
Q ss_pred hhhccCcCCCccccccCc
Q 043526 479 ELMEKSKNGSLQLSVGDN 496 (858)
Q Consensus 479 ~~~~~~~l~~l~l~~~~n 496 (858)
.+...+.++.++++..+|
T Consensus 97 ~l~~~~~L~~l~L~l~~n 114 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQ 114 (166)
T ss_dssp GGGGCSSCCEEECCCCSS
T ss_pred HHHhCccccEEeeccCCC
Confidence 444555555555554443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.91 E-value=0.023 Score=52.41 Aligned_cols=83 Identities=16% Similarity=0.171 Sum_probs=60.3
Q ss_pred CcEEEEEecCCCCccc----ccchhccccccccccCCCCCCccC----CCcccccccccceeec--cCCcCcC----CCC
Q 043526 412 PRIISLNLSSSGLTGE----IAPYLSNLTLIQSLDLSNNSLSGN----VPEFLSRLQFLRVLNL--KGNKFTG----PIP 477 (858)
Q Consensus 412 ~~l~~L~L~~n~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~L--~~N~l~g----~iP 477 (858)
++|+.|+|++|.++.. |-..+...++|+.|++++|.++.. +-..+...++|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 5789999999999754 334566789999999999998743 3355777888987555 5677752 244
Q ss_pred hhhhccCcCCCcccccc
Q 043526 478 VELMEKSKNGSLQLSVG 494 (858)
Q Consensus 478 ~~~~~~~~l~~l~l~~~ 494 (858)
..+...+.|..|+++++
T Consensus 126 ~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHCSSCCEEECCCS
T ss_pred HHHHhCCCcCEEeCcCC
Confidence 45566777887777654
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=80.95 E-value=13 Score=32.28 Aligned_cols=81 Identities=11% Similarity=0.131 Sum_probs=53.0
Q ss_pred CCCceeeeCCCCCCCceEEEEEEeeeccCCCCCCCCeeeEEeccee-EEEEecCCccccceeEEEEecCCCeeEEEEeec
Q 043526 90 GMRNCYTLNPTEGKGSKYSIRASFMYGNYDAANKPPQFDLYLGVNL-WDSIKLDNATAMEMKEIIHIPTENHVLICLVNT 168 (858)
Q Consensus 90 ~~~ncy~l~~~~~~~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~-w~~v~~~~~~~~~~~e~i~~~~~~~~~vcl~~~ 168 (858)
+...-|.+++ ++|.|-|++.+. + .-..++.+.|-. ..+. .....-....+-+.++.+.+=|...
T Consensus 62 ~~~~~f~v~v---PnG~Y~Vtv~~G--d------~~~~~~~~eg~~~~~~~----~g~~~~~~~~V~VtDG~L~l~ft~~ 126 (146)
T d2o14a1 62 KSNNTFNVDL---PNGLYEVKVTLG--N------TARASVAAEGVFQVINM----TGDGAEDTFQIPVTDGQLNLLVTEG 126 (146)
T ss_dssp TCSCCEEEEC---CSEEEEEEEEES--S------CSEEEEEETTEEEEEEE----ESTTCEEEEEEEECSSEEEEEEEES
T ss_pred CCCceEEEEC---CCCeEEEEEEEe--c------CCCccEEEeeEEecccc----CCccEEEEEEEEEECCeEEEEEecC
Confidence 3445687754 799999999875 2 223466666643 1111 1111234567778899999988655
Q ss_pred CCC-CceeeeEEeeeccC
Q 043526 169 GLG-TPFISALELRLLRN 185 (858)
Q Consensus 169 ~~~-~pfis~lEl~~l~~ 185 (858)
..| .|-||+||+.++.+
T Consensus 127 ~~G~~~~in~l~I~~~~d 144 (146)
T d2o14a1 127 KAGTAFTLSALKIKKLSD 144 (146)
T ss_dssp STTSCCEEEEEEEEEEES
T ss_pred CCCCccEEEEEEEEeccc
Confidence 555 59999999998754
|